Citrus Sinensis ID: 003843
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 792 | 2.2.26 [Sep-21-2011] | |||||||
| O81905 | 850 | Receptor-like serine/thre | yes | no | 0.955 | 0.890 | 0.437 | 1e-179 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.948 | 0.886 | 0.431 | 1e-179 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.944 | 0.897 | 0.414 | 1e-177 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.958 | 0.900 | 0.422 | 1e-175 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.948 | 0.888 | 0.408 | 1e-169 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.926 | 0.864 | 0.411 | 1e-167 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.917 | 0.928 | 0.395 | 1e-162 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.969 | 0.896 | 0.397 | 1e-162 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.955 | 0.887 | 0.406 | 1e-160 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.954 | 0.897 | 0.391 | 1e-157 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 629 bits (1622), Expect = e-179, Method: Compositional matrix adjust.
Identities = 367/839 (43%), Positives = 512/839 (61%), Gaps = 82/839 (9%)
Query: 22 SLAADTVTPAS--FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVAN 78
S++A+T++ + I +VS FELGFF PG YLGI ++ I VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNP-VAQLRDDGNLVIRDNS 136
RD P+S + L IS++ NLV+L+Q++ +WSTN++ +V++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLYK----- 190
+A + LWQSFD+PTDTLL +MKLGWD K R++ SW+S DDPS DF +K
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 191 ---------------------------------QFMMEN----KDECVYWYEAYNRPSIM 213
++M+ N K+E Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 273
L ++ SG + R W E + W++ + P C +Y CG C + P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 274 LES-QV--NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 330
+ QV + G C R L C GD F+ L ++K PD S+++ + +++C+ +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 331 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 387
++C+C A+AN++++ S SGC+ W G+L D IRN+ GQ +Y+R+ A+ L +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 388 ILVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETY---QDLLAFDINMN---ITTR 438
+I + + V+LL SF +F+ +RK +K + +ET L + D+ MN I++R
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRK--QKRSILIETPIVDHQLRSRDLLMNEVVISSR 497
Query: 439 TNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV 498
+ E N D D LPL + AT NFS KLG+GGFG VYKG+LL+GQE+
Sbjct: 498 RHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEM 551
Query: 499 AVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 558
AVKRLS S QG EFKNE+ LIA+LQH NLVRLL CCV+ GEK+LI EY+ N SL+ L
Sbjct: 552 AVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHL 611
Query: 559 FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618
FD ++ LNWQ R II GIA+GLLYLHQ SRFRIIHRDLKASNILLDK M PKISDFG
Sbjct: 612 FDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFG 671
Query: 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVY 678
+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SSK+N G Y
Sbjct: 672 MARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFY 731
Query: 679 NAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM--LMRYINVALLCVQENAADRP 735
N+D NLLG W WK+ + ++IDP+I + ++R I + LLCVQE A DRP
Sbjct: 732 NSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRP 791
Query: 736 TMSDVISMINNEHLNLPSPKEPAF--TKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
TMS VI M+ +E +P PK P + + + +SS S E +VN +TVS++ R
Sbjct: 792 TMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 628 bits (1619), Expect = e-179, Method: Compositional matrix adjust.
Identities = 359/832 (43%), Positives = 500/832 (60%), Gaps = 81/832 (9%)
Query: 27 TVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRDRPISD 85
+ T + I + ++S SQ FELGFF+P S YLGI ++ IP VWVANRD P+S
Sbjct: 31 SATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSS 90
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRDNSSGNATES 143
+N L IS+N NLV+ +Q++ +WSTN++ +V++PVA +L D GN V+RD S N
Sbjct: 91 SNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRD-SKNNKPSG 148
Query: 144 YLWQSFDYPTDTLLQDMKLGWDFKNR-LERYLSSWRSADDPS-------------PDF-- 187
+LWQSFD+PTDTLL DMK+GWD K+ R L SW++ DDPS P+F
Sbjct: 149 FLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYI 208
Query: 188 -------------LYKQF---------------MMENKDECVYWYEAYNRPSIMTLKLNP 219
L +F EN + VY Y L L+
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSS 268
Query: 220 SGFVTRQIWNENSNKWDELFSVP----DQY--CGKYGYCGANTICSLDQKPMCECLEGFK 273
+G + R W E + W +L+ P D Y CG YGYC ANT P+C C++GF+
Sbjct: 269 TGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT------SPICNCIKGFE 322
Query: 274 L--ESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 331
E + + C R L C D F+ L +++ PD + S+++ + L++C+ CLK
Sbjct: 323 PMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLK 382
Query: 332 NCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLWI 388
C+C A+AN++++ SGC++W G L D IRN+ GQ +Y+RV A L +K++
Sbjct: 383 GCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSK 438
Query: 389 LVI---LVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEA 445
+I + + ++LL SF +F+ +RK + T + + D MN + + +
Sbjct: 439 KIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTS 498
Query: 446 NGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN 505
+ D + LPL ++ AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS
Sbjct: 499 KENKTDYLE---LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSK 555
Query: 506 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 565
S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ LFD T+
Sbjct: 556 MSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSS 615
Query: 566 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG+AR+FG
Sbjct: 616 NLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGR 675
Query: 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFN 684
+E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G YN++ N
Sbjct: 676 EETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLN 735
Query: 685 LLGHAWDLWKDDRVHDLIDPV---IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741
LLG W WK+ + +++DP+ + E ++R I + LLCVQE A DRP MS V+
Sbjct: 736 LLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVM 795
Query: 742 SMINNEHLNLPSPKEPAFTKG-INVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
M+ +E +P PK P F G +++ S S++ + C+VN VT+S+I R
Sbjct: 796 VMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 622 bits (1603), Expect = e-177, Method: Compositional matrix adjust.
Identities = 348/839 (41%), Positives = 492/839 (58%), Gaps = 91/839 (10%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDR 81
++ DT+ +RDGE ++S+ +RF GFFS G S+ RY+GI + QI +VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISDNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSS 137
PI+D + ++ SN GNL + N T IWSTNVS + P VA L D GNLV+ D +
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVT 136
Query: 138 GNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------------- 184
G + W+SFD+PTDT L M+LG+ K+ L+R L+SW+S DP
Sbjct: 137 GRS----FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 185 --------------------------PD----FLYKQFMMENKDECVYWYEAYNRPSIMT 214
P+ +++ + N+DE + Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 215 LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPM--CECLEGF 272
+N +G + R W +W++ +SVP + C Y +CG N C C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 273 KLES------QVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCK 326
+ + + + G K +R+ C D F++L +K PD D S++ + L++CK
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASI--CSEKDGFVKLKRMKIPDTSDASVDMNITLKECK 370
Query: 327 AECLKNCSCRAYANS---NVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 380
CLKNCSC AYA++ + + + GCL W+G ++DAR + +GQ Y+RV +L
Sbjct: 371 QRCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARW 428
Query: 381 ------GNKKLLWILVILVIPVVLLPS-FYVFYRRRRKCQEKETENVETYQDLLAFDINM 433
G +++L IL+ L+ V+LL + R RRK + + FD +
Sbjct: 429 NRNGLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESF 488
Query: 434 NITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL 493
+DK+++ LPLF L +I AAT NFS Q KLG GGFGPVYKG L
Sbjct: 489 RFE-------------QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQ 535
Query: 494 NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 553
N E+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKS
Sbjct: 536 NRMEIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKS 595
Query: 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613
L+ F+F ++ L+W R+ I+ GIA+G+LYLHQ SR RIIHRDLKASNILLD +M PK
Sbjct: 596 LDYFIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPK 655
Query: 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
ISDFG+AR+FGG++++G T ++VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++ KK
Sbjct: 656 ISDFGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKK 715
Query: 674 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD 733
N+ ++ +S NL+GH WDLW++ ++ID ++ Q+ +M+ I + LLCVQENA+D
Sbjct: 716 NS-AFHEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASD 774
Query: 734 RPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
R MS V+ M+ + NLP+PK PAFT + + SVNDVT S I R
Sbjct: 775 RVDMSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1585), Expect = e-175, Method: Compositional matrix adjust.
Identities = 354/838 (42%), Positives = 506/838 (60%), Gaps = 79/838 (9%)
Query: 18 SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
+ VS + T + I + ++S SQ FELGFF+P S YLGI ++ IP VWV
Sbjct: 22 AFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWV 81
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSS-EVKNPVA-QLRDDGNLVIRD 134
ANRD P+S +N L IS N NLV+ +Q++ +WSTN++ +V++PVA +L D+GN ++RD
Sbjct: 82 ANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRD 140
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS---------- 184
+++ LWQSFD+PTDTLL +MKLGWD K R L SW++ DDPS
Sbjct: 141 SNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLET 195
Query: 185 ---PDF--------LYKQ------------------FMMEN----KDECVYWYEAYNRPS 211
P+F LY+ +M+ N K+E Y Y
Sbjct: 196 SEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNL 255
Query: 212 IMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEG 271
L LN +G + R W E + W +L+ P C Y CG C + P C C++G
Sbjct: 256 YSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKG 315
Query: 272 FKLESQVN---QPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAE 328
FK ++ + G C R L C D F L +K PD +++ + L+ CK
Sbjct: 316 FKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKER 375
Query: 329 CLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLW 387
CL++C+C A+AN++++ SGC++W +++D R + GQ +Y+R+ A++L +K++
Sbjct: 376 CLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYVRLAAAELEDKRIKN 433
Query: 388 ILVI---LVIPVVLLPSFYVFY---RRRRKCQEKETENVETY--QDLLAFDINMNITTRT 439
+I + + ++LL SF +F+ R++++ +T NV+ QD L D+ ++ T
Sbjct: 434 EKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYT 493
Query: 440 NEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 499
++ + KS+ LPL L ++ AT NFS KLG+GGFG VYKGRLL+G+E+A
Sbjct: 494 SK--------EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIA 545
Query: 500 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 559
VKRLS S QG EF NE+ LIAKLQH NLVRLLGCCV++GEK+LI EY+ N SL+ LF
Sbjct: 546 VKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLF 605
Query: 560 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
D T+ LNWQ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M PKISDFG+
Sbjct: 606 DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGM 665
Query: 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679
AR+FG +E + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S K+N G YN
Sbjct: 666 ARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYN 725
Query: 680 AD-SFNLLGHAWDLWKDDRVHDLIDPV---IMQDEISLPMLMRYINVALLCVQENAADRP 735
++ NLLG W WK+ +++DP+ + + ++R I + LLCVQE A DRP
Sbjct: 726 SNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRP 785
Query: 736 TMSDVISMINNEHLNLPSPKEPAFTKGIN-VKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
MS V+ M+ +E +P PK P F G + ++ S S++ + C+VN +T+S+I R
Sbjct: 786 VMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 595 bits (1535), Expect = e-169, Method: Compositional matrix adjust.
Identities = 343/839 (40%), Positives = 502/839 (59%), Gaps = 88/839 (10%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GI + Q+ + +VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 DNNAVLTISNNGNLVLLNQTNGT--IWSTNVSSEVKNP--VAQLRDDGNLVIRDNSSGNA 140
D + ++ S GNL + NGT IWST+V ++ P VA+L D GNLV+ D +G +
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 141 TESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDP-SPDFLYK-------QF 192
W+SF++PT+TLL MK G+ ++ ++R ++SWRS DP S + Y+ Q
Sbjct: 143 ----FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 193 MM-----------------------------------ENKDECVYWYEAYNRPSIMTLKL 217
MM N DE Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 218 NPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTIC--SLDQKPMCECLEGFKLE 275
N +G + R WN KW +S P+ C Y +CG N C + +K C CL G++ +
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 276 SQVN---QPGPIKCERSHSLE-CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 331
+ + + C R + C + F +L +K P+ V+++ + L++C+ CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 332 NCSCRAYANSNVKE---SSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL-------- 380
NCSC AYA++ + + GCL W+G+++D R + +GQ YLRV S+L
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 381 -GNKKLLWILVILV-IPVVLLPSFYVFYRRRR-KCQEKETENVETYQDLLAFDINMNITT 437
G K+L+ IL+ L+ + ++LL SF+ + R+RR + Q + +FD+ +
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 438 RTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 497
E DKS+ LPLF L++I AT NF+ Q KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 498 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 557
+AVKRLS SGQG++EFKNE+ LI+KLQHRNLVR+LGCCVE EK+L+ EY+PNKSL+ F
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 558 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617
+F ++ L+W R+ II GI +G+LYLHQ SR RIIHRDLKASN+LLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 677
GLAR+FGG++++G+T ++VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++ K+N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
Query: 678 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM 737
Y +S NL+ H WD W++ ++ID ++ ++ +M+ +++ LLCVQEN++DRP M
Sbjct: 728 YE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDM 786
Query: 738 SDVISMINNEHLNLPSPKEPAFTKG--INVKNSSHSNSGTSEHCS--VNDVTVSLIYPR 792
S V+ M+ + ++LPSPK PAFT G N K S++ S S +NDVT++ + R
Sbjct: 787 SSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 588 bits (1516), Expect = e-167, Method: Compositional matrix adjust.
Identities = 336/816 (41%), Positives = 490/816 (60%), Gaps = 82/816 (10%)
Query: 13 LIFLLSMKVSLAADTVTPASFIRDG---EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQI 69
++ + S+AA+T+ +RDG + LVS + FELGFFSPG S R+LGI + I
Sbjct: 14 FLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNI 73
Query: 70 PD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKN---PVAQLR 125
D AVVWVANR PISD + VL ISN+GNLVLL+ N T+WS+N+ S N V +
Sbjct: 74 EDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIH 133
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP 185
D GN V+ + T+ +W+SF++PTDT L M++ + + SWRS DPSP
Sbjct: 134 DTGNFVLSETD----TDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 186 ----------------------------------------------DFLYKQFMMENKDE 199
++LY + DE
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 200 C--VYWYEAYNRPSIM-TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 256
VY+ + PS++ K+ +G WNE KW + S PD C +Y CG
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 257 ICSLD-QKPMCECLEGFKLESQVN------QPGPIKCERSHSLECKSGDQFIELDEIKAP 309
IC + +C C+ G++ S N + P+KCER+ S+ D+F+ L +K P
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISV---GEDEFLTLKSVKLP 366
Query: 310 DFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ 369
DF ++ + ++ E C+ CL+NCSC AY+ + GC++W DL+D ++ G
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVDLQQ--FEAGGS 420
Query: 370 SVYLRVPASKLGN--KKLLWILVILVIPVVLLPSFYVFYRR--RRKCQEKETENVETYQD 425
S+++R+ S++G K + ++V +++ V+L+ F + R R+K T
Sbjct: 421 SLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTS 480
Query: 426 LLAFDINMNITTRTNEYGEANGDGKDKSKD-SWLPLFSLASITAATENFSMQCKLGEGGF 484
++ D+ + T + G + + K+ + S LP+FSL +I AT +F + +LG GGF
Sbjct: 481 VVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGF 540
Query: 485 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544
GPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIAKLQHRNLVRLLGCC E EK+L
Sbjct: 541 GPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKML 600
Query: 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604
+ EYMPNKSL+ FLFD TK+ L++W+ R IIEGIA+GLLYLH+ SR RIIHRDLK SN+
Sbjct: 601 VYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNV 660
Query: 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 664
LLD +MNPKISDFG+AR+FGG++ + NT ++VGTYGYMSPEYA++GLFS+KSDV+SFG+L
Sbjct: 661 LLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVL 720
Query: 665 MLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVAL 724
+LE +S K+NT + +++ +L+G+AW L+ R +L+DP I + S +R I+VA+
Sbjct: 721 LLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKI-RVTCSKREALRCIHVAM 779
Query: 725 LCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT 760
LCVQ++AA+RP M+ V+ M+ ++ L +P++P FT
Sbjct: 780 LCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFT 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 573 bits (1476), Expect = e-162, Method: Compositional matrix adjust.
Identities = 335/848 (39%), Positives = 486/848 (57%), Gaps = 121/848 (14%)
Query: 1 MEKIPCLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR 60
ME L++ +F ++ ++ A D + ++DG+ +VS FE+GFFSPG S++R
Sbjct: 1 MEATNVLHLLIISLFS-TILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNR 59
Query: 61 YLGIRFQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNV-----S 114
YLGI +++I VVWVANRD P+ D + L +S NG+L L N N IWS++
Sbjct: 60 YLGIWYKKISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQK 119
Query: 115 SEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYL 174
+ ++NP+ Q+ D GNLV+R+ SG+ + Y+WQS DYP D L MK G +F L R+L
Sbjct: 120 ASLRNPIVQILDTGNLVVRN--SGD-DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 175 SSWRSADDPS-------------------------------------------PDFLYKQ 191
+SWR+ DDPS P+ +Y+
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 192 FMMENKDECVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYG 250
+ ++E Y Y+ N PS++T ++LNP+G + R W +N W+ S C +Y
Sbjct: 237 EYVFTEEEVYYTYKLEN-PSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYT 295
Query: 251 YCGANTICSLDQKPMCECLEGFKL---ESQVNQPGPIKCERSHSLECKSG-DQFIELDEI 306
CG+ C++++ P C CL+GF ++ V C R L+C G D F+++ ++
Sbjct: 296 LCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKL 355
Query: 307 KAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESS-GCLMWYGDLIDARRPIRN 365
K PD ++ M+L +CK CL+NC+C AY+ ++++ GC++W+GDLID R N
Sbjct: 356 KLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIRE--YN 413
Query: 366 FTGQSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQD 425
GQ +Y+ R E ET E+ +
Sbjct: 414 ENGQDLYV-----------------------------------RLASSEIETLQRESSR- 437
Query: 426 LLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 485
+++R K + +D LP L +++ AT FS KLG+GGFG
Sbjct: 438 ---------VSSR-----------KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFG 477
Query: 486 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545
PVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++ E++LI
Sbjct: 478 PVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLI 537
Query: 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLKASN+L
Sbjct: 538 YEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVL 597
Query: 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
LD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFSFG+L+
Sbjct: 598 LDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLV 657
Query: 666 LETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVAL 724
LE +S ++N G N + NLLGHAW + +D+ +++ID + + + ++R I++ L
Sbjct: 658 LEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGL 717
Query: 725 LCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDV 784
LCVQ++ DRP MS V+ ++ + + L P++P F N+ S + S E S N
Sbjct: 718 LCVQQDPKDRPNMS-VVVLMLSSEMLLLDPRQPGFFNERNLL-FSDTVSINLEIPSNNFQ 775
Query: 785 TVSLIYPR 792
T+S+I PR
Sbjct: 776 TMSVIDPR 783
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 572 bits (1474), Expect = e-162, Method: Compositional matrix adjust.
Identities = 342/860 (39%), Positives = 496/860 (57%), Gaps = 92/860 (10%)
Query: 7 LNIFCSLIFLL-SMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSR-YLGI 64
L +F +I + ++ + + + T + I + LVS FE+GFF ++ SR YLG+
Sbjct: 16 LLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLGM 72
Query: 65 RFQQIPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVS--SEVKNPV 121
++++ D VWVANRD P+S+ L IS N NLVLL+ +N +W TN++ +E V
Sbjct: 73 WYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPVV 131
Query: 122 AQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSAD 181
A+L +GN V+RD+S+ +A+E YLWQSFDYPTDTLL +MKLG++ K L R+L+SWRS+D
Sbjct: 132 AELLANGNFVMRDSSNNDASE-YLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSD 190
Query: 182 DPSP-DFLYK--------------------------------------QFM----MENKD 198
DPS +F YK +M +EN +
Sbjct: 191 DPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFIENNE 250
Query: 199 ECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVP-DQYCGKYGYCGANTI 257
E Y + N L L G+ R W + W+ +S P D C Y CG
Sbjct: 251 EVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAY 310
Query: 258 CSLDQKPMCECLEGF------KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 311
C ++ P+C C++GF + + +V G C R L C SGD F + ++K P+
Sbjct: 311 CDVNTSPVCNCIQGFNPRNIQQWDQRVWAGG---CIRRTQLSC-SGDGFTRMKKMKLPET 366
Query: 312 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--- 367
++++ + +++CK C+ +C+C A+AN++++ SGC++W L D IRN+
Sbjct: 367 TMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNYATDA 422
Query: 368 --GQSVYLRVPASKLGNKKLL---WILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET 422
GQ +Y+R+ A+ + K+ I + + + V+LL + ++R++K + ++
Sbjct: 423 IDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAISIAN 482
Query: 423 YQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEG 482
Q +N + + E+ G+ K ++ LPL + ++ ATENFS KLG+G
Sbjct: 483 TQRNQNLPMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSSCNKLGQG 537
Query: 483 GFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542
GFG VYKGRLL+G+E+AVKRLS S QG EF NE+ LIA+LQH NLV++LGCC+E EK
Sbjct: 538 GFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGDEK 597
Query: 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKAS 602
+LI EY+ N SL+ +LF T++ LNW R I G+A+GLLYLHQ SRFRIIHRDLK S
Sbjct: 598 MLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLKVS 657
Query: 603 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662
NILLDK+M PKISDFG+AR+F DE + NT ++VGTYGYMSPEYA+ G+FS KSDVFSFG
Sbjct: 658 NILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFSFG 717
Query: 663 ILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDDRVHDLIDPVIMQDEISLPML----- 716
+++LE +S KKN G YN D N LL + W WK+ R +++DPVI+ S P +
Sbjct: 718 VIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQPSIFQPQE 777
Query: 717 -MRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT---KGINVKNSSHSN 772
++ I + LLCVQE A RP MS V+ M +E +P PK P + + SS
Sbjct: 778 VLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKPPGYCVRRSPYELDPSSSWQ 837
Query: 773 SGTSEHCSVNDVTVSLIYPR 792
+E +VN T S+I R
Sbjct: 838 CDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 565 bits (1456), Expect = e-160, Method: Compositional matrix adjust.
Identities = 343/843 (40%), Positives = 499/843 (59%), Gaps = 86/843 (10%)
Query: 19 MKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVWVA 77
+ +S+ + T + I + +VS FELGFF S YLGI +++I VWVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPV-AQLRDDGNLVIRDNS 136
NRD P+S+ +L ISN NLV+L+ ++ +WSTN++ V++ V A+L D+GN V+R S
Sbjct: 87 NRDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLR-GS 144
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------------ 184
N ++ +LWQSFD+PTDTLL MKLG D K L R+++SW+S+ DPS
Sbjct: 145 KINESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLG 204
Query: 185 -PDFL-YKQFM-----------------------------MENKDECVYWYEAYNRPSIM 213
P+F + F+ EN++E Y + + S
Sbjct: 205 LPEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYS 264
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 273
L +N G + +W +W+ + +P C YG CG C + P C C++GF+
Sbjct: 265 RLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQ 324
Query: 274 -LESQVNQPGPI--KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 330
L Q G + +C R L C D+F L +K P +++R+ L++C+ +C
Sbjct: 325 PLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEKCK 383
Query: 331 KNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLW 387
+C+C AYANS+++ SGC++W G+ R IRN+ GQ +++R+ A++ G ++ +
Sbjct: 384 THCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFGERRTIR 439
Query: 388 ILVILVI---PVVLLPSF--YVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEY 442
+I +I ++L+ SF Y F+++++K + + T Y+D + I N
Sbjct: 440 GKIIGLIIGISLMLVLSFIIYCFWKKKQK-RARATAAPIGYRDRIQELIITN-------- 490
Query: 443 GEANGDGK---DKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 499
G G+ + +D LPL ++ ATENFS LG GGFG VYKGRLL+GQE+A
Sbjct: 491 GVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIA 550
Query: 500 VKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 559
VKRLS S QG EFKNE+ LIA+LQH NLVRLL CC+ EKILI EY+ N SL+ LF
Sbjct: 551 VKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLF 610
Query: 560 DSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618
++T+ LNWQ R II GIA+GLLYLHQ SRF+IIHRDLKASN+LLDK+M PKISDFG
Sbjct: 611 ETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFG 670
Query: 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVY 678
+AR+F DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S K+N G +
Sbjct: 671 MARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFH 730
Query: 679 NA-DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM-----LMRYINVALLCVQENAA 732
N+ NLLG+ W+ WK+ + +++D +I+ S+ + ++R I + LLCVQE A
Sbjct: 731 NSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAE 790
Query: 733 DRPTMSDVISMINNEHLNLPSPKEPAFTKG---INVKNSSHSNSGTSEHCSVNDVTVSLI 789
DRP MS V+ M+ +E +P PK P + G ++ +SS S SE +VN +TVS+I
Sbjct: 791 DRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVI 850
Query: 790 YPR 792
R
Sbjct: 851 NAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 557 bits (1435), Expect = e-157, Method: Compositional matrix adjust.
Identities = 334/853 (39%), Positives = 472/853 (55%), Gaps = 97/853 (11%)
Query: 6 CLNIFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIR 65
C N+ CS +++ T IR+G+ L+S + FELGFF+P S RY+GI
Sbjct: 21 CSNVSCS-----------TSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIW 69
Query: 66 FQQI-PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQL 124
++ I P VVWVANR++P+ D+ L I+++GNLV++N N TIWSTNV E N VA L
Sbjct: 70 YKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVL 129
Query: 125 RDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
G+LV+ +S + W+SF+ PTDT L M++ + R W+S DPS
Sbjct: 130 FKTGDLVLCSDSD---RRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 185 PD-----------------------------------------------FLYKQFMMENK 197
P + +K ++
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDR 246
Query: 198 DECVYW-YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANT 256
D VY+ Y A + + + P G + WN++ W+ L P C KY CG +
Sbjct: 247 DGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYS 306
Query: 257 ICSLDQKPM----CECLEGFKLESQV---NQPGPIKCERSHSLECKSG------DQFIEL 303
+C D K C C++GF+ Q N+ C+R L C D F L
Sbjct: 307 VCD-DSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDGFTVL 365
Query: 304 DEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPI 363
IK PDF V L+ N E CK C ++CSC+AYA + GC++W DLID
Sbjct: 366 KGIKVPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFE 420
Query: 364 RNFTGQSVYLRVPASKLGNKK---LLWILVILVIPVVLLP-SFYVFYRRRRKCQEKETEN 419
R G S+ +R+ SKLG K LWI+V VI LL ++ ++ ++ +
Sbjct: 421 RG--GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAF---- 474
Query: 420 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 479
+ +D+ DI N ++ GD D LP+FS S+ +AT +F+ + KL
Sbjct: 475 LWKKKDITVSDIIENRDYSSSPIKVLVGDQVDTPD---LPIFSFDSVASATGDFAEENKL 531
Query: 480 GEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539
G+GGFG VYKG G+E+AVKRLS +S QGL+EFKNE++LIAKLQHRNLVRLLGCC+E
Sbjct: 532 GQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIED 591
Query: 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599
EK+L+ EYMPNKSL+ FLFD +K+ L+W+ R +I GIA+GLLYLH+ SR +IIHRDL
Sbjct: 592 NEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDL 651
Query: 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVF 659
KASNILLD +MNPKISDFG+AR+F + NT ++VGTYGYM+PEYA++G+FS KSDV+
Sbjct: 652 KASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVY 711
Query: 660 SFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY 719
SFG+L+LE +S +KN D +L+G+AW LW + ++IDP++ +D + MR
Sbjct: 712 SFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIV-KDTRDVTEAMRC 770
Query: 720 INVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHC 779
I+V +LC Q++ RP M V+ M+ ++ LP P++P F +N + + G +
Sbjct: 771 IHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDG-HDVA 829
Query: 780 SVNDVTVSLIYPR 792
SVNDVT + I R
Sbjct: 830 SVNDVTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 792 | ||||||
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.919 | 0.673 | 0.468 | 0.0 | |
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.944 | 0.932 | 0.451 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.929 | 0.897 | 0.462 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.949 | 0.899 | 0.470 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.948 | 0.903 | 0.452 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.960 | 0.925 | 0.459 | 0.0 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.922 | 0.367 | 0.463 | 0.0 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.939 | 0.907 | 0.457 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.941 | 0.918 | 0.444 | 0.0 | |
| 255555127 | 834 | S-locus-specific glycoprotein S6 precurs | 0.969 | 0.920 | 0.433 | 0.0 |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/826 (46%), Positives = 499/826 (60%), Gaps = 98/826 (11%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
AD++ I D E LVSS Q FELGFFSPG SK+RYLGI ++ P VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
D+ VLTI NNG LVLLNQ+ IWS N+S +NPVAQL + GNLV+RD S+ ++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSN-ETSKSY 414
Query: 145 LWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS-PDF---------------- 187
+WQSFD P+DT+L MK+GW+ K L+R L+SW+S+DDPS DF
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 188 -------------------------LYKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGF 222
+YK + N DE YE+ N I L LN SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 223 VTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFKLESQVNQP- 281
+ R + + S+ WDEL+S+P + C YG+CGAN IC + + +CECL GF +SQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 282 --GPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYA 339
C R L+C+ + F+++ +K PD ID + ++L +CK CL NCSC AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 340 NSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG------NKKLLWILVILV 393
+N S GCLMW GDLID R + +Y+R+ S+LG KKL+ ILVI
Sbjct: 655 YTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIST 714
Query: 394 IPVVL---LPSFYVFYRRRRKC--QEKETENVETYQDLLAFDINMNITTRTNEYGEANGD 448
+L L ++ F+++R QE + EN+E
Sbjct: 715 FSGILTLGLSFWFRFWKKRTMGTDQESKKENLE--------------------------- 747
Query: 449 GKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG 508
LPLF L +I AT NFS K+G GGFG VYKG L G VAVKRLS S
Sbjct: 748 ---------LPLFDLPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSA 798
Query: 509 QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN 568
QG++EFKNE +LIAKLQH+NLVRLLGCC++ E+IL+ EYMPNKSL+ F+FD ++ LL
Sbjct: 799 QGVQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLA 858
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
W R I+ GIA+GLLYLHQ SRF+IIHRDLK SNILLD ++NPKISDFGLAR+FG +E+
Sbjct: 859 WDKRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEM 918
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLG 687
+ TK+IVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +S +KN G + D NLLG
Sbjct: 919 ETRTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLG 978
Query: 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747
HAW LW+ +R +L+D ++D ++R I V LLCVQ ADRP MS VI M+ NE
Sbjct: 979 HAWLLWEQNRALELMD-ACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMSSVIFMLGNE 1037
Query: 748 HLNLPSPKEPA-FTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
LP PK P FT+ +V + + SG E S N VT+S++ R
Sbjct: 1038 GATLPQPKHPGFFTERSSV--DTDTMSGKIELHSENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 689 bits (1777), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/846 (45%), Positives = 512/846 (60%), Gaps = 98/846 (11%)
Query: 1 MEKIPCLNIFCSLIFLLSMK-VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKS 59
ME +P IF S +F+ S+ +S +AD +TP ++DG+ L+S SQ FELGFFSPG SK
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKN 119
RY+GI +++ P+ VVWVANR+ P++D+ VLTI N GNLVLL+Q IWS+N SS +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRS 179
PVAQL D GNLV+RDN S TESY WQSFD P+DTLL MKLGW+ K ERYL +WRS
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 ADDPSP-DFLYK-----------------------------------------QFMMENK 197
DPSP DF Y+ ++ N+
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 198 DECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTI 257
DE Y Y N L LN SG V R + ++ W ++SVP C YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 258 CSLDQKPMCECLEGFK------LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDF 311
C P+CECL+GFK L+ Q N G KCE +L+C+SG+ F++L +K PD
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQ-NFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDL 358
Query: 312 IDVSLNQRMNLEQCKAECLKNCSCRAYANSNVK---ESSGCLMWYGDLIDARRPIRNFTG 368
++ LN+ MNL++C+AEC KNCSC A+A +N+ + SGCLMW+G+LID R + G
Sbjct: 359 LEFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIG 418
Query: 369 QSVYLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLA 428
Q +++RVPAS+L R ++ + +T V + LL
Sbjct: 419 QDIHIRVPASEL-----------------------EMARSSKRKKMLKTALVASMSALLG 455
Query: 429 FDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFSLASITAATENFSMQCKLGEGGFGPV 487
++ G D+ K+ PLF L +I AT NF+ +G GGFG V
Sbjct: 456 IFVS----------------GMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSV 499
Query: 488 YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547
YKG+LL GQE+AVK+LS SGQG++EF+NE++LIAKLQHRNLV LLG C+ + E++LI E
Sbjct: 500 YKGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYE 559
Query: 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
YMPNKSL+ F+FD + LL W+ R II GIA+GLLYLHQ S+ +I+HRDLK SN+LLD
Sbjct: 560 YMPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLD 619
Query: 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
++ PKISDFGLAR+ G D + T++++GTYGYM+PEYA+DG FS+KSDVFS G+L+LE
Sbjct: 620 SNLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLE 679
Query: 668 TLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLC 726
+S KKN G + D +LLGHAW +W + R +LID ++D L+R I V LLC
Sbjct: 680 IISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELID-TGLEDTSGKSQLLRCIQVGLLC 738
Query: 727 VQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTV 786
VQ+ DRP MS V+ M+ NE LP PK+P F I + S + S + S N+ +
Sbjct: 739 VQKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFF--IERGSVSEATSRNEDSYSTNEANI 796
Query: 787 SLIYPR 792
+++ R
Sbjct: 797 TILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 687 bits (1772), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/830 (46%), Positives = 504/830 (60%), Gaps = 94/830 (11%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GN VL++ N T+ WS+N ++ + +L+D GNLV+RD N
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLYKQFMMENKD 198
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS DF + + N +
Sbjct: 144 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 199 ------------------------------------------ECVYWYEAYNRPSIMTLK 216
E Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIV 262
Query: 217 LNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF--- 272
+N + F R WNE + W +VP YC Y CGA C + Q P+C+CLE F
Sbjct: 263 MNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPR 322
Query: 273 KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKN 332
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL+N
Sbjct: 323 SPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQN 382
Query: 333 CSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKLLWI-- 388
CSC AY +N+KE SGC +W+GDLID IR F+ GQ +Y+R+ AS+ K I
Sbjct: 383 CSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIKM 438
Query: 389 -----LVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYG 443
L I V +LL ++Y+F R+ + EN +
Sbjct: 439 TVGSALSIFVACGILLVAYYIFKRKAKHIGGNREENDQI--------------------- 477
Query: 444 EANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL 503
D K +D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K L
Sbjct: 478 ----DSGPK-EDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTL 532
Query: 504 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK 563
S SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T+
Sbjct: 533 SRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTR 592
Query: 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARMF
Sbjct: 593 GKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMF 652
Query: 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-S 682
GGD+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G + D S
Sbjct: 653 GGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPDHS 712
Query: 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
+L+GHAW LWKD + LI+ + ++MR IN++LLCVQ++ DRP+M+ V+
Sbjct: 713 LSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQHPDDRPSMATVVW 772
Query: 743 MINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
M+ E+ LP PKEP F KG S S+ T E S N++T SL+YPR
Sbjct: 773 MLGGEN-TLPQPKEPGFFKGSGPFRPSSSSKNT-ELFSNNEITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/836 (47%), Positives = 519/836 (62%), Gaps = 84/836 (10%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + IRDG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDVN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLY--------- 189
+ SYLWQSFDYP+DT+L MKLGWD + L+R LS+W+S DDPS DF +
Sbjct: 138 SG-SYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 190 --------KQF-------------------------MMENKDECVYWYEAYNRPSIMTLK 216
K F ++N +E Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFVDNGEEVYYTYNLKNKSLITRLV 256
Query: 217 LN-PSGFV-TRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF-- 272
+N +GF+ R WNE S W+ VP YC Y CGA C + Q P+CECLE F
Sbjct: 257 MNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFTP 316
Query: 273 -KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK 331
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C+++CL+
Sbjct: 317 KSPESWNSMNWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQ 376
Query: 332 NCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASK------LGNK 383
NCSC AY +++KE SGC +W+GDLID IR F GQ +Y+R+ AS+ L
Sbjct: 377 NCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSLIKM 432
Query: 384 KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVET-YQDLLAF---DINMNITTRT 439
++ L I V +LL ++Y+F K TE ++ Y LL + D + ++ +T
Sbjct: 433 EMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSFLLVYHVCDSHSLLSEKT 483
Query: 440 NEYGEANGDGKDKS--KDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 497
E N D D +D LPLF +I AT FS+ K+GEGGFGPVYKG L +GQE
Sbjct: 484 GGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLEDGQE 542
Query: 498 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 557
+AVK LS SGQGL EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPN+SL+ F
Sbjct: 543 IAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSLDSF 602
Query: 558 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617
+FD T+ +LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDF
Sbjct: 603 IFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDF 662
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 677
GLARM GGD+ +GNT +++GTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G
Sbjct: 663 GLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGF 722
Query: 678 YNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 736
Y+ D S +L HAW LWKD + DLI+ + ++MR IN++LLCVQ + DRP+
Sbjct: 723 YHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQHHPDDRPS 782
Query: 737 MSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
M+ V+ M+ E+ LP P EP F KG S S+S E S N+ T SL+YPR
Sbjct: 783 MATVVWMLGGEN-TLPQPNEPGFFKGSGPFGPSSSSSNI-ELYSNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/844 (45%), Positives = 518/844 (61%), Gaps = 93/844 (11%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
S++F LS+ S A +++ + DG+ LVSS FELGFFSPG S++RY+GI +++I
Sbjct: 18 SIVFFLSIP-STAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 72 -AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
VVWVANR+ P++D++ +L ++GNL +N TNGTIWS+N+S NPVAQL D GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------ 184
V+R + N E++LWQSFDYP D+ L MK G F L RYL+SW+S DPS
Sbjct: 137 VVRAEND-NDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 185 -------------------------------------PDFLYKQFMMENKDECVYWYEAY 207
P+ +Y + N++E Y Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255
Query: 208 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCE 267
N + + L+P G + R W + + W + C ++ CGA+ +C+++ P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315
Query: 268 CLEGFK---LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQ 324
CL+ F+ LE C R L+C +G+ FI+ IK PD N+ +NLE+
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375
Query: 325 CKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL--- 380
C+ CLKNCSC AYAN +V++ SGC++W+GDLID R+ N GQ +Y+R+ AS +
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVIDKP 433
Query: 381 ----GNKKLLWILVILVIPVVL-------LPSFYVFYRRRRKCQEKETENVETYQDLLAF 429
G K++ I+VIPV L L F F R+ ++ Q NV T +
Sbjct: 434 VKSRGKKRVR----IIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE---- 485
Query: 430 DINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYK 489
RT E +++D LPLF LA++T AT FS+ KLG+GGFGPVYK
Sbjct: 486 ------QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYK 530
Query: 490 GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549
G L +GQE+AVKRLS +S QG+ EF+NE++ IAKLQHRNLV+LLGCC+E E++LI EYM
Sbjct: 531 GILQDGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYM 590
Query: 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD 609
PNKSL+ F+FD + LL+W R II GIA+GLLYLHQ SR RIIHRDLKASNILLD +
Sbjct: 591 PNKSLDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYE 650
Query: 610 MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
MNPKISDFG+AR FGGDE NT +IVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +
Sbjct: 651 MNPKISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIV 710
Query: 670 SSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQ 728
S +KN G +A+ NLLGHAW L K+ R DLID I+ D + ++R I VALLCVQ
Sbjct: 711 SGRKNRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIV-DTCIISEVLRSIEVALLCVQ 769
Query: 729 ENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSL 788
++ DRP MS V+ M++++ + LP PKEP F ++ N S S++ E SVN++T +L
Sbjct: 770 KSPEDRPKMSIVVLMLSSD-IVLPQPKEPGFFTERDLSNDS-SSTIKHEISSVNELTSTL 827
Query: 789 IYPR 792
+ R
Sbjct: 828 LEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1746), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/834 (45%), Positives = 510/834 (61%), Gaps = 73/834 (8%)
Query: 19 MKVSLAA-DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWV 76
++VS A +T+ P ++DGE L+S+ FELGFFS G S+SRYLGI +++IP VVWV
Sbjct: 2 LRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVWV 61
Query: 77 ANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
NR+ P DN VL ++ G ++L N T G IWS+N S KNPV QL D GNL+++D +
Sbjct: 62 GNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDGN 121
Query: 137 SGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS------------ 184
GN ++ +WQSFD+P +TLL MKLGW+ L RYL+SW+S DDP+
Sbjct: 122 -GNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 185 -------------------------------PDFLYKQFMMENKDECVYWYEAYNRPSIM 213
P+ ++ + NK E Y YE N +
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPNPVFNFSFVSNKHEIYYSYELKNTSVVS 240
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFK 273
L ++ G + R W + + W FSVP C Y CGA C+++ P+C CLEGF
Sbjct: 241 RLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGFV 300
Query: 274 LESQVNQPGPI---KCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECL 330
+S + C R L C +GD F +L +K PD ++ M+L++C+ CL
Sbjct: 301 PKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMCL 360
Query: 331 KNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT--GQSVYLRVPASKLG-----NK 383
+NCSC AYANS+++ SGCL+W+ LID R+ FT GQ +Y+R+ AS+L K
Sbjct: 361 RNCSCLAYANSDIR-GSGCLLWFDHLIDMRK----FTEGGQDLYIRIAASELAKGKSHGK 415
Query: 384 KLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITT--RTNE 441
++ I+ L+I + + + Y R+RK + + V + +F I+ I +
Sbjct: 416 RVAIIVSCLIIGMGMTALGSLLYTRKRK-RNILGQAVPLVLLVSSFAIHFYIISGLAKET 474
Query: 442 YGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK 501
Y E GD K +D+ L F L +I AT NFS KLGEGGFGPVYKG LL+GQE+AVK
Sbjct: 475 YIENYGDNGAK-EDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVK 533
Query: 502 RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 561
RLS SGQG KEFKNE++LIA+LQHRNLV+LLGCC+ EK+LI EYMPNKSL+ F+FD
Sbjct: 534 RLSETSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDK 593
Query: 562 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
+ LL+W RII GIA+GLLYLHQ SR RIIHRDLKASNILLD DMNPKISDFGLAR
Sbjct: 594 KRSMLLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLAR 653
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD 681
FG D+ NTK++VGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +S K+N G + D
Sbjct: 654 TFGKDQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLD 713
Query: 682 -SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 740
S NLLGHAW LW ++R +L D QDE S+ ++R I V LLCVQ DRP MS V
Sbjct: 714 HSLNLLGHAWRLWMEERALELFDK-FSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAV 772
Query: 741 ISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEH--CSVNDVTVSLIYPR 792
+ M+ +E +LP PK+P F ++ ++S TS+ S N+++ +LI PR
Sbjct: 773 VVMLGSES-SLPQPKQPGF---YTERDPFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 671 bits (1732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/811 (46%), Positives = 515/811 (63%), Gaps = 80/811 (9%)
Query: 17 LSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD-AVVW 75
S+ V A DT+ +R + ++S+ FELGFFSPG S S ++GI +++I + VVW
Sbjct: 293 FSISVDAAPDTIFSGQMLRQTDTIISAGGNFELGFFSPGNSPSYFVGIWYKKISEQTVVW 352
Query: 76 VANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDN 135
VANRD I+ ++ LTI+++GNLV+L+ T N+S +N A L D GNL++R
Sbjct: 353 VANRDYTITGSSPSLTINDDGNLVILD-GRVTYMVANISLG-QNVSATLLDSGNLILR-- 408
Query: 136 SSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP---------- 185
N + LWQSFDYP++ L MK+G++ K +SW++A+DP
Sbjct: 409 ---NGNSNILWQSFDYPSNHFLPGMKIGYNRKTGEVWSFTSWKNAEDPGLGPVSLKMDPE 465
Query: 186 --------------------------------DFLYKQFMMENKDECVYWYEAYNRPSIM 213
D+++ E+ E + Y Y+ I
Sbjct: 466 THQFVIMWNSQMVWSSGVWNGHAFSSVPEMRLDYIFNYSYFEDMSEAYFTYSLYDNSIIS 525
Query: 214 TLKLNPSGFVTRQIWNENSNKWDELFSVPDQY-CGKYGYCGANTICSLDQKPMCECLEGF 272
L ++ SG + + W + S W+ +S P + C Y YCG+ + C+ P+C+CL GF
Sbjct: 526 RLLIDVSGNIKQLTWLDRSG-WNLFWSQPQNFECDYYSYCGSFSSCNNQTTPICQCLYGF 584
Query: 273 KLES----QVNQPGPIKCERSHSLEC-------KSGDQFIELDEIKAPDFIDVSLNQRMN 321
+ S +NQ C R SL+C D+F+++ +K P + Q +
Sbjct: 585 RPNSAGDWMMNQFRD-GCVRKTSLQCDDLTSVNSEKDKFLKMANVKFPQSPQILETQ--S 641
Query: 322 LEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARR-PIRNFTGQSVYLRVPASKL 380
+E CK CL CSC AYA++ CLMW L++ ++ ++ G+++YL++ AS+L
Sbjct: 642 IETCKMTCLNKCSCNAYAHN-----GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAASEL 696
Query: 381 GN----KKLLWILVILVIPVVLLPSF-YVFYRRRRKCQEKETENVETYQDLLAFDINMNI 435
N K W++ ++V+ V++L Y+ YR+ ++ Q++E + T QD+L ++ M
Sbjct: 697 QNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMKRVQDRE--EMTTSQDILLYEFGMGS 754
Query: 436 TTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNG 495
NE E N GKDK+KD+WLPLFS AS++AATE+FS + KLG+GGFGPVYKG L NG
Sbjct: 755 KATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNG 814
Query: 496 QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 555
QE+AVKRLS SGQGL+E KNE +L+A+LQHRNLVRLLGCC+EQGEKILI EYMPNKSL+
Sbjct: 815 QEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLD 874
Query: 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615
FLFD K+ L+W RV IIEGIAQGLLYLH+YSR RIIHRDLKASNILLD DMNPKIS
Sbjct: 875 SFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKIS 934
Query: 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675
DFG+ARMFGG+E NT +IVGTYGYMSPEYAL+GLFS KSDVFSFG+LMLE LS KKNT
Sbjct: 935 DFGMARMFGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNT 994
Query: 676 GVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 735
G YN+D+ NL+G+AW+LWK D +L+DP +++ + S ML+RYINV LLCV+E AADRP
Sbjct: 995 GFYNSDTLNLIGYAWELWKSDMAINLMDP-MLEGQSSQYMLLRYINVGLLCVEEIAADRP 1053
Query: 736 TMSDVISMINNEHLNLPSPKEPAFTKGINVK 766
T+S+V+SM+ NE LPSPK PAF+ +++
Sbjct: 1054 TLSEVVSMLTNELAVLPSPKHPAFSTASSLQ 1084
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 667 bits (1721), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/828 (45%), Positives = 504/828 (60%), Gaps = 84/828 (10%)
Query: 24 AADTVTPASFIRDG--EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIP-DAVVWVANRD 80
A+T+T + + DG LVS FELGFFSPG S++RY+GI ++ IP VVWVANR+
Sbjct: 18 TANTLTLSQSVCDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRDNSSGN 139
PI+D++ L + N GNLVL++ N T+ WS+N ++ + +L D GNLV+RD N
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRDEKDAN 137
Query: 140 ATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP-DFLY--------- 189
+ YLWQSFDYP+DTLL MKLGWD + L+R LS+W+S DDPS DF +
Sbjct: 138 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 190 -------KQF--------------------------MMENKDECVYWYEAYNRPSIMTLK 216
K++ +++ +E Y Y N+ I +
Sbjct: 197 LVMWKGSKEYYRSGPWNGIGFSGGPELRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIV 256
Query: 217 LNPSG-FVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF--- 272
+N S F R WNE + W +VP YC Y CGA C + Q P+CECLE F
Sbjct: 257 MNQSTYFRQRYTWNEINQTWVLYANVPRDYCDTYSLCGAYGNCIISQSPVCECLEKFTPK 316
Query: 273 KLESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKN 332
ES + C R+ L+C+ GD F++ +K PD + +N+ MNL++C++ CL+N
Sbjct: 317 SPESWNSMDWSQGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSICLEN 376
Query: 333 CSCRAYANSNVKESSGCLMWYGDLID-ARRPIRNFTGQSVYLRVPASKLGNKKLLWI--- 388
CSC AY +N+KE SGC +W+GDLID + P GQ +Y+R+ AS+ L +
Sbjct: 377 CSCMAYTATNIKERSGCAIWFGDLIDITQLPA---AGQEIYIRMNASESSECLSLVLMAV 433
Query: 389 ---LVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEA 445
L I V +LL ++Y+F R+ + L + + + E +
Sbjct: 434 GIALSIFVACGILLVAYYIFKRKAK----------------LIGKVTLTAFSNREENDQI 477
Query: 446 NGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN 505
+ K+ D LPLF +I AT FS KLGEGGFGPVYKG L +GQE+A K S
Sbjct: 478 DSGPKE---DLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAKTHSR 534
Query: 506 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 565
SGQG+ EFKNE++LI KLQHRNLV+LLGCC++ EKIL+ EYMPNKSL+ F+FD T+
Sbjct: 535 SSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQTRGE 594
Query: 566 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
LL+W R II GIA+GLLYLHQ SR RI+HRDLKASN+LLDKDMNPKISDFGLARMFGG
Sbjct: 595 LLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLARMFGG 654
Query: 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFN 684
D+ +GNT ++VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S KK+ G Y+ D S +
Sbjct: 655 DQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFYHPDHSLS 714
Query: 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
L+GHAW LWKD + DLI+ + ++MR IN++LLCVQ++ DRP+M+ V+ M+
Sbjct: 715 LIGHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQQHPDDRPSMATVVWML 774
Query: 745 NNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
E+ LP P EP F KG S S+S S N++T SL YPR
Sbjct: 775 GCEN-TLPQPNEPGFFKGSGPFGPSSSSSNIELS-SNNEITTSLFYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/844 (44%), Positives = 492/844 (58%), Gaps = 98/844 (11%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQ 68
IF +F +K+S A D + +RDGE LVS+ FELGFF+P S SRYLG+ +++
Sbjct: 7 IFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK 66
Query: 69 IPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDG 128
P VVWVANR PIS+ L +++ G LVLLN TN +WS+N S+ V+NPVAQL D G
Sbjct: 67 SPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSG 126
Query: 129 NLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSP--- 185
NLV+RD + N +++LWQSFDYP DTLL MKLG + L +LSSW+ ++P+P
Sbjct: 127 NLVVRDGND-NKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQF 185
Query: 186 ----------------------------------------DFLYKQFMMENKDECVYWYE 205
D +Y + N++E + +E
Sbjct: 186 TLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYFKFE 245
Query: 206 AYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPM 265
N L + PSG V W+ +N W + C Y CGAN C + P+
Sbjct: 246 LQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPV 305
Query: 266 CECLEGFKLESQV---NQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNL 322
C+CL+GF +S +Q C R L+C D F +K PD + +L
Sbjct: 306 CDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSL 365
Query: 323 EQCKAECLKNCSCRAYANSNVK-ESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG 381
+C+ C++NCSC AYAN + + SGCL W+GDLID RR GQ +Y+R+ AS+ G
Sbjct: 366 VECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYIRLAASQSG 423
Query: 382 -----------NKKLLWILVILVIPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFD 430
+ ++ VIL +++L VF RRRK ++
Sbjct: 424 VTGEKKRKKKTHAGVIGGAVILGSSILILG--IVFCIRRRKHRK---------------- 465
Query: 431 INMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKG 490
N N R E E LP+ L +I AT+NFS KLGEGGFG VYKG
Sbjct: 466 -NGNFEDRKEEEME-------------LPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKG 511
Query: 491 RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550
L+ GQE+AVKRLS SGQGL EFKNE++LIAKLQHRNLV+LLGCC+ + EK+LI EYMP
Sbjct: 512 ELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMP 571
Query: 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610
N+SL+ F+FD T+++ L+W R II+GIA+GLLYLHQ SR RIIHRD+KASNILLD ++
Sbjct: 572 NRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNEL 631
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
NPKISDFGLARMFGGD+ + NTK++VGTYGYMSPEYALDG FS+KSDVFSFG+L+LE +S
Sbjct: 632 NPKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVS 691
Query: 671 SKKNTGVYNAD--SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQ 728
KKN G + D NLLGHAW LW + +LID D + +R I+VALLCVQ
Sbjct: 692 GKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDEC-FADSCTPSEALRCIHVALLCVQ 750
Query: 729 ENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSL 788
+ DRP MS V+ M+ +E+ LP PK+P F G N S++ H S N+VTV+L
Sbjct: 751 QRPEDRPNMSSVVLMLGSEN-PLPQPKQPGFFMGSNPPEKDTSSNKHQSH-SANEVTVTL 808
Query: 789 IYPR 792
+ R
Sbjct: 809 LQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555127|ref|XP_002518601.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223542446|gb|EEF43988.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1708), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/836 (43%), Positives = 519/836 (62%), Gaps = 68/836 (8%)
Query: 9 IFCSLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQ 68
+F + + + + S ++DT+T + +G+ L+S+ Q+FELGFF+PG SK+ Y+GI ++
Sbjct: 15 LFFTFLSFYAPRFSFSSDTLTSTQSLINGQTLLSTRQKFELGFFTPGNSKNWYVGIWYKN 74
Query: 69 IPD-AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDD 127
I D VWVANRD P+++++ + I N ++VL +Q N IWS+N + NPV QL D
Sbjct: 75 ISDRTYVWVANRDNPLTNSSGIFKIFNQ-SIVLFDQGNNLIWSSN-QIKATNPVMQLLDT 132
Query: 128 GNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDP-SPD 186
G+LV+R+ N YLWQSFDYPTDTLL DMKLGWD L RYLSSW+S DDP + D
Sbjct: 133 GDLVLRE---ANVNNQYLWQSFDYPTDTLLPDMKLGWDLNKSLHRYLSSWKSKDDPGAGD 189
Query: 187 FLYK---------------------------QF---------------MMENKDECVYWY 204
+ +K +F + N+ E Y +
Sbjct: 190 YSFKLDYHGFPEIFLWNDGRKIYRSGPWNGLRFSGVPEMKPLDYISFDFVTNQSEVFYSF 249
Query: 205 EAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKP 264
+ + L + SG + R W W+ + P C Y CG IC + P
Sbjct: 250 HISSNSTYSRLTVTSSGELQRYTWIPERQDWNSFWYAPKDQCDDYKECGPYGICDSNASP 309
Query: 265 MCECLEGFK---LESQVNQPGPIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMN 321
+C+C+ GF+ L++ + G C R L+C + D+F+ L IK P+ +++ ++
Sbjct: 310 VCKCMRGFEPKNLQAWNLRDGSGGCVRKTDLQCMN-DKFLHLKNIKLPESSTSFVDRIIS 368
Query: 322 LEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKL 380
L+ C+ CL+NCSC AYANS++ +GC++W+G+L+D R+ GQ +Y+R+ AS +
Sbjct: 369 LKICEELCLRNCSCTAYANSDISNGGTGCVLWFGELLDMRQYTEG-GGQDLYVRLAASDI 427
Query: 381 GNKKLLWILVILV---IPVVLLPSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITT 437
G+ K + L+I + I +LL F +RR ++++ E Q+LL ++ I++
Sbjct: 428 GDGKNVAALIIGISVGIGTLLLGLAACFIWKRRSVRKEQKGVQERSQNLLLNEVV--ISS 485
Query: 438 RTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQE 497
+ + GE + D + LPLF +I AT+NFS + KLG+GGFG VYKGRL+ GQ
Sbjct: 486 KRDYSGEKDKDELE------LPLFDFGTIATATDNFSDENKLGQGGFGCVYKGRLVEGQV 539
Query: 498 VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF 557
VAVKRLS S QG++EFKNE+ LIA+LQHRNLVRLLGCC+E EK+LI EYM ++SL+
Sbjct: 540 VAVKRLSKTSVQGIEEFKNEVNLIARLQHRNLVRLLGCCIETNEKVLIYEYMEHRSLDSV 599
Query: 558 LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617
+F++ K+ LLNWQ R I+ GIA+GLLY+HQ SRFRIIHRDLKASNILLD + NPKISDF
Sbjct: 600 IFNNAKRSLLNWQRRFNIVCGIARGLLYMHQDSRFRIIHRDLKASNILLDGEWNPKISDF 659
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 677
G+AR+FGGD+ + +TK++VGTYGYMSPEYA+DG FS+KSDVFSFG+L+LE +S KN G
Sbjct: 660 GMARIFGGDQTEASTKRVVGTYGYMSPEYAMDGHFSVKSDVFSFGVLVLEIVSGNKNRGF 719
Query: 678 YNADS-FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 736
Y+++S NLLGHAW LWK+++ +++D + +L R I V LLCVQE A DRPT
Sbjct: 720 YHSNSELNLLGHAWRLWKEEKGLEILDSSVGSSFSPSEVL-RCIQVGLLCVQERAEDRPT 778
Query: 737 MSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
MS V+ M+++E+ +P PK P F G N + S+ E +VN VTV+++ R
Sbjct: 779 MSSVVLMLSSENATMPHPKTPGFCLGRNPFETDSSSGKQDESYTVNQVTVTMLDAR 834
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 792 | ||||||
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.744 | 0.696 | 0.441 | 1.2e-173 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.465 | 0.471 | 0.522 | 9.5e-168 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.414 | 0.407 | 0.523 | 2.7e-147 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.671 | 0.653 | 0.407 | 1.7e-139 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.417 | 0.403 | 0.507 | 1.5e-138 | |
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.603 | 0.562 | 0.462 | 9.2e-137 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.891 | 0.830 | 0.414 | 2.3e-135 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.640 | 0.628 | 0.417 | 3.7e-133 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.641 | 0.627 | 0.402 | 4.7e-133 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.424 | 0.412 | 0.543 | 6.1e-131 |
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1299 (462.3 bits), Expect = 1.2e-173, Sum P(2) = 1.2e-173
Identities = 278/629 (44%), Positives = 390/629 (62%)
Query: 186 DFLYKQFMMENKDECVYWYEAYNRPSIMT-LKLNPSGFVTRQIWNENSNKWDELFSVP-- 242
D++ F EN + VY Y N+ +I + L L+ +G + R W E + W +L+ P
Sbjct: 236 DYIDNSFT-ENNQQVVYSYRV-NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKD 293
Query: 243 --DQY--CGKYGYCGANTICSLDQKPMCECLEGFKL--ESQVNQPGPIKCERSHSLECKS 296
D Y CG YGYC ANT P+C C++GF+ E + + C R L C
Sbjct: 294 LCDNYKECGNYGYCDANT------SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDG 347
Query: 297 GDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMWYGD 355
D F+ L +++ PD + S+++ + L++C+ CLK C+C A+AN++++ SGC++W G
Sbjct: 348 RDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGG 407
Query: 356 LIDARRPIRNFT--GQSVYLRVPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYRRRR 410
L D IRN+ GQ +Y+RV A L +K+ SF +F+ +R
Sbjct: 408 LFD----IRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKR 463
Query: 411 KCQEKETENVET-YQDLL-AFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITA 468
K +K + ++T DL+ + D MN + + + + D + LPL ++
Sbjct: 464 K--QKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLE---LPLMEWKALAM 518
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
AT NFS KLG+GGFG VYKG LL+G+E+AVKRLS S QG EF NE+ LIAKLQH N
Sbjct: 519 ATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHIN 578
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LVRLLGCCV++GEK+LI EY+ N SL+ LFD T+ LNWQ R II GIA+GLLYLHQ
Sbjct: 579 LVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQ 638
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
SR RIIHRDLKASN+LLDK+M PKISDFG+AR+FG +E + NT+++VGTYGYMSPEYA+
Sbjct: 639 DSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAM 698
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPV-- 705
DG+FS+KSDVFSFG+L+LE +S K+N G YN++ NLLG W WK+ + +++DP+
Sbjct: 699 DGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINI 758
Query: 706 -IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKG-I 763
+ E ++R I + LLCVQE A DRP MS V+ M+ +E +P PK P F G
Sbjct: 759 DALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRS 818
Query: 764 NVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
+++ S S++ + C+VN VT+S+I R
Sbjct: 819 SLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 945 (337.7 bits), Expect = 9.5e-168, Sum P(3) = 9.5e-168
Identities = 195/373 (52%), Positives = 258/373 (69%)
Query: 421 ETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLG 480
E QDL + I T E + K + +D LP L +++ AT FS KLG
Sbjct: 414 ENGQDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGNKLG 472
Query: 481 EGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540
+GGFGPVYKG L GQEVAVKRLS S QG++EFKNE+ LIAKLQHRNLV++LG CV++
Sbjct: 473 QGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEE 532
Query: 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600
E++LI EY PNKSL+ F+FD ++R L+W RV II+GIA+G+LYLH+ SR RIIHRDLK
Sbjct: 533 ERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLK 592
Query: 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFS 660
ASN+LLD DMN KISDFGLAR GGDE + NT ++VGTYGYMSPEY +DG FS+KSDVFS
Sbjct: 593 ASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFS 652
Query: 661 FGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY 719
FG+L+LE +S ++N G N + NLLGHAW + +D+ +++ID + + + ++R
Sbjct: 653 FGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRV 712
Query: 720 INVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNSSHSNSGTSEHC 779
I++ LLCVQ++ DRP MS V+ M+++E L L P++P F N+ S + S E
Sbjct: 713 IHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLL-DPRQPGFFNERNLLFSD-TVSINLEIP 770
Query: 780 SVNDVTVSLIYPR 792
S N T+S+I PR
Sbjct: 771 SNNFQTMSVIDPR 783
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 868 (310.6 bits), Expect = 2.7e-147, Sum P(3) = 2.7e-147
Identities = 176/336 (52%), Positives = 237/336 (70%)
Query: 458 LPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE 517
L F + +I AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577
++LI+KLQHRNLVR+LGCC+E+ EK+LI E+M NKSL+ FLFDS K+ ++W R II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
GIA+GLLYLH SR R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT+++VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV-YNADSFNLLGHAWDLWKDD 696
T GYMSPEYA G+FS KSD++SFG+LMLE +S +K + Y + L+ +AW+ W +
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715
Query: 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKE 756
R DL+D + D + R I + LLCVQ ADRP ++++M+ +LPSPK+
Sbjct: 716 RGIDLLDQDLA-DSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPKQ 773
Query: 757 PAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
P F ++ S +++ +VN +T S+I R
Sbjct: 774 PTFAF-----HTRDDESLSNDLITVNGMTQSVILGR 804
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 1.7e-139, Sum P(2) = 1.7e-139
Identities = 238/584 (40%), Positives = 337/584 (57%)
Query: 204 YEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQK 263
Y R S ++ S + IWN N + W P C Y CG +C
Sbjct: 245 YSLERRNSNLSYTTLTSAGSLKIIWN-NGSGWVTDLEAPVSSCDVYNTCGPFGLCIRSNP 303
Query: 264 PMCECLEGF--KLESQVNQPGPIK-CERSHSLEC----------KSGDQFIELDEIKAPD 310
P CECL+GF K + + N+ C R +L C +GD F + +K PD
Sbjct: 304 PKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANVKPPD 363
Query: 311 FID-VSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQ 369
F + +SL +N E C+ CL NCSC A+ S + E GCL+W +L+D + + G+
Sbjct: 364 FYEYLSL---INEEDCQQRCLGNCSCTAF--SYI-EQIGCLVWNRELVDVMQFVAG--GE 415
Query: 370 SVYLRVPASKLG--NKKXXXXXXXXXXXXXXXXSF--YVFYRRRRKCQEKETENVETYQD 425
++ +R+ +S+L N+ F Y ++R + K + +ET QD
Sbjct: 416 TLSIRLASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQD 475
Query: 426 LLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFG 485
A+ +++ K + F + +I T NFSM+ KLG+GGFG
Sbjct: 476 --AW--------------------REQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFG 513
Query: 486 PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545
PVYKG L +G+E+A+KRLS+ SGQGL+EF NE++LI+KLQHRNLVRLLGCC+E EK+LI
Sbjct: 514 PVYKGNLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLI 573
Query: 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
E+M NKSLN F+FDSTKK L+W R II+GIA GLLYLH+ S R++HRD+K SNIL
Sbjct: 574 YEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNIL 633
Query: 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
LD++MNPKISDFGLARMF G + Q NT+++VGT GYMSPEYA G+FS KSD+++FG+L+
Sbjct: 634 LDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLL 693
Query: 666 LETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVAL 724
LE ++ K+ ++ + LL AWD W + DL+D I S + R + + L
Sbjct: 694 LEIITGKRISSFTIGEEGKTLLEFAWDSWCESGGSDLLDQDISSSG-SESEVARCVQIGL 752
Query: 725 LCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINVKNS 768
LC+Q+ A DRP ++ V+SM+ ++LP PK+P F + +S
Sbjct: 753 LCIQQQAGDRPNIAQVMSMLTTT-MDLPKPKQPVFAMQVQESDS 795
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 1.5e-138, Sum P(3) = 1.5e-138
Identities = 170/335 (50%), Positives = 235/335 (70%)
Query: 452 KSKD-SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG 510
+S+D S L F + + AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRL++ S QG
Sbjct: 476 QSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKEIAVKRLTSSSVQG 535
Query: 511 LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ 570
+EF NE+ LI+KLQHRNL+RLLGCC++ EK+L+ EYM NKSL++F+FD KK ++W
Sbjct: 536 TEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWA 595
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
R II+GIA+GLLYLH+ S R++HRDLK SNILLD+ MNPKISDFGLAR+F G++ Q
Sbjct: 596 TRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQD 655
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV-YNADSFNLLGHA 689
+T +VGT GYMSPEYA G FS KSD++SFG+LMLE ++ K+ + Y D+ NLL +A
Sbjct: 656 STGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYA 715
Query: 690 WDLWKDDRVHDLIDPVIMQ-DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748
WD W ++ +L+D + D ++ R +++ LLCVQ A DRP + V+SM+ +
Sbjct: 716 WDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIKQVMSMLTST- 774
Query: 749 LNLPSPKEPAFTKGINVKNSSHSNSGTSEHCSVND 783
+LP P +P F + ++SS S+S S S D
Sbjct: 775 TDLPKPTQPMFVLETSDEDSSLSHSQRSNDLSSVD 809
|
|
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1065 (380.0 bits), Expect = 9.2e-137, Sum P(3) = 9.2e-137
Identities = 232/502 (46%), Positives = 319/502 (63%)
Query: 311 FIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQS 370
F+ + +R++ C +CL+NCSC AYA++N + +GC +W D + + ++
Sbjct: 353 FVFNEIGRRLSSYDCYVKCLQNCSCVAYASTN-GDGTGCEIWNTDPTNENSASHH--PRT 409
Query: 371 VYLRVPASKLGNKKXXXXXXXXXXXXXXXXSFYVFYRRRR-KCQEKETENVETYQDLLAF 429
+Y+R+ SKL Y+ R+ + K +E+++
Sbjct: 410 IYIRIKGSKLAATWLVVVASLFLIIPVTWLIIYLVLRKFKIKGTNFVSESLKMISSQSCS 469
Query: 430 DINMNITT-RTN----------EYG-EANGDGKDKSKDS--WLPLFSLASITAATENFSM 475
N ++T R E G E GK ++++ L +FS S+ AT+ FS
Sbjct: 470 LTNKRLSTLRVGSTIDQEMLLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSD 529
Query: 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
KLGEGGFGPVYKGRL++G+EVA+KRLS SGQGL EFKNE MLIAKLQH NLV+LLGC
Sbjct: 530 ANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGC 589
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
CVE+ EK+LI EYMPNKSL+ FLFD +K +L+W+ R RI+EGI QGLLYLH+YSR ++I
Sbjct: 590 CVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVI 649
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 655
HRD+KA NILLD+DMNPKISDFG+AR+FG E + NTK++ GT+GYMSPEY +GLFS K
Sbjct: 650 HRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAK 709
Query: 656 SDVFSFGILMLETLSSKKNTGVYNADS---FNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712
SDVFSFG+LMLE + +KN ++ DS NL+ H W+L+K++RV ++IDP + +
Sbjct: 710 SDVFSFGVLMLEIICGRKNNSFHH-DSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVE 768
Query: 713 LPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN-LPSPKEPAFTKGINVKNSSHS 771
P ++R + VALLCVQ+NA DRP+M DV+SMI + N L PKEPAF G +
Sbjct: 769 NPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEME 828
Query: 772 -NSGTSEHCSVNDVTVSLIYPR 792
E+ S N VT++++ R
Sbjct: 829 VEPPEMENVSANRVTITVMEAR 850
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
Identities = 313/756 (41%), Positives = 437/756 (57%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN----GTIW-STNVSSEVKNPVAQLR 125
D VW N + V + +NGN VL + N G +W S + ++ P +L
Sbjct: 111 DTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLG 170
Query: 126 DDG----NLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSW---R 178
D N IR S + S + SF T+ ++ L W+ ++R+ R W R
Sbjct: 171 WDAKTGFNRFIRSWKSPDDPSSGDF-SFKLETEGF-PEIFL-WNRESRMYRS-GPWNGIR 226
Query: 179 SADDPSPD-FLYKQF-MMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWD 236
+ P F Y F +K+E Y + L ++ SG + R W E + W+
Sbjct: 227 FSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWN 286
Query: 237 ELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGFKLES-QV--NQPGPIKCERSHSLE 293
+ + P C +Y CG C + P+C C++GFK + QV + G C R L
Sbjct: 287 QFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLS 346
Query: 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES-SGCLMW 352
C GD F+ L ++K PD S+++ + +++C+ +CL++C+C A+AN++++ S SGC+ W
Sbjct: 347 CGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTW 406
Query: 353 YGDLIDARRPIRNFT--GQSVYLRVPASKLGNKKXXXXXXXXXXXXXXXX---SFYVFYR 407
G+L D IRN+ GQ +Y+R+ A+ L +K+ SF +F+
Sbjct: 407 TGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFL 462
Query: 408 RRRKCQEKETENVETY---QDLLAFDINMN---ITTRTNEYGEANGDGKDKSKDSWLPLF 461
+RK +K + +ET L + D+ MN I++R + E N D D LPL
Sbjct: 463 WKRK--QKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRENNTD------DLELPLM 514
Query: 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLI 521
+ AT NFS KLG+GGFG VYKG+LL+GQE+AVKRLS S QG EFKNE+ LI
Sbjct: 515 EFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLI 574
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
A+LQH NLVRLL CCV+ GEK+LI EY+ N SL+ LFD ++ LNWQ R II GIA+
Sbjct: 575 ARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIAR 634
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GLLYLHQ SRFRIIHRDLKASNILLDK M PKISDFG+AR+FG DE + NT+++VGTYGY
Sbjct: 635 GLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGY 694
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRVHD 700
MSPEYA+DG+FS+KSDVFSFG+L+LE +SSK+N G YN+D NLLG W WK+ + +
Sbjct: 695 MSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLE 754
Query: 701 LIDPVIMQDEISLPM--LMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 758
+IDP+I + ++R I + LLCVQE A DRPTMS VI M+ +E +P PK P
Sbjct: 755 IIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPG 814
Query: 759 FT--KGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
+ + + +SS S E +VN +TVS++ R
Sbjct: 815 YCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 3.7e-133, Sum P(2) = 3.7e-133
Identities = 229/549 (41%), Positives = 320/549 (58%)
Query: 224 TRQI-WNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF--KLESQVNQ 280
T+++ W+ N W F P+ C YG CG +C P C C +GF KL + +
Sbjct: 260 TQELSWH-NGTDWVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCTCFKGFVPKLIEEWKR 318
Query: 281 PGPIK-CERSHSLEC------KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNC 333
C R L C K + F + IK PDF + + +N+E+C+ CL NC
Sbjct: 319 GNWTGGCVRRTELYCQGNSTGKYANVFHPVARIKPPDFYEFA--SFVNVEECQKSCLHNC 376
Query: 334 SCRAYANSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLG-NK-KXXXXXXX 391
SC A+A + GCLMW DL+DA + G+ + +R+ S+LG NK K
Sbjct: 377 SCLAFAYI---DGIGCLMWNQDLMDAVQFSEG--GELLSIRLARSELGGNKRKKAITASI 431
Query: 392 XXXXXXXXXSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKD 451
+F F R + + N +ITT ++ N D K
Sbjct: 432 VSLSLVVIIAFVAFCFWRYRVKH-----------------NADITTDASQVSWRN-DLKP 473
Query: 452 KSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 511
+ L F + +I AT NFS+ KLG+GGFGPVYKG+L +G+E+AVKRLS+ SGQG
Sbjct: 474 QDVPG-LDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGK 532
Query: 512 KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQA 571
+EF NE++LI+KLQH+NLVR+LGCC+E EK+LI E+M N SL+ FLFDS K+ ++W
Sbjct: 533 EEFMNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPK 592
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
R+ II+GIA+G+ YLH+ S ++IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q N
Sbjct: 593 RLDIIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDN 652
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV-YNADSFNLLGHAW 690
T+++VGT GYM+PEYA G+FS KSD++SFG+LMLE +S +K + Y + L+ +AW
Sbjct: 653 TRRVVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAW 712
Query: 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750
+ W D DL+D + D + R + + LLCVQ ADRP +++SM+ +
Sbjct: 713 ESWCDTGGIDLLDKDVA-DSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTTTS-D 770
Query: 751 LPSPKEPAF 759
LP P++P F
Sbjct: 771 LPPPEQPTF 779
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 992 (354.3 bits), Expect = 4.7e-133, Sum P(2) = 4.7e-133
Identities = 220/546 (40%), Positives = 315/546 (57%)
Query: 226 QIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCECLEGF---KLESQVNQPG 282
+I+ N W+ F P+ C YG+CG IC + P C+C +GF +E
Sbjct: 262 KIFQHNGMDWELNFEAPENSCDIYGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRGNW 321
Query: 283 PIKCERSHSLEC------KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCR 336
C R L C K+ + F + IK PDF + + ++ E C CL NCSC
Sbjct: 322 TDGCVRHTELHCQGNTNGKTVNGFYHVANIKPPDFYEFA--SFVDAEGCYQICLHNCSCL 379
Query: 337 AYANSNVKESSGCLMWYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKXXXXXXXXXXXX 396
A+A N GCLMW DL+DA + + G+ + +R+ +S+LG K
Sbjct: 380 AFAYIN---GIGCLMWNQDLMDAVQ--FSAGGEILSIRLASSELGGNKRNKIIVASIVSL 434
Query: 397 XXXXSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKD-KSKD 455
S +V C L + + ++ + ++ D + +D
Sbjct: 435 ----SLFVILAFAAFC-------------FLRYKVKHTVSAKISKIASKEAWNNDLEPQD 477
Query: 456 -SWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF 514
S L F + +I AT+NFS+ KLG+GGFG VYKG+L +G+E+AVKRLS+ SGQG +EF
Sbjct: 478 VSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEF 537
Query: 515 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR 574
NE++LI+KLQH+NLVR+LGCC+E E++L+ E++ NKSL+ FLFDS K+ ++W R
Sbjct: 538 MNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFN 597
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
IIEGIA+GL YLH+ S R+IHRDLK SNILLD+ MNPKISDFGLARM+ G E Q NT++
Sbjct: 598 IIEGIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRR 657
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV-YNADSFNLLGHAWDLW 693
+ GT GYM+PEYA G+FS KSD++SFG+++LE ++ +K + Y LL +AW+ W
Sbjct: 658 VAGTLGYMAPEYAWTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLLAYAWESW 717
Query: 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPS 753
+ DL+D + D + R + + LLCVQ ADRP +++SM+ +L S
Sbjct: 718 CESGGIDLLDKDVA-DSCHPLEVERCVQIGLLCVQHQPADRPNTMELLSMLTTTS-DLTS 775
Query: 754 PKEPAF 759
PK+P F
Sbjct: 776 PKQPTF 781
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 960 (343.0 bits), Expect = 6.1e-131, Sum P(2) = 6.1e-131
Identities = 186/342 (54%), Positives = 252/342 (73%)
Query: 452 KSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL 511
+ +D LP+F +I+ AT++FS LG GGFGPVYKG+L +GQE+AVKRLS SGQG+
Sbjct: 479 EEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGV 538
Query: 512 KEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQA 571
+EFKNE+ LIAKLQHRNLVRLLGCC++ E +LI EYMPNKSL+ F+FD + L+W+
Sbjct: 539 EEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKK 598
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
R+ II G+A+G+LYLHQ SR RIIHRDLKA N+LLD DMNPKISDFGLA+ FGGD+ + +
Sbjct: 599 RMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESS 658
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHAW 690
T ++VGTYGYM PEYA+DG FS+KSDVFSFG+L+LE ++ K N G +AD NLLGH W
Sbjct: 659 TNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVW 718
Query: 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750
+W +DR ++ + +++ +P ++R I+VALLCVQ+ DRPTM+ V+ M ++ +
Sbjct: 719 KMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDS-S 777
Query: 751 LPSPKEPAFTKGINVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
LP P +P F NV + S S S S+ N+V+++++ R
Sbjct: 778 LPHPTQPGFFTNRNVPDISSSLSLRSQ----NEVSITMLQGR 815
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81905 | SD18_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4374 | 0.9558 | 0.8905 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 792 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-41 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 4e-40 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-37 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-35 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-29 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-27 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-25 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-24 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 3e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-16 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-14 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-08 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 1e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-05 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 5e-56
Identities = 100/281 (35%), Positives = 144/281 (51%), Gaps = 35/281 (12%)
Query: 478 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRL 532
KLGEG FG VYKG+L EVAVK L S + K+F E ++ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
LG C E+ L+LEYM L +L F S +K L+ + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYGYMSPE 645
S+ + +HRDL A N L+ +D+ KISDFGL+R ++ D + T + +M+PE
Sbjct: 122 A--SK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 646 YALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
DG+F+ KSDV+SFG+L+ E TL + G+ N + L +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLP--K 228
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
P DE+ Y + L C Q + DRPT S+++ +
Sbjct: 229 PEYCPDEL-------Y-ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 96/281 (34%), Positives = 143/281 (50%), Gaps = 34/281 (12%)
Query: 474 SMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 527
++ KLGEG FG VYKG L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+LLG C E+ ++++EYMP L +L + + L+ + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE 120
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 645
S+ IHRDL A N L+ +++ KISDFGL+R D+ K +M+PE
Sbjct: 121 --SK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK---LPIRWMAPE 174
Query: 646 YALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
+G F+ KSDV+SFG+L+ E TL + G+ NA+ L + L K
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK--------- 225
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
P E+ + L C E+ DRPT S+++ ++
Sbjct: 226 PPNCPPEL--------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 92/281 (32%), Positives = 141/281 (50%), Gaps = 35/281 (12%)
Query: 474 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHR 527
++ KLGEG FG VYKG+L EVAVK L + S Q ++EF E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+LLG C E+ +++EYM L +L + L+ + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPE 645
IHRDL A N L+ +++ KISDFGL+R D+ + K +M+PE
Sbjct: 120 SK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGK---LPIRWMAPE 173
Query: 646 YALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
+G F+ KSDV+SFG+L+ E TL + G+ N + L + + L +
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ--------- 224
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
P E+ ++ L C E+ DRPT S+++ ++
Sbjct: 225 PPNCPPEL--------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 1e-53
Identities = 92/289 (31%), Positives = 138/289 (47%), Gaps = 48/289 (16%)
Query: 473 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQH 526
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
N+VRLLG C + ++ EYMP L FL L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---YMS 643
S+ +HRDL A N L+ +++ KISDFGL+R D+ ++ G +M+
Sbjct: 119 E--SK-NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMA 172
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHDLI 702
PE DG F+ KSDV+SFG+L+ E + LG + ++ V +L+
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELL 217
Query: 703 D-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+ P DE+ LM L C + DRPT S+++ +
Sbjct: 218 EDGYRLPRPENCPDELY--ELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-50
Identities = 77/193 (39%), Positives = 110/193 (56%), Gaps = 11/193 (5%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
LGEGGFG VY R G++VA+K + + L E E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
++ L++EY SL L ++ K L+ +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 597 RDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSI 654
RDLK NILLD D K++DFGL+++ D+ T IVGT YM+PE L G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 655 KSDVFSFGILMLE 667
KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-48
Identities = 71/199 (35%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 478 KLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLG G FG VYK + G+ VAVK L ++ + + + E+ ++ +L H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
++ L++EY L +L ++ L+ +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS 653
IHRDLK NILLD++ KI+DFGLA+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 654 IKSDVFSFGILMLETLSSK 672
K DV+S G+++ E L+ K
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 69/197 (35%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 530
+ + KLGEG FG VY R G+ VA+K + + + +E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL ++ + L++EY L L + RL +AR + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHSK- 116
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
I+HRDLK NILLD+D + K++DFGLAR E VGT YM+PE L
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 651 LFSIKSDVFSFGILMLE 667
+ D++S G+++ E
Sbjct: 172 GYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 9e-41
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)
Query: 477 CKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 534 GCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
G ++ + L LEY+ SL+ L +L R + I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQ-ILEGLAYLH---S 119
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
I+HRD+K +NIL+D D K++DFG A+ G E T + GT +M+PE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 652 FSIKSDVFSFGILMLETLSSK 672
+ +D++S G ++E + K
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-40
Identities = 53/115 (46%), Positives = 70/115 (60%), Gaps = 6/115 (5%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
VVWVANR P++D++ L + ++GNLVL + +WS+N S + VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184
LV+ DNS LWQSFD+PTDTLL K G + R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 50/119 (42%), Positives = 69/119 (57%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ G+ LVSS FELGFF Y I ++ VVWVANRD P S ++ LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152
++GNLV+ + + +WS+N + N V L DDGNLV+ D+ ++LWQSFDYP
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRN 528
N+ + +G G FG VYKG L G VA+K++S + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 586
+V+ +G +ILEY N SL K+ + + + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLR-----QIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H+ +IHRD+KA+NIL KD K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
S SD++S G ++E L+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 79/201 (39%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG G FG V+ G +VAVK L + F E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 531 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+L C + E I I+ EYM SL FL K+L V + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKL-RLPQLVDMAAQIAEGMAYLE-- 120
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
IHRDL A NIL+ +++ KI+DFGLAR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
A G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 83/291 (28%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 478 KLGEGGFGPVYKGRLLN-----GQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+LGEG FG V R G++VAVK L+ + Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 532 LLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
G C + G + LI+EY+P+ SL +L + ++ + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL-LLFSSQICKGMDYLGSQ 128
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYA 647
R IHRDL A NIL++ + KISDFGLA++ D + Y +PE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
FS SDV+SFG+ + E + + A+ ++G A R+ +L +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL-----L 239
Query: 708 QDEISLP----------MLMRYINVALLCVQENAADRPTMSDVISMINNEH 748
++ LP LM+ LC + DRP+ +D+I +++
Sbjct: 240 KEGERLPRPPSCPDEVYDLMK------LCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 66/191 (34%), Positives = 105/191 (54%), Gaps = 9/191 (4%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ K +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+++ E +++E+ SL L ST + L Q + + + +GL YLH IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLHSN---GIIH 121
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+KA+NILL D K+ DFGL+ +VGT +M+PE + K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 657 DVFSFGILMLE 667
D++S GI +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 51/120 (42%), Positives = 70/120 (58%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLT 91
+ + G+ LVS + FELGFF+ Y I ++ VVWVANRD P+SD+ LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSDS-CTLT 59
Query: 92 ISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
+ ++GNLVL + +WS+N + N V L DDGNLVI D+ ++LWQSFDY
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 72/207 (34%), Positives = 109/207 (52%), Gaps = 20/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E F+++ KLG G FG V++G N VA+K L + ++F+ E+ + +L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 583
L C +I E M SL FL + L + Q +A+G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQ--------VAEGM 117
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
YL + IHRDL A NIL+ +D+ K++DFGLAR+ D + K+I Y + +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTA 172
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE A G FS KSDV+SFGIL+ E +
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 37/276 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 528
+ LG+G G VYK R G+ A+K++ + + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYL 586
+V+ G ++GE ++LEYM SL L K++ V I I +GL YL
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYL 115
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 116 HTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPER 171
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
+S +D++S G+ +LE G + F G + +L+ +
Sbjct: 172 IQGESYSYAADIWSLGLTLLECA-----LGKF---PFLPPGQP-SFF------ELMQAIC 216
Query: 707 MQDEISLP------MLMRYINVALLCVQENAADRPT 736
SLP +I+ C+Q++ RP+
Sbjct: 217 DGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 77/215 (35%), Positives = 112/215 (52%), Gaps = 29/215 (13%)
Query: 479 LGEGGFGPVYKGRL--LNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
LGEG FG VYKG L N + VA+K L N + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIEG 578
LLG C ++ ++ EY+ + L+ FL D T K L+ + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 635
IA G+ YL S +HRDL A N L+ + + KISDFGL+R ++ D +Q +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +M PE L G F+ +SD++SFG+++ E S
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 7e-31
Identities = 82/314 (26%), Positives = 133/314 (42%), Gaps = 21/314 (6%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH-R 527
++ + KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+L ++G L++EY+ SL L +K L+ + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 588 QYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGD----ELQGNTKQIVGTYGYM 642
IIHRD+K NILLD+D K+ DFGLA++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 643 SPEYALDGLF---SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699
+PE L S SD++S GI + E L+ + + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTP 233
Query: 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAF 759
L P + + ++ + ++ +R + S +S HL L
Sbjct: 234 SLASP--LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 760 TKGINVKNSSHSNS 773
K + S
Sbjct: 292 LKPDDSAPLRLSLP 305
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 13/193 (6%)
Query: 478 KLGEGGFGPVYKG-RLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ E +++EYM SL + R+ Q + + QGL YLH +
Sbjct: 83 SYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQI-AYVCREVLQGLEYLHS---QNV 137
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
IHRD+K+ NILL KD + K++DFG A + + +VGT +M+PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYGP 195
Query: 655 KSDVFSFGILMLE 667
K D++S GI+ +E
Sbjct: 196 KVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 86/282 (30%), Positives = 122/282 (43%), Gaps = 44/282 (15%)
Query: 479 LGEGGFGPVYKG--RLLNGQE--VAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
G C + +L++E P L +L L +V A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES-K 114
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARM--FGGDELQGNT--KQIVGTYGYMSPEY 646
F +HRDL A N+LL KISDFG++R G D + T + + Y +PE
Sbjct: 115 HF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169
Query: 647 ALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
G FS KSDV+S+G+ + E S +K + A+ +L L + + I
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS 229
Query: 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
IM C + DRPT S++ S
Sbjct: 230 -IMLS----------------CWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538
+G+G FG V G GQ+VAVK L + S + F E ++ L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 598
++ EYM SL +L S + ++ ++ + +G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 599 LKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDGLFSIKS 656
L A N+L+ +D+ K+SDFGLA+ + + Q G + +PE + FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 657 DVFSFGILMLETLS 670
DV+SFGIL+ E S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 83/280 (29%), Positives = 139/280 (49%), Gaps = 41/280 (14%)
Query: 479 LGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + VA+K L ++ + KE +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLH 587
LG C+ ++ LI + MP L ++ + + LLNW IA+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC------VQIAKGMSYLE 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ R++HRDL A N+L+ + KI+DFGLA++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 648 LDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
L +++ KSDV+S+G+ + E T +K G+ + +LL K +R L P
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE------KGER---LPQPP 234
Query: 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
I I + M++ + C +A RPT ++I+ +
Sbjct: 235 IC--TIDVYMVL------VKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 77/210 (36%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 479 LGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLV 530
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYL 586
+LLG C+ + +I+E M L +L D+ +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 587 HQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTYG 640
Q IHRDL A N L+ D D KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 70/284 (24%), Positives = 131/284 (46%), Gaps = 51/284 (17%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
++G+G FG VY R +G+ +K LSN S + ++ NE+ ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKR--------LLNW--QARVRIIEGIAQGLL 584
E+G+ +++EY L+ KK +L+W Q + L
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS-QKIKKQKKEGKPFPEEQILDWFVQ--------LCLALK 117
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH SR +I+HRD+K NI L + K+ DFG++++ T +VGT Y+SP
Sbjct: 118 YLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSP 172
Query: 645 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
E + ++ KSD++S G ++ E + K + ++ L
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKH---PFEGENLLELALK--------------- 214
Query: 705 VIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVISMI 744
I++ + P+ +Y N+ +Q++ +RP+++ ++
Sbjct: 215 -ILKGQYP-PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 71/197 (36%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
+ KLG G FG V++G N VAVK L + K+F E ++ KL+H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 535 CCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
C E I I+ E M SL +L R L + + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDG 650
IHRDL A N+L+ ++ K++DFGLAR+ D + G + +PE AL
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179
Query: 651 LFSIKSDVFSFGILMLE 667
FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 479 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVR 531
LGEG FG V+ G + + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQARVRIIEGI 579
G C E I++ EYM + LN FL DS L ++I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTLSQLLQIAVQI 131
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQIV 636
A G++YL + +HRDL N L+ D+ KI DFG++R ++ D + G+T +
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 ---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 71/196 (36%), Positives = 106/196 (54%), Gaps = 10/196 (5%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
K+G+G FG VYKG L EVAVK + LK F E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
V++ +++E +P SL FL KK L + +++ A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSI 654
RDL A N L+ ++ KISDFG++R G + KQI + +PE G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 655 KSDVFSFGILMLETLS 670
+SDV+S+GIL+ ET S
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 81/279 (29%), Positives = 133/279 (47%), Gaps = 41/279 (14%)
Query: 479 LGEGGFGPVYKGRL----LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LGEG FG V +G+L + +VAVK +L + ++EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 533 LGCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGL 583
+G C E ++IL +M + L+ FL S L Q ++ + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNTKQIVGTYGY 641
YL S IHRDL A N +L +DM ++DFGL++ ++ GD QG ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVH 699
++ E D +++ KSDV++FG+ M E + + GV N + ++ L H +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG---------N 232
Query: 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS 738
L P DE+ M C + + DRPT +
Sbjct: 233 RLKQPEDCLDELYDLMYS--------CWRADPKDRPTFT 263
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 86/274 (31%), Positives = 136/274 (49%), Gaps = 27/274 (9%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLL 533
+G G FG V +GRL L G++ VA+K L S + +F E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 534 GCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
G V + ++I+ EYM N SL+ FL ++ K V ++ GIA G+ YL S
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
+HRDL A NIL++ ++ K+SDFGL+R E TK + +PE F
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 653 SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712
+ SDV+SFGI+M E +S Y + WD+ D + + D + +
Sbjct: 186 TSASDVWSFGIVMWEVMS-------YGERPY------WDMSNQDVIKAVEDGYRLPPPMD 232
Query: 713 LPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
P + + L C Q++ +RPT S ++S ++
Sbjct: 233 CPSALYQL--MLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+ G + + +++EY S++ + T K L + I+ +GL YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAA-ILYQTLKGLEYLHSN 118
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ IHRD+KA NILL+++ K++DFG++ ++GT +M+PE +
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--MAKRNTVIGTPFWMAPEVIQE 173
Query: 650 GLFSIKSDVFSFGILMLE 667
++ K+D++S GI +E
Sbjct: 174 IGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 15/202 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 528
+F + K+G+G FG V+K R + + A+K+ LS + + +E +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---LNWQARVRIIEGIAQGLLY 585
++R +++G+ +++EY N L+ L + L W R I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 646 YALDGLFSIKSDVFSFGILMLE 667
D ++ KSDV++ G+++ E
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 54/299 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 523
E ++ +LG+G FG VY+G VA+K ++ N S + EF NE ++ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYM-------------PNKSLNVFLFDSTKKRLLNWQ 570
++VRLLG ++++E M P N L T ++ +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ 629
A IA G+ YL + +HRDL A N ++ +D+ KI DFG+ R ++ D +
Sbjct: 126 AE------IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLG 687
K ++ +M+PE DG+F+ KSDV+SFG+++ E TL+ + G+ N + +
Sbjct: 177 KGGKGLLPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235
Query: 688 HAWDLWKDDRVHDLID--PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
D DL + P + + LMR +C Q N RPT +++S +
Sbjct: 236 -------DGGHLDLPENCPDKLLE------LMR------MCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/245 (28%), Positives = 116/245 (47%), Gaps = 35/245 (14%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
++G G FG V+ G L ++VA+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
E+ L+ E+M + L+ +L ++ + + + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLFSI 654
DL A N L+ ++ K+SDFG+ R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 655 KSDVFSFGILMLETLSSKK---------------NTG-------VYNADSFNLLGHAWDL 692
KSDV+SFG+LM E S K N G + + + L+ H W
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKE 240
Query: 693 WKDDR 697
+DR
Sbjct: 241 RPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQH 526
+ ++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 527 RNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
N+VRL +G ++ EYM + L L DS + + Q + ++ + +GL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH I+HRD+K SNIL++ D K++DFGLAR + T +++ T Y P
Sbjct: 115 YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 645 EYAL-DGLFSIKSDVFSFGILMLETLSSK 672
E L + + D++S G ++ E K
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 77/204 (37%), Positives = 107/204 (52%), Gaps = 15/204 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E + KLG G FG V+ G +VA+K L Q + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 531 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
RL V E I I+ EYM N SL FL +L + + IA+G+ ++
Sbjct: 65 RLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKLIDMAAQIAEGMAFIE-- 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
R IHRDL+A+NIL+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 120 -RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEA 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
G F+IKSDV+SFGIL+ E ++
Sbjct: 175 INYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 479 LGEGGFGPVYKGR---LLNGQE---VAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 531
+G+G FG V++ R LL + VAVK L + S +F+ E L+A+ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------------------LNWQAR 572
LLG C L+ EYM LN FL + + L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGN 631
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 469 ATENFSMQCKLGEGGFGPVYKG--RLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLI 521
++ ++ LG G FG VY+G R +G +VAVK L + S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIE 577
+K H+N+VRL+G E+ + ++LE M L FL ++ + L + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLAR-MFGGDELQGNTK 633
+A+G YL + IHRD+ A N LL KI+DFG+AR ++ + +
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ +M PE LDG+F+ K+DV+SFG+L+ E S
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 79/270 (29%), Positives = 118/270 (43%), Gaps = 30/270 (11%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538
LG G FG V+ G+ +VA+K + + +F E ++ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRD 598
Q ++ EYM N L +L +K L + + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 599 LKASNILLDKDMNPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKS 656
L A N L+ +D K+SDFGLAR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 657 DVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPML 716
DV+SFG+LM E S K ++ + + V ++ V + P L
Sbjct: 183 DVWSFGVLMWEVFSEGKM--------------PYERFSNSEV---VESVSAGYRLYRPKL 225
Query: 717 --MRYINVALLCVQENAADRPTMSDVISMI 744
+ C E DRP ++S +
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 76/216 (35%), Positives = 114/216 (52%), Gaps = 29/216 (13%)
Query: 478 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLV 530
+LGE FG VYKG L Q VA+K L +++ L+E FK+E M+ ++LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRIIE 577
LLG ++ +I Y + L+ FL D T K L V I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQ 634
IA G+ +L S ++H+DL N+L+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +MSPE + G FSI SD++S+G+++ E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 479 LGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVR 531
LG G FG V+ + +E V VK L + EF+ E+ + KL H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 585
LLG C E +ILEY L FL + K L+ + +V + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
L S R +HRDL A N L+ K+S L++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKK 673
+ FS KSDV+SFG+LM E + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 80/296 (27%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+ ++ LGEG FG V K + VAVK L + + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 578
+ +H+N++ LLG C ++G +++EY + +L FL R E
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 579 ---------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629
+A+G+ +L + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL- 686
T +M+PE D +++ +SDV+SFG+L+ E TL G+ + F LL
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248
Query: 687 -GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741
G+ + P E+ LMR C E + RPT ++
Sbjct: 249 EGYRME-----------KPQNCTQELY--HLMRD------CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGL-KEFKNEMMLIAKLQHRN 528
E +LGEG G V K RL N + A+K ++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 529 LVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIA 580
+V+ G ++ + +EY SL DS K++ R+ +I E +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-----DSIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+GL YLH +IIHRD+K SNILL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLE 667
YM+PE +SI SDV+S G+ +LE
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 67/197 (34%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLG 534
LG+G FG V R + G+ A+K L + KE E +++++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ EK+ L+LEY P L F S + R +AR E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL--FSHLSKEGRFSEERARFYAAE-IVLALEYLHSL---G 113
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
II+RDLK NILLD D + K++DFGLA+ + + T GT Y++PE L +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKGYG 171
Query: 654 IKSDVFSFGILMLETLS 670
D +S G+L+ E L+
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 77/205 (37%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 475 MQCKLGEGGFGPV--YKGRLLN---GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 528
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 529 LVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+ GCC EQG K LI+EY+P SL +L K LN + + I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPE 645
H IHRDL A N+LLD D KI DFGLA+ G E + + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
+ FS SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 78/282 (27%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 474 SMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
LG C + +I E+M +L +L + ++ +N + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY--GYMSPEYALDG 650
IHRDL A N L+ ++ K++DFGL+R+ GD T + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYN 180
Query: 651 LFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDD----RVHDLIDP 704
FSIKSDV++FG+L+ E T G+ + + LL + + + + +V++
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE---- 236
Query: 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
LMR C Q N +DRP+ +++
Sbjct: 237 -----------LMRA------CWQWNPSDRPSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 72/194 (37%), Positives = 108/194 (55%), Gaps = 15/194 (7%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+GEG FG V +G GQ+VAVK + + + Q F E ++ KL H+NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ G I ++E M +L FL + + L++ ++ +A+G+ YL +++H
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RDL A NIL+ +D K+SDFGLAR+ G N+K V + +PE FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKS 178
Query: 657 DVFSFGILMLETLS 670
DV+S+G+L+ E S
Sbjct: 179 DVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 88/281 (31%), Positives = 137/281 (48%), Gaps = 31/281 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL ++ +I EYM SL FL ++L + IA+G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE--- 120
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEYA 647
R IHRDL+A+N+L+ + + KI+DFGLAR+ +E +G I T +PE
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAI 176
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
G F+IKSDV+SFGIL+ E ++ K G+ N+D + L + + + + P
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC-----PD 231
Query: 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ D + C +E A +RPT + S++++
Sbjct: 232 ELYD------------IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 79/206 (38%), Positives = 112/206 (54%), Gaps = 16/206 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 531 RLLGCCVEQGEKILIL-EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+L E E I I+ EYM SL FL K L V + IA G+ Y+
Sbjct: 65 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE-- 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E QG I T +PE
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEA 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
AL G F+IKSDV+SFGIL+ E L++K
Sbjct: 175 ALYGRFTIKSDVWSFGILLTE-LTTK 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 77/205 (37%), Positives = 108/205 (52%), Gaps = 13/205 (6%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E+ + KLG G FG V+ G +VAVK L + + F E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LV+L E+ I + EYM SL FL D + R L V + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPE 645
R IHRDL+++NIL+ + KI+DFGLAR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 83/267 (31%), Positives = 130/267 (48%), Gaps = 35/267 (13%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKRLS----NQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
LG E+ + LE +P SL L + S + ++ R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH--D 120
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD- 649
R +HRD+K +NIL+D + K++DFG+A+ K G+ +M+PE
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
G + + +D++S G +LE + K + ++K R +L P I D
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--------VFKIGRSKEL--PPI-PD 225
Query: 710 EISLPMLMRYINVALLCVQENAADRPT 736
+S +I L C+Q + + RPT
Sbjct: 226 HLS-DEAKDFI---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 102/321 (31%), Positives = 149/321 (46%), Gaps = 56/321 (17%)
Query: 471 ENFSMQCKLGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLI 521
+ + LGEG FG V K R VAVK L N + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLL 567
+ +H+N++ LLG C ++G +I+EY +L FL FD TK + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+++ V +A+G+ YL SR R IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNL 685
T +M+PE D +++ +SDV+SFGILM E TL G+ + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 686 L--GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT------- 736
L GH D + H+L MLMR C RPT
Sbjct: 249 LREGHRMDK-PSNCTHELY------------MLMRE------CWHAVPTQRPTFKQLVEA 289
Query: 737 MSDVISMINNEHLNLPSPKEP 757
+ V++ ++ E+L+L P E
Sbjct: 290 LDKVLAAVSEEYLDLSMPFEQ 310
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 79/297 (26%), Positives = 141/297 (47%), Gaps = 51/297 (17%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQG---LKEFKNEMMLIAKLQHRNLVR 531
LG G F Y+ R + G +AVK+++ N S + ++ + E+ L+A+L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LG E L +E+M S++ L + + K+ ++ E + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLHEN 122
Query: 590 SRFRIIHRDLKASNILLDKD-MNPKISDFGLA-----RMFGGDELQGNTKQIVGTYGYMS 643
+IIHRD+K +N+L+D +I+DFG A + G E QG Q++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
PE + DV+S G +++E ++K +NA+ H ++K +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAE--KHSNHLALIFK---IASATT 228
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFT 760
+ + +S P L +V L C++ DRP +++ K P F
Sbjct: 229 APSIPEHLS-PGLR---DVTLRCLELQPEDRPPSRELL-------------KHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 39/217 (17%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN-----EMMLIAKLQ 525
+ KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEGI 579
H N++ LL + L+ E+M K ++ L + K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYM-LM--------T 111
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG--GDELQGNTKQIVG 637
+GL YLH I+HRDLK +N+L+ D K++DFGLAR FG ++ T Q+V
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV- 164
Query: 638 TYGYMSPEYALDGLFSIKS-----DVFSFGILMLETL 669
T Y +PE LF + D++S G + E L
Sbjct: 165 TRWYRAPEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/202 (30%), Positives = 105/202 (51%), Gaps = 8/202 (3%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 528
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+ V E L++ Y+ SL + S + L+ +++ + +GL YLH
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 646
+ IHRD+KA NILL +D + KI+DFG++ GGD + K VGT +M+PE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 647 ALDGL-FSIKSDVFSFGILMLE 667
+ K+D++SFGI +E
Sbjct: 178 MEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQHRNLVRLLG 534
K+GEG +G VYK R L G+ VA+K++ + E+ L+ +L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 593
+G+ L+ E+M +++ ++R L ++ ++ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 652
I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE L D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 653 SIKSDVFSFGILMLETLS 670
S D++S G + E LS
Sbjct: 177 STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-24
Identities = 27/65 (41%), Positives = 43/65 (66%)
Query: 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWY 353
C GD F+ L +K PD +++ + L++C+ CL NCSC AYA ++++ SGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 354 GDLID 358
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 34/215 (15%)
Query: 479 LGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 534 GCCVEQGEK--ILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLY 585
G C G + L++EY+P SL +L D K L Q I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-----IVGTYG 640
L R +HRDL NIL++ + KI DFGL ++ D+ ++ I
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF---- 176
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKN 674
+ +PE + FS+ SDV+SFG+++ E + S K+
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 35/222 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 519
KLGEG FG V+ Q+ VAVK L + S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 571
++++L N+ RLLG C +I+EYM N LN FL + + L++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 628
+ + IA G+ YL +HRDL N L+ K+ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
QG +M+ E L G F+ KSDV++FG+ + E L+
Sbjct: 189 QGRA---PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFK-----NEMMLIAKL-QHRNLVR 531
+GEG F V + +E A+K L + Q +KE K E ++ +L H +++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
L ++ +LEY PN L ++ K L+ + I L YLH
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHSK-- 121
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---------------- 635
IIHRDLK NILLDKDM+ KI+DFG A++ + + K
Sbjct: 122 -GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 636 --VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
VGT Y+SPE + SD+++ G ++ + L+ K
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKR-----LSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G FG VY ++ G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
GC + + +EYMP S+ L L R + I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLH---SN 123
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYALDGL 651
I+HRD+K +NIL D N K+ DFG ++ G K + GT +MSPE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 652 FSIKSDVFSFGILMLETLSSK 672
+ K+DV+S G ++E L+ K
Sbjct: 184 YGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 78/207 (37%), Positives = 112/207 (54%), Gaps = 15/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 529
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ KL+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V L E+ I + E+M SL FL + K L Q V + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAAQIADGMAYIE-- 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYMSPEY 646
R IHRDL+A+NIL+ ++ KI+DFGLAR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
AL G F+IKSDV+SFGIL+ E ++ +
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 84/272 (30%), Positives = 124/272 (45%), Gaps = 32/272 (11%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
+LG G FG V G+ +VA+K + S EF E ++ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQYSRFRII 595
+Q ++ EYM N L +L KR Q + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL-LEMCKDVCEGMAYLESKQF-----I 122
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YGYMSPEYALDGLF 652
HRDL A N L+D K+SDFGL+R DE + VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 653 SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712
S KSDV++FG+LM E S K + ++ + K + L P + +++
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKM-------PYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
Query: 713 LPMLMRYINVALLCVQENAADRPTMSDVISMI 744
M C E A +RPT ++S I
Sbjct: 232 AIMYS--------CWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/194 (29%), Positives = 94/194 (48%), Gaps = 14/194 (7%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLL 533
+LG G G V K G+ +AVK + + K + ++ K +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G G+ + +EYM SL+ L + R+ + +I + +GL YLH + +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL-KEVQGRI-PERILGKIAVAVLKGLTYLH--EKHK 121
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
IIHRD+K SNIL++ K+ DFG++ G + K VGT YM+PE +S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGNDYS 177
Query: 654 IKSDVFSFGILMLE 667
+KSD++S G+ ++E
Sbjct: 178 VKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 479 LGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
LG+G +G VY R L+ Q +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
E G + +E +P SL+ L N Q + + I +GL YLH +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 598 DLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSI 654
D+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 655 KSDVFSFGILMLETLSSK 672
+D++S G ++E + K
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 73/208 (35%), Positives = 109/208 (52%), Gaps = 30/208 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQ----SGQGLKEFKNEMMLIAKLQHRNLV 530
KLGEG +G VYK R G+ VA+K RL N+ L+E L+ +L+H N+V
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61
Query: 531 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA----QGLLY 585
+LL K+ L+ EY + L +L + L+ +I+ I +GL Y
Sbjct: 62 KLLDVIH-TERKLYLVFEYC-DMDLKKYL--DKRPGPLS----PNLIKSIMYQLLRGLAY 113
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
H + RI+HRDLK NIL+++D K++DFGLAR F G L+ T ++V T Y +PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPE 168
Query: 646 YAL-DGLFSIKSDVFSFGILMLETLSSK 672
L +S D++S G + E ++ K
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 24/210 (11%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKR--LSNQSGQG-------LKEFKNEMMLIAKLQHRN 528
+G G FG VY G +G+ +AVK+ L + S L E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+ LG ++ + LEY+P S+ L + + ++ L+ + I +GL YL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKGLNYL 122
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IVGTYGYM 642
H +R IIHRD+K +NIL+D KISDFG+++ + L T + G+ +M
Sbjct: 123 H--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+PE ++ K+D++S G L++E L+ K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 87/311 (27%), Positives = 148/311 (47%), Gaps = 53/311 (17%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + E VA+K L+ +G + EF +E +++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 588
LG C+ + L+ + MP+ L ++ + + LLNW + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDL A N+L+ + KI+DFGLAR+ GDE + N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 649 DGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
F+ +SDV+S+G+ + E T K G+ + +LL ++ L P I
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---------EKGERLPQPPI 235
Query: 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN--------------NEHLNLP 752
++ + M+ C +A RP ++ + + ++ + LP
Sbjct: 236 CTIDVYMVMVK--------CWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLP 287
Query: 753 SPKEPAFTKGI 763
SP + F + +
Sbjct: 288 SPNDSKFFQNL 298
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 4e-23
Identities = 75/245 (30%), Positives = 117/245 (47%), Gaps = 33/245 (13%)
Query: 472 NFSMQCKLGEGGFGPVYKGRL--LNGQ----EVAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
N + LGEG FG V K L G+ VAVK L N S L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------------------- 563
H ++++L G C + G +LI+EY SL FL +S K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+R L + I++G+ YL + +++HRDL A N+L+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNAD 681
++ + +M+ E D +++ +SDV+SFG+L+ E TL G+
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237
Query: 682 SFNLL 686
FNLL
Sbjct: 238 LFNLL 242
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 73/214 (34%), Positives = 111/214 (51%), Gaps = 25/214 (11%)
Query: 478 KLGEGGFGPVYKGRLL-----NGQEVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVR 531
+LGE FG +YKG L + Q VA+K L + + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLF--------------DSTKKRLLNWQARVRIIE 577
LLG ++ ++ EY+ L+ FL D T K L+ + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIV 636
IA G+ YL S F +H+DL A NIL+ + ++ KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLS--SHF-FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M PE + G FS SD++SFG+++ E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 69/194 (35%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGCCV 537
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
++ +++E +P FL KK L + V+ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 598 DLKASNILLDKDMNPKISDFGLARMF-GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
DL A N L+ ++ KISDFG++R G KQI + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 657 DVFSFGILMLETLS 670
DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 6e-23
Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL-------SNQSGQGLKEFKNEMMLI 521
NF ++ K+G+G F VYK LL+G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIA 580
+L H N+++ L +E E ++LE L+ + K KRL+ + + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
L ++H RI+HRD+K +N+ + K+ D GL R F ++ VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPY 171
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLE 667
YMSPE + ++ KSD++S G L+ E
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 79/301 (26%), Positives = 142/301 (47%), Gaps = 36/301 (11%)
Query: 466 ITAATENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQSGQ-GLKEFKNEMM 519
I + + ++ L EG FG ++ G L++ +EV VK + + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS-LNVFL-----FDSTKKRLLNWQARV 573
L+ L H+N++ +L C+E GE +L N L +FL ++ + L+ Q V
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE--LQG 630
+ IA G+ YLH+ +IH+D+ A N ++D+++ KI+D L+R +F D L
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW 690
N + V +M+ E ++ +S SDV+SFG+L+ E L + T D F + +
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEMAAYLK 233
Query: 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750
D ++ L P+ DE+ V C + +RP+ S ++ + + H
Sbjct: 234 DGYR------LAQPINCPDEL--------FAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279
Query: 751 L 751
L
Sbjct: 280 L 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 79/278 (28%), Positives = 116/278 (41%), Gaps = 35/278 (12%)
Query: 478 KLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
KLG+G FG V +G VAVK L + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 587
G V +++ E P SL L L ++ + IA G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ------IANGMRYLE 114
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYGYMSPEY 646
R IHRDL A NILL D KI DFGL R ++ + + + + +PE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
FS SDV+ FG+ + E + Y + + L + L K D+ + ++
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERLE--- 221
Query: 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+ E NV L C N ADRPT + + +
Sbjct: 222 -RPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 44/282 (15%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V GRL L G+ VA+K L + + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G + +++ EYM N SL+ FL + V ++ GIA G+ YL S
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 647
+HRDL A NIL++ ++ K+SDFGL+R+ D T T G + +PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTAPEAI 181
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID---- 703
F+ SDV+S+GI+M E +S Y + W++ D + + +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDVIKAIEEGYRL 228
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
P M +L LM L C Q++ +RP ++S+++
Sbjct: 229 PAPMDCPAALHQLM------LDCWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 83/283 (29%), Positives = 133/283 (46%), Gaps = 44/283 (15%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V +GRL L G+ VA+K L S + + ++F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ----ARVRIIEGIAQGLLYLHQY 589
G + ++I E+M N +L+ FL R + Q V ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL------RQNDGQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG---TYGYMSPEY 646
S +HRDL A NIL++ ++ K+SDFGL+R D +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH----DLI 702
F+ SDV+S+GI+M E +S Y + WD+ D ++ D
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WDMSNQDVINAIEQDYR 229
Query: 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
P M +L LM L C Q++ RP ++S ++
Sbjct: 230 LPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 81/286 (28%), Positives = 138/286 (48%), Gaps = 42/286 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR-----LLNWQARVRIIEGIAQGLLY 585
+L V + +I E+M SL FL + L+++ A+ IA+G+ +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAF 117
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQIVGTYGYM 642
+ Q + IHRDL+A+NIL+ + KI+DFGLAR+ +E +G I T
Sbjct: 118 IEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---- 170
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHD 700
+PE G F+IKSDV+SFGIL++E ++ + G+ N + L + + + +
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE---- 226
Query: 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ P + N+ + C + +RPT + S++++
Sbjct: 227 -----------NCPEEL--YNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 62
Query: 531 RLLGCCVEQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ G ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ +HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 173
Query: 650 GLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFGIL+ E S
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 72/226 (31%), Positives = 124/226 (54%), Gaps = 23/226 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQ---EVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LGEG FG V +G+L +VAVK +++ + +++F +E + + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 534 GCCVEQGEK------ILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLL 584
G C++ E ++IL +M + L+ FL S + L Q V+ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDEL-QGNTKQIVGTYGYM 642
YL S IHRDL A N +L+++MN ++DFGL+ +++ GD QG ++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL 686
+ E D +++ KSDV+SFG+ M E T GV N++ ++ L
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 66/195 (33%), Positives = 108/195 (55%), Gaps = 13/195 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 534
K+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L H N+VRLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
V K+ L+ E++ + L ++ DS+ L+ + + QG+ Y H + R
Sbjct: 66 V-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---R 119
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 652
++HRDLK N+L+D++ K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 653 SIKSDVFSFGILMLE 667
S D++S G + E
Sbjct: 178 STPVDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 80/282 (28%), Positives = 141/282 (50%), Gaps = 44/282 (15%)
Query: 479 LGEGGFGPVYKGRL-LNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V++G L + G++ VA+K L + + ++F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G + ++I EYM N +L+ +L D + + V ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYA 647
+HRDL A NIL++ ++ K+SDFGL+R+ L+ + + T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID---- 703
F+ SDV+SFGI+M E +S + + WD+ + + + D
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS-------FGERPY------WDMSNHEVMKAINDGFRL 229
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
P M ++ LM L C Q++ A RP D++++++
Sbjct: 230 PAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-21
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 25/221 (11%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLN---GQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
N ++ +LGEG FG V+ N Q+ VAVK L + S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----------FDSTKKRLLNWQARVRI 575
H ++V+ G CVE I++ EYM + LN FL + + L + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 632
+ IA G++YL + +HRDL N L+ +++ KI DFG++R ++ D + G+T
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M PE + F+ +SDV+S G+++ E + K
Sbjct: 183 MLPI---RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-21
Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 475 MQCKLGEGGFGPVYKGR---LLNGQE---VAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
++ +LGEG FG V+ LL Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL---------FDSTKKRL---LNWQARVRII 576
+VR G C E +++ EYM + LN FL + L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQI 635
IA G++YL + +HRDL N L+ + + KI DFG++R ++ D + + +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M PE L F+ +SD++SFG+++ E + K
Sbjct: 186 LPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ + + +LG+G FG VYK + G A K + +S + L++F E+ ++++ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V L + + +++E+ +L+ + ++ L Q R + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH- 120
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
++IHRDLKA NILL D + K++DFG++ LQ +GT +M+PE
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ-KRDTFIGTPYWMAPEVVA 176
Query: 649 -----DGLFSIKSDVFSFGILMLE 667
D + K+D++S GI ++E
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 34/271 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
GC + + L++EY + ++ + KK L + I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDIL--EVHKKPLQEVEIAA-ICHGALQGLAYLHSHER-- 136
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 650
IHRD+KA NILL + K++DFG A L VGT +M+PE L +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 651 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710
+ K DV+S GI +E L+ +K ++N ++ + L H + ++D P + ++
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMSALYH---IAQND------SPTLSSND 238
Query: 711 ISLPMLMRYINVALLCVQENAADRPTMSDVI 741
S + N C+Q+ DRP+ +++
Sbjct: 239 WSD----YFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 478 KLGEGGFGPVYK------GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+G+G FG V K G++L +E+ ++ + Q L +E+ ++ +L+H N+VR
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 532 LLGCCV-EQGEKI-LILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLH- 587
+ + + +++EY L + K ++ + + RI+ + L H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 588 -QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
++HRDLK +NI LD + N K+ DFGLA++ G D K VGT YMSPE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTPYYMSPEQ 181
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
+ KSD++S G L+ E
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 83/293 (28%), Positives = 136/293 (46%), Gaps = 44/293 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRLSNQSGQGLK-EFKNEMM 519
KLGEG FG V+ ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--------FDSTKKRLLNWQA 571
++++L+ N++RLL C+ +I EYM N LN FL + +++
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 628
+ + IA G+ YL S +HRDL N L+ K+ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 688
QG + V +MS E L G F+ SDV++FG+ + E L+ K ++ +
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
Query: 689 AWDLWKDD-RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 740
+ ++D R L P + D SL LM L C + NA +RP+ ++
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPD--SLYKLM------LSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 75/280 (26%), Positives = 118/280 (42%), Gaps = 48/280 (17%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
+LG G FG V+ G+ +VA+K + N+ ++F E ++ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
+Q ++ E+M N L +L ++ L+ + + + + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPEYALDGL 651
DL A N L+ K+SDFG+ R D + + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDD-------EYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 652 FSIKSDVFSFGILMLETLS-------SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
+S KSDV+SFG+LM E + K N V S R L P
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS--------------RGFRLYRP 223
Query: 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+ + M C E RPT ++++ I
Sbjct: 224 KLASMTVYEVMYS--------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 21/205 (10%)
Query: 472 NFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 528
+F + KLG+G +G VYK RL + Q A+K L + S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 529 LVR-----LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQG 582
++ L G + +++EY P L+ + K ++L+ Q RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L LH+ +I+HRDLK++NILL + KI D G++++ + K +GT YM
Sbjct: 116 LQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
+PE +S KSD++S G L+ E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 88/296 (29%), Positives = 143/296 (48%), Gaps = 40/296 (13%)
Query: 469 ATENFSMQCKLGEGGFGPVY----KGRLLNGQE--VAVKRLSNQSGQGLK-EFKNEMMLI 521
A E +M +LG+G FG VY KG + + E VA+K ++ + + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 522 AKLQHRNLVRLLGCCVEQGEKIL-ILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 573
+ ++VRLLG V QG+ L I+E M L +L ++ + + + +
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 632
++ IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R ++ D +
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAW 690
K ++ +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N +
Sbjct: 180 KGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238
Query: 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
L K D D+ L LMR +C Q N RP+ ++IS I
Sbjct: 239 LLDKPDNCPDM-----------LFELMR------MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/200 (35%), Positives = 106/200 (53%), Gaps = 12/200 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
K+GEG +G VYKGR GQ VA+K RL ++ E+ L+ +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQYSRFR 593
+++ LI E++ + L +L DS K V+ + I QG+L+ H R
Sbjct: 67 VLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSR---R 121
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 652
++HRDLK N+L+D K++DFGLAR F G ++ T ++V T Y +PE L +
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPRY 179
Query: 653 SIKSDVFSFGILMLETLSSK 672
S D++S G + E + K
Sbjct: 180 STPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG V+KG + + VA+K + ++SG Q +E + M+ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIAQGLLYLH 587
LG C G + L+ + P SL + +RLLNW + IA+G+ YL
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLE 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
++ R++HR+L A NILL D +I+DFG+A + D+ + + +M+ E
Sbjct: 127 EH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
L G ++ +SDV+S+G+ + E +S
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 59/198 (29%), Positives = 92/198 (46%), Gaps = 41/198 (20%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ------GLKEFKNEMMLI 521
++ + KLGEG FG VYK R + G+ VA+K++ + + L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 522 AKLQHRNLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
KL+H N+V L+ VE+ +K ++ YM D LL V
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM----------DHDLSGLLE-NPSV 110
Query: 574 R--------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
+ + + +G+ YLH+ I+HRD+KA+NIL+D KI+DFGLAR + G
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 626 DELQGNTKQIVGTYGYMS 643
GT Y +
Sbjct: 168 PPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 69/203 (33%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 479 LGEGGFGPV----YKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 533 LGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL--HQ 588
G C E G LI+E++P+ SL +L K +N + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT-YGYMSPEYA 647
Y +HRDL A N+L++ + KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
+ F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 57/175 (32%), Positives = 94/175 (53%), Gaps = 18/175 (10%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG------LKEFKNEMMLIAKLQHRNLV 530
++GEG G V+K + G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+LL +L++EYMP+ L+ L D + L Q + + + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVK-SYMRMLLKGVAYMHA-- 117
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + Q V T Y +PE
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 479 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G FG VY GR L ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 533 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLLYLHQY 589
GC ++ EK L +EYMP S+ D K L + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGYMSPEYAL 648
I+HRD+K +NIL D N K+ DFG ++ + G + + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680
+ K+DV+S G ++E L+ K Y A
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 73/236 (30%), Positives = 121/236 (51%), Gaps = 30/236 (12%)
Query: 473 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH 526
F++ LG+G FG V + +L + Q+VAVK L S ++EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 527 RNLVRLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRL------LNWQARVR 574
N+++L+G + K ++IL +M + L+ FL S R+ L Q VR
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS---RIGEEPFTLPLQTLVR 117
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDEL-QGNT 632
+ IA G+ YL S IHRDL A N +L+++M ++DFGL++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL 686
++ +++ E D +++ SDV++FG+ M E T GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-21
Identities = 69/205 (33%), Positives = 106/205 (51%), Gaps = 25/205 (12%)
Query: 478 KLGEGGFGPVYKG--RLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR----NLV 530
+LG G FG V KG ++ Q +VA+K L N++ K ++EMM A++ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
R++G C E +L++E LN FL S KK + V ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPE 645
+HRDL A N+LL KISDFGL++ G D+ + + G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR----SAGKWPLKWYAPE 168
Query: 646 YALDGLFSIKSDVFSFGILMLETLS 670
FS +SDV+S+GI M E S
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 528
NF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+LL + + L+ E++ ++ L F+ D++ + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ R++HRDLK N+L++ + K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 649 DG-LFSIKSDVFSFGILMLETLSSK 672
+S D++S G + E ++ +
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 84/300 (28%), Positives = 141/300 (47%), Gaps = 55/300 (18%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QH 526
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARV 573
N++ LLG C +G L +EY P+ +L FL S + L+ Q +
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R G E+ K
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VK 179
Query: 634 QIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHA 689
+ +G +M+ E +++ SDV+S+G+L+ E +L G+ A+ + L
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239
Query: 690 WDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
+ L K DD V+DL M+ C +E +RP+ + ++ +N
Sbjct: 240 YRLEKPLNCDDEVYDL-----MRQ----------------CWREKPYERPSFAQILVSLN 278
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 35/271 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
GC + + L++EY + ++ K+ L + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 650
+IHRD+KA NILL + K+ DFG A + VGT +M+PE L +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 651 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710
+ K DV+S GI +E +++ ++N ++ + L H + P +
Sbjct: 190 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQNESPALQSGH 238
Query: 711 ISLPMLMRYINVALLCVQENAADRPTMSDVI 741
S + N C+Q+ DRPT S+V+
Sbjct: 239 WS----EYFRNFVDSCLQKIPQDRPT-SEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLV 530
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ G ++ + +I+EY S D K L+ I+ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
IHRD+KA+NILL ++ + K++DFG++ + NT VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQS 173
Query: 651 LFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 174 GYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 68/271 (25%), Positives = 128/271 (47%), Gaps = 31/271 (11%)
Query: 479 LGEGGFGP--VYK----GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G FG +Y+ L+ +EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
++ ++ +EY +L + K +L + + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
I+HRD+K NI L K K+ DFG++++ G + T +VGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 653 SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712
+ KSD+++ G ++ E L+ K+ ++A N L + + + PV+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR---TFDAT--NPLNLVVKIVQGNYT-----PVVSVYSSE 228
Query: 713 LPMLMRYINVALLCVQENAADRPTMSDVISM 743
L L+ +Q++ RPT +V+
Sbjct: 229 LISLVHS------LLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR---LLNGQ---EVAVKRLSNQSGQGLKE-FKNEMMLIAK 523
N S LG G FG V + L +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
L H N+V LLG C G ++I EY L FL ++ L + + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQIVGTY 639
+ +L + IHRDL A N+LL KI DFGLAR D ++GN + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-20
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 290 HSLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKES 346
L C D F++L ++K PD ++LE+C+ CL NCSC AYA +N S
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDNASAITA--ISLEECREACLSNCSCTAYAYNNG--S 56
Query: 347 SGCLMWYGDLIDARRPIRNFTGQSVYLRVP 376
GCL+W G L + R + G ++YLR+
Sbjct: 57 GGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 37/217 (17%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVK------RLSNQSGQGLKE----FKNEMMLIAKLQHR 527
+G+G +G VY + G+ +AVK ++ + K+ ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 528 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 580
N+V+ LG E E+ L LEY+P S+ L F+ R Q +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VL 118
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGT 638
+GL YLH I+HRDLKA N+L+D D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 639 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSSKK 673
+M+PE +S K D++S G ++LE + ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 478 KLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+LGEG FG V+ N VAVK L + + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQAR-----------VRIIEG 578
G C + I++ EYM + LN FL L++ Q R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTKQI 635
IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D + G+T
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
+ +M PE + F+ +SDV+SFG+++ E + K
Sbjct: 189 I---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 3e-20
Identities = 76/279 (27%), Positives = 132/279 (47%), Gaps = 34/279 (12%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS---NQSGQGLKEFKNEMMLIAKLQHRN 528
F+ ++G G FG VY R + EV A+K++S QS + ++ E+ + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ GC + + L++EY + ++ K+ L I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
++ +IHRD+KA NILL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 649 ---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
+G + K DV+S GI +E +++ ++N ++ + L H + P
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---------IAQNESPT 243
Query: 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+ +E S + N C+Q+ DRPT +++ +
Sbjct: 244 LQSNEWS----DYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLK-EFKNEMMLIAKLQHRNLVRLLGC 535
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
C ++ +++E + FL T+ L + ++++E A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
HRDL A N L+ + KISDFG++R G G KQI + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 654 IKSDVFSFGILMLETLS 670
+SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 43/230 (18%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-----------------VAVKRL-SNQSGQGLKEFKNEMM 519
KLGEG FG V+ ++N Q+ VAVK L + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-----LFDSTKKR--------- 565
++++L+ N++RLLG CV++ +I EYM N LN F L D +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 566 --LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-M 622
+++ + + + IA G+ YL S +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 623 FGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ GD +QG + V +M+ E L G F+ SDV++FG+ + E L
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 6e-20
Identities = 93/331 (28%), Positives = 150/331 (45%), Gaps = 54/331 (16%)
Query: 479 LGEGGFGPVY--------KGRLLNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRN 528
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 575
++ LLG C + G +++EY +L +L FD+ K + L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLW 693
+M+PE D +++ +SDV+SFG+L+ E TL G+ + F LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG---- 252
Query: 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN-------- 745
H + P E L M+MR C + RPT ++ ++
Sbjct: 253 -----HRMDKPANCTHE--LYMIMRE------CWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 746 NEHLNLPSPKEPAFTKGINVKNSSHSNSGTS 776
+E+L+L P E ++ G SS S+ S
Sbjct: 300 DEYLDLSVPFE-QYSPGCPDSPSSCSSGDDS 329
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC- 535
+GEG +G VYK R GQ VA+K + +E K E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 536 -----CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR------IIEGIAQGLL 584
+ L++E S+ + K L R++ I+ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH+ ++IHRD+K NILL K+ K+ DFG++ D G +GT +M+P
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAP 182
Query: 645 E-----YALDGLFSIKSDVFSFGILMLE 667
E D + +SDV+S GI +E
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 11/198 (5%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG+GGFG V ++ G+ A K+L + +G + NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ + L++ M L +++ + +A + I GL +LHQ RI
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---RI 116
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
++RDLK N+LLD N +ISD GLA G K GT GYM+PE ++
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 655 KSDVFSFGILMLETLSSK 672
D F+ G + E ++ +
Sbjct: 174 SVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 8e-20
Identities = 87/307 (28%), Positives = 147/307 (47%), Gaps = 53/307 (17%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + E VA+K L S + KE +E ++A + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 588
LG C+ + LI + MP L ++ + + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDL A N+L+ + KI+DFGLA++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 649 DGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
+++ +SDV+S+G+ + E T SK G+ ++ ++L K +R L P I
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------KGER---LPQPPI 235
Query: 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN--------------NEHLNLP 752
++ + M+ C +A RP ++I + +E ++LP
Sbjct: 236 CTIDVYMIMVK--------CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 287
Query: 753 SPKEPAF 759
SP + F
Sbjct: 288 SPTDSNF 294
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 73/240 (30%), Positives = 117/240 (48%), Gaps = 30/240 (12%)
Query: 479 LGEGGFGPVY--------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-QHRN 528
LGEG FG V K + VAVK L + + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTK--KRLLNWQARVRI 575
++ LLG C + G +I+EY +L +L +D + + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL--GHAWD 691
+M+PE D +++ +SDV+SFG+LM E TL G+ + F LL GH D
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 259
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRLLG 534
K+G G FG VY L+ E+ AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
V + + + +EY +L L R+L+ + +GL YLH + I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL---EHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFG------GDELQGNTKQIVGTYGYMSPEYAL 648
+HRD+K +NI LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPEVIT 176
Query: 649 DGLFSIK---SDVFSFGILMLETLSSKK 673
G +D++S G ++LE + K+
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 74/240 (30%), Positives = 117/240 (48%), Gaps = 30/240 (12%)
Query: 479 LGEGGFGPVYKGRLLNGQE--------VAVKRL-SNQSGQGLKEFKNEMMLIAKL-QHRN 528
LGEG FG V + + VAVK L S+ + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLLNWQARVRI 575
++ LLG C + G +I+EY +L +L + L+++ V
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL--GHAWD 691
+M+PE D +++ +SDV+SFG+L+ E TL GV + F LL GH D
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 262
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 21/204 (10%)
Query: 479 LGEGGFGPVYKGRLL--NGQEV--AVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 533
+G+G FG VY G L+ +GQ++ AVK L+ + + +++F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 534 GCCV-EQGEKILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQ 588
G C+ +G +++L YM + L F+ T K L+ + +V A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG--NTKQIVGTYGYMSPEY 646
+ +HRDL A N +LD+ K++DFGLAR E N +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
F+ KSDV+SFG+L+ E ++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 36/211 (17%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIAK 523
+ + +LG+G FG VY R G+ VA+K++ K+F + E+ + K
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 524 LQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVR-IIEGIA 580
L H N+V+L E E + EYM N++ L K + + ++ +R II I
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFS-ESVIRSIIYQIL 109
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN---TKQIVG 637
QGL ++H++ F HRDLK N+L+ KI+DFGLAR E++ T V
Sbjct: 110 QGLAHIHKHGFF---HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYT-DYVS 160
Query: 638 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 667
T Y +PE L +S D+++ G +M E
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 69/221 (31%), Positives = 106/221 (47%), Gaps = 34/221 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQE---------------VAVKRL-SNQSGQGLKEFKNEMMLI 521
KLGEG FG V+ E VAVK L ++ + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLN-----WQAR 572
++L++ N++RLLG CV +I EYM N LN FL +ST N
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 629
+ + IA G+ YL + +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
G + V +M+ E L G F+ SDV++FG+ + E +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 70/225 (31%), Positives = 114/225 (50%), Gaps = 16/225 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNL 529
NF KLGEG + VYKGR G+ VA+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
VRL + + +L+ EYM +K L ++ + L+ + +G+ + H+
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEYAL 648
R++HRDLK N+L++K K++DFGLAR FG + NT V T Y +P+ L
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVLL 173
Query: 649 DG-LFSIKSDVFSFGILMLETLSSKK-NTGVYNADS----FNLLG 687
+S D++S G +M E ++ + G N D F ++G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 69/220 (31%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 471 ENFSMQCKLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 524
N+ + LG G FG VY GR L ++V S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 525 QHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQ 581
+H +V+ GC + EK L +EYMP S+ D K L R I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYG 640
G+ YLH I+HRD+K +NIL D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680
+MSPE + K+DV+S ++E L+ K Y A
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLGC 535
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
+E ++++EY P +L + +KR + I+ Q LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 596 HRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
HRDLK NILLDK M KI DFG++++ + +VGT Y+SPE ++
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 655 KSDVFSFGILMLETLSSKK 673
KSD+++ G ++ E S K+
Sbjct: 181 KSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 18/205 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQHR 527
NF ++ K+G G F VY+ LL+ + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLN-VFLFDSTKKRLLN----WQARVRIIEGIAQG 582
N+++ L +E E ++LE L+ + + +KRL+ W+ V++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 478 KLGEGGFGPVYKG--RLLNGQE-VAVKRLSNQSGQGLKEFKNEMMLIAK----LQHRNLV 530
+LG G FG V KG ++ ++ VAVK L N + K+E++ A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
R++G C E +L++E LN FL K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 646
+HRDL A N+LL KISDFGL++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFG+LM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
G+ +++E+ P +++ + + + L Q +V I + + L YLH +IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 648
RDLKA N+LL D + K++DFG++ N K + +GT +M+PE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS--------AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 649 ---DGLFSIKSDVFSFGILMLE 667
D + K+D++S GI ++E
Sbjct: 186 TMKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 84/313 (26%), Positives = 151/313 (48%), Gaps = 50/313 (15%)
Query: 469 ATENFSMQCKLGEGGFGPVYKG---RLLNGQ---EVAVKRLSNQSGQGLK--EFKNEMML 520
+ E ++ +LG+G FG VY+G ++ G+ VAVK + N+S + EF NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-NESASLRERIEFLNEASV 62
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------DSTKKRLLNWQARV 573
+ ++VRLLG + ++++E M + L +L ++ + Q +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNT 632
++ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D +
Sbjct: 123 QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 179
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNAD--SFNLLGH 688
K ++ M+PE DG+F+ SD++SFG+++ E +L+ + G+ N F + G
Sbjct: 180 KGLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238
Query: 689 AWDLWKD--DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
D + +RV DL M+ +C Q N RPT ++++++
Sbjct: 239 YLDQPDNCPERVTDL-----MR----------------MCWQFNPKMRPTFLEIVNLL-K 276
Query: 747 EHLNLPSPKEPAF 759
+ L+ PS E +F
Sbjct: 277 DDLH-PSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 25/208 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA-------QG 582
V G + + + +++EY SL ++ T+ L Q IA +G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQ--------IAYVCRETLKG 113
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L YLH+ IHRD+K +NILL +D + K++DFG++ + + +GT +M
Sbjct: 114 LAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWM 168
Query: 643 SPEYA---LDGLFSIKSDVFSFGILMLE 667
+PE A G + K D+++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG-QGLKEFK-NEMMLIAKLQ---HRNLVRL 532
+GEG +G VYK R L G+ VA+K++ +G+ E+ L+ +L+ H N+VRL
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 533 LGCC-VEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
L C + ++ L+ E++ ++ L +L K L + ++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFLH 124
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ RI+HRDLK NIL+ D KI+DFGLAR++ + T +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TSVVV-TLWYRAPEVL 178
Query: 648 LDGLFSIKSDVFSFGILMLE 667
L ++ D++S G + E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR 527
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 528 NLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
LV L + E + L+++ + L L S K + Q + I E I L YL
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H IIHRD+K NILLD+ + I+DF +A D T GT GYM+PE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEV 170
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
+S+ D +S G+ E L K+
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL-----SNQSGQGLKEFKNEMMLIAKLQ 525
N+ + LG+G FG VY + G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 526 HRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQG 582
H +V+ GC + E+ L +E+MP S+ D K L + I +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN-TKQIVGTYGY 641
+ YLH I+HRD+K +NIL D N K+ DFG ++ L G K + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
MSPE + K+D++S G ++E L+ K
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 74/258 (28%), Positives = 126/258 (48%), Gaps = 34/258 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-Q 525
E+ + +GEG FG V + + A+K L + + ++F E+ ++ KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQAR 572
H N++ LLG C +G + +EY P +L FL S L Q
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
++ +A G+ YL S + IHRDL A N+L+ +++ KI+DFGL+R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 633 KQIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGH 688
K+ +G +M+ E +++ KSDV+SFG+L+ E +L G+ A+ + L
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233
Query: 689 AWDLWK----DDRVHDLI 702
+ + K DD V++L+
Sbjct: 234 GYRMEKPRNCDDEVYELM 251
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRL--SNQSGQGLKEFK-NEMMLIAKLQH 526
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 527 RNLVRLLGCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGL 583
N+V L+ +E +K L+ +Y + + F KR+ + V+ ++ I G+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMF--------GGDELQGN 631
YLH S + ++HRDLK +NIL+ + KI D GLAR+F D
Sbjct: 122 HYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD----- 173
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
+V T Y +PE L K+ D+++ G + E L+ +
Sbjct: 174 --PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-18
Identities = 92/373 (24%), Positives = 157/373 (42%), Gaps = 54/373 (14%)
Query: 376 PASKLGNKKLLWILV---ILVIPVVLLPSF-YVFYRRRRKCQEKETENVETYQDLLAFDI 431
P ++ W + + V+ L +F +VF R R + K EN + +L FD
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD- 676
Query: 432 NMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSM--QCKLGEGGFGPVYK 489
SK S SIT S+ + + G G YK
Sbjct: 677 ---------------------SKVS-------KSITINDILSSLKEENVISRGKKGASYK 708
Query: 490 GRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548
G+ + NG + VK +++ + E + + KLQH N+V+L+G C + LI EY
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEY 764
Query: 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 608
+ K+L+ L R L+W+ R +I GIA+ L +LH ++ +L I++D
Sbjct: 765 IEGKNLSEVL------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818
Query: 609 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 668
P + L + D I + Y++PE + KSD++ FG++++E
Sbjct: 819 KDEPHLR-LSLPGLLCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 669 LSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD-EISLPMLMRYINVALLCV 727
L+ K +++ A + D + IDP I D ++ ++ +N+AL C
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931
Query: 728 QENAADRPTMSDV 740
+ RP +DV
Sbjct: 932 ATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 73/286 (25%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHR 527
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-----NWQARVRIIEGIAQG 582
N+++ +E E ++LE L+ + K++ L W+ V++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H +SR R++HRD+K +N+ + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
SPE + ++ KSD++S G L+ E + + + D NL + L K ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLCK--KIEQCD 224
Query: 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748
P + D S L + +N +C+ + RP ++ V + H
Sbjct: 225 YPPLPSDHYS-EELRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRL----SNQ--SGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+G +G VY G GQ +AVK++ SN + + ++ + E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYS 590
LG C++ + +E++P S++ L R V + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV----GTYGYMSPEY 646
++HRD+K +N++L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ + KSD++S G + E + K
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 72/271 (26%), Positives = 132/271 (48%), Gaps = 34/271 (12%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-VAVKRLS---NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
GC +++ L++EY + ++ K+ L I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DG 650
+IHRD+KA NILL + K++DFG A VGT +M+PE L +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 651 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710
+ K DV+S GI +E +++ ++N ++ + L H + ++D P + +E
Sbjct: 196 QYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYH---IAQND------SPTLQSNE 244
Query: 711 ISLPMLMRYINVALLCVQENAADRPTMSDVI 741
+ +++ C+Q+ +RP ++++
Sbjct: 245 WT-DSFRGFVD---YCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV 537
+G G +G VYKGR + ++A ++ + +G +E K E+ ++ K HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 538 EQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
++ + L++E+ S+ L +TK L + I I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL--- 648
++IHRD+K N+LL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 649 --DGLFSIKSDVFSFGILMLE 667
D + KSD++S GI +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 479 LGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG G FG VYKG + E VA+K L N S + KE +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQ 588
LG C+ + L+ + MP L ++ ++ + LLNW + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDL A N+L+ + KI+DFGLAR+ DE + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
F+ +SDV+S+G+ + E ++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 58/191 (30%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+GEG G V R +G++VAVK + + Q + NE++++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ E +++E++ +L D + LN + + E + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K+ +ILL D K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 657 DVFSFGILMLE 667
D++S GI+++E
Sbjct: 199 DIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 479 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQHRNLVRLLGCC 536
LG G G V K + G +A K + + + K+ E+ ++ + + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSRFRI 594
+ + + +E+M SL D K+ + +I + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSL-----DRIYKKGGPIPVEILGKIAVAVVEGLTYL--YNVHRI 125
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
+HRD+K SNIL++ K+ DFG++ G+ + VGT YMSPE G +++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 655 KSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714
KSDV+S GI ++E K N D L DL+ ++ + LP
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-------DLLQQIVQEPPPRLP 234
Query: 715 ------MLMRYINVALLCVQENAADRPTMSDVISM 743
L +++ C+ ++ +RPT + +M
Sbjct: 235 SSDFPEDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 11/199 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 528
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ R G ++ + +I+EY+ S D K L I+ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHS 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 175 QSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 479 LGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 534
LG+GGFG V ++ G+ A K+L+ + + K ++ M+ ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKK-------RLLNWQARVRIIEGIAQGLLYLH 587
+ + L++ M L +++ ++ R + A+ I GL +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ------IISGLEHLH 114
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
Q RII+RDLK N+LLD D N +ISD GLA + Q TK GT G+M+PE
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELL 169
Query: 648 LDGLFSIKSDVFSFGILMLETLSSK 672
+ D F+ G+ + E ++++
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK-NE 517
L ++ S+ + ++ K+G+G G VY + GQEVA+K++ N Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINE 66
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577
++++ + +H N+V L + E +++EY+ SL D + ++ +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCR 122
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
T +M+PE + K D++S GI+ +E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 65/204 (31%), Positives = 111/204 (54%), Gaps = 20/204 (9%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 534
K+GEG +G VYK R + + +A+K++ Q +G+ E+ L+ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG----IAQGLLYLHQYS 590
+ L+ EY+ + L + DS+ ++ R+I+ I +G+ Y H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSP----DFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 591 RFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
R++HRDLK N+L+D+ N K++DFGLAR F G ++ T ++V T Y +PE L
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 650 GL-FSIKSDVFSFGILMLETLSSK 672
+S D++S G + E ++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 478 KLGEGGFGPVYKG--RLLNGQE--VAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRL 532
+GEG FG VY+G ++ VAVK N + ++E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+G E I ++E P L +L K L+ + + ++ L YL S+
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLE--SK- 126
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
R +HRD+ A N+L+ K+ DFGL+R + +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 653 SIKSDVFSFGILMLETLS--SKKNTGVYNAD 681
+ SDV+ FG+ M E L K GV N D
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG GGFG V ++ + A+K + ++GQ + +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKLY 59
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
++ +++EY L L D + + AR I + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
II+RDLK N+LLD + K+ DFG A+ + T GT Y++PE L+ +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 654 IKSDVFSFGILMLETL 669
D +S GIL+ E L
Sbjct: 171 FSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 77/250 (30%), Positives = 126/250 (50%), Gaps = 34/250 (13%)
Query: 479 LGEGGFGPVYKGRLLNG---QEVAVKRLSNQSGQG-LKEFKNEMMLIAKL-QHRNLVRLL 533
+GEG FG V K R+ + A+KR+ + + ++F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIA 580
G C +G L +EY P+ +L FL S L+ Q + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G E+ K+ +G
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGRLP 174
Query: 641 --YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWK-- 694
+M+ E +++ SDV+S+G+L+ E +L G+ A+ + L + L K
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234
Query: 695 --DDRVHDLI 702
DD V+DL+
Sbjct: 235 NCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 53/231 (22%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG------------------LKEFKNEMM 519
LGEG +G V K L G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN---KSLN--VFLFDSTKKRLLNWQARVR 574
++ +++H N++ L+ VE L+++ M + K ++ + L +S K +L Q
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL-LQ---- 127
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
I GL LH++ +HRDL +NI ++ KI+DFGLAR +G +
Sbjct: 128 ----ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 635 I------------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSK 672
V T Y +PE + + D++S G + E L+ K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 473 FSMQCKLGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFK---NEMMLIAKLQHRN 528
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LV+LL + L +EY+P L + L AR + E + LH+
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFE-AVDALHE 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
IHRDLK N L+D + K++DFGL++ G +VG+ YM+PE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVLR 171
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+ D +S G ++ E L
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 57/214 (26%), Positives = 111/214 (51%), Gaps = 10/214 (4%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 518
L ++ SI + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 578
+++ +L++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 30/206 (14%)
Query: 482 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLLGCCV 537
G +G V+ + G A+K + + + E ++++ Q +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 538 EQGEKILIL--EYMPN---KSL--NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
QG+K L L EY+P SL NV D AR+ I E I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDLASLLENVGSLDED-------VARIYIAE-IVLALEYLHSNG 113
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLA------RMFGGDELQGNTKQIVGTYGYMSP 644
IIHRDLK NIL+D + + K++DFGL+ R ++ + K+IVGT Y++P
Sbjct: 114 ---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 645 EYALDGLFSIKSDVFSFGILMLETLS 670
E L S D +S G ++ E L
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 525
+ + +GEG +G V K R G+ VA+K+ + + ++ K E+ ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLR 58
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIA 580
H N+V L +G L+ EY+ L + R WQ +
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ--------LL 110
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ----IV 636
Q + Y H IIHRD+K NIL+ + K+ DFG AR L+ V
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYV 162
Query: 637 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLS 670
T Y +PE + D + DV++ G +M E L
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 9e-17
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 473 FSMQCKLGEGGFGPVY---------KGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIA 522
+ +Q +LG+G FG VY + RL +E+ V L+ N++ Q E L++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA----NQEAQLLS 57
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 580
KL H +V+ +E+ +I EY + L+ L T K L + ++ E
Sbjct: 58 KLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL----SENQVCEWFI 113
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q LL +H + RI+HRDLKA NI L ++ KI DFG++R+ G T GT
Sbjct: 114 QLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPY 170
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLE 667
YMSPE + KSD++S G ++ E
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 10/214 (4%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM 518
L S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 578
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 58/214 (27%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFKNEM 518
L S+ S+ + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG 578
+++ + ++ N+V L + E +++EY+ SL D + ++ +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
Q L +LH ++IHRD+K+ NILL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+M+PE + K D++S GI+ +E + +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)
Query: 478 KLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS---GQGLKEFKNEMML--IAKLQHRNLV 530
++GEG +G V+K R L G+ VA+KR+ Q+ G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 531 RLLGCCV-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
RL C + + L+ E++ ++ L +L D + + + ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH + R++HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D++S G + E K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRN 528
+ + K+GEG FG +Y + + E V + + + +KE K E++L+AK++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQ 581
+V E G +++EY L LF ++ ++L+W + I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF--SEDQILSWFVQ------ISL 112
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
GL ++H +I+HRD+K+ NI L K+ M K+ DFG+AR T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
Y+SPE + ++ K+D++S G ++ E + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 28/215 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIAK 523
+ + ++ EG +G VY+ R G+ VA+K+L + G L+E N ++ K
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 524 LQHRNLVRLLGCCVEQG-EKI-LILEYMPN--KSLNVFLFDSTKKRLLNWQARVR-IIEG 578
LQH N+V + V +KI +++EY+ + KSL ++ K+ L Q+ V+ ++
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQ 114
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ G+ +LH I+HRDLK SN+LL+ KI DFGLAR + G L+ T Q+V T
Sbjct: 115 LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVT 169
Query: 639 YGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
Y +PE L +S D++S G + E L+ K
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLK-EFKNEMMLIAKLQHRNLVRLLG 534
++GEG +G VY+ R +G+ VA+K++ + G+ E+ L+ L+H N+V L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 535 CCV-EQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
V + + I L++EY + L D+ Q + ++ + +GL YLH F
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS--LLDNMPTPFSESQVKC-LMLQLLRGLQYLH--ENF 128
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
IIHRDLK SN+LL KI+DFGLAR + G + T ++V T Y +PE L
Sbjct: 129 -IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPELLLGCTT 185
Query: 653 SIKS-DVFSFGILMLETLSSK 672
+ D+++ G ++ E L+ K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 64/197 (32%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLLG 534
LG G FG V R + A+K LS LK+ NE ++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKK--RLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L++EY+P L F +K R AR + + L YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHSLD-- 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
I++RDLK N+LLD D KI+DFG A+ ++G T + GT Y++PE L +
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 653 SIKSDVFSFGILMLETL 669
D ++ GIL+ E L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
K+GEG G V + G++VAVK++ + Q + NE++++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V + + E +++E++ +L D +N + + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+IHRD+K+ +ILL D K+SDFG + + K +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISR 189
Query: 650 GLFSIKSDVFSFGILMLE 667
+ + D++S GI+++E
Sbjct: 190 LPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/195 (27%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQH---RNLVRLL 533
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G ++ +I+EY S+ + K + + II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LF 652
+IHRD+KA+NIL+ N K+ DFG+A + + + +T VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYY 179
Query: 653 SIKSDVFSFGILMLE 667
K+D++S GI + E
Sbjct: 180 DTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 25/202 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+LG+G FG VYK + G A K + +S + L+++ E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ +++E+ +++ + + ++ L Q RV + + + L YLH+ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI------VGTYGYMSPEYAL-- 648
RDLKA NIL D + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 649 ---DGLFSIKSDVFSFGILMLE 667
D + K+DV+S GI ++E
Sbjct: 179 TSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 31/203 (15%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
++G G G VYK G+ A+K + N ++ E+ ++ + H N+V+
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
GE ++LE+M SL + T ++ L AR +I+ GIA YLH R
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVAR-QILSGIA----YLH---RR 187
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------ 646
I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLN 245
Query: 647 --ALDGLFSIKSDVFSFGILMLE 667
A DG D++S G+ +LE
Sbjct: 246 HGAYDGY---AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 73/283 (25%), Positives = 131/283 (46%), Gaps = 45/283 (15%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGC 535
+G G FG V K G +AVKR+ S + K ++ ++ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 536 CVEQGEKILILEYMPNKSLNVF---LFDSTKKRLLNWQARVRIIEGIA----QGLLYLHQ 588
+G+ + +E M + SL+ F +++ K + I+ IA + L YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYGYMSPE- 645
+IIHRD+K SNILLD++ N K+ DFG++ +L + + G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 178
Query: 646 ---YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
A DG + ++SDV+S GI + E TG + +N + D++ ++
Sbjct: 179 IDPSARDG-YDVRSDVWSLGITLYEV-----ATGKFPYPKWNSVF--------DQLTQVV 224
Query: 703 --DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743
DP I+ + ++N LC+ ++ + RP +++
Sbjct: 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 70/256 (27%), Positives = 111/256 (43%), Gaps = 46/256 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
++ +G G FG V+ R ++ A+K ++ LK+ NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++RL +Q +++EY+P L F + R N E I L YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYL 117
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H I++RDLK NILLDK+ + K++DFG A+ +L+ T + GT Y++PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE- 168
Query: 647 ALDGLFSIKS-------DVFSFGILMLETLSSK-----KNT-GVYNA---------DSFN 684
I+S D ++ GIL+ E L N G+Y +
Sbjct: 169 ------VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLD 222
Query: 685 LLGHAWDLWKDDRVHD 700
L +A DL K V D
Sbjct: 223 L--YAKDLIKKLLVVD 236
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 7e-16
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 37/211 (17%)
Query: 479 LGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 536 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVRIIEGIAQG 582
+ P SL F L + K + L+ ++ I +G
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L Y+H IIHRDLK SNI +++D KI DFGLAR DE+ G V T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYR 182
Query: 643 SPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 48/150 (32%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 478 KLGEGGFGPVYKGRLLNGQE-VAVKRLS-NQSGQGLKEFK-NEMMLIAKLQHRNLVRLLG 534
K+GEG +G V+K + E VA+KR+ + +G+ E+ L+ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY ++ L + FDS + + + + + +GL + H + +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFG 624
+HRDLK N+L++K+ K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQG-----LKEFKNEMMLIAKLQHRNLV 530
K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 531 RLLGCCVEQGEK--------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
L+ C + L+ E+ + L L S K ++++ + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKFTLSEIKKVMKMLLNG 131
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI--VGTYG 640
L Y+H R +I+HRD+KA+NIL+ KD K++DFGLAR F + + V T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 641 YMSPEYAL-DGLFSIKSDVFSFGILMLE 667
Y PE L + + D++ G +M E
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--EMMLIAKLQ-HRNLVRL 532
K+GEG F V K + G+ A+K + + + L++ N E+ + +L H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 533 LGCCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQY 589
+ ++ G L+ E M +N++ +KR L + RV+ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH-- 117
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 648
R I HRD+K NIL+ D K++DFG R G T+ I T Y +PE L
Sbjct: 118 -RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLT 172
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
DG + K D+++ G + E LS
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 18/217 (8%)
Query: 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 522
L+++ F + +G G +G VYKGR + ++A ++ + + +E K E+ ++
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 523 KL-QHRNLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 575
K HRN+ G +++ + L++E+ S+ L +TK L I
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYI 126
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
I +GL +LH + ++IHRD+K N+LL ++ K+ DFG++ D G
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTF 181
Query: 636 VGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLE 667
+GT +M+PE D + +SD++S GI +E
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
K+GEG +G V+K R GQ VA+K+ S K E+ ++ +L+H NLV L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ + L+ EY + LN R + +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLF 652
IHRD+K NIL+ K K+ DFG AR+ G + V T Y +PE + D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178
Query: 653 SIKSDVFSFGILMLETLSS 671
DV++ G + E L+
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQ---HRNLV 530
++G G +G VYK R +G VA+K + +N+ G L + E+ L+ +L+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65
Query: 531 RLLGCC----VEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
RL+ C ++ K+ L+ E++ ++ L +L D L + ++ +GL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH I+HRDLK NIL+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D++S G + E K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 528
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ IHRD+KA+N+LL + K++DFG+A +++ N VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
F + ++GEG +G VYK R G+ VA+K RL N+ E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 530 VRLLGCCV----------EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
V L ++G L+ EYM + + + + + ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL---ESGLVHFSEDHIKSFMKQL 125
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+GL Y H+ + +HRD+K SNILL+ K++DFGLAR++ +E + T +++ T
Sbjct: 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 640 GYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK 672
Y PE L + + DV+S G ++ E + K
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQH-RNLVRLL 533
+LG G +G V K R + G +AVKR+ + + Q K ++ + + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQGLLYLH 587
G +G+ + +E M + SL+ F K++ + + +I I + L YLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFY-----KKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-VGTYGYMSPEY 646
S+ +IHRD+K SN+L++++ K+ DFG++ G + K I G YM+PE
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE- 173
Query: 647 ALDGL-----FSIKSDVFSFGILMLE 667
++ + +KSDV+S GI M+E
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 8e-15
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 41/213 (19%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMML 520
+ + KLG+G +G V+K + VA+K++ F+N E+M
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMF 59
Query: 521 IAKL-QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577
+ +L H N+V+LL + +K L+ EYM V + +L + I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-----RANILEDVHKRYIMY 114
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI-- 635
+ + L Y+H S +IHRDLK SNILL+ D K++DFGLAR EL+ N +
Sbjct: 115 QLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVL 169
Query: 636 ---VGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
V T Y +PE L S ++ G+ M
Sbjct: 170 TDYVATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 74/281 (26%), Positives = 123/281 (43%), Gaps = 44/281 (15%)
Query: 479 LGEGGFGPVYKG--RLLNGQE--VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG G FG + +G +L + +E VA+ L + S + + F E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G +++ EYM N +L+ FL + L + ++ G+A G+ YL S
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS---------P 644
+H+ L A +L++ D+ KIS F + + Y MS P
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 645 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
E FS SDV+SFGI+M E +S Y + WD+ D + + D
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMS-------YGERPY------WDMSGQDVIKAVEDG 224
Query: 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
+ + P L+ + L C Q+ +RP S + S+++
Sbjct: 225 FRLPAPRNCPNLLH--QLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 27/79 (34%), Positives = 36/79 (45%)
Query: 195 ENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGA 254
EN +E Y Y N L L+ G + R W NS W+ +S P C YG CG
Sbjct: 29 ENNEEVYYTYRMTNNSIYSRLTLSSEGSLERFTWIPNSQDWNLFWSAPKDQCDVYGRCGP 88
Query: 255 NTICSLDQKPMCECLEGFK 273
C ++ P C C++GF
Sbjct: 89 YGYCDVNTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQG-LKEFKNEMMLIAKLQHRN 528
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + G ++ + +I+EY+ S D + + +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ IHRD+KA+N+LL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E+F + ++G G +G VYK R +N G+ A+K + + G+ + E++++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V G + + + + +E+ SL ++ T L+ + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL- 648
+ +HRD+K +NILL + + K++DFG++ K +GT +M+PE A
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAV 180
Query: 649 --DGLFSIKSDVFSFGILMLE 667
G ++ D+++ GI +E
Sbjct: 181 ERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-14
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 51/221 (23%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMMLIAKLQHRN 528
+G G +G V G++VA+K++SN F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLN----VF-LFDSTKKRLLNWQARVRIIEGIAQ-- 581
++ LL IL + N V L ++ +++ ++ + + Q
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVI--KSPQPLTDDHIQYF 108
Query: 582 ------GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-Q 634
GL YLH +IHRDLK SNIL++ + + KI DFGLAR DE + +
Sbjct: 109 LYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 635 IVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSK 672
V T Y +PE L +I D++S G + E L+ K
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 478 KLGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
K+GEG FG G+ +E+ + ++S + + E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-----RIIEGIAQGLLYL 586
E G ++++Y L + +N Q V +I++ Q L L
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL---------YKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPE 645
+I+HRD+K+ NI L KD K+ DFG+AR+ EL + +GT Y+SPE
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYYLSPE 171
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
+ ++ KSD+++ G ++ E + K
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 71/284 (25%), Positives = 130/284 (45%), Gaps = 42/284 (14%)
Query: 479 LGEGGFGPVYK-------GRLLNGQEVAVKRLS-----NQSGQGLKEFKNEMMLIAK-LQ 525
LG G FG VYK LL +E+ V + + + + + +E+ +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW-QARV-RIIEGIAQGL 583
H N+VR +E ++++ + L F+S K++ + + R+ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
YLH+ R I+HRDL +NI+L +D I+DFGLA+ + +VGT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
PE + + K+DV++FG ++ + Y S N+L A + V + +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFY---STNMLSLATKI-----VEAVYE 231
Query: 704 PV---IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
P+ + ++++ ++ C+ +A RP + V +MI
Sbjct: 232 PLPEGMYSEDVTD-VITS-------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L+L M L ++ + +A E I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
RI++RDLK NILLD + +ISD GLA + G ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 652 FSIKSDVFSFGILMLETLSSK 672
++ D ++ G L+ E ++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 479 LGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLK-----EFKNEMMLIAKLQHRNL 529
LG+G FG V+ R + GQ A+K L + LK K E ++A++ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLLYLHQ 588
V+L +G+ LIL+++ L F K ++ + V+ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
II+RDLK NILLD++ + K++DFGL++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+ +D +SFG+LM E L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 26/219 (11%)
Query: 463 LASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMM 519
++ T + +G G FG V R L GQ VA+K++ + K E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
L+ L+H N++ L + E I + + L+ L R L Q + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTKQ 634
+GL Y+H ++HRDLK SNIL++++ + KI DFGLAR M G
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG---------- 164
Query: 635 IVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L + ++ D++S G + E L K
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 16/191 (8%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
LG G G VYK LL + +AVK + + + + K+ +E+ ++ K ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ + E+M SL+V+ R + RI + +GL YL +I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKILH 118
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K SN+L++ K+ DFG++ + K VGT YM+PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 657 DVFSFGILMLE 667
DV+S GI +E
Sbjct: 175 DVWSLGISFME 185
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ + + KR+ + G+ + NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 587
+ L+L M L +++ ++R L + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 646
+ + ++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEV 172
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ +++ D + G L+ E + +
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 530 VRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRL-LNWQARVRIIEGIAQGLLYLH 587
V G + + + + +EY SL +++ L + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ +HRD+K +NILL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 648 L---DGLFSIKSDVFSFGILMLE 667
+G ++ D+++ GI +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 27/234 (11%)
Query: 443 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR 502
A+ D D +P A A+ +++ L G G V+ GQ V
Sbjct: 39 DSASES-DDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPDPVVL 96
Query: 503 LSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST 562
Q G L E ML+ + H +++R+ V ++L P+ S +++ + +
Sbjct: 97 KIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYTYLTK 149
Query: 563 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
+ R L + I + I +GL YLH RIIHRD+K NI ++ I D G A+
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 622 -----MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
F G + GT +PE ++ K+D++S GI++ E L+
Sbjct: 207 PVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 478 KLGEGGFGPVYKGRL---LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG V G + +V VK L + S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 591
G C E +L++E+ P L +L K L+ R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLA 620
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 478 KLGEGGFGPVYKG---RLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG V G R ++ V VK L + F E+ +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV--RIIEGIAQGLLYLHQYSR 591
G C+E +L+LE+ P L +L + Q V R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD- 120
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA---- 647
IH DL N L D++ KI D+GLA ++ +++PE
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 648 ---LDGLFSIKSDVFSFGILMLE 667
L + KS+++S G+ M E
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/196 (26%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 478 KLGEGGFGPV-YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+GEG G V G++VAVK++ + Q + NE++++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ E +++E++ +L D +N + + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K+ +ILL D K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 657 DVFSFGILMLETLSSK 672
D++S GI+++E + +
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 53/191 (27%), Positives = 95/191 (49%), Gaps = 10/191 (5%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+GEG G V + +G+ VAVK++ + Q + NE++++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ E +++E++ +L D +N + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKS 656
RD+K+ +ILL D K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 657 DVFSFGILMLE 667
D++S GI+++E
Sbjct: 198 DIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKR-LSNQSGQGLKEFK-NEMMLIAKLQHRN-LVRLL 533
K+GEG +G VYK R G+ VA+K+ +G+ E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 534 GCCVEQGEK-------ILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIAQGL 583
VE E+ L+ EY+ + L F+ DS + R L + + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ H++ ++HRDLK N+L+DK KI+D GL R F ++ T +IV T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178
Query: 643 SPEYALDGL-FSIKSDVFSFGILMLETL 669
+PE L +S D++S G + E
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLH 587
+ L+L M L +++ ++R + + A I GL LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE------ITCGLEDLH 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 646
R RI++RDLK NILLD + +ISD GLA + G+ ++G VGT GYM+PE
Sbjct: 120 ---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEV 172
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ ++ D + G L+ E + K
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAK 523
NF + LG G +G V+ R + G + A+K L Q + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 524 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
++ + L + K+ LIL+Y+ L L+ + VR+ IA+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE----SEVRVY--IAEI 114
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+L L + II+RD+K NILLD + + ++DFGL++ F +E + GT YM
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 643 SPEYAL--DGLFSIKSDVFSFGILMLETLS 670
+PE G D +S G+L E L+
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
I GL +LH+ II+RDLK N+LLD + + KI+DFG+ + + GG T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFC 157
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
GT Y++PE + D ++ G+L+ E L
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 479 LGEGGFGPV---YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 534 -----GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+E ++ ++ + LN + K + L+ + +I + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLN----NIVKCQKLSDEHVQFLIYQLLRGLKYIHS 136
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
IIHRDLK SN+ +++D +I DFGLAR DE+ G V T Y +PE L
Sbjct: 137 AG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIML 188
Query: 649 DGL-FSIKSDVFSFGILMLETLSSK 672
+ + ++ D++S G +M E L K
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-13
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 20/191 (10%)
Query: 495 GQEVAVKRLSNQSGQGLKE---FKNEMMLIAKLQHRNLVRLL--GCCVEQGEKILILEYM 549
G EVA+K L + + + F+ E L A+L H N+V LL G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--- 606
P ++L L L R++ + L H I+HRDLK NI++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 607 DKDMNPKISDFGLARMFGG----DELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSF 661
+ K+ DFG+ + G D T +++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 662 GILMLETLSSK 672
G++ LE L+ +
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 479 LGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL-- 533
+G G +G V G VAVK+LS QS K E+ L+ ++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 534 ---GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+E+ + ++ ++ LN + K + L +I I +GL Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 140
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
IIHRDLK SN+ +++D KI DFGLAR DE+ G V T Y +PE L+
Sbjct: 141 ---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNW 192
Query: 651 L-FSIKSDVFSFGILMLETLSSK 672
+ ++ D++S G +M E L+ +
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 527
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 528 NLVRLLGCCVEQG------EKILILEYMPNKSLNV--FLFDSTKKRLLNWQARVRIIEGI 579
N++ LL + L++ YM + K + L +Q +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------M 126
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTR 178
Query: 640 GYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
Y +PE L+ + ++ D++S G +M E L+ K
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL--KEFKNEMMLIAKLQHRN 528
++F +LG G G V K + + ++L + + + E+ ++ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYL 586
+V G GE + +E+M SL+ L ++ + + +L +V I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL---GKVSI--AVLRGLAYL 119
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
+ + +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 647 ALDGLFSIKSDVFSFGILMLE 667
+S++SD++S G+ ++E
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 51/147 (34%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + VYKGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY+ +K L +L D +N + + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKV 125
Query: 595 IHRDLKASNILLDKDMNPKISDFGLAR 621
+HRDLK N+L+++ K++DFGLAR
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 59/183 (32%), Positives = 87/183 (47%), Gaps = 24/183 (13%)
Query: 495 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEKILIL 546
GQ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 547 EYMPNKSLNVFLFDSTKKRL--LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604
E M V D +R+ L +Q + G+ +LH IIHRDLK SNI
Sbjct: 101 ELMDANLCQVIQMDLDHERMSYLLYQ--------MLCGIKHLHSAG---IIHRDLKPSNI 149
Query: 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGIL 664
++ D KI DFGLAR G + T +V Y Y +PE L + D++S G +
Sbjct: 150 VVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCI 206
Query: 665 MLE 667
M E
Sbjct: 207 MGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KRL +SG+ + + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLH 587
+ L++ M L +++ ++ R++++ A+ I G+L+LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY 646
I++RD+K N+LLD N ++SD GLA + G Q GT GYM+PE
Sbjct: 113 S---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEI 165
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
+ +S D F+ G + E ++ +
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 38/209 (18%)
Query: 479 LGEGGFGPV----YKGRLLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKLQHRN 528
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLLNWQARVRIIEGIAQG 582
LV L C + ++EY L +VF ++ R + + A V + G
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----SEPRAVFYAACVVL------G 113
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYG 640
L YLH+ +I++RDLK N+LLD + KI+DFGL + M GD T GT
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPE 166
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETL 669
+++PE + ++ D + G+L+ E L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQ-----GLKEFKNEMMLIAKL 524
+ +GEG +G V G +VA+K++S Q L+E K ++ +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 525 QHRNLVRLLGC----CVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
+H N++ +L E + ++ E M L+ K + L+ + I
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQI 115
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---V 636
+GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR+ D +T + V
Sbjct: 116 LRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYV 170
Query: 637 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
T Y +PE L+ K+ D++S G ++ E LS++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
E + +GEG +G V K + GQ VA+K+ S K E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQ 581
NLV L+ + L+ E++ + L+ L +S ++ L +Q I+ GI
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL-FQ----ILRGIE- 114
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
+ H ++ IIHRD+K NIL+ + K+ DFG AR V T Y
Sbjct: 115 ---FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVYTDYVATRWY 166
Query: 642 MSPEYAL-DGLFSIKSDVFSFGILMLETLS 670
+PE + D + D+++ G L+ E L+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 32/248 (12%)
Query: 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 535
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 536 CVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-----LHQ 588
+ ++ L+ +Y + ++ F K + V++ G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 589 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 643
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 644 PEYALDGLFSIKS-DVFSFGILMLETLSSK----------KNTGVYNADS----FNLLGH 688
PE L K+ D+++ G + E L+S+ K + Y+ D FN++G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 689 AWDL-WKD 695
D W+D
Sbjct: 244 PADKDWED 251
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 53/154 (34%), Positives = 77/154 (50%), Gaps = 22/154 (14%)
Query: 477 CKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
KLGEG + VYKGR L GQ VA+K RL ++ G + E L+ L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLH 69
Query: 534 GCCVEQGEKILILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
+ L+ EY+ + L ++ RL +Q + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ--------LLRGLAYCH 120
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
Q R++HRDLK N+L+ + K++DFGLAR
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 523
NF + LG G +G V+ R ++G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 524 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
++ + L + K+ LIL+Y+ L F S ++R + ++ E I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGE-IVLA 117
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
L +LH + II+RD+K NILLD + + ++DFGL++ F DE++ GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 643 SPEYAL--DGLFSIKSDVFSFGILMLETLS 670
+P+ DG D +S G+LM E L+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V G GE + +E+M SL+ L K + +I + +GL YL +
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ +I+HRD+K SNIL++ K+ DFG++ G + VGT YMSPE
Sbjct: 118 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 171
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGVY 678
++++SD++S G+ ++E G Y
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMA-----IGRY 196
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 479 LGEGGFGPVYKGRLLNGQE----VAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLV 530
LG+GG+G V++ R + G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 531 RLLGCCVEQGEKILILEYMPNKSL-------NVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L+ G+ LILEY+ L +F+ D+ L I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE----------ISLAL 113
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN--TKQIVGTYGY 641
+LHQ II+RDLK NILLD + K++DFGL + + + T GT Y
Sbjct: 114 EHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEY 166
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLS 670
M+PE + D +S G LM + L+
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 13/212 (6%)
Query: 479 LGEGGFGPV--YKGRLLNGQEVAVK-RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G+G +G V + R Q V K L N S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 536 CV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
E G +++ + L L + K L Q ++ IA L YLH+ I
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ-IAMALQYLHEK---HI 123
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI 654
+HRDLK N+ L + K+ D G+AR+ +T ++GT YMSPE + ++
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNY 181
Query: 655 KSDVFSFGILMLETLSSKKNTGVYNADSFNLL 686
KSDV++ G + E + K +NA N L
Sbjct: 182 KSDVWALGCCVYEMATLKH---AFNAKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
IA GL +LH II+RDLK N++LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
GT Y++PE + D ++FG+L+ E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 479 LGEGGFGPV------YKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
LG+GGFG V G++ +++ KR+ + G+ + NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L+L M L +++ +A E + GL L R
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE-LCCGLEDLQ---RE 121
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
RI++RDLK NILLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177
Query: 652 FSIKSDVFSFGILMLETL 669
++ D + G L+ E +
Sbjct: 178 YTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 468 AATENFSMQCKLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSGQGLKEFK--NEMMLIAKL 524
AAT +++ KLGEG + VYKG +NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 525 QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIE 577
+H N+V LL + E + + EYM + L ++ RL +Q
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ------- 111
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ +GL Y+H I+HRDLK N+L+ K++DFGLAR Q + ++V
Sbjct: 112 -LLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV- 165
Query: 638 TYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 669
T Y P+ L +S D++ G + +E L
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 460 LFSLASITAATENFSMQCKLGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEM 518
+ L S+ T+ + + +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 519 MLIAKL-QHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR 572
++ L H N+V+ G + G+ L+LE S+ + K LL R
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQR 124
Query: 573 VR------IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626
+ I+ G GL +LH RIIHRD+K +NILL + K+ DFG++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181
Query: 627 ELQGNTKQIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLE 667
L+ NT VGT +M+PE D + + DV+S GI +E
Sbjct: 182 RLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 9/99 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+AQG+ +L + IHRD+ A N+LL KI DFGLAR D ++GN +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674
V +M+PE D +++++SDV+S+GIL+ E S K+
Sbjct: 278 VK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM--LIAKLQHR--NLVRLL 533
+G G G VYK R G +AVK++ + +E K +M + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 590
G + + + +E M D KR+ ++ I + L YL +
Sbjct: 81 GYFITDSDVFICMELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE-- 132
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ +IHRD+K SNILLD N K+ DFG++ R+ + + T+ G YM+PE +D
Sbjct: 133 KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRS-AGCAAYMAPE-RID 187
Query: 650 -----GLFSIKSDVFSFGILMLE 667
+ I++DV+S GI ++E
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVE 210
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
L+ EY+ +K L ++ D +++ + I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFS 653
+HRDLK N+L+++ K++DFGLAR + + ++V T Y P+ L +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 654 IKSDVFSFGILMLETLSSK 672
+ D++ G + E S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 71/256 (27%), Positives = 115/256 (44%), Gaps = 40/256 (15%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LG+G FG V RL +G+ AVK L Q + +L H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 534 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 591
CC + +++ ++E++ L +F K R + +AR R I L++LH
Sbjct: 63 -CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 649
II+RDLK N+LLD + + K++DFG+ + +F G T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
L+ D ++ G+L+ E L GHA ++ + DL + I+ D
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLC----------------GHA--PFEAENEDDLFE-AILND 211
Query: 710 EISLPMLMRYINVALL 725
E+ P + V +L
Sbjct: 212 EVVYPTWLSQDAVDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 479 LGEGGFG-PVYKGRLLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
+GEG FG + + + Q+ A+K + +S +++ + E +L+AK++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 537 VEQGEKILILEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
G +++EY L + + +L W + + G+ ++H+
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
R++HRD+K+ NI L ++ K+ DFG AR+ T VGT Y+ PE +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176
Query: 652 FSIKSDVFSFGILMLE 667
++ KSD++S G ++ E
Sbjct: 177 YNNKSDIWSLGCILYE 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFK-NEMMLIAKLQHRNLVRLLGC 535
CK+G G +G VYK + +G++ L G G+ E+ L+ +L+H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 536 CVEQGEK--ILILEYMPNKSLNVFLF----DSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 588
+ ++ L+ +Y + ++ F + KK + ++ V+ ++ I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 589 YSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMS 643
++HRDLK +NIL+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 644 PEYALDGLFSIKS-DVFSFGILMLETLSSK 672
PE L K+ D+++ G + E L+S+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 479 LGEGGFGPVYK---GRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G G FG V+ R +G+ VA+K++ N Q+ K E+ ++ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 534 GC-------CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
E E ++ E M + + + + + L + +V + + I +GL YL
Sbjct: 66 DILQPPHIDPFE--EIYVVTELMQSDLHKIIV---SPQPLSSDHVKVFLYQ-ILRGLKYL 119
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H I+HRD+K N+L++ + KI DFGLAR+ DE + T+++V Y Y +PE
Sbjct: 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175
Query: 647 ALDGL--FSIKSDVFSFGILMLETLSSK 672
L G ++ D++S G + E L +
Sbjct: 176 -LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 479 LGEGGFGPVYKGRLLN-GQEVAVK-----RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G GGFG VY R + G+ A+K R+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY----AAEIILGLE------ 111
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 647 ALDGL-FSIKSDVFSFGILMLETL 669
G+ + +D FS G ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
I GL +LH+ II+RDLK N+LLDKD + KI+DFG+ + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
GT Y++PE ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 495 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL--------------LGCCVEQG 540
+ VAVK++ Q +K E+ +I +L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600
++ EYM NV + L AR+ + + + +GL Y+H + ++HRDLK
Sbjct: 90 SVYIVQEYMETDLANVL----EQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDLK 141
Query: 601 ASNILLD-KDMNPKISDFGLARMFGGD-ELQGNTKQIVGTYGYMSPEYALDGLFSIKS-D 657
+N+ ++ +D+ KI DFGLAR+ +G + + T Y SP L K+ D
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAID 201
Query: 658 VFSFGILMLETLSSK 672
+++ G + E L+ K
Sbjct: 202 MWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 29/174 (16%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSF-NLLGHAWDL 692
+ +M+PE D +++ +SDV+SFG+L+ E +L + GV + F L +
Sbjct: 239 L---KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
P EI ML C N DRPT S+++ ++ +
Sbjct: 296 RA---------PEYATPEIYSIMLD--------CWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 13/153 (8%)
Query: 517 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--KRLLNWQARVR 574
E+ ++ + +V G GE + +E+M SL+ L + + +++L +V
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVS 109
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
I + +GL YL + + +I+HRD+K SNIL++ K+ DFG++ G +
Sbjct: 110 I--AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANS 161
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
VGT YMSPE +S++SD++S G+ ++E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-11
Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 37/224 (16%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRL-SNQSGQGL--KEFKNEMMLIAKLQHRNLVRLL 533
+G+GG G VY + + VA+K++ + S L K F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 534 GCCVEQGEKILILEYMPN------KSL--NVFLFDSTKKRL---LNWQARVRIIEGIAQG 582
C G+ + MP KSL +V+ +S K L + A + I I
Sbjct: 69 SIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE-----LQGNTK---- 633
+ Y+H S+ ++HRDLK NILL I D+G A +E + + +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 634 -------QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+IVGT YM+PE L S +D+++ G+++ + L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 495 GQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILIL 546
G VAVK+LS Q+ K E++L+ + H+N++ LL Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606
E M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 106 ELMDANLCQVIHMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 666
D KI DFGLAR + + T +V Y Y +PE L + D++S G +M
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 667 E 667
E
Sbjct: 214 E 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 61/197 (30%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 479 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 534 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ EK+ +L+Y+ L F ++ L +AR E +A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHSLN-- 116
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
II+RDLK NILLD + ++DFGL + G E + T GT Y++PE +
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 653 SIKSDVFSFGILMLETL 669
D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + V+KGR L VA+K RL ++ G + E+ L+ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY+ + L +L D+ + ++ + + + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 595 IHRDLKASNILLDKDMNPKISDFGLAR 621
+HRDLK N+L+++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 28/204 (13%)
Query: 479 LGEGGFGPVY------KGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G GGFG VY G++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+ +K+ IL+ M L+ L F + R II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY----ATEIILGLE------ 111
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H ++RF +++RDLK +NILLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 647 ALDGL-FSIKSDVFSFGILMLETL 669
G + +D FS G ++ + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSN----QSGQGLKEFKNEMMLIAK 523
NF + LG G +G V+ R + G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 524 LQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQ 581
++ + L + K+ LIL+Y+ + L+ +R + VR G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
L +LH + I++RD+K NILLD + + ++DFGL++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 642 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSSKKNT 675
M+PE K+ D +S GIL+ E TL ++NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 474 SMQCKLGE----GGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHR 527
+ +G+ + K + VAVK+ L + S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N++ + + E ++ M S L + L A I++ + L Y+H
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQ----GNTKQIVGTYGYM 642
IHR +KAS+ILL D +S + M + Q K V ++
Sbjct: 119 SKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 643 SPEYALDGL--FSIKSDVFSFGI 663
SPE L ++ KSD++S GI
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 534 GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ +K+ +L+Y+ L F ++ +AR E IA L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
II+RDLK NILLD + ++DFGL + G E T GT Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 52/192 (27%), Positives = 90/192 (46%), Gaps = 10/192 (5%)
Query: 479 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSG-QGLKEFK-NEMMLIAKLQHRNLVRLLGC 535
+GEG +G V K R +E VA+K+ + + +KE E+ ++ L+ N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
+G+ L+ EY+ L + + + N ++ I Q + +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELL------EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV 122
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 655
HRD+K N+L+ + K+ DFG AR + N + V T Y SPE L +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 656 SDVFSFGILMLE 667
D++S G ++ E
Sbjct: 182 VDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 33/93 (35%), Positives = 53/93 (56%)
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q LL +H +IHRD+K++NILL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
Y++PE +S K+D+FS G+L+ E L+ K+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
+LG+G +G VYK G +A+K RL + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+G + +EYM SL+ + RI + +GL +L + I
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY------AL 648
IHRD+K +N+L++ + K+ DFG++ G+ + K +G YM+PE
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ ++++SDV+S G+ +LE
Sbjct: 181 NPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQ--EVAVKRLSNQSGQGLKEFK---NEMMLIAKLQ 525
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLN-----WQARVRIIEGIA 580
H V L G ++ L+LE++ F F KR N + A++ +I
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q L I++RDLK N+LLDKD K++DFG A++ + T + GT
Sbjct: 148 QSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPE 193
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETL 669
Y++PE L+ +D ++ GI + E L
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 51/147 (34%), Positives = 80/147 (54%), Gaps = 10/147 (6%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
KLGEG + VYKG+ +NG+ VA+K RL + G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ L+ EY+ + L ++ D L ++ + + + +GL Y+HQ R+ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQ--RY-I 124
Query: 595 IHRDLKASNILLDKDMNPKISDFGLAR 621
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/174 (31%), Positives = 88/174 (50%), Gaps = 29/174 (16%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+A+G+ +L SR + IHRDL A NILL ++ KI DFGLAR D +G+ +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLW 693
+ +M+PE D +++ +SDV+SFG+L+ E +L + GV + F
Sbjct: 240 LK---WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------- 286
Query: 694 KDDRVHDLIDPVIMQ-DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
L D M+ E + P + R + L C Q + +RPT S ++ ++ +
Sbjct: 287 ----CQRLKDGTRMRAPENATPEIYR---IMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE---LQGNTKQI 635
+A+G+ +L + IHRDL A NILL KI DFGLAR D ++GN +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 55/185 (29%), Positives = 87/185 (47%), Gaps = 20/185 (10%)
Query: 496 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 547
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 103 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 668 TLSSK 672
+ K
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 482 GGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQHRNLVRLLGCC 536
G FG VY + G A+K L + N +++ + + + +L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRL----LNWQARVRIIEGIAQGLLYLHQYSRF 592
+ L++EY+ + K L +W A+ I E + G+ LHQ
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDW-AKQYIAE-VVLGVEDLHQRG-- 117
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT Y++PE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGVG 169
Query: 653 SIK-SDVFSFGILMLETL 669
K SD +S G ++ E L
Sbjct: 170 DDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 51/194 (26%), Positives = 91/194 (46%), Gaps = 22/194 (11%)
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H LV L C + ++EY+ L + +++L AR E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNY 111
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIA 164
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
PE + D ++ G+LM E ++ + F+++G + + D D +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDN--PDQNTEDYLF 214
Query: 704 PVIMQDEISLPMLM 717
VI++ +I +P +
Sbjct: 215 QVILEKQIRIPRSL 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLL 533
LG+G FG V+ L Q A+K L + + M+ L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 534 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
C + E + ++EY+ L +F S K L +A E I GL +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDLP-RATFYAAE-IICGLQFLHSKG-- 116
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDG 650
I++RDLK NILLD D + KI+DFG+ + M G T GT Y++PE L
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDYIAPEILLGQ 171
Query: 651 LFSIKSDVFSFGILMLETL 669
++ D +SFG+L+ E L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 479 LGEGGFGPVYK-GRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 536
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 537 ----VEQGEKI-LILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYS 590
V+ G+++ L+LE S+ + K+ + I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY---- 646
+ IHRD+K +NILL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 199
Query: 647 -ALDGLFSIKSDVFSFGILMLE 667
LD + + DV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 39/212 (18%)
Query: 479 LGEGGFGPV-YKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G G +G V G +VA+K+L QS K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 536 CVEQGEKILILEYMPNKSLNVF-------------LFDSTKKRLLNWQARVR-IIEGIAQ 581
+ P+ SL+ F L K L+ + R++ ++ + +
Sbjct: 83 ------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQMLK 129
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTRWY 181
Query: 642 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK 672
+PE L+ + ++ D++S G +M E L+ K
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 31/208 (14%)
Query: 479 LGEGGFGPVYKGRLLN---------GQEVAVKR-LSNQSGQGLKEFKNEMMLIAKLQHRN 528
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
LV+L G CV E I++ EY+ L+VFL L+W+ V + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV--AKQLASALHYLED 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNP-------KISDFGLARMFGGDELQGNTKQIVGTYGY 641
+++H ++ NIL+ + K+SD G+ E + V +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPW 170
Query: 642 MSPEYALDGLFSIKS--DVFSFGILMLE 667
++PE +G S+ D +SFG +LE
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 21/205 (10%)
Query: 472 NFSMQCKLGEGGFGPV----YKGRLLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKL 524
+F M LG G FG V +KG G+ A+K L + +K+ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H +V ++ ++ +LE++ L F R N A+ E +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAE-LVLAFE 132
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH II+RDLK N+LLD + K++DFG A+ ++ T + GT Y++P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 645 EYALDGLFSIKSDVFSFGILMLETL 669
E D ++ G+L+ E +
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 46/222 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM---------- 519
E+F + +G G FG V R + ++V A+K LS K EM+
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 520 ---LIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFL--FDSTKKRLLNWQAR 572
++A +V+L Q +K L ++EYMP L + +D +K W AR
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----W-AR 145
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGN 631
E + L +H IHRD+K N+LLDK + K++DFG +M ++ +
Sbjct: 146 FYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201
Query: 632 TKQIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETL 669
T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 202 TA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 20/185 (10%)
Query: 496 QEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKILILE 547
+ VA+K+LS Q+ K E++L+ + H+N++ LL Q + +++E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
M V + +R+ ++ + G+ +LH IIHRDLK SNI++
Sbjct: 110 LMDANLCQVIQMELDHERM------SYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 160
Query: 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 161 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 668 TLSSK 672
+
Sbjct: 218 MIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
LG+G FG V L EV A+K L + M +L +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 534 GCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSR 591
CC + +++ ++EY+ L +F + R + + R R + L++LH++
Sbjct: 63 -CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG- 116
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALD 649
+I+RDLK NILLD + + K++DFG+ + + G T GT Y++PE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQE 170
Query: 650 GLFSIKSDVFSFGILMLETLSSK 672
+ D ++ G+LM E ++ +
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 61/234 (26%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 530
+G G FG V+ R + +V A+K L NQ + E ++A +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH----VRAERDILADADSPWIV 64
Query: 531 RLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG------IAQG 582
+L Q E+ L ++EYMP L +N R + IA+
Sbjct: 65 KLY--YSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAEL 110
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--------RMFGGDELQGNTKQ 634
+L L + IHRD+K NIL+D D + K++DFGL R + ++ +
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 635 -------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
VGT Y++PE + ++ D +S G+++ E L
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLLG 534
LG+G FG V R +G+ A+K L + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFR 593
+ ++EY+ L F +++R+ + + R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I++RDLK N++LDKD + KI+DFGL + G K GT Y++PE D +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 654 IKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 686
D + G++M E + + YN D L
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQDHEKLF 204
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 8e-09
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 501 KRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE---YMPNK----S 553
KR+ S + + +NE++ + +L H N++++ E+IL E YM +
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 554 LNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610
L F++D K R L Q R I++ + + Y+H ++IHRD+K NI L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLETL 669
+ DFG A F E + VGT SPE A DG I +D++S G+++L+ L
Sbjct: 305 KIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
Query: 670 S 670
S
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 636
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 637 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSK 672
T Y +PE L K+ DV+S G ++ E L K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 24/136 (17%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
I L YLH +++RDLK N++LDKD + KI+DFGL + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698
Y++PE D + D + G++M E + + YN D
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD----------------- 199
Query: 699 HDLIDPVIMQDEISLP 714
H+ + +I+ +EI P
Sbjct: 200 HEKLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVA---VKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
++G G FG V + VA VK L +N S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKR----LLNWQARVRIIEGIAQGLLYLHQY 589
G CVE +L+ EY L +L R LL Q R+ IA G+ ++H++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMHKH 118
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+ +H DL N L D+ K+ D+G+ + D ++ + V +++PE
Sbjct: 119 N---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 649 ---DGLFSIK----SDVFSFGILMLE 667
GL + + S+V++ G+ + E
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMM---LIAKLQHRNLVRLLG 534
LG+G FG V L G+ AVK L + + M+ ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 535 CCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
C + E + ++E++ L + D K R ++A E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAE-IVCGLQFLHSKG--- 116
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
II+RDLK N++LD+D + KI+DFG+ + +FG GT Y++PE
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFCGTPDYIAPEILQGLK 172
Query: 652 FSIKSDVFSFGILMLETL 669
++ D +SFG+L+ E L
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 602
++EY L F +++R+ + + R R I L YLH S +++RDLK
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFS-EDRARFYGAEIVSALDYLH--SEKNVVYRDLKLE 125
Query: 603 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662
N++LDKD + KI+DFGL + G + K GT Y++PE D + D + G
Sbjct: 126 NLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 663 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714
++M E + + YN D H+ + +I+ +EI P
Sbjct: 184 VVMYEMMCGR--LPFYNQD-----------------HEKLFELILMEEIRFP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 55/221 (24%)
Query: 478 KLGEGGFGPVYKG-RLLNGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLV 530
+G G +G V +G++VA+K++ + + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 531 RLLGCCVEQGEKILILEYMPNKSL--NVFL-FDSTKKRLLNWQARVRIIEG--------- 578
+ IL P + +V++ D + L II
Sbjct: 68 AIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHI 109
Query: 579 ------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 630
+ +GL Y+H + +IHRDLK SN+L+++D +I DFG+AR E +
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 631 NTKQIVGTYGYMSPE--YALDGLFSIKSDVFSFGILMLETL 669
+ V T Y +PE +L ++ D++S G + E L
Sbjct: 167 FMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-08
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 295 KSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY 353
KS D F+ L K P F + ++ +LE+C ++CL NCSCR++ +N + GCL+W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNG--TKGCLLWS 57
Query: 354 -GDLIDARRPIRNFTGQSVYLRV 375
L DAR + G +Y ++
Sbjct: 58 ESSLGDAR--LFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+A+G+ +L + +HRDL A N+LL + KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D L++ SDV+S+GIL+ E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
IA GL +LH II+RDLK N++LD + + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
Y++PE + D ++FG+L+ E L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 45/147 (30%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL-NWQARVRIIEGIAQGLLYLH 587
LV L C L++EY+ L +F ++R L AR E I L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLH 113
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPE 645
+ II+RDLK N+LLD D + K++D+G+ + + GD T GT Y++PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPE 166
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSK 672
+ D ++ G+LM E ++ +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ +L+Y+ L F ++ L +AR E IA L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALGYLHS---LN 116
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I++RDLK NILLD + ++DFGL + E G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 654 IKSDVFSFGILMLETL 669
D + G ++ E L
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/172 (26%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLHQYSRFRIIHRDLKAS 602
++EY L F +++R+ + R R I L YLH +++RD+K
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHSRD---VVYRDIKLE 124
Query: 603 NILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662
N++LDKD + KI+DFGL + D K GT Y++PE D + D + G
Sbjct: 125 NLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 182
Query: 663 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714
++M E + + YN D H+ + +I+ +EI P
Sbjct: 183 VVMYEMMCGR--LPFYNQD-----------------HERLFELILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF------KNEMMLIAKLQHRNLVR 531
+G+G FG VY+ R + + + A+K LS + KE +N ++ + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
L + L+ +YM L F + R +A+ I E + L +LH+Y
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAE-LVLALEHLHKYD- 116
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
I++RDLK NILLD + + DFGL++ D NT GT Y++PE LD
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEK 172
Query: 652 -FSIKSDVFSFGILMLE 667
++ D +S G+L+ E
Sbjct: 173 GYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 22/191 (11%)
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H LV L C + ++E++ L + +++L AR E I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNF 111
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIA 164
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
PE + D ++ G+LM E ++ + F+++G + + D D +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGMSDN--PDQNTEDYLF 214
Query: 704 PVIMQDEISLP 714
VI++ +I +P
Sbjct: 215 QVILEKQIRIP 225
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 29/146 (19%), Positives = 58/146 (39%), Gaps = 13/146 (8%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCC 536
L G VY ++ +K ++ +E + ++ + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
G L++E++ ++L+ ++ + + I E +A+ L LHQ + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 597 RDLKASNILLDKDMNPKISDFGLARM 622
DL NIL+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIV 636
I+ GL +LH+ II+RDLK N++LD + + KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
GT Y++PE + D +++G+L+ E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 58/196 (29%), Positives = 88/196 (44%), Gaps = 13/196 (6%)
Query: 479 LGEGGFGPVY-KGRLLNGQEVAVKRLSNQSGQGLKEFKNEM----MLIAKLQHRNLVRLL 533
+G+G FG V R L+G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ +L+++ L F ++ +AR E IA L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS---IN 116
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I++RDLK NILLD + ++DFGL + G T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 654 IKSDVFSFGILMLETL 669
D + G ++ E L
Sbjct: 175 NTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 68/240 (28%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 450 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 503
K+K+ D++L + + + E++ + +G G FG V R + Q+V A+K L
Sbjct: 17 KNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL 76
Query: 504 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL--ILEYMPNKSLNV 556
S +S F E ++A +V+L C Q +K L ++EYMP L
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVN 132
Query: 557 FL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614
+ +D +K + A V +L L +IHRD+K N+LLDK + K+
Sbjct: 133 LMSNYDVPEKWAKFYTAEV---------VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183
Query: 615 SDFGLA-RMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 669
+DFG +M ++ +T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 184 ADFGTCMKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 2/92 (2%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
A+ L L +F +I+RDLK NILLD + + DFGL ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
Y++PE L ++ D ++ G+L+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E + V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171
Query: 639 YGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSK 672
Y +PE L + +I DV+S G + E L K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 479 LGEGGFGPVYKG--------RLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
LG+G F ++KG L+ EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
G CV E I++ EY+ SL+ +L K L+N ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 591 RFRIIHRDLKASNILL-----DKDMNP---KISDFGLA 620
+ H ++ A N+LL K NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 21/181 (11%)
Query: 506 QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKR 565
++ G K E+ ++ + HR ++ L+ K + MP ++F + +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTY-VDRSG 180
Query: 566 LLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625
L + + I + + L YLH IIHRD+K NI LD+ N + DFG A
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 626 DELQGNTKQIVGTYGYM---SPEY-ALDGLFSIKSDVFSFGILMLE------TLSSKKNT 675
+T Q G G + SPE ALD + K+D++S G+++ E TL K+
Sbjct: 238 HP---DTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
Query: 676 G 676
Sbjct: 294 S 294
|
Length = 392 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 51/217 (23%)
Query: 479 LGEGGFGPVYKGRLLNGQE-VAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRNLVRLLGC- 535
+G G FG VY+ ++ E VA+K++ ++KN E++++ L H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 536 ---CVEQGEKIL----ILEYMP-------------NKSLNVFLFDSTKKRLLNWQARVRI 575
C ++ EK + ++E++P N +L +FL +L ++Q
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLAR-MFGGDELQGNTK 633
+ + L Y+H S+F I HRDLK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229
Query: 634 QIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 669
I + Y +PE L ++ D++S G ++ E +
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)
Query: 515 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR 574
++E+ +A H +V+ + +LI+EY LN + K+ L + V
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
++ Q +L L + +++HRDLK++NI L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
GT Y++PE +S K+D++S G+++ E L+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 52/275 (18%), Positives = 113/275 (41%), Gaps = 57/275 (20%)
Query: 487 VYKGRLLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK- 542
+YKG N +EV ++ + +NE+ + ++ N++++ G ++ +
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 543 ---ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599
LILEY L L K++ L+++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNL 149
Query: 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS---IKS 656
+ + L+ ++ KI GL ++ L + V Y S + D +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 657 DVFSFGILMLETLSSK---KN---TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710
D++S G+++ E + K +N +Y+ I+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDL-------------------------IINKN 238
Query: 711 ISLPMLM---RYI-NVALLCVQENAADRPTMSDVI 741
SL + + I + C ++ RP + +++
Sbjct: 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
|
Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 6e-07
Identities = 66/240 (27%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIA-----KLQHRNLVRL 532
K+G G FG V+ + QE + S +GLKE + ++I +L+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 533 LGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQY 589
+ + + + L ++E+ L+ + K + A V I + L Y H
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 590 ----SRFRIIHRDLKASNILLD-------------KDMN----PKISDFGLARMFGGDEL 628
+ R++HRDLK NI L ++N KI DFGL++ G +
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---I 194
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSSKKNTGVYNADSFNLL 686
+ VGT Y SPE L S KSD+++ G ++ E S K T + A++F+ L
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+A G+ +L + +HRDL A N+L+ + KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE + L++ SDV+SFGIL+ E +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM---------FGG----DELQ 629
L YLH Y I+HRDLK N+L+ + K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
KQ+ GT Y++PE L + D ++ GI++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 525
++F + +G G FG V ++ + + + ++ N+ + LK F+ E ++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNK-WEMLKRAETACFREERNVLVNGD 59
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+ + L ++ L+++Y L + L + RL AR I A+ +L
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYI----AEMVLA 114
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 644
+H + +HRD+K N+LLD + + +++DFG +M +Q + VGT Y+SP
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VGTPDYISP 172
Query: 645 EY--ALD---GLFSIKSDVFSFGILMLETL 669
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVG 637
+A+ +L + + +HRD+K N+LLDK+ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 638 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETL 669
T Y+SPE A++ G + + D +S G+ M E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 37/97 (38%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQGNTKQIVGTY 639
+ L Y+H + F HRDLK NIL + D KI DFGLAR F V T
Sbjct: 114 RALKYIHTANVF---HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 640 GYMSPEYALDGLFSIKS----DVFSFGILMLETLSSK 672
Y +PE L G F K D++S G + E L+ K
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 29/237 (12%)
Query: 450 KDKSKDSWLPLFS-----LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRL 503
K+K+ D++L + + + E++ + +G G FG V R + ++V A+K L
Sbjct: 17 KNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL 76
Query: 504 SN-----QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL 558
S +S F E ++A +V+L + +++EYMP L +
Sbjct: 77 SKFEMIKRSDSAF--FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 134
Query: 559 --FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616
+D +K + A V +L L IHRD+K N+LLDK + K++D
Sbjct: 135 SNYDVPEKWARFYTAEV---------VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 185
Query: 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEY----ALDGLFSIKSDVFSFGILMLETL 669
FG + + VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 186 FGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 24/138 (17%)
Query: 544 LILEYMPNKSLNVFL------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597
L++EY P L L FD + +A+ +L +H + +HR
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----------LAELVLAIHSVHQMGYVHR 126
Query: 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY--ALDG----L 651
D+K N+L+D+ + K++DFG A +++ N+K VGT Y++PE ++G
Sbjct: 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 652 FSIKSDVFSFGILMLETL 669
+ ++ D +S G++ E +
Sbjct: 186 YGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQ 525
E+F + +G G FG V +L N +V ++ N+ + LK F+ E ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGD 59
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
++ + L ++ L+++Y L + L + RL AR + A+ ++
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIA 114
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFG-LARMFGGDELQGNTKQIVGTYGYMSP 644
+ + +HRD+K NIL+D + + +++DFG ++ +Q + VGT Y+SP
Sbjct: 115 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISP 172
Query: 645 EY--ALD---GLFSIKSDVFSFGILMLETL 669
E A++ G + + D +S G+ M E L
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 8/151 (5%)
Query: 517 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
E ++ + H ++++L G LIL P +++ + + K+ + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
+ + + YLH+ RIIHRD+KA NI ++ + + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
GT +PE + D++S GI++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 60/263 (22%), Positives = 98/263 (37%), Gaps = 85/263 (32%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH 526
E+F +G+G FG V RL+ G+ A+K L K+EM +L H
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAH 47
Query: 527 ----RNL---------VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
R++ V L + LI+E++P L L + +
Sbjct: 48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFS 99
Query: 574 RIIEG--IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA----------- 620
+ +A+ +L + + IHRD+K NIL+D+ + K+SDFGL+
Sbjct: 100 EDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 621 --RMFGGDELQ------------------GNTKQI--------------VGTYGYMSPEY 646
++ G + + QI VGT Y++PE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 647 ALDGLFSIKSDVFSFGILMLETL 669
L + + D +S G +M E L
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 60/225 (26%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN---EMMLIAKLQHRNLVRLL 533
LG+G G V+ RL G+ A+K L + + K E ++A L H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ L+++Y P L L K L AR E + L YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG--- 123
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARM---------------------------FGGD 626
I++RDLK NILL + + +SDF L++ +
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183
Query: 627 ELQGNTKQIVGTYGYMSPEY-ALDG-LFSIKSDVFSFGILMLETL 669
E + VGT Y++PE + DG ++ D ++ GIL+ E L
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 15/122 (12%)
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLL 584
+ N ++L +LI++Y+ + L FD KK L+ +II + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
LH++ IIH D+K N+L D+ + + D+GL ++ G GT Y S
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 644 PE 645
PE
Sbjct: 175 PE 176
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 6e-05
Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 32/167 (19%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E F + + G FG VY GR N + AVK + + N+ M+ R+
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDA 57
Query: 530 VRL--------LGCCVEQGEKI-LILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRI 575
+ L L ++ + L++EY+ + L FD + V+
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKY 109
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622
I +A L YLH++ IIHRDLK N+L+ + + K++DFGL+++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 40/160 (25%)
Query: 479 LGEGGFGPVYKGRL----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNL- 529
+G G FG V RL G A+K+L K+EM+ ++ H R++
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLR----------KSEMLEKEQVAHVRAERDIL 55
Query: 530 --------VRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
V+L Q E LI+EY+P + L K + R I E I
Sbjct: 56 AEADNPWVVKLY--YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI 111
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
L + + IHRD+K N+LLD + K+SDFGL
Sbjct: 112 ----LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 9e-05
Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 751 LPSPKEPAFTKG-INVKNSSHSNSGTSEHCSVNDVTVSLIYPR 792
+P PK+P F G + S S++ E +VN VTVS+I R
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIAKLQHRNLV 530
+G G FG V R ++ + A+K L NQ+ K E ++A+ + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH----VKAERDILAEADNEWVV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+L ++ +++Y+P + L ++ L AR I E + + +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL----ARFYIAE-LTCAIESVH- 118
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+ IHRD+K NIL+D+D + K++DFGL F
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603
LI+E++P + L KK L + I A+ +L + + IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYI---AETVLAIDSIHQLGFIHRDIKPDN 131
Query: 604 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 634
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 635 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 475 MQCKLGEG--GFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+Q ++G G VY R G V V+ L N + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVR-IIEGIAQGLLYLHQ 588
+ +I +M S N L + + +A + I+ G +GL YLHQ
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRGLNYLHQ 119
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-----QGNTKQIVGTY---- 639
IHR++KAS+IL IS GL + G L G ++V +
Sbjct: 120 NG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168
Query: 640 ----GYMSPEYALDGL--FSIKSDVFSFGILMLE 667
++SPE L +++KSD++S GI E
Sbjct: 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 41/159 (25%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603
LI+E++P + L KK L+ +A I + +HQ IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131
Query: 604 ILLDKDMNPKISDFGLARMF-----------------------------GGDELQGNTKQ 634
+LLD + K+SDFGL + + N +Q
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 635 I----VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
+ VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 56/242 (23%), Positives = 96/242 (39%), Gaps = 59/242 (24%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V ++ + A+K L + + + K E ++A+ + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
++ +++Y+P + L + + L + IA+ L + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY--------IAELTLAIESVHKM 120
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFG---------------------------- 624
IHRD+K NIL+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 625 -----GDEL----QGNTKQ--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
GD L Q TKQ +VGT Y++PE L ++ D +S G+++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 668 TL 669
L
Sbjct: 241 ML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 52/240 (21%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 479 LGEGGFGPVYKGRLLNGQEV-AVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V R ++ + + A+K L + + K E ++A+ + +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
++ +++Y+P + L R+ + + IA+ + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFY-IAELTCAVESVHKMGF 122
Query: 595 IHRDLKASNILLDKDMNPKISDFGLARMF----------GGDELQGNT------------ 632
IHRD+K NIL+D+D + K++DFGL F GD ++ ++
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 633 -----------------------KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
+VGT Y++PE L ++ D +S G+++ E L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
L++++ H +L + G CV E I++ E++ + L+V L + + W ++ + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNP--KISDFGLARMFGGDELQGNT 632
A L YL + ++H ++ A NILL + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 633 KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 667
++I +++PE G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 21/173 (12%)
Query: 516 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 575
+E L+ +L H ++ LL V G L+L P +++ + + R L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 576 IEGIAQGLL----YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
+ +A+ LL Y+H IIHRD+K N+L++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 684
I GT +PE ++ D++S G+++ E V+ A F+
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE-------AAVHTASLFS 364
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 792 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.51 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.22 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.49 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.32 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.23 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.0 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.99 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.86 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.86 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.83 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.72 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.27 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.21 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.19 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.07 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.91 | |
| PLN02236 | 344 | choline kinase | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.87 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.76 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.72 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.44 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.37 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.29 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.01 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.82 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=444.37 Aligned_cols=288 Identities=42% Similarity=0.725 Sum_probs=254.3
Q ss_pred CCCcccHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeee
Q 003843 457 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536 (792)
Q Consensus 457 ~~~~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 536 (792)
....|++.++..+|++|.-.+.||+|+||.||+|.+.+++.||||++.....+..++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46679999999999999999999999999999999999999999998765443145699999999999999999999999
Q ss_pred eecC-eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 537 VEQG-EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 537 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
.+.+ +.+||||||++|+|.++|+..... .|+|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875544 89999999999999999999999998899999999999999999999999
Q ss_pred ccccceecCCCcccccccee-ecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC-ccccccccchhhhc
Q 003843 616 DFGLARMFGGDELQGNTKQI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN-ADSFNLLGHAWDLW 693 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~-~~~~~~~~~~~~~~ 693 (792)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++..... .....+..|++..+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999765431 1111112 79999999999999999999999999999999999998887544 33445788888888
Q ss_pred ccCccccccccccccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 694 KDDRVHDLIDPVIMQDEISL-PMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+++.+++|+.+....... .+...+..++.+|++.+|++||+|.||+++|+.+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 88999999999986566654 6888899999999999999999999999999664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=373.57 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=209.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-eeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~ 548 (792)
+++.++.||+|..|+|||++++ +++.+|+|.+... .+...+++.+|++++++.+||+||.++|+|..+. ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4556789999999999999986 5788999999543 4556788999999999999999999999999999 59999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++|+|++++. +.+.+++..+.+|+.++++||.|||+ ++ ||||||||+|||++..|++||||||.+..+.+.
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999984 33669999999999999999999996 55 999999999999999999999999999977543
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
..+..+||..|||||.+.+..|+.++||||||+.++|+..|+.|+....+... ...++++....
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-------------~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-------------DIFELLCAIVD 296 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-------------CHHHHHHHHhc
Confidence 34567999999999999999999999999999999999999999875422111 11222222221
Q ss_pred --cCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 --QDEISL-PMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 --~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+. ..+.++.+++..||++||.+||++.|++++
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112222 367789999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=388.18 Aligned_cols=262 Identities=32% Similarity=0.508 Sum_probs=213.7
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-eeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 547 (792)
..+.+.+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 34455567999999999999996555599999976432 22569999999999999999999999999988 7999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-CeeecccccceecCCC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGD 626 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~ 626 (792)
|+++|+|..+++.. .+..+++..+++++.+||+||.|||+++. ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999664 46779999999999999999999999974 99999999999999997 9999999999876543
Q ss_pred ccccccceeecccceeCccccc--CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
. ...+...||+.|||||++. ...|+.|+||||||++||||+||+.||...... .. +.... ....
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~---~~~v~-----~~~~-- 263 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QV---ASAVV-----VGGL-- 263 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HH---HHHHH-----hcCC--
Confidence 2 2223368999999999999 569999999999999999999999999754431 11 11011 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCC
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 752 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 752 (792)
+..++......+..++.+||+.||++||++.+++..|+.+.....
T Consensus 264 ---Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 264 ---RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ---CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 222233356688899999999999999999999999987654443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=384.21 Aligned_cols=256 Identities=32% Similarity=0.493 Sum_probs=214.1
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.+.+.+.+.||+|.||+||.|.++....||+|.++.. ....+.|.+|+++|++|+|+|||+++++|..++.++||||||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 3456677999999999999999987789999999764 334578999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
+.|+|.+||.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.+.
T Consensus 284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999999965 34567899999999999999999999998 999999999999999999999999999966555443
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
... ...-+..|.|||.+..+.|+.|+|||||||+||||+| |+.|++..... ++.+.++..- +
T Consensus 360 ~~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~le~Gy-R 422 (468)
T KOG0197|consen 360 ASE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLELLERGY-R 422 (468)
T ss_pred ecC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHHHhccC-c
Confidence 322 2234679999999999999999999999999999999 77776543321 1112222211 2
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
-+.+..++.++.+++..||+.+|++|||++.+...|+..
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 233444677899999999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=383.58 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=214.0
Q ss_pred cCccccceecccCceeEEEEEE-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999998 77999999999663 4556778899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|+|++++|.+++ ++++.+++.++..++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988 36678999999999999999999999998 999999999999999999999999999988654
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.. ...+.+|||.|+|||++.....+..+||||+|||||-||.|++||+...-. +..+..-
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------ety~~Ik 231 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ETYNKIK 231 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HHHHHHH
Confidence 32 345689999999999999999999999999999999999999999753211 1111110
Q ss_pred -ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 -MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.....+...+.+..+||..+|+.+|.+|||+++|+.+
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0112233556788999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=366.36 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=203.4
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCch-------hHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++++..-. ......+|+++|++++|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 56788899999999999999976 46999999999754211 12235799999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---CCeeecccc
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFG 618 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kL~DFG 618 (792)
.|+||||++||.|-+++ ..++.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999998888 44556788888899999999999999999 9999999999999766 679999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCC---CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF---SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
+|+..+.. ....+.+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||...-.+.. ..+....
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILK 396 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhc
Confidence 99987633 34567899999999999986543 3478999999999999999999974322210 0111111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
++.. .....-....++..++|.+||..||++|||+.|++++
T Consensus 397 G~y~-------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYA-------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccc-------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1110 0112223457789999999999999999999999764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=363.22 Aligned_cols=203 Identities=30% Similarity=0.535 Sum_probs=182.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..+|.+.+.||+|+||+||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999985 4789999998654 5666778899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC------CCeeecccccc
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD------MNPKISDFGLA 620 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~------~~~kL~DFGla 620 (792)
|||.+|+|..||. +.+.+++..+..++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999993 4457999999999999999999999999 9999999999999765 45899999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD 681 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~ 681 (792)
+.+.... ...+.+|++.|||||++...+|+.|+|+||+|+|||||++|+.||......
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9887543 344579999999999999999999999999999999999999999755443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=395.17 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=216.3
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
..+.+..+.||+|+||+||+|+.. +.+.||||.++...+. ..++|++|+++|..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566799999999999999853 2457999999877655 788999999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCC-----------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 543 ILILEYMPNKSLNVFLFDSTK-----------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
++|+|||..|+|.+||..... ...|+..+.+.|+.|||.||+||.++. +|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999953211 234889999999999999999999997 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+||||++.....++......-.-+.+|||||.|..++||.++|||||||+|||+++ |+.|+.....++ +.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------VI 715 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------VI 715 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------HH
Confidence 99999999998876666554444456789999999999999999999999999999999 777765433221 11
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+....+++ -+.+...+.+++.|+..||+.+|.+||+++||-..|+..
T Consensus 716 e~i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 716 ECIRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred HHHHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 11112211 233445677899999999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=350.43 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=210.3
Q ss_pred cCccccceecccCceeEEEEEE-cCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCCcceEee-eeeecCe-eEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLG-CCVEQGE-KILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 545 (792)
.+|+++++||+|.||+|||+.. .+|..+|.|.+.- .+.+..+....|+.+|++++|||||++++ -+.++.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4688999999999999999974 5799999998853 34566778899999999999999999998 5566655 8999
Q ss_pred EEecCCCccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcC-CCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 546 LEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYS-RFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~-~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
||++..|+|..++.+..+ ++.+++..+++++.|++.||.++|..- +..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999976544 456999999999999999999999832 224999999999999999999999999999998
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... .....+|||.||+||.+.+..|+.|+||||+||++|||+.-++||...+ + .++ .
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~-------------~~L-~ 237 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----L-------------LSL-C 237 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----H-------------HHH-H
Confidence 66542 3445799999999999999999999999999999999999999986431 1 111 1
Q ss_pred cccccCC---CC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 704 PVIMQDE---IS-LPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 704 ~~l~~~~---~~-~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
..+.+.+ .+ ...+..+..||..|+..||+.||+...+++.+..
T Consensus 238 ~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 238 KKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111222 22 4567899999999999999999996666655544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=355.39 Aligned_cols=240 Identities=26% Similarity=0.368 Sum_probs=202.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|+++++||+|+||+||.++.+ +++.+|+|++++. .....+..++|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 578999999999999999999865 4888999999764 234567788999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+||+.||.|..+| ++.+.+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999998888 55677999999999999999999999999 99999999999999999999999999986432
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. ...+..++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.. ++.+..
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------------------~~~~~I 237 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------------------KMYDKI 237 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------------------HHHHHH
Confidence 2 22345589999999999999999999999999999999999999999743321 111111
Q ss_pred cccC--CCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 706 IMQD--EISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 706 l~~~--~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
+... ..+.....+.++++...|+.||++|.
T Consensus 238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111 11222456788999999999999996
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=378.84 Aligned_cols=290 Identities=27% Similarity=0.386 Sum_probs=231.7
Q ss_pred cCccccceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
....|.++||.|.||+|++|+++- ...||||.++.. .+.+..+|+.|+.||.++.||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 456778999999999999999853 346999999875 456778999999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
.|||+||+|+.||.... +.+.+.++.-++++||.||.||.+.+ +|||||.++|||++.+..+|++||||++.+.+
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999996543 55999999999999999999999999 99999999999999999999999999998755
Q ss_pred Ccccccccee--ecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 626 DELQGNTKQI--VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 626 ~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
+.. ...+.. .-+.+|.|||.+...++|.++||||||+++||.++ |.+|+-.+.. .++...+
T Consensus 784 d~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---------------QdVIkaI 847 (996)
T KOG0196|consen 784 DPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---------------QDVIKAI 847 (996)
T ss_pred CCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---------------HHHHHHH
Confidence 431 111212 23679999999999999999999999999999887 8888653322 1122222
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCCCCCCCCccc-ccccCCCCCCCCCCCCcccc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTK-GINVKNSSHSNSGTSEHCSV 781 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 781 (792)
.... +-+.+++++..|.+|++.|||+|-.+||.+.+|+.+|++.+....+-+..+... +.+..-..++.++.....++
T Consensus 848 e~gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r~s~~lld~~~~~~~~f~sv 926 (996)
T KOG0196|consen 848 EQGY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPRPSQPLLDRSGSDFTPFRSV 926 (996)
T ss_pred Hhcc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCCCcccccCCCCCCCcccCCH
Confidence 2222 345567788899999999999999999999999999999866655555555443 33333333344444444444
Q ss_pred c
Q 003843 782 N 782 (792)
Q Consensus 782 ~ 782 (792)
+
T Consensus 927 ~ 927 (996)
T KOG0196|consen 927 G 927 (996)
T ss_pred H
Confidence 3
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.14 Aligned_cols=253 Identities=26% Similarity=0.361 Sum_probs=211.1
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
...+|.+.+.||+|+|++|++|+.+ .++++|||++.+. .+...+-...|-.+|.+| .||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3578999999999999999999865 5889999998653 233345567899999999 8999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|+||+++|+|.++| .+.+.|++.....++.+|+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999 45577999999999999999999999999 999999999999999999999999999988
Q ss_pred CCCccc---------ccc--ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 624 GGDELQ---------GNT--KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 624 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
...... ... ..++||..|.+||++.....+..+|+|+||||||+|+.|++||...++-..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli--------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI--------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---------
Confidence 543221 112 458999999999999999999999999999999999999999975443211
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
+.++++- .-+++....+.+.+|+.+.|..||++|++..+|.++.
T Consensus 296 -----FqkI~~l---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 -----FQKIQAL---DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----HHHHHHh---cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 0111111 1223333446788999999999999999999998875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.70 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=205.2
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
+.|+.+.++|+|+||+|||.++++ |+.||||++....+ ...+-.++|+++|++++|+|+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888999999999999999875 99999999965433 334557899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++..-|.++- .....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+....
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99988776654 22334889999999999999999999998 9999999999999999999999999999886321
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCc-ccccccc--------chhhhcc-cC
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSFNLLG--------HAWDLWK-DD 696 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~-~~~~~~~--------~~~~~~~-~~ 696 (792)
..-+.++.|.-|.|||.+.+ .+|....||||+||++.||++|.+-|+...+ +....+. .....+. .+
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 22344678999999999987 7899999999999999999999998875443 2211111 1111111 11
Q ss_pred ccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 RVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.++-+.-|.. +...+ +.....+.+++..||+.||++|++-++++.+
T Consensus 234 ~F~Gv~lP~~-~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEP-EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCC-CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111 11111 1234478899999999999999999988753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.67 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=205.9
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC--eeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~E 547 (792)
.++...+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999998765 8999999986654334778999999999999999999999855444 6899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCC-
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG- 625 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~- 625 (792)
|+++|+|.+++..... .|++..+.+++.||++||+|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954432 6999999999999999999999999 999999999999999 79999999999987754
Q ss_pred CccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
...........||+.|||||++..+ ....++|||||||++.||+||++||.... +. .... ...+ ...
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-~~---~~~~---~~ig-----~~~ 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-EE---AEAL---LLIG-----RED 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-ch---HHHH---HHHh-----ccC
Confidence 1222234457899999999999964 34469999999999999999999997530 00 0000 0000 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
. ...++...+.+..+++.+|++.+|++|||+++++++.-.
T Consensus 240 ~--~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 240 S--LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred C--CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 0 113444466788999999999999999999999988643
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=380.07 Aligned_cols=259 Identities=31% Similarity=0.501 Sum_probs=214.7
Q ss_pred hcCccccceecccCceeEEEEEEcC--Cc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++.++.+.||+|+||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556778999999999999998653 33 4999999765 566778999999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
++++|||++|+|..||.+.+. ...|...+++.++.+||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976422 346899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
||+.+...++........-+..|||||.+..+.|+.|+|||||||+|||++| |..|++...... .+.. ..+.+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--v~~~---~~~gg- 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--VLLD---VLEGG- 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH--HHHH---HHhCC-
Confidence 9997766555544444445679999999999999999999999999999999 777876433211 1100 11111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+-+.+..++..+++++..||+.+|++||++..+++.+..+
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 1223444667889999999999999999999999988775
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=350.35 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=217.3
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
+.+.+.+.++||+|-||+|.+.+...+..||||+++.... ...++|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 4567788899999999999999997789999999987654 445899999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
||++|+|..||..+.... +.-....+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...+
T Consensus 616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999997654332 455667789999999999999998 9999999999999999999999999999877766
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh--CCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
+.......+-+.+|||||.+..++++.++|||+||+.+||+++ ...|++....+. .+.........+.....+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~l--- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVVL--- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCcceec---
Confidence 6665566677899999999999999999999999999999865 566776433321 111111111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.-++..+.+++++||..+.++||+++++...|.+.
T Consensus 767 ----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 ----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11223456788999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=350.52 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=210.8
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
...|...++||+|+.|.||.|+. ..++.||||++........+-+.+|+.+|+..+|+|||++++.|..++++++||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35567778999999999999975 45889999999776666667789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
|++|+|.+.+ ....+++.++..|.+++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999998 4445999999999999999999999999 99999999999999999999999999998866543
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.....+||+.|||||++....|++|.||||||++++||+-|.+||-..++ ... .+.....+ .+ .
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrA---lyLIa~ng------~P---~ 488 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRA---LYLIATNG------TP---K 488 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHH---HHHHhhcC------CC---C
Confidence 34557999999999999999999999999999999999999999854221 111 01011111 11 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
-......+..+.+++.+||+.|+++||++.|++++
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 12223346688999999999999999999999875
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.22 Aligned_cols=264 Identities=30% Similarity=0.449 Sum_probs=213.3
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
.+.....+.+.+.+.||+|.||+||+|++. -.||||++.-. .++..+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 555566778888999999999999999984 36999998543 45678999999999999999999999999998887
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.+|+.+|+|.+|+.+|+..+ ..|...+.++|+.|||+||.|||.++ |||||||..||+|.+++.|||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999996543 45888899999999999999999999 9999999999999999999999999997
Q ss_pred ecCCCccccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
.-....-........|...|||||+++. .+|++.+||||||+++|||++|..|+.....+..-. ..++-
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif--------mVGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF--------MVGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE--------Eeccc
Confidence 6543322333444567889999999975 479999999999999999999999998333222111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.-..|.. ........++.+|+..||..++++||.+.+|+.+|+.+
T Consensus 609 ~l~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 609 YLMPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred ccCccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 0001110 11223455889999999999999999999999988876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.70 Aligned_cols=284 Identities=26% Similarity=0.396 Sum_probs=220.7
Q ss_pred CCCCCCCcccHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhh--cCCCCcc
Q 003843 453 SKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLV 530 (792)
Q Consensus 453 ~~~~~~~~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv 530 (792)
...+++|.+-..++ ..+..+.+.||+|.||+||+|++ .|+.||||++...++ +.+.+|.+|.+. |+|+||+
T Consensus 196 GSGSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 196 GSGSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred CCCCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhh
Confidence 34567888877776 56889999999999999999998 689999999976544 556778887776 5999999
Q ss_pred eEeeeeeecC----eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-----cCCCceeecCCCC
Q 003843 531 RLLGCCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-----YSRFRIIHRDLKA 601 (792)
Q Consensus 531 ~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~ivH~Dlkp 601 (792)
.+++.-..+. +++||.+|.++|||.+|| ....++.+..++++..+|.||+|||. +|++.|.|||||.
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 9999876543 789999999999999999 34579999999999999999999994 5789999999999
Q ss_pred CcEEEcCCCCeeecccccceecCCC--ccccccceeecccceeCcccccCCC----CC--CcCceeehhHHHHHHHhCCC
Q 003843 602 SNILLDKDMNPKISDFGLARMFGGD--ELQGNTKQIVGTYGYMSPEYALDGL----FS--IKSDVFSFGILMLETLSSKK 673 (792)
Q Consensus 602 ~NILl~~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~s--~~~DVwSlGvll~elltg~~ 673 (792)
+|||+..++.+.|+|+|||...... ......+..+||.+|||||++.+.. |. ..+||||||+++||+.....
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999887544 3344556679999999999986542 22 45999999999999986442
Q ss_pred CCCCCCccccccccch-----hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 674 NTGVYNADSFNLLGHA-----WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 674 p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.-+...+....+.... .+.+.+--..+-++|.++....+.+.+..+.++++.||..+|..|.|+=-+.+.|.++
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 2111111111111110 1111112223344555555566778899999999999999999999999999999876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=353.70 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=204.9
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
+.++|++.++||+|+||.||+|... .++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4578999999999999999999742 35679999997543 33456789999999999 8999999999887644
Q ss_pred -eeEEEEEecCCCccceeeeccCC--------------------------------------------------------
Q 003843 541 -EKILILEYMPNKSLNVFLFDSTK-------------------------------------------------------- 563 (792)
Q Consensus 541 -~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 563 (792)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988853211
Q ss_pred ---CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccc
Q 003843 564 ---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (792)
Q Consensus 564 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (792)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999998 99999999999999999999999999986543322222223456788
Q ss_pred eeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHH
Q 003843 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY 719 (792)
Q Consensus 641 y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l 719 (792)
|+|||++.+..++.++||||||++||||++ |..||........ . ......+.. ...+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~----~~~~~~~~~----------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F----CQRLKDGTR----------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H----HHHHhcCCC----------CCCCCCCCHHH
Confidence 999999999999999999999999999997 9999864332110 0 001111100 01112234578
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 720 INVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 720 ~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+++.+||+.||++||++.|++++|++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=334.01 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=210.3
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..+.|++.++||.|.-++||+|+. +.++.||||++.-. .....+.+.+|+..|..++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 357899999999999999999985 46899999999543 2334788999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
.||.+|++.++++..-.. .+++..+..|++++++||.|||.+| .||||||+.||||+.+|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998654333 3899999999999999999999999 999999999999999999999999998766332
Q ss_pred cc--ccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 627 EL--QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 627 ~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.. ....+...||+.|||||++.. ..|+.|+||||||+...||.+|..||..+.+-..-++. .... .....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~-pp~~~ 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQND-PPTLL 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCC-CCCcc
Confidence 21 112256789999999999644 46999999999999999999999999876643221111 1110 00000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
-..+ ..+........+.+++..||+.||++|||++++++.
T Consensus 254 t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0001 111122234578999999999999999999998864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=341.72 Aligned_cols=265 Identities=28% Similarity=0.464 Sum_probs=203.9
Q ss_pred hcCccccceecccCceeEEEEEEcC-----------------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 531 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 531 (792)
.++|++.++||+|+||.||++++.+ +..||+|.+.... .....+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4678899999999999999997532 3369999987643 334567999999999999999999
Q ss_pred EeeeeeecCeeEEEEEecCCCccceeeeccC----------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 003843 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDST----------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595 (792)
Q Consensus 532 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 595 (792)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999998874321 1234788899999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhC--CC
Q 003843 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS--KK 673 (792)
Q Consensus 596 H~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg--~~ 673 (792)
||||||+|||++.++.+||+|||+++.+.............++..|+|||++....++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876443322223334567899999999999999999999999999999974 45
Q ss_pred CCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 674 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 674 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
|+...... ............... .. ....+...+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~~~--~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDE--QVIENAGEFFRDQGR-QV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHH--HHHHHHHHHhhhccc-cc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 55432211 111111111100000 00 000112234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=318.20 Aligned_cols=237 Identities=26% Similarity=0.366 Sum_probs=202.7
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
-++|++.+.||.|+||.|.+++.+. |..+|+|++.+.. -.+.+...+|..+|+.+.||+++++++.+.+.+.+++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3678899999999999999999864 7789999997653 23456678899999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||.+||.|..+| ++.+.+++..+..++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999998 45567999999999999999999999998 99999999999999999999999999997643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.+-+.+|||.|+|||.++...+..++|.|||||++|||+.|.+||...++... + .+++..
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y--------~KI~~~- 256 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------Y--------EKILEG- 256 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------H--------HHHHhC-
Confidence 35668999999999999999999999999999999999999999975443110 1 111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCC
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADR 734 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~R 734 (792)
+-.++......+.+|+...|+.|-++|
T Consensus 257 --~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 --KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 113344456678899999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=348.39 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=210.6
Q ss_pred cCccccceecccCceeEEEEEE-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.-|++.+.||+|+-|.|-.|++ .+|+.+|||++.+. .......+.+|+-+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578889999999999999987 46999999999654 2334566889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|-|.+++ .+++.|++.++++++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 56778999999999999999999999998 999999999999999999999999999875443
Q ss_pred ccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. ...+.+|.+.|.|||++.+.+| +.++||||.|||||.||+|+.||+..+.. .++.+.
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir------------------~LLlKV 224 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR------------------VLLLKV 224 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH------------------HHHHHH
Confidence 2 2345699999999999999998 57899999999999999999999843321 111111
Q ss_pred cccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 706 IMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 706 l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
. ++ +.+...+.++.+|+.+|+..||++|.|++||+++-
T Consensus 225 ~-~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 225 Q-RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred H-cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1 12 23344567899999999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=350.15 Aligned_cols=264 Identities=30% Similarity=0.412 Sum_probs=210.9
Q ss_pred HHHhcCccccceecccCceeEEEEEEcC--C--cE-EEEEEecc---cCchhHHHHHHHHHHHhhcCCCCcceEeeeeee
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLLN--G--QE-VAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 538 (792)
....++..+.++||+|+||.||+|++.. + .. ||||..+. .......+|.+|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3345677777999999999999998753 2 23 89999874 346778899999999999999999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
...+++|||++.||+|+++|.... ..++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 999999999999999999995432 25999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
|++.-.. +........-+..|+|||.+....|+.++|||||||++||+++ |..|+....... ...
T Consensus 308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~------ 373 (474)
T KOG0194|consen 308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKA------ 373 (474)
T ss_pred cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHH------
Confidence 9886431 1111112245679999999999999999999999999999998 677765433211 000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCC
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 752 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 752 (792)
.++.... +...+...+.++..++.+||..+|++||+|.++.+.|+.+.....
T Consensus 374 --kI~~~~~-r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 374 --KIVKNGY-RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred --HHHhcCc-cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0101000 122233445677888899999999999999999999988754444
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.98 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=204.9
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 543 (792)
..+.|+.+++||+|.||.||+|+. .+|+.||+|+++-.. +....-..+|+.||++|.||||++|.+...+. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 356788899999999999999986 468999999986543 44556678999999999999999999998876 6899
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
||+|||++ +|..++.. ..-.+++.++..++.||+.||+|+|+.+ |+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999986 56666622 2335899999999999999999999999 999999999999999999999999999988
Q ss_pred CCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cccccc-----hhhhcccC
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGH-----AWDLWKDD 696 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~~~~~-----~~~~~~~~ 696 (792)
....... .+..+-|.-|.|||.+.+. .|+.+.|+||.||||.||+.|++.+....+-+ .+.+-. ....|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 7655433 3345679999999999875 79999999999999999999999886544311 111111 01112211
Q ss_pred cc--ccccccccccCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 RV--HDLIDPVIMQDEI----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 ~~--~~~~~~~l~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
++ ...+.+....... .........+|+..+|..||.+|.|+.++++.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 1122221100000 11123567889999999999999999998754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.77 Aligned_cols=242 Identities=26% Similarity=0.412 Sum_probs=202.3
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
.++-||.|+.|.||+|++ .++.||||+++... ..+++-|++|+|+||+.+.|+|.....+++|||||..|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 357899999999999999 57899999986432 3478889999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+.| +....+.......+..+||.||.|||.+. |||||||.-||||..+..+||+|||.++..... .....
T Consensus 200 ~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 200 YEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 9999 34556888899999999999999999998 999999999999999999999999999876543 22334
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
+.||..|||||++.+.+.++|.|||||||||||||||..|+...+.. .+.|. -+ .....-+.+..
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwG-----VG-------sNsL~LpvPst 335 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWG-----VG-------SNSLHLPVPST 335 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEe-----cc-------CCcccccCccc
Confidence 78999999999999999999999999999999999999998643321 11111 11 11112233444
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
++.-+.-|+++||+..|..||++++++.+|+=..
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 5667888999999999999999999999997543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=343.05 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=209.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. .++..+.+.+|++|+++++|||||.+++.|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999865 5788999998654 45567889999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+.| +|..+|. ..+.++++.+..++.++..||.|||+.. |+|||+||.|||++.++.+|++|||+|+......
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999984 4456999999999999999999999998 9999999999999999999999999999875432
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
...+.+.|||.|||||...+.+|+..+|.||+|||+|||.+|++||-... +.+++...+.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------------i~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------------ITQLVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------------HHHHHHHHhc
Confidence 33455789999999999999999999999999999999999999985311 1222222221
Q ss_pred cC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QD-EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+ ..+......+.+++...|++||.+|.+-.+++.+
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11 1223566789999999999999999999998765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=343.25 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=205.2
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc----Cc-hhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ----SG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 541 (792)
...+|.+.+.||+|+||.|+.|+.. ++..||+|++... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4678999999999999999999764 6899999977543 12 33556778999999998 9999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeecccccc
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 620 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla 620 (792)
.++||||+.+|+|.+++.+ .+.+.+.++.+++.|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999943 567899999999999999999999999 9999999999999999 99999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCC-CC-CcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+.... .. .
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--~~----k------ 234 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--YR----K------ 234 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH--HH----H------
Confidence 9873 1122345579999999999999987 85 789999999999999999999975221110 00 0
Q ss_pred ccccccccccCCCCHHH-HHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 699 HDLIDPVIMQDEISLPM-LMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
+... .-.++... ..++..++.+||..+|.+|+++.+++
T Consensus 235 --i~~~---~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 --IRKG---EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --HhcC---CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0000 01112222 67889999999999999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.73 Aligned_cols=265 Identities=25% Similarity=0.341 Sum_probs=207.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHH--HHHHHHHhhcC-CCCcceEeeeeeecC-eeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF--KNEMMLIAKLQ-HRNLVRLLGCCVEQG-EKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 544 (792)
.++|.+.++||.|.||.||+|+.. .++.||||++++.... +++. .+|++.|++++ |||||++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 578999999999999999999864 5889999999765433 3333 67999999998 999999999999988 9999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|||||+. +|.+++.+. ++.+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999954 788887543 678999999999999999999999999 9999999999999999999999999999764
Q ss_pred CCccccccceeecccceeCccccc-CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cc-----cccchhhhccc-C
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FN-----LLGHAWDLWKD-D 696 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~-----~~~~~~~~~~~-~ 696 (792)
.. ..-+.++.|.-|+|||++. .+.|+.+.|+|++|||++|+.+-++-|...++-. .. +....++.|.+ .
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 33 2345578899999999875 5689999999999999999999998886544311 10 01111112222 1
Q ss_pred ccccccccccc---cCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 697 RVHDLIDPVIM---QDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 697 ~~~~~~~~~l~---~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.+...+.-.+. ... .-.....++.+++.+|+.-||.+|||++|.+++-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 11111111111 111 1123567899999999999999999999998864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.15 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=209.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
...|+.+++||+|.||.||+|... .++.||+|++.-. .....+++++|+.++..++++||.++++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777799999999999999864 5888999999643 44567889999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+.+|++.+.| .....+.+..+.-++.+++.||.|||.++ .+|||||+.|||+.++|.+||+|||.+-.+....
T Consensus 92 y~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999998 33445588888899999999999999998 9999999999999999999999999998876554
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.. +.-++-+..
T Consensus 166 ~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~~- 227 (467)
T KOG0201|consen 166 KRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKSA- 227 (467)
T ss_pred hcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCCC-
Confidence 433 56899999999999999899999999999999999999999987544311 111111111
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+.......+.+++..||..+|+.||++.+++++
T Consensus 228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 112223456678999999999999999999999865
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.05 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=202.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--------------chhHHHHHHHHHHHhhcCCCCcceEee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------------GQGLKEFKNEMMLIAKLQHRNLVRLLG 534 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~l~~ 534 (792)
-++|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+...+|+.+|++++|+|||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 578999999999999999999864 58899999995421 112467889999999999999999999
Q ss_pred eeeec--CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCe
Q 003843 535 CCVEQ--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (792)
Q Consensus 535 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 612 (792)
+..+. +.+|||+|||..|.+...= .....|++.++.+++.++..||+|||.++ ||||||||+|+||+++|++
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 98764 5799999999998875442 22223999999999999999999999999 9999999999999999999
Q ss_pred eecccccceecCCC---ccccccceeecccceeCcccccCCC----CCCcCceeehhHHHHHHHhCCCCCCCCCcccccc
Q 003843 613 KISDFGLARMFGGD---ELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 685 (792)
Q Consensus 613 kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~ 685 (792)
||+|||.+..+... ..........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-....-.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~--- 326 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE--- 326 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH---
Confidence 99999999877332 1112233468999999999998732 3578999999999999999999986322110
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
-..+++...+ .-+...++.+.+.+||.++|++||++|.+..+|..+.
T Consensus 327 -----------l~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 -----------LFDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----------HHHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 0122222222 2222335678899999999999999999999997765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=333.68 Aligned_cols=244 Identities=18% Similarity=0.327 Sum_probs=198.4
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCch---hHHHHHHHHHHHhhcCCCCcceEeeeeee----cCeeEEEEEec
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILILEYM 549 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 549 (792)
..||+|++|.||+|+. +|+.||||+++..... ..+.|.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 7899999999754332 25778899999999999999999999877 34678999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
++|+|.+++.. .+.+++...++++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 34689999999999999999999985 6 8899999999999999999999999998654322
Q ss_pred ccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .... ..... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~---i~~~~-----~---- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDL---IINKN-----N---- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHH---HHhcC-----C----
Confidence 12467889999999976 689999999999999999999999997433211 1000 00000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.||++|||++|+++.|+..
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111223456789999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.41 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=206.0
Q ss_pred HHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
....++|+++++||+|+||.||+++-+ +|+.+|+|++++.. ..+.+..+.|-.+|....++.||+++..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 335689999999999999999999865 58999999997753 34456678899999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
||||||++||++..+| .+.+.|++..+..++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999998 56778999999999999999999999999 99999999999999999999999999964
Q ss_pred cCC----------------------Ccccc-----c------------------cceeecccceeCcccccCCCCCCcCc
Q 003843 623 FGG----------------------DELQG-----N------------------TKQIVGTYGYMSPEYALDGLFSIKSD 657 (792)
Q Consensus 623 ~~~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~s~~~D 657 (792)
+.. .+... . ....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 311 00000 0 01247999999999999999999999
Q ss_pred eeehhHHHHHHHhCCCCCCCCCcccc--ccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 658 VFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 658 VwSlGvll~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
.||||||+||||.|.+||....+... .++.|.. .+ .-+.......+..+||.+|+. ||++|.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------~l------~fP~~~~~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------TL------KFPEEVDLSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------hc------cCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999986654332 1111110 00 111112233678899999998 999997
Q ss_pred C---HHHHHH
Q 003843 736 T---MSDVIS 742 (792)
Q Consensus 736 s---~~evl~ 742 (792)
- +.||.+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 5 555544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=342.71 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=207.4
Q ss_pred HHHhcCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCe
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 541 (792)
...-++|+++++||+|+||+|+++..+. ++.+|||.+++. .....+..+.|..|+... +||.+++++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 3456889999999999999999999864 778999999875 355677888899998887 59999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
++.||||..||++..+. ..+.+++..+..++..|+.||.|||+++ |||||||.+|||||.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999954333 4567999999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.--. ....+.+++|||.|||||++.+..|+...|.|||||+|||||.|..||..+++++.
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------------------ 576 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------------------ 576 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------
Confidence 6321 22356779999999999999999999999999999999999999999986554432
Q ss_pred cccccc-cCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003843 702 IDPVIM-QDEISLPMLMRYINVALLCVQENAADRPTM 737 (792)
Q Consensus 702 ~~~~l~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 737 (792)
.|..+. ...++.-.+.+.+.++.++|..+|++|.-+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222221 112344456788999999999999999877
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.87 Aligned_cols=265 Identities=26% Similarity=0.358 Sum_probs=205.5
Q ss_pred cCccccceecccCceeEEEEEE-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|...++||+|.||.||+|+. .+|+.||||+++-.. +.......+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4678889999999999999986 469999999986542 2234567899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
||+. +|...+.+ +...++..++..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9964 78777743 3456899999999999999999999998 9999999999999999999999999999987554
Q ss_pred cccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cccccch-----hhhcccCcccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHA-----WDLWKDDRVHD 700 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~~~~~~-----~~~~~~~~~~~ 700 (792)
... ...+-|.-|.|||.+.+. .|+...|+||.|||+.||+-|.+-|....+-+ ...+-.+ .+.|.+ +..
T Consensus 156 ~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~--~~~ 231 (318)
T KOG0659|consen 156 RIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE--MTS 231 (318)
T ss_pred ccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc--ccc
Confidence 322 222678999999999875 68999999999999999999987765443211 1111111 111111 111
Q ss_pred cccc-------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 701 LIDP-------VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 701 ~~~~-------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
+-|- .......-......+.+++..++..||.+|++++|++++=-
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 1111 11111122334567799999999999999999999988743
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.99 Aligned_cols=259 Identities=27% Similarity=0.386 Sum_probs=203.9
Q ss_pred hcCccccceecccCceeEEEEEE------cCCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 541 (792)
.++|++.++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999964 235689999996432 33456789999999999 89999999999999999
Q ss_pred eEEEEEecCCCccceeeeccC-----------------------------------------------------------
Q 003843 542 KILILEYMPNKSLNVFLFDST----------------------------------------------------------- 562 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~----------------------------------------------------------- 562 (792)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988874321
Q ss_pred -------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 563 -------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 563 -------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
....+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1124788999999999999999999998 999999999999999999999999999876443222
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.....+.. .......+. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~~----------~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIKEGY----------R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-----HHHHHHhCc----------c
Confidence 22222345678999999999999999999999999999998 7888754322110 001111110 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...+.....++.+++.+||+.||++||++.||+++|++
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 00011123578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.31 Aligned_cols=272 Identities=27% Similarity=0.401 Sum_probs=209.5
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhh--cCCCCcceEeeeeeecC----eeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQG----EKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 544 (792)
...++.++||+|.||.||||.+ +++.||||++.. +..+.|++|-.|.+. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4456678999999999999999 569999999964 456778888888776 58999999999876655 8999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc------CCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY------SRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
|+||.+.|+|.+|| +...++|....+|+..+++||+|||+. .+++|+|||||.+||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999 556799999999999999999999964 36789999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCC-CC-----CcCceeehhHHHHHHHhCCCCCCCCCccccc--cccch-
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSSKKNTGVYNADSFN--LLGHA- 689 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~~DVwSlGvll~elltg~~p~~~~~~~~~~--~~~~~- 689 (792)
||..+.........-..+||.+|||||++.+.. +. .+.||||+|.|||||++...........+.. +....
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999998766665555679999999999997642 22 4689999999999999987654321111111 11000
Q ss_pred ----hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 690 ----WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 690 ----~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
.+.+...-+++-.+|.++........+..+.+.+..||..|++.|.|+.=|-+.+.+....
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 0001111122222333322223334567889999999999999999999999998876433
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=346.50 Aligned_cols=261 Identities=29% Similarity=0.429 Sum_probs=205.0
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.+ +|+||+++++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 4568999999999999999998742 24579999997543 33456789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccC----------------------------------------------------------
Q 003843 541 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 562 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 562 (792)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999988874321
Q ss_pred ---------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccc
Q 003843 563 ---------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633 (792)
Q Consensus 563 ---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 633 (792)
....+++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 1124788899999999999999999998 9999999999999999999999999998664332211122
Q ss_pred eeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCC
Q 003843 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712 (792)
Q Consensus 634 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 712 (792)
...++..|+|||++.+..++.++||||||+++|||++ |+.||........ . ....... . ....+
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~----~~~~~~~---------~-~~~~~ 337 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-F----YKMVKRG---------Y-QMSRP 337 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-H----HHHHHcc---------c-CccCC
Confidence 2345678999999999999999999999999999997 9999864322110 0 0000000 0 00111
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 713 LPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 713 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...+.++.+++.+||+.+|++||++.+|+++|+++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11245788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.08 Aligned_cols=257 Identities=30% Similarity=0.486 Sum_probs=207.2
Q ss_pred cCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
++|++.+.||+|+||.||+|.... .+.||+|.+.... ....++|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 478889999999999999998643 2579999986543 344567999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC
Q 003843 544 LILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 610 (792)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854321 145889999999999999999999998 99999999999999999
Q ss_pred CeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccch
Q 003843 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 689 (792)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 689 (792)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~---- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--V---- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H----
Confidence 999999999987644332222334456889999999999999999999999999999998 988875432211 0
Q ss_pred hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...+..+. ....+...+.++.+|+.+||+.+|.+||+++||+++|++
T Consensus 236 ~~~i~~~~----------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQ----------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCC----------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 00111110 011223345688999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=323.06 Aligned_cols=247 Identities=22% Similarity=0.391 Sum_probs=211.2
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
..+|++.+.||+|.||.|-+|.. ..|+.||||.+++. +++..-.+.+|++||..++||||+.++.+|+..+..++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45789999999999999999975 67999999998654 556677789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||..+|.|.+|+ ...+.|++.+...++.||..|+.|+|.+. ++|||||.+|||||.|+++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999999 45667999999999999999999999998 99999999999999999999999999988755
Q ss_pred CccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. ...+++|++.|.+||++.+.+| .+..|-|||||+||.|+.|.-||+..+.. .++..
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------------------~lvrQ 264 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------------------RLVRQ 264 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------------------HHHHH
Confidence 43 3456799999999999999998 58899999999999999999998643211 11111
Q ss_pred ccccCCC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 705 VIMQDEI-SLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 705 ~l~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
+..+.+ .++.+....-||++||..+|++|-|+.+|..+.
T Consensus 265 -Is~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 265 -ISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -hhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112222 222345677899999999999999999999876
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.53 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=204.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999986 48899999996542 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999983 3446899999999999999999999998 99999999999999999999999999986543
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ... ..+ ...+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~i-~~~-----~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW--ENL-KYW-----KETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH--HHH-Hhc-----cccccCCC
Confidence 223457899999999999999999999999999999999999998654322110 000 000 00000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........++.+++.+||+.+|.+||++.+++++
T Consensus 222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000012235678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.24 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=205.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999876 5788999998654 33445779999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999998843 345899999999999999999999853 3999999999999999999999999999865332
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccch-hhh-------c--cc-
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHA-WDL-------W--KD- 695 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~-~~~-------~--~~- 695 (792)
......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .... ... . ..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 1233568999999999999999999999999999999999999986433211100 0000 000 0 00
Q ss_pred ----------------Cccccccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 696 ----------------DRVHDLIDPVIM---QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 696 ----------------~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
....++.+.... ..........++.+|+.+||+.||++|||+.|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000000000000 0001112356789999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=336.95 Aligned_cols=246 Identities=22% Similarity=0.294 Sum_probs=201.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367899999999999999999875 5889999998643 223456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999998884 3446889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ......+.
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~----~~~i~~~~-------- 231 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--I----YEKILAGR-------- 231 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--H----HHHHhcCC--------
Confidence 2 223578999999999999999999999999999999999999986432110 0 00111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
+ ..+.....++.+++.+||+.||++||+ +++++.+
T Consensus 232 ~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 L---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred c---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 111112356789999999999999997 6777755
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.59 Aligned_cols=245 Identities=23% Similarity=0.265 Sum_probs=201.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999875 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999884 3346899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........ . ......
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~----~~i~~~---------- 213 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI--Y----EKILAG---------- 213 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHhC----------
Confidence 2235689999999999999999999999999999999999999864332110 0 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
....+......+.+++.+||+.||.+||+ +++++++
T Consensus 214 -~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 -KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00111222457889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=327.19 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=201.4
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3778899999999999999864 68999999986432 2334567899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998877432 2335899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ...... +...
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~~--------~~~~--- 220 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDRR--------VKED--- 220 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHHH--------hhcc---
Confidence 1 22346899999999999999999999999999999999999998753321100 000000 0000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
...+.......+.+|+.+||+.||++||+ +++++++
T Consensus 221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 11122234557889999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=347.43 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=213.4
Q ss_pred HHHHhcCccccceecccCceeEEEEEEcCC-cEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeee-eee----
Q 003843 466 ITAATENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC-CVE---- 538 (792)
Q Consensus 466 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---- 538 (792)
+....-++++.+.|.+|||+.||.|++..+ .+||+|++-..+++..+..++|+++|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345567889999999999999999998766 999999997778899999999999999997 9999999993 221
Q ss_pred --cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecc
Q 003843 539 --QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (792)
Q Consensus 539 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~D 616 (792)
.-+.+|.||||.+|.|-+++......+ |++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 136789999999999999996544444 999999999999999999999985 6799999999999999999999999
Q ss_pred cccceecCCCc-cccccc------eeecccceeCcccc---cCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccc
Q 003843 617 FGLARMFGGDE-LQGNTK------QIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 686 (792)
Q Consensus 617 FGla~~~~~~~-~~~~~~------~~~gt~~y~aPE~~---~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~ 686 (792)
||.|...-... ...... ...-|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99997532211 000000 12458999999987 577899999999999999999999999974321
Q ss_pred cchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 687 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+++... .-+........+.+||..||+.+|.+||++-+|++.+.++
T Consensus 264 ------------laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 264 ------------LAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ------------eeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 12222222 2223356788999999999999999999999999999765
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.16 Aligned_cols=258 Identities=27% Similarity=0.451 Sum_probs=207.5
Q ss_pred hcCccccceecccCceeEEEEEEcC------CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|.+.+.||+|+||.||+|+..+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568889999999999999998643 478999999765444 567899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 543 ILILEYMPNKSLNVFLFDST-----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999985431 2345889999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~--- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIE--- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH---
Confidence 99999999986543322222223345788999999999999999999999999999998 999975433211 000
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
....+.. ..........+.+++.+||+.+|++||++.||++.|++
T Consensus 236 -~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 -CITQGRL----------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0011100 01112234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.76 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=204.4
Q ss_pred hcCccccceecccCceeEEEEEEc----CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457899999999999999999763 35689999997653 3345678999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999998432 346899999999999999999999998 9999999999999999999999999876542
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ... ......
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~----~~~~~~------ 225 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIK----AVEDGF------ 225 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH----HHHCCC------
Confidence 22111 1112234678999999999999999999999999999775 999986433211 000 001000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.+......+.+++.+||+.+|.+||+++++++.|++.
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111222445788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.51 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=210.6
Q ss_pred cCccccceecccCceeEEEEEEc------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999743 345699999977666666789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 545 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985432 2245899999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~----~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V----I 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----H
Confidence 99999999986644332222233456789999999999999999999999999999999 999876433211 0 0
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
.....+... ......+..+.+++.+||+.+|++||++++|+++|+++..
T Consensus 236 ~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHhCCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111111 0111234578899999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=334.63 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=196.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 5889999999753 2334566788999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (792)
+|.+++. +.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9988873 3456899999999999999999999998 9999999999999999999999999997532211 123
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 712 (792)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .. ....+ ...++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~----~~~~~-----------~~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILME-----------EIRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HH----HHHcC-----------CCCCC
Confidence 345799999999999999999999999999999999999999864322110 00 00000 00112
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 713 LPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 713 ~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
.....++.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22345788999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.72 Aligned_cols=251 Identities=34% Similarity=0.544 Sum_probs=195.6
Q ss_pred cccceecccCceeEEEEEEc-----CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 474 SMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+.+++||||++++|++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35689999999999999986 2568999999654 33457899999999999999999999999998888999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.++|... ....+++..++.++.||++||+|||+.+ ++|+||+++||++++++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999654 2356899999999999999999999998 9999999999999999999999999999874332
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.............|+|||.+....++.++||||||+++|||++ |+.|+....... .... .....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--~~~~----~~~~~--------- 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--IIEK----LKQGQ--------- 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--HHHH----HHTTE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc----ccccc---------
Confidence 2222333456789999999999999999999999999999999 678875432211 1110 01110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
....+......+.+++.+||..+|++||++.++++.|
T Consensus 223 -~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 -RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111222345688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=340.62 Aligned_cols=261 Identities=26% Similarity=0.376 Sum_probs=206.6
Q ss_pred HhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 540 (792)
..++|++.++||+|+||.||+|+... +..||||++.... ....+.|.+|+++++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 46789999999999999999998532 3479999996543 334567999999999996 999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccC----------------------------------------------------------
Q 003843 541 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 562 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 562 (792)
..++||||+++|+|.++|....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999988875321
Q ss_pred -----------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc
Q 003843 563 -----------------------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 563 -----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 607 (792)
....+++.++..++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 0124788889999999999999999998 99999999999999
Q ss_pred CCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccc
Q 003843 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLL 686 (792)
Q Consensus 608 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~ 686 (792)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence 999999999999987644322222233456788999999999999999999999999999997 88888643221100
Q ss_pred cchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 687 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
......+. ...........+.+++.+||+.+|++||++.+|.++|+..
T Consensus 350 ---~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 00000000 0011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.57 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=211.4
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+..+|++.++||.|+||.||+|+..+++.+|+|.+........+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45679999999999999999999988999999999876665677899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..+..++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998653 2346899999999999999999999998 99999999999999999999999999987643322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.. ....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....... .... .. ...
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~----~~---------~~~- 221 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQ----IT---------AGY- 221 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHH----HH---------hCC-
Confidence 11 12345678999999999999999999999999999998 788886433111 1000 00 000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...........+.+++.+||+.+|.+|||++++++.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 111122334678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=320.61 Aligned_cols=255 Identities=29% Similarity=0.430 Sum_probs=206.6
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|++|.||+|...+++.||+|.++... ...++|.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46789999999999999999998778899999986543 34577899999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999998 999999999999999999999999999877533211
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
. ......+..|+|||.+.+..++.++||||||++++||++ |+.|+....... ... ...... .
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~----------~ 222 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ----QVDQGY----------R 222 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcCC----------C
Confidence 1 111223468999999999999999999999999999999 888886432111 000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
..........+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01112234678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=326.87 Aligned_cols=265 Identities=21% Similarity=0.299 Sum_probs=202.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999986 4788999998653 23345678899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99998776554 22345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccch--------hh-hcccCc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHA--------WD-LWKDDR 697 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~--------~~-~~~~~~ 697 (792)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .... .. ......
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12233578999999999999999999999999999999999999997543211100 0000 00 000000
Q ss_pred ccccccccccc-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 698 VHDLIDPVIMQ-----DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 698 ~~~~~~~~l~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
......+.... .......+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01110010000 0001123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=321.12 Aligned_cols=255 Identities=30% Similarity=0.445 Sum_probs=207.3
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+....+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46799999999999999999998888899999986533 34578999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 2345888999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||++....++.++||||||+++|||++ |+.||....... .... .... . .
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~----~~~~-----~-----~ 222 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSA----LQRG-----Y-----R 222 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHH----HHcC-----C-----C
Confidence 1122345678999999999999999999999999999998 898986432211 0000 0000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+........+.+++.+|++.+|++||+++++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=327.10 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=208.8
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 357889999999999999999752 24569999997766666778999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 544 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
+||||+++++|.+++.... +...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999998885321 2235899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhh
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||....... .. ..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~----~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VI----EC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HH
Confidence 999999986643322222223345778999999999999999999999999999998 888875433211 00 01
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
...+... .........+.+++.+||+.+|.+||++.+|++.|+++.
T Consensus 235 i~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111100 001122356899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.62 Aligned_cols=257 Identities=30% Similarity=0.458 Sum_probs=205.8
Q ss_pred hcCccccceecccCceeEEEEEEcC----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|++.. ...||||.++... ......|.+|+.++++++|+||+++++.+.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578899999999999999998743 3579999986543 3445678999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
+|||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999998442 236899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .. .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~----~~~~~~~------ 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VI----KAVEDGY------ 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HH----HHHHcCC------
Confidence 2221111122344678999999999999999999999999999998 888875332111 00 0000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.....+..+.+++.+|++.+|++||++.||+++|++.
T Consensus 226 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.98 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=204.2
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
.+++|++.+.||+|+||.||+|... .+..||+|++.... .....+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 24679999986432 3345678999999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 542 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998854221 234678889999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhc
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+....... ... ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~----~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLR----FV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----HH
Confidence 99999986644332222222345778999999999999999999999999999999 677875432211 000 00
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...... ..+......+.+++.+||+.+|++||++.|++++|++
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGLL----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000000 1111234578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.56 Aligned_cols=267 Identities=29% Similarity=0.381 Sum_probs=203.9
Q ss_pred ccccceecccCceeEEEEEE-----cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 544 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 544 (792)
|++.+.||+|+||+||++.. .+++.||+|.+.... ....+.|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 357789999987543 33457789999999999999999999988654 35789
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
+|||+++++|.+++.. ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998832 34899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc-ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
...... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 332111 1112245667999999999999999999999999999999999976433221111111111111111111222
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
... ..+.+.....++.+++.+||+.+|++||++++|+++|+.+
T Consensus 239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111 1122233456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.38 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=203.9
Q ss_pred cCccccceecccCceeEEEEEE-----cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
++|++.+.||+|+||.||+|+. ..++.|++|.+.... ....+.|.+|++++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999975 245789999997533 3445789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccC--------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC
Q 003843 545 ILEYMPNKSLNVFLFDST--------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 610 (792)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884221 1235889999999999999999999998 99999999999999999
Q ss_pred CeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccch
Q 003843 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 689 (792)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 689 (792)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~-- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIE-- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH--
Confidence 999999999987644332222333445778999999998899999999999999999998 88887532211 0000
Q ss_pred hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
....... .........++.+++.+|++.+|++||++.+|+++|..
T Consensus 238 --~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVRKRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000000 01111234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=334.43 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=201.7
Q ss_pred hcCccccceecccCceeEEEEEEcC--CcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++..++||||+++++++.++...++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 4679999999999999999998653 368999998543 23345678899999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.+++. +...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999884 3346899999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ......
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~----~~i~~~-------- 243 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IY----QKILEG-------- 243 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HH----HHHhcC--------
Confidence 32 234578999999999999999999999999999999999999986432211 00 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
.. .++......+.+++.+|++.+|++|+ ++++++++
T Consensus 244 ~~---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 II---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 00 11122234678999999999999995 89998776
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.27 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=202.6
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
++|++.+.||+|+||.||+++.+++..+|+|.+... ....+.|.+|+.++++++||||+++++++.++...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 468888999999999999999988889999988643 2334678999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999888532 235899999999999999999999998 9999999999999999999999999998654332211
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ...+. ....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~----i~~~~--~~~~------ 222 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEM----ISRGF--RLYR------ 222 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HHCCC--CCCC------
Confidence 112235668999999998899999999999999999999 888886432211 1110 00000 0000
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
+.....++.+++.+||+.+|++||++.++++.|.
T Consensus 223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112356899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=329.95 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=202.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCc----EEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..+|++.+.||+|+||.||+|++. +++ .||+|++.... ....+++.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356899999999999999999864 333 48999986543 34567899999999999999999999998765 577
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999988532 345889999999999999999999998 999999999999999999999999999976
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............++..|+|||++.+..++.++||||||+++|||++ |+.|+........ ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~----- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGE----- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHhCCC-----
Confidence 54332222222334678999999999999999999999999999998 8998864322111 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+........+.+++.+||+.+|++||++.+++..|...
T Consensus 229 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 229 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.80 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=213.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe-eEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE-KILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 545 (792)
.++|..++++|+|+||.++..+.+ +++.+++|++.- ..+...+...+|+.++++++|||||.+.+.+.+++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999998775 477899998743 344555678899999999999999999999999998 9999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|+|++||+|.+.|...+ ...++++.+.+++.|++.|+.|||+.. |+|||||+.||+++.++.+||.|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999986543 567999999999999999999999776 99999999999999999999999999999876
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.... + .+++..
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L--i------------~ki~~~- 221 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL--I------------LKINRG- 221 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--H------------HHHhhc-
Confidence 54 234567999999999999999999999999999999999999999875432211 0 111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ..+.+.....++..++..|++.+|..||++.+++.+
T Consensus 222 ~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 L-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred c-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 234566677899999999999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=298.73 Aligned_cols=265 Identities=22% Similarity=0.235 Sum_probs=212.9
Q ss_pred HHhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----e
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----E 541 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 541 (792)
...++|++.++||+|||+-||.++. .+++.+|+|++.....++.+..++|++.-++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 4578999999999999999999984 468899999998777788899999999999999999999999876543 4
Q ss_pred eEEEEEecCCCccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 542 KILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
.|++++|...|+|.+.+..... +..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999998865544 347999999999999999999999986 47999999999999999999999999999
Q ss_pred eecCCCccccc-------cceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchh
Q 003843 621 RMFGGDELQGN-------TKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 621 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 690 (792)
....-...... -..-.-|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 86532111000 01124578999999885 456789999999999999999999999743221
Q ss_pred hhcccCccc-cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 691 DLWKDDRVH-DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 691 ~~~~~~~~~-~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+.+. .+....+ .-+.....++.+.+++.+|++.||.+||++.+++..++..
T Consensus 248 ----GgSlaLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----CCeEEEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 1122222 1122223677899999999999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=372.97 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=208.7
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
...+...+.||+|+||.||+|+. .+++.||||++...... ..+|++.+++++|||||++++++.++...++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35677788999999999999987 46899999998653322 23468899999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.+++. .++|.++.+++.||++||+|||.....+|+||||||+||+++.++..++. ||.+......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999983 38999999999999999999996655569999999999999999988875 6665433211
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
....+++.|+|||++.+..++.++|||||||++|||++|+.|+............+.............+++.+..
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1236789999999999999999999999999999999999998543333333333333333333344455555422
Q ss_pred C-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 D-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. .....+..++.+++.+||+.+|++||+|+||+++|++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 2 33456677889999999999999999999999999886
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.17 Aligned_cols=240 Identities=20% Similarity=0.270 Sum_probs=193.0
Q ss_pred ecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999875 4789999998643 234456788999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988843 446899999999999999999999998 9999999999999999999999999998643221 12334
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. .. ++.. ....+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~----~~--------~~~~---~~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--MY----RK--------ILQE---PLRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--HH----HH--------HHcC---CCCCCCc
Confidence 578999999999999999999999999999999999999986432211 00 00 0000 0111222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...++.+++.+||+.||++||++..+.+.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 34578899999999999999864433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.37 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=196.7
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.||+|+||.||+++.. +++.||+|++... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999875 5889999999653 2344567889999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (792)
+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9988773 3346899999999999999999999998 9999999999999999999999999987542211 122
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 712 (792)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..... ...++
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--~~----~~~~~-----------~~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LILME-----------DIKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--HH----HhccC-----------CccCC
Confidence 345789999999999999999999999999999999999999864322110 00 00000 00112
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 713 LPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 713 ~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
.....++.+++.+||+.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 22345788999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.61 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=195.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677899999999999999875 58999999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.... .+.+..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986542 3567788899999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||.............. ....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~------- 291 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---ICMS------- 291 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhcc-------
Confidence 1233578999999998753 2345689999999999999999999873222111000000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ..........++.+++.+||+.||++||++.|++++
T Consensus 292 ~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 Q---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred C---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111122344578999999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.28 Aligned_cols=265 Identities=24% Similarity=0.359 Sum_probs=202.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999876 5788999988654 33445679999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ .|+|+||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999843 345889999999999999999999752 2999999999999999999999999999765322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccc-c------chhhh--cccCc-
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL-G------HAWDL--WKDDR- 697 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~-~------~~~~~--~~~~~- 697 (792)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||........... . ..... .....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 12234689999999999999999999999999999999999999864332111000 0 00000 00000
Q ss_pred ----------------cccccccccccC--CC-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 ----------------VHDLIDPVIMQD--EI-SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ----------------~~~~~~~~l~~~--~~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+.+...... .. ......++.+|+.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000000000000 00 01124568899999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.81 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=207.7
Q ss_pred HhcCccccceecccCceeEEEEEEcC------CcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
..++|++.+.||+|+||.||++.... ...+|+|.+... ..+...++.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 45678999999999999999998642 367999998753 334556789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCccceeeecc-------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc
Q 003843 541 EKILILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 607 (792)
..+++|||+++++|.+++... .....+++..+++++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999988532 22356899999999999999999999998 99999999999999
Q ss_pred CCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccc
Q 003843 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLL 686 (792)
Q Consensus 608 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~ 686 (792)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 999999999999987654332222222345678999999999999999999999999999998 8888754322110
Q ss_pred cchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 687 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
........ ....+......+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 244 ---~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ---FKLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 00110000 0111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=346.91 Aligned_cols=252 Identities=19% Similarity=0.234 Sum_probs=204.6
Q ss_pred CccccceecccCceeEEEEEEc-C-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4889999999999999999754 3 5778999876555555667889999999999999999999999999999999999
Q ss_pred CCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 550 PNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 550 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
++|+|.+++... .....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887543 23446889999999999999999999998 99999999999999999999999999997654332
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ....+..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~----~~~~~~~---------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQ----QVLYGKY---------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhCCC----------
Confidence 223344579999999999999999999999999999999999999986422110 000 0000000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.+.+......+.+++.+||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0111223457899999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.31 Aligned_cols=260 Identities=28% Similarity=0.433 Sum_probs=203.7
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeec-C
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 540 (792)
.++|++.++||+|+||.||+|... .++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 467999999999999999999642 24789999986543 33456788899999999 899999999988654 5
Q ss_pred eeEEEEEecCCCccceeeeccCC---------------------------------------------------------
Q 003843 541 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 563 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 563 (792)
..++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 68899999999999888743211
Q ss_pred -CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeeccccee
Q 003843 564 -KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642 (792)
Q Consensus 564 -~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~ 642 (792)
...+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999998 9999999999999999999999999998764333222233345677899
Q ss_pred CcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHH
Q 003843 643 SPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYIN 721 (792)
Q Consensus 643 aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~ 721 (792)
|||++.+..++.++|||||||+||||++ |..||........ . ........ ....+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~---~~~~~~~~----------~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F---CRRLKEGT----------RMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H---HHHHhccC----------CCCCCccCCHHHHH
Confidence 9999999999999999999999999998 9988854221110 0 00001000 00111223457889
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 722 VALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 722 li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
++.+||+.+|++||++.|++++|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=326.38 Aligned_cols=242 Identities=26% Similarity=0.353 Sum_probs=195.0
Q ss_pred ceecccCceeEEEEEEc----CCcEEEEEEeccc----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++||+|+||.||+++.. .++.||+|+++.. .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999753 5788999998643 223345678999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. +.+.+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999988873 3456888899999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .. . .+....
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~~----~--------~~~~~~--- 216 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--TI----D--------KILKGK--- 216 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--HH----H--------HHHcCC---
Confidence 12233578999999999999999999999999999999999999986433211 00 0 000000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
...+......+.+++.+||+.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011222345688999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.74 Aligned_cols=242 Identities=22% Similarity=0.290 Sum_probs=195.7
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.||+|+||.||+++.. +|+.||+|++... .......+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999875 5889999999653 2334566788999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (792)
+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988773 3446899999999999999999999998 9999999999999999999999999987542221 112
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 712 (792)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ..... ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~----~~~~~-----------~~~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILME-----------EIRFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHhcC-----------CCCCC
Confidence 235789999999999999999999999999999999999999864322110 00 00000 00111
Q ss_pred HHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 713 LPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 713 ~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
.....++.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 22345778999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.33 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=199.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999875 57899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 78777632 2335789999999999999999999998 99999999999999999999999999986533221
Q ss_pred ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc-----hhhhccc----Cc
Q 003843 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH-----AWDLWKD----DR 697 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~-----~~~~~~~----~~ 697 (792)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ..... ....+.. ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223467899999999875 5689999999999999999999999865432111 00000 0000000 00
Q ss_pred cccccccccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+...... .......++.+++.+||+.||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111100000 011123567899999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.31 Aligned_cols=252 Identities=30% Similarity=0.433 Sum_probs=202.9
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
++|++.+.||+|+||.||+|+..++..+|+|.+.... ...+.|.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999999988777789999986432 334679999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999988432 235899999999999999999999998 9999999999999999999999999998764332211
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ...... ..
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~--~~----~~~~~~----------~~ 220 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET--VE----KVSQGL----------RL 220 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH--HH----HHhcCC----------CC
Confidence 112235678999999998899999999999999999998 8888864332110 00 000000 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.........+.+++.+||+.+|++||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011112467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.80 Aligned_cols=264 Identities=24% Similarity=0.300 Sum_probs=197.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 588999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666532 2345889999999999999999999998 9999999999999999999999999997643221
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------hcccCcc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD--------LWKDDRV 698 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 698 (792)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+ ..... .+.....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL-ERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHHhCCCChhhccchhh
Confidence 11223467899999999875 458899999999999999999999997543211100 00000 0000000
Q ss_pred ccccccc-cc-cCCCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 699 HDLIDPV-IM-QDEIS-------LPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 699 ~~~~~~~-l~-~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....++. .. ..+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 00 00000 011246789999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=315.35 Aligned_cols=248 Identities=26% Similarity=0.373 Sum_probs=197.0
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
+.||+|+||.||+|+.. +++.||+|.+.... ......|.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68899999886543 34557799999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998843 2345889999999999999999999998 99999999999999999999999999986543221111111
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISL 713 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 713 (792)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+........ ..... ... ....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~------~~~~~---------~~~-~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT------REAIE---------QGV-RLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH------HHHHH---------cCC-CCCCcc
Confidence 223467999999999999999999999999999998 8888754322110 00000 000 011122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 714 PMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 714 ~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
..+..+.+++.+|++.+|++||++.+|+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=333.94 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=197.2
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.|++++.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999874 5789999999653 23445678999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999884 3346889999999999999999999998 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------ccccceeecccceeCcccccCCCCCCcCceeehh
Q 003843 628 L---------------------------------------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662 (792)
Q Consensus 628 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlG 662 (792)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHh--ccccCCCCCCCHHHH
Q 003843 663 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL--CVQENAADRPTMSDV 740 (792)
Q Consensus 663 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~--cl~~dp~~RPs~~ev 740 (792)
|++|||++|+.||........... ...... .+ ..+.......++.+++.+ |+..++..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~-----i~~~~~-------~~-~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLK-----VINWEN-------TL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHH-----HHcccc-------cc-CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999975432211100 000000 00 001111223466777776 556667779999999
Q ss_pred HHH
Q 003843 741 ISM 743 (792)
Q Consensus 741 l~~ 743 (792)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.46 Aligned_cols=256 Identities=26% Similarity=0.440 Sum_probs=202.3
Q ss_pred ccccceecccCceeEEEEEEcC----CcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe-----
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 541 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 541 (792)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|++.++.++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998643 367999998743 23445789999999999999999999998876554
Q ss_pred -eEEEEEecCCCccceeeeccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccc
Q 003843 542 -KILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (792)
Q Consensus 542 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DF 617 (792)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccC
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
|+++...............++..|+|||.+....++.++||||||+++|||++ |..|+....... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYD----YLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC
Confidence 99987654332222222345678999999999999999999999999999999 888875432211 110 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. ....+.....++.+++.+||+.||++||++.|+++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0111223445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.07 Aligned_cols=257 Identities=30% Similarity=0.455 Sum_probs=203.9
Q ss_pred cCccccceecccCceeEEEEEEcC------CcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.+|++.++||+|+||.||+|.... ++.||+|+++.... ...+.|.+|+.++..++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 357788999999999999998643 47899999975433 33567899999999999999999999999999999
Q ss_pred EEEEecCCCccceeeecc-------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC
Q 003843 544 LILEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 610 (792)
+++||+++++|.+++... ..+..+++..+..++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999887421 11235888999999999999999999998 99999999999999999
Q ss_pred CeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccch
Q 003843 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 689 (792)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 689 (792)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~--- 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VI--- 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH---
Confidence 999999999987643332222233456789999999998899999999999999999998 777775432211 00
Q ss_pred hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
....... ...........+.+++..|++.+|++||++.+|++.|+.
T Consensus 237 -~~i~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 -EMIRNRQ----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHcCC----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0111110 011122345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.08 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=205.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.+|++.+.||+|+||.||+|... .++.||+|.+... ....+++.+|++++++++|+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888899999999999999875 4788999998653 344578899999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988432 2345899999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+. .+...... . .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~-----~-----~ 223 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKG-----Y-----R 223 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCC-----C-----C
Confidence 1 112234568999999999999999999999999999998 888876432211 01111100 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...+...+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=297.45 Aligned_cols=249 Identities=26% Similarity=0.362 Sum_probs=208.1
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
-++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+...++.+|++|-..++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4689999999999999999998764 667999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+||.+.|.|...|... +...+++.....++.|+|.||.|+|..+ +|||||||+|+|++..+.+||+|||-+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999888532 4456889999999999999999999998 9999999999999999999999999997543
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.......+||..|++||+..+...+...|+|++|++.||++.|.+||.....++ .+.. +...
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkr--------I~k~- 237 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKR--------IRKV- 237 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHH--------HHHc-
Confidence 234556899999999999999999999999999999999999999997543211 1111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.-.++......+.++|.+|+..+|.+|.+..|++.+
T Consensus 238 --~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 --DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111223445678999999999999999999999865
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=347.17 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=206.8
Q ss_pred HHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC---
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--- 540 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 540 (792)
....++|++.++||+|+||+||+|+.. +++.||||++... .......+.+|+..+..++|+|+++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344679999999999999999999864 6899999998643 3455677899999999999999999988775432
Q ss_pred -----eeEEEEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 541 -----EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 541 -----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999885432 2356899999999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~----~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VM----HKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HH----HHHh
Confidence 99999987654332333344679999999999999999999999999999999999999986432111 00 0000
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+. ..+.+.....++.+++.+||+.+|.+||++.+++++
T Consensus 259 ~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR----------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 000 011222344678899999999999999999999864
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.47 Aligned_cols=257 Identities=27% Similarity=0.429 Sum_probs=205.7
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..+|++.++||+|+||.||+++.. ++..+|+|.+........+.|.+|+++++.++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356788899999999999999642 35679999988777677788999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCC------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 544 LILEYMPNKSLNVFLFDSTK------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
++|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999998854321 135889999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |++||........ .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~---- 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--I---- 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--H----
Confidence 99999999986643322222223345788999999999999999999999999999998 8888753222110 0
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
....... ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 235 ~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000000 00111123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.61 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=204.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999875 58899999996532 244567899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998433 56899999999999999999999998 999999999999999999999999999876433
Q ss_pred c---------------------------cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 627 E---------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 627 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
. .........||+.|+|||.+.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234578999999999999999999999999999999999999987543
Q ss_pred ccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 003843 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVISM 743 (792)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~ 743 (792)
.... .. .... .. ..+ ..+.......++.+++..|++ +|.+||+ +++++++
T Consensus 235 ~~~~--~~---~i~~------~~-~~~-~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET--YN---KIIN------WK-ESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH--HH---HHhc------cC-Ccc-cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2110 00 0000 00 000 000111134678899999997 9999999 9999886
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.42 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=203.7
Q ss_pred HhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
..++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35779999999999999999998753 5679999886443 3345679999999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC---Ceee
Q 003843 542 KILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKI 614 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kL 614 (792)
.++||||+++++|.+++..... ...+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999998 99999999999998765 5999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhc
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||........ .. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--ME----FV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HH----HH
Confidence 99999987643322222222234568999999999999999999999999999997 8888864332111 00 00
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.... ....+...+..+.+++.+|++.+|++||++.+|+++|.
T Consensus 235 ~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0000 01112223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.96 Aligned_cols=272 Identities=25% Similarity=0.410 Sum_probs=204.4
Q ss_pred hcCccccceecccCceeEEEEEEc-----CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 542 (792)
.++|++.+.||+|+||.||++..+ +++.||+|++........+.|.+|++++++++|+||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357888999999999999999753 478999999987766777889999999999999999999998754 3468
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 8999999999999998432 245899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCcccc-ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh-hcccCcccc
Q 003843 623 FGGDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-LWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 700 (792)
........ ......++..|+|||.+.+..++.++||||||++++||++|..++................ ......+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64332111 1111223456999999999999999999999999999999877654222111000000000 000000001
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+.... ..+.......++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111100 0111222345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.81 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=203.8
Q ss_pred CccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
+|++.+.||+|+||.||+|+.. ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999753 23578999886543 3445779999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccC---------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q 003843 545 ILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 603 (792)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998874321 1235889999999999999999999998 9999999999
Q ss_pred EEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccc
Q 003843 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADS 682 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~ 682 (792)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322112222345678999999999999999999999999999998 888885432211
Q ss_pred cccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. +...... . ..........++.+++.+|++.+|++||++.|+++.|++.
T Consensus 238 --~----~~~~~~~---------~-~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 --L----FNLLKTG---------Y-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --H----HHHHhCC---------C-CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 0 1111110 0 0111122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.10 Aligned_cols=252 Identities=23% Similarity=0.304 Sum_probs=198.5
Q ss_pred CccccceecccCceeEEEEEEc----CCcEEEEEEeccc----CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
+|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++.++ +|+||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999753 5789999998642 223456688899999999 599999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++|+|.+++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999988884 3346899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ...... +
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~--------~ 223 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRR--------I 223 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHH--------H
Confidence 5332211 22345789999999999875 4789999999999999999999998643321110 000000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
... ....+......+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 224 LKC---DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred hcC---CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 000 1111222345678999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=333.94 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=199.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|++++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999875 5889999999653 2334566889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998843 346899999999999999999999998 999999999999999999999999999765321
Q ss_pred cccc------------------------------------ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh
Q 003843 627 ELQG------------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670 (792)
Q Consensus 627 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt 670 (792)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 003843 671 SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSDVISM 743 (792)
Q Consensus 671 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 743 (792)
|..||........ ... ..... .. + ..+........+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~~--~~~---i~~~~--~~-----~-~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET--YRK---IINWK--ET-----L-QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH--HHH---HHcCC--Cc-----c-CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999964332110 000 00000 00 0 000111224567788999986 9999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=311.83 Aligned_cols=268 Identities=24% Similarity=0.339 Sum_probs=206.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCCcceEeeeeee-----cCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-----QGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 541 (792)
...|...+.||+|+||.|..+... +|+.||||++.+ ......++..+|+++|+.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456666789999999999999875 589999999974 344556788999999999999999999999865 347
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.|+|+|+| ..+|...+ +.++.|+......+++||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 66888887 33445999999999999999999999999 9999999999999999999999999999
Q ss_pred ecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCc-cccccccchhhh-------
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSFNLLGHAWDL------- 692 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~-~~~~~~~~~~~~------- 692 (792)
...........+.++.|.-|.|||++.. ..|+.+.||||.||||.||++|++-|...+. +...++......
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8865433334466788999999999864 5799999999999999999999998865432 222222111111
Q ss_pred -cccCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 693 -WKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 693 -~~~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
...+.....+.........+ +......++|+.+||..||.+|+|++|.+++=
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 11111111221111111111 22346789999999999999999999998763
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=315.16 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=208.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999875 6889999987542 2344567899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+++++|.+++.... +...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988875432 2345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+.....+...... ... ....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~----~~~-----~~~~-- 225 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ----KIE-----QCDY-- 225 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH----HHh-----cCCC--
Confidence 321 112346788999999999988999999999999999999999998543221111110 000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...........+.+++.+||+.+|++||++.+|++.|++.
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111223446789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=319.38 Aligned_cols=265 Identities=27% Similarity=0.425 Sum_probs=206.4
Q ss_pred hcCccccceecccCceeEEEEEEcC-----------------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-----------------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVR 531 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 531 (792)
.++|++.+.||+|+||.||+++... +..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999997643 2458999987543 345678999999999999999999
Q ss_pred EeeeeeecCeeEEEEEecCCCccceeeeccC--------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q 003843 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (792)
Q Consensus 532 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 603 (792)
+++++..+...++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1235899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh--CCCCCCCCCcc
Q 003843 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNAD 681 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt--g~~p~~~~~~~ 681 (792)
|+++.++.++|+|||+++...............+++.|+|||.+....++.++||||||+++|||++ +..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999987644433223334456789999999998899999999999999999998 55666432211
Q ss_pred ccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 682 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.........+........ .+.....+.++.+++.+||+.+|++||++.||++.|++
T Consensus 241 --~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 --QVIENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111100000 01111234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.53 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=208.3
Q ss_pred HhcCccccceecccCceeEEEEEEcC-----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeee-cCe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 541 (792)
..++|++.+.||+|+||.||+|.... +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998765 688999998654 33456778999999999999999999998776 467
Q ss_pred eEEEEEecCCCccceeeeccCCC-----ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecc
Q 003843 542 KILILEYMPNKSLNVFLFDSTKK-----RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~D 616 (792)
.++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 56899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhccc
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ... ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE--MAA----YLKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH--HHH----HHHc
Confidence 999987644332222222345678999999999999999999999999999999 999986432211 111 0111
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
+. ..........++.+++.+||+.+|++||++.++++.|+...
T Consensus 235 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 GY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 00011112356889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.67 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=196.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----eeE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 543 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 543 (792)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999875 5889999998643 2234457889999999999999999999886432 479
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+. ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 57877773 3446899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCcc-ccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------hhh
Q 003843 624 GGDEL-QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWD 691 (792)
Q Consensus 624 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~~~ 691 (792)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 111234578999999999876 6789999999999999999999999864332110 00000 000
Q ss_pred hcccCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 LWKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+........+.......... ......+.+++.+||+.+|++||+++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000110000000000 0123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.91 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=200.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCc----EEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
++|++.+.||+|+||+||+|+.. +++ .+++|.+.... .....++..|+..++++.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 57888899999999999999864 344 47888875433 234567888999999999999999999875 456788
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998532 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ .+....+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~--~~ 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGERL--AQ 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCcC--CC
Confidence 4332222334457789999999999999999999999999999998 9888864322110 0011111100 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.......+.+++.+|+..+|++||++.|+++.|....
T Consensus 233 --------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 233 --------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0112345788999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=316.76 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=199.3
Q ss_pred ccccceecccCceeEEEEEEcCCc---EEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------Ce
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLNGQ---EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GE 541 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 541 (792)
|.+.++||+|+||.||+|+..... .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999875432 5899988653 344567899999999999999999999987532 24
Q ss_pred eEEEEEecCCCccceeeecc---CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 542 KILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
.++++||+++|+|.+++... .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999998887432 12345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~----~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--I----YDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHcCC
Confidence 9987644332222222345778999999999999999999999999999999 788875422211 1 11111111
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.. .........+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 11112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.47 Aligned_cols=264 Identities=25% Similarity=0.419 Sum_probs=201.6
Q ss_pred hcCccccceecccCceeEEEEEEcC---------------CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN---------------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLL 533 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 533 (792)
.++|++.+.||+|+||.||+++... ...||+|+++.. .....+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4579999999999999999987532 235899998754 334456799999999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCccceeeeccC---------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcE
Q 003843 534 GCCVEQGEKILILEYMPNKSLNVFLFDST---------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (792)
Q Consensus 534 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NI 604 (792)
+++..+...++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999884321 1124788999999999999999999998 99999999999
Q ss_pred EEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh--CCCCCCCCCccc
Q 003843 605 LLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADS 682 (792)
Q Consensus 605 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt--g~~p~~~~~~~~ 682 (792)
+++.++.+||+|||++................++..|+|||.+.+..++.++||||||++++||++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999986543322222223345778999999999999999999999999999998 445554322111
Q ss_pred cccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
............. ... ........+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 241 --~~~~~~~~~~~~~------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQG------RQI-YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhcc------ccc-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111000000000 000 00111123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.52 Aligned_cols=241 Identities=24% Similarity=0.327 Sum_probs=190.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4788999998653 223345566677777654 899999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888743 346899999999999999999999998 9999999999999999999999999998653222 22
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .. ..... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~----~i~~~-----------~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FD----SILND-----------RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHcC-----------CCCC
Confidence 3345789999999999999999999999999999999999999864332110 00 00000 0111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMS-DVIS 742 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 742 (792)
+.....++.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 222345678999999999999999976 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.98 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=206.7
Q ss_pred hcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4688999999999999999998643 3689999986543 34456789999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccC-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 543 ILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999985432 1234788999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcc
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~----~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLK----FVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHH----HHh
Confidence 9999987654433222333456789999999998899999999999999999998 888875432211 110 011
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.... ...+......+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGH----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0000 01112235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.81 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=195.3
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.||+|+||.||+++.. +++.||+|++... .......+.+|++++..++|+||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 6889999999653 2334567788999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
+|..++. +...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9988773 34468999999999999999999997 67 9999999999999999999999999997543221 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.. . ...... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~----~~i~~~-----------~~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--F----ELILME-----------EIRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--H----HHHhcC-----------CCCC
Confidence 2335689999999999999999999999999999999999999864332111 0 000000 0011
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
+.....++.+++.+||+.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 122345688999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=324.68 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=194.4
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999753 233456678899988877 899999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988773 3356899999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc---ccccchhhhcccCcccccccccccc
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF---NLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~---~ 221 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------K---Q 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------C---C
Confidence 2345789999999999999999999999999999999999999864221110 000001111100 0 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPT------MSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~ 743 (792)
..++......+.+++.+||+.||++||+ +.+++++
T Consensus 222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1122234457889999999999999998 4666544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=332.59 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=195.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.|+++++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999875 57889999986532 3345678899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999988843 346889999999999999999999998 9999999999999999999999999986431100
Q ss_pred ---------------------------------------------cccccceeecccceeCcccccCCCCCCcCceeehh
Q 003843 628 ---------------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFG 662 (792)
Q Consensus 628 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlG 662 (792)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHH
Q 003843 663 ILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSD 739 (792)
Q Consensus 663 vll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~e 739 (792)
|++|||++|+.||.......... ..... ...+ ..+.......++.+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~-----~i~~~-------~~~~-~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQM-----KVINW-------QTSL-HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHH-----HHHcc-------CCCc-CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999997543211100 00000 0000 00111122345667777766 49999997 777
Q ss_pred HHHH
Q 003843 740 VISM 743 (792)
Q Consensus 740 vl~~ 743 (792)
++++
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=319.17 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=194.2
Q ss_pred cCccccceecccCceeEEEEEEc--CCcEEEEEEecccC--chhHHHHHHHHHHHhhc---CCCCcceEeeeeee-----
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE----- 538 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 538 (792)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46789999886432 22334566777777765 69999999999852
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 446899999996 5788877432 2335899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 697 (792)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|++||......... .+...........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 99876433 2233456899999999999999999999999999999999999998754321110 0000000000000
Q ss_pred c-------ccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 698 V-------HDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 698 ~-------~~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
. ...+..... ...........+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000 00011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=314.39 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=201.6
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.+|++.+.||+|+||.||+|+...+..+|+|.+.... ...+.|.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4578889999999999999998777789999986432 234578899999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988532 236899999999999999999999998 9999999999999999999999999998654322111
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .... ... .
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~----~~~~-----~~~-----~ 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE----SVSA-----GYR-----L 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHH----HHHc-----CCc-----C
Confidence 111223457999999999999999999999999999999 788886433211 000 0000 000 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
..+...+.++.+++.+||+.+|++||++.|++++|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11122455789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.98 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=196.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||+||+++.. +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999875 58899999996532 234467888999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. +.+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999765321
Q ss_pred ccc---------------------------------cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCC
Q 003843 627 ELQ---------------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673 (792)
Q Consensus 627 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~ 673 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccc--cCCCCCCCHHHHHHH
Q 003843 674 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQ--ENAADRPTMSDVISM 743 (792)
Q Consensus 674 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~evl~~ 743 (792)
||........ ... ..... ..+. + .. ......++.+++.+++. .++..||+++|++++
T Consensus 235 Pf~~~~~~~~--~~~----i~~~~-~~~~---~-p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQET--YKK----VMNWK-ETLI---F-PP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHH--HHH----HHcCc-Cccc---C-CC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9964332111 000 00000 0000 0 00 11123456667766443 344467999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.12 Aligned_cols=253 Identities=19% Similarity=0.302 Sum_probs=201.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999875 58899999997532 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998432 246899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccceeecccceeCccccc------CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ . .........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~---~~i~~~~~~-- 227 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--Y---NNIMNFQRF-- 227 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--H---HHHHcCCCc--
Confidence 221 222346899999999987 45678999999999999999999999864332110 0 000000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+ ..+........+.+++..|++ +|.+||++.+++++
T Consensus 228 -~-----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 -L-----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -c-----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 001111234567889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=312.70 Aligned_cols=254 Identities=31% Similarity=0.474 Sum_probs=203.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|+||.||+|...++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457899999999999999999988888999999975433 3467999999999999999999999875 45689999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999988542 2345899999999999999999999998 999999999999999999999999999876443211
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ..... . .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~----~~~~~---------~-~ 221 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLE----QVERG---------Y-R 221 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcC---------C-C
Confidence 1112235668999999998999999999999999999999 888885432111 110 00000 0 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+.+......+.+++.+|++.+|.+|||+.++++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122334678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=332.79 Aligned_cols=253 Identities=23% Similarity=0.286 Sum_probs=197.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999864 6889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999884 3356889999999999999999999998 999999999999999999999999999643211
Q ss_pred ccc------------c---------------------------------ccceeecccceeCcccccCCCCCCcCceeeh
Q 003843 627 ELQ------------G---------------------------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSF 661 (792)
Q Consensus 627 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSl 661 (792)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012468999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC---CCHH
Q 003843 662 GILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR---PTMS 738 (792)
Q Consensus 662 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~ 738 (792)
||++|||++|+.||........ ... ...... .+ .-+.......++.+++.+|++ +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~--~~~---i~~~~~-------~~-~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET--YRK---IINWRE-------TL-YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH--HHH---HHccCC-------cc-CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999864332111 000 000000 00 000011123567889999997 66665 5999
Q ss_pred HHHHH
Q 003843 739 DVISM 743 (792)
Q Consensus 739 evl~~ 743 (792)
|++++
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=313.21 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=204.0
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|+||.||+|+..++..||+|+++... ...+.|.+|++++++++|+||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 46799999999999999999998777789999997532 23467899999999999999999999875 45679999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998543 2345789999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ....... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~----------~ 221 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERGY----------R 221 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH----HHHhcCC----------C
Confidence 1122346678999999999999999999999999999999 777875432211 00 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.......+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.16 Aligned_cols=259 Identities=27% Similarity=0.441 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEc--------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
.++|.+.+.||+|+||.||+++.. ....+|+|.+... ......++.+|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999753 2346999999754 234556788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
+..++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999854321 235889999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 685 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~ 685 (792)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....+. .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H
Confidence 9999999999999986643222111222234568999999999999999999999999999998 778875322111 0
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
........ ..+.+.....++.+++.+|++.+|++||++.+|++.|+.+
T Consensus 252 ----~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 ----FKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ----HHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 00011110 0111122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.90 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=194.2
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHH---hhcCCCCcceEeeeeeecCeeEEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLI---AKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++ ..++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999875 58899999996432 23345667776655 466899999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999987773 346899999999999999999999998 99999999999999999999999999875322
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ .. . +....
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~----~--------i~~~~ 217 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FD----S--------IVNDE 217 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HH----H--------HHhCC
Confidence 11 122345789999999999999999999999999999999999999864332110 00 0 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
...+......+.+++.+||+.||.+|| ++.+++++
T Consensus 218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 011122345678999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.31 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=206.7
Q ss_pred HhcCccccceecccCceeEEEEEEc--------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 538 (792)
..++|++.+.||+|+||.||+++.. ++..||+|.+... .....+.+.+|+.++..+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3578889999999999999999742 2457999998653 234567899999999999 89999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 539 QGEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
....++||||+++++|.+++.... ....+++.+++.++.||++||.|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999985432 1235788999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~ 684 (792)
++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+.......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 99999999999999987754332222223345678999999999999999999999999999998 677764322111
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
......... ...........+.+++.+||+.+|.+||++.|+++.|+++
T Consensus 248 ----~~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 248 ----LFKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred ----HHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 001111110 0011123346788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.92 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=196.6
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCC-CcceEeeeeeecCeeEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 546 (792)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999875 4678999998653 234456788899999999765 5888999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988873 3345889999999999999999999998 999999999999999999999999998753221
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~----~i~~~---------- 216 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQ----SIMEH---------- 216 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHHcC----------
Confidence 1 122345789999999999999999999999999999999999999864332111 00 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 743 (792)
....+.....++.+++.+||+.+|.+||+. .++.++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011112234577899999999999999986 565543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.62 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=203.3
Q ss_pred hcCccccceecccCceeEEEEEEc-----------------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-----------------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVR 531 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 531 (792)
.++|++.++||+|+||.||+++.. +...+|+|++... .....+.|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999998532 2346899998754 3345678999999999999999999
Q ss_pred EeeeeeecCeeEEEEEecCCCccceeeeccCC--------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q 003843 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTK--------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (792)
Q Consensus 532 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 603 (792)
+++++..++..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999998854321 234788899999999999999999998 9999999999
Q ss_pred EEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh--CCCCCCCCCcc
Q 003843 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNAD 681 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt--g~~p~~~~~~~ 681 (792)
||++.++.+||+|||+++.+.............++..|+|||......++.++|||||||++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999987643322222222344678999999988899999999999999999998 56676533221
Q ss_pred ccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 682 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
. ............. .... .+........+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ~--~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q--VIENTGEFFRDQG-RQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H--HHHHHHHHHhhcc-cccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1110000000000 0000 01112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=332.79 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=197.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.+|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999875 48899999986432 233566889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999984 3456889999999999999999999998 999999999999999999999999998533100
Q ss_pred c-----------------------------------------cccccceeecccceeCcccccCCCCCCcCceeehhHHH
Q 003843 627 E-----------------------------------------LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665 (792)
Q Consensus 627 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll 665 (792)
. .........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00001234799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC---CHHHHHH
Q 003843 666 LETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP---TMSDVIS 742 (792)
Q Consensus 666 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~evl~ 742 (792)
|||++|+.||............. .+.. . + ..+........+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~---~~~~----~-----~-~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVI---NWET----T-----L-HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHh---ccCc----c-----c-cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999997543221100000 0000 0 0 00011122345667777766 5999999 8899887
Q ss_pred H
Q 003843 743 M 743 (792)
Q Consensus 743 ~ 743 (792)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.26 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=195.7
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+++.. +++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999875 5789999999753 233456688999999998 799999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
|+|..++. +.+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99988773 3356999999999999999999999998 9999999999999999999999999997532111 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc---ccccchhhhcccCcccccccccccc
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF---NLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~~--- 221 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEKQ--- 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcCC---
Confidence 2345789999999999999999999999999999999999999964322110 0000011111 1110
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPT------MSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~evl~~ 743 (792)
...+.....++.+++.+||+.||.+||+ +++++++
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0112223457889999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=312.35 Aligned_cols=246 Identities=29% Similarity=0.420 Sum_probs=195.6
Q ss_pred eecccCceeEEEEEEc---CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 478 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+||+|+||.||+|.+. +++.+|+|+++... ....+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999653 57889999986443 334678999999999999999999999875 45678999999999
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc-c
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-N 631 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~ 631 (792)
+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999883 3346899999999999999999999998 9999999999999999999999999998764432211 1
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....... .. .....+. ..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~----~~i~~~~----------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VT----QMIESGE----------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHCCC----------CCC
Confidence 112234578999999988889999999999999999998 999986433211 10 0111110 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+.....++.+++.+||+.+|++||++++|++.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 122244678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=319.28 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=204.3
Q ss_pred HhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
..++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999997532 4579999886443 2334568899999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCC-------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 542 KILILEYMPNKSLNVFLFDSTK-------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
.++||||+++|+|.+++..... ...+.+..+..++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999854221 234567888999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhc
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+. ... ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~----~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLK----FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HH
Confidence 99999986544332222222345678999999999999999999999999999998 677775322111 000 00
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+... ..........+.+++.+|++.+|++||++.++++.|.+.
T Consensus 235 --------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 --------MDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00000 011112245789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.48 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=202.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.++.+++|+||+++++++..+...++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999874 6789999999765555566788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999998874 2346899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
......++..|+|||.+. ...++.++||||||+++|||++|+.|+.......... ....... ..+.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~~---~~~~ 230 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSNF---QPPK 230 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCCC---CCCC
Confidence 122346888999999884 4457889999999999999999999985332111100 0000000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
. .........+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00112345788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=330.64 Aligned_cols=254 Identities=21% Similarity=0.267 Sum_probs=201.3
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
..++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3578999999999999999999875 5889999998642 22334567899999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999988832 34788899999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceeecccceeCcccccCC----CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ........
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~--- 263 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHK--- 263 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCC---
Confidence 33211 12335799999999998653 478999999999999999999999874332110 00000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 743 (792)
..+ .-+.....+.++.+++.+||+.+|.+ ||++.|++++
T Consensus 264 ---~~~-~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 ---NSL-TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---CcC-CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 00111123467889999999999987 9999999775
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=331.85 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=205.0
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 540 (792)
..++|.+.++||+|+||.||+|++. .++.||||++.... ....+.+.+|+++|.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4567888999999999999999863 24689999997543 333457899999999997 999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccC----------------------------------------------------------
Q 003843 541 EKILILEYMPNKSLNVFLFDST---------------------------------------------------------- 562 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~---------------------------------------------------------- 562 (792)
..++|+||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999998885421
Q ss_pred -------------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 563 -------------------------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 563 -------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
....+++..++.++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124677888999999999999999988 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~ 684 (792)
+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999987543221111222356789999999999999999999999999999998 8888754321110
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.......+. ....+.....++.+++.+||+.+|.+||++++|++.|++.
T Consensus 351 ----~~~~~~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ----FYNAIKRGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----HHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 000000000 0011122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=323.49 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=194.6
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+.. +++.||+|++... .....+.+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 4789999998653 234456678899998876 799999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99988873 3346899999999999999999999998 9999999999999999999999999998643221 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ...... . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~----~i~~~~--------~---~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FE----SILHDD--------V---LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HH----HHHcCC--------C---CC
Confidence 2345789999999999999999999999999999999999999975432211 00 000000 0 01
Q ss_pred CHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRP-------TMSDVISM 743 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RP-------s~~evl~~ 743 (792)
+.....++.+++..||+.+|++|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111245788999999999999999 78888755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.49 Aligned_cols=260 Identities=18% Similarity=0.217 Sum_probs=195.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..+|++.++||+|+||.||+++.. +++.||+|.... +.+.+|++++++++||||+++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 467999999999999999999874 578999997532 4568899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+. ++|..++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 85 67777763 3345899999999999999999999998 9999999999999999999999999997543221
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCc-cc----cccccchhhhc-------c--
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DS----FNLLGHAWDLW-------K-- 694 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~-~~----~~~~~~~~~~~-------~-- 694 (792)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-.... +. ...+....... .
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122345799999999999999999999999999999999999987642211 00 00000000000 0
Q ss_pred -cCcccccc----cccc--ccCCC----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 695 -DDRVHDLI----DPVI--MQDEI----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 695 -~~~~~~~~----~~~l--~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........ .... ..... ......++.+++.+||+.||++|||++|++++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0000 00000 01234578899999999999999999999853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.18 Aligned_cols=282 Identities=23% Similarity=0.321 Sum_probs=209.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCch--hHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ--GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 544 (792)
-+.|+.++.|++|.||.||+|+++ +++.||+|+++-..+. .--...+|+.+|.+++|||||.+-.+..-. +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467899999999999999999975 5788999999654321 122357899999999999999999887643 47999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||++. +|..++... ...+...++.-+..|+++|++|||... |+||||||+|+|+...|.+||+|||||+.++
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999976 677777433 256888999999999999999999998 9999999999999999999999999999887
Q ss_pred CCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcc-ccccc----cc-hhhhcccCc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLL----GH-AWDLWKDDR 697 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~-~~~~~----~~-~~~~~~~~~ 697 (792)
... ...+..+-|.-|.|||.+.+. .|+...|+||+|||+.||+++++-|....+- ..+.+ .. ....|..-.
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 652 234456789999999999876 5899999999999999999999887654321 11111 00 011111111
Q ss_pred cccccc-cccc-------cCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCCCCCCCCccc
Q 003843 698 VHDLID-PVIM-------QDEISLP-MLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTK 761 (792)
Q Consensus 698 ~~~~~~-~~l~-------~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~p~~~~~~~ 761 (792)
....+. -.+. +..+... ..+.-.+|+..+|..||.+|.|++|.+++ +-..+.|.|..|..++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFP 377 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcC
Confidence 111110 0000 0111111 33566789999999999999999999875 2335667777776554
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.46 Aligned_cols=271 Identities=26% Similarity=0.400 Sum_probs=203.1
Q ss_pred cCccccceecccCceeEEEEEE-----cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--Cee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 542 (792)
+.|++.+.||+|+||.||+++. .+++.||+|.++... ....+.+.+|+++++.++|+|++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999974 247789999987543 44457899999999999999999999998875 568
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999988432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|...........................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433211 112234567789999999998999999999999999999998765432111000000000000000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.... ..+.....+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 1111222456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.26 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=209.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999886 7899999988532 2334678999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+++++|.+++.... ....+++.+++.++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998885432 2445899999999999999999999998 99999999999999999999999999986643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+............ ....+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~--------- 223 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEKC--------- 223 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh----hhhcC---------
Confidence 321 122346788999999999999999999999999999999999998543221111100 00000
Q ss_pred cccCCCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 706 IMQDEISL-PMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. ..+.+. .....+.+++.+||+.+|++||++.+|+++|++.
T Consensus 224 ~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 D-YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C-CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 0 011111 3445788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=323.13 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=196.4
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 546 (792)
+|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999876 46799999987532 23345667788888877 5899999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988873 3345899999999999999999999998 999999999999999999999999999754322
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~----~i~~~---------- 216 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ----SIMEH---------- 216 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HH----HHHhC----------
Confidence 1 122345789999999999999999999999999999999999999864332111 00 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 742 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~ 742 (792)
....+.....++.+++.+|++.+|++|++. .++.+
T Consensus 217 -~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 217 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 011122234578899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.73 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=202.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|++.++||+|+||.||+|+.. +++ .||+|++... .....+++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 467889999999999999999853 444 4899998654 33456778999999999999999999999875 4578
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+++||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999988432 346899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........ . .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~----- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI--P----DLLEKGE----- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--H----HHHHCCC-----
Confidence 54322111222234678999999999999999999999999999998 8888754322110 0 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+........+.+++.+||+.||++||++.++++.|...
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0011122345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.68 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=200.8
Q ss_pred cCccccceecccCceeEEEEEEcC-Cc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 545 (792)
++|++.+.||+|+||.||+|+..+ +. .+++|.++.. .....+.|.+|++++.++ +||||+++++++.+....+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 32 4788888743 344567799999999999 799999999999999999999
Q ss_pred EEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCe
Q 003843 546 LEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 612 (792)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985422 1235889999999999999999999998 9999999999999999999
Q ss_pred eecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhh
Q 003843 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 691 (792)
||+|||++....... .......+..|+|||++....++.++|||||||++|||++ |..||....... .. .
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~----~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LY----E 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----H
Confidence 999999986432110 1111223557999999999999999999999999999997 999986432211 00 0
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+ . ....+......+.+++.+||+.+|.+||+++++++.|.+.
T Consensus 230 ~~~~~---------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 KLPQG---------Y-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred HHhcC---------C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000 0 0111122345788999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.63 Aligned_cols=271 Identities=28% Similarity=0.415 Sum_probs=206.0
Q ss_pred cCccccceecccCceeEEEEEEc-----CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeee--cCee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEK 542 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 542 (792)
+.|++.+.||+|+||.||+|+.. .++.+|||.+...... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999864 3678999999765443 56789999999999999999999999887 5578
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998533 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7532211 111122345679999999999999999999999999999999988754322111100000000000001111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.... ..........++.+++.+||+.+|++||++.||+++|+++
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 1111122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.82 Aligned_cols=254 Identities=31% Similarity=0.441 Sum_probs=204.6
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 56789999999999999999998889999999986543 34568899999999999999999999864 56789999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999987543 2346899999999999999999999998 999999999999999999999999999876532221
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
. .....++..|+|||.+....++.++||||||+++|||++ |+.||....... ... ..... . .
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~-----~-----~ 221 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ----NLERG-----Y-----R 221 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH----HHHcC-----C-----C
Confidence 1 112345678999999999999999999999999999999 999986432211 000 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+.......++.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01112234578999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.80 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=202.6
Q ss_pred cCccccceecccCceeEEEEEEcC-C---cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
..|++.+.||+|+||.||+|+... + ..||||.+... .....++|.+|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999998753 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++... .+.+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999988432 346899999999999999999999998 99999999999999999999999999986643
Q ss_pred Cccccccce-ee--cccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccc
Q 003843 626 DELQGNTKQ-IV--GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 626 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
......... .. .+..|+|||.+....++.++||||||+++|||++ |..||....... .... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~----i~~~----- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINA----IEQD----- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHH----HHcC-----
Confidence 322111111 11 2457999999999999999999999999999886 888885432211 1000 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. ..+.....+..+.+++.+||+.+|.+||++.+|+++|++.
T Consensus 228 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y-----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0011122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=323.08 Aligned_cols=236 Identities=24% Similarity=0.344 Sum_probs=190.6
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+.+ +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 4789999998643 233456678888888876 699999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
|+|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 99988873 3346899999999999999999999998 9999999999999999999999999987642221 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ....... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~----~~i~~~~-----------~~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL--F----EAILNDE-----------VVY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--H----HHHhcCC-----------CCC
Confidence 2345789999999999999999999999999999999999999974332111 0 0000000 011
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTM 737 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~ 737 (792)
+.....++.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 11234577899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.06 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=208.1
Q ss_pred cCccccceecccCceeEEEEEE-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+++. .+++.+|||.+... .....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 47899999987543 2334568899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999885422 2456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||.....+....... +.....+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~~~- 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK---------IEQCDYP- 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh---------hhcCCCC-
Confidence 321 1123468889999999999999999999999999999999999985332211111000 0000001
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..........+.+++.+||+.+|++||||.+|++++.+.
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111123456789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.22 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=205.2
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 541 (792)
.++|++.+.||+|+||.||++... .+..||+|+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 467999999999999999999742 24579999987543 34456799999999999 79999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999985322 234899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ . . +
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~----~---------~ 255 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-F----Y---------K 255 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-H----H---------H
Confidence 6643321111222345778999999999999999999999999999998 8888754322110 0 0 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+.... ..........++.+++.+|++.+|++||++.|+++.|++.
T Consensus 256 ~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 LIKEGY-RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000 0011112245789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.64 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=199.9
Q ss_pred HHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
....++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334678999999999999999999876 4788999998642 223345688999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999883 234789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccceeecccceeCcccccCC----CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
+..... .......||+.|+|||++... .++.++|||||||++|||++|+.||........ .
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--~------------ 256 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--Y------------ 256 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--H------------
Confidence 643221 112345799999999998764 378999999999999999999999964332110 0
Q ss_pred cccccccc-ccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003843 699 HDLIDPVI-MQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l-~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 743 (792)
..+++... ..-+........+.+++..|++.++.+ ||++.|++++
T Consensus 257 ~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00110000 000111123456788889999755543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.90 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=208.4
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
-+.|++++.||+|.-|+||++++.+ +..+|+|++.+.. .....+.+.|-+||+.+.||.+..|++.++.+...+++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4567888999999999999999875 5789999997653 33455677899999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||||+||+|...++. +..+.+++..+..++.+++-||+|||..| ||+|||||+||||.++|++.|+||.|+.....
T Consensus 156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999888744 45667999999999999999999999999 99999999999999999999999999864411
Q ss_pred ---------------------------------C-c--------------------cccccceeecccceeCcccccCCC
Q 003843 626 ---------------------------------D-E--------------------LQGNTKQIVGTYGYMSPEYALDGL 651 (792)
Q Consensus 626 ---------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~ 651 (792)
. . .......++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 001122457999999999999999
Q ss_pred CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCC
Q 003843 652 FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENA 731 (792)
Q Consensus 652 ~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp 731 (792)
.+.+.|.|+|||+||||+.|+.||...+... .+..++...+ .-+.....+..+.+||++.|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------------Tl~NIv~~~l-~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------------TLRNIVGQPL-KFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh--------------hHHHHhcCCC-cCCCCCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999997654332 1222232222 111222456788999999999999
Q ss_pred CCCCC----HHHHHHH
Q 003843 732 ADRPT----MSDVISM 743 (792)
Q Consensus 732 ~~RPs----~~evl~~ 743 (792)
++|.. +.||.++
T Consensus 377 ~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhccccchHHhhcC
Confidence 99998 7777654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.30 Aligned_cols=252 Identities=26% Similarity=0.320 Sum_probs=201.3
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.|++.++||+|+||+||++... +++.||+|++.... ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999874 58899999986432 2234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998887532 2345899999999999999999999998 9999999999999999999999999998754322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ... +...+...
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~---------~~~~~~~~-- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REE---------VERRVKED-- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHH---------HHHHhhhc--
Confidence 1 1234689999999999999999999999999999999999999864322110 000 00000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
...........+.+++.+||+.||++|| ++.+++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1112223456788999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.73 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=199.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.++||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46788899999999999999864 6889999998654 334456799999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999986542 4688889999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccccc-chhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG-HAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~ 707 (792)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||............ .......... .+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~- 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL- 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC-
Confidence 22357899999999999999999999999999999999999998643321111000 0000000000 0001
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.......++.+++.+|++.+|++||+++|++++
T Consensus 221 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 ---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111234568899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.97 Aligned_cols=260 Identities=26% Similarity=0.442 Sum_probs=205.6
Q ss_pred hcCccccceecccCceeEEEEEEcC--------CcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
..+|++.+.||+|+||.||+++... ...||+|.+... .....+++.+|+++++++ +|+||+++++++.++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3578999999999999999997421 236899988653 344567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 540 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
+..++++||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999885421 2235888999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 685 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~ 685 (792)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH--
Confidence 9999999999999987644322222222344568999999999999999999999999999998 7788754321111
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
........ ..........++.+++.+|++.+|++||++.|+++.|+.+.
T Consensus 246 ----~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 ----FKLLKEGH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHcCC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 00111000 00111223457889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=324.77 Aligned_cols=238 Identities=26% Similarity=0.318 Sum_probs=192.0
Q ss_pred ceecccCceeEEEEEE----cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 477 CKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
+.||+|+||.||+++. .+++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6899999999999875 357899999996532 2234567889999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988883 3446899999999999999999999998 9999999999999999999999999998653321 1
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ... . +.... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~----~--------i~~~~---~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMT----M--------ILKAK---LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHH----H--------HHcCC---CC
Confidence 2234578999999999999899999999999999999999999986432211 000 0 00000 01
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTMSD 739 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~~e 739 (792)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11223456789999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.59 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=205.1
Q ss_pred hcCccccceecccCceeEEEEEEc--------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
.++|.+.++||+|+||.||+++.. ....+|+|.+... .....+.+.+|+.+++++ +|+||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 467889999999999999999752 2457999998754 334567789999999999 699999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 540 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
...+++|||+++++|.+++.... ....+++.++..++.||+.||.|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999985432 1245899999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 685 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~ 685 (792)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--L 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999987643322111222234568999999999999999999999999999999 788875432211 0
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
......... .........++.+++.+||+.+|++||++.++++.|++..
T Consensus 246 ----~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 ----FKLLREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 001111100 0111223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.59 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=204.2
Q ss_pred hcCccccceecccCceeEEEEEEcC-C---cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|+..+.||+|+||.||+|+... + ..+|+|.+... .....+.+.+|++++.+++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3578888999999999999998753 3 37999998654 34456789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998432 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccccc-ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDELQGNT-KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
........ .....+..|+|||++....++.++||||||+++|||++ |+.|+....... .. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~----~~i~~~------ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VM----KAINDG------ 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH----HHHhcC------
Confidence 33211111 11223457999999998899999999999999999997 999985432211 00 001000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. ..+........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 227 ---~-~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---F-RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---C-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1111122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.69 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||.||+|.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46788999999999999999987 488999999976544 5678999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999884332 236899999999999999999999998 99999999999999999999999999987632211
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
....+..|+|||.+....++.++||||||++++||++ |..||....... ... ..... . .
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~----~~~~~---------~-~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----HVEKG---------Y-R 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHhcC---------C-C
Confidence 2234568999999998899999999999999999997 888876432211 000 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...+...+..+.+++.+||+.+|++||+++|++++|++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 01112234678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.67 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=196.1
Q ss_pred ecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||+|+||+||+++.. +++.||+|.+.... ....+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 58899999986432 22346678899999999999999999999999999999999999999
Q ss_pred ceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccc
Q 003843 555 NVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633 (792)
Q Consensus 555 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 633 (792)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88774432 3456899999999999999999999998 99999999999999999999999999987644322 123
Q ss_pred eeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCH
Q 003843 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISL 713 (792)
Q Consensus 634 ~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 713 (792)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ... ...++... ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~--------~~~~~~~~---~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KEL--------KQRILNDS---VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHH--------HHhhcccC---CCCcc
Confidence 357899999999999999999999999999999999999998643321100 000 00011110 01122
Q ss_pred HHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 714 PMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 714 ~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
..+..+.+++.+||+.+|++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3456788999999999999999 66777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.20 Aligned_cols=250 Identities=35% Similarity=0.518 Sum_probs=204.1
Q ss_pred ceecccCceeEEEEEEcC----CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|++.+..++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 788999999765433 367899999999999999999999999999999999999999
Q ss_pred CccceeeeccCC------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 552 KSLNVFLFDSTK------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 552 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
++|.+++..... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999855421 367999999999999999999999998 99999999999999999999999999998755
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
...........++..|+|||.+....++.++||||||+++|||++ |..||....... . ........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~----~~~~~~~~------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--V----LEYLRKGY------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--H----HHHHHcCC-------
Confidence 432222334567889999999998899999999999999999999 588886542211 1 00111100
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
....+...+.++.+++.+||+.+|.+||++.+++++|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.91 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=204.2
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||++... ++..||+|++.... ....++|.+|+.++++++|+||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999864 36789999987543 34457799999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q 003843 543 ILILEYMPNKSLNVFLFDST-------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 603 (792)
++|+||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788999999999999999999998 9999999999
Q ss_pred EEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccc
Q 003843 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADS 682 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~ 682 (792)
|++++++.+||+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986643322222222344678999999999999999999999999999998 777764322111
Q ss_pred cccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.. ......... ..+.....++.+++.+||+.+|.+||++.|+++.|++
T Consensus 241 --~~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VI----YYVRDGNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH----HHHhcCCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 011111100 0111234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.18 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=196.1
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----eeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 544 (792)
-.|+..+++|.|+||.||+|++.+ ++.||||+.-.... .--+|+++|+++.|||||+++.+|.... ...+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 457777999999999999998754 68999999854322 1136999999999999999999987543 3468
Q ss_pred EEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeeccccccee
Q 003843 545 ILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 622 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla~~ 622 (792)
|||||+. +|..++.+. ..+..++...+.-+..||++||+|||+.+ |+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 676776432 23456788888889999999999999998 9999999999999987 8999999999998
Q ss_pred cCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcc-ccccccchhhhcccCcc--
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHAWDLWKDDRV-- 698 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~-- 698 (792)
+...+.. ..+.-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|...... ....+.........+++
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 8655422 345678999999999875 6999999999999999999999988764421 11111111111111111
Q ss_pred -----ccccccccccCC----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 -----HDLIDPVIMQDE----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 -----~~~~~~~l~~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+...+.+.... .......++.+|+.++|+.+|.+|.++.|++.+
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111112221111 233345688999999999999999999998864
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.20 Aligned_cols=240 Identities=23% Similarity=0.322 Sum_probs=191.4
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+.. +++.||+|.++... ....+.+..|..++... +|+||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 57899999996532 23445667788888764 899999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 99988873 3346889999999999999999999998 9999999999999999999999999987532111 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~----~~~~~------~~-----~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFE----SIRVD------TP-----HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhC------CC-----CC
Confidence 234578999999999999999999999999999999999999986433211 100 00000 00 11
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMS-DVI 741 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~-evl 741 (792)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112345678999999999999999985 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.50 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=204.7
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|++|.||+|+.. +++.|++|.+... .....+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999875 5889999988643 345567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998543 2356899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||++.+..++.++||||||++++||++|+.||....... ... ....+ . .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~~~--------~--~ 218 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LIL----KIIRG--------V--F 218 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHcC--------C--C
Confidence 1223467889999999999999999999999999999999999986443211 000 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.10 Aligned_cols=249 Identities=30% Similarity=0.413 Sum_probs=199.6
Q ss_pred ceecccCceeEEEEEEcC--C--cEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.|.+|+.++++++|+||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998743 2 3699999977655 667889999999999999999999999988 889999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc-c
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-G 630 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 630 (792)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999855332 46899999999999999999999998 999999999999999999999999999877442211 1
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .... ..... . ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~---~~~~~-------~---~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKK---IDKEG-------E---RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH---HHhcC-------C---cC
Confidence 1123456789999999999999999999999999999999 999985332211 0000 00000 0 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=318.97 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=210.8
Q ss_pred HhcCccccceecccCceeEEEEEEcC---Cc--EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN---GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
..+..++.++||.|-||.||+|.+.+ |+ .||||..+.. .....+.|..|..+|++++||||++++|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 34556667899999999999998643 33 5899998774 455678899999999999999999999999864 78
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|||.++.|.|.+||.. ++..|+......+++||+.||+|||+.. +|||||.++|||+....-+||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 999999999999999953 4556899999999999999999999997 99999999999999999999999999999
Q ss_pred cCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCc-cccccccchhhhcccCcccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNA-DSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 700 (792)
+..+.+.... ...-+..|||||.+.-.+|+.++|||.|||.+||+++ |.+||..... +.... ++.++
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iEnGe--- 609 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IENGE--- 609 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ecCCC---
Confidence 8776655443 3345779999999999999999999999999999987 8889864322 11110 11111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.+.++.++..++.|+.+||..+|.+||.+.|+...|+.+
T Consensus 610 -------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 610 -------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred -------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 2345566778899999999999999999999999888553
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.61 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=191.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+|+.. +++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 47889999996532 23345667788888764 899999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
|+|..++. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99998883 2345889999999999999999999998 9999999999999999999999999997542211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~----~i~~~------~~-----~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQ----SIRMD------NP-----CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhC------CC-----CC
Confidence 234578999999999999999999999999999999999999986433211 100 00000 00 11
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMS-DVIS 742 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 742 (792)
+.....++.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 112345678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=309.77 Aligned_cols=254 Identities=27% Similarity=0.386 Sum_probs=193.1
Q ss_pred ceecccCceeEEEEEEcC---CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.||+|+||.||+|...+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998643 4579999986543 334457899999999999999999999999999999999999999
Q ss_pred ccceeeeccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 553 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 553 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999854322 234677788899999999999999998 9999999999999999999999999997654332222
Q ss_pred ccceeecccceeCcccccCC-------CCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 631 NTKQIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~-------~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
......++..|+|||++... .++.++||||||+++|||++ |+.||........ ... ... +......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~---~~~-~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY---TVR-EQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH---Hhh-cccCCCC
Confidence 22334567889999998642 35789999999999999996 9999864332211 000 000 0011111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
++. ........+.+++..|+ .+|++||+++||+..|.
T Consensus 232 ~~~-----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPR-----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCc-----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 11123345778999998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.06 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=201.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|++. ++. .+++|.+... .....+.|.+|++++.++ +|+||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357888999999999999999874 343 4688877643 334557889999999999 89999999999999999999
Q ss_pred EEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 545 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999885432 1235889999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+|||+++..... .......++..|+|||++.+..++.++||||||+++|||++ |..||........ ..
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~--- 234 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--YE--- 234 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--HH---
Confidence 999999998643211 11111234668999999988889999999999999999998 9998853322110 00
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..... . ...........+.+++.+|++.+|++||++.+++++|.++
T Consensus 235 -~~~~~---------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -KLPQG---------Y-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HHhcC---------C-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000 0 0011112345678999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.38 Aligned_cols=242 Identities=23% Similarity=0.298 Sum_probs=194.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999876 4789999999753 233456678899999888 799999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99988773 3346899999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||........ .. ...... ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~--~~----~i~~~~-----------~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL--FQ----SILEDE-----------VRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH--HH----HHHcCC-----------CCC
Confidence 2335789999999999999999999999999999999999999864332110 00 000000 011
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTM-----SDVISM 743 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 743 (792)
+......+.+++.+||+.||++||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 12234578899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.98 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=201.1
Q ss_pred hcCccccceecccCceeEEEEEE------cCCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeec-C
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ-G 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 540 (792)
.++|++.++||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999974 346789999997543 33456788999999999 789999999988654 4
Q ss_pred eeEEEEEecCCCccceeeeccCC---------------------------------------------------------
Q 003843 541 EKILILEYMPNKSLNVFLFDSTK--------------------------------------------------------- 563 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 563 (792)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999888743210
Q ss_pred -------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceee
Q 003843 564 -------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636 (792)
Q Consensus 564 -------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 636 (792)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788889999999999999999998 9999999999999999999999999998753332212222234
Q ss_pred cccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHH
Q 003843 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPM 715 (792)
Q Consensus 637 gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 715 (792)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ . ......+.. ...+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~----~~~~~~~~~----------~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F----CRRLKEGTR----------MRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-H----HHHHhccCC----------CCCCCCC
Confidence 5678999999999999999999999999999997 8888754321110 0 000111100 0001112
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 716 LMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 716 ~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..++.+++..||+.+|++||++.||+++|+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.70 Aligned_cols=240 Identities=22% Similarity=0.345 Sum_probs=190.0
Q ss_pred ceecccCceeEEEEEEcC-------------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 477 CKLGEGGFGPVYKGRLLN-------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
+.||+|+||.||+|+... ...|++|.+..........|.+|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997532 2358999887665556678899999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC-------eeecc
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-------PKISD 616 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-------~kL~D 616 (792)
+||||+++++|+.++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2345899999999999999999999998 999999999999987664 89999
Q ss_pred cccceecCCCccccccceeecccceeCccccc-CCCCCCcCceeehhHHHHHHH-hCCCCCCCCCccccccccchhhhcc
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETL-SSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|..|+......... ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~ 223 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------RFYE 223 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH------HHHh
Confidence 9998754321 2245788999999887 467899999999999999998 477776532211100 0000
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
. . .....+...++.+++.+||+.||++||++.++++.|+
T Consensus 224 -~--------~---~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 -G--------Q---CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -c--------C---ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 0011122356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=307.80 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=202.9
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|++|.||+|....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688999999999999999998777789999886533 34567899999999999999999999875 45688999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999998543 2345889999999999999999999998 999999999999999999999999999876433221
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ..... . .
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~-----~-----~ 221 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLE----QVERG-----Y-----R 221 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC-----C-----C
Confidence 1112345678999999999999999999999999999999 888886432211 000 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.......+..+.+++.+||+.+|++||++++|++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01122334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.64 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=202.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
++|++.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 58899999886432 1234578899999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999888743 345889999999999999999999998 9999999999999999999999999998664
Q ss_pred CCccccc-cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ . ....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~~~~~-----~- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--I---FKIATQP-----T- 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--H---HHHhccC-----C-
Confidence 3221111 1234678899999999999999999999999999999999999853221100 0 0000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+......+.+++.+||+.+|.+||++.+++++
T Consensus 225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111222344578899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=314.06 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=204.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..+|++.+.||+|+||.||+|+.. +++.|++|.+........+.+.+|+.+++.+.|+|++++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 468999999999999999999864 5889999999766555667899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999883 235789999999999999999999998 99999999999999999999999999886543221
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ...... . +.
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-----~~~~~~--~----~~--- 235 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNG--T----PE--- 235 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH-----HHhcCC--C----CC---
Confidence 1223468889999999999889999999999999999999999986433211100 000000 0 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 01112234568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.35 Aligned_cols=237 Identities=24% Similarity=0.298 Sum_probs=187.7
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHH-HHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999875 58899999986432 222344555544 56779999999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99988874 3456899999999999999999999998 9999999999999999999999999987532211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. .. ++.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~----~~--------i~~~~~---~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MY----DN--------ILNKPL---RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HH----HH--------HHcCCC---CC
Confidence 334578999999999999999999999999999999999999986432211 00 00 000000 11
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMS 738 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~ 738 (792)
.......+.+++.+||+.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 112345788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.27 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=212.4
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..-|.+.+.||+|.|+.|-+|++ -+|..||||++.+.. ......+.+|++-|+.++|||||+++.+......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34578889999999999999975 479999999997653 344566889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~ 625 (792)
|.-++|+|.+||.++.++ +++....+++.||..|+.|+|+.. +|||||||+||.+-+ -|-+||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999766543 899999999999999999999998 999999999998754 58899999999988765
Q ss_pred CccccccceeecccceeCcccccCCCCC-CcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.+ .....+|...|.|||++.+..|+ ++.||||||||||.|++|++||...++.+. +..++|-
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDC 234 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDC 234 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhcc
Confidence 53 34456999999999999999986 789999999999999999999986554322 2222332
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+...+.....++.+||..||+.||.+|.+.+||+..
T Consensus 235 ---KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 ---KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 445567778899999999999999999999999754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.30 Aligned_cols=247 Identities=27% Similarity=0.371 Sum_probs=198.4
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccc
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 555 (792)
++||+|+||.||+|...+++.+|+|.+..... .....|.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876543 33457899999999999999999999999999999999999999999
Q ss_pred eeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccccee
Q 003843 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635 (792)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (792)
+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 887432 345889999999999999999999998 999999999999999999999999999765332211 11122
Q ss_pred ecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 636 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
.++..|+|||++....++.++||||||+++|||++ |..||........ . ....... .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~----~~~~~~~----------~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--R----EQVEKGY----------RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--H----HHHHcCC----------CCCCCCC
Confidence 34568999999999999999999999999999998 8888864322110 0 0000000 0011122
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.74 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=203.4
Q ss_pred cCccccceecccCceeEEEEEEcC----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.+|++.+.||+|+||.||+|+... +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578889999999999999998642 3379999986532 34457899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998432 245899999999999999999999998 99999999999999999999999999987644
Q ss_pred Cccccc-cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 626 DELQGN-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 626 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||....... ... ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~----~~~~~-----~- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIK----AIEEG-----Y- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHH----HHhCC-----C-
Confidence 321111 111223568999999999999999999999999999887 999986433211 000 00100 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.....+..+.+++.+|++.+|.+||++.++++.|++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011122345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=307.41 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=195.1
Q ss_pred eecccCceeEEEEEEc---CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCc
Q 003843 478 KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKS 553 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 553 (792)
.||+|+||.||+|.+. .+..||+|++.... ....+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 35579999986553 334567999999999999999999999875 457899999999999
Q ss_pred cceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc-cc
Q 003843 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NT 632 (792)
Q Consensus 554 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~ 632 (792)
|.+++.. ....+++..+++++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..+....... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998843 2346899999999999999999999998 9999999999999999999999999998654332111 11
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
....++..|+|||.+....++.++||||||+++|||++ |+.||........ ........ ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~----------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------MSFIEQGK----------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHHCCC----------CCCC
Confidence 11223578999999998899999999999999999996 9999864322110 00000000 1112
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223356788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=318.74 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=194.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999875 4788999999753 233456688999999888 699999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988773 3346899999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhhhcccCccccccccccccCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~---~~~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EK---PIR 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hC---CCC
Confidence 2345789999999999999999999999999999999999999964332111 11111111110 00 011
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTM------SDVISM 743 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 743 (792)
.+......+.+++.+||+.||++||++ .+++++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 222234567899999999999999984 566544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=308.01 Aligned_cols=256 Identities=31% Similarity=0.476 Sum_probs=206.6
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..++|++.++||+|+||.||+|...+++.||||.+.... ...+++.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357899999999999999999998888899999987533 3457799999999999999999999999998999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998543 2345899999999999999999999998 99999999999999999999999999987653221
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. .......+..|+|||.+.+..++.++||||||++++||++ |+.||....... .... .... .
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~----~~~~-----~----- 221 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQ----VERG-----Y----- 221 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHcC-----C-----
Confidence 1 1112234568999999999999999999999999999998 898885332111 0000 0000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
....+...+.++.+++.+|++.+|.+||+++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.37 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=209.6
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
...+..+..+||-|.||.||.|.++. .-.||||.++. +.-..++|..|+.+|+.++|||+|+++|+|..+..+|||+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34456777899999999999999865 55799999965 44567999999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
||.+|+|.+||.+-. +..++.-.++.++.||+.||+||..++ +|||||.++|+|+.++..+|++||||++++..+.
T Consensus 344 fM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred cccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999996543 345777788899999999999999998 9999999999999999999999999999987665
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
+.... ...-++.|.|||-+....|+.|+|||+|||+||||.| |-.|+...+ +..++.+++.+-
T Consensus 420 YTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgy--------- 483 (1157)
T KOG4278|consen 420 YTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGY--------- 483 (1157)
T ss_pred eeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhccc---------
Confidence 43322 1233678999999999999999999999999999998 555654322 122233332221
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
+..-+.-+++.+++|++.||+-.|.+||+++|+.+.++.
T Consensus 484 -RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 484 -RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred -cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 112233356788999999999999999999999887743
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=300.50 Aligned_cols=268 Identities=25% Similarity=0.311 Sum_probs=200.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCC-cceEeeeeeecC-----
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQG----- 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 540 (792)
...|..+++||+|+||+||+|+.+ +|+.||+|+++-..+ .......+|+.++++++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345677788999999999999865 588999999865433 23455689999999999999 999999999877
Q ss_pred -eeEEEEEecCCCccceeeeccCCC-ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 541 -EKILILEYMPNKSLNVFLFDSTKK-RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 541 -~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
..++|+||++ .+|..++....+. ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999995 4788887544322 35677889999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-c----ccc-chhh
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N----LLG-HAWD 691 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~----~~~-~~~~ 691 (792)
+|+.+.-... .....++|.-|.|||++.+. .|+...||||+|||+.||++++.-|....+..+ . .+. ..-+
T Consensus 166 lAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9997653321 13345788999999999887 799999999999999999999887765443111 0 000 0011
Q ss_pred hcccCccccccccccccCC----CCHHH---HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 LWKDDRVHDLIDPVIMQDE----ISLPM---LMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~----~~~~~---~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.|.......-.+.....-. ..... .....+++.+||+.+|.+|.|++.++++
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111111111111110000 00111 1367899999999999999999999887
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=305.41 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=199.2
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccc
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 555 (792)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred eeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccccee
Q 003843 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635 (792)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (792)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988432 235789999999999999999999998 999999999999999999999999999865432222111222
Q ss_pred ecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 636 ~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+......... .... ... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~------~~~~---------~~~-~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR------ERIE---------SGY-RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH------HHHh---------cCC-CCCCCcc
Confidence 34567999999998999999999999999999999 77787543321100 0000 000 0111222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.+..+.+++.+|++.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.08 Aligned_cols=260 Identities=20% Similarity=0.230 Sum_probs=201.9
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
..+....++|++.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999876 4788999998642 223345678999999999999999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++||||+++|+|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999998883 234788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCC----CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
++.+...... ......||+.|+|||++... .++.++|||||||++|||++|+.||...+.... .......
T Consensus 189 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNH 262 (371)
T ss_pred eeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHcC
Confidence 9876433211 12345799999999998754 378999999999999999999999964332110 0000000
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 003843 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISMI 744 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L 744 (792)
.... .-+........+.+++.+|++.++.+ ||++.+++++.
T Consensus 263 ~~~~--------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSL--------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcc--------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000 00111223557788999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.26 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=199.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeee-ecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||++.. .+..||+|.++... ..+.|.+|+.++++++|+|++++++++. ++...++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 35788999999999999999987 47889999986432 3567899999999999999999999765 45678999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999988542 2335889999999999999999999998 9999999999999999999999999998653321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. .....+.
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~----~~~~~~~---------- 216 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV----PRVEKGY---------- 216 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHhcCC----------
Confidence 12234568999999999999999999999999999998 888875432111 00 0000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...........+.+++.+|++.+|++||++.++++.|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 011112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=302.57 Aligned_cols=248 Identities=24% Similarity=0.407 Sum_probs=208.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+-|.++++||+|+||.||||.++ .|+.+|||++.- +..++++..|+.+|++...+++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 45778899999999999999876 599999999864 456789999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
-.|+..+++. .+++.|.+.++..++...++||+|||... -||||||+.|||++.+|.+||+|||.|-.+....
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 9999999984 35567999999999999999999999987 8999999999999999999999999998765332
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
...+.+.||+.|||||++..-.|+.++||||||+...||..|++|+....+- .. +. ++ +.-+..
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--RA------------IF-MI-PT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--RA------------IF-MI-PTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--ce------------eE-ec-cCCCCC
Confidence 2345679999999999999999999999999999999999999998632211 00 00 00 000011
Q ss_pred C--CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 710 E--ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 710 ~--~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. .+...+.++.++++.||...|++|-|+-+++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1 233456789999999999999999999988875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.82 Aligned_cols=239 Identities=22% Similarity=0.278 Sum_probs=188.7
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHH-HHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+++.. +|+.||+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 5889999998643 2233345555654 46778999999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988773 3456899999999999999999999998 9999999999999999999999999997532211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ... +...+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~----~~~--------~~~~~---~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MY----DNI--------LHKPL---VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HH----HHH--------HcCCc---cC
Confidence 234578999999999999999999999999999999999999986432211 00 000 00000 11
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMSDV 740 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~ev 740 (792)
.......+.+++.+|++.+|++||++.+.
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 11234567899999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=324.08 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=199.3
Q ss_pred hcCccccceecccCceeEEEEEEc---CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..+|++.+.||+|+||.||++... .++.||+|.+... +.+.+|++++++++|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 568999999999999999999753 3578999988643 33568999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|++. ++|.+++ .....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5777776 33456999999999999999999999998 999999999999999999999999999876544
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cccccchhhhcccCc-------c
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHAWDLWKDDR-------V 698 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~-------~ 698 (792)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+........... .
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 33333345679999999999999999999999999999999999999985433211 000000000000000 0
Q ss_pred ccc------cccccccCCCC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDL------IDPVIMQDEIS-------LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~------~~~~l~~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+ ..... +.... .....++.+++.+||+.||++||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVL-RPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccc-cCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000 00000 1123467889999999999999999999866
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=310.84 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=201.2
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+.|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++|+|++++++++..+...++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 346788999999999999998764 7788999987666667788999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|..++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 99999887743 2346899999999999999999999998 9999999999999999999999999997653321
Q ss_pred cccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.......++..|+|||++. +..++.++|||||||++|||++|++|+........ ... ... .. .+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~---~~~-~~-----~~ 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK---IAK-SE-----PP 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH---Hhh-cC-----CC
Confidence 1223346889999999984 45578899999999999999999999864332110 000 000 00 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+ ..+.....++.+++.+||+.+|.+||++.+++++
T Consensus 227 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TL---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1111234578899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=305.38 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=204.6
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|+||.||++...++..+|+|.+... ....+.|.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 5789999999999999999999877888999988653 3345778999999999999999999999887 7789999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2345788999999999999999999998 999999999999999999999999999876433211
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||++....++.++|+||||+++|||++ |+.||....... ... ...... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~----~~~~~~----------~ 221 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR----ALERGY----------R 221 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHhCCC----------C
Confidence 1122345678999999999899999999999999999999 888886432111 000 000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=307.53 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=202.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.++||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 467889999999999999999865 5889999998766555567788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ..+.+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999873 3346899999999999999999999998 9999999999999999999999999998664321
Q ss_pred ccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... . . ..... ..+.
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~----~-~~~~~---~~~~ 230 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-L----M-TKSNF---QPPK 230 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-h----h-hccCC---CCCc
Confidence 1223457899999999975 4568899999999999999999999975432211000 0 0 00000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. .. .......+.+++.+||+.+|++||++++|+++
T Consensus 231 ~-~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 L-KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c-cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 00 01123467899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=305.48 Aligned_cols=248 Identities=31% Similarity=0.455 Sum_probs=196.1
Q ss_pred ceecccCceeEEEEEEcC----CcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++.+.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999875543 34567999999999999999999999875 4568999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc-
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG- 630 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~- 630 (792)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998432 36899999999999999999999998 9999999999999999999999999998764332111
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .... ..... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~----~~~~~----------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAM----LESGE----------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHH----HHcCC----------cC
Confidence 1111223568999999999999999999999999999998 999986433211 1111 01110 00
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=309.75 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=200.5
Q ss_pred ccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHH--HHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLK--EFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
|++.+.||+|+||+||+++... ++.+|+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6788999999999999999865 568999999776544332 3456999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++. +...+++..+..++.||++||++||+.+ ++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999985 4556899999999999999999999998 99999999999999999999999999986521 12
Q ss_pred cccceeecccceeCccccc-CCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhhhcccCccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.......++..|+|||++. +..++.++||||||+++++|++|..|+........ .... +.......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~------------~~~~~~~~ 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE------------KILKRPLP 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH------------HHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh------------hccccccc
Confidence 2334457889999999998 88899999999999999999999999875411110 0000 00000000
Q ss_pred cC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QD-EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. .........+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0001112688999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=310.83 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=203.2
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.+.|++.++||.|+||.||+|+... ++.+++|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 4679999999999999999998754 889999999877777778899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|..++... ...+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998876432 345899999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.......+++.|+|||++. ...++.++|||||||++|||++|+.|+........ .. ..... ..
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~-~~~~~-----~~ 232 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LL-KIAKS-----EP 232 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HH-HHhcC-----CC
Confidence 1123356788999999985 34578899999999999999999999864332110 00 00000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+. ...+.....++.+++.+||+.+|++||++.+++++
T Consensus 233 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PT---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cc---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 01112234568899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.20 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=197.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 5889999999643 2334567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999998755321
Q ss_pred ccc---------------------------------cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCC
Q 003843 627 ELQ---------------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673 (792)
Q Consensus 627 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~ 673 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113468999999999999999999999999999999999999
Q ss_pred CCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 003843 674 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSDVISM 743 (792)
Q Consensus 674 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~ 743 (792)
||........ .. ...... ..+ .+ +.......++.+++.+++. +|.+|++ +.|++++
T Consensus 235 Pf~~~~~~~~--~~----~i~~~~-~~~---~~---p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQET--YR----KVMNWK-ETL---VF---PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHH--HH----HHHcCC-Cce---ec---CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9864332211 00 000000 000 00 0011134567788888764 9999985 5666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=305.07 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=204.3
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+... ++.+++|.+..... .+++.+|++++++++|+||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678999999999999999999865 78999999865432 67899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999998843 2356899999999999999999999998 99999999999999999999999999987644321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+........... . .....+ .
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~-----~~~~~~---~ 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------I-----PNKPPP---T 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------h-----ccCCCC---C
Confidence 22334578899999999999999999999999999999999999864322111000 0 000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...+.....++.+++.+||+.+|++||++.||++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112223457889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=318.01 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=192.9
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 546 (792)
+|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999875 5889999998653 2334566788999998885 577888999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|..++. +...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988873 3346899999999999999999999998 999999999999999999999999999754322
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . +...
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~----~--------i~~~-- 216 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQ----S--------IMEH-- 216 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH----H--------HHhC--
Confidence 11 1233568999999999999999999999999999999999999986433211 000 0 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTM 737 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 737 (792)
....+.....++.+++.+||+.+|.+|++.
T Consensus 217 -~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 -NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 001112234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=294.64 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=201.3
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.+.|++.+.||+|.|+.||+... .+|+.+|+|++.- -.....+++.+|+.|-+.++||||+++...+.+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 57889999999999999999865 4688999998732 24457788999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---CCeeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kL~DFGla~~~ 623 (792)
|+|+|++|..=| ..+-..++..+-..+.||+++|.|+|.++ |||||+||+|+|+-.. --+||+|||+|..+
T Consensus 90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999985544 23345788888899999999999999999 9999999999999543 34899999999988
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
+.... .....|||+|||||++...+|+..+|||+.||+||-|+.|.+||...+.... ++.+..+.. +.
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~~g~y-d~-- 231 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIKAGAY-DY-- 231 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHhcccc-CC--
Confidence 74332 2335899999999999999999999999999999999999999964332111 111111100 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.=....++..+|+++||..||.+|.|+.|.+.+
T Consensus 232 ----~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 ----PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111122345678999999999999999999987643
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.98 Aligned_cols=240 Identities=24% Similarity=0.287 Sum_probs=188.0
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHH-HHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++|+||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999876 46789999986432 12223444444 456778999999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 99988884 3345788888999999999999999998 9999999999999999999999999997542211 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . +.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~----~--------i~~~~---~~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYD----N--------ILNKP---LQL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHH----H--------HHhCC---cCC
Confidence 334579999999999999999999999999999999999999986433211 000 0 00000 011
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
.......+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 122345788999999999999999987443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=327.72 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=195.5
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..+|.+.+.||+|+||.||++.... ++.||||... ...+.+|+++|++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5679999999999999999998764 7889999642 23467899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+. ++|..++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 677777633 2346899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcc-c-cccccchhhhcccCcc-----cc-
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-S-FNLLGHAWDLWKDDRV-----HD- 700 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~-----~~- 700 (792)
........||+.|+|||++.+..++.++|||||||+||||++|..++-..... . ................ ..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 22223457999999999999999999999999999999999987654221111 0 0000000000000000 00
Q ss_pred ----cc---cc-----cccc-CCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 ----LI---DP-----VIMQ-DEIS----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ----~~---~~-----~l~~-~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+. .. .... .... ......+.+|+.+||+.||++|||+.|++++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00 0000 0000 0112367889999999999999999999875
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=307.29 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=201.2
Q ss_pred CccccceecccCceeEEEEEEcCCcEEEEEEecccC------chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+|++.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 22345688999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 345889999999999999999999998 99999999999999999999999999986532
Q ss_pred Cc----cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 626 DE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 626 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.. .........++..|+|||.+.+..++.++||||||++++||++|+.||.......... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--------~~~~~~~- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--------YIGAHRG- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--------HhhhccC-
Confidence 11 1112233468899999999999999999999999999999999999986432211000 0000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
. ..........++.+++.+||+.+|.+||++.|+++
T Consensus 226 ~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 L-----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 01112234567889999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=331.52 Aligned_cols=262 Identities=18% Similarity=0.285 Sum_probs=192.2
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-------- 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 539 (792)
..++|++.++||+|+||.||+|... +++.||||++.... ....+|+.+|+.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3568999999999999999999875 58899999885432 2345799999999999999999887432
Q ss_pred CeeEEEEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-Ceeeccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDF 617 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DF 617 (792)
...++||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999986 555555322 33456899999999999999999999998 99999999999999765 6999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc-
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD- 695 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 695 (792)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||........ +.........
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCC
Confidence 9998764322 12235689999999998764 689999999999999999999999864332110 0000000000
Q ss_pred ---------Cccccccccccc----cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 696 ---------DRVHDLIDPVIM----QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 696 ---------~~~~~~~~~~l~----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....++.-+... ...++.....++.+|+.+||+.+|.+|||+.|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000000 001111234578999999999999999999999854
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.23 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 478999999999999999999864 6899999999765555667789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999873 245789999999999999999999998 99999999999999999999999999987543321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....... ....+ .+ .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~---~ 234 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TP---E 234 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CC---C
Confidence 12234678899999999999999999999999999999999999864332111000 00000 00 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112234567899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.99 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=201.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999875 5788999988654 333456788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++.. .+.+++..+..++.|+++||.|||+ .+ ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999999843 3568999999999999999999997 45 999999999999999999999999998765322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccchhhhcccC----------
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHAWDLWKDD---------- 696 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~---------- 696 (792)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ...........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1233568899999999988889999999999999999999999985432211100 00000000000
Q ss_pred -------ccccccccccccCC--C-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 697 -------RVHDLIDPVIMQDE--I-SLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 697 -------~~~~~~~~~l~~~~--~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
...+..+....... . ......++.+++.+||+.+|++||++.+|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000000 0 011345688999999999999999999998763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=341.00 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=202.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||.||+|+.. +++.||+|++... .....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 4889999998653 2234567999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccC--------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 547 EYMPNKSLNVFLFDST--------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234567788999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcc----------------ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc
Q 003843 619 LARMFGGDEL----------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682 (792)
Q Consensus 619 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~ 682 (792)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123468999999999999999999999999999999999999986422111
Q ss_pred cccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003843 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 747 (792)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~ 747 (792)
... . ..+.++.. .......+..+.+++.+|++.||++|| +++++++.|+..
T Consensus 239 i~~---------~---~~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISY---------R---DVILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhh---------h---hhccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 0 00011100 000112345678999999999999995 677777777654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=305.12 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=201.9
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.+|++.+.||+|+||.||++...+++.+|+|.+.... ...+.|.+|++++++++|+|++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4688889999999999999988778899999986432 234678999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++... ...++++.+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999887432 245889999999999999999999998 9999999999999999999999999998664332211
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ..... .....+
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~--~~~~~~----- 223 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE----TINAG--FRLYKP----- 223 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH----HHhCC--CCCCCC-----
Confidence 112234678999999998999999999999999999998 888886432211 000 00000 011111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
......+.+++.+||+.+|++||++.+++++|.
T Consensus 224 ---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 ---RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 112357899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.24 Aligned_cols=244 Identities=29% Similarity=0.486 Sum_probs=205.2
Q ss_pred eecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccce
Q 003843 478 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 556 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 556 (792)
+||+|.||+||.|++.+ ...+|||-+.....+..+-+.+|+.+-++++|.|||+++|.+.+++..-+.||..+||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999865 45799999988777777888999999999999999999999999999999999999999999
Q ss_pred eeeccCCCccC--CHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCCCccccccc
Q 003843 557 FLFDSTKKRLL--NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTK 633 (792)
Q Consensus 557 ~l~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~ 633 (792)
+|. .+=+++ ++..+-.+.+||++||.|||++. |||||||-+|||++. .|.+||+|||.++.+.. ....+.
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 983 233455 78888899999999999999998 999999999999965 58899999999998743 344566
Q ss_pred eeecccceeCcccccCC--CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 634 QIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 634 ~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.+.||..|||||++..+ .|+.++|||||||.+.||.||++||-..+...-... +-+- .-...++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-------kVGm-------yKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-------KVGM-------YKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-------hhcc-------eecCCCC
Confidence 78899999999999865 488999999999999999999999964433211110 0000 0014566
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
+.+...++..+|++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7778899999999999999999999999975
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=308.09 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=190.5
Q ss_pred ceecccCceeEEEEEEcC---CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.||+|+||.||+|.... ...+++|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888876443 334567899999999999999999999999999999999999999
Q ss_pred ccceeeeccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 553 SLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 553 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865432 234567888999999999999999998 9999999999999999999999999987543322222
Q ss_pred ccceeecccceeCcccccC-------CCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 631 NTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+....... ... ..... ....+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~---~~~~~-~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK---QVVRE-QDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH---HHhhc-cCccCC
Confidence 2223345778999998743 456889999999999999999 777775432211 000 00000 011111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.+ .........+.+++..|+ .||++||++++|++.|.
T Consensus 232 ~~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 112223456677888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=307.95 Aligned_cols=257 Identities=28% Similarity=0.420 Sum_probs=204.2
Q ss_pred cCccccceecccCceeEEEEEEc------CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67889999999999999999864 2467999988665443 5678999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCC------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccc
Q 003843 544 LILEYMPNKSLNVFLFDSTKK------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DF 617 (792)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998544322 25899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccC
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
|++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... .....
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLN----RLQAG 234 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHH----HHHcC
Confidence 998754322211 2223356778999999998889999999999999999999 777875322111 000 00101
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
... ..........+.+++.+||+.+|++||++.|++++|.+
T Consensus 235 ~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 235 KLE---------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CcC---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 100 01112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=316.56 Aligned_cols=252 Identities=24% Similarity=0.312 Sum_probs=211.6
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCc---hhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 543 (792)
..+.|++.+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 35689999999999999999999875 99999999976543 24568899999999998 999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC----CCeeeccccc
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKISDFGL 619 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kL~DFGl 619 (792)
+|||++.||.|.+.+... .+++.++..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999988554 3999999999999999999999998 9999999999999543 4799999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......... ....++.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 998765 234566899999999999999999999999999999999999999997655332221 0001111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+ ..+.-......+.+++..++..||.+|+|+.+++++
T Consensus 256 -----~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CC-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 122223346788999999999999999999999985
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.45 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=193.3
Q ss_pred ecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||+|+||.||+++.+ +|+.||+|.+.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 58999999986421 12234556799999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887433 2334889999999999999999999998 9999999999999999999999999998764332 1223
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.......... . .. ...+...+ . .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~-~----~~-----~~~~~~~~-~-~~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE-E----LK-----RRTLEDEV-K-FEHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH-H----HH-----HHhhcccc-c-ccccc
Confidence 468899999999999999999999999999999999999986432211100 0 00 00000000 0 00112
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
...++.+++.+||+.||++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 345688999999999999999998876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=324.09 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=197.3
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----eeE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 543 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 543 (792)
+|++.++||+|+||.||+++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999874 6899999998653 2334567889999999999999999999998776 789
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46666652 3456899999999999999999999998 999999999999999999999999999875
Q ss_pred CCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc----
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV---- 698 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 698 (792)
...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ .............
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence 433211 12234678899999998874 579999999999999999999999865432110 0000000000000
Q ss_pred ------cccccccccc-------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 ------HDLIDPVIMQ-------DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ------~~~~~~~l~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+...... .........++.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 01111224578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=307.06 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=195.1
Q ss_pred ceecccCceeEEEEEEcC-Cc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+|++.+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998754 33 5788888753 344567889999999999 899999999999999999999999999
Q ss_pred CccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 552 KSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 552 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885422 1235889999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||....... .. .......
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY----EKLPQGY 228 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HH----HHHhCCC
Confidence 98632211 11111233567999999998999999999999999999997 999985432111 00 0000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+........+.+++.+|++.+|.+||++.++++.|+++
T Consensus 229 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 229 ----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011112335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.99 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=201.2
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34556666679999999999999865 47789999987766667788999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~ 625 (792)
||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999854322212278888899999999999999998 999999999999986 67899999999986543
Q ss_pred CccccccceeecccceeCcccccCCC--CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
... ......+++.|+|||++.... ++.++||||||+++|||++|+.|+........... ... ...
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-------~~~----~~~ 228 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-------KVG----MFK 228 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-------hhh----hhc
Confidence 221 122245789999999987644 78999999999999999999999864322111000 000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ....+.....++.+++.+||+.+|.+||++.|++++
T Consensus 229 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 I---HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred c---CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0 111222344678899999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=315.15 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=197.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999875 57889999986443 23345678899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 67666632 2345889999999999999999999998 99999999999999999999999999986533221
Q ss_pred ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------hhhhcccCc-
Q 003843 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWDLWKDDR- 697 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~~~~~~~~~- 697 (792)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..... .+..+....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999999865 4689999999999999999999999865432111 10000 000000000
Q ss_pred cccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+..... ........++.+++.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000 0011234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.83 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=199.3
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec------
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ------ 539 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 539 (792)
.+++.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35678999999999999999999875 47889999986543 3446788999999998 799999999998753
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...+++|||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999988542 3346899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
+....... .......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......... ....
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~ 230 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPR 230 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhc
Confidence 98654321 1223457889999999986 3467889999999999999999999986432211000 0000
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. .. ..........+.+++.+||+.+|.+||++.+++++
T Consensus 231 -~~-----~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 -NP-----AP----RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -CC-----CC----CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 00 00111223468899999999999999999999753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.50 Aligned_cols=237 Identities=23% Similarity=0.282 Sum_probs=186.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHH-HHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+.. +++.||+|++.... ......+.+|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 57899999986432 222344555554 67889999999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99987773 3456888999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+... .. .. ++... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~----~~--------i~~~~---~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--MY----DN--------ILHKP---LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--HH----HH--------HhcCC---CCC
Confidence 334578999999999999999999999999999999999999986432111 00 00 00000 111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHH
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMS 738 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~ 738 (792)
+......+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 222345788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=308.37 Aligned_cols=256 Identities=29% Similarity=0.432 Sum_probs=203.0
Q ss_pred hcCccccceecccCceeEEEEEEcC-Cc----EEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..+|++.+.||+|+||.||+|..+. ++ .+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3578889999999999999998643 32 58999886553 3455788999999999999999999999887 7889
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998532 334899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............++..|+|||.+....++.++||||||++++|+++ |+.||......... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~----- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP------DLLEKGE----- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhCCC-----
Confidence 53322111111223568999999998999999999999999999998 99998643321110 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||..+|++||++.++++.|++.
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 -----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011111334678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.91 Aligned_cols=251 Identities=32% Similarity=0.485 Sum_probs=198.7
Q ss_pred ceecccCceeEEEEEEcC-------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2579999886543 34567889999999999999999999999999999999999
Q ss_pred cCCCccceeeeccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-----Ceeeccccc
Q 003843 549 MPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-----NPKISDFGL 619 (792)
Q Consensus 549 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-----~~kL~DFGl 619 (792)
+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2234789999999999999999999988 99999999999999887 899999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQ----HVTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHH----HHhcCC-
Confidence 986644332222223345678999999999999999999999999999998 998886432211 100 000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
........+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001122234678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=319.05 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=172.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-C-----CCcceEeeeeeecCeeE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-----RNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 543 (792)
-+|++++.||+|+||.|.++... +++.||||++++.. .-..+-..|+.+|..|+ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 38999999999999999999764 58999999998753 34466678999999997 4 48999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC--Ceeecccccce
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLAR 621 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kL~DFGla~ 621 (792)
||+|.+ ..+|.++|..... ..|+...+..++.||++||.+||+.+ |||+||||+||||.+.+ .+||+|||.|.
T Consensus 265 iVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 999988 5589999966543 34899999999999999999999998 99999999999997654 59999999999
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~ 680 (792)
.....- ..+..+..|.|||++.+.+|+.+.|+||||||+.||++|.+-|...++
T Consensus 340 ~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 340 FESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 754432 256789999999999999999999999999999999999877765443
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.75 Aligned_cols=257 Identities=26% Similarity=0.347 Sum_probs=204.1
Q ss_pred HHHhcCccccceecccCceeEEEEEEcCCcEEEEEEec--ccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeE
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 543 (792)
......|+++++||+||.+.||++...+.+.+|+|++. ..+.+..+-|.+|+.+|.+++ |.+||++++|-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34567899999999999999999998778889998764 346677889999999999995 999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||- ..+|..+|... ...++.-.+..+..|++.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+
T Consensus 437 mvmE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEeecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999975 55888888432 223332377789999999999999999 99999999999984 578999999999988
Q ss_pred CCCccccccceeecccceeCcccccCCC-----------CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGL-----------FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
..+...-.....+||+.||+||.+.... .+.++||||||||||+|+.|+.||+.+...
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~----------- 578 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ----------- 578 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----------
Confidence 7776665566679999999999985432 568899999999999999999999853311
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+++.+.++.-.-.-...+...++++++..||+.||++||++.|++++
T Consensus 579 --~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 --IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 0122333444210000111112238999999999999999999999865
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=307.99 Aligned_cols=239 Identities=22% Similarity=0.335 Sum_probs=187.8
Q ss_pred eecccCceeEEEEEEcC-------------------------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceE
Q 003843 478 KLGEGGFGPVYKGRLLN-------------------------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 532 (792)
+||+|+||.||+|.+.. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555556778999999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC--
Q 003843 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-- 610 (792)
Q Consensus 533 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-- 610 (792)
++++.++...++||||+++++|..++.. ..+.+++..+..++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999888843 2346899999999999999999999998 99999999999997654
Q ss_pred -----CeeecccccceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHH-hCCCCCCCCCcccc
Q 003843 611 -----NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SSKKNTGVYNADSF 683 (792)
Q Consensus 611 -----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~ell-tg~~p~~~~~~~~~ 683 (792)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999998654221 12356788999998875 56899999999999999995 68888754322111
Q ss_pred ccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 684 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
. . . +... ...+.+....+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~---~---~---------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 E---R---F---------YEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---H---H---------HHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 0 0 0000 0011112246889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.39 Aligned_cols=252 Identities=29% Similarity=0.406 Sum_probs=206.1
Q ss_pred cccceecccCceeEEEEEE-cCCc----EEEEEEecc-cCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 474 SMQCKLGEGGFGPVYKGRL-LNGQ----EVAVKRLSN-QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~-~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
+..++||+|+||+||+|.+ .+|+ +||+|++.. ...+..+++.+|+.+|.++.|||+++++++|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458999999999999976 3343 689998854 35566789999999999999999999999998776 889999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
||+.|.|.+|+..+ +..+..+..+.+..|||+||.|||++. ++||||.++|||+.+...+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999654 345888999999999999999999987 9999999999999999999999999999987665
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
..-......-.+.|||-|.+....|+.++|||||||.+||++| |..|+.....++ +.+++...-
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle~ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLEKGE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHhccc
Confidence 4444443444678999999999999999999999999999998 777765433221 122222111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+-+.++-...++..++.+||..|+..||+++++...+.+-
T Consensus 918 -RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 918 -RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred -cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 1122334567889999999999999999999999888653
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.00 Aligned_cols=261 Identities=23% Similarity=0.263 Sum_probs=196.4
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----- 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 540 (792)
..++|++.+.||+|+||.||+++.. .++.||+|++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999874 5889999998643 3344567889999999999999999999986543
Q ss_pred -eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 541 -EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 541 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 479999999764 444431 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh-------
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL------- 692 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~------- 692 (792)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCcHH
Confidence 97643221 12335789999999999999999999999999999999999999975432110 0000000
Q ss_pred ------------ccc------Cccccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 ------------WKD------DRVHDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ------------~~~------~~~~~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
... ....+....... ...........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000000000 000111124568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=311.32 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=204.1
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++..+...++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35799999999999999999986 46899999999765555667889999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998873 335899999999999999999999998 99999999999999999999999999886543322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.......... ...... . +.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~~~--~----~~~-- 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG--T----PEL-- 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcC--C----ccc--
Confidence 1223467889999999999999999999999999999999999986433211100 000000 0 000
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+.+++.+||+.+|++||++.+++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111233467889999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.02 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=203.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999875 58899999986543 44556789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999988843 26899999999999999999999998 9999999999999999999999999998775432
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .. ..... ..+.+..
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~----~~~~~-----~~~~~~~ 220 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LF----LIPKN-----NPPSLEG 220 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HH----Hhhhc-----CCCCCcc
Confidence 122334678899999999998999999999999999999999999864332110 00 00000 0111100
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.+++.+||+.+|++||++++++++
T Consensus 221 ----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 ----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0134568899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.02 Aligned_cols=254 Identities=30% Similarity=0.387 Sum_probs=208.1
Q ss_pred hcCccccceecccCceeEEEEEEcC--Cc--EEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++..+.++||+|.||.|++|.+.. |+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3455667899999999999998753 44 5899999765443 77899999999999999999999999887 78899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|+|.++.|+|.+.|.+ ..+..|-...+..++.|||.||.||..+. +|||||.++|+||-....+||+||||.+.++
T Consensus 188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999976 45667888999999999999999999998 9999999999999999999999999999886
Q ss_pred CCc-cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
..+ .........-...|.|||.+....|+.++|||+|||.||||++ |..||..... ..+.+.+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------~qIL~~i 328 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------IQILKNI 328 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------HHHHHhc
Confidence 543 2222223345678999999999999999999999999999999 5567643221 1122333
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
|.. .+-+.+..+.+++++++.+||..+|.+||++..|++.+
T Consensus 329 D~~-erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAG-ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccc-ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 321 12233455788999999999999999999999998554
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=309.15 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=204.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||.|+||.||+++.. +++.+|+|.+........+.|.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 567999999999999999999875 5889999999776666778899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988432 245899999999999999999999998 99999999999999999999999999876533211
Q ss_pred ccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
......+++.|+|||.+. ...++.++||||||+++|||++|+.|+........ .. ...... .
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~~-----~ 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL----KILKSE-----P 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH----HHhcCC-----C
Confidence 123356889999999975 34578899999999999999999999864322110 00 000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+.+ ..+.....++.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 PTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000 0111234568899999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.93 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=202.4
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999875 5889999988543 3445677889999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887432 3345889999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||........ .. ....+.. .
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~----~~~~~~~----------~ 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--IL----KVCQGSY----------K 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HH----HHhcCCC----------C
Confidence 12235688899999999999999999999999999999999999864321110 00 0000100 0
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+......+.+++.+||+.+|++||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.41 Aligned_cols=266 Identities=25% Similarity=0.331 Sum_probs=198.5
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|++|.||+|+.. +++.||+|+++.. .....+.+.+|+.++.+++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999875 5889999998643 223356788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
++ ++|.+++........+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 578777754444467899999999999999999999998 99999999999999999999999999986543211
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc--ccc----hhhhcccC----c
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL--LGH----AWDLWKDD----R 697 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~--~~~----~~~~~~~~----~ 697 (792)
......+++.|+|||.+.+. .++.++||||||++++||++|+.|+.......... ... ....+... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223568899999988754 57899999999999999999999986433211000 000 00000000 0
Q ss_pred cccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.......... ..........++.+++.+||+.||++|||+.+|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 000011134577899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=290.67 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=200.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--------chhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
.++|.-.+.||+|..++|-+...+ +|+++|+|++.... ..-.+.-.+|+.||+++ -||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 456777789999999999888664 58899999884321 12244557799999998 699999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++|+|.|+.|.|.++| ...-.+++++..+|+.|+.+|++|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 9999999999999999999 45567999999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC------CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+..+...+ .....+|||+|+|||.+.. ..|+...|.|++|||+|.|+.|.+||-.... +-.. ..+
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----mlML-R~I 240 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----MLML-RMI 240 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HHHH-HHH
Confidence 99876553 3445799999999999853 3478889999999999999999999842110 0000 000
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+++ .+. ..+.=.+.+....+||.+||+.||++|.|++|++++
T Consensus 241 meGk-yqF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGK-YQF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhcc-ccc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0110 000 111113345678999999999999999999998764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.33 Aligned_cols=255 Identities=23% Similarity=0.364 Sum_probs=202.6
Q ss_pred hcCccccceecccCceeEEEEEEcCC----cEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|.+.++||+|+||.||+|...+. ..|+||...... ....+.+.+|+.++++++|+||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 45688899999999999999986432 468999887654 4556789999999999999999999998875 56789
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++... ...+++..++.++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999998432 235899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
....... ....++..|+|||.+....++.++||||||++++||++ |..||........ .. ......
T Consensus 159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~------ 225 (270)
T cd05056 159 DESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IG----RIENGE------ 225 (270)
T ss_pred cccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH----HHHcCC------
Confidence 4322111 12234568999999988899999999999999999996 9999864332111 00 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
........+..+.+++.+|+..+|.+||++.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.40 Aligned_cols=249 Identities=28% Similarity=0.450 Sum_probs=200.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCc---------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4678899999999999999864 578999998854322 123568899999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++|+||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999983 3356889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcccc----ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 622 MFGGDELQG----NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 622 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~---~~------ 223 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI---FK------ 223 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH---HH------
Confidence 775321111 1123457889999999999999999999999999999999999986432110 00 00
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
..... ....+......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENA-----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccC-----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00001 11122234567889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.48 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=201.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 35677789999999999999865 47889999986443 34567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988873 345889999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... . +.... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~---------~~~~~-~ 218 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------L---------IPKNS-P 218 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------h---------hhcCC-C
Confidence 1223467889999999999999999999999999999999999976332211000 0 00000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11122234578899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.76 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=205.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+.. +++.+++|.+........+.+.+|++++++++|+||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467999999999999999999875 4788999999776666678899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999887432 246899999999999999999999998 9999999999999999999999999998654321
Q ss_pred ccccceeecccceeCcccccCC---CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+........... ..... +.+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~------~~~~~----~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL------ISKSN----FPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhcc----CCCc
Confidence 112234678899999999877 889999999999999999999999864332111000 00000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
..........++.+++.+||+.+|.+||++.+|+.
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=331.70 Aligned_cols=267 Identities=21% Similarity=0.280 Sum_probs=193.3
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC------CcceEeeee
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR------NLVRLLGCC 536 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~ 536 (792)
.++....++|++.++||+|+||+||+|+.. .++.||||+++... ...+.+..|++++..++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455789999999999999999999875 47889999996532 2344567788888777654 588888888
Q ss_pred eec-CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCC----
Q 003843 537 VEQ-GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM---- 610 (792)
Q Consensus 537 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~---- 610 (792)
..+ ...++|||++ +++|.+++. +.+.+++..+..++.||+.||+|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 764 4788999987 667777763 335689999999999999999999974 7 99999999999998765
Q ss_pred ------------CeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCC
Q 003843 611 ------------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVY 678 (792)
Q Consensus 611 ------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~ 678 (792)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864321 223467999999999999999999999999999999999999999754
Q ss_pred Ccccc-ccccchh----hhcc----cCccccc----------cccc----cccC--CCCHHHHHHHHHHHHhccccCCCC
Q 003843 679 NADSF-NLLGHAW----DLWK----DDRVHDL----------IDPV----IMQD--EISLPMLMRYINVALLCVQENAAD 733 (792)
Q Consensus 679 ~~~~~-~~~~~~~----~~~~----~~~~~~~----------~~~~----l~~~--~~~~~~~~~l~~li~~cl~~dp~~ 733 (792)
..... ..+.... ..+. .....++ .++. +... .........+.+|+.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 32111 1110000 0000 0000000 0000 0000 000112346789999999999999
Q ss_pred CCCHHHHHHH
Q 003843 734 RPTMSDVISM 743 (792)
Q Consensus 734 RPs~~evl~~ 743 (792)
|||++|++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999863
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=307.26 Aligned_cols=240 Identities=24% Similarity=0.396 Sum_probs=190.7
Q ss_pred ceecccCceeEEEEEEcC--------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+.||+|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 235888888665555667899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC--------eeecccccc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PKISDFGLA 620 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~kL~DFGla 620 (792)
+++|+|..++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998533 235899999999999999999999998 999999999999987765 599999998
Q ss_pred eecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCC-CCCCCCCccccccccchhhhcccCcc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+......... . ...
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--~----~~~---- 219 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--Q----FYE---- 219 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--H----HHH----
Confidence 754321 23467889999999987 45799999999999999999985 454322211100 0 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
. ....+.....++.+++.+||+.+|++||+++++++.|+
T Consensus 220 -----~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 -----D---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----c---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01112223356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.43 Aligned_cols=255 Identities=20% Similarity=0.249 Sum_probs=196.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999875 4889999998642 2334566889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998843 2345899999999999999999999998 999999999999999999999999999766433
Q ss_pred ccccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ . ...........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~---~~i~~~~~~~~- 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--Y---GKIMNHKEHFQ- 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--H---HHHHcCCCccc-
Confidence 211 1223468999999999873 4578899999999999999999999864321110 0 00000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccC--CCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQEN--AADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~d--p~~RPs~~evl~~ 743 (792)
+ ..........+.+++.+|+..+ +..||++.+++++
T Consensus 229 ----~--~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----F--PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----C--CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0001113456778888877543 3347899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.10 Aligned_cols=253 Identities=22% Similarity=0.377 Sum_probs=201.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999876 6899999988653 334457899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999998885433344689999999999999999999974 6 9999999999999999999999999997653221
Q ss_pred cccccceeecccceeCcccccCC------CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ... ...+
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~---------~~~~ 222 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQ---------LSAI 222 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHH---------HHHH
Confidence 2234578899999998654 358899999999999999999999864321110 000 0001
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.. ..........++.+++.+||+.+|.+||++.+++..
T Consensus 223 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1100 112223355678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.83 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=202.6
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeee---
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCV--- 537 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 537 (792)
+..+..+.++|++.+.||+|+||.||+++.. +++.+|+|.+.... ...+++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3445567889999999999999999999875 47899999886532 2346788999999999 6999999999884
Q ss_pred --ecCeeEEEEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 538 --EQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 538 --~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345689999999999999887532 23346889999999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA 689 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~ 689 (792)
+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ ...
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~-- 240 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFK-- 240 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhh--
Confidence 99999987643321 1223468999999999853 4578999999999999999999999864322110 000
Q ss_pred hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.... ..+.+ ..+......+.+++.+||+.+|++||++.||++++
T Consensus 241 ---~~~~-----~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 ---IPRN-----PPPTL---HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---cccc-----CCCcc---cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 00000 00111234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.84 Aligned_cols=262 Identities=25% Similarity=0.373 Sum_probs=192.9
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhc---CCCCcceEeeeeeec-----C
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQ-----G 540 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 540 (792)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++.+ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999876 58899999986432 22234566777777765 699999999988642 4
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..+++|||+++ +|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 777776432 2345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------h
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD--------L 692 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~ 692 (792)
+...... ......++..|+|||++.+..++.++|||||||++|||++|++||........ ...... .
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhh
Confidence 8764322 12234678999999999999999999999999999999999999864332110 000000 0
Q ss_pred cccC-cc-ccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDD-RV-HDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~-~~-~~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+... .. .....+... ...........+.+++.+||+.||++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00 000000000 001112234567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.70 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=203.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..|+..++||.|+||.||+|+.. +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45777899999999999999875 5889999998644 345567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998873 245889999999999999999999998 99999999999999999999999999987644321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||++.+..++.++||||||+++|||++|+.|+......... ..+.... .
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---------------~~~~~~~-~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL---------------FLIPKNN-P 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh---------------hhhhcCC-C
Confidence 122346788999999999989999999999999999999999998643321100 0000000 1
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233455678899999999999999999999766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.18 Aligned_cols=198 Identities=26% Similarity=0.427 Sum_probs=160.5
Q ss_pred cceecccCceeEEEEEEc---CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCeeEEEEEecC
Q 003843 476 QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMP 550 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 550 (792)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999865 46789999986532 23557889999999999999999998864 456789999986
Q ss_pred CCccceeeecc------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE----cCCCCeeecccccc
Q 003843 551 NKSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLA 620 (792)
Q Consensus 551 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kL~DFGla 620 (792)
+ +|.+++... .+...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 665555321 12235899999999999999999999998 9999999999999 45678999999999
Q ss_pred eecCCCcc-ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 621 RMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 621 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
+.+..... ........+|+.|+|||++.+. .++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87654321 1122345789999999999774 58999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.12 Aligned_cols=250 Identities=27% Similarity=0.350 Sum_probs=198.7
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|++++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677899999999999999875 58899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888432 2335899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... .. ....+... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~---------~~~~~~~~--~ 221 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE---------VERLVKEV--Q 221 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HH---------HHhhhhhh--h
Confidence 112346899999999999999999999999999999999999998643221100 00 00000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPT-----MSDVIS 742 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~ 742 (792)
.........++.+++..||+.||++||+ +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1111223456789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.98 Aligned_cols=193 Identities=25% Similarity=0.333 Sum_probs=164.6
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
....+|++.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++|+||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999875 4678999975432 2356899999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|++. ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577777633 3346899999999999999999999998 999999999999999999999999999753221
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCC
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~ 675 (792)
.......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999999999999999999999999865544
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.39 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=200.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCc----EEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|+..+.||+|+||.||+|+.. +++ .||+|.+.... .....++.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999864 343 57889886543 23345789999999999999999999998754 567
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999888432 335889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~---- 229 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI------PDLLEKGER---- 229 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHCCCC----
Confidence 54322222223345678999999999999999999999999999997 8888854321110 001111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. .........+.+++..||..+|++||+++++++.|+..
T Consensus 230 ---~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 230 ---L---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred ---C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 01111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.25 Aligned_cols=238 Identities=26% Similarity=0.451 Sum_probs=189.4
Q ss_pred ceecccCceeEEEEEEcCCc-----------EEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 477 CKLGEGGFGPVYKGRLLNGQ-----------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+.||+|+||.||+|.+.+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886433 5788887654333 6789999999999999999999999988 788999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-------Ceeecccc
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-------NPKISDFG 618 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-------~~kL~DFG 618 (792)
|||+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999985432 26899999999999999999999998 99999999999999888 79999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCC--CCCCcCceeehhHHHHHHHhC-CCCCCCCCccccccccchhhhccc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+......... ..+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~------~~~~- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------RFYQ- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH------HHHh-
Confidence 9986543 1223466789999999876 789999999999999999994 6666543211100 0000
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
. ......+....+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------D----QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------c----CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00011111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.86 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=206.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||.|+||.||+|... +++.+|+|++... .....+.+.+|+++++.++|+|++++++.+..+...++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 5788999998643 233567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999855433356899999999999999999999998 99999999999999999999999999987654322
Q ss_pred c--cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 629 Q--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 629 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. .......++..|+|||.+... .++.++|+||||++++||++|+.||........ . ...... ..+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~---~~~~~~------~~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--L---MLTLQN------DPPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--H---HHHhcC------CCCC
Confidence 2 122334688999999998877 789999999999999999999999864332110 0 000000 0001
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+............+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 10101012334678899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.08 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=200.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+|++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999886 58899999886432 2334668899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++++.|..++. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2345899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccc--------hhhhcccCc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGH--------AWDLWKDDR 697 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~--------~~~~~~~~~ 697 (792)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .... ....+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 56889999999999999999999998644321110 0000 000000000
Q ss_pred c-ccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 V-HDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~-~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. .....+.. ..... ......+.+++.+||+.+|++||++.|++.+
T Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000000 00000 1124678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.88 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=192.1
Q ss_pred ceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeee-ecCeeEEEEEecC
Q 003843 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKILILEYMP 550 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~ 550 (792)
+.||+|+||.||+|.+.+ ...||+|++... .....+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998642 357999998543 3345678899999999999999999999876 4556889999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc-
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ- 629 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~- 629 (792)
+++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998432 234677888999999999999999998 999999999999999999999999999865432211
Q ss_pred -cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCC-CCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 630 -GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 630 -~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.......++..|+|||.+.+..++.++||||||+++|||++|. +|+..... ...... . ..+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~---~-~~~~---------- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVY---L-LQGR---------- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH---H-hcCC----------
Confidence 1112234577899999999899999999999999999999964 45542211 111100 0 0000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0000111235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=310.93 Aligned_cols=255 Identities=19% Similarity=0.243 Sum_probs=197.0
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999875 5788999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998532 346889999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .. ..........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~---~i~~~~~~~~- 228 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YG---KIMNHEERFQ- 228 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--HH---HHHcCCCccc-
Confidence 22 11223568999999999876 5678999999999999999999999864332110 00 0000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 743 (792)
+ .........++.+++.+|+...+++ |+++++++++
T Consensus 229 ----~--p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F--PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C--CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0001123457888999988865544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.17 Aligned_cols=261 Identities=25% Similarity=0.345 Sum_probs=204.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||+||+++.. +++.||+|++.... ....+.+.+|+++++.++|+||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 457888999999999999999875 58889999886543 3456789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|+++++|.+++. +.+.+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999988873 33468999999999999999999997 45 999999999999999999999999998754322
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ...... ......+....
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~ 230 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-DPMGIL--DLLQQIVQEPP 230 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-hhhHHH--HHHHHHhhccC
Confidence 12235689999999999988999999999999999999999999875433211000 000000 00001111000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
..........++.+++.+|++.+|.+||++.|++++.
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 -PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000112345788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.00 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=201.1
Q ss_pred CccccceecccCceeEEEEEEcC--CcEEEEEEeccc----------CchhHHHHHHHHHHHhh-cCCCCcceEeeeeee
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQ----------SGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCVE 538 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 538 (792)
+|++.+.||+|+||.||+|+... ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 678999987532 22345567788888875 799999999999999
Q ss_pred cCeeEEEEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISD 616 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~D 616 (792)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999998887432 234468999999999999999999996 55 99999999999999999999999
Q ss_pred cccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ... .....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~----~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LAT----KIVEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHH----HHhhc
Confidence 99998765432 2234568899999999999899999999999999999999999985322110 000 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.. .+ .........+.+++.+||+.||++||++.||.+++.
T Consensus 229 ~~----~~-----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY----EP-----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC----Cc-----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 00 001122357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.35 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=194.6
Q ss_pred ccceeccc--CceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 475 MQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 475 ~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
++++||+| +|++||+++.. +|+.||+|++... .....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 78899999874 6889999998653 2334567788999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc-
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL- 628 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~- 628 (792)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 234899999999999999999999998 99999999999999999999999987654321110
Q ss_pred ----ccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc---hhhhc------
Q 003843 629 ----QGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH---AWDLW------ 693 (792)
Q Consensus 629 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~---~~~~~------ 693 (792)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||............. .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 011122356778999999976 468999999999999999999999986432211000000 00000
Q ss_pred ------------ccCcccc--c---ccccc---ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 ------------KDDRVHD--L---IDPVI---MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ------------~~~~~~~--~---~~~~l---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....... . ..+.. ...+........+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0000000 0 00000 0001122234578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.18 Aligned_cols=248 Identities=28% Similarity=0.416 Sum_probs=201.0
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999886 68999999886433 23567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998843 345889999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... . .........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~---~~~~~~~~~------- 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--A---VFKIGRSKE------- 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--H---HHHHHhccc-------
Confidence 32 123356888999999998776 8999999999999999999999986433110 0 000000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+......+.+++.+||+.+|.+||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011122234677899999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=299.48 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=204.2
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|+..+.||.|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999864 5889999987543 345567889999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++.... ...+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 346899999999999999999999998 99999999999999999999999999987644332
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||.+.+..++.++||||||++++||++|+.|+........ .. ....+..
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~----~~~~~~~---------- 218 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL--VV----KIVQGNY---------- 218 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHcCCC----------
Confidence 22335689999999999988899999999999999999999999864322110 00 0000100
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.........++.+++.+||+.+|.+||++.++++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011122345788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=305.11 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=198.7
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.|+..+.||+|+||+||+|+.. +++.||+|.+.... ....+.+.+|++++++++|+|++++.+++..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677789999999999999875 58899999986532 2234567889999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998887543 2345899999999999999999999998 9999999999999999999999999997653321
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ...... +...
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~--------~~~~--- 220 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRR--------VLET--- 220 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh--------hhcc---
Confidence 112346899999999999999999999999999999999999998643221100 000000 0000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
...........+.+|+..|++.+|++||+ +.+++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00111223456789999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.32 Aligned_cols=246 Identities=31% Similarity=0.472 Sum_probs=200.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecc---cCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
+.|+-++.||.|+||.||.|++. +.+.||||++.- .....+.++..|+..|.+++|||++.+-|||..+...+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 44666789999999999999864 577899999953 34556788999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|||-| +-.+++.- -+++|-+.++..|..+.++||+|||+++ .||||||+.|||+.+.|.+||+|||.|....
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-- 177 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-- 177 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC--
Confidence 99954 55555522 2456889999999999999999999998 9999999999999999999999999998653
Q ss_pred ccccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..+.++|||.|||||++. .+.|+-|+||||||++..||.-.++|.-.++ .+...+....++ .
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----AMSALYHIAQNe------s 242 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNE------S 242 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----HHHHHHHHHhcC------C
Confidence 345579999999999985 5789999999999999999999999864332 122111111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
|.+ ...+.+..+.+++..||+.-|.+|||.++++.+
T Consensus 243 PtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 111 134567789999999999999999999877654
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=300.18 Aligned_cols=251 Identities=33% Similarity=0.526 Sum_probs=200.8
Q ss_pred ccccceecccCceeEEEEEEcC-----CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
+++.+.||.|+||.||+++... +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998754 378999999765433 5678999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999843221 12899999999999999999999998 999999999999999999999999999877544
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
...... ...+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... ... .......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~----~~~~~~~------- 222 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLE----YLKKGYR------- 222 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcCCC-------
Confidence 222211 2236789999999988899999999999999999998 777775422111 000 0000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.........++.+++.+|+..+|++|||+.++++.|
T Consensus 223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 ---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011112355788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.03 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccccceecccCceeEEEEEEc----CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
|++.+.||+|+||.||+|... .++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 3688999998653 3445678899999999999999999999886542
Q ss_pred eeEEEEEecCCCccceeeeccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccc
Q 003843 541 EKILILEYMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DF 617 (792)
..++++||+++++|..++.... +...+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988764321 2235789999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccC
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
|+++...............+++.|++||.+....++.++||||||+++|||++ |++|+....... ... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYN----YLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHH----HHHcC
Confidence 99987644332222223345678999999999999999999999999999999 788876432211 100 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. . ..........+.+++.+|++.+|++||++.++++.|+++
T Consensus 232 ~-------~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N-------R---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-------c---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0 001112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.45 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=194.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-----chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--Cee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 542 (792)
.+|+..+.||+|+||.||+|... +++.|++|++.... .+..+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999875 58899999885431 23456788999999999999999999988753 567
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999988843 345889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcc-ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||........ . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-----~---------~~~ 221 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-----I---------FKI 221 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----H---------HHH
Confidence 533211 1112234578899999999999999999999999999999999999864321110 0 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.... .....+......+..++ +||..+|++||+++||++
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 01112222344566666 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.95 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=189.8
Q ss_pred ceecccCceeEEEEEEcCC---cEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 477 CKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
++||+|+||.||+|+..++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976443 346677765433 345678999999999999999999999999999999999999999
Q ss_pred ccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 553 SLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 553 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
+|.+++..... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999854322 234677788899999999999999998 99999999999999999999999999864322221122
Q ss_pred cceeecccceeCcccccC-------CCCCCcCceeehhHHHHHHHhC-CCCCCCCCccccccccchhhhcccCccccccc
Q 003843 632 TKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... ..... .. .+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~---~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLNH---VI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH---HH-hhcccccCC
Confidence 233567889999998753 3457899999999999999974 5566432211 11110 11 111122233
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
+.+ .......+.+++..|+ .+|++||++++|++.|.
T Consensus 232 ~~~-----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL-----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc-----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322 1223456778889999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=319.02 Aligned_cols=263 Identities=24% Similarity=0.282 Sum_probs=196.7
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 539 (792)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 5889999998653 233456788999999999999999999988643
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 4544442 24788999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-c-cccc---------
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLGH--------- 688 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~-~~~~--------- 688 (792)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ....
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 12335789999999999999999999999999999999999999864331100 0 0000
Q ss_pred ------hhhhcc-cCcccccccc-----ccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 689 ------AWDLWK-DDRVHDLIDP-----VIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 689 ------~~~~~~-~~~~~~~~~~-----~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...... ......+..+ .+. ...........+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000 0000000000 000 001111234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=300.86 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=198.6
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
++|++.+.||+|+||.||++.. .++.||+|+++... ..+.+.+|+.++.+++|+|++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688999999999999999975 67889999986532 346789999999999999999999998765 4799999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999985432 335889999999999999999999998 9999999999999999999999999998643221
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||........ ....... . ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~---------~-~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV------KECVEKG---------Y-RM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHHhCC---------C-CC
Confidence 11234568999999999999999999999999999998 8888864332110 0011100 0 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
......+..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.14 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=195.7
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||.||+++.+. ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478999999999999999998764 678999998542 2233456888999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998432 345899999999999999999999998 999999999999999999999999999765332
Q ss_pred ccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ... .........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--~~~---~i~~~~~~~-- 227 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYG---KIMNHKERF-- 227 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--HHH---HHhCCCccc--
Confidence 21 1122357899999999986 3468899999999999999999999986432111 000 000000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAA--DRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~evl~~ 743 (792)
.+ .........++.+++.+|+..++. .|+++.|++++
T Consensus 228 ---~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000112345678888888755443 46899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.47 Aligned_cols=265 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999875 57899999986432 33345678899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
++ ++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5787776432 345889999999999999999999998 99999999999999999999999999976533221
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cc--------cchhhhccc-Cc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LL--------GHAWDLWKD-DR 697 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~--------~~~~~~~~~-~~ 697 (792)
......+++.|+|||.+.+. .++.++||||||+++|||++|++||......... .. ...+..+.. ..
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 11223568899999998754 5789999999999999999999998654321110 00 000000000 00
Q ss_pred ccccccccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.... ..........+.+++.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000000 00011124467899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=335.22 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=198.0
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 543 (792)
..++|+++++||+|+||.||+++... ++.||+|.+... .......|..|+.++.+++|||||+++++|.+. ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 35789999999999999999998754 678899988643 334567789999999999999999999988653 5689
Q ss_pred EEEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCC----CceeecCCCCCcEEEcCC---------
Q 003843 544 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSR----FRIIHRDLKASNILLDKD--------- 609 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~ivH~Dlkp~NILl~~~--------- 609 (792)
+||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999885432 23569999999999999999999998541 249999999999999642
Q ss_pred --------CCeeecccccceecCCCccccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 610 --------MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 610 --------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998764332 1233578999999999864 458999999999999999999999986432
Q ss_pred ccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
... .++ ...... +.+. ......++.+||..||+.+|.+||++.|++.
T Consensus 248 ~~~-qli----~~lk~~-------p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS-QLI----SELKRG-------PDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH-HHH----HHHhcC-------CCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 000 000000 0000 0112457889999999999999999999984
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.84 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=200.7
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee-cCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E 547 (792)
+|++.+.||+|++|.||+++.. +++.||+|++... .....+.+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4889999999999999999875 4788999998643 23455678999999999999999999998764 446789999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++... ....+++.++..++.+++.|+++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888542 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.......+++.|+|||++.+..++.++||||||++++||++|+.|+...+.... .. ....+. +
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-----~~-~~~~~~--------~- 219 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-----VY-RIIEGK--------L- 219 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HH-HHHhcC--------C-
Confidence 122335688999999999999999999999999999999999999863321110 00 000000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+|++.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.30 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=196.6
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 539 (792)
..++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999864 5788999999653 234456788999999999999999999987543
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++||||+++ +|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999976 5555542 23788899999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc------
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW------ 693 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~------ 693 (792)
++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ........
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHH
Confidence 98654322 12334689999999999999999999999999999999999999965432110 00000000
Q ss_pred -------------cc-Cc-----cccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 -------------KD-DR-----VHDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 -------------~~-~~-----~~~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. .. ..++...... ...........+.+++.+||+.||.+|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00 0000000000 000111123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.51 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=203.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++|+||+++++.+..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999886 58899999987653 34557789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999885432 568899999999999999999999 77 9999999999999999999999999987653221
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ....++..|+|||.+.+..++.++||||||+++++|++|+.|+............... . .....
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~--------~~~~~-- 220 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ-Y--------IVNEP-- 220 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-H--------HhcCC--
Confidence 1 1156788999999999999999999999999999999999998654321111111000 0 00000
Q ss_pred cCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLP-MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....... ...++.+++.+||+.+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0011111 45578899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=315.96 Aligned_cols=260 Identities=26% Similarity=0.329 Sum_probs=194.7
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeec------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 539 (792)
..++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 57899999986532 23345678999999999999999999988643
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++++|++ +++|..++ +...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999987 77887776 2345899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh------
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL------ 692 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~------ 692 (792)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+... ........
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSP 237 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9875432 233568999999999877 578999999999999999999999986432110 00000000
Q ss_pred -----cccCcccccccc--ccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 -----WKDDRVHDLIDP--VIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 -----~~~~~~~~~~~~--~l~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+.. ...... ........+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 000000 000112357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.47 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=197.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--Cee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 542 (792)
++|++.+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999875 4889999987532 123456789999999999999999999988764 467
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
+++|||+++++|.+++.. ...+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999988843 245788999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~------------~~ 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF------------KI 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH------------HH
Confidence 5432111 122334688899999999988999999999999999999999999863321100 00 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... .....+......+.+++.+|+. +|++||+++|++++
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred hcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000 0112233345577888999985 99999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.79 Aligned_cols=266 Identities=23% Similarity=0.329 Sum_probs=202.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.++||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999876 4789999988643 23345788999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++++.+..++. +...+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887766552 2345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccch--------hhhcc-cC
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHA--------WDLWK-DD 696 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~--------~~~~~-~~ 696 (792)
. .......++..|+|||++.+. .++.++||||||+++|||++|++||......... ..... ...+. ..
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678899999999888 8899999999999999999999988643221100 00000 00000 00
Q ss_pred -----ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 -----RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 -----~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+..+..............++.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000000111122235788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.37 Aligned_cols=265 Identities=22% Similarity=0.335 Sum_probs=199.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.++||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++|+||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999986 48899999885432 2235678899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|..+.. ....+++.++..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999987753 2334899999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc--cccc-------chhhhcccCc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLG-------HAWDLWKDDR 697 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~--~~~~-------~~~~~~~~~~ 697 (792)
.......++..|+|||++.+ ..++.++||||||++++||++|++|+........ .... ..........
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 12223467889999999875 4578899999999999999999988864331100 0000 0000000000
Q ss_pred c-cccccccccc----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 V-HDLIDPVIMQ----DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~-~~~~~~~l~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. .....+.... ..........+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000 00011235678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.57 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=206.0
Q ss_pred hcCccccceecccCceeEEEEEEcCCc-EEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.+.|+|+..||.|+||.||+|..++.. ..|.|.+.......+++|.-|++||....||+||++++.|..++.++++.||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 456788899999999999999877543 4577888877888899999999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
|.||-.+.++... ...|.+.++..+.+|++.||.|||++. |||||||+.|||++.+|.++|+|||.+.......
T Consensus 111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~- 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR- 184 (1187)
T ss_pred cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHH-
Confidence 9999998887443 456999999999999999999999998 9999999999999999999999999987643221
Q ss_pred ccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.....+.|||+|||||+.. ..+|+.++||||||+.|.||..+.+|....++ +... ..+-.
T Consensus 185 -qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVl---------lKiaK 249 (1187)
T KOG0579|consen 185 -QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVL---------LKIAK 249 (1187)
T ss_pred -hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHH---------HHHhh
Confidence 2234578999999999874 56899999999999999999999988642221 1100 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+..+.---+......+.+++.+||..||..||++++++++
T Consensus 250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111111233456788999999999999999999998765
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.22 Aligned_cols=197 Identities=27% Similarity=0.435 Sum_probs=159.8
Q ss_pred ceecccCceeEEEEEEcC---CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 5689999986542 23567899999999999999999999854 4578999999875
Q ss_pred Cccceeeecc------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE----cCCCCeeecccccce
Q 003843 552 KSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 621 (792)
Q Consensus 552 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kL~DFGla~ 621 (792)
+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555554211 12235889999999999999999999998 9999999999999 566789999999998
Q ss_pred ecCCCccc-cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 622 MFGGDELQ-GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 622 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
.+...... .......+|+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76543221 122345789999999998764 58999999999999999999999986433
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=303.11 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=204.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++|||++++++++......++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 468999999999999999999864 5789999998765555567889999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999883 235789999999999999999999998 99999999999999999999999999876643322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||.+....++.++||||||+++|||++|+.||........... ....+. + .
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-----~~~~~~------~---~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNGT------P---E 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-----hhcCCC------C---C
Confidence 12234688899999999988899999999999999999999999864332111000 000000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112234568899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.74 Aligned_cols=262 Identities=25% Similarity=0.354 Sum_probs=202.7
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
...++..+.++|++.+.||+|+||.||++... +++.+|+|.+.... ...+.+.+|+.++.++ +|+|++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455566889999999999999999999874 58899999986532 2345678899999999 899999999998754
Q ss_pred -----CeeEEEEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 540 -----GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 540 -----~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
...++|+||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3589999999999999887532 23346899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCC-----CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 688 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~ 688 (792)
|+|||++......... .....++..|+|||.+... .++.++|||||||++|||++|+.|+........ ..
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~-- 243 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LF-- 243 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HH--
Confidence 9999999876433221 1224678899999998643 368999999999999999999999864322110 00
Q ss_pred hhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 689 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. .......+. ........+.+++.+||+.+|++||++.|++++
T Consensus 244 --~~-~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 --KI-PRNPPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HH-hcCCCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 000000000 111233468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.47 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=198.7
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-----hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+|++.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999875 588999999965432 2345677899999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999884322 36899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc--------c-c
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW--------K-D 695 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~--------~-~ 695 (792)
... ......+++.|+|||.+.+ ..++.++||||||++++||++|.+++....... ......... . .
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhc
Confidence 321 1122346788999998865 467899999999999999999977765433211 000000000 0 0
Q ss_pred Ccccccccccc----ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 696 DRVHDLIDPVI----MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 696 ~~~~~~~~~~l----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........... ...........++.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0001112235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=301.45 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=200.7
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 540 (792)
++++|++.+.||+|++|.||+|+.. +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4689999999999999999999975 578899999865433 447799999999999 6999999999997654
Q ss_pred eeEEEEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875432 2456899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
+....... .......++..|+|||.+.. ..++.++||||||++++||++|+.||........ . .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~----~---- 228 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-L----F---- 228 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-H----H----
Confidence 98654322 11223468899999998753 3467899999999999999999999863221110 0 0
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
++................++.+++.+||..||++|||+.++++
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -----KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000000011111224567889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=306.02 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=201.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+.|.....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34444578999999999999875 58899999987665566778999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 9999988873 235889999999999999999999998 9999999999999999999999999997654322
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ... .. ...+...+
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~----~~-----~~~~~~~~--- 238 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMR----RI-----RDNLPPRV--- 238 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HH-----HhcCCCcc---
Confidence 12233568899999999998899999999999999999999999986422111 000 00 00111111
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+.+++.+|++.+|.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0111234467889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=300.27 Aligned_cols=255 Identities=27% Similarity=0.391 Sum_probs=199.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC----------chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG 540 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 540 (792)
+|.+.+.||.|+||.||+|... +++.||+|.++... ....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4777899999999999999864 58899999875321 112356888999999999999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988432 56899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCC--CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
+...............++..|+|||.+.... ++.++||||||++++||++|..|+....... ....... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~ 229 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMFKLGN-KRS 229 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHHHhhc-ccc
Confidence 8654322222223346788999999987755 8899999999999999999999985322110 0000000 000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+. ..........+.+++.+||+.+|.+||++.+|+++
T Consensus 230 ~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCC-----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111 11112235678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.50 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=200.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999875 47889999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++.. .+.+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999998742110
Q ss_pred cc-------------ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 627 EL-------------QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 627 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||....... ... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~----~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFG----QV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HH
Confidence 00 001112357889999999999899999999999999999999999985322111 100 00
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.... ...+ .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~~~---~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISDD---IEWP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhcc---cCCC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0000 0000 0011234567899999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=297.52 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=206.6
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||+|++|.||+++... ++.|++|++..... ...+.+.+|+..+.+++|+|++++++++..+...++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999998864 89999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998432 568999999999999999999999 88 9999999999999999999999999998765433
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... .. ....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~----~~--------~~~~- 219 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ----AI--------CDGP- 219 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----HH--------hcCC-
Confidence 22 123567889999999999999999999999999999999999986543211 00100 00 0000
Q ss_pred ccCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLP-MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....... ....+.+++.+||+.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111222 45678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=310.44 Aligned_cols=240 Identities=23% Similarity=0.278 Sum_probs=185.7
Q ss_pred ecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc---CCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
||+|+||+||+|+.. +++.||||++.... ......+..|..++... +||||+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 58899999986432 22233455666777665 699999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988873 3456899999999999999999999998 9999999999999999999999999997543221 12
Q ss_pred cceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCC
Q 003843 632 TKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i~~~~------~~~~~-- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNIAFGK------VRFPK-- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHHHcCC------CCCCC--
Confidence 2345799999999998765 489999999999999999999999864322110 00000000 00101
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRP----TMSDVIS 742 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RP----s~~evl~ 742 (792)
......+.+++.+||+.+|.+|| ++.++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11235678999999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=298.46 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=201.5
Q ss_pred CccccceecccCceeEEEEEE-cCCcEEEEEEecccC------chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
+|+..+.||+|++|.||+|+. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 468899999986432 2245788999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-Ceeecccccceec
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 623 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~ 623 (792)
|+||+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998843 346889999999999999999999998 99999999999998876 5999999999876
Q ss_pred CCCccc--cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 624 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 624 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... .......++..|+|||.+.+..++.++||||||+++++|++|+.|+.......... .. .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~---------~~~ 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA--LI---------FKI 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH--HH---------HHH
Confidence 543211 11223567899999999998899999999999999999999999986432211000 00 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
... ......+.....++.+++.+|++.+|.+||++.++++
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASA-TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hcc-CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 0011223344567889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.54 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=199.0
Q ss_pred cccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 474 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++|||++++++++..+...++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999875 58899999986655555677899999999999999999999999999999999999999
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (792)
+|..++. ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..... ..
T Consensus 104 ~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 104 ALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred CHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 9988762 345899999999999999999999998 99999999999999999999999999976543321 12
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 712 (792)
....++..|+|||++.+..++.++||||||++++||++|+.||....... ... ...... .... ...
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~----~~~~~~-----~~~~---~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK----RLRDSP-----PPKL---KNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHhccC-----CCCc---ccc
Confidence 33568899999999999999999999999999999999999986432211 000 000000 0000 001
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 713 LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 713 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1223467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.77 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=201.4
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 688999999876544 3678899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++.. ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998843 345889999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccc--cceeecccceeCcccccCCC---CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGN--TKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
... .....++..|+|||++.+.. ++.++||||||++++||++|+.||........ . ...... . ..
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~---~~~~~~-~-----~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-I---MFHVGA-G-----HK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-H---HHHHhc-C-----CC
Confidence 111 12346788999999998776 89999999999999999999999864321110 0 000000 0 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
+.+ +........+.+++.+||+.+|.+||++.+++.
T Consensus 225 ~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPI---PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC---CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 001112456789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.35 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=202.2
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.+|+++.. +++.||+|.+... .....+++.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999864 5889999998643 334556889999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887432 2235789999999999999999999998 99999999999999999999999999987644321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......|++.|+|||.+.+..++.++||||||++++||++|+.|+........ .. .++... .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-----~~---------~~~~~~--~ 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-----VL---------KIIRGS--Y 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-----HH---------HHhcCC--C
Confidence 12234578899999999999999999999999999999999999864321110 00 000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........++.+++.+||+.+|.+||++.+|+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122335578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=303.10 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=200.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999875 58899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999988843 356899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....... ..... ...
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~--------~~~-- 213 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKI--------LEG-- 213 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH--------hcC--
Confidence 233468899999999998889999999999999999999999986433110 00000 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
....+......+.+++.+||+.+|.+|| +++|++++
T Consensus 214 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0111222346788999999999999999 66776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=303.80 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=195.4
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.||+|+.. +|+.||+|+++... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 58899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++ +|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 66666532 2345899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC------ccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD------RVHDL 701 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 701 (792)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+......... ........... .....
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChHHhHHhhhc
Confidence 12224568899999998765 4789999999999999999999886432221100 00000000000 00000
Q ss_pred cc--------cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 ID--------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~--------~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+ ..............++.+++.+||+.||.+|||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 0000001112234678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=299.30 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=206.7
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
...+.|+.-++||+|+||.||-.+.. +|+.+|.|++.+. ..++..-..+|..+|.+++.+.||.+-..|+..+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567888899999999999998764 5899999988542 2344456788999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|+..|.||+|.-+|++... ..++++.+..++.+|+.||++||... ||.|||||+|||||+.|+++|+|.|||..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999987644 57999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
...+. ....+||.+|||||++.+..|+...|.|||||+||||+.|+.||....+ ....+-+|
T Consensus 338 ~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke---------------Kvk~eEvd 399 (591)
T KOG0986|consen 338 PEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE---------------KVKREEVD 399 (591)
T ss_pred CCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh---------------hhhHHHHH
Confidence 66543 2234899999999999999999999999999999999999999864322 11112222
Q ss_pred cccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003843 704 PVIM--QDEISLPMLMRYINVALLCVQENAADRPTM 737 (792)
Q Consensus 704 ~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 737 (792)
.... ...++...++++.+|....|+.||++|..-
T Consensus 400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2221 224455667788999999999999999743
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.52 Aligned_cols=263 Identities=24% Similarity=0.350 Sum_probs=200.9
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788999999999999999875 58899999986543 34457899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998875432 56899999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh--------ccc-C--
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL--------WKD-D-- 696 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~-~-- 696 (792)
.......++..|+|||.+.+. .++.++||||||++++||++|.+++....... ........ +.. .
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE--QLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH--HHHHHHHHcCCCChHHHhhccCc
Confidence 112234688999999998754 46899999999999999999987775432211 00000000 000 0
Q ss_pred -cccccccccc---ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 -RVHDLIDPVI---MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 -~~~~~~~~~l---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+..+.. .-..........+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0000111234688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.38 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=195.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999876 578999999865332 2234577899999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+.+ +|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877432 236889999999999999999999998 99999999999999999999999999875432211
Q ss_pred ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc---Cc-------
Q 003843 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD---DR------- 697 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~------- 697 (792)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ......+..... ..
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1112246789999999876 458999999999999999999999986433110 000000000000 00
Q ss_pred --cc----cccc-cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 698 --VH----DLID-PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 698 --~~----~~~~-~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.. .... ..+............+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000 000000001111257789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=297.96 Aligned_cols=248 Identities=23% Similarity=0.420 Sum_probs=199.3
Q ss_pred CccccceecccCceeEEEEEE-cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcC---CCCcceEeeeeeecCeeEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 546 (792)
.|++.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999986 46889999998654 3445677889999999996 999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988732 36899999999999999999999998 999999999999999999999999999877543
Q ss_pred ccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||........ .. . ......+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~----~-----~~~~~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MM----L-----IPKSKPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hh----c-----cccCCCCC
Confidence 31 12234688899999998754 578999999999999999999999864322110 00 0 00000011
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+... ....++.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN----GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1010 134578899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.37 Aligned_cols=265 Identities=25% Similarity=0.267 Sum_probs=196.0
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999864 58899999986543 233346788999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 566555532 2245788889999999999999999998 999999999999999999999999999764322
Q ss_pred ccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc----------
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD---------- 695 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 695 (792)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||........ .+...+.....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhh
Confidence 11 11223568899999998764 578999999999999999999999864432111 11110000000
Q ss_pred --Ccc-ccccc----cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 696 --DRV-HDLID----PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 696 --~~~-~~~~~----~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
... ..... ..+............+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000 000000000112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.54 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=201.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 546 (792)
++|+..+.||.|++|.||++.+. +++.+|+|.+.... .....++.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999985 57889999986543 34557789999999999999999999998654 4689999
Q ss_pred EecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+++++|.+++... .....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998887432 23455889999999999999999999998 99999999999999999999999999876532
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............. ........... +...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNPE-LKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCchh-hccC
Confidence 21 123457889999999999999999999999999999999999987543211100000 00000000000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.+|.+|||+.|++++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 01112235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.41 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=201.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999874 5788999998643 334567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-CeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++... ....+++..+..++.+++++|+|||+.+ ++|+||+|+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345899999999999999999999998 99999999999998654 57999999998764432
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...+.... ... .....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~----~~~~~---------- 217 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLK----IMSGT---------- 217 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHH----HHhcC----------
Confidence 12234678899999999998899999999999999999999999864332111 000 00000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...........+.+++.+||+.+|.+|||+.|++++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 011122234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.17 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=201.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+-|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++.+++|+||+++++++.++...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34777899999999999999864 57899999886432 34456789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998873 345899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......++..|+|||.+.+..++.++||||||+++|||++|..|+........ .. ...... .
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~~----------~ 218 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV--LF----LIPKNN----------P 218 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH--HH----HHhcCC----------C
Confidence 12234678899999999988999999999999999999999999864321100 00 000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+|++.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11122234568899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.44 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=201.7
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCeeEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKILIL 546 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 546 (792)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 5788999988643 34456678899999999999999999998764 45679999
Q ss_pred EecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHH-----hcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 547 EYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLH-----QYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
||+++++|.+++.... ....+++..++.++.||+.||+||| +.+ ++|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999985432 2456899999999999999999999 665 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
......... .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+....... .. .......
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~~~--- 226 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LA----SKIKEGK--- 226 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HH----HHHhcCC---
Confidence 877543321 223468899999999999999999999999999999999999987533111 10 0111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+......+.+++.+|++.+|++||++.+|+++
T Consensus 227 -------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 -------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011222345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.09 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=201.4
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||.||++.... ++.||+|.+..... ...+.+.+|++++..++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999998764 89999999865432 24567899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999987432 3356899999999999999999999998 999999999999999999999999998765322
Q ss_pred ccc---------------------------cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 627 ELQ---------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 627 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123467889999999999999999999999999999999999986433
Q ss_pred ccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 003843 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT----MSDVIS 742 (792)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~evl~ 742 (792)
.... . ..+..... ...........+.+++.+||+.+|++||+ +.|++.
T Consensus 237 ~~~~--~------------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET--F------------SNILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH--H------------HHHhcCCc-cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 0 00111110 00111114567899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.45 Aligned_cols=268 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred CccccceecccCceeEEEEEEcC---CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKI 543 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 543 (792)
+|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999998754 7899999997632 44456788999999999999999999999988 7899
Q ss_pred EEEEecCCCccceeeeccC-C-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC----CCCeeeccc
Q 003843 544 LILEYMPNKSLNVFLFDST-K-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK----DMNPKISDF 617 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kL~DF 617 (792)
+||||+++ +|.+++.... . ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 4545443222 2 236899999999999999999999998 999999999999999 899999999
Q ss_pred ccceecCCCcc-ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-------ccc
Q 003843 618 GLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-------LGH 688 (792)
Q Consensus 618 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-------~~~ 688 (792)
|++..+..... ........++..|+|||.+.+. .++.++||||||++++||++|++||.......... +..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122335678899999988764 57899999999999999999999987544322000 000
Q ss_pred hhhhcc------------cCccccc---cc-cccccCC----CCH--HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 689 AWDLWK------------DDRVHDL---ID-PVIMQDE----ISL--PMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 689 ~~~~~~------------~~~~~~~---~~-~~l~~~~----~~~--~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+. ....... .. ....... ... ....++.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0000000 00 0000000 000 233578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.02 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=192.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHH-HhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.+.||+|+||.||+++.. +|+.||+|++.... .....++..|+.+ ++..+|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999875 58999999986542 2333455566665 556789999999999999999999999
Q ss_pred ecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 548 YMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 548 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 5777766432 2345689999999999999999999987 6 99999999999999999999999999986543
Q ss_pred CccccccceeecccceeCcccccC----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.......... ..... .
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~-~----- 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL----KQVVE-E----- 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----HHHHh-c-----
Confidence 21 1122457889999998865 456899999999999999999999986322111000 00000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
..+.+. ....+.++.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001110 1113457889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.15 Aligned_cols=247 Identities=24% Similarity=0.296 Sum_probs=201.6
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
+|++.+.||.|+||.||+++.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 58899999986532 2456789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999998833 246899999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+............ ..... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------~~~~~--~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR------------AKQET--A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH------------HHhcc--c
Confidence 122346788999999999988999999999999999999999998754422111000 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTM--SDVI 741 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~evl 741 (792)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111222234688899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.51 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=204.8
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..+.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+++++.++|+|++++++++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4677888899999999999999886 588999999976544 56778999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985432 36899999999999999999999988 9999999999999999999999999987654322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... ........
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~------~~~~~~~~-------- 234 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF------LITTKGIP-------- 234 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcCCC--------
Confidence 1 1223457889999999998899999999999999999999999986433211100 00000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...........+.+++.+|++.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 001111134578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.42 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=205.8
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILIL 546 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 546 (792)
+|++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999986 688999999865542 5578899999999999999999999999988 8899999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++... ..+++.+++.++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998432 37899999999999999999999988 999999999999999999999999999987554
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
..........++..|+|||.+.....+.++||||||+++++|++|+.|+....... ...........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~--------- 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM----AALYKIGSSGE--------- 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH----HHHHhccccCC---------
Confidence 32112233568889999999998889999999999999999999999987544111 00110000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+......+.+++.+|++.+|++||++.+++.+
T Consensus 222 -~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 222 -PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111222335678999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=290.18 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=204.5
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.|++.+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999986 588999999977655567889999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999998884322 46899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
.....++..|+|||.+....++.++||||||+++++|++|+.|+.......... ......... + .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~-----~---~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIATNGPPG-----L---R 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhcCCCC-----c---C
Confidence 234578899999999998889999999999999999999999986432111000 000000000 0 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011124578999999999999999999999764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.82 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeee-
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE- 538 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 538 (792)
.+.++..+.+.|++.+.||.|+||.||+|+.. +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34445556789999999999999999999874 57889999885533 3446788999999998 69999999999863
Q ss_pred -----cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 539 -----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 539 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
....+++|||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999988542 2345788889999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 688 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~ 688 (792)
|+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--- 236 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--- 236 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---
Confidence 99999988653221 1123356889999999986 3567889999999999999999999986432111000
Q ss_pred hhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 689 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....... ...........+.+++.+||+.+|.+||++.|+++
T Consensus 237 -----------~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -----------LIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----------hHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000 00011123457899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=297.43 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=199.6
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+|++++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3444579999999999999864 688999999876555556778999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998843 45899999999999999999999998 99999999999999999999999999876543221
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
......|++.|+|||.+.+..++.++||||||++++||++|+.|+....... ... ..... ..+.. .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--~~~----~~~~~-----~~~~~---~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--AMK----RIRDN-----LPPKL---K 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--HHH----HHHhc-----CCCCC---c
Confidence 1223468899999999999899999999999999999999999985422110 000 00000 00001 0
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11113457899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.98 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=196.6
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999875 58899999886432 23346789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5787777432 2356899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC-----------
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD----------- 696 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 696 (792)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||........ .. .........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LF-RIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HH-HHHHHhCCCChhhhhhhhHH
Confidence 112235678999999887654 58899999999999999999999864332110 00 000000000
Q ss_pred -----ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 -----RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 -----~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+ .........++.+++.+||+.||.+||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 00011223567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=304.76 Aligned_cols=263 Identities=24% Similarity=0.290 Sum_probs=197.8
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 539 (792)
..++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999875 6889999998643 334456778899999999999999999988643
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 357999999965 66666521 2888999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-c------------cc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N------------LL 686 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~------------~~ 686 (792)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... . ..
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987644321 2234678899999999999999999999999999999999999864432100 0 00
Q ss_pred ---cchhhhcc-------cCccccccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 687 ---GHAWDLWK-------DDRVHDLIDPVIM---QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 687 ---~~~~~~~~-------~~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+. .....++....+. ...........+.+++.+||+.||++||++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000111111110 000112235578899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.06 Aligned_cols=203 Identities=29% Similarity=0.450 Sum_probs=177.7
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------eeE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EKI 543 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 543 (792)
.+...+.||+|+||.||+|+++ .|+.||||.+.+. .....+...+|+++|++++|+|||+++++-.+.. ..+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3455688999999999999964 6999999999764 3345677889999999999999999999866543 578
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc--CCC--Ceeeccccc
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDM--NPKISDFGL 619 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~--~~~--~~kL~DFGl 619 (792)
+|||||.+|+|...|....+...|++.+.+.++..+..||.|||+++ |+||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999988888888999999999999999999999998 99999999999983 334 379999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~ 680 (792)
|+.+..+. ....+.||..|++||.... ..|+..+|.|||||++||.+||..||.....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99886654 4566899999999999984 8899999999999999999999999976543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=296.35 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=198.9
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+|++.++||.|++|.||+|+.. +++.||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999985 588999999865432 33467788999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777754444456899999999999999999999998 99999999999999999999999999976533211
Q ss_pred cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh--------cccCcccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL--------WKDDRVHD 700 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~ 700 (792)
......++..|++||.+.+. .++.++||||||+++|||++|+.||........ ....... +.......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCc
Confidence 11223568899999988664 578999999999999999999999864432111 0000000 00000000
Q ss_pred cccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 701 LIDPVIMQ------DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 701 ~~~~~l~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
........ ..........+.+++.+|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=298.43 Aligned_cols=248 Identities=30% Similarity=0.447 Sum_probs=196.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.+.|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|+++++.++|||++++++++.++...++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888999999999999999875 58899999886432 23446788999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 999974 55555422 2345899999999999999999999998 99999999999999999999999999976532
Q ss_pred CccccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ ....... .
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~~-~----- 230 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQN-D----- 230 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhcC-C-----
Confidence 2 2346788999999874 45688999999999999999999999854321110 0000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.+.+ ........+.+++.+||+.+|++||++.+++.+.
T Consensus 231 ~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 231 SPTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CCCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 0112345789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.45 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=208.6
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
....|.+.+.||+|.|+.|.+|++. ++.+||||.+.+.. ....+.+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567999999999999999999864 68999999997653 33345688999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+.+|.+.++|. +.+.+.+..+..++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999994 4445667888899999999999999999 99999999999999999999999999998864
Q ss_pred CccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
. ......+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+... +..+-..
T Consensus 208 ~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~------------------lk~Lr~r 266 (596)
T KOG0586|consen 208 G---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN------------------LKELRPR 266 (596)
T ss_pred c---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc------------------cccccch
Confidence 3 23455799999999999999877 589999999999999999999986321 1111111
Q ss_pred ccc-cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 705 VIM-QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 705 ~l~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.+. +-.++.....++.++++++|..+|.+|++++++.+.-
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111 1233444567889999999999999999999987653
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.41 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=197.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 545 (792)
++|++.+.||+|+||.||+|+.. +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57889999999999999999986 47899999986432 22334677899999999999999999999877 889999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+||+++ +|.+++... ...+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 887777432 236899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-c-ccc-------chhhhc--
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-N-LLG-------HAWDLW-- 693 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~-~~~-------~~~~~~-- 693 (792)
.. .......+++.|+|||.+.+. .++.++|+||||++++||++|+.||........ . ... ..|..+
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 32 112234578899999998764 468999999999999999999999864332110 0 000 000000
Q ss_pred ----ccCccccccccccccCCCCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 ----KDDRVHDLIDPVIMQDEISLP-MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ----~~~~~~~~~~~~l~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
............+ ...+... ....+.+++.+||+.+|++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000001 1111111 35567899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.65 Aligned_cols=268 Identities=22% Similarity=0.333 Sum_probs=198.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Cee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 542 (792)
+++|++.++||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999864 5889999998643 233456788999999999999999999987654 357
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++++||+++ +|..++ ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 666555 3346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc---Cc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD---DR 697 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 697 (792)
....... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+... ........... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 6432211 11233568899999998765 568999999999999999999999986432110 00000000000 00
Q ss_pred cccccc--------cccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003843 698 VHDLID--------PVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 747 (792)
Q Consensus 698 ~~~~~~--------~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 747 (792)
...+.+ ......... .....++.+++.+||+.+|++||++.|++++ ++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 000000001 1124578899999999999999999999987 5554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.38 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
+-++.-..+||.|.||.||-|... +|+-.|+|-+... .....+...+|+.++..++|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 455666789999999999999864 5888999976433 3445667889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|||++|+|.+.+. ..+..++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999983 3344566666778899999999999999 999999999999999999999999999988655
Q ss_pred c--cccccceeecccceeCcccccCCC---CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 627 E--LQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 627 ~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
. .........||+.|||||++.+.. ...++||||||||+.||+||++||..++.+- ..+-++ ..-
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-aIMy~V---------~~g 1457 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-AIMYHV---------AAG 1457 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-HHHhHH---------hcc
Confidence 2 233445678999999999998754 4578999999999999999999998655431 111110 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
- ..+++.....+-.+++.+||+.||++|.++.|++++=
T Consensus 1458 h-----~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1458 H-----KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred C-----CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 0 2233344566778999999999999999999888764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.29 Aligned_cols=265 Identities=24% Similarity=0.299 Sum_probs=195.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCe-----
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGE----- 541 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 541 (792)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999875 58899999876432 223467889999999994 6999999999987665
Q ss_pred eEEEEEecCCCccceeeeccCC--CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccc
Q 003843 542 KILILEYMPNKSLNVFLFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFG 618 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFG 618 (792)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777643322 346899999999999999999999998 999999999999998 8899999999
Q ss_pred cceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ . ...........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~-~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-L-LHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-H-HHHHHHhCCCC
Confidence 9986543211 1112356788999998865 4579999999999999999999999865332110 0 00000000000
Q ss_pred ------cccccc----ccccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 ------VHDLID----PVIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ------~~~~~~----~~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.....+ +.... .........++.+++.+||+.+|.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00000 00011234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.94 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=195.4
Q ss_pred ecccCceeEEEEEEcC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||.|++|.||+++... ++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999854 8899999986532 23456799999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345899999999999999999999998 9999999999999999999999999998765432 1223
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..++..|+|||.+....++.++|+||||+++|||++|+.|+.....+...... .+.+.. .....+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~-~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN------------DILKGN-GKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH------------HHhccC-CCCCCCcc
Confidence 46788999999998888999999999999999999999998754421111110 000000 01111222
Q ss_pred HHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003843 715 MLMRYINVALLCVQENAADRPT-----MSDVIS 742 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs-----~~evl~ 742 (792)
...++.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2567899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.03 Aligned_cols=242 Identities=24% Similarity=0.305 Sum_probs=186.9
Q ss_pred eecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhh---cCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAK---LQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.||+|+||.||+++.. +++.+|+|.+.... ......+.+|..++.. .+|+|++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 58899999886432 1222334455444433 479999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++. ..+.+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999988873 3346999999999999999999999998 9999999999999999999999999997654322
Q ss_pred ccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....|+..|+|||.+.. ..++.++|||||||++|||++|+.||.............. .... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------~~~~-----~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------TLTV-----NV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---------hhcC-----Cc
Confidence 122468999999999874 5689999999999999999999999864332111110000 0000 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 710 EISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
..+.....++.+++.+||+.||.+|| +++|++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12223456788999999999999999 59988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.88 Aligned_cols=260 Identities=17% Similarity=0.219 Sum_probs=182.9
Q ss_pred hcCccccceecccCceeEEEEEEcCC----cEEEEEEecccCchhH-----------HHHHHHHHHHhhcCCCCcceEee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVRLLG 534 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~ 534 (792)
.++|++.++||+|+||.||+|+..++ ..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 57899999999999999999987543 4566665432221110 11223344556678999999999
Q ss_pred eeeecC----eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC
Q 003843 535 CCVEQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (792)
Q Consensus 535 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 610 (792)
++.... ..++++|++.. ++.+.+. .....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876543 33566776533 3444432 1223578888999999999999999998 99999999999999999
Q ss_pred CeeecccccceecCCCcc-----ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc
Q 003843 611 NPKISDFGLARMFGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 685 (792)
Q Consensus 611 ~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~ 685 (792)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||+++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 111223469999999999999999999999999999999999999997543221110
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.....+. ...+....+ ........+.+++..|++.+|++||++.++++.|+
T Consensus 244 ~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDF-----IKRLHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHH-----HHHhhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000000 011111111 01112467889999999999999999999998763
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=294.52 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=196.1
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
|++.++||.|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.++...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567899999999999999875 68999999986442 233467889999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68888874322 235899999999999999999999998 99999999999999999999999999976543211
Q ss_pred cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc--ccccc-------hhhhc-ccCcc
Q 003843 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGH-------AWDLW-KDDRV 698 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~--~~~~~-------~~~~~-~~~~~ 698 (792)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..... .+... .....
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999988764 578999999999999999999999864432110 00000 00000 00000
Q ss_pred cccccccc--ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVI--MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+.... ............+.+++.+|++.+|++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000 0000111233578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=290.60 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=200.2
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999875 4789999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC-eeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988542 2235799999999999999999999998 999999999999998865 6999999998764332
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......|++.|+|||.+.+..++.++||||||++++||++|+.|+....... ...... ... +
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~-~~~----~----- 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKIC-QGY----F----- 219 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHh-ccc----C-----
Confidence 1 1223468889999999998899999999999999999999999986432111 000000 000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+|++.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112234578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.17 Aligned_cols=246 Identities=27% Similarity=0.399 Sum_probs=194.2
Q ss_pred cccceecccCceeEEEEEEc-CCcEEEEEEec----ccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe--eEEEE
Q 003843 474 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE--KILIL 546 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 546 (792)
+...+||+|+|-+||||.+. +|.+||--.++ ...+...++|..|+.+|+.|+|+||++++.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34478999999999999764 46677654332 1245667899999999999999999999999987654 78999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla~~~~~ 625 (792)
|.+..|+|..|+.+ .+.++.+.+..+++||++||.|||++. ++|||||||-+||+|+.+ |.+||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999844 455888999999999999999999985 689999999999999766 8999999999998654
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. ...+.|||.|||||+.. ..|+...||||||+.++||+|+..|+....... ..+.....+
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-----QIYKKV~SG--------- 259 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-----QIYKKVTSG--------- 259 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-----HHHHHHHcC---------
Confidence 32 33479999999999777 889999999999999999999999986432211 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+....+..-...++.+||.+|+.. .++|||+.|++..
T Consensus 260 iKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 260 IKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111111112234678999999998 9999999999864
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=297.78 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=195.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 544 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 58899999986432 22234567899999999999999999998765 46899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+.+ +|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 677776432 246899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc--Cccc--
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD--DRVH-- 699 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~-- 699 (792)
.... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......... ....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChhhchh
Confidence 3321 1122345788999999875 5679999999999999999999999864332111 0000000000 0000
Q ss_pred ----ccccc-ccccCCC------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 ----DLIDP-VIMQDEI------SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ----~~~~~-~l~~~~~------~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... .+..... .......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0000000 01124567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.78 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=193.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
-++|++.++||+|+||.||+|+.. +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999875 58899999885432 223345678999999999999999999987654
Q ss_pred --eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 541 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 541 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
..++||||+.+ +|.+++.. ....+++.++..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 35999999975 66666532 2235899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccc--cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhh---
Q 003843 619 LARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWD--- 691 (792)
Q Consensus 619 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~--- 691 (792)
++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ ..+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876433211 112234578899999988765 478999999999999999999998864432110 00000000
Q ss_pred --hcccCccccccccc-cccCC-------C-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 --LWKDDRVHDLIDPV-IMQDE-------I-SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 --~~~~~~~~~~~~~~-l~~~~-------~-~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+......+..+.. ..... . .......+.+++.+||+.+|.+||+++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000000000 00000 0 00123456789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.80 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=205.1
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|+||.||++... +++.+++|++.... ....+.+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999875 58899999986543 25567789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885432 2366899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.......+++.|+|||.+....++.++||||+|+++++|++|+.|+....... ... ......
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~----~~~~~~---------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LAL----KILKGQ---------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHH----HHhcCC----------
Confidence 12233568889999999999999999999999999999999999986433111 000 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011112334578899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.06 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=197.4
Q ss_pred cceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 476 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
..+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+|++++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 368999999999999874 6889999998665555667899999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 88763 235789999999999999999999998 99999999999999999999999999876543221 1233
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||........ ... .. ..+...+ .....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~~~----~~-----~~~~~~~---~~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--MKM----IR-----DNLPPKL---KNLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HH-----hhCCccc---CCccc
Confidence 4678999999999888899999999999999999999999864221110 000 00 0000111 00111
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 23467889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=288.76 Aligned_cols=251 Identities=27% Similarity=0.376 Sum_probs=198.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--Cee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 542 (792)
.+|++.+.||+|+||.||+|+.. +++.||+|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999874 5889999987432 234456889999999999999999999998764 467
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++++||+++++|.+++. +...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999988873 2345889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.||....... .. .+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~------------~~~ 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AI------------FKI 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HH------------HHH
Confidence 5332111 11223468899999999999889999999999999999999999986422110 00 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... .....+......+.+++.+|++ +|..||+..+++.+
T Consensus 222 ~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0000 0112233445678999999998 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.84 Aligned_cols=262 Identities=26% Similarity=0.369 Sum_probs=197.9
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEEEEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILILE 547 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 547 (792)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667899999999999999876 47899999997653 34456788999999999999999999999988 89999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++ +|.+++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 787777432 246899999999999999999999998 9999999999999999999999999998775432
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc---cC---cccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK---DD---RVHD 700 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~---~~~~ 700 (792)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ......... .. ...+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhcccccc
Confidence 1 11222356788999998765 4679999999999999999999999865442111 000000000 00 0000
Q ss_pred c-----ccccc-----ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 L-----IDPVI-----MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~-----~~~~l-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+ ..... ........+...+.+++.+||+.+|.+||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000 0000111125678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=280.42 Aligned_cols=248 Identities=24% Similarity=0.307 Sum_probs=202.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|..+++||+|.||.|.+.+.+ .++.+|+|++++.. ......-..|-++|+..+||.+..+-..|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 578899999999999999999875 58899999998753 23334456788999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||..||.|.-+| .+.+.+++.....+-..|..||.|||+++ ||.||||.+|.|+|.+|++||+||||++.--
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 9999999998887 45667899988899999999999999998 9999999999999999999999999998521
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.....++.++|||.|+|||++....|..+.|.|.+||++|||++|+.||...+.+.. .+++-..
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---------------FeLIl~e 383 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---------------FELILME 383 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---------------HHHHHhh
Confidence 223456678999999999999999999999999999999999999999864332211 1111000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 742 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~ 742 (792)
.-.++.....+...|+...|..||++|. .+.||.+
T Consensus 384 --d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 384 --DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred --hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1122333445677888899999999996 4555544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=285.13 Aligned_cols=247 Identities=30% Similarity=0.421 Sum_probs=202.6
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++.+++|+|++++++++.++...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999875 578999999976543 4567899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998843 356899999999999999999999998 99999999999999999999999999987754332
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
. .....++..|+|||.+.+..++.++||||||+++++|++|+.|+........ .+... .. . .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~-~~-~---------~ 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIV-QD-D---------H 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHh-cc-C---------C
Confidence 1 2234678899999999888899999999999999999999999864321100 00000 00 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112223457889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=288.77 Aligned_cols=249 Identities=27% Similarity=0.382 Sum_probs=203.9
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|++.++||+|+||.||+++.. +++.+|+|.+... ......++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999765 5789999998653 334456788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885422 2356899999999999999999999998 9999999999999999999999999998765441
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.....+++.|+|||.+.+..++.++|+||||++++||++|+.|+...+..... . ......
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~--~----~~~~~~---------- 217 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR--Y----KVQRGK---------- 217 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHhcCC----------
Confidence 22245788999999999999999999999999999999999998643321110 0 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........++.+++.+|++.+|++||++.+++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 112223455678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.31 Aligned_cols=263 Identities=23% Similarity=0.286 Sum_probs=193.5
Q ss_pred cceeccc--CceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 476 QCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 476 ~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.+.||+| +||+||+++.. .++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3567777 99999999875 6899999998643 33445788999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999998885432 234889999999999999999999998 9999999999999999999999998654332111100
Q ss_pred -----ccceeecccceeCcccccCC--CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh------------
Q 003843 631 -----NTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD------------ 691 (792)
Q Consensus 631 -----~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~------------ 691 (792)
......++..|+|||++.+. .++.++|||||||++|||++|+.||................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01112345679999999764 47899999999999999999999986543211100000000
Q ss_pred ---hccc-----------Ccc-----ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 ---LWKD-----------DRV-----HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ---~~~~-----------~~~-----~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.. ... ..+....+ ..+........+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 000 00000111 112233456788999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.14 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=194.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|+..++||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 35666789999999999999875 47899999986532 345567899999999996 9999999999999999999999
Q ss_pred ecCCCccceeeec--cCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|+.. +|.++... ......+++..+..++.+++.||+|||+. + ++||||||+||+++.++.+||+|||+++.+.
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9864 44332211 12235689999999999999999999975 6 9999999999999999999999999997654
Q ss_pred CCccccccceeecccceeCcccccCC---CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ......... .
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~----- 226 (288)
T cd06616 160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVVK-G----- 226 (288)
T ss_pred cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhcC-C-----
Confidence 3221 1223578899999999876 6899999999999999999999998643310 000000000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.+ ..........++.+++.+||+.+|++||++.+|+++
T Consensus 227 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPIL-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcC-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 111112345678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=290.67 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=197.2
Q ss_pred ecccCceeEEEEEEcC-CcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||.|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 89999999865433 4567789999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc------
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL------ 628 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~------ 628 (792)
.+++... +.+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988432 36899999999999999999999998 99999999999999999999999999886533211
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
........++..|+|||.+.....+.++||||||++++||++|+.||........ .. ....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~----~~~~~~~---------~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI--FQ----NILNGKI---------E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHhcCCc---------C
Confidence 1122334678899999999988899999999999999999999999864432211 00 0000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+........+.+++.+|++.+|.+||++.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00011124678899999999999999999777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.10 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=199.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 542 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 58899999986542 2345678889999999999999999998763 3468
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|+||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 57877773 3345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc--cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------hh
Q 003843 623 FGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AW 690 (792)
Q Consensus 623 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~~ 690 (792)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 6433211 11223468889999999865 4689999999999999999999999864332110 00000 00
Q ss_pred hhcccCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 691 DLWKDDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.........+.++......... .....++.+++.+||+.+|++||++++++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 0000011111111100011111 12356789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=294.70 Aligned_cols=250 Identities=30% Similarity=0.417 Sum_probs=196.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
+.|+..+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++|+|++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34777899999999999999865 5889999998643 2334567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++ +|.+++.. ....+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 66666532 2345899999999999999999999998 999999999999999999999999998754322
Q ss_pred ccccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
....+++.|+|||++. ...++.++||||||+++|||++|+.|+........ .. . +..
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~--------~~~ 238 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY----H--------IAQ 238 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HH----H--------HHh
Confidence 2346788999999974 45789999999999999999999999754321110 00 0 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
... ...........+.+++.+||+.+|.+||++.++++++-..
T Consensus 239 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 239 NES-PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred ccC-CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 000 0011122345688999999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.10 Aligned_cols=268 Identities=21% Similarity=0.315 Sum_probs=198.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Ce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 541 (792)
.++|.+.+.||+|+||.||+|+.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999864 5889999998653 233456678899999999999999999988654 35
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 57777763 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------hhh
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWD 691 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~~~ 691 (792)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+.... ..... .+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764332 11223467889999998865 4689999999999999999999999864321100 00000 000
Q ss_pred hcccCcccccccccccc-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 003843 692 LWKDDRVHDLIDPVIMQ-----DEISLPMLMRYINVALLCVQENAADRPTMSDVISM--INN 746 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~ 746 (792)
..........+...... .........++.+++.+||+.+|++||++++++++ +..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000000000000000 00111235678899999999999999999999987 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=299.02 Aligned_cols=266 Identities=25% Similarity=0.332 Sum_probs=197.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec--CeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ--GEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 543 (792)
.++|++.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 578999999999999999999875 5789999988542 233456678899999999 999999999998653 3689
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 488777632 26889999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc---cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccch--------h
Q 003843 624 GGDELQ---GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------W 690 (792)
Q Consensus 624 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~--------~ 690 (792)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 443221 12234568899999998765 5678999999999999999999999864332110 000000 0
Q ss_pred hhcccCccccccccccccC-----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 691 DLWKDDRVHDLIDPVIMQD-----EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.......+++...... ........++.+++.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000001111000000 0011134578999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=286.56 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=190.9
Q ss_pred HHHHhcCcccccee--cccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCe
Q 003843 466 ITAATENFSMQCKL--GEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 466 i~~~~~~y~~~~~L--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 541 (792)
+....++|++.+.+ |+|+||.||+++.+ +++.+|+|.+........ |+.....+ +|+|++++++.+..++.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677787777 99999999999864 578899999865322111 22222222 79999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-Ceeecccccc
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLA 620 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla 620 (792)
.++||||+++++|.+++.. ...+++.++..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999843 237899999999999999999999998 99999999999999998 9999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
+...... ...++..|+|||++.+..++.++||||||+++|||++|+.||.....+.........
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 221 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK---------- 221 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH----------
Confidence 8654321 235788999999999999999999999999999999999998743322211111000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVIS 742 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~ 742 (792)
.... ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus 222 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 RQQK---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhcc---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 01111234567899999999999999995 688874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=289.11 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=191.7
Q ss_pred ecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||+|+||+||++... +++.||+|.+.... ....+.+.+|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999764 58899999986432 22345678899999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 988854322 36899999999999999999999998 9999999999999999999999999998654321 1223
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..++..|+|||.+.+..++.++||||||+++++|++|+.||.......... ..... .... ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~----~~~~---~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE------ELKRR----TLEM---AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH------HHHhc----cccc---cccCCcc
Confidence 457889999999998889999999999999999999999986433211000 00000 0000 1111222
Q ss_pred HHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003843 715 MLMRYINVALLCVQENAADRP-----TMSDVIS 742 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RP-----s~~evl~ 742 (792)
....+.+++.+||+.+|.+|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 355788999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=291.97 Aligned_cols=264 Identities=24% Similarity=0.314 Sum_probs=194.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.+.||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 58899999886432 2344678899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCCC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGD 626 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~ 626 (792)
|+++ +|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 666665322 2223678888899999999999999998 999999999999985 557999999999865432
Q ss_pred ccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC--c------
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD--R------ 697 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~------ 697 (792)
. .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ........... .
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChhhccccc
Confidence 1 111223568899999998764 578999999999999999999999865332110 00000000000 0
Q ss_pred -ccccc--ccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 -VHDLI--DPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 -~~~~~--~~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+.... .+..... ........++.+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0000000 0011234568899999999999999999999863
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.81 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=199.0
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
|++.+.||.|++|.||+++.. +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 688999999865432 34567889999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++ +|.+++... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 777766332 246899999999999999999999998 9999999999999999999999999998775443
Q ss_pred cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc---Ccccccc---
Q 003843 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD---DRVHDLI--- 702 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--- 702 (792)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.... .......... .......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCchHhcccchhhh
Confidence 112224577899999999877 789999999999999999999998864332110 0000000000 0000000
Q ss_pred --------cccc-ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 703 --------DPVI-MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 703 --------~~~l-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+... ...........++.+++.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0001122345688999999999999999999999753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=315.09 Aligned_cols=269 Identities=22% Similarity=0.319 Sum_probs=187.3
Q ss_pred HhcCccccceecccCceeEEEEEEcC--CcEEEEE------------------EecccCchhHHHHHHHHHHHhhcCCCC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVK------------------RLSNQSGQGLKEFKNEMMLIAKLQHRN 528 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 528 (792)
..++|++.++||+|+||+||++..+. +...++| .+. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35789999999999999999986532 2222222 111 12234567889999999999999
Q ss_pred cceEeeeeeecCeeEEEEEecCCCccceeeeccC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDST--KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 529 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
|+++++++...+..++|+|++.+ +|.+++.... ........++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999854 5555553321 1122345677889999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCC-CCCCCCcccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNL 685 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~-p~~~~~~~~~~~ 685 (792)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|.. |+..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876543221 1223578999999999999999999999999999999999875 443222111110
Q ss_pred ccchhhhcc--cCc-------cccccccc-cccC--CC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 686 LGHAWDLWK--DDR-------VHDLIDPV-IMQD--EI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 686 ~~~~~~~~~--~~~-------~~~~~~~~-l~~~--~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+........ ... +.+.++.. +... .. .......+.+++.+||+.||++||++.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000 000 00000000 0000 00 00112356778999999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=289.72 Aligned_cols=259 Identities=22% Similarity=0.299 Sum_probs=191.8
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCCcceEeeeeeec--CeeEEEEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILILE 547 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 547 (792)
|++.++||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567899999999999999865 58899999986542 222234457888999885 99999999999987 88999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++ +|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9975 66666632 2346899999999999999999999998 999999999999999 999999999998764332
Q ss_pred cccccceeecccceeCccccc-CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh-----------hccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-----------LWKD 695 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-----------~~~~ 695 (792)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.||...+... ....... ....
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcc
Confidence 1 12245788999999765 4567899999999999999999999986543211 0000000 0000
Q ss_pred CccccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 696 DRVHDLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 696 ~~~~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........+..... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0012235789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=291.02 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=200.0
Q ss_pred CccccceecccCceeEEEEEEc----CCcEEEEEEecccC----chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
+|++.+.||+|++|.||+++.. +++.||||.++... ....+.+.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999753 46789999986432 23446788999999999 599999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999888742 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccceeecccceeCcccccCCC--CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
+...... ......++..|+|||.+.+.. .+.++||||||++++||++|..|+......... ..... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~---------~ 223 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-SEISR---------R 223 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH-HHHHH---------H
Confidence 6433211 122346789999999987765 788999999999999999999998643221100 00000 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.... ....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 224 ~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKS---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHcc---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000 011122234567899999999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-33 Score=276.69 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=200.6
Q ss_pred ceecccCceeEEEEE-EcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
+.||+|+|+.|--.. +.+|+++|||++.+...+...+..+|++++.+.+ |+||+.++.+|+++...|||||.|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999998886 5689999999999988888899999999999995 99999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeecccccceecCCC-----
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMFGGD----- 626 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~DFGla~~~~~~----- 626 (792)
..+| .+...+++.++.++..+|+.||.|||.+| |.||||||+|||...... +||+||.|..-+...
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 8888 45567999999999999999999999999 999999999999966554 899999988644211
Q ss_pred ccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc-
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD- 700 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 700 (792)
.........+|+..|||||+.. ...|+.++|.||||||||-||+|.+||...-.... -|..+..-.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdrGe~Cr~ 309 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDRGEVCRV 309 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccCCCccHH
Confidence 1112233468899999999873 34689999999999999999999999964322111 122222211
Q ss_pred ---ccccccccC--CCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 701 ---LIDPVIMQD--EISL----PMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 701 ---~~~~~l~~~--~~~~----~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.+-..+..+ +++. ..+.+..+++...+..++.+|.++.+++.
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111 2222 24668889999999999999999999876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=286.54 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=189.5
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccCc---hhHHHHHHHHHHH-hhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLI-AKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.||+|+||.||+|+.. +++.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999874 588999999865422 2223345555544 445899999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999884 3346899999999999999999999998 99999999999999999999999999986432
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
.....++..|+|||.+.+..++.++||||||+++|||++|..||........ .......... . ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~------~-~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRRIN------W-PEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcccC------C-CCcc
Confidence 2234578899999999988899999999999999999999999864332110 0000000000 0 0111
Q ss_pred CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 712 SLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 712 ~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
.......+.+++.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1123467899999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=294.01 Aligned_cols=264 Identities=22% Similarity=0.251 Sum_probs=195.0
Q ss_pred cccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
.+.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+++..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666655 6899999998654 345667899999999999999999999999999999999999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc---
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL--- 628 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~--- 628 (792)
++|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999885432 235889999999999999999999998 99999999999999999999999999876532211
Q ss_pred --ccccceeecccceeCcccccCC--CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchh----hhcc------
Q 003843 629 --QGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW----DLWK------ 694 (792)
Q Consensus 629 --~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~----~~~~------ 694 (792)
........++..|+|||++... .++.++||||||+++|||++|+.||........ ...... ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhh
Confidence 1112234567889999998763 588999999999999999999999874332111 000000 0000
Q ss_pred -cCcccc----cccccc---ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 695 -DDRVHD----LIDPVI---MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 695 -~~~~~~----~~~~~l---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...... ..++.. ...........++.+++.+||+.+|++||++++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 000000 0111223345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=292.64 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 545 (792)
++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|++++.+++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999875 6899999998652 2334567889999999998 99999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++. +...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999884 3346999999999999999999999998 99999999999999999999999999987654
Q ss_pred Cccc------------------cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccccc
Q 003843 626 DELQ------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687 (792)
Q Consensus 626 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~ 687 (792)
.... .......++..|+|||.+....++.++||||||++++++++|+.|+....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~ 232 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TFQ 232 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HHH
Confidence 3221 12233467889999999998889999999999999999999999987433110 000
Q ss_pred chhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 003843 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM----SDVIS 742 (792)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~evl~ 742 (792)
..... ....+......+.+++.+||+.+|.+||++ +++++
T Consensus 233 ------------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 ------------KILKL---EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ------------HHHhc---CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00000 111222235678999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=292.90 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=193.2
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|+... ++.||||+++... .....++..|+.++.+.. |+||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678899999999999999999865 8899999996543 234456677887777775 999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+.+ +|..++... ...+++..+..++.||+.||+|||+ .+ |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99854 565555322 2368999999999999999999997 46 99999999999999999999999999986543
Q ss_pred CccccccceeecccceeCcccccCCC----CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
... .....++..|+|||.+.... ++.++||||||+++|||++|+.||.....+.. .... ... ...
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~---~~~-~~~--- 236 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTK---ILQ-EEP--- 236 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHH---Hhc-CCC---
Confidence 221 12235778999999987654 78999999999999999999999864322110 1100 000 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+.+ +.......++.+++.+||+.+|.+||++.+++++
T Consensus 237 --~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 --PSL---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0011234578999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=273.34 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=195.6
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEeccc-CchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 547 (792)
++.+.+..||.|..|.|++.+... |...|||.+... ..+..+++...+.++.+-+ .|+||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345566889999999999998764 889999999765 4456678888888887775 8999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
.|.. .++.++.. -++.+++.-+-++...+.+||.||.++. .|+|||+||+|||+|+.|++||||||++-.+-...
T Consensus 172 lMs~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8843 33444422 2345888888899999999999999865 59999999999999999999999999998764432
Q ss_pred cccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
..+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.|+...+.+-..+ . .+++.
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l-t------------kvln~ 310 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL-T------------KVLNE 310 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH-H------------HHHhc
Confidence 2233578899999999864 478999999999999999999999997644432211 1 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.-+.....+..+.+++..||+.|+.+||...+++++
T Consensus 311 ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 110001111145678999999999999999999999875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=291.42 Aligned_cols=267 Identities=24% Similarity=0.328 Sum_probs=196.3
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 540 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 540 (792)
...++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 48899999986432 233456788999999999999999999987654
Q ss_pred ------eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 541 ------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 541 ------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
..++|+||+++ +|..++.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 55555532 2346899999999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+|||++..+...... ......++..|+|||.+.+ ..++.++|||||||+++||++|++||....... .+.......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHh
Confidence 999999876443221 1122345778999998865 457899999999999999999999986432211 000000000
Q ss_pred ccC-----------ccccccccccc-cC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 KDD-----------RVHDLIDPVIM-QD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ~~~-----------~~~~~~~~~l~-~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
... ......+.... .. ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00000000000 00 0000124578999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=288.99 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=196.1
Q ss_pred CccccceecccCceeEEEEEE----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 472 NFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
+|++.+.||.|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 368899999986532 22346788999999999 699999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998843 345889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccceeecccceeCcccccCC--CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
+...... ......|+..|+|||.+... .++.++||||||+++|+|++|+.|+........ ...... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~---------~ 223 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAEISR---------R 223 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHHHHH---------H
Confidence 6433221 12234688999999998753 468899999999999999999999864221100 000000 0
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
+... ..+.+......+.+++.+|++.+|++|| +..+++.+
T Consensus 224 ~~~~---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 224 ILKS---EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred hhcc---CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 1112222345778999999999999997 66666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=318.15 Aligned_cols=263 Identities=30% Similarity=0.440 Sum_probs=208.8
Q ss_pred HHHhcCccccceecccCceeEEEEEEcC--------CcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeee
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 536 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 536 (792)
+...++..+.+.||+|.||.|++|.... ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3445666777899999999999997531 3479999997653 35678899999999999 699999999999
Q ss_pred eecCeeEEEEEecCCCccceeeeccC-----------CC--ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q 003843 537 VEQGEKILILEYMPNKSLNVFLFDST-----------KK--RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (792)
Q Consensus 537 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 603 (792)
..++..++|+||+..|+|.+||.+.+ .. ..|+..+.+.++.|||.||+||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999996544 00 23899999999999999999999998 9999999999
Q ss_pred EEEcCCCCeeecccccceecCCCcccccc-ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcc
Q 003843 604 ILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNAD 681 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~ 681 (792)
||+.++..+||+|||+|+........... ....-+..|||||.+....|+.|+||||||++||||++ |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999976554333211 11113557999999999999999999999999999999 66776531100
Q ss_pred ccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 682 SFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+ .++..+.+. +.+.+..+..++.++++.||+.+|++||++.++++.|+..
T Consensus 529 -~~----l~~~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 -EE----LLEFLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HH----HHHHHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 00 111112221 2223334467889999999999999999999999999883
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-33 Score=317.85 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=188.9
Q ss_pred HHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ----- 539 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 539 (792)
.+-..+|+.++.||+||||.|||++.+ +|+.||||++.-. +......+.+|++.+++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 344567888999999999999999976 7999999998654 445566788999999999999999998532110
Q ss_pred --------------------------------------------------------------------------------
Q 003843 540 -------------------------------------------------------------------------------- 539 (792)
Q Consensus 540 -------------------------------------------------------------------------------- 539 (792)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHH
Q 003843 540 ----------------------------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585 (792)
Q Consensus 540 ----------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y 585 (792)
..+|+=||||+...|++++....-.. .....++++.+|++||+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 11355677777777777763221111 367789999999999999
Q ss_pred HHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC----C------------CccccccceeecccceeCcccccC
Q 003843 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG----G------------DELQGNTKQIVGTYGYMSPEYALD 649 (792)
Q Consensus 586 LH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~ 649 (792)
+|++| ||||||||.||+++++..+||+|||+|.... . .......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999999721 0 001112345689999999999976
Q ss_pred CC---CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc-CCCCHHHHHHHHHHHHh
Q 003843 650 GL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ-DEISLPMLMRYINVALL 725 (792)
Q Consensus 650 ~~---~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~l~~li~~ 725 (792)
.. |+.|+|+||||+||+||+. ||+..-+. +. .+..+-+..++. ..+..+....-..+|.+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-------a~------iL~~LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-------AS------ILTNLRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHH-------HH------HHHhcccCCCCCCcccccccchHHHHHHHH
Confidence 54 9999999999999999984 34421111 00 011111222211 12234455566889999
Q ss_pred ccccCCCCCCCHHHHHH
Q 003843 726 CVQENAADRPTMSDVIS 742 (792)
Q Consensus 726 cl~~dp~~RPs~~evl~ 742 (792)
+++.||++|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999964
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=286.07 Aligned_cols=242 Identities=25% Similarity=0.309 Sum_probs=186.6
Q ss_pred eecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHH---HhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMML---IAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.||+|+||.||+++.. +++.||+|.+.... ......+.+|..+ +....|++|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999886532 1222234444443 444579999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|..++. +...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999988873 3456999999999999999999999998 9999999999999999999999999997653321
Q ss_pred ccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.............. ..... .
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~-----~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------TLTMA-----V 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH---------hhccC-----C
Confidence 1234689999999999754 689999999999999999999999864322111000000 00000 1
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 710 EISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
..+.....++.+++.+|++.+|.+|| ++.+++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11222346788999999999999999 99999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=285.55 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=194.1
Q ss_pred ccccceecccCceeEEEEEEcC-CcEEEEEEecccC--chhHHHHHHHHHHHhhc---CCCCcceEeeeeeecCe-----
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVEQGE----- 541 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 541 (792)
|++.+.||+|+||.||+|+... ++.||+|++.... ......+.+|+.++.++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678999999999999999864 8999999996432 22234566788877766 59999999999988776
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7877764322 235899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc-------
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK------- 694 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 694 (792)
.+..... .....++..|+|||.+.+..++.++||||||+++|||++|++|+........ .........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence 7644321 1223578899999999999999999999999999999999988864332110 000000000
Q ss_pred -cCcc--ccccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 695 -DDRV--HDLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 695 -~~~~--~~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.... ......... ...........+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 000000000 01111233467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=297.39 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=201.6
Q ss_pred CccccceecccCceeEEEEEEcC-CcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----eeE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKI 543 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 543 (792)
+|++.+.||.|++|.||+|+... ++.||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 57888999999999999999754 8899999987643 345577899999999999999999999988775 789
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
++|||+++ +|.+++. +...+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7877773 3347899999999999999999999998 999999999999999999999999999976
Q ss_pred CCCcc-ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhhh--------
Q 003843 624 GGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDL-------- 692 (792)
Q Consensus 624 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~-------- 692 (792)
..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||........ ..+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 1122334678899999999888 889999999999999999999999865442110 000000000
Q ss_pred cccCccccccccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDE-----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+........ ........+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000111110000000 111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=291.71 Aligned_cols=267 Identities=25% Similarity=0.321 Sum_probs=193.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
.++|++.++||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999875 58899999885432 223356788999999999999999999875433
Q ss_pred --eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 541 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 541 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
..++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 45554432 2346899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccc---------cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-cccc
Q 003843 619 LARMFGGDELQ---------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG 687 (792)
Q Consensus 619 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~ 687 (792)
+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++|++||........ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99876433211 111234678889999988654 589999999999999999999999864332110 0000
Q ss_pred chhhhccc------Cccccccccc-cccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 688 HAWDLWKD------DRVHDLIDPV-IMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 688 ~~~~~~~~------~~~~~~~~~~-l~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
........ ..+....+.. ....+. .......+.+++.+||+.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 0000000000 000000 0112257889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=297.38 Aligned_cols=262 Identities=25% Similarity=0.346 Sum_probs=194.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
.++|.+.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999864 5899999998643 2333456889999999999999999999987543
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999864 555443 235889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-------- 691 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-------- 691 (792)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence 764321 223467889999999876 468999999999999999999999987433111 0000000
Q ss_pred ---hcccCccccccc--cccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003843 692 ---LWKDDRVHDLID--PVIMQDEI---SLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 747 (792)
Q Consensus 692 ---~~~~~~~~~~~~--~~l~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 747 (792)
..........+. +....... .......+.+++.+||+.||++||++.+++.+ ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000000 00000000 01123467899999999999999999999865 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=285.93 Aligned_cols=263 Identities=26% Similarity=0.332 Sum_probs=195.3
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-hhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEEec
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
|++.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999985 478899999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788887774322 246899999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-----cccc-hhhhcccC-ccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-----LLGH-AWDLWKDD-RVHDL 701 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-----~~~~-~~~~~~~~-~~~~~ 701 (792)
.....++..|+|||++.. ..++.++|+||||++++||++|+.||......... .... ....+... .....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 223467889999998854 56799999999999999999999988644321110 0000 00000000 00000
Q ss_pred ccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQ------DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+..+.. ..........+.+++.+||+.+|++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1100000 00001124678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=281.28 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=218.1
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEcC------CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEee
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 534 (792)
...++.....++++..++-+|.||.||.|.+.+ .+.|.+|.++.. ++-+...+..|...+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345566667788988999999999999996543 456888888654 4456778899999999999999999999
Q ss_pred eeeec-CeeEEEEEecCCCccceeee-----ccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC
Q 003843 535 CCVEQ-GEKILILEYMPNKSLNVFLF-----DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 608 (792)
Q Consensus 535 ~~~~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~ 608 (792)
++.++ ...+++|.++.-|+|..||. +....+.+...+...++.|++.|++|||.++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98765 46788899999999999997 4455567888899999999999999999999 999999999999999
Q ss_pred CCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccccc
Q 003843 609 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLG 687 (792)
Q Consensus 609 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~ 687 (792)
..++||+|=.+++.+-+.++......-..+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+...
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-- 509 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-- 509 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--
Confidence 99999999999998877666655555556789999999999999999999999999999998 788876544332211
Q ss_pred chhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+++. +-..+.+++.++..++.-||...|++||++++++.-|.+-
T Consensus 510 ----ylkdGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 510 ----YLKDGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ----HHhccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 111111 1112334566889999999999999999999999998764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=290.05 Aligned_cols=249 Identities=32% Similarity=0.445 Sum_probs=195.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
+.|...+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44777789999999999999875 5788999988632 2334567889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+. ++|.+++.. ....+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 566666532 2345889999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
....+++.|+|||.+. ...++.++||||||+++|||++|+.|+........ . ... .....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~-~~~~~----- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHI-AQNES----- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--H---HHH-hhcCC-----
Confidence 2346788999999974 35678999999999999999999999754321110 0 000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
+ ..........+.+++.+||+.+|++||++.++++.--.
T Consensus 232 ~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 232 P----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred C----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0 00112234568899999999999999999999977544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=288.90 Aligned_cols=244 Identities=30% Similarity=0.448 Sum_probs=191.5
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
|...++||+|+||.||+|+.. +++.|++|++... .....+.+.+|+++++.++|+|++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666688999999999999874 5889999998643 223446788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+.+ +|.+++.. ....+++.++..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 964 66555532 2345899999999999999999999998 99999999999999999999999999864321
Q ss_pred ccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.....|+..|+|||++. ...++.++||||||+++|||++|.+|+........ ...... ... +.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~-~~~-----~~ 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQ-NDS-----PT 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHh-cCC-----CC
Confidence 22356888999999984 46688999999999999999999999754321110 000000 000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ........+.+++.+||+.+|.+||++.+++.+
T Consensus 240 ~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 L----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111123457899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=293.07 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=197.2
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee-cCeeE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKI 543 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 543 (792)
..+++|++.+.||.|+||.||++... +++.||+|++... .....+.+.+|++++.+++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45788999999999999999999865 6889999988542 23345678899999999999999999999876 45788
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+++||+ +++|..++. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 557877762 345788888899999999999999998 999999999999999999999999999754
Q ss_pred CCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cc--------cchhhhc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LL--------GHAWDLW 693 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~--------~~~~~~~ 693 (792)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .. .......
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 321 122456889999998866 56899999999999999999999998643321100 00 0000000
Q ss_pred ccCccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISL-----PMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+..+.+.........+. ....++.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111111111000111111 124678999999999999999999999766
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=296.03 Aligned_cols=268 Identities=25% Similarity=0.309 Sum_probs=197.7
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
..++-...++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445566789999999999999999999986 46889999998653 223356788899999999999999999988643
Q ss_pred ------CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 540 ------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 540 ------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
...+++++++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467777776 778877762 235899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccc-c---
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLL-G--- 687 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~-~--- 687 (792)
|+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ... .
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999864321 223467889999999876 5688999999999999999999999854322110 000 0
Q ss_pred ----chhhhcccCccccccc--cccccCCC---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 688 ----HAWDLWKDDRVHDLID--PVIMQDEI---SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 688 ----~~~~~~~~~~~~~~~~--~~l~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..............+. +....... ......++.+++.+|++.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000 00000000 00124568899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=295.20 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=194.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec---------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--------- 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 539 (792)
..+|++.+.||.|+||.||+|+.. +++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999875 5889999998766666677899999999999999999999876543
Q ss_pred -----CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCee
Q 003843 540 -----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPK 613 (792)
Q Consensus 540 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~k 613 (792)
...++|+||++ ++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 47777662 345889999999999999999999998 999999999999974 56789
Q ss_pred ecccccceecCCCccc-cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchh
Q 003843 614 ISDFGLARMFGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAW 690 (792)
Q Consensus 614 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~ 690 (792)
|+|||+++.+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999876432211 11122357889999998754 5688999999999999999999999964332110 0000000
Q ss_pred hhccc---Cccc----cccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 691 DLWKD---DRVH----DLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 691 ~~~~~---~~~~----~~~~~~l~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... .... ............ ......++.+++.+||+.||++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 0000 000000000000 11233578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=291.94 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=195.2
Q ss_pred hcCcc-ccceecccCceeEEEEEEc-CCcEEEEEEecccCchh--------------HHHHHHHHHHHhhcCCCCcceEe
Q 003843 470 TENFS-MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG--------------LKEFKNEMMLIAKLQHRNLVRLL 533 (792)
Q Consensus 470 ~~~y~-~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~ 533 (792)
.++|. +.+.||.|+||.||+|+.. .++.||||++....... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4577999999999999875 58899999986432211 12578899999999999999999
Q ss_pred eeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 534 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
+++..+...++||||+. ++|.+++. ....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999997 57877773 3445899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCcc------------ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCc
Q 003843 614 ISDFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNA 680 (792)
Q Consensus 614 L~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~ 680 (792)
|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987652110 1111123467889999998764 468999999999999999999999875443
Q ss_pred cccccccchhhhcccCc---ccc--------cccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 681 DSFNLLGHAWDLWKDDR---VHD--------LIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 681 ~~~~~~~~~~~~~~~~~---~~~--------~~~~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
... ............ ... ........ .........++.+++.+||+.+|++||+++|++.+
T Consensus 240 ~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 211 110000000000 000 00000000 00011224568899999999999999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-33 Score=274.79 Aligned_cols=274 Identities=24% Similarity=0.319 Sum_probs=200.4
Q ss_pred hcCccccceecccCceeEEEEEEcC-----CcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeee-cCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 541 (792)
-..|++...||+|.||.||+|.-.+ .+.+|+|+++...+ .......+|+.+++.++|+|++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4678999999999999999995432 34799999976532 234567899999999999999999999987 788
Q ss_pred eEEEEEecCCCccceeeecc--CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC----CCeeec
Q 003843 542 KILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD----MNPKIS 615 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~----~~~kL~ 615 (792)
.++++||.+. +|..+|+.+ .+.+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999987 455555432 34467999999999999999999999997 9999999999999877 899999
Q ss_pred ccccceecCCCcccc-ccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccc-----cc--cc
Q 003843 616 DFGLARMFGGDELQG-NTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADS-----FN--LL 686 (792)
Q Consensus 616 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-----~~--~~ 686 (792)
|||+++.+...-..- ....++-|.-|.|||.+.+. .||.+.|||+.|||+.||++-++-|....... .. .+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999986543222 34456789999999999875 69999999999999999999887775432211 00 00
Q ss_pred cc-----------hhhhccc-Ccccccccccccc--CCCCHH--------HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 687 GH-----------AWDLWKD-DRVHDLIDPVIMQ--DEISLP--------MLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 687 ~~-----------~~~~~~~-~~~~~~~~~~l~~--~~~~~~--------~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.. .|..++. .+-...+...... ...+.. ......+|+..+|+.||.+|.|+++.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 00 0111000 0000111000000 000000 012367899999999999999999999876
Q ss_pred hcc
Q 003843 745 NNE 747 (792)
Q Consensus 745 ~~~ 747 (792)
--.
T Consensus 339 yF~ 341 (438)
T KOG0666|consen 339 YFT 341 (438)
T ss_pred ccc
Confidence 443
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=294.52 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=195.4
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG---- 540 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 540 (792)
...++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++|+||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34678999999999999999999864 6889999998543 2334467889999999999999999999987654
Q ss_pred --eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 541 --EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 541 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
..++||||+ +++|.+++. ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999998 678877763 345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc--ccc-------c
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LLG-------H 688 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~--~~~-------~ 688 (792)
++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ... .
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99865332 223457889999999876 45889999999999999999999998643321000 000 0
Q ss_pred hhhhcccCcccccccc--ccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 689 AWDLWKDDRVHDLIDP--VIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~--~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....+........+.. ..... .........+.+++.+|++.||++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 00000 001122346889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.40 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=191.8
Q ss_pred CccccceecccCceeEEEEEEcC---CcEEEEEEeccc--CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec----Ce
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ----GE 541 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 541 (792)
+|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47888999999999999998753 678999998643 222356788999999999 599999999875432 35
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 57877773 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc--cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-cccc--------ch
Q 003843 622 MFGGDELQ--GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLG--------HA 689 (792)
Q Consensus 622 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~--------~~ 689 (792)
.+...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.... .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76433211 11233578999999998766 4689999999999999999999999865332100 0000 00
Q ss_pred hhhcccCccccccccc--ccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 690 WDLWKDDRVHDLIDPV--IMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~--l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+............ ... ..........+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000000 000 00011124578899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=287.16 Aligned_cols=243 Identities=25% Similarity=0.383 Sum_probs=196.3
Q ss_pred cceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 476 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
.++||+|-||+||-|+.+ +|+.||||++.+. ......++.+|+.||++++||.||.+-..|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999874 6999999998654 3345578999999999999999999999999999999999999665
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---CCeeecccccceecCCCccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kL~DFGla~~~~~~~~~ 629 (792)
-|.-+| ...++.|++..-..++.||+.||.|||.++ |+|+||||+|||+... -.+||||||+|+.++....
T Consensus 649 MLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 554444 234567898888889999999999999999 9999999999999654 4699999999999876543
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
...++||+.|+|||++++..|...-|+||.|||+|--++|..||..+.+-..+ + -+..++-.
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ-I---------------QNAaFMyP 784 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ-I---------------QNAAFMYP 784 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH-h---------------hccccccC
Confidence 34478999999999999999999999999999999999999999743321111 1 11111122
Q ss_pred CCCH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 710 EISL-PMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 710 ~~~~-~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
+.+. +...+.++||...||..-++|-+...-+.
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2222 23457789999999999999988876543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=282.89 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=198.1
Q ss_pred ccccceecccCceeEEEEEEcC-CcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
|++.+.||+|++|.||+|+... ++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667899999999999998764 8999999987653 344567889999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988884322 46899999999999999999999998 99999999999999999999999999987643321
Q ss_pred cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc--cc-------cchhhhcccCc-c
Q 003843 630 GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN--LL-------GHAWDLWKDDR-V 698 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~--~~-------~~~~~~~~~~~-~ 698 (792)
......++..|+|||.+.+. .++.++||||||++++||++|+.||......... .. ...+..+..-. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12223457789999998776 8899999999999999999999988653321100 00 00000000000 0
Q ss_pred ccccccccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... +..... .........+.+++.+||+.+|++||++.+++.+
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000 000000 0011124578999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=310.36 Aligned_cols=262 Identities=21% Similarity=0.234 Sum_probs=208.5
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEcC-CcEEEEEEecc---cCchhHHHHHHHHHHHhhcCCCCcceEeeeee
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 537 (792)
....+....++|+++++||+|+||.|..++.+. ++.||+|++.+ .......-|..|-.+|..-+.+=|+.++..|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 345566678999999999999999999999864 78899999976 23445567899999999999999999999999
Q ss_pred ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccc
Q 003843 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (792)
Q Consensus 538 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DF 617 (792)
++..+|+|||||+||+|-.++.. ...++++.+..++..|..||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999843 336999999999999999999999999 999999999999999999999999
Q ss_pred ccceecCCCccccccceeecccceeCccccc----C-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|.+-.+..+.. ......+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||....- +...-..
T Consensus 220 GsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-----veTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-----VETYGKI 293 (1317)
T ss_pred hhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----HHHHHHH
Confidence 99988764432 2334468999999999985 3 6789999999999999999999999864321 1111111
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT---MSDVISMI 744 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~evl~~L 744 (792)
+...+.. .-+.....++++.+||.+.+ -+|+.|.. +.++..+-
T Consensus 294 m~hk~~l--------~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 294 MNHKESL--------SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred hchhhhc--------CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCc
Confidence 1111111 11111225667888888876 47888887 88876553
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=292.70 Aligned_cols=262 Identities=24% Similarity=0.308 Sum_probs=196.6
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe----
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE---- 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 541 (792)
..++|++.+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3678999999999999999999885 4789999998643 23344667889999999999999999998876554
Q ss_pred --eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 542 --KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 542 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
.++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 568888773 245899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------h
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------A 689 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~ 689 (792)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..... .
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9865432 223467889999999865 3678999999999999999999999864332110 00000 0
Q ss_pred hhhcccCccccccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 690 WDLWKDDRVHDLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+........+......... .......+.+++.+||+.+|++|||+.||+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000000000000000 01125678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=280.07 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=194.5
Q ss_pred CccccceecccCceeEEEEEEcC-CcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998754 444556655431 222344577899999999999999999999999999999
Q ss_pred EEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
+||+++++|.+++... .....+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999998887542 23456899999999999999999999998 999999999999975 569999999998764
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+...... ... .. ....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~---~~---------~~~~ 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--SVV---LR---------IVEG 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHH---HH---------HHcC
Confidence 3321 122345788999999998888999999999999999999999998532210 000 00 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ....+.....++.+++.+||+.+|++||++.|+++.
T Consensus 221 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 P--TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred C--CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0 111223345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=312.95 Aligned_cols=146 Identities=29% Similarity=0.434 Sum_probs=131.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.++||+|+||.||+|+.. +++.||||+++... ......+.+|+.+++.++|+||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999886 58899999986532 33456788999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
|||+++++|.+++.. .+.+++..++.++.||+.||+|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998843 345889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=278.66 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=197.0
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
...+|.++.+||+|+||.|.+|..+. .+.+|||++++. .+...+--+.|-++|+.. +-|.++.++.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 35678899999999999999997654 556999999764 233344456788888776 5788999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+.||+|--++ +.-+.+.+..+..++..||-||-+||+++ ||.||||.+||+||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999996665 44556888889999999999999999999 999999999999999999999999999852
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
-- ....+...+|||.|+|||++...+|+..+|.|||||+||||+.|++||+..++++... .+.+
T Consensus 501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------aI~e 564 (683)
T KOG0696|consen 501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------AIME 564 (683)
T ss_pred cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------HHHH
Confidence 11 1234567899999999999999999999999999999999999999998665543211 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
. .-.++...+.+...+....+..+|.+|.
T Consensus 565 h---nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 H---NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c---cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 1234455666778888888999999995
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=275.45 Aligned_cols=236 Identities=26% Similarity=0.343 Sum_probs=192.1
Q ss_pred ecccCceeEEEEEEc-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 479 LGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
||+|+||.||++... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 488999999865432 2456889999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccce
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 634 (792)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 998843 335899999999999999999999988 9999999999999999999999999998764432 12234
Q ss_pred eecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 635 ~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||...+... ... . +... ....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~----~--------~~~~---~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYE----K--------ILKD---PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----H--------HhcC---CCCCCCC
Confidence 567889999999998889999999999999999999999986433210 000 0 0000 1111222
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHH
Q 003843 715 MLMRYINVALLCVQENAADRPTMSD 739 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~e 739 (792)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2457789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=293.50 Aligned_cols=260 Identities=22% Similarity=0.381 Sum_probs=210.0
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeee--
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE-- 538 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-- 538 (792)
++.+...++.|++.+.||.|.+|.||+++.. +++.+|+|++.... ...++++.|..+++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 4444556889999999999999999999864 68889999886543 3446778899999988 69999999999864
Q ss_pred ---cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 539 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 539 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
+++++||||||.+|+..+++.... ...+.|..+..|++.++.||.+||... ++|||||=.|||++.++.+||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 568999999999999999986655 667999999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchh
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~ 690 (792)
|||++..+.... .......||+.|||||++.. ..|+.++|+||||++..||--|.+|+..+.+-
T Consensus 166 DFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------- 234 (953)
T KOG0587|consen 166 DFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------- 234 (953)
T ss_pred eeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence 999998775432 33455789999999999964 34778999999999999999999997633211
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.-+..+.....+.-.-+.....++.++|..||..|.++||++.+++++
T Consensus 235 -----raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 -----RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -----hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 001111111111112234467899999999999999999999988754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=275.88 Aligned_cols=258 Identities=27% Similarity=0.345 Sum_probs=198.9
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc--Cc-----hhHHHHHHHHHHHhhcCCCCcceEeeeeee-c
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-Q 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 539 (792)
..++|-++.+||+|||++||||.+ ...+.||||+-.-. -. .-.+...+|..|-+.|.||.||++++++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 357788899999999999999975 45778999975321 11 113446789999999999999999999965 4
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeecc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISD 616 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~D 616 (792)
+.++-|+||++|.+|+-||. ..+.++++++..|+.||..||.||.+.. ++|||-||||.||||-. -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 57889999999999999993 4567999999999999999999999874 67999999999999944 47899999
Q ss_pred cccceecCCCcccc-----ccceeecccceeCcccccC----CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccccc
Q 003843 617 FGLARMFGGDELQG-----NTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687 (792)
Q Consensus 617 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~ 687 (792)
|||++.+..+.+.. .+....||..|++||.+.- .+++.|.||||.|||+|..+.|++||+....... .+.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-ILq 695 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-ILQ 695 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-HHh
Confidence 99999987654432 2455689999999998753 3578999999999999999999999986443211 111
Q ss_pred chhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
+.. ++...-..-+..+....+...+|++||+..-++|....++.
T Consensus 696 -------eNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -------ENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -------hhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 11111111222333456788999999999999998776653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=262.50 Aligned_cols=247 Identities=21% Similarity=0.273 Sum_probs=193.3
Q ss_pred hcCcccc-ceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeee----cCee
Q 003843 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 542 (792)
Q Consensus 470 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 542 (792)
+++|++. ++||-|-.|.|.....+ +++++|+|++... ....+|+++--.. .|+|||.++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 5667665 58999999999988765 5889999998643 3446788776655 69999999999864 4577
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeeccccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~DFGl 619 (792)
.+|||.|+||.|...+.+ +....+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 899999999999887743 23456999999999999999999999998 999999999999964 45699999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
|+.-.. .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-.... ..+ .
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~ai-------------s 272 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAI-------------S 272 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccC-------------C
Confidence 986432 2334456789999999999999999999999999999999999999853221 110 0
Q ss_pred cccccccccC--CCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIMQD--EIS----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~~~--~~~----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.-+...+..+ +++ ...++...++|+.+|..+|++|.|+.++..+
T Consensus 273 pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111111111 222 2236678899999999999999999999765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=289.97 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=194.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++.|++...+|.|+|+.|-.+... +++..+||++.+.. .+-.+|+.++... +|+||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 678999999999999999888764 58889999997652 2234567666665 79999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE-cCCCCeeecccccceecCCC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl-~~~~~~kL~DFGla~~~~~~ 626 (792)
.+.++-|.+.+. ..+... .++..|+.+|+.|+.|||.+| +|||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999988766652 222233 777789999999999999998 9999999999999 68999999999999876544
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
....+-|..|.|||++....|++++|+||||++||+||+|+.|+.....+ .++ . ..+
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei----~-------------~~i 526 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEI----H-------------TRI 526 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHH----H-------------Hhh
Confidence 22345688999999999999999999999999999999999998753332 111 1 111
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....++...+....+|+.+||+.||.+||+|.++..+
T Consensus 527 ~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1223334556788999999999999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=262.60 Aligned_cols=249 Identities=22% Similarity=0.361 Sum_probs=200.4
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
.-++|.++++||+|+|+.|..++++ +.+.+|+|++++. .++..+-.+.|..+..+. +||.+|.+..+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3478999999999999999999875 4678999998764 344556667787777776 7999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|.||.++|+|--++ ++++.|+++.+..+...|..||.|||+.| ||.||||.+|||+|..|++||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999985444 66777999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc-ccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH-DLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 702 (792)
-.. ...+..++|||.|.|||++++..|....|.|+|||+++||+.|+.||.....+..+.-. +..+. -++
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-------edylfqvil 472 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-------EDYLFQVIL 472 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-------hHHHHHHHh
Confidence 221 23456689999999999999999999999999999999999999999764432211111 01111 122
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
...+ .++...+.+...++..-|.+||++|.
T Consensus 473 ekqi---riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 473 EKQI---RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhcc---cccceeehhhHHHHHHhhcCCcHHhc
Confidence 2222 33444556677888889999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=268.74 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=194.2
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+++-+..||.|+||+|+|-.++ .|+..|||+++... ....+++..|.+...+- +.||||+++|.+..++..++.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3444578999999999999775 58999999997654 35667888888876655 799999999999999999999999
Q ss_pred cCCCccceeeec--cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|. .+|+.+-.. ..++..+++.-+-+|.....+||.||...- +|||||+||+|||++..|.+||||||++-.+...
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 455544321 234556888888899999999999998754 6999999999999999999999999999765432
Q ss_pred ccccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. .+.-.|-..|||||.+.. ..|+.++||||||+.|+|+.||+.|+...+.. ..+..... .+.. +
T Consensus 222 iA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~~Vv-~gdp-----p 288 (361)
T KOG1006|consen 222 IA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLCQVV-IGDP-----P 288 (361)
T ss_pred HH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHHHHH-cCCC-----C
Confidence 21 222467789999999964 34899999999999999999999998644321 11111111 1111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.......+....+..++..|+.+|..+||.+.++.++
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111222223456688999999999999999999998754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.26 Aligned_cols=220 Identities=20% Similarity=0.120 Sum_probs=176.0
Q ss_pred cCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccceeeec
Q 003843 482 GGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 560 (792)
Q Consensus 482 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 560 (792)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 58899999996542 234455566667899999999999999999999999999999888843
Q ss_pred cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccc
Q 003843 561 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (792)
Q Consensus 561 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (792)
...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 335899999999999999999999998 999999999999999999999999988765432 112345678
Q ss_pred eeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHH
Q 003843 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYI 720 (792)
Q Consensus 641 y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 720 (792)
|+|||.+....++.++||||+|+++|||++|+.|+........ ... ....+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------THT-----TLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------ccc-----ccCCcccCCHHHH
Confidence 9999999888899999999999999999999987642211000 000 0011122345688
Q ss_pred HHHHhccccCCCCCCCHH
Q 003843 721 NVALLCVQENAADRPTMS 738 (792)
Q Consensus 721 ~li~~cl~~dp~~RPs~~ 738 (792)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=270.05 Aligned_cols=263 Identities=20% Similarity=0.246 Sum_probs=198.9
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcC-C-C----CcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-H-R----NLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 542 (792)
+++|.+..++|+|.||.|-+..+.. +..||||++++-. .-.+..+-|++++.++. + | -+|.+.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 7899999999999999999997644 6789999997532 33455677999999993 2 2 267778889999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC--------------
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------------- 608 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-------------- 608 (792)
++|+|.+ |-|+.+||... +...++...+..|+.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999988 66899998442 3446889999999999999999999998 999999999999831
Q ss_pred ------CCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc
Q 003843 609 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682 (792)
Q Consensus 609 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~ 682 (792)
+..+||+|||.|..-... ...++.|..|.|||++.+-.++.++||||+||||+|+.+|..-|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 335899999999875332 255788999999999999999999999999999999999998776544211
Q ss_pred -cccccchhh--------------hcccCcc-----------ccccccc---cccCCCCHHHHHHHHHHHHhccccCCCC
Q 003843 683 -FNLLGHAWD--------------LWKDDRV-----------HDLIDPV---IMQDEISLPMLMRYINVALLCVQENAAD 733 (792)
Q Consensus 683 -~~~~~~~~~--------------~~~~~~~-----------~~~~~~~---l~~~~~~~~~~~~l~~li~~cl~~dp~~ 733 (792)
...++.... ....+.+ ....++. -........+..++.+|+..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 111111100 0000100 0011110 0011223456778999999999999999
Q ss_pred CCCHHHHHHH
Q 003843 734 RPTMSDVISM 743 (792)
Q Consensus 734 RPs~~evl~~ 743 (792)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=294.73 Aligned_cols=262 Identities=19% Similarity=0.210 Sum_probs=168.4
Q ss_pred HhcCccccceecccCceeEEEEEEcC-----CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeee------ee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGC------CV 537 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 537 (792)
..++|++.++||+|+||.||+|++.+ +..||||++...... +.+.+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999998754 689999998643221 112221 1122222222222221 24
Q ss_pred ecCeeEEEEEecCCCccceeeeccCCC-----------------ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 003843 538 EQGEKILILEYMPNKSLNVFLFDSTKK-----------------RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (792)
Q Consensus 538 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 600 (792)
++...++|+||+++++|.+++...... .......+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999998887532110 01123345679999999999999998 9999999
Q ss_pred CCcEEEcC-CCCeeecccccceecCCCccccccceeecccceeCcccccCCC----------------------CCCcCc
Q 003843 601 ASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL----------------------FSIKSD 657 (792)
Q Consensus 601 p~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~s~~~D 657 (792)
|+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+.... ++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57899999999986543221 1223467899999999764322 345679
Q ss_pred eeehhHHHHHHHhCCCCCCCCCcccccccc---chhhhcccCcccccccccc----cc-CCCCHHHHHHHHHHHHhcccc
Q 003843 658 VFSFGILMLETLSSKKNTGVYNADSFNLLG---HAWDLWKDDRVHDLIDPVI----MQ-DEISLPMLMRYINVALLCVQE 729 (792)
Q Consensus 658 VwSlGvll~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l----~~-~~~~~~~~~~l~~li~~cl~~ 729 (792)
||||||+||||+++..+...........+. .....|. ..+.+.. .. ............+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWR-----KLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHH-----HhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999876654321000000000 0000000 0011100 00 000011122456899999999
Q ss_pred CCCCCCCHHHHHHH
Q 003843 730 NAADRPTMSDVISM 743 (792)
Q Consensus 730 dp~~RPs~~evl~~ 743 (792)
||++|||+.|++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=261.26 Aligned_cols=238 Identities=28% Similarity=0.362 Sum_probs=192.2
Q ss_pred CceeEEEEEEcC-CcEEEEEEecccCchh-HHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccceeeec
Q 003843 483 GFGPVYKGRLLN-GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD 560 (792)
Q Consensus 483 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 560 (792)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+|++++++++..+...++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999997655444 78899999999999999999999999999999999999999999998843
Q ss_pred cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccc
Q 003843 561 STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640 (792)
Q Consensus 561 ~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~ 640 (792)
. ..+++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22889999999999999999999998 9999999999999999999999999998775432 2234567889
Q ss_pred eeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHH
Q 003843 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYI 720 (792)
Q Consensus 641 y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 720 (792)
|++||.+....++.++||||||+++++|++|..|+....... ... ......... ..........++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~----~~~~~~~~~--------~~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELF----KKIGKPKPP--------FPPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHH----HHHhccCCC--------CccccccCCHHHH
Confidence 999999998899999999999999999999999986421110 000 000000000 0000000345788
Q ss_pred HHHHhccccCCCCCCCHHHHHH
Q 003843 721 NVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 721 ~li~~cl~~dp~~RPs~~evl~ 742 (792)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=282.71 Aligned_cols=265 Identities=19% Similarity=0.251 Sum_probs=181.1
Q ss_pred HhcCccccceecccCceeEEEEEE-----------------cCCcEEEEEEecccCchhHHHH--------------HHH
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-----------------LNGQEVAVKRLSNQSGQGLKEF--------------KNE 517 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 517 (792)
..++|++.++||+|+||.||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 2356799999865433333333 346
Q ss_pred HHHHhhcCCCCc-----ceEeeeeee--------cCeeEEEEEecCCCccceeeeccC---------------------C
Q 003843 518 MMLIAKLQHRNL-----VRLLGCCVE--------QGEKILILEYMPNKSLNVFLFDST---------------------K 563 (792)
Q Consensus 518 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~---------------------~ 563 (792)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 667777653 356899999999999998885321 1
Q ss_pred CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeC
Q 003843 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643 (792)
Q Consensus 564 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 643 (792)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788899999999999999998 999999999999999999999999999765432211 1112234789999
Q ss_pred cccccCCCC----------------------CCcCceeehhHHHHHHHhCCC-CCCCCCcccccc--ccchhhhcccCcc
Q 003843 644 PEYALDGLF----------------------SIKSDVFSFGILMLETLSSKK-NTGVYNADSFNL--LGHAWDLWKDDRV 698 (792)
Q Consensus 644 PE~~~~~~~----------------------s~~~DVwSlGvll~elltg~~-p~~~~~~~~~~~--~~~~~~~~~~~~~ 698 (792)
||.+..... ..+.||||+||+++||+++.. |+.....-.... .......|.....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998864321 134799999999999999875 543211100000 0000001110000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENA---ADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~evl~~ 743 (792)
.. . .-...........+++.++|..+| .+|+|++|++++
T Consensus 459 ~~-~-----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK-Y-----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC-C-----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 0 001112234577889999998765 789999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-31 Score=256.52 Aligned_cols=268 Identities=23% Similarity=0.385 Sum_probs=194.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEec--ccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee--------c
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS--NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------Q 539 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 539 (792)
..|+-..+||+|.||+||+|+.+ +|+.||+|++- +..+.--....+|+++|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666789999999999999875 47788998653 2223333456789999999999999999998853 3
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
..+++||++|+. +|..+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 358999999975 56666632 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCcc--ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cccccc-----hh
Q 003843 620 ARMFGGDEL--QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGH-----AW 690 (792)
Q Consensus 620 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~~~~~-----~~ 690 (792)
++.+..... ....+..+-|.-|++||.+.+. .|+++.|||.-|||+.||.++.+-+....+.. ..++.. ..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987743322 2222334669999999998865 68999999999999999999988775443221 112111 11
Q ss_pred hhcccCc---cccccccc-cccCCCC--HHH------HHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 691 DLWKDDR---VHDLIDPV-IMQDEIS--LPM------LMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 691 ~~~~~~~---~~~~~~~~-l~~~~~~--~~~------~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
+.|.+-. +.+.+... +.++... .+. ..+..+|+..++..||.+|+++++++.+-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2222211 11112111 1111111 111 22677899999999999999999988664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=235.78 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=191.6
Q ss_pred CccccceecccCceeEEEEEEcC-CcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+|.-.++||+|.||+||||+..+ ++.||+|+++-. ++.......+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566899999999999999764 778999988543 333456778999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
|.. +|..|.. .-++.++.+....++.|+++||.++|+++ +.|||+||.|.||+.+|++||+|||+++.++-...
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 5655542 23456888999999999999999999998 99999999999999999999999999998764421
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCC-CCCCCcccc-ccccchhhhcccC---cccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKN-TGVYNADSF-NLLGHAWDLWKDD---RVHDLI 702 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p-~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~ 702 (792)
.....+-|.-|.+|.++.+. .|+...|+||-|||+.|+.....| |...+.+.+ .-+-+......++ .+..+-
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 11223568899999999876 479999999999999999885444 443222111 0000000011111 111222
Q ss_pred ccccc---c-----CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 703 DPVIM---Q-----DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 703 ~~~l~---~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
|.... . ..+-+.....=++++...+.-+|.+|.++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 21110 0 00111122344677888888999999999988654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=272.54 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=205.2
Q ss_pred hcCccccceecccCceeEEEEEEcCCc-EEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQ-EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
-.+++++..||-|+||.|=+++....+ .+|+|++++. +..+.+....|-.+|...+.|.||+++-.|.+....|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345666788999999999999875544 3788887653 445567788899999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||-|-||.|-..| +.++.++......++..+.+|++|||.++ ||+|||||+|.+|+.+|-+||.|||+|+.+..
T Consensus 499 mEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999888 45667888889999999999999999999 99999999999999999999999999998865
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .+-+++|||.|.|||++.+...+.++|.||||+++|||++|.+||...++-... .. +..-+|
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY------n~-----ILkGid-- 636 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY------NL-----ILKGID-- 636 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH------HH-----HHhhhh--
Confidence 43 455689999999999999999999999999999999999999999754431110 00 011111
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISMI 744 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~L 744 (792)
.-.++........+++++.+..+|.+|.. +.++.++-
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11223344557789999999999999985 66776654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=284.36 Aligned_cols=246 Identities=28% Similarity=0.388 Sum_probs=188.8
Q ss_pred ccccceecccCcee-EEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEecC
Q 003843 473 FSMQCKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 473 y~~~~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
|.-.+.+|.|+-|+ ||+|.. +|++||||++-. ...+-..+|+..|+.- +|||||++++.-.+++..|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34446789999985 799988 789999999853 2334567899999988 6999999999999999999999999
Q ss_pred CCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---C--CCeeecccccceecC
Q 003843 551 NKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---D--MNPKISDFGLARMFG 624 (792)
Q Consensus 551 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~--~~~kL~DFGla~~~~ 624 (792)
..+|++++... ...........+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 45899998653 11111122445678899999999999988 999999999999976 2 469999999999986
Q ss_pred CCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhC-CCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.+... .......||-+|+|||++....-+.++|||||||++|+.++| .+||+..-...-+.+...... . .+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L------~-~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL------V-HL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce------e-ee
Confidence 65332 224456899999999999999999999999999999999996 889985433322222211110 0 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....+. +..+||.+|++.+|..||++.+|+.
T Consensus 736 -------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111111 7789999999999999999999974
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=229.22 Aligned_cols=110 Identities=48% Similarity=0.790 Sum_probs=82.2
Q ss_pred CCeEEEEecCCCCCCCC--CceEEEeeCCcEEEEcCCCceEEEe-ccCCCC-CcceEEEecCCcEEEeeCCCCCCccccc
Q 003843 70 PDAVVWVANRDRPISDN--NAVLTISNNGNLVLLNQTNGTIWST-NVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYL 145 (792)
Q Consensus 70 ~~t~vW~anr~~p~~~~--~~~l~~~~~g~l~l~~~~~~~~wst-~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~ 145 (792)
|+|+||+|||+.|+... ..+|.|+.||||+|++++++++|++ ++.+.+ ....|+|+|+|||||++..+ .+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~-----~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSG-----NVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTS-----EEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecc-----eEE
Confidence 46999999999999553 4789999999999999999999999 555444 57889999999999999654 899
Q ss_pred ccccCCCcchhhcccccccccccccceeEEEeccCCCCC
Q 003843 146 WQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPS 184 (792)
Q Consensus 146 WqSFd~Ptdtllpg~~l~~~~~~~~~~~l~Sw~~~~dps 184 (792)
||||||||||+||+|+|+.+..++.+..++||++..|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988888778899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=268.28 Aligned_cols=215 Identities=23% Similarity=0.336 Sum_probs=179.1
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeee
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 538 (792)
+........-|..++.||-|+||+|.+++- ++...+|+|.+++.+ .......+.|-.||+.-..+=||+|+..|.+
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 334444456788889999999999999964 446679999987653 2344557889999999999999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
++.+|+||||++||++-.+| .+.+.+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||.|||
T Consensus 701 kdnLYFVMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred CCceEEEEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecc
Confidence 99999999999999998887 45567888889999999999999999999 9999999999999999999999999
Q ss_pred cceecC---------CCccc-------------------------------cccceeecccceeCcccccCCCCCCcCce
Q 003843 619 LARMFG---------GDELQ-------------------------------GNTKQIVGTYGYMSPEYALDGLFSIKSDV 658 (792)
Q Consensus 619 la~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~DV 658 (792)
|+.-+. ..+.. ......+||+.|+|||++....++..+|.
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 987441 00000 00113579999999999999999999999
Q ss_pred eehhHHHHHHHhCCCCCCCCCcccc
Q 003843 659 FSFGILMLETLSSKKNTGVYNADSF 683 (792)
Q Consensus 659 wSlGvll~elltg~~p~~~~~~~~~ 683 (792)
||.|||||||+.|+.||-...+.+.
T Consensus 855 ws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 855 WSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999976555433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-30 Score=248.54 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=197.3
Q ss_pred cccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-----eeEEE
Q 003843 474 SMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-----EKILI 545 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 545 (792)
+-.+.||.|+||.||..++. +|+.||+|++.+.. -...+.+.+|+++|..++|.|++..++...-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34478999999999999864 69999999996542 234577889999999999999999988765432 56788
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
+|.|. .+|..+| .....|+...+.-+++||++||+|||+.+ |+||||||.|.|++.|..+||||||+++....
T Consensus 136 TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 88884 4777777 34556888888899999999999999998 99999999999999999999999999998665
Q ss_pred CccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcc-ccccccch--------hhhccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHA--------WDLWKD 695 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~-~~~~~~~~--------~~~~~~ 695 (792)
++.... +..+-|..|.|||++.+. .|+.+.||||.|||+.||+..+.-|...++- ..+++... ....-+
T Consensus 209 d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 543333 334678999999999875 6999999999999999999988877654432 11221111 111111
Q ss_pred CccccccccccccCC--------CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 696 DRVHDLIDPVIMQDE--------ISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~--------~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+....+++....... .......+...+...++..+|.+|.+..+.+..+...
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 111222222111111 1112234566778889999999999999998887554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=229.24 Aligned_cols=209 Identities=28% Similarity=0.392 Sum_probs=170.8
Q ss_pred HHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 466 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 466 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
++...+.+.-...||+|++|.|-+-++. +|+..|+|++... ..+..++..+|+.+..+. .+|.+|+++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4455666667789999999999888764 6899999999654 345566778888877665 799999999999999999
Q ss_pred EEEEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 543 ILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
++.||.|. .+|+.|-.+. .+.+.+++.-+-+|+..+.+||.|||++- .+||||+||+|||++.+|++|+||||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 4776664332 34567899999999999999999999864 69999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccC----CCCCCcCceeehhHHHHHHHhCCCCCCCCCc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DVwSlGvll~elltg~~p~~~~~~ 680 (792)
.+.+... .+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++....
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 7654321 112357789999999853 4689999999999999999999999875543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=233.46 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=195.5
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecC--eeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv 545 (792)
.++|++.+++|+|.+++||.|.. .+.++++||+++.- ..+.+++|+.||..+. ||||++++++..+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999974 46789999999753 4467899999999997 999999999987754 66799
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla~~~~ 624 (792)
+||..+.+...+- ..|+..++..++.++++||.|+|+.| |.|||+||.|+++|.. ..++|+|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999887765443 34778888999999999999999999 9999999999999865 469999999999886
Q ss_pred CCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------hc--
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD--------LW-- 693 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~-- 693 (792)
..... +..+.+..|.-||.+.. ..|+..-|+|||||+|..|+..+.||-.......+++.-+.- ..
T Consensus 185 p~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 55322 22356778899999876 468999999999999999999999986544433333322111 00
Q ss_pred ----ccCccccccccccc-------cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 ----KDDRVHDLIDPVIM-------QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ----~~~~~~~~~~~~l~-------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+...++..-.. ..+...-...+.++++...|..|-.+|||++|...+
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111111000 000001123678899999999999999999998643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=233.50 Aligned_cols=211 Identities=36% Similarity=0.613 Sum_probs=184.1
Q ss_pred ecccCceeEEEEEEcC-CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccce
Q 003843 479 LGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 556 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 556 (792)
||+|.+|.||+++... ++++++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999854 899999999765432 45789999999999999999999999999999999999999999999
Q ss_pred eeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCCCcccccccee
Q 003843 557 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQI 635 (792)
Q Consensus 557 ~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~ 635 (792)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 884321 35889999999999999999999998 999999999999999 89999999999987654321 12234
Q ss_pred ecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHH
Q 003843 636 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLP 714 (792)
Q Consensus 636 ~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 714 (792)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999887 889999999999999999
Q ss_pred HHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 715 MLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 715 ~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4678999999999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=255.68 Aligned_cols=271 Identities=20% Similarity=0.225 Sum_probs=206.0
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC------CCCcceEeeee
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ------HRNLVRLLGCC 536 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~ 536 (792)
.--+....+|.+....|+|-|++|..|... .|+.||||++.+.. .-.+.=+.|+++|++|+ .-|.++++-.|
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 333455788999999999999999999864 48899999998753 22344578999999996 34789999999
Q ss_pred eecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-Ceeec
Q 003843 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKIS 615 (792)
Q Consensus 537 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~ 615 (792)
...+++|||+|-+ ..+|.+.|....++-.|....+..++.|+..||..|..-+ |+|.||||.|||+++.. .+|||
T Consensus 504 ~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 504 KHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 9999999999987 5688999987777777899999999999999999999998 99999999999998875 58999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcc-ccccccch-----
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNAD-SFNLLGHA----- 689 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~-~~~~~~~~----- 689 (792)
|||.|.....++.. .+.-+..|.|||++.+.+|+...|+||.||.||||.||+..|+..... ...+....
T Consensus 580 DfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 580 DFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 99999887655432 234567899999999999999999999999999999999877543321 11111110
Q ss_pred ------------------------hhhcccCcc---cccccc------cc-ccCCCC---HHHHHHHHHHHHhccccCCC
Q 003843 690 ------------------------WDLWKDDRV---HDLIDP------VI-MQDEIS---LPMLMRYINVALLCVQENAA 732 (792)
Q Consensus 690 ------------------------~~~~~~~~~---~~~~~~------~l-~~~~~~---~~~~~~l~~li~~cl~~dp~ 732 (792)
.+.+.+... ...+.| .+ ....++ ......+.+|+..||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 000000000 001111 11 111122 23456788999999999999
Q ss_pred CCCCHHHHHHH
Q 003843 733 DRPTMSDVISM 743 (792)
Q Consensus 733 ~RPs~~evl~~ 743 (792)
+|.|..+++.+
T Consensus 736 KRit~nqAL~H 746 (752)
T KOG0670|consen 736 KRITVNQALKH 746 (752)
T ss_pred hcCCHHHHhcC
Confidence 99999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=256.34 Aligned_cols=196 Identities=24% Similarity=0.368 Sum_probs=167.9
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC--------chhHHHHHHHHHHHhhcC---CCCcceEeeeee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCV 537 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 537 (792)
...|+.++.+|.|+||.|+.+.++. ..+|+||.+.+.. +..+-..-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999999865 5689999886531 111122446999999997 999999999999
Q ss_pred ecCeeEEEEEec-CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecc
Q 003843 538 EQGEKILILEYM-PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (792)
Q Consensus 538 ~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~D 616 (792)
+++.+||+||-. ++.+|.++| ..+..+++.++..|+.|++.|+++||+++ |||||||-+||.++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 999999999986 566788887 45567999999999999999999999999 99999999999999999999999
Q ss_pred cccceecCCCccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCC
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNT 675 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~ 675 (792)
||.|...... ....++||..|.|||++.+.+| ...-|||++|++||.++....|+
T Consensus 714 fgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 714 FGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred ccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9999876443 3556899999999999999988 56689999999999998877665
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=207.30 Aligned_cols=115 Identities=43% Similarity=0.728 Sum_probs=102.3
Q ss_pred ccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCCceEEEe
Q 003843 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (792)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst 111 (792)
++|..|++|+|++|.|++|||.+......+.+|||...+.++||.|||+.|. ...+.|.|+.||+|+|+|.+|.++|++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 5788999999999999999999876545999999988778899999999984 447889999999999999999999999
Q ss_pred ccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCCC
Q 003843 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (792)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (792)
++.+.....+|+|+|||||||++.++ .+||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSDG-----NFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEEcCCCCC
Confidence 98863445688999999999999765 7899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=230.12 Aligned_cols=199 Identities=34% Similarity=0.481 Sum_probs=173.0
Q ss_pred ccccceecccCceeEEEEEEcC-CcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
|++.+.||.|++|.||+++..+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999865 889999999765544 67889999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 9999998843221 1789999999999999999999998 99999999999999999999999999988754321 1
Q ss_pred ccceeecccceeCcccc-cCCCCCCcCceeehhHHHHHHHhCCCCCCC
Q 003843 631 NTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTGV 677 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvll~elltg~~p~~~ 677 (792)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678899999998 677788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-27 Score=255.33 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=202.8
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..++|+++..+|.|.||.|||++++ .++..|+|+++-.......-++.|+-+++..+|+||+.+++.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4578999999999999999999875 588899999987777777888899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+.+|+|++.-+ ..+.|++.++..+.+..++||+|||+.+ -+|||||-.|||+.+.|.+|++|||.+..+....
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999998863 4567999999999999999999999999 8999999999999999999999999998765432
Q ss_pred cccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
...+.+.||+.|||||+.. .+.|..++|||++|+...|+---++|.-... .. .+..++.. ...++
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pm----r~l~LmTk----S~~qp 234 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PM----RALFLMTK----SGFQP 234 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hH----HHHHHhhc----cCCCC
Confidence 3345578999999999874 5678999999999999999977666532100 00 00001110 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
.- -.-.....+.+-++++.++..+|++||+++.++
T Consensus 235 p~--lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 235 PT--LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred Cc--ccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 11 111222456788999999999999999987654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=238.64 Aligned_cols=264 Identities=22% Similarity=0.260 Sum_probs=191.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-----C---CCcceEeeeeee--
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----H---RNLVRLLGCCVE-- 538 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 538 (792)
..+|.++++||-|.|++||++.+. ..+.||+|+.+.. .+-.+....|+++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999875 4668999998643 334456788999999984 2 469999999975
Q ss_pred --cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-------
Q 003843 539 --QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD------- 609 (792)
Q Consensus 539 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~------- 609 (792)
+.+.++|+|++ |.+|..+|.. ...+.++...+.+|+.||+.||.|||..+ .|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 45899999999 5566666643 23456899999999999999999999987 69999999999998310
Q ss_pred --------------------------------------------------------------------------------
Q 003843 610 -------------------------------------------------------------------------------- 609 (792)
Q Consensus 610 -------------------------------------------------------------------------------- 609 (792)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 003843 610 -------------------------------------------------------------------------------M 610 (792)
Q Consensus 610 -------------------------------------------------------------------------------~ 610 (792)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred CeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCc-----ccccc
Q 003843 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA-----DSFNL 685 (792)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~-----~~~~~ 685 (792)
++||+|||-|..+... .+.-..|..|.|||++.+..|+..+||||++|++|||+||..-|+.... ++.++
T Consensus 392 ~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 0334444444332211 1223568899999999999999999999999999999999987765332 22211
Q ss_pred c--cc-----hhhhccc-----------Ccccc--------ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003843 686 L--GH-----AWDLWKD-----------DRVHD--------LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSD 739 (792)
Q Consensus 686 ~--~~-----~~~~~~~-----------~~~~~--------~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 739 (792)
. .. .+..... +.+.. +.+-...+...+.++..++.+++.-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1 10 0111111 11110 011111234567778889999999999999999999999
Q ss_pred HHHH
Q 003843 740 VISM 743 (792)
Q Consensus 740 vl~~ 743 (792)
.+++
T Consensus 547 cl~h 550 (590)
T KOG1290|consen 547 CLKH 550 (590)
T ss_pred HhcC
Confidence 9854
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=230.84 Aligned_cols=261 Identities=25% Similarity=0.275 Sum_probs=191.7
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------C
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 540 (792)
..+|.-++.+|.|.- .|-.+-+ -.++.||+|++... .....++..+|...+..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788999988 5555533 35889999988543 344567778999999999999999999998643 3
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
+.|+|||+|. .+|...+. -.++-+.+..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 6799999995 46766663 23677888899999999999999999 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCc-ccccc----c---------
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA-DSFNL----L--------- 686 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~-~~~~~----~--------- 686 (792)
+..... -..+.++.|..|.|||++.+..+...+||||+||++.||++|+.-|...+. +.... +
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 865433 234456889999999999998899999999999999999999977653221 11000 0
Q ss_pred ---cchhhhccc------CccccccccccccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 687 ---GHAWDLWKD------DRVHDLIDPVIMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 687 ---~~~~~~~~~------~~~~~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+...... -...+.+...+... +.+.-....+.+++.+||..+|++|.++++++.+
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000000 01111111111011 1112234567899999999999999999999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=218.42 Aligned_cols=252 Identities=19% Similarity=0.313 Sum_probs=186.8
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeee-eeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC-CVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~ 546 (792)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.++... ...++|.+|...--.| .|.||+.-+++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4679999999999999999999865 6679999886543 3457899998776666 58999987765 56667788999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc--CCCCeeecccccceecC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFG 624 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kL~DFGla~~~~ 624 (792)
||++.|+|.+-+ ....+.+.-..+++.|++.|+.|||+.+ +||||||.+||||- +..++||||||+.+..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998877 3345778888899999999999999998 99999999999993 33479999999998654
Q ss_pred CCccccccceeecccceeCcccccCC-----CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
.. .....-+..|.+||..... ...+.+|||.||+++|.+++|++||......... -+.|..|..+...
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~--Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP--YWEWEQWLKRKNP 247 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch--HHHHHHHhcccCc
Confidence 22 1122335679999987532 2468899999999999999999999844332222 2233344433322
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+-+. -....+.+.++.++-+..++++|=-+.++.++
T Consensus 248 ~~P~~-------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPKK-------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCchh-------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 21111 11234567788888999999999544444443
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=196.19 Aligned_cols=113 Identities=45% Similarity=0.772 Sum_probs=100.4
Q ss_pred ccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCCceEEEe
Q 003843 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (792)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst 111 (792)
+.|..|+.|+|+++.|++|||.+... ..+.+|||+..+.++||+|||+.|+.+ ++.|.|+.||+|+|++.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 56888999999999999999988654 689999998877789999999999876 5889999999999999999999999
Q ss_pred ccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCC
Q 003843 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (792)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (792)
++.......+++|+|+|||||++..+ .++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEeCCCCC
Confidence 98744455688999999999999766 699999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-25 Score=230.11 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=198.2
Q ss_pred HHHHhcCccccceecccCceeEEEEEEcC----CcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 466 ITAATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 466 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
+....+.|..+++||+|.|++||++.+.. .+.||+|.+...+ ....+.+|++.|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34456788999999999999999997643 5689999986543 336688999999999 4999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeeccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGL 619 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGl 619 (792)
...+|+||++.....++.. .++..++..++..++.||+++|.+| ||||||||+|+|.+.. +.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999988877762 3678899999999999999999999 9999999999999754 6789999999
Q ss_pred ceecCCCc------c-------c---------------------c--------ccceeecccceeCcccccC-CCCCCcC
Q 003843 620 ARMFGGDE------L-------Q---------------------G--------NTKQIVGTYGYMSPEYALD-GLFSIKS 656 (792)
Q Consensus 620 a~~~~~~~------~-------~---------------------~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~ 656 (792)
|....... . . . ......||++|.|||++.. ...+.+.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98321100 0 0 0 0012368999999999875 4679999
Q ss_pred ceeehhHHHHHHHhCCCCCCCCCccccccccch--------------hh---hcccCcccc---------ccc-ccccc-
Q 003843 657 DVFSFGILMLETLSSKKNTGVYNADSFNLLGHA--------------WD---LWKDDRVHD---------LID-PVIMQ- 708 (792)
Q Consensus 657 DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~--------------~~---~~~~~~~~~---------~~~-~~l~~- 708 (792)
||||-|||++-+++++.||-....+...+...+ .. .+...++.. -++ ..+..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999865444332221110 00 111111000 010 00101
Q ss_pred -------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 -------DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+|+..||.+|.|+++.+++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01111224478999999999999999999999765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-25 Score=264.55 Aligned_cols=197 Identities=19% Similarity=0.242 Sum_probs=139.3
Q ss_pred hcCC-CCcceEeeee-------eecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003843 523 KLQH-RNLVRLLGCC-------VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594 (792)
Q Consensus 523 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 594 (792)
.++| .||++++++| .+....++++|++ +++|.++|... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 5788888877 2334677888987 56999998432 345999999999999999999999998 9
Q ss_pred eecCCCCCcEEEcC-------------------CCCeeecccccceecCCCcc--------------ccccceeecccce
Q 003843 595 IHRDLKASNILLDK-------------------DMNPKISDFGLARMFGGDEL--------------QGNTKQIVGTYGY 641 (792)
Q Consensus 595 vH~Dlkp~NILl~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 641 (792)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44567777777764311000 0001123578899
Q ss_pred eCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHH
Q 003843 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYIN 721 (792)
Q Consensus 642 ~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~ 721 (792)
||||++.+..++.++|||||||+||||++|.+|+..... ... ... ...+.+. ......+...
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~----~~~----~~~~~~~------~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMS----SLR----HRVLPPQ------ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHH----HHH----HhhcChh------hhhcCHHHHH
Confidence 999999999999999999999999999998877542110 000 000 0001110 0112334568
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 003843 722 VALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 722 li~~cl~~dp~~RPs~~evl~~ 743 (792)
++.+||+.+|.+||+|.|++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=205.26 Aligned_cols=167 Identities=20% Similarity=0.137 Sum_probs=123.9
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 631 (792)
|+|.+++.. .+..+++.+++.++.||++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 577777743 2346999999999999999999999886 999999999999999 99998764322
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 711 (792)
..||+.|||||++.+..++.++|||||||++|||++|+.|+........... ...... ... .+. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~-----~~~-~~~--~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE-ILLNGM-----PAD-DPR--DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH-HHHHHh-----ccC-Ccc--cccc
Confidence 2588999999999999999999999999999999999999854322111000 000000 000 000 0011
Q ss_pred CHHHH--HHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 712 SLPML--MRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 712 ~~~~~--~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..... .++.+++.+||+.+|++||++.|+++++...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11122 2689999999999999999999999998653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=219.95 Aligned_cols=177 Identities=20% Similarity=0.236 Sum_probs=135.7
Q ss_pred HHHhcCccccceecccCceeEEEEEEc--CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
....++|++.+.||+|+||+||+|++. +++.||||++... .....+.|.+|+++|++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345688999999999999999999875 4777899987533 22345679999999999999999853322 2
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCcEEEcCCCCeeecccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFG 618 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kL~DFG 618 (792)
+..++||||+++++|.... .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 4679999999999996221 11 1 1467889999999999998 999999 9999999999999999999
Q ss_pred cceecCCCccc------cccceeecccceeCcccccCCC------CCCcCcee
Q 003843 619 LARMFGGDELQ------GNTKQIVGTYGYMSPEYALDGL------FSIKSDVF 659 (792)
Q Consensus 619 la~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~------~s~~~DVw 659 (792)
+|+.+...... .......+++.|+|||++...+ .+..+|-|
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99987543211 1113456788999999986543 23446666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=212.54 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=192.0
Q ss_pred CccccceecccCceeEEEEEEcCC--cEEEEEEecccCchhHHHHHHHHHHHhhcCC----CCcceEeeee-eecCeeEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLNG--QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH----RNLVRLLGCC-VEQGEKIL 544 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 544 (792)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999987654 4788888766543333378889999999873 5888888888 47778899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-----CCeeeccccc
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGL 619 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kL~DFGl 619 (792)
||+.+ |.+|.++..... .+.++..+.++|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99976 788888764433 567999999999999999999999999 9999999999999765 4599999999
Q ss_pred ce--ecCCCcc----cc-c-cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh
Q 003843 620 AR--MFGGDEL----QG-N-TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 620 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 691 (792)
++ .+..... .. . .....||..|.+++.+.+...+.+.|+||++.++.|++.|..||........ ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~---- 247 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KS---- 247 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HH----
Confidence 99 4321111 11 1 2345699999999999999999999999999999999999999854332111 00
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
............. ..... ..++.++...+-..+..++|....+...|....
T Consensus 248 ~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR---FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHHhhhhcccc---ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 0000000000000 01112 233444444444589999999999999986653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=198.84 Aligned_cols=260 Identities=29% Similarity=0.392 Sum_probs=197.6
Q ss_pred ccccceecccCceeEEEEEEcCCcEEEEEEecccCch---hHHHHHHHHHHHhhcCCC-CcceEeeeeeecCeeEEEEEe
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ---GLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 548 (792)
|++.+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999886 88999998654332 467899999999999988 799999999777778999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-CeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 627 (792)
+.++++.+++........+.......++.|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866532211136889999999999999999999999 99999999999999998 79999999998665443
Q ss_pred ccc----ccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCcc--ccccccchhhhcccCcc
Q 003843 628 LQG----NTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNAD--SFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 628 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 698 (792)
... ......|+..|+|||.+.+ ...+...|+||+|++++++++|..|+...... ........ .....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcCC
Confidence 221 2355789999999999988 57889999999999999999999996544321 01111110 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ...... ...........+.+++..++..+|..|.++.+....
T Consensus 233 ~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-cccccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000 000002223567889999999999999999987764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=189.15 Aligned_cols=202 Identities=22% Similarity=0.308 Sum_probs=169.1
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.-+|++.++||+|.||+++.|+. .+++.||||.-...++ .-++..|....+.| ..++|...+.+-.++.+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 56899999999999999999974 5799999998754332 24566778888877 57899999988889989999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-----CCeeeccccccee
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-----MNPKISDFGLARM 622 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-----~~~kL~DFGla~~ 622 (792)
.+ |-+|.++..- -.+.++.++++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 6788776521 2345899999999999999999999998 9999999999999644 3489999999998
Q ss_pred cCCCcc-----ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 623 FGGDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 623 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
+..... ....+...||.+||+=..+.+.+.+.+.|+-|||-+++..|-|..||....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 854432 233456789999999999999999999999999999999999999997544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.1e-21 Score=183.81 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=190.1
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC-CCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 547 (792)
..+|.++++||.|+||.+|.|.. .+|.+||||.-++...+ .++.-|..+...++| ..|..+..+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 57899999999999999999975 56999999998654333 456778889999975 677788888888899999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---CCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kL~DFGla~~~~ 624 (792)
.+ |-+|.++..-- .+.++.++++.++-|++.-++|+|.++ +|||||||+|+|+.-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 77887765322 234788899999999999999999999 9999999999999654 458999999999874
Q ss_pred CCcc-----ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 625 GDEL-----QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 625 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
.... ........||.+|.+=..+.+...+.+.|+-|+|.+|..+.-|..||......... ..++.+.+....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---QKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---HHHHHHHHhhcC
Confidence 3321 22334568999999999888889999999999999999999999999754332111 111111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
..+.. ++.+ .+.++...+.-|-...-++-|...-+.+.+.
T Consensus 243 ~~ie~-LC~G-----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 243 TPIEV-LCKG-----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred CCHHH-HhCC-----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 11111 1111 1234555556666666677777766555543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.7e-22 Score=193.13 Aligned_cols=249 Identities=21% Similarity=0.365 Sum_probs=189.1
Q ss_pred CccccceecccCceeEEEEEEcCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
++.+..+|.+...|+.|+|++. |..+++|++.- -.....++|..|.-.|+-+.||||+++++.|.....+.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4455678999999999999994 55677777643 23444578999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec--ccccceecCCCc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS--DFGLARMFGGDE 627 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~--DFGla~~~~~~~ 627 (792)
+.|+|...|++. ..-.++..++.+++.++|+|++|||+..+ -|.---|....+++|++.+.+|. |--++..
T Consensus 270 p~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred cchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999999654 33457788999999999999999999873 13344689999999999988774 3222211
Q ss_pred cccccceeecccceeCcccccCCCCC---CcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFS---IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.....-.+.||+||.++..+-+ .++|+|||.++||||.|...||....+-+... +. ..+-+
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----ki-----alegl-- 406 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----KI-----ALEGL-- 406 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----hh-----hhccc--
Confidence 1112336799999999877654 57999999999999999999997544322110 00 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+..+++..+..+.+++.-|+..||.+||.+..|+-+|++-
T Consensus 407 ---rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 ---RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ---cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2233444556788999999999999999999999998863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=225.18 Aligned_cols=253 Identities=20% Similarity=0.278 Sum_probs=186.7
Q ss_pred ccceecccCceeEEEEEEc-CCcEEEEEEec----c-cCchh-HHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 475 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS----N-QSGQG-LKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..+.+|.|++|.|+..... ..+..+.|.+. . ..... ...+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988777543 23333444322 1 11111 1225668888888999999988888877776666699
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++ +|..++. ....+...++..++.|++.|+.|||+.| |.|||+|++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9988873 3346888899999999999999999999 9999999999999999999999999999875443
Q ss_pred cc--cccceeecccceeCcccccCCCCCCc-CceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQ--GNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. ......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||............... ..-..+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-----~~~~~~~-- 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-----SDQRNIF-- 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----ccccccc--
Confidence 33 44556789999999999999999765 89999999999999999999765433222100000 0000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.....+......+.+.++.++|+.+|++|.|+++|++
T Consensus 548 -~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 -EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0011122334567889999999999999999999975
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=167.62 Aligned_cols=88 Identities=35% Similarity=0.837 Sum_probs=82.6
Q ss_pred ceeeeeeccceeEEEEeecCCCceeeEEeCCCCceEEEEEeCCCCceEEeeeccCCcCCCCCCCCCCcccCCCCCCCccc
Q 003843 189 YKQFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQYCGKYGYCGANTICSLDQKPMCEC 268 (792)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~~C~~~g~CG~~g~C~~~~~~~C~C 268 (792)
+...+..+.++.||+|...+.+.++|++||.+|+++++.|++..++|.+.|.+|.++||+|+.||+||+|+.+..|.|+|
T Consensus 23 ~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~Cd~y~~CG~~g~C~~~~~~~C~C 102 (110)
T PF00954_consen 23 YNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQCDVYGFCGPNGICNSNNSPKCSC 102 (110)
T ss_pred eEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCCCCccccCCccEeCCCCCCceEC
Confidence 44456688999999999999999999999999999999999999999999999999999999999999999988999999
Q ss_pred cCCccccC
Q 003843 269 LEGFKLES 276 (792)
Q Consensus 269 ~~Gf~~~~ 276 (792)
|+||+|++
T Consensus 103 l~GF~P~n 110 (110)
T PF00954_consen 103 LPGFEPKN 110 (110)
T ss_pred CCCcCCCc
Confidence 99999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=186.55 Aligned_cols=171 Identities=16% Similarity=0.187 Sum_probs=134.9
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchh---HHH------HHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---LKE------FKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
..++|++.++||.|+||.||.... ++..+|||.+.+..... ... +.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 478999999999999999999755 67789999996543222 222 68999999999999999999886643
Q ss_pred --------CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 540 --------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 540 --------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
...+++|||++|.+|.++. .++. ....+++.+|..||..+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997763 1222 24569999999999999 99999999999999988
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHH
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ell 669 (792)
++|+|||........... ..+.....+..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988755322110 11345556778999999999987764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=182.73 Aligned_cols=139 Identities=18% Similarity=0.166 Sum_probs=108.8
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCch--h-------HHH-----------------HHHHHHHHhhcCCCCc
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--G-------LKE-----------------FKNEMMLIAKLQHRNL 529 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 529 (792)
.+.||+|+||.||+|...+|+.||||+++..... . ... ..+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999653211 0 112 2349999999988776
Q ss_pred ceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCceeecCCCCCcEEEcC
Q 003843 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLKASNILLDK 608 (792)
Q Consensus 530 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivH~Dlkp~NILl~~ 608 (792)
.....+. ....++||||++++++...+. +...++..++..++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433222 223489999999987754431 234688999999999999999999 6888 99999999999998
Q ss_pred CCCeeecccccceec
Q 003843 609 DMNPKISDFGLARMF 623 (792)
Q Consensus 609 ~~~~kL~DFGla~~~ 623 (792)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-19 Score=176.39 Aligned_cols=142 Identities=20% Similarity=0.239 Sum_probs=112.3
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEecccCch--------------------------hHHHHHHHHHHHhhcCCCC
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--------------------------GLKEFKNEMMLIAKLQHRN 528 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~n 528 (792)
+.+.||+|+||.||+|+..+|+.||||+++..... ....+.+|.+.+.++.|++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999878999999998754211 0122467899999999998
Q ss_pred cceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEc
Q 003843 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 529 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~ 607 (792)
+.....+... ..++||||++++++..... ....++..+...++.|++.++.+||+ .+ |+||||||+||+++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 7544443332 3489999999885533321 23457788999999999999999999 88 99999999999999
Q ss_pred CCCCeeecccccceecCC
Q 003843 608 KDMNPKISDFGLARMFGG 625 (792)
Q Consensus 608 ~~~~~kL~DFGla~~~~~ 625 (792)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 88999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-19 Score=207.05 Aligned_cols=252 Identities=20% Similarity=0.229 Sum_probs=181.0
Q ss_pred CccccceecccCceeEEEEEEcCCcEEEEEEecccC-chhHHHHHHHHHHH--hhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-GQGLKEFKNEMMLI--AKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++...+.||++.|=+|.+|++++|. |+||++-+.. .-.++.|+++++-+ ..++|||.+++.-.-..+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777799999999999999998887 9999986654 44566666554444 445899999998877777777888887
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC-CCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~-~~~ 627 (792)
..+ +|.+.| ..+..|...+...|+.|++.||..+|..+ |+|||||.+||||+.=.=+.|+||-.-+... .++
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 744 566665 44556788888899999999999999999 9999999999999998889999998766432 122
Q ss_pred cccccceee----cccceeCcccccCC----------C-CCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhh
Q 003843 628 LQGNTKQIV----GTYGYMSPEYALDG----------L-FSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 628 ~~~~~~~~~----gt~~y~aPE~~~~~----------~-~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 691 (792)
.......+. .-..|+|||.+... . .+++-||||+||++.||++ |+++|...+ +... .
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aY--r 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAY--R 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhH--h
Confidence 222222222 23479999987441 2 6788999999999999998 566765211 1100 0
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.........++.. + +...++++++.|++.||.+|.++++.++.-.+.
T Consensus 249 ~~~~~~~e~~Le~------I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGNADDPEQLLEK------I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCccCHHHHHHh------C---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0000000111110 0 112678999999999999999999999986553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-19 Score=199.10 Aligned_cols=232 Identities=25% Similarity=0.314 Sum_probs=183.2
Q ss_pred eecccCceeEEEEE----EcCCcEEEEEEecccCchh--HHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEEecC
Q 003843 478 KLGEGGFGPVYKGR----LLNGQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
.+|.|.||.|+..+ .+.++.+|+|.+++..... ....+.|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999864 3357778999886543211 124566888899887 9999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+|.|...+. +...+.+.....+...++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999977763 3445677777788889999999999999 99999999999999999999999999987643322
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
.+||..|||||++. .....+|.||||++++||++|..||.. + ....++.. +-.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~---------------~~~~Il~~---~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D---------------TMKRILKA---ELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H---------------HHHHHhhh---ccC
Confidence 28999999999998 567889999999999999999999874 0 01111211 234
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCH--HHHHHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTM--SDVISMI 744 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~--~evl~~L 744 (792)
.+......+.+++..++..+|..|.-. ..+.+++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 456667788899999999999999755 3444443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-18 Score=190.55 Aligned_cols=214 Identities=27% Similarity=0.376 Sum_probs=162.9
Q ss_pred HhhcCCCCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCce-eecCC
Q 003843 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI-IHRDL 599 (792)
Q Consensus 521 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i-vH~Dl 599 (792)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.-...++++|++||+|||+.. | .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578999999999999999999999999999999999965 3345888889999999999999999876 4 99999
Q ss_pred CCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCC-------CCCcCceeehhHHHHHHHhCC
Q 003843 600 KASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSSK 672 (792)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~s~~~DVwSlGvll~elltg~ 672 (792)
++.|+++|....+||+|||+.................-..-|.|||.+.... .+.++||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999998764311111111122356799999997641 467799999999999999999
Q ss_pred CCCCCCCccccc--cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 673 KNTGVYNADSFN--LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 673 ~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.||......... .+.. .+. .....+.|.+.... +...++..++..||..+|.+||++++|...++..
T Consensus 156 ~~~~~~~~~~~~~eii~~----~~~-~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILR----VKK-GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHH----HHh-cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999864433221 1111 111 11222333321111 2333789999999999999999999999998775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.7e-19 Score=206.51 Aligned_cols=202 Identities=21% Similarity=0.235 Sum_probs=161.9
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC---CCCcceEeeeeeecC
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQG 540 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 540 (792)
.++....+.|.|.+.||+|+||+||+|...+|+.||+|+-+....-. |---.+++.+|+ -+.|+.+..++.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 34455678999999999999999999998889999999986654321 111122333333 244566666666777
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-------CCCCee
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-------KDMNPK 613 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-------~~~~~k 613 (792)
.-++|+||.+.|+|.+++. ..+.++|...+.++.|+++.+++||..+ |||+||||+|+||. .+..++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 8899999999999999994 5667999999999999999999999999 99999999999993 234599
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCC
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p 674 (792)
|+|||-+-.+..-.........++|-.+-.+|+..+.+++.++|.|.|..+++-||.|+..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999765332222345567889999999999999999999999999999999998753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-18 Score=167.35 Aligned_cols=184 Identities=18% Similarity=0.136 Sum_probs=138.9
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEecccCch----hHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEEec
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ----GLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+...|++|+||+||.+.. .+.+++.+.+.....- ....|.+|+++|++++ |+++.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997765 6778887877543321 1235889999999995 5889999886 4469999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL-KASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dl-kp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+|.+|...+. . ....++.|++++|.++|.+| |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998854331 1 11357789999999999999 999999 79999999999999999999986543321
Q ss_pred c----c--c-----cceeecccceeCcccccCC-CCC-CcCceeehhHHHHHHHhCCCCCC
Q 003843 629 Q----G--N-----TKQIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSSKKNTG 676 (792)
Q Consensus 629 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~s-~~~DVwSlGvll~elltg~~p~~ 676 (792)
. . . ......++.|++|+...-. ..+ ...+.++.|.-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 0 0112357788888765433 334 56789999999999999988754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=176.63 Aligned_cols=234 Identities=19% Similarity=0.249 Sum_probs=150.9
Q ss_pred cCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhcCC----------CCcceEeeee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH----------RNLVRLLGCC 536 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~ 536 (792)
..+...+.||.|+++.||.+++.+ ++++|||++... .....+++++|......+.+ -.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345667899999999999999864 899999987433 23456778888766666433 2222222222
Q ss_pred e---------ec---C-----eeEEEEEecCCCccceeee---ccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 003843 537 V---------EQ---G-----EKILILEYMPNKSLNVFLF---DSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595 (792)
Q Consensus 537 ~---------~~---~-----~~~lv~E~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 595 (792)
. .. . ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+.| ++
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV 167 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV 167 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence 1 11 1 225566666 557766642 2111 223445556677799999999999999 99
Q ss_pred ecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccC--------CCCCCcCceeehhHHHHH
Q 003843 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLE 667 (792)
Q Consensus 596 H~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DVwSlGvll~e 667 (792)
|+||+|+|++++++|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+||+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 9999999999999999999999988765432211 234578999997643 257889999999999999
Q ss_pred HHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC
Q 003843 668 TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR 734 (792)
Q Consensus 668 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R 734 (792)
|.++..||+.......... . -..+. +.++.+..||..+|+.+|++|
T Consensus 243 lWC~~lPf~~~~~~~~~~~------------------~--f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW------------------D--FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG------------------G--GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc------------------c--chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999985433211100 1 12333 567788999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-17 Score=166.54 Aligned_cols=135 Identities=22% Similarity=0.288 Sum_probs=105.8
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhc-----CCCCcceEeeeeeecC---e-eEEE
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-----QHRNLVRLLGCCVEQG---E-KILI 545 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lv 545 (792)
-.++||+|+||.||. +++....+||++........+.+.+|+.++..+ .||||+++++++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 443333479988765445567899999999999 5799999999998874 3 3378
Q ss_pred EEe--cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHH-HHHHhcCCCceeecCCCCCcEEEcC----CCCeeecccc
Q 003843 546 LEY--MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL-LYLHQYSRFRIIHRDLKASNILLDK----DMNPKISDFG 618 (792)
Q Consensus 546 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivH~Dlkp~NILl~~----~~~~kL~DFG 618 (792)
+|| +++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 567999999933 235554 35677888777 9999998 999999999999974 3479999944
Q ss_pred cc
Q 003843 619 LA 620 (792)
Q Consensus 619 la 620 (792)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.3e-17 Score=165.90 Aligned_cols=153 Identities=18% Similarity=0.170 Sum_probs=116.8
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEE--EcCCcEEEEEEecccCch------------------------hHHHHH
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQ------------------------GLKEFK 515 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~ 515 (792)
++-++......|++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+.
T Consensus 19 ~~~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (237)
T smart00090 19 ALYSLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE 98 (237)
T ss_pred HHHHHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence 334444445568999999999999999998 567999999998643210 112357
Q ss_pred HHHHHHhhcCCCC--cceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003843 516 NEMMLIAKLQHRN--LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593 (792)
Q Consensus 516 ~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 593 (792)
+|+..+.++.+.. +.++++. ...++||||+++.+|...+. ....+...+...++.||+.++++||+.+ .
T Consensus 99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~ 169 (237)
T smart00090 99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--E 169 (237)
T ss_pred HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--C
Confidence 8999999997633 3344432 24589999999988876542 2234556667899999999999999987 4
Q ss_pred eeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 594 IIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 594 ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|+||||||+||+++ ++.++|+|||++....
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999999 8899999999998644
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-17 Score=133.03 Aligned_cols=66 Identities=50% Similarity=1.105 Sum_probs=59.5
Q ss_pred cCCCCeEEEeccccCCCccccccccccCHHHHHHHHhhcCCceeeeccccCCCceeEEeccccccc
Q 003843 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDA 359 (792)
Q Consensus 294 C~~~d~f~~~~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~g~l~~~ 359 (792)
|+.+|+|+++++|++|++....++.++++++|++.|++||||+||+|.+++++++|++|+|+|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 556799999999999999777776779999999999999999999998777889999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-17 Score=167.77 Aligned_cols=197 Identities=18% Similarity=0.287 Sum_probs=133.6
Q ss_pred CCCCcceEeeeeee---------------------------cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHH
Q 003843 525 QHRNLVRLLGCCVE---------------------------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE 577 (792)
Q Consensus 525 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 577 (792)
+|||||++.++|.+ ...+|+||..++ .+|.+++.. ...+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 59999999988753 235677877664 367777632 2355666778999
Q ss_pred HHHHHHHHHHhcCCCceeecCCCCCcEEE--cCCC--CeeecccccceecCCC--c--cccccceeecccceeCcccccC
Q 003843 578 GIAQGLLYLHQYSRFRIIHRDLKASNILL--DKDM--NPKISDFGLARMFGGD--E--LQGNTKQIVGTYGYMSPEYALD 649 (792)
Q Consensus 578 ~ia~aL~yLH~~~~~~ivH~Dlkp~NILl--~~~~--~~kL~DFGla~~~~~~--~--~~~~~~~~~gt~~y~aPE~~~~ 649 (792)
|+++|+.|||.++ |.|||+|.+|||+ |+++ .+.|+|||.+-.-... + +....-...|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 3333 4788999987533221 1 1111122356778999998765
Q ss_pred CC--C----CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHH
Q 003843 650 GL--F----SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVA 723 (792)
Q Consensus 650 ~~--~----s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li 723 (792)
.+ . -.|+|.|+.|.+.||+++...||-...+-.... .. +.+ ..+ ...+......+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--r~---Yqe--------~qL--Palp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--RT---YQE--------SQL--PALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--hh---hhh--------hhC--CCCcccCChHHHHHH
Confidence 33 1 268999999999999999998985422111100 00 011 111 122333445778999
Q ss_pred HhccccCCCCCCCHHHHHHHH
Q 003843 724 LLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 724 ~~cl~~dp~~RPs~~evl~~L 744 (792)
...|+.||++|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876555444
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=157.54 Aligned_cols=146 Identities=18% Similarity=0.194 Sum_probs=114.3
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCc----------------------hhHHHHHHHHHHH
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG----------------------QGLKEFKNEMMLI 521 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l 521 (792)
.++......|.+.+.||+|+||.||++...+|+.||||++..... .....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344455555888899999999999999988899999998754220 0112367789999
Q ss_pred hhcCCCC--cceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 003843 522 AKLQHRN--LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDL 599 (792)
Q Consensus 522 ~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dl 599 (792)
..+.|++ +.+.++ ....++||||+++++|..+.. ......++.+++.++.++|+.+ |+|+||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998774 444443 245689999999999876642 0345678899999999999998 999999
Q ss_pred CCCcEEEcCCCCeeecccccceecCC
Q 003843 600 KASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 600 kp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+||++++++.++|+|||++..+..
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.9e-16 Score=160.71 Aligned_cols=134 Identities=20% Similarity=0.295 Sum_probs=113.6
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCc--------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 678899998653221 1124578899999999999998877777778889999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|++|.+++... .. .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998887321 12 77899999999999999998 99999999999999 78999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.8e-16 Score=155.67 Aligned_cols=130 Identities=23% Similarity=0.363 Sum_probs=106.8
Q ss_pred eecccCceeEEEEEEcCCcEEEEEEecccCc--------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.||+|+||.||+|.. ++..|++|+...... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 678899998643211 12356788999999999887766555666677789999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++++|.+++.... ..++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763211 078999999999999998 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.1e-16 Score=178.89 Aligned_cols=137 Identities=21% Similarity=0.345 Sum_probs=111.9
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEE-eccc-C------chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQ-S------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
...|...++||+|+||.||+|.+... .+++|+ +.+. . ....+.+.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456678999999999999987544 344443 2221 1 1123568899999999999999988888877778
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988772 35678999999999999998 9999999999999 67899999999997
Q ss_pred e
Q 003843 622 M 622 (792)
Q Consensus 622 ~ 622 (792)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.1e-17 Score=176.56 Aligned_cols=175 Identities=26% Similarity=0.344 Sum_probs=131.9
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
.+++.|+++...+|.++|.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766666668888999999999999999 66 999999999999999999999999999
Q ss_pred eecCCCc----cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhC-CCCCCCCCccccccccchhhhccc
Q 003843 621 RMFGGDE----LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 621 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
....... .....+...||..||+||.+.+..|+.|+||||||+||+|++.- ...+.. .
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------------~ 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------------I 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------------H
Confidence 8765443 22334557899999999999999999999999999999999971 111110 0
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 003843 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV 740 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev 740 (792)
....++-+-.+ ++........-+.|+.+++...|.+||++.++
T Consensus 467 ~t~~d~r~g~i--p~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ATLTDIRDGII--PPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhhhhhcCCC--ChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 00111111111 00111122244678899999999999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.5e-16 Score=182.28 Aligned_cols=211 Identities=23% Similarity=0.255 Sum_probs=144.1
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..+|..++.|..|+||.||..+++. .+.+|+|+-++. -- .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-li----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-LI----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc-hh----hhc---cccccCCccee------------------
Confidence 4678889999999999999998864 567888443211 00 001 12222233332
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC--
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD-- 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~-- 626 (792)
|+-...+. .-+.++... +.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 136 ---gDc~tllk---~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK---NIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc---cCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 22222221 112344332 77899999999 999999999999999999999999999864211
Q ss_pred -----------ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc
Q 003843 627 -----------ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 627 -----------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
...-..++++||+.|.|||++....|....|.|++|+|+||.+-|+.||..+.+++..
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf----------- 267 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF----------- 267 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH-----------
Confidence 0111234578999999999999999999999999999999999999999765544321
Q ss_pred CccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH
Q 003843 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM 737 (792)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 737 (792)
..++...+...+-......++++++.+.|+.+|..|--.
T Consensus 268 ---g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 268 ---GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred ---hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 111111111122233334577889999999999999533
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-14 Score=136.95 Aligned_cols=135 Identities=21% Similarity=0.245 Sum_probs=115.3
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC--CCcceEeeeeeecCeeEEEEEecCCC
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
+.+.||+|.++.||+++..+ +.+++|....... ...+.+|+.++..++| .++.+++.+...++..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899999865443 5678999999999976 58899998888888899999999988
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
.+..+ +......++.+++++|++||......++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566778899999999999987544599999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=144.37 Aligned_cols=137 Identities=20% Similarity=0.245 Sum_probs=98.7
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCch--hHHH----------------------HHHHHHHHhhcCCCC--c
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ--GLKE----------------------FKNEMMLIAKLQHRN--L 529 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 529 (792)
.+.||+|+||.||+|...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4789999999999999888999999988653211 1111 134666666664432 3
Q ss_pred ceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcC
Q 003843 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDK 608 (792)
Q Consensus 530 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~ 608 (792)
.+.+++ ...++||||++++.+........ .. ..+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh---hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 24689999999965432111100 01 15677899999999999999 77 99999999999999
Q ss_pred CCCeeecccccceecC
Q 003843 609 DMNPKISDFGLARMFG 624 (792)
Q Consensus 609 ~~~~kL~DFGla~~~~ 624 (792)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.1e-15 Score=172.42 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=190.2
Q ss_pred hcCccccceecccCceeEEEEEEcC--CcEEEEEEecccC--chhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 544 (792)
...|.+.+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+-..+. |.|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4567778889999999998876533 4457777665432 333445556888888886 9999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHH-hcCCCceeecCCCCCcEEEcCCC-Ceeeccccccee
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARM 622 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~ 622 (792)
+.||..++++.+.+... .....+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .+|++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999998877311 1113555667788999999999999 877 99999999999999999 999999999998
Q ss_pred cCC-Cccccccceeec-ccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 623 FGG-DELQGNTKQIVG-TYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 623 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............+ ......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~~ 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW-----KSNKGR 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee-----cccccc
Confidence 866 444444555678 9999999999885 45688999999999999999999987654433222111 111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
. ....-........++...++..+|..|.+.+++..
T Consensus 250 ~-------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 F-------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c-------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00001112234567778888899999999888743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.5e-14 Score=143.48 Aligned_cols=135 Identities=23% Similarity=0.279 Sum_probs=104.4
Q ss_pred ceec-ccCceeEEEEEEcCCcEEEEEEecccC-------------chhHHHHHHHHHHHhhcCCCCc--ceEeeeeeecC
Q 003843 477 CKLG-EGGFGPVYKGRLLNGQEVAVKRLSNQS-------------GQGLKEFKNEMMLIAKLQHRNL--VRLLGCCVEQG 540 (792)
Q Consensus 477 ~~LG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 540 (792)
..|| .|+.|+||++.. .+..++||++.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 888999999877 47789999874311 1223567889999999998875 66777654432
Q ss_pred ----eeEEEEEecCC-CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 541 ----EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 541 ----~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
..++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688877632 234443 3578999999999999 9999999999999999999999
Q ss_pred ccccceec
Q 003843 616 DFGLARMF 623 (792)
Q Consensus 616 DFGla~~~ 623 (792)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99999753
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-13 Score=113.63 Aligned_cols=71 Identities=21% Similarity=0.353 Sum_probs=60.8
Q ss_pred cCCCCeEEEeccccCCCccccccccccCHHHHHHHHhh---cCCceeeeccccCCCceeEEecccc-ccccCCCCCCCCc
Q 003843 294 CKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK---NCSCRAYANSNVKESSGCLMWYGDL-IDARRPIRNFTGQ 369 (792)
Q Consensus 294 C~~~d~f~~~~~~~~pd~~~~~~~~~~s~~~C~~~Cl~---nCsC~ay~~~~~~~~~~C~~w~g~l-~~~~~~~~~~~~~ 369 (792)
|...++|+++.+|++|++.. ++++||++.|++ ||||+||+|.+. ++||++|++++ ++++.+ ...+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~--~~~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKE--FSHGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhc--cCCCc
Confidence 45567899999999998764 689999999999 999999999753 46999999999 999876 44588
Q ss_pred eEEEe
Q 003843 370 SVYLR 374 (792)
Q Consensus 370 slylr 374 (792)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 99997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=9e-13 Score=147.60 Aligned_cols=141 Identities=24% Similarity=0.292 Sum_probs=101.8
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchhH------------------------------H----------HHHH
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGL------------------------------K----------EFKN 516 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 516 (792)
+.||.|++|.||+|++++|+.||||+.+....... + +|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 68999999999999999999999999865321110 0 2445
Q ss_pred HHHHHhhcC----CCCcceEeeeee-ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHH-HHHHHHhcC
Q 003843 517 EMMLIAKLQ----HRNLVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ-GLLYLHQYS 590 (792)
Q Consensus 517 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~ 590 (792)
|+..+.+++ |.+-+.+-.++. .....++||||++|++|.++...... .. ....++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666665552 333344433333 24567999999999999887632111 11 23456666666 478889888
Q ss_pred CCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 591 ~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
++|+|+||.||+++.+++++|+|||++..+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.6e-12 Score=108.18 Aligned_cols=80 Identities=41% Similarity=0.861 Sum_probs=64.9
Q ss_pred CcccCCC---CeEEEeccccCCCccccccccccCHHHHHHHHhhcCCceeeeccccCCCceeEEeccccccccCCCCCCC
Q 003843 291 SLECKSG---DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDLIDARRPIRNFT 367 (792)
Q Consensus 291 ~l~C~~~---d~f~~~~~~~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~g~l~~~~~~~~~~~ 367 (792)
+++|... +.|++++++++|++.... .+.++++|++.|++||+|+||+|.+ ++++|.+|.+.+.+.+.. ...
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~--~~~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSL--SSG 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEee--cCC
Confidence 4567554 699999999999875443 6789999999999999999999974 478999999999887754 334
Q ss_pred CceEEEecc
Q 003843 368 GQSVYLRVP 376 (792)
Q Consensus 368 ~~slylrl~ 376 (792)
+..+|||++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 678999984
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.7e-12 Score=140.41 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=180.1
Q ss_pred cCccccceecc--cCceeEEEEEE---cCCcEEEEEEecc--cCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 471 ENFSMQCKLGE--GGFGPVYKGRL---LNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 471 ~~y~~~~~LG~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
..+.+.+.+|. |.+|.||++.. .++..+|+|+-+. ..+.....=.+|+....++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999986 3577899997432 2223333335677777777 599999988889999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHH----HHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeeccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ----GLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDF 617 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DF 617 (792)
++-+|.+. .+|..+.+. ....++...++....+... ||.++|... ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 677666532 2334777788888888888 999999998 9999999999999999 88999999
Q ss_pred ccceecCCCcccccc---ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc
Q 003843 618 GLARMFGGDELQGNT---KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 618 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
|+...+......... ....|...|++||.. ...++...|+|++|.++.|...+.......-.. .|....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~~~r 339 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWSQLR 339 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Cccccc
Confidence 999998766533222 233678899999954 467789999999999999998876543211000 111111
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.. . ...++-.....++...+..+++.+|..|++.+.+..
T Consensus 340 ~~---~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QG---Y------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cc---c------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11 0 112222222345556888999999999998877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-11 Score=119.05 Aligned_cols=130 Identities=23% Similarity=0.191 Sum_probs=98.5
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcce-EeeeeeecCeeEEEEEecCCCccc
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR-LLGCCVEQGEKILILEYMPNKSLN 555 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~E~~~~gsL~ 555 (792)
+.|+.|.++.||+++.. ++.+++|....... ....+.+|++++..+.+.++++ ++.+ .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 67899999999999874 78899999765432 2235688999999987666554 4433 233468999999998875
Q ss_pred eeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 556 VFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 556 ~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
... . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 431 0 11245678999999999987 23469999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-11 Score=136.19 Aligned_cols=146 Identities=18% Similarity=0.242 Sum_probs=96.6
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCch------------------------------h----HH--
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQ------------------------------G----LK-- 512 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~----~~-- 512 (792)
...|+. +.||+|++|.||+|++++ |+.||||++++.-.+ . .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345766 789999999999999987 999999998654211 0 11
Q ss_pred ----HHHHHHHHHhhcC----CCCcceEeeeeee-cCeeEEEEEecCCCccceeeeccCCC---ccCCHHHHHHHHHHHH
Q 003843 513 ----EFKNEMMLIAKLQ----HRNLVRLLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKK---RLLNWQARVRIIEGIA 580 (792)
Q Consensus 513 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia 580 (792)
+|.+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+.+.++..-...+ ..+....+..++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 1334544444442 4444444444443 45778999999999997642111111 11222222223333
Q ss_pred HHHHHHHhcCCCceeecCCCCCcEEEcCCC----CeeecccccceecCCC
Q 003843 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFGLARMFGGD 626 (792)
Q Consensus 581 ~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kL~DFGla~~~~~~ 626 (792)
++..| ++|+|+||.||+++.++ +++++|||++..+...
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 34466 99999999999999988 9999999999987543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.4e-12 Score=128.05 Aligned_cols=205 Identities=20% Similarity=0.225 Sum_probs=140.5
Q ss_pred HHHhhcCCCCcceEeeeeeec-----CeeEEEEEecCCCccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 003843 519 MLIAKLQHRNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRF 592 (792)
Q Consensus 519 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~ 592 (792)
.-|-.+-|.|||+++.|+.+. ....++.|||..|+|..+|.+..+ ...+......+++.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 344556799999999887543 357889999999999999976544 345888888899999999999999975 6
Q ss_pred ceeecCCCCCcEEEcCCCCeeecccccceecCC---CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHH
Q 003843 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGG---DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669 (792)
Q Consensus 593 ~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ell 669 (792)
+|+|+++..+.|++..++-+|+.- +-...... ...........+-++|.|||.=.....+..+|||+||...+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 799999999999999999888742 11111110 01111122235678999999887778889999999999999998
Q ss_pred hCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 670 SSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 670 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.+..-....... ...+......+-. . +...-+.++..|++.+|..||+|++++.+.
T Consensus 277 ilEiq~tnseS~----------~~~ee~ia~~i~~----l-----en~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSESK----------VEVEENIANVIIG----L-----ENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcce----------eehhhhhhhheee----c-----cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 876532211100 0001111111000 0 000123567789999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-10 Score=128.33 Aligned_cols=168 Identities=18% Similarity=0.209 Sum_probs=128.6
Q ss_pred EcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHH
Q 003843 492 LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQA 571 (792)
Q Consensus 492 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~ 571 (792)
..++.+|.|+..+.......+..++-++.|+.++||||++++..+..++..|+|+|-+. .|..++. .+....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk------~l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK------ELGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH------HhHHHH
Confidence 34688899998877666555667888999999999999999999999999999999763 3444442 133566
Q ss_pred HHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCC
Q 003843 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651 (792)
Q Consensus 572 ~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 651 (792)
...-+.||+.||.|||+.+ .++|++|..+.|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6778899999999999777 599999999999999999999999999875432221 111122233566676554333
Q ss_pred CCCcCceeehhHHHHHHHhCCC
Q 003843 652 FSIKSDVFSFGILMLETLSSKK 673 (792)
Q Consensus 652 ~s~~~DVwSlGvll~elltg~~ 673 (792)
...|.|-||++++|++.|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --cchhhhhHHHHHHHHhCccc
Confidence 45699999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.1e-09 Score=107.98 Aligned_cols=137 Identities=15% Similarity=0.124 Sum_probs=99.0
Q ss_pred ceecccCceeEEEEEEcC-------CcEEEEEEeccc-------------C---------chhHHHHH----HHHHHHhh
Q 003843 477 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQ-------------S---------GQGLKEFK----NEMMLIAK 523 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 523 (792)
..||.|--+.||.|...+ +..+|||+.+.. . ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997543 478999986421 0 01122333 79999999
Q ss_pred cCC--CCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHH-HhcCCCceeecCCC
Q 003843 524 LQH--RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL-HQYSRFRIIHRDLK 600 (792)
Q Consensus 524 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivH~Dlk 600 (792)
+.. -++.+++++ ...++||||+.+..+..-. .+...++.++...+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 854 455566654 5678999999775442211 1122345566677889999999999 7787 9999999
Q ss_pred CCcEEEcCCCCeeecccccceecC
Q 003843 601 ASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~ 624 (792)
+.|||++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.5e-10 Score=112.19 Aligned_cols=142 Identities=18% Similarity=0.271 Sum_probs=111.4
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCC--CcceEeeeeeecC---eeEEEEEecC
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHR--NLVRLLGCCVEQG---EKILILEYMP 550 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~E~~~ 550 (792)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999887678999999765332 2456789999999999764 4566777766542 5689999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS---------------------------------------- 590 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------- 590 (792)
+.++...+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776521 34677788888889999999998531
Q ss_pred -------------CCceeecCCCCCcEEEcC--CCCeeeccccccee
Q 003843 591 -------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARM 622 (792)
Q Consensus 591 -------------~~~ivH~Dlkp~NILl~~--~~~~kL~DFGla~~ 622 (792)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-09 Score=103.22 Aligned_cols=143 Identities=24% Similarity=0.337 Sum_probs=107.0
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEE-EecccCc-------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVK-RLSNQSG-------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK-~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.+..|-+|+-+.|+++.. .|+.++|| ++.+... -...+-++|++++.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457899999999999988 57777777 4433221 12356788999999998767766566677777788999
Q ss_pred EecCC-CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeeccccccee
Q 003843 547 EYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARM 622 (792)
Q Consensus 547 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~DFGla~~ 622 (792)
||+++ .++.+++........ ..+....++..|-+.+.-||..+ |+|+||.++||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 467777654333222 22233678889999999999998 999999999999966553 58999999964
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-09 Score=103.26 Aligned_cols=131 Identities=22% Similarity=0.340 Sum_probs=102.2
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEE-ecccCc-h------hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKR-LSNQSG-Q------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~-~~~~~~-~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..+++|+-+.+|.+.+. |..+++|. +++... . -.++-.+|+.++.+++.-.|-...-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999764 44466663 333211 1 123457899999999877776666677788888999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
.+|..|.+++... ...++..+-..+.-||..+ |+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998887332 2467788888899999999 99999999999997765 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.3e-10 Score=122.53 Aligned_cols=248 Identities=19% Similarity=0.203 Sum_probs=175.4
Q ss_pred HHhcCccccceecccCceeEEEEEE--cCCcEEEEEEecccCchhHHHH--HHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEF--KNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
....+|..+..||.|.|+.|++... .++..+++|.+.+.......+. ..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999754 3577899998866544333332 3466666665 589999988888888888
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeecccccce
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLAR 621 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla~ 621 (792)
++=-||++++++...+ .-...+.+..++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+.
T Consensus 342 ~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 8889999999886665 23345778888999999999999999988 9999999999999886 788999999986
Q ss_pred ecCCCccccccceeec-ccce-eCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 622 MFGGDELQGNTKQIVG-TYGY-MSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~g-t~~y-~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
.+.-.. ..... +..| .+|+......+-.++|++|||.-+.|.+++..-..... ...
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------------~~~ 473 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------------QSL 473 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------------cce
Confidence 432111 11122 2334 36666677788999999999999999998865322100 001
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
.+....... ......++..+...+...++..||.+.++..+.+.
T Consensus 474 ~i~~~~~p~---~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 TIRSGDTPN---LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeecccccC---CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 111111101 11112456667777889999999999888766543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.8e-10 Score=129.12 Aligned_cols=250 Identities=18% Similarity=0.195 Sum_probs=169.3
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
..+.+.+.+-+-+|.++.++.++-. .|...++|..... .....+....+-.++-..+||-+++...-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4577888889999999999987532 2333333332211 11112222333333333456666666555566778899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
+++|..+++|...|+.. +..+.+-....+..+.++++|||... +.|+|++|.|+|...+++.++.|||+.....
T Consensus 882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 99999999998887543 23444455556677889999999987 8999999999999999999999998544321
Q ss_pred CC-------------------------ccc----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCC
Q 003843 625 GD-------------------------ELQ----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (792)
Q Consensus 625 ~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~ 675 (792)
.- ... .......+|+.|.+||...+......+|.|+.|++++|.++|.+|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 000 1122357899999999999999999999999999999999999998
Q ss_pred CCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003843 676 GVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS 738 (792)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 738 (792)
.....+.. +..++...+....-......+..+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~--------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI--------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhh--------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 75443211 11122222222222333455677888888899999997776
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.5e-08 Score=107.85 Aligned_cols=169 Identities=20% Similarity=0.292 Sum_probs=129.7
Q ss_pred ceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCeeEEEEEecCC-Ccccee
Q 003843 484 FGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILILEYMPN-KSLNVF 557 (792)
Q Consensus 484 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~~~-gsL~~~ 557 (792)
-.+.||+.. .+|..|++|+++....+.......-++..+++.|.|+|++..++.. +..+++||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788864 4799999999955444443344556889999999999999999873 4578999999985 466555
Q ss_pred eecc------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 558 LFDS------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 558 l~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
-+.. ..+...++..+|.++.|++.||.++|+.| +.-+-|.+.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4432 22345788999999999999999999999 99999999999999999999999998877644
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCC
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p 674 (792)
+.. |.+.+ -.+-|.=.||.+++.|.+|...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 11111 1346778899999999998654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.5e-08 Score=95.19 Aligned_cols=126 Identities=25% Similarity=0.296 Sum_probs=83.5
Q ss_pred eEEEEEEcCCcEEEEEEecccC--------------c------------hhHHHHHHHHHHHhhcCCCC--cceEeeeee
Q 003843 486 PVYKGRLLNGQEVAVKRLSNQS--------------G------------QGLKEFKNEMMLIAKLQHRN--LVRLLGCCV 537 (792)
Q Consensus 486 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~ 537 (792)
.||.|...+|..+|||+.+... . ......++|.+.|.++...+ +.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998899999999864210 0 01234578999999998664 4555543
Q ss_pred ecCeeEEEEEecC--CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHH-HHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 538 EQGEKILILEYMP--NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY-LHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 538 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
...++||||++ +..+..+... .++.+....++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 6555443311 11234456677788885555 56877 9999999999999988 9999
Q ss_pred cccccceecC
Q 003843 615 SDFGLARMFG 624 (792)
Q Consensus 615 ~DFGla~~~~ 624 (792)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.4e-08 Score=100.14 Aligned_cols=134 Identities=18% Similarity=0.151 Sum_probs=97.6
Q ss_pred ceeEEEEEEcCCcEEEEEEecccCch-hHH----------HHHHHHHHHhhcCCCCc--ceEeeeeee-----cCeeEEE
Q 003843 484 FGPVYKGRLLNGQEVAVKRLSNQSGQ-GLK----------EFKNEMMLIAKLQHRNL--VRLLGCCVE-----QGEKILI 545 (792)
Q Consensus 484 fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~lv 545 (792)
...|++..+ +|+.+.||+....... ..+ .+.+|...+.++...+| .+++++... ...-++|
T Consensus 35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 334667655 6788999977433211 112 47889999999854444 445556543 2357899
Q ss_pred EEecCCC-ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-------CCCeeeccc
Q 003843 546 LEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------DMNPKISDF 617 (792)
Q Consensus 546 ~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-------~~~~kL~DF 617 (792)
+|++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|++++|||++. +..+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999986 7888873221 223456677789999999999999999 999999999999975 467999999
Q ss_pred cccee
Q 003843 618 GLARM 622 (792)
Q Consensus 618 Gla~~ 622 (792)
+.++.
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=4e-07 Score=92.04 Aligned_cols=149 Identities=19% Similarity=0.214 Sum_probs=104.8
Q ss_pred cccHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEeccc----------C------------chhHHHHHHH
Q 003843 460 LFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----------S------------GQGLKEFKNE 517 (792)
Q Consensus 460 ~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----------~------------~~~~~~~~~E 517 (792)
...+..+.....-..+..+||-|--+.||.|....|.++|||.=+-. . .......++|
T Consensus 80 ~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rE 159 (304)
T COG0478 80 ALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAERE 159 (304)
T ss_pred HHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHH
Confidence 34455555545456677899999999999999999999999953211 0 0112345789
Q ss_pred HHHHhhcCCC--CcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCcee
Q 003843 518 MMLIAKLQHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595 (792)
Q Consensus 518 ~~~l~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iv 595 (792)
.++|.++... .+.+.+++ +...+||||+++-.|...- ++.+..-.++..|++-+..+-..| +|
T Consensus 160 f~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iV 224 (304)
T COG0478 160 FEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IV 224 (304)
T ss_pred HHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---cc
Confidence 9999998654 55555543 4567999999997774432 123333344445555555555666 99
Q ss_pred ecCCCCCcEEEcCCCCeeecccccceec
Q 003843 596 HRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 596 H~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
|+|+.+-||+++++|.+.++||--+...
T Consensus 225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 225 HGDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ccCCchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999999776543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.2e-06 Score=90.83 Aligned_cols=260 Identities=15% Similarity=0.144 Sum_probs=155.6
Q ss_pred cccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeee------eecC-eeEEE
Q 003843 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC------VEQG-EKILI 545 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~------~~~~-~~~lv 545 (792)
...+.||+|+-+.+|-.-. -...+.|+..........+ .+..|... .||-+-.-+.+= -+.+ ..-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457899999999996422 1223557776654433222 22333333 455433211110 1112 24566
Q ss_pred EEecCCCc-cceeeec---cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 546 LEYMPNKS-LNVFLFD---STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 546 ~E~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
|..+++.. ...++.. .+.-...+|.-.++.+..+|.+.+.||..| .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 66665542 2222211 122345789999999999999999999999 9999999999999999999999865544
Q ss_pred ecCCCccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhC-CCCCCCCCc--cccccccchhhhc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSS-KKNTGVYNA--DSFNLLGHAWDLW 693 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg-~~p~~~~~~--~~~~~~~~~~~~~ 693 (792)
...++. .....+|...|.+||.-. +..-+...|.|.||+++++++.| ++||..... +...-.+. .+
T Consensus 166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~I 239 (637)
T COG4248 166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DI 239 (637)
T ss_pred eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hh
Confidence 432221 222347888999999765 33446789999999999999987 888864321 11110000 00
Q ss_pred ccCccccccccc--c--ccCCCCHHH-HHHHHHHHHhcccc--CCCCCCCHHHHHHHHhcc
Q 003843 694 KDDRVHDLIDPV--I--MQDEISLPM-LMRYINVALLCVQE--NAADRPTMSDVISMINNE 747 (792)
Q Consensus 694 ~~~~~~~~~~~~--l--~~~~~~~~~-~~~l~~li~~cl~~--dp~~RPs~~evl~~L~~~ 747 (792)
..+.....-+.. . .....+... ...+..+..+|+.. ++.-||+++..+..|...
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 111111111111 0 011222222 34667777888865 367899999988888654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.4e-07 Score=101.20 Aligned_cols=142 Identities=17% Similarity=0.214 Sum_probs=96.0
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchh------------------------------HH----------HHHH
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG------------------------------LK----------EFKN 516 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 516 (792)
+.|+.++-|.||+|++++|+.||||+.++.-... .+ +|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999999999999999999975431110 11 1344
Q ss_pred HHHHHhhc----CCCCcceEeeeee-ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHH-HHHHHhcC
Q 003843 517 EMMLIAKL----QHRNLVRLLGCCV-EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG-LLYLHQYS 590 (792)
Q Consensus 517 E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~ 590 (792)
|+.-+.++ ++..-+++-.++. -.+..+++|||++|..+.++..... ..++.+.+ +..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 55555554 2333334444443 3567899999999999988853222 23443333 3333332 22333345
Q ss_pred CCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 591 ~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
+.|.|.+|.||+++.++++.+.|||+...+...
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999877543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-06 Score=88.78 Aligned_cols=107 Identities=24% Similarity=0.264 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhhcCCC--CcceEeeeeeecC----eeEEEEEecCCC-ccceeeeccCCCccCCHHHHHHHHHHHHHHH
Q 003843 511 LKEFKNEMMLIAKLQHR--NLVRLLGCCVEQG----EKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583 (792)
Q Consensus 511 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL 583 (792)
.....+|...+..++.. ...+.+++..... ..++|+|++++. +|.+++.... .++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 34678888888888543 4456666665532 458999999874 7888874321 256667788999999999
Q ss_pred HHHHhcCCCceeecCCCCCcEEEcCCC---Ceeecccccceec
Q 003843 584 LYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMF 623 (792)
Q Consensus 584 ~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kL~DFGla~~~ 623 (792)
+-||..| |+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.7e-08 Score=107.23 Aligned_cols=153 Identities=19% Similarity=0.314 Sum_probs=103.7
Q ss_pred HHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc------c-cceeecccceeCccccc
Q 003843 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG------N-TKQIVGTYGYMSPEYAL 648 (792)
Q Consensus 576 ~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~------~-~~~~~gt~~y~aPE~~~ 648 (792)
+.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+.......... . .........|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999876 59999999999999999999999999987654421110 0 11123356899999999
Q ss_pred CCCCCCcCceeehhHHHHHHHhCCCCC-CCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhcc
Q 003843 649 DGLFSIKSDVFSFGILMLETLSSKKNT-GVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCV 727 (792)
Q Consensus 649 ~~~~s~~~DVwSlGvll~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl 727 (792)
+...+.++|+||+|+++|-+..|..+. ...+.... .... ....+.. ..-++...+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~~-------~~~~~~~--~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSFS-------RNLLNAG--AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch----hhhh-------hcccccc--cccccccCcHHHHHHHHHHh
Confidence 989999999999999999999555443 22111100 0000 0001110 11122334567778888899
Q ss_pred ccCCCCCCCHHHHHHH
Q 003843 728 QENAADRPTMSDVISM 743 (792)
Q Consensus 728 ~~dp~~RPs~~evl~~ 743 (792)
..++..||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999987776543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.1e-06 Score=83.88 Aligned_cols=138 Identities=16% Similarity=0.197 Sum_probs=102.3
Q ss_pred ecccCceeEEEEEEcCCcEEEEEEecccC------chhHHHHHHHHHHHhhcCCCC--cceEeeeee-ec----CeeEEE
Q 003843 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRN--LVRLLGCCV-EQ----GEKILI 545 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~~----~~~~lv 545 (792)
-|+||-+-|+...+ +|+.+-+|+-.+.. +-....|.+|...|.++...+ +.+.. ++. .. -.-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46688888999776 45579999875321 335678999999999996433 44444 332 11 246799
Q ss_pred EEecCC-CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC--eeeccccccee
Q 003843 546 LEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARM 622 (792)
Q Consensus 546 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kL~DFGla~~ 622 (792)
+|-+++ .+|.+++.+. .-...+......++.++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5777776332 1224567777899999999999999999 999999999999987677 99999987764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=80.33 Aligned_cols=138 Identities=17% Similarity=0.202 Sum_probs=95.2
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHH---------HHHHHHHhhcCCCC---cceEeeee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEF---------KNEMMLIAKLQHRN---LVRLLGCC 536 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~l~~~~ 536 (792)
...+|.+.+++-......|.+-.. +|+.+++|..++......+.| .+++..+.+++... ...++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 467888888888888777877766 678999998876544333333 23444455553322 22322222
Q ss_pred e-----ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 537 V-----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 537 ~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
. .....+++|||++|..|.++.. ++. .++..+.+++.-||+.| +.|+|..|+|++++.+ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence 2 2235578999999998866641 222 24566778899999999 9999999999999855 4
Q ss_pred eeeccccccee
Q 003843 612 PKISDFGLARM 622 (792)
Q Consensus 612 ~kL~DFGla~~ 622 (792)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.29 E-value=2e-06 Score=71.90 Aligned_cols=72 Identities=38% Similarity=0.771 Sum_probs=54.0
Q ss_pred CeEEEeccccCCCccccccccccCHHHHHHHHhh-cCCceeeeccccCCCceeEEec-cccccccCCCCCCCCceEEEe
Q 003843 298 DQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLK-NCSCRAYANSNVKESSGCLMWY-GDLIDARRPIRNFTGQSVYLR 374 (792)
Q Consensus 298 d~f~~~~~~~~pd~~~~~~~~~~s~~~C~~~Cl~-nCsC~ay~~~~~~~~~~C~~w~-g~l~~~~~~~~~~~~~slylr 374 (792)
..|.+++++.+++..... ....++++|++.|++ +|+|.||.|.. .+++|.+|. +.+.+... ....+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~~--~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDARL--FPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCcccccee--cccCCceeEEe
Confidence 569999999999664332 345799999999999 99999999974 578999999 66655542 23444555554
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=9.1e-06 Score=83.09 Aligned_cols=133 Identities=17% Similarity=0.157 Sum_probs=86.8
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc--ceEeeeeeecCeeEEEEEecCCCc-
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLGCCVEQGEKILILEYMPNKS- 553 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~lv~E~~~~gs- 553 (792)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-.+ .+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567888876533 33456889999999865444 567777777777889999999963
Q ss_pred cceeeeccCCCccCCHHHHHHHHHHHHHHHH---------------------------------------HHHhc-CCCc
Q 003843 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLL---------------------------------------YLHQY-SRFR 593 (792)
Q Consensus 554 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~---------------------------------------yLH~~-~~~~ 593 (792)
+...+. .+......++..+++.+. +|... ....
T Consensus 82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 221110 011111111222222222 22211 2334
Q ss_pred eeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 594 IIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 594 ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|+|+.|.||++++++ +.|+||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 78999999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-05 Score=72.81 Aligned_cols=100 Identities=26% Similarity=0.412 Sum_probs=67.9
Q ss_pred CeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEe-cCCCCCCCCCceEEEeeCCcEEEEcCCCceEEEeccCCC
Q 003843 38 EKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVA-NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSE 116 (792)
Q Consensus 38 ~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~ 116 (792)
+.+.+.+|.+.|-|...|+ |-|... ..+++|.+ +...... ..+.|.|..||||||+|..+.++|++.. .
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFD--Y 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--S
T ss_pred cccccccccccceECCCCe-----EEEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecC--C
Confidence 4565655999999999885 555432 25779999 4333332 4678999999999999999999999943 2
Q ss_pred CCcceEEEec--CCcEEEeeCCCCCCcccccccccCCCc
Q 003843 117 VKNPVAQLRD--DGNLVIRDNSSGNATESYLWQSFDYPT 153 (792)
Q Consensus 117 ~~~~~~~l~d--~GNlvl~~~~~~~~~~~~~WqSFd~Pt 153 (792)
...+....++ +||++ +.... .+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~~-----~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKNDS-----LTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EESTS-----SEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccce-----EEeECCCCCCC
Confidence 3456667777 89999 65443 56888877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-05 Score=90.60 Aligned_cols=142 Identities=19% Similarity=0.225 Sum_probs=93.2
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchh---------------------------HH----------HHHHHHH
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---------------------------LK----------EFKNEMM 519 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~----------~~~~E~~ 519 (792)
+.||.-+.|.||+|++++|+.||||+-++.-.+. .+ +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999875432111 01 2444554
Q ss_pred HHhhc----CCCC---cceEeeeeee-cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003843 520 LIAKL----QHRN---LVRLLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591 (792)
Q Consensus 520 ~l~~l----~h~n---iv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 591 (792)
-..++ .|-+ -|.+-.++.+ ....+|+||||+|..+.+...- .+..++...+..-+.+... .-|-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~--~qIf~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYL--EQIFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHH--HHHHhcC-
Confidence 44443 3555 2223334433 4578999999999988777432 2223555544433333222 1222344
Q ss_pred CceeecCCCCCcEEEcC----CCCeeecccccceecCC
Q 003843 592 FRIIHRDLKASNILLDK----DMNPKISDFGLARMFGG 625 (792)
Q Consensus 592 ~~ivH~Dlkp~NILl~~----~~~~kL~DFGla~~~~~ 625 (792)
++|+|=+|.||++.. ++.+.+-|||+...+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999984 67799999999987644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=4e-05 Score=78.55 Aligned_cols=144 Identities=22% Similarity=0.225 Sum_probs=85.4
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEeeeeee---cCeeEEEEEecC
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVE---QGEKILILEYMP 550 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---~~~~~lv~E~~~ 550 (792)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+.... +.+++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3689999999999999866 69999997654 45677888999998885333 4566654432 234689999999
Q ss_pred CCccce----------------eee---cc-CCCccCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 003843 551 NKSLNV----------------FLF---DS-TKKRLLNWQA---------RVRI------------IEGIAQ-GLLYLHQ 588 (792)
Q Consensus 551 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-aL~yLH~ 588 (792)
+..+.. .+. .. .....+.... .... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 110 00 0000011000 0000 111222 2333332
Q ss_pred ----cCCCceeecCCCCCcEEEc-CCCCeeeccccccee
Q 003843 589 ----YSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 622 (792)
Q Consensus 589 ----~~~~~ivH~Dlkp~NILl~-~~~~~kL~DFGla~~ 622 (792)
.....++|+|+.|+|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1344599999999999999 666678999988864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=4e-05 Score=79.50 Aligned_cols=141 Identities=14% Similarity=0.132 Sum_probs=86.0
Q ss_pred eecccCc-eeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEEecCCCccc
Q 003843 478 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLN 555 (792)
Q Consensus 478 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 555 (792)
.|-.|.. ..||+.... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 688998764 4788888876543 345678999998884 434556777776666789999999998876
Q ss_pred eeee-------------------ccCC-CccCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 003843 556 VFLF-------------------DSTK-KRLLNW--QARVRIIE--------------------GIAQGLLYLHQ----Y 589 (792)
Q Consensus 556 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~aL~yLH~----~ 589 (792)
.... .... ...+.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 0000 000000 00000000 01111222211 1
Q ss_pred CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 590 ~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234589999999999999987789999998853
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.3e-06 Score=97.14 Aligned_cols=189 Identities=16% Similarity=0.123 Sum_probs=136.2
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC-cceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN-LVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 548 (792)
++-+.....+++|++++++|.+....+....+.+... ....-++++|.+++||| .++.++-+..+...++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 4445555778999999999987644444455655432 34456889999999999 66777767777788899999
Q ss_pred cCCC-ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 549 MPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
+..+ +-..-. ....-.+..-+...+...-++++++||+.. =+|+| ||+..+ +..|..||+....+....
T Consensus 316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9776 211111 011112333344456666778899999874 58998 777765 678999999998775543
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCC
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~ 676 (792)
..+...+++.++|||+..+..+..+.|+|++|+-..+|--|-+|..
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3445678999999999999999999999999998778777766643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.99 E-value=9.2e-05 Score=74.52 Aligned_cols=154 Identities=19% Similarity=0.214 Sum_probs=99.0
Q ss_pred ccHHHHHHHhcCccccce---ecccCceeEEEEEEcCCcEEEEEEecccCchh---------HHH---------------
Q 003843 461 FSLASITAATENFSMQCK---LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQG---------LKE--------------- 513 (792)
Q Consensus 461 ~~~~~i~~~~~~y~~~~~---LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~--------------- 513 (792)
.++..+.....+..+... |..|--+.||+|...++..+|||+++...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345555555566655554 55677778999988889999999985432111 001
Q ss_pred HHHHHHHHhhcC--CCCcceEeeeeeecCeeEEEEEecCCCcc-ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC
Q 003843 514 FKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILILEYMPNKSL-NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590 (792)
Q Consensus 514 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 590 (792)
..+|+.-|.++. +-.+.+.+++. .-.|||||+....+ .=.| +.-.+...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 134666666653 33333444332 34799999965421 0011 1112333356677788888888887733
Q ss_pred CCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 591 ~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
.+||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 399999999999999 88999999999976543
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.4e-06 Score=73.78 Aligned_cols=55 Identities=31% Similarity=0.588 Sum_probs=43.6
Q ss_pred eEEEeeCCcEEEEcCC-CceEEEeccCCCCC-cceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 89 VLTISNNGNLVLLNQT-NGTIWSTNVSSEVK-NPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~wst~~~~~~~-~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.+.++.||+||+++.. +.+||++++..... +..+.|+++|||||++.++ .++|+|
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S 79 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDG-----RVVWSS 79 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCC-----CEEEEe
Confidence 3566789999999765 58999999864433 3678899999999998765 678987
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=4.6e-05 Score=75.34 Aligned_cols=105 Identities=22% Similarity=0.232 Sum_probs=83.1
Q ss_pred HHHHHHHhhcCC-CCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 003843 515 KNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593 (792)
Q Consensus 515 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 593 (792)
.+|.-+++.+++ +++.+++|+|- .+++.||...+++...-..-..-...+|..+.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 69999999993 3678999987765422000011123689999999999999999999866556
Q ss_pred eeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 594 IIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 594 ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+.-.|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999999999999999999887654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.1e-05 Score=70.84 Aligned_cols=131 Identities=20% Similarity=0.281 Sum_probs=90.7
Q ss_pred ccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 473 FSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
.+..+.|++|.+|.||++.+ .|.++|+|+-+.. .....+..|+++|..++-.++.+=+..+- .-++.|||+.|-
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~ 97 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCc
Confidence 34557899999999999988 4568899987643 34578899999999998877765333222 223459999998
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC-CCcEEEcCCCCeeeccccccee
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK-ASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk-p~NILl~~~~~~kL~DFGla~~ 622 (792)
.|.+.-... +- +-+..+++.---|...| |-|+.|. |..++|-.++.+.|+||..|..
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 875553111 11 22334555545556666 9999987 4555555555999999999974
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.4e-05 Score=72.47 Aligned_cols=55 Identities=31% Similarity=0.532 Sum_probs=43.1
Q ss_pred EEEee-CCcEEEEcCC-CceEEEeccCCC-CCcceEEEecCCcEEEeeCCCCCCccccccccc
Q 003843 90 LTISN-NGNLVLLNQT-NGTIWSTNVSSE-VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (792)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~wst~~~~~-~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (792)
+.++. ||+||+++.. +.+||++++... .....+.|.++|||||++.++ .++|+|=
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S~ 81 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG-----TVVWSSN 81 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCC-----cEEEEec
Confidence 45665 9999999764 589999998652 345578899999999998766 6789864
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00021 Score=87.29 Aligned_cols=80 Identities=18% Similarity=0.383 Sum_probs=58.7
Q ss_pred cceecccCceeEEEEEEcCC---cEEEEEEecccC-chhHHHHHHHHHHHhhcC-CCCc--ceEeeeeeec---CeeEEE
Q 003843 476 QCKLGEGGFGPVYKGRLLNG---QEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQ-HRNL--VRLLGCCVEQ---GEKILI 545 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 545 (792)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 467888764432 123357889999999995 6665 6777777654 467899
Q ss_pred EEecCCCccc
Q 003843 546 LEYMPNKSLN 555 (792)
Q Consensus 546 ~E~~~~gsL~ 555 (792)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999987543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00029 Score=70.07 Aligned_cols=132 Identities=18% Similarity=0.259 Sum_probs=91.9
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccC----------------chhHHHHHHHHHHHhhcC------CCCcceEe
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----------------GQGLKEFKNEMMLIAKLQ------HRNLVRLL 533 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 533 (792)
...||+|+.-.||. +++....+||++.... ....+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 36799999999996 4566778899886554 223566677777766665 78899999
Q ss_pred eeeeecCeeEEEEEecCC--C----ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc
Q 003843 534 GCCVEQGEKILILEYMPN--K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 534 ~~~~~~~~~~lv~E~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 607 (792)
|...++.-.-+|+|.+.+ | +|.+++ +.+.++. ...+. +-+-..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 3 344554 3334544 33333 334455666666 99999999999995
Q ss_pred CCC----Ceeecc-cccc
Q 003843 608 KDM----NPKISD-FGLA 620 (792)
Q Consensus 608 ~~~----~~kL~D-FGla 620 (792)
... .+.|+| ||-.
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 432 467776 3433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00056 Score=73.09 Aligned_cols=78 Identities=14% Similarity=0.120 Sum_probs=57.4
Q ss_pred cccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC---CCcceEeeeeee---cCeeEEEEE
Q 003843 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVE---QGEKILILE 547 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~E 547 (792)
.-.+.||.|..+.||+....++ .+++|..+.. .....|.+|++.|+.+.. ..+.++++++.. .+..++|||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3346899999999999876555 4666775431 123578899999999853 357788887754 356899999
Q ss_pred ecCCCcc
Q 003843 548 YMPNKSL 554 (792)
Q Consensus 548 ~~~~gsL 554 (792)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00025 Score=73.17 Aligned_cols=75 Identities=12% Similarity=0.162 Sum_probs=47.6
Q ss_pred ceecccCce-eEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC---CcceEeeeeeec---CeeEEEEEec
Q 003843 477 CKLGEGGFG-PVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQ---GEKILILEYM 549 (792)
Q Consensus 477 ~~LG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~E~~ 549 (792)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|++++..+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567877776 48875 345777875542 2345788999999888532 233344333222 1347899999
Q ss_pred CCCcccee
Q 003843 550 PNKSLNVF 557 (792)
Q Consensus 550 ~~gsL~~~ 557 (792)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99887543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00041 Score=71.45 Aligned_cols=74 Identities=19% Similarity=0.246 Sum_probs=49.7
Q ss_pred ceecccCceeEEEEEEcC--CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcc-eEeeeeeecCeeEEEEEecCCCc
Q 003843 477 CKLGEGGFGPVYKGRLLN--GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKS 553 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gs 553 (792)
+.|..|-...+|+....+ ++.|++|+........ -...+|+.++..+...+++ ++++.+ + ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 578888888999988754 6789999775432221 2235788888888544444 444332 2 247999999977
Q ss_pred cc
Q 003843 554 LN 555 (792)
Q Consensus 554 L~ 555 (792)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00039 Score=72.71 Aligned_cols=139 Identities=14% Similarity=0.084 Sum_probs=80.6
Q ss_pred eecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcc-eEeeeeeecCeeEEEEEecCCCccce
Q 003843 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPNKSLNV 556 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL~~ 556 (792)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....++ +++... .-++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456677888998874 5778889876543322212357899999998654443 333332 1368999999877653
Q ss_pred ee-----------------eccC-CCccCCHHH-HHHHHHH---------HHHHHHHHHhc-----CCCceeecCCCCCc
Q 003843 557 FL-----------------FDST-KKRLLNWQA-RVRIIEG---------IAQGLLYLHQY-----SRFRIIHRDLKASN 603 (792)
Q Consensus 557 ~l-----------------~~~~-~~~~l~~~~-~~~i~~~---------ia~aL~yLH~~-----~~~~ivH~Dlkp~N 603 (792)
-. +... ....++... ......+ +...+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 20 1100 011122211 1111111 11112222211 12358999999999
Q ss_pred EEEcCCCCeeeccccccee
Q 003843 604 ILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~ 622 (792)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0012 Score=72.63 Aligned_cols=74 Identities=14% Similarity=0.201 Sum_probs=53.7
Q ss_pred ceecccCceeEEEEEEcCC-cEEEEEEeccc-----C--chhHHHHHHHHHHHhhcC---CCCcceEeeeeeecCeeEEE
Q 003843 477 CKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQ-----S--GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 545 (792)
+.||.|.+..||++...+| +.++||.-... . +...+++..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999998776 58999985321 1 224567788888888863 2345566655 44567899
Q ss_pred EEecCCC
Q 003843 546 LEYMPNK 552 (792)
Q Consensus 546 ~E~~~~g 552 (792)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00068 Score=66.87 Aligned_cols=125 Identities=25% Similarity=0.423 Sum_probs=89.3
Q ss_pred cCccccceecccCc-eeEEEEEEcCCcEEEEEEecc---c---------Cc---------hhHHHHHHHHHHHhhcC---
Q 003843 471 ENFSMQCKLGEGGF-GPVYKGRLLNGQEVAVKRLSN---Q---------SG---------QGLKEFKNEMMLIAKLQ--- 525 (792)
Q Consensus 471 ~~y~~~~~LG~G~f-g~Vy~~~~~~~~~vavK~~~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 525 (792)
..++.++.||.|.- |.||++++ +|+.+|+|.+.. . .. .-.+-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 99999998 688999999421 0 00 11235778888888875
Q ss_pred CCCc--ceEeeeeeecC------------------eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHH
Q 003843 526 HRNL--VRLLGCCVEQG------------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585 (792)
Q Consensus 526 h~ni--v~l~~~~~~~~------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~y 585 (792)
+.++ |+++|+..-.. ...+|.||.+... .+ ...-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4456 89999874321 1245666654322 11 22345677778889
Q ss_pred HHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 586 LH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99998 999999999985 3578999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0026 Score=68.00 Aligned_cols=143 Identities=18% Similarity=0.169 Sum_probs=86.6
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEeee------eeecCeeEEEEE
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC------CVEQGEKILILE 547 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~E 547 (792)
.+.|..|....+|+.... +..+++|+... ...+....|++++..+.+.+ +.+++.. ...++..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 457788888899998764 45788898764 23356677888888885433 3444432 123445689999
Q ss_pred ecCCCcccee----e----------ecc----CC----CccCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 003843 548 YMPNKSLNVF----L----------FDS----TK----KRLLNWQARV----------RIIEGIAQGLLYLHQY----SR 591 (792)
Q Consensus 548 ~~~~gsL~~~----l----------~~~----~~----~~~l~~~~~~----------~i~~~ia~aL~yLH~~----~~ 591 (792)
|++|..+... + +.. .. .....|.... .....+..++.++... -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876431 0 000 00 0011111110 0112233444555431 12
Q ss_pred CceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 592 FRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 592 ~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00034 Score=51.71 Aligned_cols=45 Identities=38% Similarity=0.685 Sum_probs=35.5
Q ss_pred CCCCCCCCCCCcccccccCCCCCCCCCC-CCcccccceeeccccCC
Q 003843 748 HLNLPSPKEPAFTKGINVKNSSHSNSGT-SEHCSVNDVTVSLIYPR 792 (792)
Q Consensus 748 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 792 (792)
...+|.||+|+|+.++...+...+++.+ ...+++|++|+|.|+||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 4679999999999977766553333333 48899999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0019 Score=69.32 Aligned_cols=141 Identities=27% Similarity=0.344 Sum_probs=84.4
Q ss_pred ceecccCceeEEEEEEcC-------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcc-eEeeeeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLN-------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~ 548 (792)
+.|..|--..+|+....+ ++.+++|+...... ......+|.+++..+....+. ++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 456667777899987654 47899999765432 223457888888888644444 4455443 2 358999
Q ss_pred cCCCcccee-e----------------eccCCCc------cCC--HHHHHH--------------------------HHH
Q 003843 549 MPNKSLNVF-L----------------FDSTKKR------LLN--WQARVR--------------------------IIE 577 (792)
Q Consensus 549 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 577 (792)
++|..+... + +...... ..+ +..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998876432 1 1100000 011 111100 111
Q ss_pred HHHHHHHHHHh------cCCCceeecCCCCCcEEEcCC----CCeeeccccccee
Q 003843 578 GIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 622 (792)
Q Consensus 578 ~ia~aL~yLH~------~~~~~ivH~Dlkp~NILl~~~----~~~kL~DFGla~~ 622 (792)
.+...+..|.. ..+..++|+|+.+.|||++++ +.++|+||+.+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134569999999999999985 8899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0021 Score=77.01 Aligned_cols=198 Identities=18% Similarity=0.187 Sum_probs=135.3
Q ss_pred HHHHHHHHHhhcCCCCcceEeeeeeecCeeE----EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh
Q 003843 513 EFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588 (792)
Q Consensus 513 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 588 (792)
....|...+.++.|+|+++++.|-.+....- +..|++..-++...+ .....++......+..++.+||+|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3455778888899999999999887654332 335667666666555 334567888888899999999999999
Q ss_pred cCCCceeecCCCCC---cEEEcCCCCeeec--ccccceecCCCccccccceeecccceeCcccccCCCCCC--cCceeeh
Q 003843 589 YSRFRIIHRDLKAS---NILLDKDMNPKIS--DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSI--KSDVFSF 661 (792)
Q Consensus 589 ~~~~~ivH~Dlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~~DVwSl 661 (792)
.. ..|.-+..+ +.-.+.++...+. ||+.++.+...... ....-+..+.+||......+.. ..|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHH
Confidence 85 566555555 4555666777777 99988876543221 1123355678888887766554 4799999
Q ss_pred hHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 662 GILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 662 Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
|..+..+..|..+..... ....+++... ...+......|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~-----------------~~~~~l~~~~---------~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-----------------VPVSLLDVLS---------TSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc-----------------chhhhhcccc---------chhhhhhhhhhcchhhhhccchhhhh
Confidence 999999998875532110 0011111100 01456777889999999999999998
Q ss_pred HHHh
Q 003843 742 SMIN 745 (792)
Q Consensus 742 ~~L~ 745 (792)
.+.-
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 8764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0072 Score=64.35 Aligned_cols=138 Identities=19% Similarity=0.250 Sum_probs=87.0
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecc--cCchhHHHHHHHHHHHhhcCC--CCcceEeeeeeecC--eeEEEEEec
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQG--EKILILEYM 549 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~ 549 (792)
.+.+..|..-.+|..... +++++++ ... ..........+|+.+|+.+.- .-..+.+++|.++. ..+.||+|.
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344434444445555443 7788888 331 223344556778888888753 23445567776665 679999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHH-HHHHHHHHHHHhc---------------------------------------
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRII-EGIAQGLLYLHQY--------------------------------------- 589 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~aL~yLH~~--------------------------------------- 589 (792)
+|..+...+.... .. .+++ ..+++.|+-||+-
T Consensus 108 eGe~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 108 EGEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred cceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 9865544331111 01 1222 2555666666641
Q ss_pred ----------------CCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 590 ----------------SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 590 ----------------~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
++..++|+|+.+.||+++.+.-+-|.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2345999999999999999988999999999753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.013 Score=63.45 Aligned_cols=141 Identities=19% Similarity=0.207 Sum_probs=77.0
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEee------eeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLG------CCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lv~E~ 548 (792)
+.|+.|....+|+....+| .+++|++.... .+....|+.++..+...+ +.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5577788789999876555 68899875222 233344555665553222 223332 11234567899999
Q ss_pred cCCCcccee-----------e---eccCC--------CccC-CHHHHHH------------HH-HHHHHHHHHHHhc---
Q 003843 549 MPNKSLNVF-----------L---FDSTK--------KRLL-NWQARVR------------II-EGIAQGLLYLHQY--- 589 (792)
Q Consensus 549 ~~~gsL~~~-----------l---~~~~~--------~~~l-~~~~~~~------------i~-~~ia~aL~yLH~~--- 589 (792)
++|..+... | +.... ...+ .|..... .+ ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 998765321 0 00000 0011 1111111 11 1111222333211
Q ss_pred -CCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 590 -SRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 590 -~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
-+..++|+|+.|.||+++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12349999999999999976556899999886
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0063 Score=66.47 Aligned_cols=141 Identities=17% Similarity=0.244 Sum_probs=83.6
Q ss_pred ceecccCceeEEEEEEcC-----CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcc-eEeeeeeecCeeEEEEEecC
Q 003843 477 CKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~ 550 (792)
+.|-.|---.+|+....+ ++.|++|+.........++ .+|..+++.+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455557777899987532 3679999886654444444 7799999988655554 455555332 5899998
Q ss_pred CCcccee-----------------eeccC-C-Cc-cCCHHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 003843 551 NKSLNVF-----------------LFDST-K-KR-LLNWQARVRIIEGI-----------------AQGLLYL----HQ- 588 (792)
Q Consensus 551 ~gsL~~~-----------------l~~~~-~-~~-~l~~~~~~~i~~~i-----------------a~aL~yL----H~- 588 (792)
+.+|..- ++... . .. ...+.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 01100 0 01 11123222222111 1112222 21
Q ss_pred cCCCceeecCCCCCcEEEcC-CCCeeeccccccee
Q 003843 589 YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 622 (792)
Q Consensus 589 ~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~ 622 (792)
..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345899999999999986 46899999988863
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.011 Score=62.36 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=75.7
Q ss_pred ecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC-CcceEeeeeeecCeeEEEEEecCCCcccee
Q 003843 479 LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR-NLVRLLGCCVEQGEKILILEYMPNKSLNVF 557 (792)
Q Consensus 479 LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~~~~gsL~~~ 557 (792)
.++|--..|+.....+|+.+++|+-+. ........+|+++|..+... -+ +.-.+... ..-+++|++++|..+...
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~v-pvP~~~~~-~~~~~~y~~i~G~p~~~~ 94 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPV-QVPDWRVH-TPELIAYPKLPGVPAATI 94 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCC-CCCceeee-cCceEEEeccCCCccccc
Confidence 444544556655444688899988753 23346678999999998531 11 11111111 123567888877655322
Q ss_pred eeccCC--CccCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 003843 558 LFDSTK--KRLLNWQARVRIIEGIAQGLLYLHQ----------------------------------------------- 588 (792)
Q Consensus 558 l~~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~----------------------------------------------- 588 (792)
-..... -..........++.++++.|+-||+
T Consensus 95 ~~~~~~~~~~~~~~~~~~~la~~la~~La~LH~i~~~~~~~~g~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ 174 (276)
T cd05152 95 DPEIGEYVWNFDHKNPPEVFIESLAKALAELHSIPQDEAEAAGIPVETPEEVRQTMADRMDRVKEEFGVSEALWNRWQAW 174 (276)
T ss_pred CcccccceecccCCCcCHHHHHHHHHHHHHHhCCChhhccccCCCCCCHHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHH
Confidence 100000 0000001111233334444444431
Q ss_pred -------cCCCceeecCCCCCcEEEcCCCC-eeeccccccee
Q 003843 589 -------YSRFRIIHRDLKASNILLDKDMN-PKISDFGLARM 622 (792)
Q Consensus 589 -------~~~~~ivH~Dlkp~NILl~~~~~-~kL~DFGla~~ 622 (792)
..+..++|+|++|.|||++++++ .-|+||+.+..
T Consensus 175 L~~~~~~~~~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 175 LDDDSYWPRHTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred HhhcCCCCCCCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 11234899999999999997555 56999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0095 Score=63.01 Aligned_cols=75 Identities=17% Similarity=0.222 Sum_probs=49.3
Q ss_pred cccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC---CCCcceEeeeeeecCeeEEEEEecC
Q 003843 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
+-.+.|+.|....+|+.. .+++.+.||.-. ......|..|++-|+.|. -..+.+++++...++..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 334678999999999987 578899999876 334467888888888884 3456688888877777899999998
Q ss_pred CC
Q 003843 551 NK 552 (792)
Q Consensus 551 ~g 552 (792)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.028 Score=60.41 Aligned_cols=143 Identities=20% Similarity=0.217 Sum_probs=82.5
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEeeee------eecCeeEEEEE
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCC------VEQGEKILILE 547 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~E 547 (792)
.+.++.|....+|+....++ .+++|+..... ..+....|.+++..+.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999876444 67788875422 1234556677777774322 33443321 22456789999
Q ss_pred ecCCCcccee--------------eeccCCC---------ccCCHHHHH------------HHHHHHHHHHHHHHh----
Q 003843 548 YMPNKSLNVF--------------LFDSTKK---------RLLNWQARV------------RIIEGIAQGLLYLHQ---- 588 (792)
Q Consensus 548 ~~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~aL~yLH~---- 588 (792)
|++|..+... ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665321 0100000 001111110 011123344555543
Q ss_pred cCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 589 ~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.-...++|+|+.+.||++++++...|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 113459999999999999998877899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.004 Score=64.97 Aligned_cols=145 Identities=14% Similarity=0.189 Sum_probs=98.3
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEec----------cc-------Cchh-----HHHHHHHHH
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS----------NQ-------SGQG-----LKEFKNEMM 519 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~----------~~-------~~~~-----~~~~~~E~~ 519 (792)
.+.++.....-+.+.++||-|--+-||.+-..+|++.++|.-+ +. .... .-...+|..
T Consensus 83 AlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 83 ALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred HHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 3444444444577889999999999999999889999998421 00 0001 112356888
Q ss_pred HHhhcC-CCC-cceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 003843 520 LIAKLQ-HRN-LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597 (792)
Q Consensus 520 ~l~~l~-h~n-iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~ 597 (792)
.|+.+. |-. +.+.++ ....++|||++.+-.|...-+ ..+... +...+..-+.-|..+| +||+
T Consensus 163 fmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHg 226 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHG 226 (465)
T ss_pred HHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceec
Confidence 888884 322 333443 345689999999988865531 122233 3333444456677778 9999
Q ss_pred CCCCCcEEEcCCCCeeeccccccee
Q 003843 598 DLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 598 Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
|+.-=||++++++.++++||--.-.
T Consensus 227 DFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 227 DFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ccchheeEEecCCCEEEeechHhhc
Confidence 9999999999999999999965543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.026 Score=60.05 Aligned_cols=143 Identities=19% Similarity=0.224 Sum_probs=96.9
Q ss_pred cccceecccCceeEEEEEEcCCcEEEEEEeccc-------C--chh----------------HH-HHHHHHHHHhhcCCC
Q 003843 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ-------S--GQG----------------LK-EFKNEMMLIAKLQHR 527 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~-------~--~~~----------------~~-~~~~E~~~l~~l~h~ 527 (792)
.+...|..|--+.||.+.-.+|..+|||+++.. . ..+ .+ -...|++-|++|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445678889999999999989999999987421 0 000 00 124577777777654
Q ss_pred CcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc
Q 003843 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 528 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 607 (792)
.|...--+.. ...+|||+|+.... +-....+...++...+..+-.+++.-|.-|.+.+ ++||.||.--|+|+.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4321111111 23478999985322 2211223445777788888889999999998887 599999999999985
Q ss_pred CCCCeeecccccceecC
Q 003843 608 KDMNPKISDFGLARMFG 624 (792)
Q Consensus 608 ~~~~~kL~DFGla~~~~ 624 (792)
+|.+.|+|-+-+....
T Consensus 300 -dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHD 315 (520)
T ss_pred -CCEEEEEEccccccCC
Confidence 5689999988776543
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.0035 Score=51.54 Aligned_cols=35 Identities=26% Similarity=0.592 Sum_probs=30.3
Q ss_pred ccCHHHHHHHHhhcCCceeeeccccCCCceeEEeccc
Q 003843 319 RMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGD 355 (792)
Q Consensus 319 ~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~g~ 355 (792)
..+.++|++.|+.+|+|.||.|. .+.+.|+++.+.
T Consensus 24 ~~s~~~Cq~~C~~~~~C~afT~~--~~~~~C~lk~~~ 58 (73)
T cd01100 24 ASSAEQCQAACTADPGCLAFTYN--TKSKKCFLKSSE 58 (73)
T ss_pred cCCHHHHHHHcCCCCCceEEEEE--CCCCeEEcccCC
Confidence 46899999999999999999997 346789998875
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.0089 Score=60.42 Aligned_cols=123 Identities=21% Similarity=0.275 Sum_probs=60.6
Q ss_pred CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEEEecCCCccceeeec-------------
Q 003843 495 GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKSLNVFLFD------------- 560 (792)
Q Consensus 495 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~------------- 560 (792)
.+.|+||+....... .-.-.+|..+++.+...++ .++++.+..+ .|+||+++..|..--..
T Consensus 2 ~~~~~~Ri~g~~t~~-~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTEN-FIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGCS-HHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCccc-ccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence 467888888765433 3445778999988865555 4555554332 57799977665331100
Q ss_pred ------c--CCCccCCHHHHHHH----------------------HHHHHHHHHHHH----hc-CCCceeecCCCCCcEE
Q 003843 561 ------S--TKKRLLNWQARVRI----------------------IEGIAQGLLYLH----QY-SRFRIIHRDLKASNIL 605 (792)
Q Consensus 561 ------~--~~~~~l~~~~~~~i----------------------~~~ia~aL~yLH----~~-~~~~ivH~Dlkp~NIL 605 (792)
. .....-.+..+..+ +..+.+-+..+. .. ....+.|+|+.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 0 00000011111111 011111122221 11 1234899999999999
Q ss_pred E-cCCCCeeeccccccee
Q 003843 606 L-DKDMNPKISDFGLARM 622 (792)
Q Consensus 606 l-~~~~~~kL~DFGla~~ 622 (792)
+ +.++.++|+||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.03 Score=60.80 Aligned_cols=141 Identities=16% Similarity=0.231 Sum_probs=80.9
Q ss_pred ceecccCceeEEEEEEcC----CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcc-eEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~ 551 (792)
+.|..|---.+|+....+ +..|++|+.........+ -.+|..+++.+...++. ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557777889886543 237899988665443333 36789999998766664 5555553 22 58999987
Q ss_pred Ccccee-------e----------eccC--CCc-cCCHHHHHHHHHHH----------------------HHHHHH----
Q 003843 552 KSLNVF-------L----------FDST--KKR-LLNWQARVRIIEGI----------------------AQGLLY---- 585 (792)
Q Consensus 552 gsL~~~-------l----------~~~~--~~~-~l~~~~~~~i~~~i----------------------a~aL~y---- 585 (792)
..|..- + +... ... .-.+..+.++..++ .+-+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 765321 0 1100 000 11122222222111 111111
Q ss_pred HHh-cCCCceeecCCCCCcEEEcC-CCCeeeccccccee
Q 003843 586 LHQ-YSRFRIIHRDLKASNILLDK-DMNPKISDFGLARM 622 (792)
Q Consensus 586 LH~-~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~ 622 (792)
+.. .....++|+|+.+.|||+++ ++.++++||+.|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 11234899999999999975 57899999998853
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.079 Score=58.42 Aligned_cols=73 Identities=10% Similarity=0.049 Sum_probs=49.9
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccC-------chhHHHHHHHHHHHhhcC---CCCcceEeeeeeecCeeEEE
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS-------GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 545 (792)
.+.||.|....||+... .++.++||+-.... +...++-..|++.|+.+. ...+.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999886 45679999764211 123344455566666653 246777887766 456788
Q ss_pred EEecCC
Q 003843 546 LEYMPN 551 (792)
Q Consensus 546 ~E~~~~ 551 (792)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.046 Score=59.13 Aligned_cols=73 Identities=15% Similarity=0.176 Sum_probs=47.6
Q ss_pred eecccCceeEEEEEEcCC-cEEEEEEecc-------cCchhHHHHHHHHHHHhhcC--CCCcceEeeeeeecCeeEEEEE
Q 003843 478 KLGEGGFGPVYKGRLLNG-QEVAVKRLSN-------QSGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 478 ~LG~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E 547 (792)
.||.|....||++...+| +.|+||.-.. .-+-..++..-|.+.|.... -|..++-+- +.++....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 589999999999998654 6899997532 11333455566777776653 344443322 334556678999
Q ss_pred ecCC
Q 003843 548 YMPN 551 (792)
Q Consensus 548 ~~~~ 551 (792)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 792 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-23 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-23 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-19 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-19 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-19 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-19 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-19 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-19 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-19 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-17 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 9e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-132
Identities = 101/299 (33%), Positives = 154/299 (51%), Gaps = 19/299 (6%)
Query: 458 LPLFSLASITAATENFSMQC------KLGEGGFGPVYKGRLLNGQEVAVKRLSN----QS 507
FS + T NF + K+GEGGFG VYKG + N VAVK+L+ +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT 70
Query: 508 GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLL 567
+ ++F E+ ++AK QH NLV LLG + + L+ YMPN SL L L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+W R +I +G A G+ +LH+ IHRD+K++NILLD+ KISDFGLAR
Sbjct: 131 SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687
T +IVGT YM+PE L G + KSD++SFG+++LE ++ + + LL
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHREPQLLLD 245
Query: 688 HAWDLWKDDR-VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
++ +++ + D ID + ++ + +VA C+ E RP + V ++
Sbjct: 246 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-131
Identities = 115/298 (38%), Positives = 175/298 (58%), Gaps = 7/298 (2%)
Query: 457 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLK-EFK 515
L FSL + A++NFS + LG GGFG VYKGRL +G VAVKRL + QG + +F+
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ 75
Query: 516 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVR 574
E+ +I+ HRNL+RL G C+ E++L+ YM N S+ L + + + L+W R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 575 IIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ 634
I G A+GL YLH + +IIHRD+KA+NILLD++ + DFGLA++ + T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA- 194
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT---GVYNADSFNLLGHAWD 691
+ GT G+++PEY G S K+DVF +G+++LE ++ ++ + N D LL
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749
L K+ ++ L+D +Q + + I VALLC Q + +RP MS+V+ M+ + L
Sbjct: 255 LLKEKKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-117
Identities = 102/286 (35%), Positives = 169/286 (59%), Gaps = 6/286 (2%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-LNWQARVRIIEGI 579
++ +H +LV L+G C E+ E ILI +YM N +L L+ S + ++W+ R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
A+GL YLH + IIHRD+K+ NILLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN-ADSFNLLGHAWDLWKDDRV 698
GY+ PEY + G + KSDV+SFG+++ E L ++ + NL A + + ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
++DP + D+I L ++ + A+ C+ ++ DRP+M DV+ +
Sbjct: 266 EQIVDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 3e-92
Identities = 70/310 (22%), Positives = 124/310 (40%), Gaps = 32/310 (10%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
++ + + G FG V+K +L + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 521 IAKLQHRNLVRLLGCCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
+ ++H N+++ +G + LI + SL+ FL K +++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 577 EGIAQGLLYLHQ-------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629
E +A+GL YLH+ + I HRD+K+ N+LL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 630 GNTKQIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 684
G+T VGT YM+PE + ++ D+++ G+++ E S +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--Y 245
Query: 685 LLGHAWDLWKDDR--------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 736
+L ++ + VH PV+ + C +A R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 737 MSDVISMINN 746
V I
Sbjct: 306 AGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-80
Identities = 72/334 (21%), Positives = 129/334 (38%), Gaps = 41/334 (12%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 521 IAKLQHRNLVRLLGCCVE-----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRI 575
+ ++H N+ R + + E +L++EY PN SL +L +W + R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 576 IEGIAQGLLYLHQ------YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG---- 625
+ +GL YLH + + I HRDL + N+L+ D ISDFGL+ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 626 --DELQGNTKQIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSSKKNT 675
E VGT YM+PE L+G ++ + D+++ G++ E +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 676 GVYNADSFNLLGHAWDLWKDDRVHDLID--------PVIMQDEISLPMLMRYI-NVALLC 726
+ + ++ D+ P + + +R + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 727 VQENAADRPTMSDVISMINNEHLNLPSPKEPAFT 760
++A R T + + K + T
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-64
Identities = 74/295 (25%), Positives = 137/295 (46%), Gaps = 28/295 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 528
+ +++ K+G G FG V++ +G +VAVK L Q + + EF E+ ++ +L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V +G + ++ EY+ SL L S + L+ + R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
I+HR+LK+ N+L+DK K+ DFGL+R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708
D + KSDV+SFG+++ E + ++ W + ++ V +
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQ------------------PWGNLNPAQVVAAVGFK 254
Query: 709 D---EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN-EHLNLPSPKEPAF 759
EI + + + C RP+ + ++ ++ +P P
Sbjct: 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-63
Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 27/289 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ ++ +G G FG V K + ++VA+K++ ++S K F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C+ L++EY SL L + + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 591 RFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
+S K DVFS+GI++ E ++ +K ++ W + R P ++++
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR------PPLIKN 228
Query: 710 -EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEP 757
+ LM C ++ + RP+M +++ ++ + P EP
Sbjct: 229 LPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-61
Identities = 64/300 (21%), Positives = 113/300 (37%), Gaps = 44/300 (14%)
Query: 478 KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+ I EY+ +L + W RV + IA G+ YLH IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQ------------GNTKQIVGTYGYMSP 644
RDL + N L+ ++ N ++DFGLAR+ ++ Q +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 645 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
E + K DVFSFGI++ E + +A + +
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIG---------------RVNADPDYLPRTM-----D 231
Query: 705 VIMQDEISLPMLM------RYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 758
+ L + + + C + RP+ + + ++L
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 5e-60
Identities = 77/283 (27%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRL----SNQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
+G GGFG VY+ G EVAVK Q ++ + E L A L+H N++ L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G C+++ L++E+ LN L + + V IA+G+ YLH +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 594 IIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
IIHRDLK+SNIL+ + + KI+DFGLAR + G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-LWKDDRVHDLIDP 704
+FS SDV+S+G+L+ E L+ + + + L A+
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLA------L 233
Query: 705 VIMQD-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
I LM C + RP+ ++++ +
Sbjct: 234 PIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 70/295 (23%), Positives = 135/295 (45%), Gaps = 46/295 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQG-------LKEFKNEMMLIA 522
+ ++G+GGFG V+KGRL+ + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
L H N+V+L G +++E++P L L D K + W ++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ Y+ I+HRDL++ NI L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 638 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSSK---KNTGVYNADSFNLLGHAWDL 692
+ +M+PE A + ++ K+D +SF +++ L+ + N++
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---- 244
Query: 693 WKDDRVHDLIDPVIMQD-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ R P I +D L ++ LC + RP S ++ ++
Sbjct: 245 -EGLR------PTIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 2e-58
Identities = 74/284 (26%), Positives = 130/284 (45%), Gaps = 30/284 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 528
++ ++G G FG VYKG+ +G +VAVK L+ + Q L+ FKNE+ ++ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
++ +G I + ++ SL L + + + I A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHA 138
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 645
S IIHRDLK++NI L +D KI DFGLA +Q+ G+ +M+PE
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
+S +SDV++FGI++ E ++ + + + N D + +
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSL------- 243
Query: 705 VIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVISMINN 746
D + R + C+++ +RP+ +++ I
Sbjct: 244 --SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 56/287 (19%), Positives = 114/287 (39%), Gaps = 40/287 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRN 528
+ + KL E G ++KGR G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 529 LVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++ +LG C I +MP SL L + T + + V+ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMAFL 127
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H I L + ++++D+DM +IS + F + + +++PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 647 ALDG----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
AL +D++SF +L+ E ++ + + D ++
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------VPFADLSNMEIG 220
Query: 703 DPVIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
V ++ I + + +C+ E+ A RP ++ ++
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 6e-57
Identities = 70/301 (23%), Positives = 125/301 (41%), Gaps = 32/301 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHR 527
+ ++ +G+G +G V++G G+ VAVK S++ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 528 NLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
N++ + + LI Y SL +L + L+ + +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGL 118
Query: 584 LYLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIV 636
+LH I HRDLK+ NIL+ K+ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 637 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS---FNLLG 687
GT YM+PE + D+++FG+++ E + G+ ++++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 688 H--AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
+ +++ + D P I S P L + C +N + R T + +
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 746 N 746
Sbjct: 299 K 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 5e-56
Identities = 66/285 (23%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G+G FG VY GR +G EVA++ + + + LK FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
C+ +I ++L + D K +L+ +I + I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---IL 152
Query: 596 HRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI---VGTYGYMSPE------- 645
H+DLK+ N+ D + I+DFGL + G + ++ G +++PE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 646 --YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
FS SDVF+ G + E + + W + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELH-----AREWPFKTQPAEAIIWQMGTGMK------ 260
Query: 704 PVIMQDEISLPM--LMRYINVALLCVQENAADRPTMSDVISMINN 746
P + Q + + ++ + C +RPT + ++ M+
Sbjct: 261 PNLSQIGMGKEISDILLF------CWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-56
Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 34/301 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRN 528
+ M ++G+G +G V+ G+ G++VAVK + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 529 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
++ + ++ LI +Y N SL +L K L+ ++ +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLC 148
Query: 585 YLHQYSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVG 637
+LH I HRDLK+ NIL+ K+ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 638 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSSKKNTGV---YNADSFNLLG 687
T YM PE LD I +D++SFG+++ E + G+ Y +L+
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 688 H--AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
+++ ++ + P S L + + C N A R T V +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 746 N 746
Sbjct: 328 K 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 2e-53
Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 34/297 (11%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNE--MMLIAKLQHRNLVRL 532
+Q +G+G FG V++G+ G+EVAVK S++ + + E + L+H N++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGF 101
Query: 533 LGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 589 YSRFR-----IIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGY 641
I HRDLK+ NIL+ K+ I+D GLA D + VGT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 642 MSPEYALDGL-------FSIKSDVFSFGILMLETLSSKKNTGV---YNADSFNLLGH--A 689
M+PE LD ++D+++ G++ E G+ Y ++L+ +
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ + + P I S L + C N A R T + ++
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 3e-50
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 526 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 579
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 123
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 635
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 124 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWK 694
+ + +PE + FS+ SDV+SFG+++ E + + + A+ ++G+
Sbjct: 181 I---FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 695 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ +L+ P DEI M+M C N RP+ D+ ++
Sbjct: 238 VFHLIELLKNNGRLPRPDGCPDEIY--MIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-50
Identities = 88/326 (26%), Positives = 147/326 (45%), Gaps = 44/326 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
+ +LG+G FG V R G VAVK+L + ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 526 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 579
+V+ G G + L++EY+P+ L FL RLL + + I
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS------QI 136
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+G+ YL SR R +HRDL A NIL++ + + KI+DFGLA++ D+ +V
Sbjct: 137 CKGMEYLG--SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREP 189
Query: 640 G-----YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694
G + +PE D +FS +SDV+SFG+++ E + + +A+ ++G D+
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 695 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747
R+ +L++ P E+ LM LC + DRP+ S + ++
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVH--ELM------KLCWAPSPQDRPSFSALGPQLDML 301
Query: 748 HLNLPSPKEPAFTKGINVKNSSHSNS 773
+ AFT K+ S S S
Sbjct: 302 WSGSRGCETHAFTAHPEGKHHSLSFS 327
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-50
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 44/289 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRN 528
E+ + ++G G FG V+ GRL + VAVK +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+VRL+G C ++ +++E + FL T+ L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEY 646
IHRDL A N L+ + KISDFG++R G +Q+ + +PE
Sbjct: 232 K---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHDLID- 703
G +S +SDV+SFGIL+ ET S + + N + ++
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------------TREFVEK 330
Query: 704 ------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
P + D + M C RP+ S + + +
Sbjct: 331 GGRLPCPELCPDAVFRLMEQ--------CWAYEPGQRPSFSTIYQELQS 371
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-50
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 43/299 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ 525
+ +LG+G FG V R G+ VAVK+L + + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 526 HRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGI 579
H N+V+ G C G + LI+EY+P SL +L +LL + + I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS------QI 154
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQI 635
+G+ YL ++ R IHRDL NIL++ + KI DFGL ++ D+ ++ +
Sbjct: 155 CKGMEYLG--TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWK 694
+ + +PE + FS+ SDV+SFG+++ E + + + A+ ++G+
Sbjct: 212 I---FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 695 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ +L+ P DEI M+M C N RP+ D+ ++
Sbjct: 269 VFHLIELLKNNGRLPRPDGCPDEIY--MIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-50
Identities = 79/295 (26%), Positives = 129/295 (43%), Gaps = 37/295 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
LGEG FG V G+ VAVK L ++ Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 525 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
H ++++ GCC + G L++EY+P SL +L + + + + I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGT 638
+ YLH ++ IHRDL A N+LLD D KI DFGLA+ ++ + V
Sbjct: 147 MAYLH--AQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV-- 201
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698
+ +PE + F SDV+SFG+ + E L+ ++ L+G A R+
Sbjct: 202 -FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 699 HDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+L++ P E+ LM C + A+ RPT ++I ++
Sbjct: 261 TELLERGERLPRPDKCPAEVY--HLM------KNCWETEASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 76/298 (25%), Positives = 126/298 (42%), Gaps = 43/298 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
LGEG FG V R G++VAVK L G + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 525 QHRNLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEG 578
H N+V+ G C E G LI+E++P+ SL +L + K+ L +
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV------Q 134
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQ 634
I +G+ YL + +HRDL A N+L++ + KI DFGL + D+ ++ +
Sbjct: 135 ICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694
V + +PE + F I SDV+SFG+ + E L+ + A ++G
Sbjct: 192 PV---FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 695 DDRVHDLID-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
R+ + + P DE+ LM C + ++R + ++I
Sbjct: 249 VTRLVNTLKEGKRLPCPPNCPDEVY--QLM------RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 55/310 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRLSNQSGQGLKEFKNEMMLIAKL 524
+ ++ +LGEG FG V+ N VAVK L + + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQA 571
QH ++V+ G C + I++ EYM + LN FL K L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--EL 628
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLL 686
G+T + +M PE + F+ +SDV+SFG+++ E + K + N + +
Sbjct: 192 GGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
Query: 687 GHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
L + V+D +M C Q R + ++
Sbjct: 249 TQGRVLERPRVCPKEVYD-----VMLG----------------CWQREPQQRLNIKEIYK 287
Query: 743 MINNEHLNLP 752
+++ P
Sbjct: 288 ILHALGKATP 297
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 84/326 (25%), Positives = 141/326 (43%), Gaps = 51/326 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG----QEVAVKRL--SNQSGQGLKEFKNEMMLIAKL 524
+ F++ LG+G FG V + +L +VAVK L + ++EF E + +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 525 QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDS---TKKRLLNWQARVRI 575
H ++ +L+G + K +IL +M + L+ FL S L Q VR
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNT 632
+ IA G+ YL S IHRDL A N +L +DM ++DFGL+R ++ GD +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAW 690
K V +++ E D L+++ SDV++FG+ M E T G+ NA+ +N L
Sbjct: 200 KLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 691 DLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
L + + V+D +M C + RP+ + + + N
Sbjct: 257 RLKQPPECMEEVYD-----LMYQ----------------CWSADPKQRPSFTCLRMELEN 295
Query: 747 EHLNLPSPKEPAFTKGINVKNSSHSN 772
+L IN++ + H +
Sbjct: 296 ILGHLSVLSTSQDPLYINIERAHHHH 321
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-46
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C+EQ L+ E+M + L+ +L T++ L + + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+IHRDL A N L+ ++ K+SDFG+ R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+S KSDV+SFG+LM E S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 57/297 (19%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 580
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 641 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHA 689
M+ E L +++ +SDV+S+G+ + E ++ SK G+ ++ ++L
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232
Query: 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
++ L P I ++ M+M C +A RP ++I +
Sbjct: 233 ------EKGERLPQPPICTIDVY--MIM------RKCWMIDADSRPKFRELIIEFSK 275
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 531 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ + I EYM SL +L S + +L ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 643
+HRDL A N+L+ +D K+SDFGL + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----------EASSTQDTGKLPVKWTA 182
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE + FS KSDV+SFGIL+ E S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-46
Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 56/305 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+LGE FG VYKG L Q VA+K L G +EF++E ML A+
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQ 570
LQH N+V LLG + +I Y + L+ FL D T K L
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--E 627
V ++ IA G+ YL S ++H+DL N+L+ +N KISD GL R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNL 685
L GN+ + +M+PE + G FSI SD++S+G+++ E + + G N D +
Sbjct: 186 LLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 686 LGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741
+ + L V+ L M+ C E + RP D+
Sbjct: 243 IRNRQVLPCPDDCPAWVYAL-------------MIE--------CWNEFPSRRPRFKDIH 281
Query: 742 SMINN 746
S +
Sbjct: 282 SRLRA 286
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 85/305 (27%), Positives = 137/305 (44%), Gaps = 50/305 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL--SNQSGQGLKEFKNEMMLIAKL 524
+ LGEG FG V +G L VAVK + N S + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 525 QHRNLVRLLGCCVEQG-----EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRII 576
H N++RLLG C+E + ++IL +M L+ +L S T + + Q ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 633
IA G+ YL S +HRDL A N +L DM ++DFGL++ ++ GD K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWD 691
V +++ E D +++ KSDV++FG+ M E T GV N + ++ L H
Sbjct: 211 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
Query: 692 LWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747
L + D +++ IM C + + DRPT S + +
Sbjct: 268 LKQPEDCLDELYE-----IMYS----------------CWRTDPLDRPTFSVLRLQLEKL 306
Query: 748 HLNLP 752
+LP
Sbjct: 307 LESLP 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 54/303 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRLSNQSGQGLKEFKNEMMLIAKL 524
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL------------FDSTKKRLLNWQAR 572
QH+++VR G C E +++ EYM + LN FL + L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQ 629
+ + +A G++YL + +HRDL N L+ + + KI DFG++R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLG 687
G T + +M PE L F+ +SDV+SFG+++ E T + + N ++ + +
Sbjct: 218 GRTMLPI---RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
Query: 688 HAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743
+L + V+ + M C Q R ++ DV +
Sbjct: 275 QGRELERPRACPPEVYAI-------------MRG--------CWQREPQQRHSIKDVHAR 313
Query: 744 INN 746
+
Sbjct: 314 LQA 316
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-46
Identities = 83/329 (25%), Positives = 139/329 (42%), Gaps = 73/329 (22%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 521
+ ++ LGEG FG V + VAVK L + + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 578
+ +H+N++ LLG C + G +I+EY +L +L + R+ E
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 579 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 626
+A+G+ YL + + IHRDL A N+L+ ++ KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 627 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYN 679
+ T G +M+PE D +++ +SDV+SFG+LM E TL G+
Sbjct: 212 YYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 680 ADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 735
+ F LL + K + ++ + M C + RP
Sbjct: 266 EELFKLLKEGHRMDKPANCTNELYMM-------------MRD--------CWHAVPSQRP 304
Query: 736 TMSDVISMI--------NNEHLNLPSPKE 756
T ++ + N E+L+L P E
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQPLE 333
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E ++ +LG G FG V G+ +VAVK + + EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ G C ++ ++ EY+ N L +L + + L + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+ IHRDL A N L+D+D+ K+SDFG+ R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV---KWSAPEVFH 178
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
+S KSDV++FGILM E S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-46
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
++ + +LG G FG V G+ +VA+K + + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C +Q +I EYM N L +L + Q + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+ +HRDL A N L++ K+SDFGL+R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
FS KSD+++FG+LM E S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 82/300 (27%), Positives = 133/300 (44%), Gaps = 50/300 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
E +M +LG+G FG VY+G + VA+K + S + EF NE ++ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------FDSTKKRLLNWQARVRII 576
++VRLLG + ++I+E M L +L ++ + +++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 633
IA G+ YL + + +HRDL A N ++ +D KI DFG+ R ++ D G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLL--GHA 689
V +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N + G
Sbjct: 202 LPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258
Query: 690 WDLWKD--DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747
D + D + +L M M C Q N RP+ ++IS I E
Sbjct: 259 LDKPDNCPDMLFEL-------------MRM--------CWQYNPKMRPSFLEIISSIKEE 297
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 78/314 (24%), Positives = 127/314 (40%), Gaps = 55/314 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 579
H+N+VR +G ++ + +++E M L FL ++ L + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 633
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWD 691
V +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 207 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 692 LWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--- 744
+ V+ + M C Q DRP + ++ I
Sbjct: 264 MDPPKNCPGPVYRI-------------MTQ--------CWQHQPEDRPNFAIILERIEYC 302
Query: 745 --NNEHLNLPSPKE 756
+ + +N P E
Sbjct: 303 TQDPDVINTALPIE 316
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-46
Identities = 74/279 (26%), Positives = 125/279 (44%), Gaps = 32/279 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 531 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ + ++ EYM SL +L S + +L ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+HRDL A N+L+ +D K+SDFGL + Q K V + +PE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALRE 360
Query: 650 GLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
FS KSDV+SFGIL+ E S + + D + ++ + + P
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------EKGYKMDAPDGC 411
Query: 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ +M+ C +AA RPT + + +
Sbjct: 412 PPAVY--DVMKN------CWHLDAATRPTFLQLREQLEH 442
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYA 647
+ IHRDL A N L+ ++ K++DFGL+R+ GD K + + +PE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESL 184
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
FSIKSDV++FG+L+ E +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-45
Identities = 79/314 (25%), Positives = 127/314 (40%), Gaps = 55/314 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I+K
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL----FDSTKKRLLNWQARVRIIEGI 579
H+N+VR +G ++ + ++LE M L FL ++ L + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 633
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWD 691
V +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 248 LPV---KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 692 LWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--- 744
+ V+ + M C Q DRP + ++ I
Sbjct: 305 MDPPKNCPGPVYRI-------------MTQ--------CWQHQPEDRPNFAIILERIEYC 343
Query: 745 --NNEHLNLPSPKE 756
+ + +N P E
Sbjct: 344 TQDPDVINTALPIE 357
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-45
Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 54/307 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
+G+G FG VY G ++ + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 526 HRNLVRLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H N++ L+G + + L YM + L F+ +R + + +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGME 138
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---- 640
YL + + +HRDL A N +LD+ K++DFGLAR E + +
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HRHARLPV 192
Query: 641 -YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWK--- 694
+ + E F+ KSDV+SFG+L+ E T + + D + L L +
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252
Query: 695 -DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN------- 746
D ++ + M C + + A RPT ++ +
Sbjct: 253 CPDSLYQV-------------MQQ--------CWEADPAVRPTFRVLVGEVEQIVSALLG 291
Query: 747 -EHLNLP 752
++ LP
Sbjct: 292 DHYVQLP 298
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-45
Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 26/277 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ +M+ KLG G +G VY+G VAVK L + ++EF E ++ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+LLG C + +I E+M +L +L ++ ++ + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+ IHR+L A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 650 GLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
FSIKSDV++FG+L+ E + + G+ + + LL ++ + + P
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---------EKDYRMERPEGC 444
Query: 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+++ LM C Q N +DRP+ +++
Sbjct: 445 PEKVY--ELM------RACWQWNPSDRPSFAEIHQAF 473
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 72/202 (35%), Positives = 105/202 (51%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL ++ I I EYM N SL FL + L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + K + + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI---KWTAPEAIN 183
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
G F+IKSDV+SFGIL+ E ++
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVT 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 48/292 (16%)
Query: 478 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 533 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LG C+ L +L YM + L F+ + + + +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMSPE 645
+ +HRDL A N +LD+ K++DFGLAR D + G +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLLGHAWDLWK----DDRVH 699
F+ KSDV+SFG+L+ E ++ V D L L + D ++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262
Query: 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 751
++ M C A RP+ S+++S I+
Sbjct: 263 EV-----MLK----------------CWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-45
Identities = 82/305 (26%), Positives = 137/305 (44%), Gaps = 61/305 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKL-Q 525
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 572
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
+ +A+G+ YL S+ + IHRDL A NIL+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 633 KQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNL 685
G +M+ E +++ SDV+S+G+L+ E +L G+ A+ +
Sbjct: 200 M------GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 686 LGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741
L + L K DD V+D +M+ C +E +RP+ + ++
Sbjct: 254 LPQGYRLEKPLNCDDEVYD-----LMRQ----------------CWREKPYERPSFAQIL 292
Query: 742 SMINN 746
+N
Sbjct: 293 VSLNR 297
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 83/379 (21%), Positives = 154/379 (40%), Gaps = 77/379 (20%)
Query: 404 VFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSW-LPLFS 462
+ RR+ + + ++ + L+ ++ T T + + + W P
Sbjct: 24 IPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-EYELPEDPKWEFPR-- 80
Query: 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKE 513
+ ++ LGEG FG V + VAVK L + + + L +
Sbjct: 81 --------DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 514 FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------F 559
+EM ++ + +H+N++ LLG C + G +I+EY +L +L
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 560 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
+ + + ++ V +A+G+ YL + + IHRDL A N+L+ ++ KI+DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 620 AR-MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSS 671
AR + D + T G +M+PE D +++ +SDV+SFG+LM E TL
Sbjct: 250 ARDINNIDYYKKTTN------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 672 KKNTGVYNADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCV 727
G+ + F LL + K + ++ + M C
Sbjct: 304 SPYPGIPVEELFKLLKEGHRMDKPANCTNELYMM-------------MRD--------CW 342
Query: 728 QENAADRPTMSDVISMINN 746
+ RPT ++ ++
Sbjct: 343 HAVPSQRPTFKQLVEDLDR 361
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
++ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N++RL G +++ EYM N SL+ FL T V ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 641
L S +HRDL A N+L+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 642 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 670
+PE FS SDV+SFG++M E L+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSG-QGLKEFKNEMMLIAKL 524
LG G FG V+KG + E V +K + ++SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 580
H ++VRLLG C ++ + +Y+P SL + + LLNW IA
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIA 125
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL ++HR+L A N+LL +++DFG+A + D+ KQ++ +
Sbjct: 126 KGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD-----KQLLYSEA 177
Query: 641 -----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+ E G ++ +SDV+S+G+ + E ++
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-45
Identities = 80/316 (25%), Positives = 133/316 (42%), Gaps = 70/316 (22%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+N + LGEG FG V K + VAVK L N S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 562
+ H ++++L G C + G +LI+EY SL FL D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 563 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
+R L + I+QG+ YL + +++HRDL A NIL+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 622 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKN 674
++ D ++ G +M+ E D +++ +SDV+SFG+L+ E TL
Sbjct: 200 VYEEDSYVKRSQ------GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 675 TGVYNADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQEN 730
G+ FNLL + + + ++ +M C ++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYR-----LMLQ----------------CWKQE 292
Query: 731 AADRPTMSDVISMINN 746
RP +D+ +
Sbjct: 293 PDKRPVFADISKDLEK 308
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-44
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG G FG V+ +VAVK + ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L ++ I I E+M SL FL + + IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMSPEYAL 648
+ IHRDL+A+NIL+ + KI+DFGLAR+ +E + K + + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAIN 358
Query: 649 DGLFSIKSDVFSFGILMLETLS 670
G F+IKSDV+SFGIL++E ++
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVT 380
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H N++RL G + ++I EYM N +L+ FL K + V ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMK 161
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG---- 640
YL + +HRDL A NIL++ ++ K+SDFGL+R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 641 --YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +PE F+ SDV+SFGI+M E ++
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 85/328 (25%), Positives = 145/328 (44%), Gaps = 71/328 (21%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRL-SNQSGQGLKEFKNEMMLIAKL 524
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS----TKKRLLNWQARVRIIEGIA 580
+ ++ RLLG C+ ++ I + MP L ++ + + LLNW IA
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIA 127
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+G+ YL R++HRDL A N+L+ + KI+DFGLA++ G +E Y
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYH 175
Query: 641 Y---------MSPEYALDGLFSIKSDVFSFGILMLETLS--SKKNTGVYNADSFNLLGHA 689
M+ E L +++ +SDV+S+G+ + E ++ SK G+ ++ ++L
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232
Query: 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI----- 744
++ L P I ++ M+M + C +A RP ++I
Sbjct: 233 ------EKGERLPQPPICTIDVY--MIM------VKCWMIDADSRPKFRELIIEFSKMAR 278
Query: 745 ---------NNEHLNLPSPKEPAFTKGI 763
+E ++LPSP + F + +
Sbjct: 279 DPQRYLVIQGDERMHLPSPTDSNFYRAL 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-44
Identities = 74/291 (25%), Positives = 118/291 (40%), Gaps = 46/291 (15%)
Query: 478 KLGEGGFGPVYKGRLLNG----QEVAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+G G FG VY G LL+ AVK L + +F E +++ H N++ L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 533 LGCCVEQGEKIL-ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LG C+ L +L YM + L F+ + + + +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG-----YMSPEY 646
+ +HRDL A N +LD+ K++DFGLAR E T +M+ E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN---KTGAKLPVKWMALES 267
Query: 647 ALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWK----DDRVHD 700
F+ KSDV+SFG+L+ E T + V D L L + D +++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327
Query: 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 751
+ ML C A RP+ S+++S I+
Sbjct: 328 V-------------MLK--------CWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-44
Identities = 82/324 (25%), Positives = 137/324 (42%), Gaps = 66/324 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRL-SNQSGQGLKEFKNEMMLI 521
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-- 578
+ +H+N++ LLG C + G +I+EY +L +L L E
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 579 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 626
+A+G+ YL + + IHRDL A N+L+ +D KI+DFGLAR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 627 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYN 679
+ T G +M+PE D +++ +SDV+SFG+L+ E TL GV
Sbjct: 246 YYKKTTN------GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 680 ADSFNLLGHAWDLWK----DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 735
+ F LL + K + ++ + M C + RP
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNELYMM-------------MRD--------CWHAVPSQRP 338
Query: 736 TMSDVISMINNEHLNLPSPKEPAF 759
T ++ ++ + L S +E +
Sbjct: 339 TFKQLVEDLDRI-VALTSNQEMGY 361
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-44
Identities = 75/301 (24%), Positives = 116/301 (38%), Gaps = 54/301 (17%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 531 RLLGCCVEQGEKILI-LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
RL+G C Q E +++ +E L+ FL K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG------YMS 643
+HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYA 181
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHDLI 702
PE FS +SDV+S+G+ M E LS G + K V I
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFI 226
Query: 703 D-------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPK 755
+ P E+ LM C DRP V + + +L S
Sbjct: 227 EQGKRMECPPECPPELY--ALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
Query: 756 E 756
E
Sbjct: 279 E 279
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 7e-44
Identities = 66/231 (28%), Positives = 103/231 (44%), Gaps = 37/231 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG------QEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
N +GEG FG V++ R VAVK L S +F+ E L+A+
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL---------------------FDST 562
+ N+V+LLG C L+ EYM LN FL S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 563 KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
L+ ++ I +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 622 MFGGD--ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
++ D + GN + +M PE ++ +SDV+++G+++ E S
Sbjct: 224 IYSADYYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 37/228 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRL-SNQSGQGLKEFKNEMMLIAK 523
+ + LG G FG V + + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 524 L-QHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG--- 578
+ H N+V LLG C + G + +I+E+ +L+ +L + + A + +
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 579 ----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDE 627
+A+G+ +L + + IHRDL A NILL + KI DFGLAR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 628 LQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 204 YVRKGD------ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-43
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 651 LFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708
F+IKSDV+SFGIL+ E T G+ N + + + +R + + P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 407
Query: 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ + LM C ++ +RPT + + + +
Sbjct: 408 ESLH--DLM------CQCWRKEPEERPTFEYLQAFLED 437
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-43
Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 26/278 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + F E ++ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L E+ I + EYM SL FL + L V + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
R +HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 651 LFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708
F+IKSDV+SFGIL+ E T G+ N + + + +R + + P
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---------ERGYRMPCPPECP 490
Query: 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ + LM C ++ +RPT + + + +
Sbjct: 491 ESLH--DLM------CQCWRKEPEERPTFEYLQAFLED 520
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 59/302 (19%), Positives = 112/302 (37%), Gaps = 63/302 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRL--------LNGQEVAVKRLSNQSGQGLKEFKNEMMLIA 522
E+ LG+G F ++KG L+ EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
KL H++LV G CV E IL+ E++ SL+ +L K +N ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAA 125
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNP--------KISDFGLARMFGGDELQGNTKQ 634
+ +L +IH ++ A NILL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 635 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLSSKKN--TGVYNADSFNLL 686
+ PE + ++ +D +SFG + E S + + +
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 687 --GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
H K + +L + C+ RP+ +I +
Sbjct: 232 EDRHQLPAPKAAELANL-------------INN--------CMDYEPDHRPSFRAIIRDL 270
Query: 745 NN 746
N+
Sbjct: 271 NS 272
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-43
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
N S+ +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N++RL G + +++ EYM N SL+ FL V ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY---- 641
L S +HRDL A NIL++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 642 --------MSPEYALDGLFSIKSDVFSFGILMLETLS 670
SPE F+ SDV+S+GI++ E +S
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-43
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAY 131
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 643
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 185
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE F+ SDV+ FG+ M E L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 38/229 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 578
L H N+V LLG C G ++I EY L FL + + + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 579 -----------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGD 626
+A+G+ +L + IHRDL A NILL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 627 ELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE + +++ +SDV+S+GI + E S
Sbjct: 200 NYVVKGN------ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 478 KLGEGGFGPVYKGRLLNG---QEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHRNLVRL 532
+LG G FG V KG + VAVK L E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 533 LGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+G C + E L++E LN +L + R + + + ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEYA 647
+HRDL A N+LL KISDFGL++ DE Q + K V + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192
Query: 648 LDGLFSIKSDVFSFGILMLETLS 670
FS KSDV+SFG+LM E S
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAK 523
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L HRNL+RL G + K+ + E P SL L + R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGM 134
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT---YG 640
YL R IHRDL A N+LL KI DFGL R ++ ++ +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +PE FS SD + FG+ + E +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
E+ + LGEG FG VY+G N + VAVK + + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E+ I I+E P L +L K L V I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 643
L +HRD+ NIL+ K+ DFGL+R ++ T+ + +MS
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI---KWMS 182
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLS 670
PE F+ SDV+ F + M E LS
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-42
Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
N LG G FG V + + VAVK L S + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-----------FDSTKKRLLNWQA 571
L QH N+V LLG C G ++I EY L FL + + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-MFGGDELQG 630
+ +AQG+ +L + IHRD+ A N+LL KI DFGLAR +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 631 NTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+M+PE D +++++SDV+S+GIL+ E S
Sbjct: 223 KGN------ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-42
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 49/290 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+F +G GGFG V+K + ++G+ +KR+ + ++ + E+ +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 530 VRLLGCCVEQGEKI----------------LILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
V GC + +E+ +L ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL- 125
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ E I +G+ Y+H ++I+RDLK SNI L KI DFGL D G
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693
+ GT YMSPE + + D+++ G+++ E L A++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------------TAFET- 224
Query: 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743
+ + I+ D + + + DRP S+++
Sbjct: 225 --SKFFTDLRDGIISDIFD-KKEKTLLQ---KLLSKKPEDRPNTSEILRT 268
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 8e-42
Identities = 73/300 (24%), Positives = 117/300 (39%), Gaps = 48/300 (16%)
Query: 475 MQCKLGEGGFGPVYKGRLLNGQE---VAVKRL-SNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL+G C + + ++E L+ FL K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE----LQGNTKQIVGTYGYMSPEY 646
+HR+L A N+LL KISDFGL++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHDLID-- 703
FS +SDV+S+G+ M E LS G + K V I+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFIEQG 555
Query: 704 -----PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 758
P E+ LM C DRP V + + +L S E
Sbjct: 556 KRMECPPECPPELY--ALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 56/221 (25%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 528
+F LG GGFG V++ + ++ A+KR+ ++ E+ +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 529 LVRLLGCCVEQGEKI------------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
+VR +E+ + ++ ++L ++ + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ-- 634
IA+ + +LH ++HRDLK SNI D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 635 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
VGT YMSPE +S K D+FS G+++ E
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-41
Identities = 63/234 (26%), Positives = 91/234 (38%), Gaps = 43/234 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE------VAVKRL-SNQSGQGLKEFKNEMMLIAK 523
EN LG G FG V + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG---- 578
L H N+V LLG C G LI EY L +L +K +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 579 ----------------IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR- 621
+A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 622 MFGGDELQGNTKQIVGTYG-----YMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M+PE +G+++IKSDV+S+GIL+ E S
Sbjct: 222 IMSDSNYVVRGN------ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 68/267 (25%), Positives = 114/267 (42%), Gaps = 31/267 (11%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 535 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ +L+ E M + +L +L + +++ + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 591 RFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
+ DV++FG+ MLE T Y ++ +A +++ RV + P
Sbjct: 205 K-YDESVDVYAFGMCMLEMA-----TSEY---PYSECQNAAQIYR--RVTSGVKPASFDK 253
Query: 710 EISLPMLMRYINVALLCVQENAADRPT 736
P + I C+++N +R +
Sbjct: 254 VAI-PEVKEIIE---GCIRQNKDERYS 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 67/285 (23%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE----VAVKRL-SNQSGQGLKEFKNEMMLIAKLQ 525
E + +GEG FG V++G ++ + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E I I+E L FL +K L+ + + ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAY 506
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE--LQGNTKQIVGTYGYMS 643
L R +HRD+ A N+L+ + K+ DFGL+R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 644 PEYALDGLFSIKSDVFSFGILMLE--TLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701
PE F+ SDV+ FG+ M E K GV N D + + L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------ENGERL 611
Query: 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
P + LM C + + RP +++ + ++
Sbjct: 612 PMPPNCPPTLY--SLM------TKCWAYDPSRRPRFTELKAQLST 648
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-40
Identities = 63/280 (22%), Positives = 122/280 (43%), Gaps = 33/280 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+ E G ++++Y L + ++ K L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+I+HRD+K+ NI L KD ++ DFG+AR+ +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
+ ++ KSD+++ G ++ E + K + A S L I+
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMKNLVLK----------------II 238
Query: 708 QDEISLPMLMRY----INVALLCVQENAADRPTMSDVISM 743
P+ + Y ++ + N DRP+++ ++
Sbjct: 239 SGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 68/305 (22%), Positives = 129/305 (42%), Gaps = 31/305 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEFKNEMMLIAKLQH 526
NF ++ K+G G F VY+ LL+G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLLY 585
N+++ +E E ++LE L+ + K++ L + V + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+H R++HRD+K +N+ + K+ D GL R F ++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
+ ++ KSD++S G L+ E + + + D NL + + D P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDY------PP 257
Query: 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGINV 765
+ D S + + +C+ + RP ++ V ++ +
Sbjct: 258 LPSDHYSEEL----RQLVNMCINPDPEKRPDVTYV--------YDVAKRMHACTASSLEH 305
Query: 766 KNSSH 770
+ H
Sbjct: 306 HHHHH 310
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIA 522
S++ +S+ ++G GG V++ Q A+K L Q L ++NE+ +
Sbjct: 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 523 KLQHRNL--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 580
KLQ + +RL + +++E N LN +L KK + W+ + + +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERK-SYWKNML 137
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+ + +HQ+ I+H DLK +N L+ K+ DFG+A D VGT
Sbjct: 138 EAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 641 YMSPE-----------YALDGLFSIKSDVFSFGILMLETLSSK 672
YM PE S KSDV+S G ++ K
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+F LG+G FG V K R L+ + A+K++ + + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 529 LVRLLGCCVEQGEKI-------------LILEYMPNKSLNVFLFD--STKKRLLNWQARV 573
+VR +E+ + + +EY N +L +D ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF---------- 623
R+ I + L Y+H IIHRDLK NI +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 624 --GGDELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 667
N +GT Y++ E G ++ K D++S GI+ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-39
Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRN 528
+S+ ++G GG V++ Q A+K L Q L ++NE+ + KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 529 L--VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+RL + +++E N LN +L KK + W+ + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTI 124
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 645
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 646 ----------YALDGLFSIKSDVFSFGILMLETLSSK 672
S KSDV+S G ++ K
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-38
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL 533
++G GG V++ Q A+K L Q L ++NE+ + KLQ + +RL
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
+ +++E N LN +L KK + W+ + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-------- 645
I+H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 646 ---YALDGLFSIKSDVFSFGILMLETLSSK 672
S KSDV+S G ++ K
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 538 EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII-EGIAQGLLYLHQYSRFRIIH 596
E G + +E +P SL+ L S L + + + + I +GL YLH +I+H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 597 RDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE---YALDGLF 652
RD+K N+L++ KISDFG ++ G + T+ GT YM+PE G +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG-Y 202
Query: 653 SIKSDVFSFGILMLETLSSK 672
+D++S G ++E + K
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 32/277 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKL-QH 526
++F +LG G +G V+K R +G+ AVK + + E+ K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
VRL E G L E SL ++ L Q + + L +L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRD-TLLALAHL 173
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H ++H D+K +NI L K+ DFGL G + G YM+PE
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPE- 226
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
L G + +DVFS G+ +LE + + + + + L P
Sbjct: 227 LLQGSYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLR------------QGYLPPE 272
Query: 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743
+S + +V ++ ++ + R T ++++
Sbjct: 273 FTAGLSSEL----RSVLVMMLEPDPKLRATAEALLAL 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 10/205 (4%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
E++ + +G G +G K R +G+ + K + + + +E+ L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 528 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARV-RIIEGIAQGLL 584
N+VR +++ L ++EY L + TK+R + V R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 585 YLHQ--YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H+ ++HRDLK +N+ LD N K+ DFGLAR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 643 SPEYALDGLFSIKSDVFSFGILMLE 667
SPE ++ KSD++S G L+ E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 55/318 (17%)
Query: 466 ITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL 524
+ +++ KLGEGGF V L +G A+KR+ Q +E + E +
Sbjct: 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83
Query: 525 QHRNLVRLLGCCVEQGEK----ILILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEG 578
H N++RL+ C+ + L+L + +L + L Q ++ G
Sbjct: 84 NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLG 142
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR-----MFGGDELQGNTK 633
I +GL +H HRDLK +NILL + P + D G + G +
Sbjct: 143 ICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 634 QI--VGTYGYMSPE------YALDGLFSIKSDVFSFGILM--LETLSSKKNTGVYNADSF 683
T Y +PE + + ++DV+S G ++ + + DS
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 684 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSD 739
L +Q+++S+P R+ + + + RP +
Sbjct: 257 AL--------------------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPL 296
Query: 740 VISMINNEHLNLPSPKEP 757
++S + E L P+P +
Sbjct: 297 LLSQL--EALQPPAPGQH 312
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQHRNLVRLLG 534
LG+GGF ++ + A K + +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
E + + ++LE +SL +K L +AR + I G YLH+ R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQYLHRN---R 135
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 654 IKSDVFSFGILM 665
+ DV+S G +M
Sbjct: 194 FEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-36
Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 14/200 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 526
+ LG+GGF ++ + A K + +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+++V G E + + ++LE +SL +K L +AR + I G Y
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEAR-YYLRQIVLGCQY 156
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH+ R+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE 211
Query: 646 YALDGLFSIKSDVFSFGILM 665
S + DV+S G +M
Sbjct: 212 VLSKKGHSFEVDVWSIGCIM 231
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 533
KLG GG VY + +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
E L++EY+ +L+ ++ L+ + I G+ + H R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
I+HRD+K NIL+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 654 IKSDVFSFGILMLETLSSKKNTGV--YNADS 682
+D++S GI++ E L G +N ++
Sbjct: 191 ECTDIYSIGIVLYEML-----VGEPPFNGET 216
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 18/209 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ Q ++G G FG V++ + G + AVK++ + + E++ A L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLLYLH 587
+V L G E + +E + SL + + L + R G +GL YLH
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALEGLEYLH 167
Query: 588 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQ---IVGTYGYMS 643
RI+H D+KA N+LL D + + DFG A D L + I GT +M+
Sbjct: 168 TR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSK 672
PE + K D++S +ML L+
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 54/199 (27%), Positives = 103/199 (51%), Gaps = 10/199 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V L + E +++EY+ SL D + ++ + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
++IHRD+K+ NILL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ K D++S GI+ +E
Sbjct: 190 RKAYGPKVDIWSLGIMAIE 208
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 13/204 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS--GQGLKE-FKNEMMLIAKLQH 526
E+F + LG+G F VY+ + G EVA+K + ++ G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+++ L E + L+LE N +N +L + K +AR + I G+LY
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR-HFMHQIITGMLY 127
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y+SPE
Sbjct: 128 LH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPE 182
Query: 646 YALDGLFSIKSDVFSFGILMLETL 669
A ++SDV+S G + L
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLL 206
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 465 SITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLI 521
S+ ++ +LG G +G V K R + +GQ +AVKR+ + + Q K ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RI 575
+ V G +G+ + +E M + SL+ F K++++ + +I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKI 114
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
I + L +LH S+ +IHRD+K SN+L++ K+ DFG++ D++ +
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-- 169
Query: 636 VGTYGYMSPE----YALDGLFSIKSDVFSFGILMLE 667
G YM+PE +S+KSD++S GI M+E
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
K+GEG G V R +G++VAVK + + Q + NE++++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V + + E +++E++ +L D + LN + + E + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+IHRD+K+ +ILL D K+SDFG D + + +VGT +M+PE
Sbjct: 160 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 649 DGLFSIKSDVFSFGILMLE 667
L++ + D++S GI+++E
Sbjct: 215 RSLYATEVDIWSLGIMVIE 233
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 34/223 (15%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKNEMMLIAKL-Q 525
T F K+G G FG V+K L+G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEG-IAQGLL 584
H ++VR E ++ EY SL + ++ + +A ++ + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLARMFGG 625
Y+H ++H D+K SNI + + P KI D G
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184
Query: 626 DELQGNTKQIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 667
+ + G +++ E + K+D+F+ + ++
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/204 (27%), Positives = 108/204 (52%), Gaps = 13/204 (6%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E + + +LG+G FG VYK + G A K + +S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+LLG G+ +++E+ P +++ + + L Q +V + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE--- 645
RIIHRDLKA N+L+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 646 --YALDGLFSIKSDVFSFGILMLE 667
D + K+D++S GI ++E
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 11/226 (4%)
Query: 444 EANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKR 502
E D + + + ++F +LG G G V+K +G +A K
Sbjct: 6 ELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL 65
Query: 503 LS-NQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS 561
+ + E+ ++ + +V G GE + +E+M SL+ L
Sbjct: 66 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--- 122
Query: 562 TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
K + Q ++ + +GL YL + +I+HRD+K SNIL++ K+ DFG++
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
+ N+ VGT YMSPE +S++SD++S G+ ++E
Sbjct: 181 QL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 525
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N++RL G + LILEY P ++ L + + I +A L Y
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALSY 124
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177
Query: 646 YALDGLFSIKSDVFSFGILMLETL 669
+ K D++S G+L E L
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 56/200 (28%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 527
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
+ + G ++ + +I+EY+ S D + L+ I+ I +GL YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ IHRD+KA+N+LL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 648 LDGLFSIKSDVFSFGILMLE 667
+ K+D++S GI +E
Sbjct: 192 KQSAYDSKADIWSLGITAIE 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+ G + + +++EY S++ + K L + I++ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R IHRD+KA NILL+ + + K++DFG+A + NT ++GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 649 DGLFSIKSDVFSFGILMLE 667
+ ++ +D++S GI +E
Sbjct: 199 EIGYNCVADIWSLGITAIE 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 40/200 (20%), Positives = 79/200 (39%), Gaps = 24/200 (12%)
Query: 478 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLG 534
+ GG G +Y +NG+ V +K L + + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 535 CCVEQGEKI-----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+++EY+ +SL + L + + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+++ DLK NI+L ++ K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 650 GLFSIKSDVFSFGILMLETL 669
G ++ +D+++ G +
Sbjct: 252 GP-TVATDIYTVGRTLAALT 270
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 533
LG GG V+ R L + ++VAVK L + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 534 --GCCVEQGEKI--LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
G + +++EY+ +L + + + + + +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYMSPEYAL 648
+ IIHRD+K +NI++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGV--YNADS 682
+SDV+S G ++ E L TG + DS
Sbjct: 193 GDSVDARSDVYSLGCVLYEVL-----TGEPPFTGDS 223
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 18/211 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQHRNLVRLL 533
+G GG G VY+ + + VA+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
G+ + + + L L ++ L V I+ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFS 653
HRD+K NIL+ D + DFG+A ++L VGT YM+PE + +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHAT 213
Query: 654 IKSDVFSFGILMLETLSSKKNTGV--YNADS 682
++D+++ ++ E L TG Y D
Sbjct: 214 YRADIYALTCVLYECL-----TGSPPYQGDQ 239
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 528
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 529 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 587 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 643 SPE--------YALDGLFSIKSDVFSFGILMLETLS 670
P+ + D++S G+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 23/210 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL-SNQSGQGLKEFKNEM-MLIAKLQHR 527
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV------RIIEGIAQ 581
+V+ G +G+ + +E M + S + F K + +I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
L +L +IIHRD+K SNILLD+ N K+ DFG++ + G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 642 MSPE----YALDGLFSIKSDVFSFGILMLE 667
M+PE A + ++SDV+S GI + E
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/233 (21%), Positives = 97/233 (41%), Gaps = 20/233 (8%)
Query: 443 GEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK 501
G + GK + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 502 RL-SNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF 559
++ + + + K ++ +++ +V+ G + + + +E M +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE---KL 113
Query: 560 DSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
+ + + ++ I + L YL + +IHRD+K SNILLD+ K+ DFG+
Sbjct: 114 KKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 620 ARMFGGDELQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 667
+ D+ + G YM+PE + I++DV+S GI ++E
Sbjct: 172 SGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRN 528
+ + LG+G V++GR G A+K +N S + E ++ KL H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 529 LVRLLGC--CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+L K+LI+E+ P SL L + + L + ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 587 HQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ I+HR++K NI+ D K++DFG AR DE + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 643 SPE--------YALDGLFSIKSDVFSFGILM 665
P+ + D++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-31
Identities = 49/214 (22%), Positives = 85/214 (39%), Gaps = 29/214 (13%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLV 530
+F + LG G G + + + ++VAVKR+ + E+ +L +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 531 RLLGCCVEQGEKI--LILEYMPNKSLNVFLFD---STKKRLLNWQARVRIIEGIAQGLLY 585
R C E+ + + +E L + L + +++ GL +
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 586 LHQYSRFRIIHRDLKASNILL-----DKDMNPKISDFGLARMFGGDEL-QGNTKQIVGTY 639
LH I+HRDLK NIL+ + ISDFGL + + GT
Sbjct: 134 LHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 640 GYMSPEY---ALDGLFSIKSDVFSFGILMLETLS 670
G+++PE + D+FS G + +S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 66/326 (20%), Positives = 121/326 (37%), Gaps = 54/326 (16%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
L EGGF VY+ + + +G+E A+KRL + + + E+ + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 536 CVEQGEK-------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
E+ L+L + L FL + L+ ++I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI----------VGT 638
+ IIHRDLK N+LL K+ DFG A + Q T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 639 YGYMSPE-YALDGLFSI--KSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 695
Y +PE L F I K D+++ G ++ + + L
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC-----FRQHPFEDGAKLR-------- 260
Query: 696 DRVHDLIDPVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVI----SMINNE 747
I+ + S+P ++ +Q N +R ++++V+ +
Sbjct: 261 ----------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310
Query: 748 HLNLPSPKEPAFTKGINVKNSSHSNS 773
++N SP + +++ S
Sbjct: 311 NVNPKSPITELLEQNGGYGSATLSRG 336
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLS-----------------NQSGQGLKE 513
++ + L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 514 FKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL------NVFLFDSTKKRLL 567
FKNE+ +I +++ + G E +I EYM N S+ L + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ II+ + Y+H + I HRD+K SNIL+DK+ K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 628 LQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 669
++G GTY +M PE + +G K D++S GI +
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-30
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNL 529
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 530 VRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
V +L +EY L +L L ++ I+ L
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 584 LYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
YLH+ RIIHRDLK NI+L + + KI D G A+ EL + VGT
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQ 188
Query: 641 YMSPEYALDGLFSIKSDVFSFGILM 665
Y++PE +++ D +SFG L
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 20/206 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQ 525
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 583
H N++R+ ++ L+LE+ P L + R ++ +E +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 644 PEYALDGLFSIKSDVFSFGILMLETL 669
PE K D++ G+L E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-30
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 16/218 (7%)
Query: 462 SLASITAATENFSMQCKLGEG--GFGPVYKGR-LLNGQEVAVKR--LSNQSGQGLKEFKN 516
++S + + +G+G V R G+ V V+R L S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 517 EMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
E+ + H N+V + E ++ +M S L + +N A I+
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYIL 134
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT---- 632
+G+ + L Y+H +HR +KAS+IL+ D +S +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 633 -KQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLE 667
K V ++SPE L + KSD++S GI E
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 461 FSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMM 519
L+++ F + +G G +G VYKGR + GQ A+K + + +G +E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEIN 72
Query: 520 LIAKL-QHRNLVRLLGCCVEQGEKI------LILEYMPNKSLNVFLFDSTKKRLLNWQAR 572
++ K HRN+ G +++ L++E+ S+ + ++ L
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
I I +GL +LHQ ++IHRD+K N+LL ++ K+ DFG++ + NT
Sbjct: 133 Y-ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 633 KQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 667
+GT +M+PE D + KSD++S GI +E
Sbjct: 189 --FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRN 528
+++ +Q +G G V ++VA+KR++ + Q + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIE--GIA------ 580
+V V + E L+++ + S+ D K + + + +++ IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 581 -QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL-ARMFGGDELQGNTKQ--IV 636
+GL YLH + IHRD+KA NILL +D + +I+DFG+ A + G ++ N + V
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 637 GTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 667
GT +M+PE + K+D++SFGI +E
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-30
Identities = 67/308 (21%), Positives = 103/308 (33%), Gaps = 81/308 (26%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEM-MLIAKLQHRNLVRLLGCC 536
LG G G V G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 537 VEQGEK--ILILEYMPNKSLNVFL-----FDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
E ++ + LE N +L + D K + ++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHSL 134
Query: 590 SRFRIIHRDLKASNILLD-------------KDMNPKISDFGLARMFGGDE--LQGNTKQ 634
+IIHRDLK NIL+ +++ ISDFGL + + + N
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 635 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSSKK-------------N 674
GT G+ +PE + D+FS G + LS K
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 675 TGVYNADSFNLLGHAWDLWKD--DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAA 732
G+++ D + DLI ++ +
Sbjct: 252 RGIFSLDEM-----KCLHDRSLIAEATDLIS-------------------QMIDH--DPL 285
Query: 733 DRPTMSDV 740
RPT V
Sbjct: 286 KRPTAMKV 293
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 525
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N ++ GC + + L++EY + + L + KK L + + G QGL Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH + +IHRD+KA NILL + K+ DFG A N+ VGT +M+PE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPE 220
Query: 646 ---YALDGLFSIKSDVFSFGILMLE 667
+G + K DV+S GI +E
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIE 245
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 56/190 (29%), Positives = 92/190 (48%), Gaps = 34/190 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
ENF K+GEG +G VYK R L G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 575
+L H N+V+LL + + L+ E++ + + + +Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----- 111
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ QGL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T ++
Sbjct: 112 ---LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEV 164
Query: 636 VGTYGYMSPE 645
V T Y +PE
Sbjct: 165 V-TLWYRAPE 173
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 40/302 (13%), Positives = 84/302 (27%), Gaps = 64/302 (21%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQH-------- 526
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 527 --------RNLVRLLGCC-----VEQGEKILILEY---MPNKSLNVFLF------DSTKK 564
+LV+ + +L P N+ F S+
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 565 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 625 GDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679
G + + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-----CADL- 315
Query: 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSD 739
DD + I + ++P +R + L + DR
Sbjct: 316 ------------PNTDDAALGGSEW-IFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQ 360
Query: 740 VI 741
+
Sbjct: 361 AM 362
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 34/189 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 522
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 576
+L H N+V L+ + L+ E+M L DS K L +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYL-YQ------ 127
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
+ +G+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T ++V
Sbjct: 128 --LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 637 GTYGYMSPE 645
T Y +P+
Sbjct: 182 -TLWYRAPD 189
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 36/219 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 575
+L+H+N+VRL + L+ E+ S N L K L +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL-FQ----- 109
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ +GL + H ++HRDLK N+L++++ K+++FGLAR F G ++ + ++
Sbjct: 110 ---LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEV 162
Query: 636 VGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSKK 673
V T Y P+ L+S D++S G + E ++ +
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 33/228 (14%), Positives = 65/228 (28%), Gaps = 24/228 (10%)
Query: 465 SITAATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEM 518
++ + LGEG F VY+ N Q+ +K + M
Sbjct: 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118
Query: 519 MLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRI 575
+ ++ + Q +L+ E +L ++ +K +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILL-----------DKDMNPKISDFGLARMFG 624
+ + + +H IIH D+K N +L D + D G +
Sbjct: 179 MR-MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
T G+ E + ++ + D F + L
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-29
Identities = 25/246 (10%), Positives = 57/246 (23%), Gaps = 43/246 (17%)
Query: 459 PLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL---SNQSGQGLKEF 514
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 515 KNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILEYMPN-----------KSLNVFL---- 558
A+L + + + ++ P N L
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 559 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
F + A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226
Query: 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 663
+ D + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 664 LMLETL 669
+
Sbjct: 282 SIYRVW 287
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 584
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y+H+++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 34/189 (17%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLIA 522
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRII 576
+L+H N+V+L + +L+ E++ L T K L Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-LQ------ 108
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
+ G+ Y H R++HRDLK N+L++++ KI+DFGLAR F G ++ T +IV
Sbjct: 109 --LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 637 GTYGYMSPE 645
T Y +P+
Sbjct: 163 -TLWYRAPD 170
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-28
Identities = 62/192 (32%), Positives = 93/192 (48%), Gaps = 36/192 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN--------EMM 519
+ + LGEG F VYK R Q VA+K +L ++S E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-----EAKDGINRTALREIK 64
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARV 573
L+ +L H N++ LL + L+ ++M K ++ L S K +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYM-LM--- 120
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
QGL YLHQ+ I+HRDLK +N+LLD++ K++DFGLA+ F G + T
Sbjct: 121 -----TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171
Query: 634 QIVGTYGYMSPE 645
Q+V T Y +PE
Sbjct: 172 QVV-TRWYRAPE 182
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
E +++ C LG+G FG V K + + QE AVK + ++ + E+ L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 584
N+++L + ++ E L FD +KR A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y+H++ I+HRDLK NILL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
+E + KLG G +G V R + E A+K + ++ S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 584
N+++L ++ L++E L FD + + A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
YLH+++ I+HRDLK N+LL +KD KI DFGL+ +F + K+ +GT Y
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
++PE L + K DV+S G+++
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/194 (27%), Positives = 88/194 (45%), Gaps = 33/194 (17%)
Query: 468 AATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLI 521
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYM----------PNKSLNVFLFDSTKKRLLNWQA 571
+L+H N+VRL + + L+ E+M + + WQ
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
+ QGL + H+ +I+HRDLK N+L++K K+ DFGLAR F G +
Sbjct: 117 -------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTF 165
Query: 632 TKQIVGTYGYMSPE 645
+ ++V T Y +P+
Sbjct: 166 SSEVV-TLWYRAPD 178
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 18/202 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYL 586
++RL + + L++E LF+ K+ A RI++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 587 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
H+ + HRDLK N L D K+ DFGLA F ++ + VGT Y+S
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 644 PEYALDGLFSIKSDVFSFGILM 665
P+ L+GL+ + D +S G++M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS----NQSGQGLKEFKNEMMLIAKLQHRNLVRLL 533
LGEG +G V + AVK L + G K E+ L+ +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 534 G-CCVEQGEKI-LILEYMPNKSLNVFLFDS-TKKRLLNWQAR---VRIIEGIAQGLLYLH 587
E+ +K+ +++EY + DS +KR QA ++I+G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I+H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 648 L-----DGLFSIKSDVFSFGI 663
G K D++S G+
Sbjct: 184 NGLDTFSGF---KVDIWSAGV 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQ 525
++ + Q LG+G FG V + + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGL 583
H N+++L ++G L+ E L FD ++KR A RII + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 584 LYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Y+H+ I+HRDLK N+LL KD N +I DFGL+ F + K +GT
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193
Query: 641 YMSPEYALDGLFSIKSDVFSFGILM 665
Y++PE L G + K DV+S G+++
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHR 527
+ F + KLG G FG V+ +G E +K ++ ++S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW------QARVRIIEGIAQ 581
N++++ + +++E L + +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
L Y H ++H+DLK NIL KI DFGLA +F DE GT
Sbjct: 136 ALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILM 665
YM+PE + K D++S G++M
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-----LKEFKNEMMLIAKL 524
E + KLGEG + VYKG+ L VA+K + + +G ++E L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIEG 578
+H N+V L + L+ EY+ + K L +Q
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL-FQ-------- 108
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ +GL Y H+ +++HRDLK N+L+++ K++DFGLAR + ++V T
Sbjct: 109 LLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-T 163
Query: 639 YGYMSPE 645
Y P+
Sbjct: 164 LWYRPPD 170
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 52/253 (20%), Positives = 91/253 (35%), Gaps = 37/253 (14%)
Query: 504 SNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTK 563
S + ++ + +N V L + + ++ ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 564 KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623
+ I IA+ + +LH ++HRDLK SNI D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 624 GGDELQGNTKQI----------VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
DE + VGT YMSPE +S K D+FS G+++ E L
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE-LLYSF 273
Query: 674 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL---CVQEN 730
+T +RV + D + + L +Y ++ + +
Sbjct: 274 STQ------------------MERVRIITD--VRNLKFPLLFTQKYPQEHMMVQDMLSPS 313
Query: 731 AADRPTMSDVISM 743
+RP +D+I
Sbjct: 314 PTERPEATDIIEN 326
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 43/310 (13%), Positives = 87/310 (28%), Gaps = 77/310 (24%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ--------- 525
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 526 ----------------HRNLVRLLGCC-VEQGEKILILEYMPNKSLNVF---LFD-STKK 564
+ ++R+ L +L F L S+
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 565 RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
+ L AR+++ + + L LH Y ++H L+ +I+LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 625 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKK 673
G + G+ PE L + D ++ G+++
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW---- 307
Query: 674 NTGVYNADSFNLLGHAWDL-WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAA 732
DL D + I + ++P +R + L
Sbjct: 308 -CA--------------DLPITKDAALGGSEW-IFRSCKNIPQPVRALLEGFLRY--PKE 349
Query: 733 DRPTMSDVIS 742
DR +
Sbjct: 350 DRLLPLQAME 359
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
L+ L ++ E +LILE++ LFD + + ++ + + +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 587 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H++ I+H D+K NI+ K + KI DFGLA DE K T + +P
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E +D+++ G+L
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
S LG G FG V+K G ++A K + + + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+L + + +L++EY+ LFD + L + ++ I +G+ ++HQ
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 589 YSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
I+H DLK NIL ++D KI DFGLAR + E K GT +++PE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEV 259
Query: 647 ALDGLFSIKSDVFSFGILM 665
S +D++S G++
Sbjct: 260 VNYDFVSFPTDMWSVGVIA 278
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 51/190 (26%), Positives = 78/190 (41%), Gaps = 35/190 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRI 575
+L+H NLV LL + L+ EY + + + K + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQ----- 110
Query: 576 IEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQI 635
Q + + H++ IHRD+K NIL+ K K+ DFG AR+ ++
Sbjct: 111 ---TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEV 163
Query: 636 VGTYGYMSPE 645
T Y SPE
Sbjct: 164 A-TRWYRSPE 172
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 59/194 (30%), Positives = 84/194 (43%), Gaps = 39/194 (20%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN--------EMMLI 521
+ + KLGEG +G VYK + + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPN--KSL---NVFLFDSTKKRLLNWQARVRII 576
+LQHRN++ L LI EY N K N + K L +Q
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-YQ------ 140
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN 631
+ G+ + H R +HRDLK N+LL KI DFGLAR F G ++
Sbjct: 141 --LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 632 TKQIVGTYGYMSPE 645
T +I+ T Y PE
Sbjct: 195 THEII-TLWYRPPE 207
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 14/206 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 527 RNLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
V+L Q ++ L L Y N L + R E I L
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YLH IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SP
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 645 EYALDGLFSIKSDVFSFGILMLETLS 670
E + SD+++ G ++ + ++
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 537 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 591
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 646 YALDGLFSIKSDVFSFGI 663
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 523
+ + + +G+G F V + GQ+ AVK + ++ G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQ------ARVRIIE 577
L+H ++V LL G ++ E+M L KR A +
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQ 634
I + L Y H IIHRD+K +LL + K+ FG+A G
Sbjct: 138 QILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
VGT +M+PE + DV+ G+++
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS-------------NQSGQGLKEFK 515
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 516 NEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV 573
NE+ L+ L H N+++L ++ L+ E+ L F+ + + A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQG 630
I++ I G+ YLH+++ I+HRD+K NILL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 665
+ +GT Y++PE L ++ K DV+S G++M
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLIAK 523
E + +GEG +G V K R G+ VA+K S+ K K E+ L+ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPN------KSLNVFLFDSTKKRLLNWQARVRIIE 577
L+H NLV LL C ++ L+ E++ + + L ++ L +Q
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-FQ------- 132
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
I G+ + H + IIHRD+K NIL+ + K+ DFG AR + ++
Sbjct: 133 -IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA- 186
Query: 638 TYGYMSPE 645
T Y +PE
Sbjct: 187 TRWYRAPE 194
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGC 535
+G+G F V R +L G+EVA+K + + L++ E+ ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 536 CVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+E + + LI+EY + FD R+ +AR I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 646
RI+HRDLKA N+LLD DMN KI+DFG + F G Y +PE Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKY 190
Query: 647 ALDGLFSIKSDVFSFGILM 665
DG + DV+S G+++
Sbjct: 191 --DGP---EVDVWSLGVIL 204
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+++ + +LG G FG V++ G A K + + + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
LV L + E ++I E+M LF+ + + ++ V + + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 587 HQYSRFRIIHRDLKASNILL-DKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H+ + +H DLK NI+ K N K+ DFGL + + K GT + +P
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E A +D++S G+L
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 29/198 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
LGEG +G V + + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 537 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARV---RIIEGIAQGLLYLHQYSR 591
E + L LEY L FD + A+ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 646 YALDGLFSIKSDVFSFGI 663
+ DV+S GI
Sbjct: 184 F--HAE---PVDVWSCGI 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 26/206 (12%)
Query: 453 SKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RL 503
++D+ LP S EN+ + LG G V + +E AVK
Sbjct: 1 TRDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSF 58
Query: 504 SNQSGQGLKE-FKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD- 560
S + Q L+E E+ ++ K+ H N+++L L+ + M L FD
Sbjct: 59 SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDY 114
Query: 561 -STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619
+ K L + R +I+ + + + LH+ I+HRDLK NILLD DMN K++DFG
Sbjct: 115 LTEKVTLSEKETR-KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170
Query: 620 ARMFGGDELQGNTKQIVGTYGYMSPE 645
+ E +++ GT Y++PE
Sbjct: 171 SCQLDPGEK---LREVCGTPSYLAPE 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS--TKKRLLNWQARVRIIEGIAQGLL 584
N+VRL E+ L+ + + L F+ ++ A I+ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 642 MSPE 645
+SPE
Sbjct: 174 LSPE 177
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH I H DLK NI+L + K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+ + + +LG G F V K R G E A K + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
++ H N++ L + + +LILE + LFD +K L+ + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH I H DLK NI+L DK++ K+ DFGLA K I G
Sbjct: 127 GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+++ M +LG G F V K R G+E A K RLS+ +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
+++H N++ L + + +LILE + LFD +K L + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH RI H DLK NI+L + K+ DFG+A K I G
Sbjct: 120 GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ F LG G F V+ + L G+ A+K + +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
+V L L+++ + LFD + A +I+ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 587 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
H+ I+HRDLK N+L +++ I+DFGL++M + GT GY++
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175
Query: 644 PEYALDGLFSIKSDVFSFGILM 665
PE +S D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 48/249 (19%), Positives = 86/249 (34%), Gaps = 60/249 (24%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKEFKNEMMLIAK 523
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV---------- 573
L H N+ RL ++ L++E L D + + +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 574 -------------------------------RIIEGIAQGLLYLHQYSRFRIIHRDLKAS 602
I+ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 603 NILL--DKDMNPKISDFGLARMFGGDELQGNT--KQIVGTYGYMSPE--YALDGLFSIKS 656
N L +K K+ DFGL++ F GT +++PE + + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 657 DVFSFGILM 665
D +S G+L+
Sbjct: 258 DAWSAGVLL 266
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 26/190 (13%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE---FKNEMML 520
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 578
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 636 VGTYGYMSPE 645
GT Y++PE
Sbjct: 177 CGTPTYLAPE 186
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 45/201 (22%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRN 62
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
++ L E ++I E++ +F+ +T LN + V + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 587 HQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H ++ I H D++ NI+ + KI +FG AR + + + Y +P
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAP 172
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E + S +D++S G L+
Sbjct: 173 EVHQHDVVSTATDMWSLGTLV 193
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 23/188 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-------RLSNQSGQGLKE-FKNEMML 520
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 521 IAKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIE 577
+ ++ H +++ L+ L+ + M L FD + K L + R I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ + + +LH I+HRDLK NILLD +M ++SDFG + E +++ G
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 638 TYGYMSPE 645
T GY++PE
Sbjct: 262 TPGYLAPE 269
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 48/198 (24%)
Query: 477 CKLGEGGFGPVYKGR---LLNGQEVAVKRLSN----QSGQGLKEFKNEMMLIAKLQHRNL 529
CK+G G +G VYK + + ++ A+K++ S E+ L+ +L+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 530 VRLLGCCVEQGEKI--LILEYM--------------PNKSLNVFLFDSTKKRLLNWQARV 573
+ L + ++ L+ +Y V L K LL +Q
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-YQ--- 136
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFG--GDE 627
I G+ YLH ++HRDLK +NIL+ + KI+D G AR+F
Sbjct: 137 -----ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 628 LQGNTKQIVGTYGYMSPE 645
L +V T+ Y +PE
Sbjct: 189 LADLDPVVV-TFWYRAPE 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 43/200 (21%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKE-FKN----EMMLIA 522
+ K+G+G FG V+K R GQ+VA+K + N+ KE F E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----KEGFPITALREIKILQ 71
Query: 523 KLQHRNLVRLLGCCVEQGEKI--------LILEYMPN------KSLNVFLFDSTKKRLLN 568
L+H N+V L+ C + L+ ++ + ++ V S KR++
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM- 130
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG---G 625
+ GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F
Sbjct: 131 QM--------LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 626 DELQGNTKQIVGTYGYMSPE 645
+ T ++V T Y PE
Sbjct: 180 SQPNRYTNRVV-TLWYRPPE 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 23/186 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHRN 528
++ +G G FG V++ +L+ EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 529 LVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGIA 580
+V L G+K L+LEY+P +++ + K+ + ++ + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMYQ-LL 151
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTY 639
+ L Y+H I HRD+K N+LLD K+ DFG A++ + N I Y
Sbjct: 152 RSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY 206
Query: 640 GYMSPE 645
Y +PE
Sbjct: 207 -YRAPE 211
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK-----RLSNQSGQGLKE-FKNEMMLIA 522
+ + +LG G F V K R G + A K R + +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQ 581
++QH N++ L + + ILILE + LFD +K L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 582 GLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
G+ YLH I H DLK NI+L KI DFGLA K I G
Sbjct: 126 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179
Query: 638 TYGYMSPEYALDGLFSIKSDVFSFGILM 665
T +++PE +++D++S G++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLS--------NQSGQGLKEFKNEMML 520
+ + M LG G G V ++VA++ +S + + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEG 578
+ KL H ++++ + + ++LE M L FD KRL +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQI 635
+ + YLH+ IIHRDLK N+LL ++D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 636 VGTYGYMSPE 645
GT Y++PE
Sbjct: 302 CGTPTYLAPE 311
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQH 526
++N+ ++ +LG+G F V + G E A K + S + ++ + E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLL 584
N+VRL E+ L+ + + LF+ ++ A I+ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 585 YLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196
Query: 642 MSPEYALDGLFSIKSDVFSFGILM 665
+SPE +S D+++ G+++
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 50/177 (28%), Positives = 76/177 (42%), Gaps = 33/177 (18%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKN----EMMLI 521
AT + ++G G +G VYK R +G VA+K R+ N G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 522 AKLQ---HRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLL 567
+L+ H N+VRL+ C L+ E++ + + L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
Q +GL +LH I+HRDLK NIL+ K++DFGLAR++
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS-----------------NQSGQGLKEFKNEMML 520
+G+G +G V + A+K LS + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 521 ------IA---KLQHRNLVRLLGCCVEQGEK---ILILEYMPNKSLNVFLFD-STKKRLL 567
IA KL H N+V+L+ ++ + ++ E + + + T K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF-GGD 626
QAR + + +G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 627 ELQGNTKQIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 663
L NT VGT +M+PE +L I DV++ G+
Sbjct: 192 ALLSNT---VGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--------RLSNQSGQGLKEFKNEMMLIA 522
+S LG G FG V+ +EV VK L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 523 KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
+++H N++++L QG L++E + L++F F RL A I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ YL IIHRD+K NI++ +D K+ DFG A +L GT Y
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196
Query: 643 SPE------YALDGLFSIKSDVFSFGILM 665
+PE Y G + +++S G+ +
Sbjct: 197 APEVLMGNPY--RGP---ELEMWSLGVTL 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V G L G +VAVK L+ Q S + + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+ +++EY+ L FD R+ +AR R+ + I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---R 129
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 186
Query: 646 YALDGLFSIKSDVFSFGILM 665
Y G + D++S G+++
Sbjct: 187 Y--AGP---EVDIWSCGVIL 201
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 33/174 (18%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR--LLNGQEVAVKRL---SNQSG---QGLKEFKNEMMLIA 522
+ + ++GEG +G V+K R G+ VA+KR+ + + G ++E + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRHLE 69
Query: 523 KLQHRNLVRLLGCCV----EQGEKI-LILEYMPN--KSL-----NVFLFDSTKKRLLNWQ 570
+H N+VRL C ++ K+ L+ E++ + + T K ++ +Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM-FQ 128
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624
+ +GL +LH + R++HRDLK NIL+ K++DFGLAR++
Sbjct: 129 --------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 58/187 (31%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 527
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 528 NLVRLLGCCVEQGEKI------LILEYMPNKSLNVFL--FDSTKKRLLNWQARVRIIEGI 579
N+VRL GEK L+L+Y+P +++ + K+ L ++ + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQ-L 165
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGT 638
+ L Y+H F I HRD+K N+LLD D K+ DFG A+ E N I
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSR 220
Query: 639 YGYMSPE 645
Y Y +PE
Sbjct: 221 Y-YRAPE 226
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 50/178 (28%), Positives = 72/178 (40%), Gaps = 18/178 (10%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCC 536
LGEG V L+ QE AVK + Q G E+ ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 537 VEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRII 595
E+ L+ E M S+ K+R N +++ +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIA 133
Query: 596 HRDLKASNILL---DKDMNPKISDFGLARMF-----GGDELQGNTKQIVGTYGYMSPE 645
HRDLK NIL ++ KI DF L G+ YM+PE
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 30/209 (14%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL------SNQSGQGLKEFKNEMMLIAKL 524
+ + LG GGFG VY G + + VA+K + E++L+ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 525 QHR--NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIA 580
++RLL +LILE LFD + + L AR +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELAR-SFFWQVL 159
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+ + + H ++HRD+K NIL+D + K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 640 GYMSPEYAL----DGLFSIKSDVFSFGIL 664
Y PE+ G + V+S GIL
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGIL 238
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 18/192 (9%)
Query: 463 LASITAA--TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNE 517
+A+IT TE + + +LG+G F V + +L GQE A + S + ++ + E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRII 576
+ L+H N+VRL E+G LI + + L F+ + + I
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADASHCI 116
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTK 633
+ I + +L+ HQ ++HR+LK N+LL K K++DFGLA G+ Q
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWF 171
Query: 634 QIVGTYGYMSPE 645
GT GY+SPE
Sbjct: 172 GFAGTPGYLSPE 183
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLS----------NQSGQGLKEFKNEMMLIAKLQHR 527
LG+GGFG V+ G L + +VA+K + + S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
++RLL Q +L+LE P + ++F + + K L +R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 588 QYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
++HRD+K NIL+D K+ DFG + + GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW 209
Query: 647 ALDGLFS-IKSDVFSFGIL 664
+ + + V+S GIL
Sbjct: 210 ISRHQYHALPATVWSLGIL 228
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR-NLVRLL 533
+LG G F V + GQE A K + + E +E+ ++ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNW---QARVRIIEGIAQGLLYLHQYS 590
E ILILEY + F L +R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN- 150
Query: 591 RFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I+H DLK NILL + KI DFG++R G ++I+GT Y++PE
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEIL 205
Query: 648 LDGLFSIKSDVFSFGILM 665
+ +D+++ GI+
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 30/200 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
LG G FG V G+ L G +VAVK L+ Q S + + + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
+ I +++EY+ L FD RL ++R R+ + I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESR-RLFQQILSGVDYCH---R 134
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------ 645
++HRDLK N+LLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 191
Query: 646 YALDGLFSIKSDVFSFGILM 665
Y G + D++S G+++
Sbjct: 192 Y--AGP---EVDIWSSGVIL 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQ--SGQGLKE-FKNEMMLIAKLQHRNLVRLLG 534
LGEG FG V Q+VA+K +S Q + + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 535 CCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ ++++EY + LFD KKR+ + R R + I + Y H R
Sbjct: 77 VITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RH 127
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 646
+I+HRDLK N+LLD ++N KI+DFGL+ + K G+ Y +PE Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLY 184
Query: 647 ALDGLFSIKSDVFSFGILM 665
G + DV+S GI++
Sbjct: 185 --AGP---EVDVWSCGIVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 18/182 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLH 587
++ L + ++ E M L D +++ + + ++ I + + YLH
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 588 QYSRFRIIHRDLKASNILL-DKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
++HRDLK SNIL D+ NP +I DFG A+ + G T +++
Sbjct: 134 AQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFVA 188
Query: 644 PE 645
PE
Sbjct: 189 PE 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 50/198 (25%), Positives = 80/198 (40%), Gaps = 40/198 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKL 524
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 525 QHRNLVRLLGCCVEQGEK-------ILILEYMP---------NKSLNVFLFDSTKKRLLN 568
H N+V+L GE+ +++EY+P V K L
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL- 135
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-KISDFGLARMFGGDE 627
+Q + + + LH S + HRD+K N+L+++ K+ DFG A+ E
Sbjct: 136 FQ--------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 628 LQGNTKQIVGTYGYMSPE 645
N I Y Y +PE
Sbjct: 187 P--NVAYICSRY-YRAPE 201
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
++ F ++ +LG G VY+ + + A+K L + K + E+ ++ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYL 586
+++L E L+LE + L FD K A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 587 HQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT GY +
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218
Query: 644 PEYALDGLFSIKSDVFSFGILM 665
PE + + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 47/201 (23%), Positives = 83/201 (41%), Gaps = 30/201 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
LG G G V + GQ+ A+K L + + + E+ + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 536 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 587
+I+E M L F ++R +A I+ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 588 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
++ I HRD+K N+L +KD K++DFG A+ + L + T Y++P
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAP 198
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E + D++S G++M
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 18/194 (9%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
LGEG F K + Q AVK +S + + E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 536 CVEQGEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+Q L++E + L F+ KK+ + I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---V 127
Query: 595 IHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
+HRDLK N+L + ++ KI DFG AR+ D K T Y +PE
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNG 185
Query: 652 FSIKSDVFSFGILM 665
+ D++S G+++
Sbjct: 186 YDESCDLWSLGVIL 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 6e-22
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
F LG+GGFG V ++ ++ A K+L + +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
R +V L E + + L+L M L ++ + +A E I GL
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH R RI++RDLK NILLD + +ISD GLA + K VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 646 YALDGLFSIKSDVFSFGILMLETL 669
+ ++ D ++ G L+ E +
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMI 379
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-21
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLS-------NQSGQGLKEFKNEMMLIA 522
+FS+ +G GGFG VY R + ++ A+K L L E + + L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 523 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
+V + +K+ IL+ M L S R E I
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAAE-IIL 303
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL ++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGY 356
Query: 642 MSPEYALDGLFSIKS-DVFSFGILMLETL 669
M+PE G+ S D FS G ++ + L
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
+ F LG GGFG V+ ++ ++ A K+L+ + +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRI-IEGIAQGLL 584
R +V L E + L++ M + +++ + + R I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
+LHQ II+RDLK N+LLD D N +ISD GLA + TK GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAP 358
Query: 645 EYALDGLFSIKSDVFSFGILMLETL 669
E L + D F+ G+ + E +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 30/197 (15%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQHRNLVRLLGCC 536
+G G FG R L + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 537 VEQGEKILILEYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594
+ +I+EY L ++ R +AR + + G+ Y H +I
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQI 137
Query: 595 IHRDLKASNILLDKD--MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE------Y 646
HRDLK N LLD KI DFG ++ K VGT Y++PE Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEY 194
Query: 647 ALDGLFSIKSDVFSFGI 663
DG +DV+S G+
Sbjct: 195 --DGK---IADVWSCGV 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 29/201 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGC 535
LG G G V + ++ A+K L + + + E+ L + ++VR++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 536 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 587
+++E + L F + R +A I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 588 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
+ I HRD+K N+L + K++DFG A+ + T Y++P
Sbjct: 179 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232
Query: 645 EYALDGLFSIKSDVFSFGILM 665
E + D++S G++M
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 23/197 (11%), Positives = 58/197 (29%), Gaps = 43/197 (21%)
Query: 478 KLGEGGFGPVYKGR--LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHRNLVRL 532
G ++ L ++VA+ + Q L+E + + ++++ + R+
Sbjct: 38 FHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
L + +++ E++ SL A +R ++ +A H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGA-IRAMQSLAAAADAAH---RA 148
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF 652
+ S + + D + ++ M
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------- 179
Query: 653 SIKSDVFSFGILMLETL 669
+ + D+ G + L
Sbjct: 180 NPQDDIRGIGASLYALL 196
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 16/240 (6%)
Query: 436 TTRTNEYGEANGDGKDKSKDSWLPLFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRL-L 493
+ E+ + K+K+ +L + S A + F LG G FG V +
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE 64
Query: 494 NGQEVAVKRLSNQSGQGLKEF---KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550
+G A+K L Q LK+ NE ++ + LV+L + +++EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610
+ F R AR + I YLH +I+RDLK N+L+D+
Sbjct: 125 GGEM--FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPENLLIDQQG 178
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+++DFG A+ ++G T + GT ++PE L ++ D ++ G+L+ E +
Sbjct: 179 YIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 41/199 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + ++ +G G +G V + L + VA+K++ F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 520 LIAKLQHRNLVRLLGCCV----EQGEKI-LILEYMPN------KSLNVFLFDSTKKRLLN 568
++ +L H ++V++L + E+ +++ ++LE + ++ V+L + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
+ + G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 629 QGNTKQIVGTYGYMSPEYA 647
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTF 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 17/209 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
+ + L + + L+++Y L + L + RL AR + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+HQ +HRD+K NIL+D + + +++DFG D + VGT Y+SPE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246
Query: 646 YALDGLFSIKS-----DVFSFGILMLETL 669
D +S G+ M E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 51/247 (20%), Positives = 103/247 (41%), Gaps = 57/247 (23%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN-EMMLIAKLQHR 527
++ +S+ LG G FG V + + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 528 NLVRLLGCCVEQGEKI--------------------------------------LILEYM 549
N+++L+ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 550 PNKSLNVFL--FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607
P +L+ L F + + + + I + + + + ++H I HRD+K N+L++
Sbjct: 121 P-DTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 608 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILM 665
KD K+ DFG A+ + + I + Y +PE L ++ D++S G +
Sbjct: 176 SKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 666 LETLSSK 672
E + K
Sbjct: 233 GELILGK 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 48/211 (22%), Positives = 88/211 (41%), Gaps = 19/211 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
++F + +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
R + +L + + L++EY L + L +R+ AR + E I +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+H+ +HRD+K NILLD+ + +++DFG D + VGT Y+SPE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233
Query: 646 -------YALDGLFSIKSDVFSFGILMLETL 669
G + + D ++ G+ E
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
++F + LG G FG V+ R + A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++R+ G + + +I++Y+ L F +R N A+ E + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAAE-VCLALEYL 122
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLS 670
++ D +SFGIL+ E L+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 520 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 570
L+ + H+N++ LL +E+ + + +++E M + + + L LL +Q
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL-YQ 135
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
+ G+ +LH IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 136 --------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 182
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L + D++S G +M E +
Sbjct: 183 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 9e-18
Identities = 60/275 (21%), Positives = 95/275 (34%), Gaps = 81/275 (29%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-----------LKE 513
+ + LG G FG V + + VAVK L + L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 514 F----------------KNEMMLIAKL-QHRNLVRLLGCCVEQGE--KILILEYMPNKSL 554
+M+I + + NL L + K + K
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 555 NVFLFDSTKKRL------------------------------------LNWQARVRIIEG 578
+ K+RL L + +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL---QGNTKQI 635
+A+G+ +L + + IHRDL A NILL + KI DFGLAR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 636 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 670
+ +M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 38/226 (16%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKE--FKN---------EM 518
+++Q + G +G V G G VA+KR+ N G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 519 MLIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMPN------KSLNVFLFDSTKKRLL 567
L+ H N++ L K+ L+ E M + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ I GL LH+ ++HRDL NILL + + I DF LAR D
Sbjct: 141 -YH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
N V Y +PE + F+ D++S G +M E + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR 527
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 528 NLVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
N++ L + + L+ E++ N + L ++ R + E I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145
Query: 586 LHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
H S I+HRD+K N+++D + ++ D+GLA Q ++ Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 645 EYALDGLFSIKS-DVFSFGILMLETLSSKK 673
E +D S D++S G ++ + K+
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + +G G G V + + VA+K+LS F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 520 LIAKLQHRNLVRLL------GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
L+ + H+N++ LL E + L++E M L + L + +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ + + G+ +LH S IIHRDLK SNI++ D KI DFGLAR G +
Sbjct: 169 LLYQ-MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MT 221
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L + D++S G +M E + K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKE---FKNEMMLIAKLQH 526
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V+L + +++EYMP L + + + AR E + L +
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL---VNLMSNYDVPEKWARFYTAE-VVLALDAI 184
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE- 645
H IHRD+K N+LLDK + K++DFG + + VGT Y+SPE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEV 240
Query: 646 ---YALDGLFSIKSDVFSFGILMLETL 669
DG + + D +S G+ + E L
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKN---EMMLIAKLQH 526
++F + +G+G FG V + + +++ A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 527 RNLVRLLGCCVEQ-GEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
LV L Q E + ++++ + L ++ I E + L
Sbjct: 75 PFLVNLWYSF--QDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICE-LVMALD 129
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YL RIIHRD+K NILLD+ + I+DF +A M + + GT YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 645 EYALDGLFSIKS---DVFSFGILMLETL 669
E + S D +S G+ E L
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 526
+ + +G G +G V +G++VA+K+LS QS K E++L+ +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 527 RNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARVRIIE 577
N++ LL + L++ +M K + + + + L+ +Q
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV-YQ------- 134
Query: 578 GIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVG 637
+ +GL Y+H ++HRDLK N+ +++D KI DFGLAR + V
Sbjct: 135 -MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 185
Query: 638 TYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
T Y +PE L ++ D++S G +M E L+ K
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAE-IVSALDY 263
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH S +++RDLK N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYLA 317
Query: 644 PEYALDGLFSIKSDVFSFGILMLETL 669
PE D + D + G++M E +
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 59/252 (23%), Positives = 110/252 (43%), Gaps = 29/252 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
++F + +G G + V RL + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H LV L C + ++ ++EY+ L +++L AR E I+ L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALN 124
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
YLH+ II+RDLK N+LLD + + K++D+G+ + + GD T GT Y+
Sbjct: 125 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYI 177
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
+PE + D ++ G+LM E + G F+++G + + ++ D +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMM-----AG---RSPFDIVGSSDNPDQNTE--DYL 227
Query: 703 DPVIMQDEISLP 714
VI++ +I +P
Sbjct: 228 FQVILEKQIRIP 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 6e-16
Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 41/202 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+N+ ++ +G G +G VY + VA+K+++ F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77
Query: 520 LIAKLQHRNLVRLLGCCVEQGEKI-----LILEYMPN------KSLNVFLFDSTKKRLLN 568
++ +L+ ++RL + ++LE + K+ +FL + K +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTIL- 135
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 136 YN--------LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 629 QGNTKQIVGTYGYMSPEYALDG 650
+ L
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKK 206
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 64/303 (21%), Positives = 123/303 (40%), Gaps = 29/303 (9%)
Query: 420 VETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKL 479
+ Y D ++ T G +++ + AS + ++F + +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVI 60
Query: 480 GEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQHRNLVRLLG 534
G G + V RL + A++ + + ++ H LV L
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 535 CCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
C + ++ ++EY+ L +++L AR E I+ L YLH+
Sbjct: 120 SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLHE---RG 173
Query: 594 IIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMSPEYALDGL 651
II+RDLK N+LLD + + K++D+G+ + + GD T GT Y++PE
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGED 229
Query: 652 FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711
+ D ++ G+LM E + G F+++G + + ++ L VI++ +I
Sbjct: 230 YGFSVDWWALGVLMFEMM-----AG---RSPFDIVGSSDNPDQNTE-DYLFQ-VILEKQI 279
Query: 712 SLP 714
+P
Sbjct: 280 RIP 282
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
++ +GEG +G V LN VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 520 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 571
++ + +H N++ + +EQ + + ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 632 T-KQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
+ V T Y +PE L+ ++ D++S G ++ E LS++
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.8 bits (193), Expect = 8e-16
Identities = 34/199 (17%), Positives = 60/199 (30%), Gaps = 46/199 (23%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRL--------SNQSGQGLKEFKNEMML 520
TE K+GEG FG V++ + VA+K + + + +E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 521 IAKLQ---------HRNLVRLLGCCVEQGE--KILILEYM----PNKSLNVFL------- 558
+L + L QG +L+ + S N
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 559 -------------FDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605
+ + +L + I+ + L R HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 606 LDKDMNPKISDFGLARMFG 624
L K K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEM----MLIAKLQ 525
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H L + C + E + ++EY+ L + + +A E I GL
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAE-IILGLQ 132
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
+LH I++RDLK NILLDKD + KI+DFG+ + M G T GT Y+
Sbjct: 133 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDYI 185
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE L ++ D +SFG+L+ E L
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 18/206 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEF---KNEMMLIAKLQH 526
+F LG+G FG V R A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 527 RNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
L L + +++ ++EY L F S ++ +AR E I L Y
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAE-IVSALEY 120
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYMS 643
LH +++RD+K N++LDKD + KI+DFGL + + G K GT Y++
Sbjct: 121 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLA 173
Query: 644 PEYALDGLFSIKSDVFSFGILMLETL 669
PE D + D + G++M E +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ LG GG G V+ + VA+K++ Q +K E+ +I +L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 529 LVRLL--------------GCCVEQGEKILILEYMP---NKSLNVFLFDSTKKRLLNWQA 571
+V++ G E ++ EYM L RL +Q
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ- 128
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQG 630
+ +GL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR+
Sbjct: 129 -------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 631 NT-KQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSK 672
+ + T Y SP L ++ D+++ G + E L+ K
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 2e-15
Identities = 71/399 (17%), Positives = 136/399 (34%), Gaps = 23/399 (5%)
Query: 283 PIKCERSHSLECKSGDQFIELDEIKAPDFIDVSLNQRMNLEQCKAECLKNCSCRAYANSN 342
P C H+ +D + + N ++ S
Sbjct: 149 PSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSE 208
Query: 343 VKESSGCLM---WYGDLIDARRPIRNFTGQSVYLRVPASKLGNKKLLWILVILVIPVVLL 399
K+ + + R ++ + ++ + L
Sbjct: 209 SKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQ 268
Query: 400 PSFYVFYRRRRKCQEKETENVETYQDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLP 459
+ + + +E E NV + + + + G+ ++K+ ++
Sbjct: 269 KAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISK 328
Query: 460 LFSLASITAAT-ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNE 517
+ + +F+ LG+G FG V E+ AVK L + +
Sbjct: 329 FDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 518 MM----LIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQAR 572
M+ L + L +L C + +++ ++EY+ L R A
Sbjct: 389 MVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAV 445
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQG 630
E IA GL +L II+RDLK N++LD + + KI+DFG+ + ++ G
Sbjct: 446 FYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---- 497
Query: 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
TK GT Y++PE + D ++FG+L+ E L
Sbjct: 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
+F +G+G FG V R + AVK L ++ KE K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H LV L + +K+ +L+Y+ L F ++ L +AR E IA L
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAE-IASALG 153
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
YLH + I++RDLK NILLD + ++DFGL + + T GT Y+
Sbjct: 154 YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEYL 206
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE + D + G ++ E L
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
L +L C + +++ ++EY+ L R A E IA GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAE-IAIGLF 135
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTYGYM 642
+L II+RDLK N++LD + + KI+DFG+ + ++ G TK GT Y+
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYI 188
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE + D ++FG+L+ E L
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 34/215 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF---------KNE 517
F + LG+G FG V+ + ++G + A+K L K K E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 518 MMLIAKLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRII 576
++ ++ H +V+L + K+ LIL+++ L F S + + +
Sbjct: 77 RDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 133
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQ 634
E +A L +LH II+RDLK NILLD++ + K++DFGL++ + +
Sbjct: 134 E-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AYS 185
Query: 635 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669
GT YM+PE + +D +SFG+LM E L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 526
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 527 RNLVRLL-----GCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 580
N++ LL ++ L++ +M L + K L ++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQML 138
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
+GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 190
Query: 641 YMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
Y +PE L+ ++ D++S G +M E ++ K
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 26/156 (16%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGC 535
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 536 CVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNW----QARVRIIEGIAQGLLYLH 587
+++E + L F + R +A I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 588 QYSRFRIIHRDLKASNILL---DKDMNPKISDFGLA 620
+ I HRD+K N+L + K++DFG A
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQS-GQGLKEF---KNEMMLIA 522
E F + LG+GG+G V++ R + G A+K L + K+ K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 523 KLQHRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
+++H +V L+ + G K+ LILEY+ L F+ + + A + E I+
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAE-ISM 132
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR--MFGGDELQGNTKQIVGTY 639
L +LHQ II+RDLK NI+L+ + K++DFGL + + G T GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGTI 185
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETL 669
YM+PE + + D +S G LM + L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV-AVKRLSNQSGQGLKEFKNEMM----LIAKLQ 525
+NF LG+G FG V R+ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 526 HRNLVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H L +L CC + +++ ++E++ L +R +AR E I L+
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAE-IISALM 138
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA--RMFGGDELQGNTKQIVGTYGYM 642
+LH II+RDLK N+LLD + + K++DFG+ + G T GT Y+
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYI 191
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETL 669
+PE + L+ D ++ G+L+ E L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEML 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 43/223 (19%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
E + +G G +G V G VAVK+LS F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 520 LIAKLQHRNLVRLL-----GCCVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQ 570
L+ ++H N++ LL +E+ + L+ M N + + L +Q
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630
I +GL Y+H IIHRDLK SN+ +++D KI DFGLAR
Sbjct: 141 --------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTAD 184
Query: 631 NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSK 672
V T Y +PE L+ ++ D++S G +M E L+ +
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 43/195 (22%), Positives = 83/195 (42%), Gaps = 40/195 (20%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 520 LIAKLQHRNLVRLLGC----CVEQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQA 571
++ +H N++ + E ++ +I E M ++ ++ + + +Q
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ- 120
Query: 572 RVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGN 631
+ + LH + +IHRDLK SN+L++ + + K+ DFGLAR+ DE +
Sbjct: 121 -------TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAAD 168
Query: 632 TKQIVGTYGYMSPEY 646
+ G M E+
Sbjct: 169 NSEPTGQQSGMV-EF 182
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 34/198 (17%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKN---------EMM 519
+ + KLG+G +G V+K G+ VAVK++ + F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 520 LIAKLQ-HRNLVRLLGCCV-EQGEKI-LILEYMP---NKSLNVFLFDSTKKRLLNWQARV 573
++ +L H N+V LL + + L+ +YM + + + + K+ + +Q
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ--- 117
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ + + YLH S ++HRD+K SNILL+ + + K++DFGL+R F N
Sbjct: 118 -----LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 634 QIVGTYGYMSPEYALDGL 651
+ + + L
Sbjct: 170 PLSINENTENFDDDQPIL 187
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-13
Identities = 20/126 (15%), Positives = 42/126 (33%), Gaps = 19/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ +T + G+ L + VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCNLVLYD--------HSTSVWASNTGIL-GK 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ ++GN V+ + ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDY 151
W + Y
Sbjct: 103 WSTGTY 108
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 34/218 (15%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEV----AVKRLSNQSGQGLKEF-----------K 515
ENF + LG G +G V+ R ++G + A+K L K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTR 106
Query: 516 NEMMLIAKLQHRN-LVRLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARV 573
E ++ ++ LV L + K+ LIL+Y+ L F S ++R + ++
Sbjct: 107 TERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQI 163
Query: 574 RIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK 633
+ E I L +LH+ II+RD+K NILLD + + ++DFGL++ F DE +
Sbjct: 164 YVGE-IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AY 218
Query: 634 QIVGTYGYMSPEYALDGLFSIKSDV--FSFGILMLETL 669
GT YM+P+ G V +S G+LM E L
Sbjct: 219 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-12
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 19/123 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
++++ + + G L + L G VW +N
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNFVLYDSGK--------PVWASNTGGL--G 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ NNGNLV+ +Q+N IW T + + + V L+ D N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQS 148
W +
Sbjct: 103 WAT 105
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 30/211 (14%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFK-------NEMMLIAKLQH 526
KLG G F V+ + ++N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 527 RNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582
++++LL +G ++ E + ++L + + + + +I + + G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLLG 143
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNP------KISDFGLARMFGGDELQGNTKQIV 636
L Y+H R IIH D+K N+L++ +P KI+D G A + + +
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY----TNSI 196
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
T Y SPE L + +D++S L+ E
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 41/185 (22%), Positives = 79/185 (42%), Gaps = 22/185 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RN 528
+ + K+G G FG +Y G + G+EVA+K ++ E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 66
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+ + C E ++++E + SL LF+ ++ + + + + + + + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLE-DLFNFCSRK-FSLKTVLLLADQMISRIEYIHS 123
Query: 589 YSRFRIIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQGNT-------KQIVGT 638
+ IHRD+K N L+ I DFGLA+ + + + + K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLTGT 178
Query: 639 YGYMS 643
Y S
Sbjct: 179 ARYAS 183
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 43/194 (22%), Positives = 73/194 (37%), Gaps = 40/194 (20%)
Query: 472 NFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
NF + K+G G FG + G+ L + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRIIEGIAQGL 583
++ ++LE + SL LFD + + Q + +E
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRTFSLKTVLMIAIQL-ISRME------ 119
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGNTKQ---- 634
Y+H + +I+RD+K N L+ + N I DF LA+ + + TK+
Sbjct: 120 -YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY----IDPETKKHIPY 171
Query: 635 -----IVGTYGYMS 643
+ GT YMS
Sbjct: 172 REHKSLTGTARYMS 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 32/201 (15%), Positives = 77/201 (38%), Gaps = 34/201 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR---------LLNGQEVAVKRLSNQSGQGLKEFK------ 515
+ ++ G +Y+ Q+ ++K L + G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 516 -----NEMMLIAKLQHRNLVRLLGCCVEQGE-KILILEYMPNKSLNVFLFDSTKKRLLNW 569
N+ + + +G V Q + + L+L + +SL D + K +L+
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSE 158
Query: 570 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMF--GG 625
++ +++ + L +LH+ +H ++ A NI +D + ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 626 DEL---QGNTKQIVGTYGYMS 643
+ +G+ G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-11
Identities = 27/124 (21%), Positives = 51/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + L + + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK-- 48
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
+ VL + N+GNLV+ + + IW++N + + N L+ D N+VI D +S NA
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYD-NSNNA---- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 4e-06
Identities = 18/69 (26%), Positives = 36/69 (52%), Gaps = 1/69 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+++ + I N+ NLVL + N +W++ + + V ++++DGNLVI S
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 SYLWQSFDY 151
+ Q+ +Y
Sbjct: 75 NTNRQNGNY 83
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 40/187 (21%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHR 527
++ + ++GEG FG +++G LLN Q+VA+K +S Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
+ + E +L+++ + SL L D ++ + + + + + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-SVKTVAMAAKQMLARVQSIH 123
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPK-----ISDFGLARMFGGDELQGN------TKQIV 636
+ S +++RD+K N L+ + + + DFG+ + + D + K +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS 179
Query: 637 GTYGYMS 643
GT YMS
Sbjct: 180 GTARYMS 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 527
+ + +G+G FG V K + + VA+K + N+ Q E + L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR----LLELMNKHD 111
Query: 528 -----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQ 581
+V L + + L+ E + S N++ L +T R ++ + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTY 639
LL+L IIH DLK NILL KI DFG + G + Q + +
Sbjct: 169 ALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRIY----QYIQSR 222
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLE 667
Y SPE L + + D++S G +++E
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-11
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + L + + L + +W +N DR
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNLVKYQ--------NGRQIWASNTDR--RG 50
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ LT+ ++GNLV+ + N +W + + L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 7e-11
Identities = 18/76 (23%), Positives = 33/76 (43%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+W N N + +G LV++ N T+W + V+ + + V L+ D N+VI
Sbjct: 50 PIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 133 RDNSSGNATESYLWQS 148
++ LW +
Sbjct: 108 YGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 6e-08
Identities = 19/77 (24%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 73 VVWVANRDRPISDNNA-VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
++ + + + + NLVL + N IW+TN A L+ DG LV
Sbjct: 16 ILHATESLEILFGTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLV 74
Query: 132 IRDNSSGNATESYLWQS 148
+ N + +WQS
Sbjct: 75 VITNEN-----VTVWQS 86
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 39/201 (19%), Positives = 77/201 (38%), Gaps = 48/201 (23%)
Query: 478 KLGEGGFGPVYKGRLLNGQ------EVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
+G+GGFG +Y + + + VK + +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 532 LL-------------GCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRL-------LNW 569
G + G+ +I++ L ++++ KR L+
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRFSRKTVLQLSL 159
Query: 570 QARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGGDE 627
+ + I+E Y+H++ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 160 RI-LDILE-------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 628 L-----QGNTKQIVGTYGYMS 643
+ + GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 1e-10
Identities = 25/123 (20%), Positives = 45/123 (36%), Gaps = 20/123 (16%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L ++ R+ + +W N D
Sbjct: 2 NILYSGETLSPGEFL--NNGRYVFIMQEDCNLVLYDVDK--------PIWATNTGGL--D 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
L++ ++GNLV+ + N IW++N E N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLV-RLL 533
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFR 593
VE +L+++ + SL LF+ ++ L+ + + + + + + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 594 IIHRDLKASNILLDKDMNPK---ISDFGLARMFGGDELQG------NTKQIVGTYGYMS 643
+HRD+K N L+ I DFGLA+ + D K + GT Y S
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYAS 181
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 5e-10
Identities = 20/112 (17%), Positives = 40/112 (35%), Gaps = 13/112 (11%)
Query: 21 VSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRD 80
+ + + + +L + + +L W +N
Sbjct: 2 IPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN---------LVLYGGKYGWQSNTH 50
Query: 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+ + L +++ G L++ + TIWS+ SS+ V L+DDG VI
Sbjct: 51 G--NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 16/71 (22%), Positives = 28/71 (39%), Gaps = 7/71 (9%)
Query: 78 NRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSS 137
D ++ N L + + NLVL W +N ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 GNATESYLWQS 148
+W S
Sbjct: 74 KT-----IWSS 79
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 39/203 (19%), Positives = 73/203 (35%), Gaps = 55/203 (27%)
Query: 478 KLGEGGFGPVYKG-RLLNGQEVA---VKRLSNQSGQGLKEFKNEMML-----IAKLQHRN 528
K+G GGFG +Y ++ A VK ++G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 529 LVRLLG----------CCVEQGEKILILEYMPNKSLNVFLFDSTKK-----------RLL 567
+ LG + + +++E + L + R+L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGIRML 161
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI--SDFGLARMFGG 625
+ ++E Y+H+ +H D+KA+N+LL ++ +D+GL+ +
Sbjct: 162 D------VLE-------YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205
Query: 626 DEL-----QGNTKQIVGTYGYMS 643
+ + K GT + S
Sbjct: 206 NGNHKQYQENPRKGHNGTIEFTS 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 28/202 (13%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR------N 528
+G+G FG V K Q VA+K + N+ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
++ +L + + E + S+N++ L K + + + I Q L LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217
Query: 588 QYSRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
+ RIIH DLK NILL + K+ DFG + + + + + Y +PE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQSRFYRAPE 269
Query: 646 YALDGLFSIKSDVFSFGILMLE 667
L + + D++S G ++ E
Sbjct: 270 VILGARYGMPIDMWSLGCILAE 291
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 2e-09
Identities = 22/126 (17%), Positives = 41/126 (32%), Gaps = 23/126 (18%)
Query: 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRP 82
L + + + L + F+L W +N
Sbjct: 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCNLVLYNGN-----------WQSNTAN- 46
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+ + LT+++ G LV+ N T+W + S N A + DG LV+ S
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPS------ 99
Query: 143 SYLWQS 148
+++
Sbjct: 100 --VFKI 103
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-08
Identities = 11/76 (14%), Positives = 31/76 (40%), Gaps = 10/76 (13%)
Query: 73 VVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVI 132
+VW + + + + ++G L + + T++ +N + + V L+ +G V+
Sbjct: 46 IVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
Query: 133 RDNSSGNATESYLWQS 148
+ +W +
Sbjct: 104 YGPA--------VWST 111
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-07
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 6/67 (8%)
Query: 83 ISDNNAVLTISNNGNLVL-LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141
++ + L + ++ NLVL +W + S ++ +L G L I D+
Sbjct: 21 LATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNT-- 78
Query: 142 ESYLWQS 148
++ S
Sbjct: 79 ---VFVS 82
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 54.2 bits (129), Expect = 4e-08
Identities = 18/79 (22%), Positives = 27/79 (34%), Gaps = 10/79 (12%)
Query: 70 PDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGN 129
D VW N + NG + +L N +W++ S V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSGNATESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 8e-05
Identities = 26/156 (16%), Positives = 41/156 (26%), Gaps = 11/156 (7%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKNRLERYLSSWRSADDPSPDFLYK 190
I LW S +++ + S
Sbjct: 101 TIYG--------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPY 152
Query: 191 QFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQ 226
+ ME V + S T Q
Sbjct: 153 RLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQ 188
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.8 bits (102), Expect = 9e-05
Identities = 17/89 (19%), Positives = 37/89 (41%), Gaps = 6/89 (6%)
Query: 66 FQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLR 125
Q D + + + + L++ + NLVL + + +WSTN + + A L+
Sbjct: 130 STQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFD-RDDRVWSTNTAGKGTGCRAVLQ 188
Query: 126 DDGNLVIRDNSSGNATESYLWQSFDYPTD 154
+G + + N + +W S + +
Sbjct: 189 PNGRMDVLTNQN-----IAVWTSGNSRSA 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 3e-07
Identities = 80/624 (12%), Positives = 162/624 (25%), Gaps = 199/624 (31%)
Query: 154 DTLLQDMKLGWDF----KNRLERYLSSWRSADDPSPDFLYKQFMMENKDECVYW--YEAY 207
D + ++L W + +++++ + FL E + + Y
Sbjct: 59 DAVSGTLRLFWTLLSKQEEMVQKFVEE---VLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115
Query: 208 NRPSIMTLKLNPSGFVTRQIWNENSNKWDELFSV-PDQY---CGKYGYCG----ANTICS 259
++ V+R + L + P + G G G A +C
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQA--LLELRPAKNVLIDGVLG-SGKTWVALDVCL 172
Query: 260 LDQKPMCECLEGFKLESQVNQPGPI------KCERSHSLECKSGDQFIELDEIKAPDF-- 311
K C I C ++ ++D P++
Sbjct: 173 -SYKVQC------------KMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTS 215
Query: 312 -IDVSLNQRMNLEQCKAECLKNCSCRAYANS-----NVKESS-------GCLMWYGDLID 358
D S N ++ + +AE + + Y N NV+ + C + L+
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI----LLT 271
Query: 359 AR-RPIRNFTGQSVYLRVPASKLGN-------KKLL--WI----------------LVIL 392
R + + +F + + K LL ++ +
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS 331
Query: 393 VIPVVL--LPSFYVFYRR---------RRKC--QEKETENVETYQDLLAFDINMNITTRT 439
+I + + + ++ + E + + L F + +I T
Sbjct: 332 IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL 391
Query: 440 NEYGEANGDGKDKSKDSWLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVA 499
L L I + + +K L+ Q
Sbjct: 392 ------------------LSLIWFDVIKSDVMVVVNKL----------HKYSLVEKQP-- 421
Query: 500 VKRLSNQSGQGLKEFKNEMMLIA---KLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNV 556
KE + I K++ N L + ++ Y K+
Sbjct: 422 ------------KESTISIPSIYLELKVKLENEYAL--------HRSIVDHYNIPKT--- 458
Query: 557 FLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-----SRFRIIHRDLKASNILLDKD-M 610
FDS Y + + R + LD +
Sbjct: 459 --FDSDDLIPPYLDQ-------------YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 611 NPKISDFGLARMFGGDELQGNTKQIVGTY-GYMSPEYALDGLFS-IKSDVFSFGILMLET 668
KI A G L NT Q + Y Y+ D + + + + F + +E
Sbjct: 504 EQKIRHDSTAWNASGSIL--NTLQQLKFYKPYICDN---DPKYERLVNAILDF-LPKIEE 557
Query: 669 --LSSK-----------KNTGVYN 679
+ SK ++ ++
Sbjct: 558 NLICSKYTDLLRIALMAEDEAIFE 581
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 7e-05
Identities = 62/457 (13%), Positives = 131/457 (28%), Gaps = 165/457 (36%)
Query: 355 DLIDARRPIRNFTGQSV--YLRVPASKLGNKKLLWILVILVIPVVLLPSFYVFYRRRRKC 412
D+ D + I + + + + + G +L W L
Sbjct: 37 DVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTL----------------------- 71
Query: 413 QEKETENVETY-QDLLAFDINMNITTRTNEYGEANGDGKDKSKDSWLPLFSLASITAATE 471
K+ E V+ + +++L + Y +L ++ I
Sbjct: 72 LSKQEEMVQKFVEEVLRIN-----------YK-------------FL----MSPIKTEQR 103
Query: 472 NFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR 531
SM ++ + RL N +V K + Q + + ++ +L+ V
Sbjct: 104 QPSMMTRMYIE-----QRDRLYNDNQVFAKY-NVSRLQPYLKLRQALL---ELRPAKNVL 154
Query: 532 L---LGCCVEQGEKILILE---------YMPNKS--LNVFLFDSTKKRLL---------- 567
+ LG G+ + L+ M K LN+ +S + L
Sbjct: 155 IDGVLGS----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID 210
Query: 568 -NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG- 625
NW +R I + + R + + + ++L + + + F
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL-N----VQNAKAWNAFNLS 265
Query: 626 -------------DELQGNTKQ---IVGTYGYMSPEYALDGLFS--IKSDVFS------- 660
D L T + ++P+ L +
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLT 324
Query: 661 ---FGILML-ETLSSKKNTGVYNADSFNLLGHAWDLWKD---DRVHDLIDPVIMQDEISL 713
+ ++ E++ T WD WK D++ +I E SL
Sbjct: 325 TNPRRLSIIAESIRDGLAT--------------WDNWKHVNCDKLTTII-------ESSL 363
Query: 714 ----PMLMR--YINVALLCVQENAADRPTMSDVISMI 744
P R + +++ +A + ++S+I
Sbjct: 364 NVLEPAEYRKMFDRLSVF--PPSA---HIPTILLSLI 395
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.2 bits (121), Expect = 4e-07
Identities = 13/69 (18%), Positives = 26/69 (37%), Gaps = 8/69 (11%)
Query: 84 SDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATES 143
+GNLV+ N +W ++ + V +L+ +G++ I D
Sbjct: 193 GKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDEKP------ 245
Query: 144 YLWQSFDYP 152
+W F +
Sbjct: 246 -VWARFGFQ 253
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.3 bits (103), Expect = 8e-05
Identities = 33/157 (21%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 22 SLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDR 81
+ + + G+ L+S +QRF+L G L I+ A VWVAN +
Sbjct: 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQQ 62
Query: 82 PIS------DNNAVLTISNNGNLVLLNQTNGTIW-----STNVSSEVKNPVAQLRDDGNL 130
P S + A L L + + +W + + + L+DDGN+
Sbjct: 63 PFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNI 122
Query: 131 VIRDNSSG-NATESYLWQSFDYPTDTLLQDMKLGWDF 166
V+ D+ + N T + + L +L
Sbjct: 123 VLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGV 159
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 7e-07
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 2/62 (3%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
+S +A + + NLVL N + +N + +L + G L I +S
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW 74
Query: 143 SY 144
Y
Sbjct: 75 VY 76
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 14/81 (17%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGT---IWSTNVSSEVKNPVAQLRDD 127
+A + +N + L ++N G L + + + T ++ +V++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSGNATESYLWQS 148
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 45/226 (19%), Positives = 75/226 (33%), Gaps = 46/226 (20%)
Query: 473 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 527
+ + LGEG FG V + +VA+K + N E ++ K++ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN----VLKKIKEK 76
Query: 528 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 580
V + G + E + N F + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL---GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 621
L +LH ++ H DLK NIL +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA- 189
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
F + IV T Y PE L+ ++ DV+S G ++ E
Sbjct: 190 TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-06
Identities = 56/284 (19%), Positives = 98/284 (34%), Gaps = 82/284 (28%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRN 528
KLG G F V+ + + VA+K + + + +E+ L+ ++
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNREM 102
Query: 529 LVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
+V+LL G ++ E + L ++ S + L + +II+ + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160
Query: 585 YLHQYSRFRIIHRDLKASNILL-------------------------------------- 606
YLH ++ RIIH D+K NILL
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 607 -----------DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIK 655
+ + KI+D G A + + T Y S E + ++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEVLIGSGYNTP 273
Query: 656 SDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699
+D++S + E TG Y F H+ + + D H
Sbjct: 274 ADIWSTACMAFELA-----TGDY---LFE--PHSGEEYTRDEDH 307
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 50/230 (21%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR- 527
F + K+G+G FG V + + N + AVK + N E ++ K+Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 528 ----NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIAQG 582
N+V+ G + LI E + +++ + + + I +
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL---GPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 583 LLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------------KISDF 617
L YL + + H DLK NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 667
G A F D I+ T Y +PE L+ + + SD++SFG ++ E
Sbjct: 207 GCA-TFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 48/227 (21%), Positives = 81/227 (35%), Gaps = 48/227 (21%)
Query: 473 FSMQCKLGEGGFGPVYKG--RLLNGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKLQHR 527
+ + LGEG FG V + G+ VAVK + N E + ++ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ----VLEHLNTT 71
Query: 528 ------NLVRLLGCCVEQGEKILILEYMPNKSLNVF-LFDSTKKRLLNWQARVRIIEGIA 580
V++L G ++ E + L+ + ++ I
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNP-------------------KISDFGLAR 621
+ + +LH ++ H DLK NIL + K+ DFG A
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA- 184
Query: 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 667
+ + +V T Y +PE L L +S DV+S G +++E
Sbjct: 185 TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 11/92 (11%), Positives = 28/92 (30%), Gaps = 2/92 (2%)
Query: 76 VANRDRPISDNNAVLTISNNGNLVLLNQTNGTI-WSTNVSSEVKNPVAQLRDDGNLVIRD 134
+ + + + + +G +V ++ +G + W N +S V + +G +
Sbjct: 163 ASLPEDDVDYKMSHFVSNGDGLVVTVDSESGDVLWIQNYASPVVA-FYVWQREGLRKVMH 221
Query: 135 NSSGNATESYLWQSFDYPTDTLLQDMKLGWDF 166
+ T YL +
Sbjct: 222 INVAVETLRYLTFMSGEVGRITKWKYPFPKET 253
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 792 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.79 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.73 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.56 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.36 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.33 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.27 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.23 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.06 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.06 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.03 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.66 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.55 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.4 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.31 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.21 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.04 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.74 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.5 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.18 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.95 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 82.85 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 81.63 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-53 Score=447.85 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=216.3
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367889999999999999999864 36789999998877777889999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccC----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 544 LILEYMPNKSLNVFLFDST----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
+||||+++|+|.++|.... ....++|.+++.++.|||.||+|||+++ ||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999996432 2356999999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhh
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....... +.. .
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~----~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----C 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH----H
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----H
Confidence 999999997755444334445679999999999999999999999999999999999 899987543211 111 1
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...+. ..+.+...+.++.+|+.+||+.||++||||+||++.|+++
T Consensus 243 i~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 0112223456789999999999999999999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=449.98 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=209.0
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 357888899999999999999864 47889999998877777889999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccC------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 544 LILEYMPNKSLNVFLFDST------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
+||||+++|+|.++|.... ....++|.+++.++.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999986532 2346999999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||....... ...
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~--- 271 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AID--- 271 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHH---
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHH---
Confidence 99999999997755544444455689999999999999999999999999999999999 899986433211 111
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
....+. ..+.+...+.++.+|+.+||+.||++||||+||+++|+.+.
T Consensus 272 -~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 272 -CITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp -HHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred -HHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 111110 11122234567899999999999999999999999998863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=442.53 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=213.3
Q ss_pred cCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..+++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677899999999999999863 46789999997543 345678999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC
Q 003843 544 LILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 610 (792)
+|||||++|+|.++|.... ....+++.++++++.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999996432 1346999999999999999999999998 99999999999999999
Q ss_pred CeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccch
Q 003843 611 NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHA 689 (792)
Q Consensus 611 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~ 689 (792)
++||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....... +..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--~~~-- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--VVE-- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--HHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--HHH--
Confidence 999999999997755444444455689999999999999999999999999999999998 899987543221 111
Q ss_pred hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 690 WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+. ..+.+...+.++.+|+.+||+.||++||||+||+++|+..
T Consensus 259 --~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 --MIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 1122333456789999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=434.87 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=204.6
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.+++++.++||+|+||+||+|++. ..||||+++.. ..+..++|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 467889999999999999999874 36999998643 34567889999999999999999999998865 56899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.++|... ...+++.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999998543 346999999999999999999999998 9999999999999999999999999998765444
Q ss_pred cccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||........ .. .....+ ...+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~----~~~~~~----~~~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-II----FMVGRG----YASP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HH----HHHHTT----CCCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HH----HHHhcC----CCCC
Confidence 3344456789999999999964 4689999999999999999999999974332111 00 001111 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
.+ .......+.++.+|+.+||+.||++||||.||+++|+.+.-
T Consensus 258 ~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 258 DL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp CS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred Cc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 11223345678999999999999999999999999987543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=432.01 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=209.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999985 58999999997665556677899999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++|+|.+++.+ ..+++.++..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998843 45999999999999999999999999 9999999999999999999999999999875432
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....... .... .... ..+ ..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~----i~~~-----~~~---~~ 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKM----IRDN-----LPP---RL 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----HHHS-----SCC---CC
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH----HHcC-----CCC---CC
Confidence 22345789999999999999999999999999999999999999996433211 1110 0000 000 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.++.+|+.+||+.||++|||++|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112334678999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=427.72 Aligned_cols=253 Identities=23% Similarity=0.250 Sum_probs=205.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.+.|++.++||+|+||+||+|+++ +|+.||||+++.... +.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356888999999999999999975 589999999975422 24799999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-CeeecccccceecCCCc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGGDE 627 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~ 627 (792)
+++|+|.++|.. .+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999943 356999999999999999999999998 99999999999999987 69999999999875443
Q ss_pred ccc---ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
... .....+||+.|||||++.+..|+.++|||||||+||||++|++||........ ... +...
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~------------i~~~ 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLK------------IASE 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHH------------HHHS
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH------------HHcC
Confidence 221 22346799999999999999999999999999999999999999975433221 100 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.......+...+..+.+++.+||+.||++|||+.|++++|...
T Consensus 272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0001122233456788999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=431.48 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=203.6
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|+++++||+|+||+||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999975 5899999999654 34556789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.++|... +...+++.+++.++.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999998532 3446799999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... ... . ++....
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~----~--------i~~~~~- 242 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--LVL----K--------IISGSF- 242 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH----H--------HHHTCC-
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH----H--------HHcCCC-
Confidence 12334689999999999999999999999999999999999999997433211 110 0 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.....+.++.+|+.+||+.||++|||++|++++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11222345678999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=424.98 Aligned_cols=271 Identities=24% Similarity=0.299 Sum_probs=204.8
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----eeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 546 (792)
++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.+++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 5688899999999999999998 6899999999654322 223345666667889999999999998764 579999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
||+++|+|.++|.. ..++++.+++++.|+++||+|||++. +.+||||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999943 45899999999999999999999871 2349999999999999999999999999999
Q ss_pred ecCCCcc--ccccceeecccceeCcccccCC------CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch----
Q 003843 622 MFGGDEL--QGNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA---- 689 (792)
Q Consensus 622 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~---- 689 (792)
....... ........||+.|||||++.+. .++.++|||||||+||||++|++|++.............
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 8754322 1223346899999999999764 467899999999999999999988765443222111100
Q ss_pred -hhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 690 -WDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 690 -~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
............+++.++......+....+.+|+.+||+.||++||||.||+++|+++
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0000000111222333322233445667899999999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=425.26 Aligned_cols=248 Identities=25% Similarity=0.330 Sum_probs=209.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 5899999999653 2345678999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.++|. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999984 3456999999999999999999999999 999999999999999999999999999988655
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... +.. ......
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~----~i~~~~--------- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IFA----KIIKLE--------- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTC---------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHcCC---------
Confidence 44445566799999999999999999999999999999999999999996433211 111 000010
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
..++.....++.+|+.+||+.||++|||++|++
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011222345788999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=431.97 Aligned_cols=266 Identities=27% Similarity=0.394 Sum_probs=216.6
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCC-CCcceEeee
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQH-RNLVRLLGC 535 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~ 535 (792)
...+...++|++.++||+|+||+||+|++.. ++.||||++.... ....+.|.+|+++|.+++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444567899999999999999999998643 3689999997653 3456789999999999965 899999999
Q ss_pred eeec-CeeEEEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 003843 536 CVEQ-GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKA 601 (792)
Q Consensus 536 ~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp 601 (792)
|.++ +..++|||||++|+|.++|..... +..+++.+++.++.|||+||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 9765 568999999999999999964321 345899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCc
Q 003843 602 SNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNA 680 (792)
Q Consensus 602 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~ 680 (792)
+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998765544444455789999999999999999999999999999999998 8999865432
Q ss_pred cccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 681 DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
... .......+. +.+.+...+.++.+++.+||+.||++|||++||+++|+++
T Consensus 294 ~~~-----~~~~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 DEE-----FCRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SHH-----HHHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-----HHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 211 011111110 1112223346789999999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=433.58 Aligned_cols=251 Identities=23% Similarity=0.328 Sum_probs=210.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.+.|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999985 5899999999776666667899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
|++|+|.+++. ...+++.++..++.||+.||+|||+++ ||||||||+||||+.++++||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999883 345999999999999999999999999 9999999999999999999999999999875432
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+.. +... ..+.+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~----i~~~-----~~~~~-- 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM----IRDN-----LPPRL-- 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHS-----CCCCC--
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH----HHcC-----CCCCC--
Confidence 2234578999999999999999999999999999999999999999643321 11110 0000 00111
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.++.+|+.+||+.||++|||+.|++++
T Consensus 368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112234578899999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=413.77 Aligned_cols=248 Identities=26% Similarity=0.417 Sum_probs=198.0
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCeeEEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 545 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 545 (792)
|++.++||+|+||+||+|++. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ +...++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999875 5889999999643 34456789999999999999999999999875 3468999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~ 624 (792)
|||+++|+|.++|.. .+.+++..+..++.||+.||+|||+++ .+|+||||||+||||+. ++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999943 456999999999999999999999875 35999999999999974 7999999999998643
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .+ ......+. .+
T Consensus 184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~----~~~i~~~~-----~~ 248 (290)
T 3fpq_A 184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVTSGV-----KP 248 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHTTTC-----CC
T ss_pred CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HH----HHHHHcCC-----CC
Confidence 22 2345689999999998865 69999999999999999999999996432211 01 01111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ..+...+.++.+|+.+||+.||++|||++|++++
T Consensus 249 ~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0111123468899999999999999999999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=405.61 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=190.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999875 5899999999653 2334567999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+ +|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678888884 3456999999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. .....+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... +.. ......
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~----~i~~~~-------- 228 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFK----NISNGV-------- 228 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTC--------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHcCC--------
Confidence 2 2334689999999999998886 579999999999999999999996432211 111 000010
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+...+.++.+|+.+||+.||++|||++|++++
T Consensus 229 ---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ---YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01112234578899999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=413.49 Aligned_cols=247 Identities=25% Similarity=0.312 Sum_probs=196.5
Q ss_pred cCccccceecccCceeEEEEEEc----CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
++|++.+.||+|+||+||+|+.. .++.||||+++... ......+.+|+++|++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 46789999996532 2334578899999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.++|. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 3456999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... .... . ...
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~----i--------~~~ 241 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMTM----I--------LKA 241 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----H--------HHC
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHHH----H--------HcC
Confidence 322 22344689999999999999999999999999999999999999996433211 1110 0 000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 742 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~ 742 (792)
. ...+...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 242 ~---~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 K---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C---CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0 01122234578899999999999999984 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=402.25 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=190.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC--------
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-------- 540 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 540 (792)
++|++++.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999875 58999999996543 345578999999999999999999999997654
Q ss_pred ----eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecc
Q 003843 541 ----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (792)
Q Consensus 541 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~D 616 (792)
..|+||||+++|+|.+++..........+..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999965444445677788999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCcccc----------ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccc
Q 003843 617 FGLARMFGGDELQG----------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 686 (792)
Q Consensus 617 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~ 686 (792)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||....+ ....+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-RVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-HHHHH
Confidence 99999875432211 1234579999999999999999999999999999999996 5532110 00000
Q ss_pred cchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 687 GHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 687 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ...... . .+........+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~----~~~~~~--------~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 T----DVRNLK--------F--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H----HHHTTC--------C--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H----HHhcCC--------C--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 000000 0 01112233456789999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=397.47 Aligned_cols=267 Identities=21% Similarity=0.304 Sum_probs=202.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeee------cC
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QG 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 540 (792)
.++|+++++||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 368999999999999999999975 68999999996542 3445678999999999999999999998764 35
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..|+||||++ |+|.+++. +.+.+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67888883 4567999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCc--cccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccch-------
Q 003843 621 RMFGGDE--LQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA------- 689 (792)
Q Consensus 621 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~------- 689 (792)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||...+.... ..+...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764332 12234457899999999998875 569999999999999999999999975432111 000000
Q ss_pred -hhhcccCccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 690 -WDLWKDDRVHDLIDPVIMQDEISL-----PMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 690 -~~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+...........+.........+. ....++.+|+.+||+.||++|||+.|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000000000111111 124578899999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=391.80 Aligned_cols=200 Identities=24% Similarity=0.369 Sum_probs=171.9
Q ss_pred HhcCccccceecccCceeEEEEEEc----CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
..+.|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|..+ +|||||++++++.+++..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999863 46789999986543 345688999999998 6999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeeccccccee
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARM 622 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla~~ 622 (792)
+||||+++|+|.+++ +.+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999888 24899999999999999999999999 9999999999999877 7999999999987
Q ss_pred cCCCccc--------------------------cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCC
Q 003843 623 FGGDELQ--------------------------GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNT 675 (792)
Q Consensus 623 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~ 675 (792)
....... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 6432211 112335799999999999876 5899999999999999999999999
Q ss_pred CCCC
Q 003843 676 GVYN 679 (792)
Q Consensus 676 ~~~~ 679 (792)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=382.60 Aligned_cols=280 Identities=36% Similarity=0.629 Sum_probs=236.6
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++...+++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+++..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34445678999999999999999999998889999999998777777889999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 544 LILEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
+||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999999865432 235899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc-cccccchhhhcccCccccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS-FNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 701 (792)
..............||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....+.......+.+...
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 654333333344578999999999999999999999999999999999999987544322 2222333333344445556
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+++.+ ...........+.+++.+||+.||++||++.||+++|+.+
T Consensus 269 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 269 VDPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSC-TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cChhh-ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 66555 4456777888999999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=405.78 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=210.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.++...++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999875 5899999999877666778899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC--CCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kL~DFGla~~~~~~ 626 (792)
+++|+|.++|.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999988843 3346999999999999999999999998 9999999999999854 89999999999987543
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||........ ... ...... . +
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~~----i~~~~~-~-~---- 375 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRN----VKSCDW-N-M---- 375 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH----HHTTCC-C-C----
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHH----HHhCCC-C-C----
Confidence 2 23456899999999999999999999999999999999999999975432211 100 000000 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........+.++.+|+.+||+.||++|||+.|++++
T Consensus 376 -~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 376 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111224578899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=377.88 Aligned_cols=289 Identities=39% Similarity=0.650 Sum_probs=238.9
Q ss_pred CCCcccHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCc-hhHHHHHHHHHHHhhcCCCCcceEeee
Q 003843 457 WLPLFSLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKLQHRNLVRLLGC 535 (792)
Q Consensus 457 ~~~~~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 535 (792)
.+..+++.++....++|++.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3566889999999999999999999999999999988899999999975432 233478999999999999999999999
Q ss_pred eeecCeeEEEEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 536 CVEQGEKILILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 536 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
+.+....++||||+++++|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999986543 3345999999999999999999999992222999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC---ccccccccchhh
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN---ADSFNLLGHAWD 691 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~---~~~~~~~~~~~~ 691 (792)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ........+...
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999997754322 22333568999999999999999999999999999999999999986321 122223333334
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.........+.+..+ ...........+.+++.+||+.||++|||++||+++|++.
T Consensus 255 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTC-TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhh-ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 444455555666555 4566788889999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=404.02 Aligned_cols=250 Identities=24% Similarity=0.291 Sum_probs=200.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHH---HHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKE---FKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
-++|++.++||+|+||.||+|+.+ +|+.||||++.+.. ...... ..+++.++..++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999975 58999999996421 112222 34456777788999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
|+||||++||+|..+|. +.+.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999994 3456999999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
+.... ....+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+. . .+
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---~--------~i 406 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---R--------MT 406 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---H--------HH
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---H--------hh
Confidence 75432 344689999999999975 57999999999999999999999999643221110000 0 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
... ...++...+.++.+|+.+||+.||++|++ ++||+++
T Consensus 407 ~~~---~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 407 LTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHC---CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred cCC---CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 000 11122234567899999999999999998 6787653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=360.85 Aligned_cols=282 Identities=35% Similarity=0.537 Sum_probs=229.8
Q ss_pred CCCcccHHHHHHHhcCcccc------ceecccCceeEEEEEEcCCcEEEEEEeccc----CchhHHHHHHHHHHHhhcCC
Q 003843 457 WLPLFSLASITAATENFSMQ------CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH 526 (792)
Q Consensus 457 ~~~~~~~~~i~~~~~~y~~~------~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 526 (792)
..+.|++.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678899999999998877 8999999999999987 6889999998643 23456789999999999999
Q ss_pred CCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 527 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999865555567999999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLL 686 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~ 686 (792)
+.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987654333323344578999999998865 588999999999999999999999875443221 1
Q ss_pred cchhhhc--ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 687 GHAWDLW--KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 687 ~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....... ....+.+.+++.+ ..........+.+++.+||+.+|++||++++|+++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1100000 1111222333322 234566778899999999999999999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.07 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=214.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 468999999999999999999985 5889999999777777788999999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999998542 345899999999999999999999998 99999999999999999999999999987744322
Q ss_pred cc------------ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC
Q 003843 629 QG------------NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 629 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~------- 236 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------- 236 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-------
Confidence 11 11145799999999999999999999999999999999999998865443222111110
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
....+. ..+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 237 --~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 237 --RGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --HHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --hccccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001111 1112223467899999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.10 Aligned_cols=264 Identities=27% Similarity=0.447 Sum_probs=206.6
Q ss_pred HHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
...++|++.+.||+|+||.||+|+. .++.||||++.... ....++|.+|++++++++||||+++++++.+....++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3467899999999999999999987 68899999986543 34567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999965443445999999999999999999999985 2499999999999999999999999999986543
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ..
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~--~~----------- 254 (309)
T 3p86_A 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVG--FK----------- 254 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH--HS-----------
T ss_pred cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH--hc-----------
Confidence 22 122345789999999999999999999999999999999999999975432211 00000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
......+.....++.+++.+||+.+|++|||+.++++.|+.....
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 001112223345788999999999999999999999999887443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=373.40 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=213.2
Q ss_pred hcCccccceecccCceeEEEEEEc--------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
.++|++.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 478999999999999999999863 3457999999765 334567899999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999865321 245899999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 685 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~ 685 (792)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999997765443333344567889999999999999999999999999999999 9999865332211
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. .....+. ....+.....++.+++.+||+.+|++||++.|+++.|+.+
T Consensus 315 ~----~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 F----KLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp H----HHHHTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHhcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 0111110 1112223345789999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.38 Aligned_cols=269 Identities=25% Similarity=0.349 Sum_probs=209.8
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----eeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 545 (792)
.++|++.++||+|+||.||+|+.. ++.||||++.... .....+.+|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 578999999999999999999874 8999999996543 33455677999999999999999999998754 36999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc----------CCCceeecCCCCCcEEEcCCCCeeec
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY----------SRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
|||+++|+|.+++.. ..+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 999999999999843 3489999999999999999999998 7 9999999999999999999999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccCC-----CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch-
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA- 689 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~- 689 (792)
|||+++.+.............||+.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999887655443344446799999999999873 456789999999999999999999875433221111000
Q ss_pred h-----hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 690 W-----DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 690 ~-----~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. ..+..........+.+...........++.+++.+||+.||++|||+.||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0 000000001111111111112234567799999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=359.64 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=208.8
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 57899999999999999999986 46899999999766666678899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999843 35899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....... + .
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~------~---~ 235 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGT------P---E 235 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHCS------C---C
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCC------C---C
Confidence 2334579999999999999999999999999999999999999986433211100 0000000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+......+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11122234568899999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=362.99 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=209.1
Q ss_pred hcCccccceecccCceeEEEEEEc----CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|++. .+..||||++... .....+.|.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 468999999999999999999984 3456999999764 44456789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 2346999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .. .....
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----~~~~~------ 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV--IS----SVEEG------ 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH----HHHTT------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHHcC------
Confidence 43221 11222356778999999999999999999999999999999 9999864332211 00 00000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
. ..+.+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 271 ---~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ---Y-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ---C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---C-CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 11122233467889999999999999999999999999873
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.11 Aligned_cols=262 Identities=25% Similarity=0.355 Sum_probs=215.0
Q ss_pred CcccHHHHHHHhcC----------ccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC
Q 003843 459 PLFSLASITAATEN----------FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR 527 (792)
Q Consensus 459 ~~~~~~~i~~~~~~----------y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 527 (792)
+.++.+++..+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777777654 777889999999999999986 6999999999876666778899999999999999
Q ss_pred CcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc
Q 003843 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 528 niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 607 (792)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 99999999999999999999999999999883 345899999999999999999999998 99999999999999
Q ss_pred CCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccccc
Q 003843 608 KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687 (792)
Q Consensus 608 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~ 687 (792)
.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH
T ss_pred CCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH
Confidence 999999999999987654321 2234579999999999999999999999999999999999999986433211 110
Q ss_pred chhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... ..+.+ .........+.+++.+||+.||++||++.|++++
T Consensus 252 ----~~~~~-----~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 ----RLRDS-----PPPKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ----HHHHS-----SCCCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHhcC-----CCCCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 1111234568899999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.40 Aligned_cols=254 Identities=26% Similarity=0.329 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 68899999986443 2334678999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999983 3446999999999999999999999998 9999999999999999999999999998764433
Q ss_pred cccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............. .... ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~--~~----- 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKK--TY----- 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-----HTTC--TT-----
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hccc--cc-----
Confidence 3333445689999999999988775 789999999999999999999997544322111110 0000 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+|+.+||+.||++|||+.|++++
T Consensus 228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00011234567899999999999999999999765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=373.48 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=211.3
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.|.+|+++|++++||||+++++++.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3578999999999999999999986 68899999997543 334567899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999998532 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
..........+++.|+|||.+.+..++.++||||||+++|||++ |..|+........ ......+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~-------- 332 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT------REFVEKGG-------- 332 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH------HHHHHTTC--------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC--------
Confidence 32222233356788999999999999999999999999999998 9999865332111 00111110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.+...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 333 --~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 --RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=361.75 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=206.7
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 47899999999654 3445677899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++.. .+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999843 345899999999999999999999998 999999999999999999999999999876443
Q ss_pred ccccccceeecccceeCcccccCCCCC-CcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||........ .. ....+
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----~i~~~--------- 229 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--RE----RVLRG--------- 229 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC---------
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhC---------
Confidence 2 23445799999999999988875 799999999999999999999964332111 00 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+.....++.+++.+||+.||.+|||++|++++
T Consensus 230 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 --KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011122234578899999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=367.09 Aligned_cols=268 Identities=26% Similarity=0.392 Sum_probs=214.7
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEe
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLL 533 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~ 533 (792)
.........++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 44555566889999999999999999999742 35789999997643 34457799999999999 799999999
Q ss_pred eeeeecC-eeEEEEEecCCCccceeeeccCC-------------------------------------------------
Q 003843 534 GCCVEQG-EKILILEYMPNKSLNVFLFDSTK------------------------------------------------- 563 (792)
Q Consensus 534 ~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------- 563 (792)
+++.+.+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998765 48999999999999999865432
Q ss_pred --------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 564 --------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 564 --------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122899999999999999999999998 999999999999999999999999999876544333
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.......||+.|+|||++.+..++.++||||||+++|||++ |+.||......... ........ .
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----~~~~~~~~----------~ 314 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGT----------R 314 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-----HHHHHHTC----------C
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-----HHHHHcCC----------C
Confidence 33445678999999999999999999999999999999998 99998653322110 00000000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...+.....++.+++.+||+.||++||++.|++++|+.+
T Consensus 315 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 315 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111222345788999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.04 Aligned_cols=274 Identities=26% Similarity=0.398 Sum_probs=208.7
Q ss_pred hcCccccceecccCceeEEEEEE-----cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--Cee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 542 (792)
.++|++.++||+|+||.||++++ .+++.||||++........+.|.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 57899999999999999999984 25889999999877777778999999999999999999999998654 568
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998543 335899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch-hhhcccCcccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA-WDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 700 (792)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+........ ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 122234567789999999999999999999999999999999998764221110000000 00000000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
.+.... ..+.+...+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 244 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 244 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 111100 112223345678999999999999999999999999988643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=370.02 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=199.1
Q ss_pred hcCccccceecccCceeEEEEEEc----CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|++. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 468999999999999999999875 4678999999754 34456789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999853 2346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCcccc-ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDELQG-NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ... .+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~-------------~i 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIK-------------AV 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHH-------------HH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-------------HH
Confidence 432111 1222345778999999999999999999999999999998 999986433211 000 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.... ..+........+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 264 ~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 264 DEGY-RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HTTE-ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCC-CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 0100 11112234467899999999999999999999999998763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.79 Aligned_cols=255 Identities=27% Similarity=0.417 Sum_probs=210.5
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||.||+|+..+++.||+|++.... ...+++.+|++++++++||||+++++++.++...++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46899999999999999999999889999999997543 23467999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999843 3346899999999999999999999998 999999999999999999999999999876443211
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ..... . .
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~--~~----~~~~~-----~-----~ 225 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE----DISTG-----F-----R 225 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT-----C-----C
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH--HH----HHhcC-----c-----c
Confidence 2223456788999999999999999999999999999999 8999864332211 00 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...+......+.+++.+||+.+|++||++.+++++|+++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111112245688999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=361.75 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|++.++||+|+||.||+|++. +++ +||+|.+... .....++|.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467999999999999999999864 343 4688888543 3455678999999999999999999999998754 78
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... .......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~----- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGE----- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------HHHHTTC-----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH------HHHHcCC-----
Confidence 65543333344567889999999999999999999999999999999 99998654322110 0000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.+|++||++.|++++|+..
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111222345788999999999999999999999999775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=349.96 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=202.8
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhh--cCCCCcceEeeeeeec----CeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQ----GEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 543 (792)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 57899999999999999999988 7899999999653 34556667777766 7999999999997653 4689
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
+||||+++|+|.+++ +...+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHH----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHH----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999998 3346999999999999999999999 776 9999999999999999999999
Q ss_pred ccccceecCCCccc--cccceeecccceeCcccccCC------CCCCcCceeehhHHHHHHHhC----------CCCCCC
Q 003843 616 DFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------KKNTGV 677 (792)
Q Consensus 616 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwSlGvll~elltg----------~~p~~~ 677 (792)
|||+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876443221 112334799999999999877 455799999999999999999 666543
Q ss_pred CCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 678 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.......... ..... ......+.+............+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFED-MRKVV----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHH-HHHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhh-hhHHH----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2221111100 00000 00111111212223345678899999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=365.77 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=214.5
Q ss_pred HhcCccccceecccCceeEEEEEEc--------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 538 (792)
..++|++.++||+|+||.||+|+.. .+..||||++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3578999999999999999999863 2357999999754 344567899999999999 99999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
++..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999865331 245999999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~ 684 (792)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999997765443334444567899999999999999999999999999999999 9999864332111
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
........ ....+.....++.+++.+||+.+|++||+++||+++|+.+.
T Consensus 303 -----~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 303 -----FKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp -----HHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01111110 01111223457889999999999999999999999998874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.06 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=213.9
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3678999999999999999999862 3578999999754 34556789999999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCC---------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 003843 542 KILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 600 (792)
.++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999865432 234899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCC
Q 003843 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYN 679 (792)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~ 679 (792)
|+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999998755443333344567889999999999999999999999999999999 999986443
Q ss_pred ccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.... ........ ...........+.+++.+||+.||++||++.+++++|+++
T Consensus 258 ~~~~------~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PERL------FNLLKTGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGGH------HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH------HHHhhcCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2211 01111110 0111223346789999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.05 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=211.1
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++.+++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 578999999999999999999998888999999975432 3477999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998542 345899999999999999999999998 999999999999999999999999999876544322
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ...... ..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~--~~------- 224 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGH--RL------- 224 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTTC--CC-------
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HHHcCC--CC-------
Confidence 1 223356778999999999999999999999999999999 999986543221100 000000 00
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
..+......+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 -YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011112346889999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.93 Aligned_cols=272 Identities=20% Similarity=0.284 Sum_probs=215.6
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC--eeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 545 (792)
.++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4689999999999999999999864 8999999997543 344677899999999999999999999998765 77999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE----cCCCCeeecccccce
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 621 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kL~DFGla~ 621 (792)
|||+++++|.+++........+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999966555555999999999999999999999998 9999999999999 788889999999999
Q ss_pred ecCCCccccccceeecccceeCccccc--------CCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc--ccccchhh
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYAL--------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWD 691 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~--~~~~~~~~ 691 (792)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 8754332 23357899999999986 57889999999999999999999999964432211 11111000
Q ss_pred hcccCcc----------ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 692 LWKDDRV----------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 692 ~~~~~~~----------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....... ....................+.+++.+||+.||++|||++|++++..+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0000000 0000011112244567788899999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=356.72 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=206.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999876 5899999999653 233467789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999988843 346899999999999999999999998 99999999999999999999999999986432
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.... .. .....
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~~~--------- 220 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILME--------- 220 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC---------
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HH----HHHcC---------
Confidence 21 223456899999999999999999999999999999999999999864332110 00 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
...++.....++.+++.+||+.||++|| +++|++++
T Consensus 221 --~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0011222345788999999999999999 89999775
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=360.63 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=214.3
Q ss_pred HHHHhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeee
Q 003843 466 ITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (792)
Q Consensus 466 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 538 (792)
+....++|++.+.||+|+||.||+|+... ++.||||+++... ....+.|.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 33456899999999999999999998753 4789999997643 3456789999999999999999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCC---------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTK---------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHR 597 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~ 597 (792)
++..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999865321 256899999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCC
Q 003843 598 DLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTG 676 (792)
Q Consensus 598 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~ 676 (792)
||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999987654433333344568899999999999999999999999999999999 999986
Q ss_pred CCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 677 VYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 677 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
....... . .....+... ..+.....++.+++.+||+.||++||++.+++++|+++.
T Consensus 279 ~~~~~~~--~----~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 279 GMAHEEV--I----YYVRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp TSCHHHH--H----HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCChHHH--H----HHHhCCCcC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 4332111 0 011111110 111223457889999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=362.05 Aligned_cols=276 Identities=25% Similarity=0.372 Sum_probs=213.6
Q ss_pred hcCccccceecccCceeEEEEEE-----cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeee--ecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 542 (792)
.++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++|+||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47899999999999999999984 358899999998777777788999999999999999999999887 45568
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999998542 235899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.....+..................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543221 122334678889999999999999999999999999999999998754222111000000000000000111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCC
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 751 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 751 (792)
+.... ...........+.+++.+||+.||++|||++|++++|+.+....
T Consensus 257 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111 11223334567899999999999999999999999999874433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.91 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=209.9
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.++||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 468999999999999999999853 4678999999654 345566799999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC---Ceeec
Q 003843 543 ILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 615 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kL~ 615 (792)
++||||+++|+|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986532 2245899999999999999999999998 99999999999999555 59999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcc
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .. ...
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~--~~----~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--LE----FVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--HH----HHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HH----HHH
Confidence 9999986533322233334567899999999999999999999999999999998 9999865332211 00 000
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
... ...........+.+|+.+||+.+|++||++.+|+++|+...
T Consensus 301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000 01112223456889999999999999999999999997753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.77 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=204.2
Q ss_pred hcCccccceecccCceeEEEEEEcC-Cc----EEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|++.++||+|+||.||+|++.. ++ +||+|.+.... ....+.+.+|+.++++++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4679999999999999999998753 44 38888875432 334566788999999999999999999886 56789
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999998532 356899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......... .......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~----- 234 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP------DLLEKGE----- 234 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH------HHHHTTC-----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH------HHHHcCC-----
Confidence 65544444455678889999999999999999999999999999999 99998754322110 0011000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
....+......+.+++.+||+.||++||++.+++++|+...
T Consensus 235 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 -----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00011112235678999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.04 Aligned_cols=253 Identities=29% Similarity=0.476 Sum_probs=197.9
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccC----chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+. .++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 48999999986542 23457899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC--------CCCeeeccc
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--------DMNPKISDF 617 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~--------~~~~kL~DF 617 (792)
|||+++++|.+++ ....+++..++.++.|++.||+|||+.+..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999988 3446899999999999999999999998666899999999999986 778999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ..
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~-~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-----GVAM-NK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----HHHT-SC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----hhhc-CC
Confidence 9998664332 223478999999999999999999999999999999999999986433211100 0000 00
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
. ....+......+.+++.+||+.+|++|||+.|++++|+.
T Consensus 231 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 L---------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C---------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 111122334578899999999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=358.64 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=210.5
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999862 3568999999754 334557899999999999 8999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccCC--------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 003843 541 EKILILEYMPNKSLNVFLFDSTK--------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 600 (792)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999865332 134899999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCC
Q 003843 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYN 679 (792)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~ 679 (792)
|+|||++.++.+||+|||++..+.............+|+.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433233344567889999999999999999999999999999998 999986543
Q ss_pred ccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
.... . ....... . ....+.....++.+++.+||+.||.+||++.+++++|+.....
T Consensus 280 ~~~~-~----~~~~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDAN-F----YKLIQNG---------F-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSHH-H----HHHHHTT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHHH-H----HHHHhcC---------C-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 2211 0 0000000 0 1111222346788999999999999999999999999886433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.94 Aligned_cols=252 Identities=24% Similarity=0.291 Sum_probs=205.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.+.|++.+.||+|+||.||+++.. +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 578999999999999999999986 588999999965432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC----Ceeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kL~DFG 618 (792)
++||||+++|+|.+++. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999983 3456999999999999999999999998 99999999999998877 79999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .. .......
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~----~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA----NITAVSY 235 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH----HHHTTCC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhcCC
Confidence 999775432 22345799999999999999999999999999999999999999864332111 00 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..++.. .......+.+++.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 --DFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --CCCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 01123568899999999999999999999853
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=355.94 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=195.2
Q ss_pred HhcCccccceecccCceeEEEEEEcCCc----EEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQ----EVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
..++|++.+.||+|+||.||+|+..... .||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3578999999999999999999875432 7999999654 345578899999999999999999999999877655
Q ss_pred ------EEEEEecCCCccceeeeccCC---CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 543 ------ILILEYMPNKSLNVFLFDSTK---KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 543 ------~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999854321 225899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhh
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. .
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~----~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YN----Y 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----H
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HH----H
Confidence 999999987755443333334567889999999999999999999999999999999 8999865332211 00 0
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
..... ..........++.+++.+||+.||++|||+.++++.|+++.
T Consensus 252 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 252 LIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 01112223457899999999999999999999999998863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.00 Aligned_cols=265 Identities=25% Similarity=0.432 Sum_probs=205.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||.||+|+. .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46799999999999999999988 4789999999643 345789999999999999999999998873 589999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC-eeecccccceecCCCcc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-PKISDFGLARMFGGDEL 628 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-~kL~DFGla~~~~~~~~ 628 (792)
++++|.+++........+++..++.++.|+++||+|||+.+...|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999966554456889999999999999999999932223999999999999998887 799999999865332
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||............. . .... .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~-~~~~----------~ 222 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---V-HNGT----------R 222 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH---H-HTTC----------C
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH---H-hcCC----------C
Confidence 223468999999999999999999999999999999999999987543322111100 0 0000 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCCCCCCCC
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 758 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~p~~~~ 758 (792)
..........+.+++.+||+.||++|||+++++++|+.+....+.+..+.
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 01111233568899999999999999999999999998765555554443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=348.21 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=207.8
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..++|++.+.||+|+||.||+++..++..||||++..... ..+++.+|++++.+++|+||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3578999999999999999999998888999999975432 347799999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999998542 345999999999999999999999998 99999999999999999999999999987644321
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ..... .
T Consensus 176 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~----~~~~~-----~----- 238 (283)
T 3gen_A 176 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE----HIAQG-----L----- 238 (283)
T ss_dssp H-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH----HHHTT-----C-----
T ss_pred c-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HH----HHhcc-----c-----
Confidence 1 1222356788999999999999999999999999999998 9999875432211 00 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.+|++|||+.+++++|.++
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0011111235788999999999999999999999999875
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.66 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=206.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 578999999999999999999875 5889999998543 334567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. .+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...... .....
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~-~~~~~---- 232 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQD-SVPNV---- 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSS-CCCCH----
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhc-cCCCc----
Confidence 321 2233457999999999999999999999999999999999999999643321110 000000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~ 747 (792)
........+..+.+++.+||+.||++|| ++.++.+.|+..
T Consensus 233 --~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 233 --TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0011122345788999999999999998 999999999886
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.36 Aligned_cols=249 Identities=20% Similarity=0.289 Sum_probs=196.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--------------------------hhHHHHHHHHHHHh
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------------------------QGLKEFKNEMMLIA 522 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 522 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999875 588999999865321 12356899999999
Q ss_pred hcCCCCcceEeeeeee--cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 003843 523 KLQHRNLVRLLGCCVE--QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (792)
Q Consensus 523 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 600 (792)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56889999999999998875 3456999999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCC---CCCcCceeehhHHHHHHHhCCCCCCC
Q 003843 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGV 677 (792)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvll~elltg~~p~~~ 677 (792)
|+|||++.++.+||+|||+++.+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654321 123457899999999998765 37889999999999999999999864
Q ss_pred CCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 678 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
..... .. ........ ..+........+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~--~~----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIMC--LH----SKIKSQAL---------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHHH--HH----HHHHHCCC---------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHHH--HH----HHHhcccC---------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 32111 00 00000000 00111123457889999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=372.54 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=211.0
Q ss_pred HHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
...++|++.++||+|+||.||+|++.++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3467899999999999999999999888999999997643 45688999999999999999999999986 667899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999998532 2235889999999999999999999998 9999999999999999999999999998764432
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.. ......+++.|+|||.+....++.++||||||++||||++ |+.||....... ... ....+ .
T Consensus 339 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~---------~ 402 (454)
T 1qcf_A 339 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR----ALERG---------Y 402 (454)
T ss_dssp HH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHHT---------C
T ss_pred ee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC---------C
Confidence 11 1122346789999999999999999999999999999999 999986433211 110 00000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
..+.+...+.++.+++.+||+.||++|||+++|++.|+...
T Consensus 403 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 -RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 01112223467899999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=351.34 Aligned_cols=261 Identities=27% Similarity=0.389 Sum_probs=213.0
Q ss_pred HhcCccccceecccCceeEEEEEE------cCCcEEEEEEecccCc-hhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQSG-QGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 357899999999999999999985 2467899999975433 4567899999999999 9999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccCC---------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 541 EKILILEYMPNKSLNVFLFDSTK---------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999865432 225899999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~ 684 (792)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999988765433333334567889999999999999999999999999999999 99998654322110
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..... ... ...........+.+++.+||+.||++||++.|++++|++.
T Consensus 258 -----~~~~~---------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 -----YKMIK---------EGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp -----HHHHH---------HTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHhc---------cCC-CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 00000 000 0111122345788999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.77 Aligned_cols=261 Identities=20% Similarity=0.215 Sum_probs=207.8
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +|+||+++++++.++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 57899999999999999999987 4688999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC-----eeeccccccee
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 622 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kL~DFGla~~ 622 (792)
|+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998543 346999999999999999999999998 999999999999998887 99999999997
Q ss_pred cCCCcccc-----ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 623 FGGDELQG-----NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 623 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....+...... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~---~~i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY---QKIGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH---HHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH---HHHHhhh
Confidence 64432211 124568999999999999999999999999999999999999999754322211000 0000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
... ....+ ....+ ++.+++..||+.+|.+||++++|++.|++..
T Consensus 237 ~~~-~~~~~-----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 237 RAT-PIEVL-----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHS-CHHHH-----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccC-CHHHH-----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000 00000 00012 7899999999999999999999999997653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=353.33 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=201.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------- 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 540 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999986 6899999999654 3345678999999999999999999999986643
Q ss_pred --------------------------------------------------eeEEEEEecCCCccceeeeccCCCccCCHH
Q 003843 541 --------------------------------------------------EKILILEYMPNKSLNVFLFDSTKKRLLNWQ 570 (792)
Q Consensus 541 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~ 570 (792)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999766555667788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc----------cccceeecccc
Q 003843 571 ARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ----------GNTKQIVGTYG 640 (792)
Q Consensus 571 ~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~ 640 (792)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 999999999999999999999999999987554211 12233579999
Q ss_pred eeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHH
Q 003843 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYI 720 (792)
Q Consensus 641 y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 720 (792)
|+|||.+.+..++.++||||||+++|||++|..|+... ..... ..... . ...........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~~~~----~~~~~--------~--~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VRIIT----DVRNL--------K--FPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HHHHH----HHHTT--------C--CCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HHHHH----Hhhcc--------C--CCcccccCChhHH
Confidence 99999999999999999999999999999986653210 00000 00000 0 0001122345678
Q ss_pred HHHHhccccCCCCCCCHHHHHHH
Q 003843 721 NVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 721 ~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+++.+||+.||++||++.|++++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=372.91 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=212.4
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..++|++.++||+|+||.||+|++.. ++.||||+++... ...++|.+|+.+|++++||||+++++++.+....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 35679999999999999999999865 8899999997543 346789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999998543 2345899999999999999999999998 9999999999999999999999999999765433
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.. ......+++.|+|||.+....++.++||||||++||||++ |+.||........ ....... .
T Consensus 373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~---------~ 436 (495)
T 1opk_A 373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKD---------Y 436 (495)
T ss_dssp EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HHHHHTT---------C
T ss_pred ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcC---------C
Confidence 22 1223356789999999999999999999999999999999 8888864432211 0111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+|+.+||+.||++||++.+|++.|+..
T Consensus 437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1112223346788999999999999999999999999886
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.88 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=201.9
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 57899999999999999999999889999999986432 2335678999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++ +|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 67666633 3345899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc---c-----
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR---V----- 698 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~----- 698 (792)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ........... .
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGGTT
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhhhc
Confidence 12233578999999999876 56899999999999999999999999754432210 00000000000 0
Q ss_pred --------ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 --------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 --------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........ ..........++.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKP-WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCC-HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCc-HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000 000111123578899999999999999999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=348.44 Aligned_cols=253 Identities=20% Similarity=0.268 Sum_probs=206.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+++.. +++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 478999999999999999999876 4789999998654 34456789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC--CCCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 626 (792)
+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999998 999999999999987 789999999999987543
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .... ....... ....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~----i~~~~~~--~~~~- 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIEN----IMNAEYT--FDEE- 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH----HHHTCCC--CCHH-
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHH----HHcCCCC--CChh-
Confidence 2 2344678999999999999989999999999999999999999986433211 0000 0000000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.....+.++.+++.+||+.||++|||+.|++++-
T Consensus 226 ----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred ----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 0011245788999999999999999999999853
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=349.44 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=205.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.+.|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999986 588999999865422 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC----Ceeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kL~DFG 618 (792)
++||||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999983 3456999999999999999999999998 99999999999999887 89999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .... ....
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~----~~~~- 233 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANV----SAVN- 233 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHH----HHTC-
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHH----HhcC-
Confidence 998875332 22345799999999999999999999999999999999999999864332110 0000 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. .... ........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 YE-FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC-CCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-cCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000 001123568899999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=366.52 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=206.1
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-eeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG-EKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E 547 (792)
..++|++.++||+|+||.||+|+.. ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3578999999999999999999884 7899999997643 5578999999999999999999999987765 7899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999543 2334799999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . .....+.
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~----~~i~~~~--------- 403 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKGY--------- 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--H----HHHHTTC---------
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcCC---------
Confidence 122356889999999999999999999999999999998 9999865432211 0 0111110
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112223446788999999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=369.66 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=205.8
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..++|++.++||+|+||.||+|++..+..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 457899999999999999999999888899999997543 345789999999999999999999999876 678999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999532 2245899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....+.
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~---------- 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD----QVERGY---------- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTTC----------
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCC----------
Confidence 1 1223456789999999999999999999999999999999 899986433211 100 001010
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
..+.+...+..+.+++.+||+.||++|||+++|++.|+....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 111222345678899999999999999999999999998743
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=353.57 Aligned_cols=261 Identities=26% Similarity=0.443 Sum_probs=212.2
Q ss_pred HhcCccccceecccCceeEEEEEEc--------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE 538 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 538 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999863 4678999999754 344567899999999999 89999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
++..++||||+++++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999865332 234899999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~ 684 (792)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH-
Confidence 99999999999999998765443333344567889999999999999999999999999999999 9999864332111
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
. ....... ...........+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 269 -~----~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 -F----KLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp -H----HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -H----HHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0000000 01112223457889999999999999999999999998863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=358.55 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=200.5
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999976 4889999999753 233456788999999988 7999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++|+|..++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999988843 346999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. . ++.
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~----~--------i~~ 238 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--FE----A--------ILN 238 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----H--------HHH
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--HH----H--------HHc
Confidence 3221 223446899999999999999999999999999999999999999965432211 00 0 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTM------SDVIS 742 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~ 742 (792)
.. ..++......+.+++.+||+.||++||++ .|+++
T Consensus 239 ~~---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 DE---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 10 01122234568899999999999999998 77765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=358.51 Aligned_cols=255 Identities=20% Similarity=0.335 Sum_probs=202.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.++||+|+||.||+++.+ +++.||||++++. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999986 4788999999754 233345688899999887 89999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999988843 346999999999999999999999998 9999999999999999999999999998632
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc---cccchhhhcccCccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN---LLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 701 (792)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ +
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~--------i 274 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------I 274 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHH--------H
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHH--------H
Confidence 221 2234568999999999999999999999999999999999999999643321110 00000000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM------SDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 743 (792)
... ...++.....++.+|+.+||+.||++||++ .|++++
T Consensus 275 ~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 275 LEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHC---CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred hcc---ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111 111222345678899999999999999995 566543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.88 Aligned_cols=268 Identities=28% Similarity=0.388 Sum_probs=208.7
Q ss_pred ccccceecccCceeEEEEEEc-----CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-----NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKIL 544 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 544 (792)
|++.++||+|+||.||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 499999999999999998653 57899999997653 34567899999999999999999999999874 57899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++.. ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999833 34899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||........................+.+.
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43221 22334567889999999999999999999999999999999999986432211111110000000011111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
... ...........+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 266 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 266 RGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 11223334567899999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.88 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=195.6
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+|+.. ..||||+++.. .....+.|.+|+.++++++|+||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 578999999999999999999863 46999998644 345567899999999999999999999965 5567899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999998843 3356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.........||+.|+|||.+. +..++.++||||||+++|||++|+.||........ .. ...........+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~----~~~~~~~~~~~~-- 247 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-II----EMVGRGSLSPDL-- 247 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-HH----HHHHHTSCCCCT--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-HH----HHhcccccCcch--
Confidence 333344567899999999987 66788999999999999999999999975432211 00 011111111000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.......+.++.+++.+||+.+|++||++.+++++|+++
T Consensus 248 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 ----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp ----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111223346789999999999999999999999999886
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=357.35 Aligned_cols=270 Identities=20% Similarity=0.253 Sum_probs=206.0
Q ss_pred hcCccccceeccc--CceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEG--GFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5789999999999 99999999986 5899999999654 24456778899999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998543 2345899999999999999999999998 9999999999999999999999999987653
Q ss_pred CCc-----cccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch--hhhc--
Q 003843 625 GDE-----LQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA--WDLW-- 693 (792)
Q Consensus 625 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~--~~~~-- 693 (792)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. ....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 1111223478999999999987 6789999999999999999999999975433221100000 0000
Q ss_pred ----ccCc-------------ccccccc--------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 ----KDDR-------------VHDLIDP--------VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ----~~~~-------------~~~~~~~--------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... ..+.+.. .....+........+.+|+.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 0000000 000001122234578999999999999999999999876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=341.45 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=200.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.++||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999985 5889999999643 33345788999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|++++.+..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99865444333 22456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred cccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc---cCc---ccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK---DDR---VHD 700 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~---~~~ 700 (792)
.......||+.|+|||.+.+.. ++.++||||||+++|||++|..|+........ .......... ... ...
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhhcc
Confidence 1223357899999999998766 79999999999999999998888533222111 1111000000 000 000
Q ss_pred ccc--------cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 LID--------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~~~--------~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+ ...............+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000011122345678899999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.36 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=202.7
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999997 468899999986431 22346789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+ +|+|.+++.. .+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 6788887743 346999999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ...+..
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~ 222 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNS 222 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCS
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHc
Confidence 32 2234579999999999998876 7899999999999999999999964332111 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ....+......+.+++.+||+.||.+|||++|++++
T Consensus 223 ~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 C--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred C--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 011122234578899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=354.05 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=212.8
Q ss_pred HHHhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
....++|++.+.||+|+||.||+|+.. .++.||||++.... ......+.+|+.++++++|+||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345688999999999999999999764 36789999997543 34456799999999999999999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccC-------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCe
Q 003843 540 GEKILILEYMPNKSLNVFLFDST-------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 612 (792)
+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 99999999999999999985422 1245789999999999999999999998 9999999999999999999
Q ss_pred eecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhh
Q 003843 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 691 (792)
||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ . .
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~----~ 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--L----R 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--H----H
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH--H----H
Confidence 9999999987654433333334567889999999999999999999999999999999 8888864332110 0 0
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....... ..........+.+++.+||+.||++||++.|++++|++.
T Consensus 252 ~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FVMEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 0111110 011122345688999999999999999999999999886
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=355.18 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=204.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999875 4789999998643 233457889999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999997654
Q ss_pred CccccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||............. ...
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~-------- 233 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFE-------- 233 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHH--------
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh--------
Confidence 32 2344689999999999974 458999999999999999999999996443221111000 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVIS 742 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~ 742 (792)
.. ....+......+.+|+.+||+.||++||+ +++|++
T Consensus 234 ~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TT---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HC---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hc---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 01122233467899999999999999998 777765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=353.75 Aligned_cols=253 Identities=22% Similarity=0.273 Sum_probs=208.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999875 5889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC--CCCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~ 626 (792)
+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999988843 2346899999999999999999999998 999999999999974 477999999999987543
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ..... ..
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i----~~~~~--~~---- 269 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNV----KRCDW--EF---- 269 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHH----HHCCC--CC----
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHH----HhCCC--CC----
Confidence 2 2234579999999999999999999999999999999999999987533211 11000 00000 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........++.+++.+||+.||++|||+.|++++
T Consensus 270 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011112234578899999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=350.94 Aligned_cols=272 Identities=25% Similarity=0.389 Sum_probs=207.3
Q ss_pred hcCccccceecccCceeEEEEEE-----cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--Ce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 541 (792)
.+.|++.++||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999984 35889999999754 334567899999999999999999999999876 66
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999998443 245899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 622 MFGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 622 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.........................
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 87544321 22333467888999999999999999999999999999999998754211100000000000000000001
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+.... ....+......+.+++.+||+.||++|||+.++++.|+.+
T Consensus 255 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 TLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 111100 1122233456789999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.70 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=200.2
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.+.||+|+||.||+|+..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999889999999986543 23357789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 985 88777743 2346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh--------cccCccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL--------WKDDRVH 699 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~ 699 (792)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ....... +......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcc
Confidence 112334689999999999764 589999999999999999999999875432111 0000000 0000000
Q ss_pred cccccccc------cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIM------QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...++... ..........++.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 001112234578899999999999999999999763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=348.14 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=205.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999985 58999999996532 23456788999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987543
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .++...
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~------------~i~~~~ 219 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYE------------KILNAE 219 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH------------HHHHCC
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhCC
Confidence 2 234579999999999999999999999999999999999999986432211 000 001110
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
+ ..+.....++.+++.+||+.||++|| +++|++++
T Consensus 220 ~---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 L---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0 11222345788999999999999999 89998854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=352.81 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=205.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 578999999999999999999875 5889999999654 3345678999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC---Ceeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kL~DFGla~~~ 623 (792)
||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999988883 3456899999999999999999999998 99999999999998654 5999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ....+.. ...
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~----~i~~~~~-~~~- 250 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYA----QIKAGAY-DYP- 250 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTCC-CCC-
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHhCCC-CCC-
Confidence 5332 1234579999999999999999999999999999999999999986433211 100 0000000 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........++.+++.+||+.||++||++.|++++
T Consensus 251 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 -----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00011234578899999999999999999999865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=355.15 Aligned_cols=262 Identities=28% Similarity=0.400 Sum_probs=210.6
Q ss_pred HHhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
...++|++.+.||+|+||.||+|+... .+.||+|++.... ....+.+.+|+.++.++ +||||+++++++.++
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 346789999999999999999998743 2479999997643 34567799999999999 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccC-----------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC
Q 003843 540 GEKILILEYMPNKSLNVFLFDST-----------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK 608 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~ 608 (792)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 99999999999999999985432 1345899999999999999999999998 999999999999999
Q ss_pred CCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccccc
Q 003843 609 DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLG 687 (792)
Q Consensus 609 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~ 687 (792)
++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--- 276 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--- 276 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---
Confidence 99999999999987644332222334567889999999999999999999999999999998 88888643322110
Q ss_pred chhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....... . ....+......+.+++.+||+.||.+||++.||+++|+..
T Consensus 277 --~~~~~~~---------~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 --YKLVKDG---------Y-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHHHHHT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHhcC---------C-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 0000000 0 0011112245788999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=352.27 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=204.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.+.|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999875 5899999998532 1224678999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeeccccc
Q 003843 544 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGL 619 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~DFGl 619 (792)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988775432 2345899999999999999999999998 999999999999987655 99999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---LFE----GIIKGKYK 250 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---HHH----HHHHTCCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---HHH----HHHcCCCC
Confidence 988754322 123457999999999999999999999999999999999999998642211 000 00000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.. ......++.+++.+||+.||++||++.|++++
T Consensus 251 --~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01124578899999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=347.57 Aligned_cols=269 Identities=25% Similarity=0.337 Sum_probs=200.8
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhc--CCCCcceEeeeeeec----Cee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL--QHRNLVRLLGCCVEQ----GEK 542 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~ 542 (792)
..++|++.++||+|+||.||+|+.. ++.||||++... ....+.+|.+++..+ +||||+++++++.+. ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 4578999999999999999999884 899999998643 234455566666654 899999999999887 688
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc--------CCCceeecCCCCCcEEEcCCCCeee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------SRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEE
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEE
Confidence 999999999999999833 3589999999999999999999988 6 999999999999999999999
Q ss_pred cccccceecCCCcccc--ccceeecccceeCcccccCCCCCCc------CceeehhHHHHHHHhCCCCCCCCCccccccc
Q 003843 615 SDFGLARMFGGDELQG--NTKQIVGTYGYMSPEYALDGLFSIK------SDVFSFGILMLETLSSKKNTGVYNADSFNLL 686 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------~DVwSlGvll~elltg~~p~~~~~~~~~~~~ 686 (792)
+|||+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||++|..|+...........
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 9999998764432211 1224579999999999988777665 9999999999999999554432211111000
Q ss_pred cc-----hhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 687 GH-----AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 687 ~~-----~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.. ...............+.+...........++.+++.+||+.||++|||+.||+++|+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 00 000000000011111111111112356778999999999999999999999999998863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.11 Aligned_cols=267 Identities=27% Similarity=0.389 Sum_probs=213.6
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEE------cCCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEee
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLG 534 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 534 (792)
........++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445578999999999999999999985 246789999997643 34556899999999999 7999999999
Q ss_pred eeeecC-eeEEEEEecCCCccceeeeccCC-------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 003843 535 CCVEQG-EKILILEYMPNKSLNVFLFDSTK-------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (792)
Q Consensus 535 ~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 600 (792)
++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 988755 58999999999999999865432 223889999999999999999999998 9999999
Q ss_pred CCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCC
Q 003843 601 ASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYN 679 (792)
Q Consensus 601 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~ 679 (792)
|+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654433333344578899999999999999999999999999999998 999986543
Q ss_pred ccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 680 ADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 680 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..... ........ ..........++.+++.+||+.||++||++.|++++|+.+
T Consensus 256 ~~~~~-----~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDEEF-----CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSHHH-----HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHH-----HHHhccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22110 00000000 0111122345788999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.86 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=198.6
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCC--CCcceEeeeeeecCeeEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 544 (792)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.++...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35789999999999999999999988999999998643 34456789999999999976 999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999843 356899999999999999999999998 99999999999997 6789999999998775
Q ss_pred CCccccccceeecccceeCcccccC-----------CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-------- 230 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-------- 230 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH--------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH--------
Confidence 4433333345679999999999865 678999999999999999999999986432211000
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
...+++.. ....+.....++.+++.+||+.||++|||+.|++++-
T Consensus 231 -----~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 231 -----HAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -----HHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HHHhcCCc-ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 01111110 1111112234688999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.76 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=196.3
Q ss_pred hcCccccceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 5789999999999999999998743 457999998754 3445678999999999999999999999974 567899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999998532 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||........ .. ......
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~----~i~~~~------ 234 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGE------ 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTC------
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HH----HHHcCC------
Confidence 43221 1223456789999999999999999999999999999996 8889864332211 00 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.||++||++.|++++|+.+
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111223346788999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=346.59 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=204.3
Q ss_pred hcCccccceecccCceeEEEEEEcC-C-------cEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-G-------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
.++|++.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4689999999999999999998653 3 4799999987767777889999999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC--------ee
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--------PK 613 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--------~k 613 (792)
.++||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998542 334899999999999999999999998 999999999999998887 99
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCC-CCCCCccccccccchhh
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSFNLLGHAWD 691 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p-~~~~~~~~~~~~~~~~~ 691 (792)
|+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..| +........ ..
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~---- 229 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQ---- 229 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HH----
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HH----
Confidence 9999999754322 23467899999999987 7799999999999999999996554 332211100 00
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.... ....+.....++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 230 ~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 230 FYED------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHT------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred Hhhc------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0000 00011111235789999999999999999999999999863
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=341.96 Aligned_cols=262 Identities=17% Similarity=0.231 Sum_probs=209.7
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 56899999999999999999986 468999999986543 335678899999999 79999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC-----eeeccccccee
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISDFGLARM 622 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kL~DFGla~~ 622 (792)
|+ +++|.+++... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998543 335899999999999999999999998 999999999999987776 99999999998
Q ss_pred cCCCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchhhhcccC
Q 003843 623 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDD 696 (792)
Q Consensus 623 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~ 696 (792)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ....... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~----~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE----K 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH----H
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh----h
Confidence 7544221 1234467999999999999999999999999999999999999999754322111 0000000 0
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
... .. ........+..+.+++.+||+.+|++||++++|++.|+++..
T Consensus 237 ~~~----~~--~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 237 KQS----TP--LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHH----SC--HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccC----cc--HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 000 00 000011224578999999999999999999999999988643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.20 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=209.8
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||.||+++..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 468999999999999999999998889999999976433 3478999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999998532 345899999999999999999999998 999999999999999999999999999876432211
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ..... . .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~----~i~~~-----~-----~ 223 (267)
T 3t9t_A 161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--VE----DISTG-----F-----R 223 (267)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HH----HHHTT-----C-----C
T ss_pred -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--HH----HHhcC-----C-----c
Confidence 1223456788999999999999999999999999999999 8989864332110 00 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...+......+.+++.+||+.+|++||++++++++|+++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112345788999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.35 Aligned_cols=265 Identities=26% Similarity=0.408 Sum_probs=201.1
Q ss_pred HHhcCccccceecccCceeEEEEEEcC----CcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC-
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG- 540 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 540 (792)
...++|++.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 346789999999999999999998643 458999998644 3445678999999999999999999999998765
Q ss_pred ----eeEEEEEecCCCccceeeecc---CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 541 ----EKILILEYMPNKSLNVFLFDS---TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 541 ----~~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
..++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 359999999999999998432 23456999999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhh
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|+|||+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |..||........ .. .
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~----~ 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YD----Y 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HH----H
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH----H
Confidence 999999987654433333344567889999999999999999999999999999999 8888864332211 00 0
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCC
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 751 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 751 (792)
..... ...........+.+++.+||+.+|++||++.+++++|+++...+
T Consensus 262 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 LLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000 00111223457889999999999999999999999998864433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=359.79 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=204.6
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
-.++|++.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3678999999999999999999874 68899999986543 34456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc---CCCCeeeccccccee
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARM 622 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kL~DFGla~~ 622 (792)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999888843 346999999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ....+.. ..
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~--~~----~i~~~~~-~~- 232 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL--YQ----QIKAGAY-DF- 232 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHHTCC-CC-
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHhCCC-CC-
Confidence 654321 22345799999999999999999999999999999999999999864332111 00 0000000 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.......++.+++.+||+.||++|||+.|++++
T Consensus 233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000111234578899999999999999999999875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.54 Aligned_cols=250 Identities=23% Similarity=0.324 Sum_probs=204.2
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCee
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 542 (792)
...++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45689999999999999999999986 58899999997532 33456788899999987 999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++|+|.+++.. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999843 346899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ... .....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~----~i~~~------ 233 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH----SIRMD------ 233 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHC------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHHhC------
Confidence 43222 22345689999999999999999999999999999999999999986433211 100 00000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMS-DVIS 742 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 742 (792)
....+.....++.+++.+||+.||++||++. ++++
T Consensus 234 -----~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 234 -----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0011122345788999999999999999997 6653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=349.47 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=204.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|..++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467999999999999999999986 4889999999754 334556788999999988 89999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999988843 346899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc---cccchhhhcccCccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN---LLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 701 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ +
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------i 231 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------I 231 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH--------H
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH--------H
Confidence 221 2234468999999999999999999999999999999999999999643221100 00000000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCH------HHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTM------SDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~evl~~ 743 (792)
... ....+.....++.+++.+||+.||++||++ .|++++
T Consensus 232 ~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 232 LEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HcC---CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 011 011222344678899999999999999995 566543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=351.33 Aligned_cols=246 Identities=20% Similarity=0.257 Sum_probs=205.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 368999999999999999999986 58999999996532 23457789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999843 345899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..+..+.
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~----~~i~~~~-------- 254 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IY----EKIVSGK-------- 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHCC--------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HH----HHHHcCC--------
Confidence 2 234689999999999999999999999999999999999999986433211 00 0000010
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
...+.....++.+++.+||+.||++||+ ++|++++
T Consensus 255 ---~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 ---VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0112223457889999999999999998 8888764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.17 Aligned_cols=267 Identities=17% Similarity=0.198 Sum_probs=201.1
Q ss_pred hcCccccceecccCceeEEEEEEc----CCcEEEEEEecccCch-----------hHHHHHHHHHHHhhcCCCCcceEee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQSGQ-----------GLKEFKNEMMLIAKLQHRNLVRLLG 534 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 534 (792)
.++|++.+.||+|+||.||+|+.. .+..||||++...... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999985 5678999998754322 1234667889999999999999999
Q ss_pred eeee----cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC
Q 003843 535 CCVE----QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM 610 (792)
Q Consensus 535 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~ 610 (792)
++.. ....++||||+ +++|.+++.. .+.+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999843 337999999999999999999999998 99999999999999887
Q ss_pred --CeeecccccceecCCCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc
Q 003843 611 --NPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF 683 (792)
Q Consensus 611 --~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~ 683 (792)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999877433211 112345799999999999999999999999999999999999999963222111
Q ss_pred ccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 684 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
...... .... ......+.... .....+.++.+++.+||+.||++||++.+|++.|++...
T Consensus 269 ~~~~~~-~~~~-~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAK-TNLL-DELPQSVLKWA----PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHH-HHHH-HTTTHHHHHHS----CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHH-Hhhc-ccccHHHHhhc----cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111000 0000 00000000000 001234578999999999999999999999999998644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.09 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=206.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999986 6889999998643 33456789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999984 3456899999999999999999999998 9999999999999999999999999998764333
Q ss_pred cccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||............ +..... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~--~~---- 228 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--YL---- 228 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-----HHTTCT--TS----
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----hhhccc--cc----
Confidence 2223344678999999999987765 78999999999999999999999754432211111 110000 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+.+++.+||+.||++|||++|++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011234567899999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.78 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=196.5
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe----
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE---- 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 541 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 57899999999999999999997 46889999999754 23445678999999999999999999999887654
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++.. .+.+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3999999999999999843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCcc-ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 622 MFGGDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 622 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
.+..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~--- 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVREDP--- 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCCC---
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCC---
Confidence 7644322 12233457899999999999999999999999999999999999998643321110 00000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHH-HHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDV-ISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ev-l~~L~~~ 747 (792)
..+. ........++.+++.+||+.||++||++.++ .+.|...
T Consensus 237 -~~~~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 -IPPS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -CCHH----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCcc----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 0011124578899999999999999966554 4555443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.64 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=200.3
Q ss_pred hcCccccceecccCceeEEEEEEcC-Cc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|++.++||+|+||.||+|+... ++ +||+|.+... .....+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 4689999999999999999998643 44 4688877543 3456788999999999999999999999998754 78
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999998543 345899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~~~~~----- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEKGE----- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTTC-----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHcCC-----
Confidence 54433333334567889999999999999999999999999999999 999987543322110 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
....+.....++.+++.+||+.||.+||++.|+++.|+...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112223457889999999999999999999999998863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=339.90 Aligned_cols=256 Identities=31% Similarity=0.433 Sum_probs=208.2
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++. ++..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 57899999999999999999999888899999996543 34578999999999999999999999886 45689999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998432 1225899999999999999999999998 999999999999999999999999999987543322
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ..... . .
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~-----~-----~ 228 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ----NLERG-----Y-----R 228 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTT-----C-----C
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHH----HHhcc-----c-----C
Confidence 1223456789999999998999999999999999999999 888886433211 110 00000 0 0
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
..........+.+++.+||+.+|++||++.++++.|++..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 0111223457889999999999999999999999998763
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=357.35 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=198.3
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcC--CCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 545 (792)
.+.|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++ |+||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 4569999999999999999999888999999998643 3455678999999999996 59999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|| +.+++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899999843 346889999999999999999999998 99999999999995 58999999999987754
Q ss_pred CccccccceeecccceeCcccccC-----------CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---------- 276 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------- 276 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----------
Confidence 433333345679999999999875 46899999999999999999999999643221100
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+..++++.. ....+......+.+|+.+||+.||++||++.|++++
T Consensus 277 ---~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 ---LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhCccc-cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011111110 001111123568899999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=340.36 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=212.3
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..++|++.+.||+|+||.||+|+... ++.||+|++... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 46789999999999999999999864 888999999754 3456789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998543 3345899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ . ...... .
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~----~~~~~~---------~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y----ELLEKD---------Y 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H----HHHHTT---------C
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHhcc---------C
Confidence 2 22233467889999999999999999999999999999999 8888865432211 0 000000 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.||++||++.++++.|+..
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1111222345788999999999999999999999999764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=339.62 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=208.9
Q ss_pred hcCccccc-eecccCceeEEEEEEc---CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|.+.+ .||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45677776 9999999999999864 5778999999764 344567899999999999999999999999 5567899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999843 3345999999999999999999999998 9999999999999999999999999999875
Q ss_pred CCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~----~i~~~~----- 230 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--MA----FIEQGK----- 230 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH--HH----HHHTTC-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--HH----HHhcCC-----
Confidence 43221 12223456889999999998999999999999999999998 9999865432211 10 001110
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
....+......+.+++.+||+.+|++||++.+++++|+....
T Consensus 231 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 231 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011222344678999999999999999999999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=347.34 Aligned_cols=249 Identities=26% Similarity=0.334 Sum_probs=194.8
Q ss_pred hcCccccceecccCceeEEEEEE----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
.++|++.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 47899999999999999999987 468999999997542 2345668899999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999998843 346899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .+
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~------------~i 233 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TID------------KI 233 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH------------HH
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HHH------------HH
Confidence 643221 12233578999999999999999999999999999999999999986433211 000 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
+... ...+.....++.+++.+||+.||++|| ++.|++++
T Consensus 234 ~~~~---~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 LKCK---LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHTC---CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HhCC---CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0000 011222345788999999999999999 77788764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.77 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=207.6
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
.++....++|++.++||+|+||.||+|+.. +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455789999999999999999999986 48899999996421 12234588999999999999999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 999999999999999998843 35899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCC----CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKD 695 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 695 (792)
++........ .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.... ..
T Consensus 215 a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~-------- 283 (410)
T 3v8s_A 215 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YS-------- 283 (410)
T ss_dssp CEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH--------
T ss_pred eEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH--HH--------
Confidence 9876543221 223468999999999998765 78999999999999999999999964332111 00
Q ss_pred Ccccccccccc-ccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 003843 696 DRVHDLIDPVI-MQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISMI 744 (792)
Q Consensus 696 ~~~~~~~~~~l-~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~L 744 (792)
.++.... ...+.......++.+|+.+||+.+|.+ ||+++||+++-
T Consensus 284 ----~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 284 ----KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp ----HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ----HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0000000 000111123457889999999999988 99999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.08 Aligned_cols=258 Identities=29% Similarity=0.441 Sum_probs=202.4
Q ss_pred hcCccccceecccCceeEEEEEEcC-----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|++.+.||+|+||.||+|+... +..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4678889999999999999998753 236999999754 3345567999999999999999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999853 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccc
Q 003843 624 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~----~~~~~~---- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK----AINDGF---- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHTTC----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHH----HHHCCC----
Confidence 543211 11222346788999999999999999999999999999999 999986433211 100 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
..+........+.+++.+||+.+|++||++.+++++|+++.
T Consensus 268 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 ------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp ------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112223457889999999999999999999999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=350.60 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=204.5
Q ss_pred HhcCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
..++|++.+.||+|+||.||+|+... ++.||||+++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999864 788999999653 233456788999999988 8999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999843 345899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . ++.
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~----~--------i~~ 235 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQ----S--------IME 235 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----H--------HHH
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HHH----H--------HHh
Confidence 3221 22345689999999999999999999999999999999999999986433211 100 0 000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
.. ..++.....++.+++.+||+.||++||+ +++++++
T Consensus 236 ~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 HN---VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC---CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 1112233467889999999999999995 5777654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.72 Aligned_cols=262 Identities=19% Similarity=0.220 Sum_probs=202.8
Q ss_pred HHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-----CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 466 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-----SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 466 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
+....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3456789999999999999999999874 5789999998643 345567899999999999999999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccC-------------------------------------CCccCCHHHHHHHHHHHHHH
Q 003843 540 GEKILILEYMPNKSLNVFLFDST-------------------------------------KKRLLNWQARVRIIEGIAQG 582 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~a 582 (792)
+..++||||+++|+|.+++.... ....+++..+..++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 12234677888999999999
Q ss_pred HHHHHhcCCCceeecCCCCCcEEEcCCC--CeeecccccceecCCCcc--ccccceeecccceeCcccccC--CCCCCcC
Q 003843 583 LLYLHQYSRFRIIHRDLKASNILLDKDM--NPKISDFGLARMFGGDEL--QGNTKQIVGTYGYMSPEYALD--GLFSIKS 656 (792)
Q Consensus 583 L~yLH~~~~~~ivH~Dlkp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~s~~~ 656 (792)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987643211 112334578999999999975 6789999
Q ss_pred ceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCC
Q 003843 657 DVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPT 736 (792)
Q Consensus 657 DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs 736 (792)
||||||+++|||++|+.||........ .. ....... .. ..+........+.+++.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~--~~---~~~~~~~--~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT--IS---QVLNKKL--CF------ENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHHCCC--CT------TSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH--HH---HHHhccc--cc------CCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999864432211 00 0000000 00 00111123457889999999999999999
Q ss_pred HHHHHHH
Q 003843 737 MSDVISM 743 (792)
Q Consensus 737 ~~evl~~ 743 (792)
+.|++++
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=345.41 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=193.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.++||+|+||+||+|+.. +++.||||++.... ......+..|+..+.++ +|+||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999986 68999999986532 33344556666666665 899999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66888877443 345999999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..++.... .+....... ..+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~----~~~~ 272 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGY----LPPE 272 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTC----CCHH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccC----CCcc
Confidence 32 2233568999999998876 79999999999999999999976653211 011111110 0010
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+ ......++.+++.+||+.||++|||++|++++
T Consensus 273 ~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 F-----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp H-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1 11224578999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=344.39 Aligned_cols=263 Identities=21% Similarity=0.246 Sum_probs=207.5
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 543 (792)
..++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999999997 4689999999977667777889999999999999999999999873 34789
Q ss_pred EEEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 544 LILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
+||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999886432 3456999999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCccc-------cccceeecccceeCcccccCCC---CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 623 FGGDELQ-------GNTKQIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 623 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
....... .......||+.|+|||.+.... ++.++||||||+++|||++|+.||............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH-----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH-----
Confidence 5321110 0012235799999999987654 689999999999999999999998532111100000
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.+.... ..+........+.+++.+||+.||++||++.+++++|+.+.
T Consensus 259 --------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 --------AVQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --------HHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --------HhhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 000000 01111223457899999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.85 Aligned_cols=254 Identities=26% Similarity=0.518 Sum_probs=203.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCch-------hHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-------GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 578999999999999999999874 6889999998643221 1267899999999999999999999987655
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC-----eeecc
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN-----PKISD 616 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~-----~kL~D 616 (792)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 699999999999888743 3346999999999999999999999985 24999999999999988876 99999
Q ss_pred cccceecCCCccccccceeecccceeCcccc--cCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYA--LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||...............
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---- 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR---- 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH----
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh----
Confidence 999985432 23345789999999998 4556789999999999999999999999754433221111100
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
... . ....+......+.+++.+||+.||++||+++|+++.|++
T Consensus 244 ~~~----~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG----L-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC----C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC----C-----CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 000 0 111222334678999999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=352.18 Aligned_cols=268 Identities=16% Similarity=0.219 Sum_probs=205.2
Q ss_pred HhcCccccceecccCceeEEEEEEcC------CcEEEEEEecccCchhH-----------HHHHHHHHHHhhcCCCCcce
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-----------KEFKNEMMLIAKLQHRNLVR 531 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~ 531 (792)
..++|++.++||+|+||.||+|++.. ++.||||++........ ..+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998865 47899999876542211 12345666777889999999
Q ss_pred Eeeeeeec----CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc
Q 003843 532 LLGCCVEQ----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD 607 (792)
Q Consensus 532 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~ 607 (792)
+++++... ...++||||+ +++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4589999999 9999999854 2356999999999999999999999998 99999999999999
Q ss_pred --CCCCeeecccccceecCCCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCc
Q 003843 608 --KDMNPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680 (792)
Q Consensus 608 --~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~ 680 (792)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999877543221 112334699999999999999999999999999999999999999974322
Q ss_pred cccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 681 DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
+... ..... ......+.+++++.+... ..+.++.+++..||+.+|++||++.+|++.|++..
T Consensus 267 ~~~~-~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 DPKY-VRDSK-IRYRENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp CHHH-HHHHH-HHHHHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CHHH-HHHHH-HHhhhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 2111 00000 000111222333322111 12357889999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.97 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=184.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 468999999999999999999874 68999999996432 22357789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999853 2356899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ......
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~------------~~~~~~- 227 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--L------------NKVVLA- 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS-
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--H------------HHHhhc-
Confidence 321 12235789999999999999999999999999999999999999864332111 0 000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....+.....++.+++.+||+.||++||+++++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 --DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00111223457889999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.49 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=189.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+....++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 578999999999999999999986 47899999997543 346788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeecccccceecCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLARMFGG 625 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~DFGla~~~~~ 625 (792)
+++++|.+++. ..+.+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 130 VTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999883 3456899999999999999999999998 999999999999975 88999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .. ....... ..
T Consensus 204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~----~i~~~~~-~~---- 270 (349)
T 2w4o_A 204 QV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FR----RILNCEY-YF---- 270 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HH----HHHTTCC-CC----
T ss_pred cc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HH----HHHhCCC-cc----
Confidence 32 223457899999999999999999999999999999999999998643322110 00 0000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.......++.+++.+||+.||++|||+.|++++
T Consensus 271 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 --ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112234578899999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.88 Aligned_cols=247 Identities=27% Similarity=0.325 Sum_probs=197.3
Q ss_pred cceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 476 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 578999999999999875 5899999999877666778899999999999999999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE--cCCCCeeecccccceecCCCcccccc
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--DKDMNPKISDFGLARMFGGDELQGNT 632 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl--~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (792)
.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..... .
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 888843 2345899999999999999999999998 9999999999999 5678899999999998754322 2
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEIS 712 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 712 (792)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... .. ... .... ...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i---~~-~~~-~~~~------~~~ 312 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNI---LA-CRW-DLED------EEF 312 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---HH-TCC-CSCS------GGG
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH---Hh-ccC-CCCh------hhh
Confidence 234699999999999999999999999999999999999999864432111 0000 00 000 0000 001
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 713 LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 713 ~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.....++.+|+.+||+.||++||++.|++++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1224578899999999999999999999873
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=359.16 Aligned_cols=263 Identities=19% Similarity=0.233 Sum_probs=208.4
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeee
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 538 (792)
+.++....++|++.++||+|+||+||+|+... ++.||||++.+.. ....+.+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455567899999999999999999999865 7889999996521 1223448899999999999999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
++..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 99999999999999999998542 356999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... .... .
T Consensus 221 la~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~--~~~i---~ 294 (437)
T 4aw2_A 221 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--YGKI---M 294 (437)
T ss_dssp TCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHH---H
T ss_pred hhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH--HHhh---h
Confidence 9987654322 1223357999999999997 56789999999999999999999999974332211 0000 0
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD--RPTMSDVISM 743 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~evl~~ 743 (792)
.... . ..+ .........++.+|+.+||+.+|++ ||+++|++++
T Consensus 295 ~~~~--~---~~~--p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKE--R---FQF--PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHH--H---CCC--CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hccc--c---ccC--CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 0 000 0011123457889999999888888 9999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.09 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=194.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 578999999999999999999986 68899999996543 2346788999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC--eeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kL~DFGla~~~~~~ 626 (792)
+++|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998843 345999999999999999999999998 999999999999987765 999999999854222
Q ss_pred ccccccceeecccceeCcccccCCCCCCc-CceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ..... .+....
T Consensus 172 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~---------~~~~~~ 238 (361)
T 3uc3_A 172 ---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQ---------RILSVK 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHH---------HHHTTC
T ss_pred ---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHH---------HHhcCC
Confidence 12234579999999999998888765 89999999999999999999753321110 00000 000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ..+........+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 Y-SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C-CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C-CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 001111224578899999999999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.41 Aligned_cols=268 Identities=27% Similarity=0.352 Sum_probs=190.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999875 58899999996543 3345778999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccC---CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFDST---KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888875321 2245899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchh-----hhcccCc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAW-----DLWKDDR 697 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~-----~~~~~~~ 697 (792)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+.... ..+....
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3321 2233578999999999976 46899999999999999999999999754432110 000000 0000000
Q ss_pred cccccccccc-----------cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIM-----------QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~-----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.+. ..........++.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 000111234578999999999999999999999753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=371.79 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=209.9
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
..++|++.++||+|+||.||+|++..+..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 457899999999999999999999888899999997543 345789999999999999999999999876 678999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.++|... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999532 2245899999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......++..|+|||.+....++.++||||||++||||++ |+.||....... ... ....+.
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~----~i~~~~---------- 481 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLD----QVERGY---------- 481 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHH----HHHTTC----------
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcCC----------
Confidence 1 1122346789999999999999999999999999999999 898986433211 110 111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
...........+.+|+.+||+.||++||++++|+++|+...
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01112233457889999999999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=359.31 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=205.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999986 68999999996532 23456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++. +.+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999983 3456999999999999999999999998 99999999999999999999999999998654
Q ss_pred CccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .. .....+
T Consensus 169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~----~~i~~~-------- 231 (476)
T 2y94_A 169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LF----KKICDG-------- 231 (476)
T ss_dssp TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HH----HHHHTT--------
T ss_pred cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HH----HHHhcC--------
Confidence 32 2234579999999999998765 789999999999999999999986433211 10 000001
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ..+.....++.+++.+||+.||++|||+.|++++
T Consensus 232 ~~---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 IF---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cc---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 00 0111223568899999999999999999999973
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.09 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=205.1
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec--CeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ--GEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+. .++.||||++... .....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46899999999999999999998 4889999999754 344567899999999999999999999999887 788999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++... ....+++.+++.++.||+.||+|||+.+ ..|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999999542 2335899999999999999999999875 3499999999999999999999999988764322
Q ss_pred CccccccceeecccceeCcccccCCCCCC---cCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSI---KSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......... ....... .
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~-----~ 228 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-----MKVALEG-----L 228 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----HHHHHSC-----C
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----HHHHhcC-----C
Confidence 2246899999999998766554 799999999999999999998643322110 0000000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.||++|||++++++.|+.+
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 -----RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1112223345788999999999999999999999999876
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=352.46 Aligned_cols=272 Identities=20% Similarity=0.286 Sum_probs=213.8
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC--eeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 545 (792)
.++|++.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4689999999999999999999864 8999999997543 344677889999999999999999999998765 77999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE----cCCCCeeecccccce
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKISDFGLAR 621 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kL~DFGla~ 621 (792)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965544445999999999999999999999998 9999999999999 777889999999998
Q ss_pred ecCCCccccccceeecccceeCcccccC--------CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc--ccccchhh
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF--NLLGHAWD 691 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~--~~~~~~~~ 691 (792)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 765432 2233578999999999875 5678899999999999999999999864332111 11110000
Q ss_pred hcccCcc----------ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 692 LWKDDRV----------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 692 ~~~~~~~----------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....... .+..................+.+++.+||+.||++||++.|+++.++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 0000000 0000011112234566788899999999999999999999999998775
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.87 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=204.6
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.++||+|+||.||+|+... ++.||+|++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 5689999999999999999998764 678999999876666678899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeecccccceecCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~~~~ 625 (792)
+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++..+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999888843 345899999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||........ .. ......
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~~~-------- 223 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--ML----KIREGT-------- 223 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC--------
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--HH----HHHhCC--------
Confidence 32 22345789999999988764 89999999999999999999999865332111 00 000000
Q ss_pred cccCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 706 IMQDEISL----PMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 706 l~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...+. .....+.+++.+||+.||++||++.++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 12457889999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=338.36 Aligned_cols=260 Identities=27% Similarity=0.385 Sum_probs=203.6
Q ss_pred hcCccccceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeee-ecCeeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV-EQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 543 (792)
..+|++.++||+|+||.||+|+..+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4578999999999999999998643 236899998754 3345678999999999999999999999865 456789
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999843 3445899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc--cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhC-CCCCCCCCccccccccchhhhcccCcccc
Q 003843 624 GGDELQ--GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-KKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 624 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++| .+|+........ ... .....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~----~~~~~--- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY----LLQGR--- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHH----HHTTC---
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHH----HhcCC---
Confidence 543321 122334678899999999999999999999999999999995 555543222111 000 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
....+......+.+++.+||+.+|++||+++|+++.|+.+...
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0011111235688999999999999999999999999886433
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.35 Aligned_cols=265 Identities=23% Similarity=0.274 Sum_probs=199.6
Q ss_pred hcCcccc-ceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.+.|++. +.||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678885 78999999999999864 6899999999876666678899999999995 7999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~DFGla~~~ 623 (792)
||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999843 346899999999999999999999998 999999999999988776 999999999866
Q ss_pred CCCcc-----ccccceeecccceeCcccccC-----CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc-hhhh
Q 003843 624 GGDEL-----QGNTKQIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH-AWDL 692 (792)
Q Consensus 624 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~-~~~~ 692 (792)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||............. ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223468999999999875 568899999999999999999999997543321100000 0000
Q ss_pred cccCccccccccccccCCCCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISL----PMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ...+.+.+... ....+. .....+.+++.+||+.||++|||+.|++++
T Consensus 245 ~-~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 C-QNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp H-HHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-HHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 00000000000 001111 124578999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.82 Aligned_cols=268 Identities=23% Similarity=0.370 Sum_probs=202.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467999999999999999999874 6899999999642 344567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999985432 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||............ ........
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~----- 256 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQCDYP----- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH----HHHTTCSC-----
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH----HhhcccCC-----
Confidence 3321 123356899999999999999999999999999999999999998643221111110 00111000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCCCCC
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPK 755 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~~p~ 755 (792)
.. .......++.+++.+||+.||++||++.+|+++|+++....+.|.
T Consensus 257 ~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 257 PL----PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp CC----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred CC----cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 00 011234578899999999999999999999999998755554443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.43 Aligned_cols=265 Identities=25% Similarity=0.303 Sum_probs=199.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67999999999999999999985 48999999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988873 3345899999999999999999999998 9999999999999999999999999998765332
Q ss_pred cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccch--------hhhcccCc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHA--------WDLWKDDR 697 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~--------~~~~~~~~ 697 (792)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 2234578999999999976 678999999999999999999999997544321110 0000 00000000
Q ss_pred c---cccccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 V---HDLIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~---~~~~~~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ..+.++.... ..........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0000000000 00001234568899999999999999999999865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=363.36 Aligned_cols=249 Identities=22% Similarity=0.270 Sum_probs=195.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999875 5889999999653 334456788999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999988843 3468999999999999999999998 77 9999999999999999999999999998643
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. ... ..
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~----~i~--------~~ 364 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FE----LIL--------ME 364 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHH--------HC
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HH----HHH--------hC
Confidence 222 123346799999999999999999999999999999999999999864332111 00 000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
...++.....++.+|+.+||+.||++|| +++|++++
T Consensus 365 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 ---EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0011222345788999999999999999 99999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.24 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=201.5
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 5789999999999999999998754 6789999985432 22356789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999988843 245899999999999999999999998 99999999999999999999999999865433
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ......
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~~--------- 222 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--Y----KRISRV--------- 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHHHHT---------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--H----HHHHhC---------
Confidence 22 2345789999999999999999999999999999999999999864332111 0 000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
....+......+.+++.+||+.||++||+++|++++-
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0111222345678999999999999999999999753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.98 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=203.5
Q ss_pred HhcCccccceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..++|++.+.||+|+||.||+|+... +..||+|++... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35789999999999999999998643 336999999765 34456789999999999999999999999765 4578
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999998542 345899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ......
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~----~~~~~~----- 231 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IG----VLEKGD----- 231 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HH----HHHHTC-----
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HH----HHhcCC-----
Confidence 543221 1223456889999999999999999999999999999998 9999864332211 00 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.||++||++.|++++|+.+
T Consensus 232 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 -----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0011112345688999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.48 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=204.8
Q ss_pred hcCccccceecccCceeEEEEEE------cCCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL------LNGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 57899999999999999999984 24678999999654 345567899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCC----CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeec
Q 003843 543 ILILEYMPNKSLNVFLFDSTK----KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKIS 615 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~ 615 (792)
++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999865432 245899999999999999999999998 999999999999984 4469999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcc
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLE----FVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHH----HHh
Confidence 9999986644333333334567899999999999999999999999999999998 888886433211 100 000
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
... ...........+.+++.+||+.||++||++.+++++|...
T Consensus 260 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 000 0011122345788999999999999999999999999775
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.46 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=202.6
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--------chhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999864 58899999996542 12344678899999999999999999999999
Q ss_pred CeeEEEEEecCCC-ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 540 GEKILILEYMPNK-SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 540 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
+..++||||+.+| +|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9988883 3446999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 998775432 2334679999999999998876 88999999999999999999998631110
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... ..+.....++.+++.+||+.||++|||+.+++++
T Consensus 237 ----~~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VEAAI---HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTTCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----Hhhcc---CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011123568899999999999999999999886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.47 Aligned_cols=265 Identities=24% Similarity=0.322 Sum_probs=206.7
Q ss_pred HHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhh--cCCCCcceEeeeeeecC----
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAK--LQHRNLVRLLGCCVEQG---- 540 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 540 (792)
....++|++.+.||+|+||.||+|+. +++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34467899999999999999999998 5899999999643 34677889999887 78999999999998876
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHH--------hcCCCceeecCCCCCcEEEcCCCCe
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--------QYSRFRIIHRDLKASNILLDKDMNP 612 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~ivH~Dlkp~NILl~~~~~~ 612 (792)
..++||||+++|+|.+++.. ..+++.+++.++.||+.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35899999999999999999999 666 9999999999999999999
Q ss_pred eecccccceecCCCccc--cccceeecccceeCcccccCCC------CCCcCceeehhHHHHHHHhC----------CCC
Q 003843 613 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSS----------KKN 674 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwSlGvll~elltg----------~~p 674 (792)
||+|||++......... .......||+.|+|||.+.+.. ++.++||||||+++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876543221 1223457899999999998763 34789999999999999999 455
Q ss_pred CCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 675 TGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 675 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
|........... ...... ......+.+............+.+++.+||+.||++||++.||+++|+.+
T Consensus 267 ~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVE-EMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHH-HHHHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHH-HHHHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 543221111000 000001 01111222211112345677899999999999999999999999999876
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.62 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=204.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999875 4889999998643 3445678899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~DFGla~~~ 623 (792)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888743 345899999999999999999999998 999999999999987665 999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .. ....... ..
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~----~~~~~~~-~~-- 226 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--YA----QIKAGAY-DY-- 226 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCC-CC--
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--HH----HHHhccc-cC--
Confidence 54322 2335789999999999999999999999999999999999999864332111 00 0000000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.......++.+++.+||+.||++|||+.|++++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111234568899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=348.84 Aligned_cols=253 Identities=15% Similarity=0.146 Sum_probs=205.3
Q ss_pred HHhcCccccceecccCceeEEEEE------EcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC---CCCcceEeeeeee
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGR------LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVE 538 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 538 (792)
...++|++.++||+|+||.||+|+ ...++.||||++... ...++.+|++++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 346789999999999999999994 446889999999754 3456788888888886 9999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccC--CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC--------
Q 003843 539 QGEKILILEYMPNKSLNVFLFDST--KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-------- 608 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-------- 608 (792)
++..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999996432 3456999999999999999999999998 999999999999998
Q ss_pred ---CCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc
Q 003843 609 ---DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 685 (792)
Q Consensus 609 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~ 685 (792)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 8999999999998764332223344567999999999999999999999999999999999999998532211100
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHhcc
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR-PTMSDVISMINNE 747 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~evl~~L~~~ 747 (792)
+...+... .....+.+++..|++.+|.+| |++.++.+.|++.
T Consensus 295 ----------------~~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 ----------------PEGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ----------------ECSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ----------------echhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 00111000 124567789999999999999 6888888888764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.29 Aligned_cols=252 Identities=24% Similarity=0.297 Sum_probs=205.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567999999999999999999986 588999999865432 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC----Ceeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kL~DFG 618 (792)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 456899999999999999999999998 99999999999999888 79999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... .....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----i~~~~- 234 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN----ITSVS- 234 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH----HHTTC-
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HHH----HHhcc-
Confidence 998765432 22345789999999999999999999999999999999999999864332111 000 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+.. .......+.+++.+||+.||++|||+.|++++
T Consensus 235 -~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 -YDFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -CCCCHHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -cccChhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 01123568899999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.74 Aligned_cols=261 Identities=21% Similarity=0.260 Sum_probs=193.0
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeee--------e
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCV--------E 538 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~ 538 (792)
...+|++.++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4568999999999999999999975 68899999997777777788999999999996 999999999984 3
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
....++||||+. |+|.+++........+++.+++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345799999996 788888865445567999999999999999999999875 249999999999999999999999999
Q ss_pred cceecCCCcccc----------ccceeecccceeCcccc---cCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc
Q 003843 619 LARMFGGDELQG----------NTKQIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL 685 (792)
Q Consensus 619 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~ 685 (792)
+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~ 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--I 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--h
Confidence 998765432111 11134689999999998 56678999999999999999999999986422111 0
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
. .... ...........+.+++.+||+.||++||++.|++++|+.+...
T Consensus 262 ~----------------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 262 V----------------NGKY-SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp --------------------C-CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h----------------cCcc-cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0000 0000111123477899999999999999999999999886443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.37 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=199.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999975 68899999996542 33457899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999843 346899999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ...... . ..
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~-~---~~-- 253 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---G---AHINQA-I---PR-- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---H---HHHHSC-C---CC--
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---H---HHhccC-C---CC--
Confidence 3221 22345689999999999999999999999999999999999999864332110 0 000000 0 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 747 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~ 747 (792)
........+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 0011122334688999999999999999 999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.21 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=196.0
Q ss_pred cCccccceecccCceeEEEEEEcC--C--cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeee-cCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 544 (792)
..|++.++||+|+||.||+|+..+ + ..||||.+... .....++|.+|+.++++++||||+++++++.+ ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 457788999999999999998642 2 36899998654 34556889999999999999999999998754 557899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++++|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999843 3345889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcccc--ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccc
Q 003843 625 GDELQG--NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 625 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........ ... ...+. .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~----~~~~~--~- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY----LLQGR--R- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHH----HHTTC--C-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHH----HHcCC--C-
Confidence 332211 1223457889999999999999999999999999999999 6667654332211 000 00000 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCC
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNL 751 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~ 751 (792)
...+......+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus 315 -------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 315 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0111123457889999999999999999999999998864433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.58 Aligned_cols=268 Identities=25% Similarity=0.375 Sum_probs=197.0
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHH--HhhcCCCCcceEeeeeee-----cCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMML--IAKLQHRNLVRLLGCCVE-----QGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 542 (792)
.++|++.++||+|+||.||+|+. +++.||||++.... .+.+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 47899999999999999999987 78999999996432 3444445554 445899999999986543 2357
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc---------CCCceeecCCCCCcEEEcCCCCee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY---------SRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
++||||+++|+|.+++.. ..+++..++.++.||++||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999833 3458999999999999999999998 7 99999999999999999999
Q ss_pred ecccccceecCCCcc------ccccceeecccceeCcccccC-------CCCCCcCceeehhHHHHHHHhCCCCCCCCCc
Q 003843 614 ISDFGLARMFGGDEL------QGNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSSKKNTGVYNA 680 (792)
Q Consensus 614 L~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvll~elltg~~p~~~~~~ 680 (792)
|+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987754321 111223468999999999987 4567889999999999999999877643322
Q ss_pred cccccccchhhhcccCc---c-----ccccccccccC-CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 681 DSFNLLGHAWDLWKDDR---V-----HDLIDPVIMQD-EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 681 ~~~~~~~~~~~~~~~~~---~-----~~~~~~~l~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
................. . .....+.+... .........+.+++.+||+.||++|||++|+++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11110000000000000 0 00011111110 112335668999999999999999999999999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=348.32 Aligned_cols=272 Identities=26% Similarity=0.414 Sum_probs=210.1
Q ss_pred hcCccccceecccCceeEEEEEE-----cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC--ee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-----LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG--EK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 542 (792)
.++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46799999999999999999984 358899999998777777789999999999999999999999987654 78
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999998543 245899999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchh-hhcccCcccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAW-DLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 700 (792)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+......... .......+.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7543221 1122345677899999999999999999999999999999999887532111000000000 0000000011
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+.... ..+.+.....++.+++.+||+.||++||++.||++.|+.+
T Consensus 275 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111100 1112223456789999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.41 Aligned_cols=255 Identities=27% Similarity=0.395 Sum_probs=204.4
Q ss_pred hcCccccc-eecccCceeEEEEEEc---CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 470 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 470 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
.++|++.+ .||+|+||.||+|.+. .++.||||++.... ....+++.+|+.+++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 9999999999999653 36789999997542 33467899999999999999999999999 667889
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999843 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccc
Q 003843 624 GGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . .......
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~----~~~~~~~---- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--T----AMLEKGE---- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH--H----HHHHTTC----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--H----HHHHcCC----
Confidence 543221 11222346789999999999899999999999999999999 9999865432211 0 0011110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+......+.+++.+||+.||++||++.++++.|++.
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111223346789999999999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=354.55 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=206.9
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeee
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 538 (792)
+.+.....++|++.++||+|+||.||+++.+ +++.||||++.+.. ....+.+.+|..++..++|+||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4444556789999999999999999999985 68999999996532 2234558899999999999999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
.+..++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999998532 236899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCccccc-------CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 691 (792)
+++.+..... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...
T Consensus 208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~--- 281 (412)
T 2vd5_A 208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET--YGK--- 281 (412)
T ss_dssp TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH---
T ss_pred hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH--HHH---
Confidence 9987654322 1123457999999999997 45789999999999999999999999965332211 000
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADR---PTMSDVISM 743 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~evl~~ 743 (792)
..... ..+.........+.++.+++.+||+ +|++| |+++|++++
T Consensus 282 i~~~~-------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYK-------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHH-------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcc-------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00000 0000000112234578999999999 99998 589999775
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=345.77 Aligned_cols=208 Identities=27% Similarity=0.333 Sum_probs=179.5
Q ss_pred ccHHHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-----CCCcceEee
Q 003843 461 FSLASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----HRNLVRLLG 534 (792)
Q Consensus 461 ~~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~ 534 (792)
+++.......++|++.++||+|+||.||+|+.. +++.||||++.. .....+.+..|+.+++.++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 333333445789999999999999999999984 588999999964 3345567888999999997 999999999
Q ss_pred eeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC------
Q 003843 535 CCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------ 608 (792)
Q Consensus 535 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~------ 608 (792)
++...+..++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 99999998543 2335899999999999999999999998 999999999999975
Q ss_pred -------------------CCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHH
Q 003843 609 -------------------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 669 (792)
Q Consensus 609 -------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ell 669 (792)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999875432 23457899999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 003843 670 SSKKNTGVYN 679 (792)
Q Consensus 670 tg~~p~~~~~ 679 (792)
+|+.||....
T Consensus 254 ~g~~pf~~~~ 263 (360)
T 3llt_A 254 TGSLLFRTHE 263 (360)
T ss_dssp HSSCSCCCSS
T ss_pred HCCCCCCCCc
Confidence 9999997543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.11 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=204.7
Q ss_pred cCccccceecccCceeEEEEEEcC----CcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee-EE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK-IL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 544 (792)
-.|++.++||+|+||.||+|++.+ +..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 356677999999999999998643 2379999997543 34567899999999999999999999999876655 99
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+.+++|.+++.. ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 101 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999854 3456899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCcc--ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCC-CCCCccccccccchhhhcccCccccc
Q 003843 625 GDEL--QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNT-GVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 625 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.... ........+++.|+|||.+.+..++.++||||||+++|||++|..|+ ....... ... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~----~~~~~~---- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTH----FLAQGR---- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHH----HHHTTC----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHH----HhhcCC----
Confidence 4321 12223456789999999999999999999999999999999966554 3222111 100 000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
....+......+.+++.+||+.||.+|||++++++.|+++...
T Consensus 246 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 246 ------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111122345788999999999999999999999999886433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=334.32 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=201.9
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeee-eecCeeEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILIL 546 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 546 (792)
..++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++.++|++++..+..+ .++...++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 357899999999999999999987 4688999998754322 24578899999999988877776665 5667889999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~~ 623 (792)
||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998532 345999999999999999999999998 9999999999999 78999999999999987
Q ss_pred CCCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchhhhcccCc
Q 003843 624 GGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDDR 697 (792)
Q Consensus 624 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~ 697 (792)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------- 229 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER--------- 229 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH---------
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhh---------
Confidence 544321 1223467899999999999999999999999999999999999999754322111 1000
Q ss_pred ccccccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 698 VHDLIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 698 ~~~~~~~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
+....... .......+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus 230 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 230 ---ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp ---HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ---hhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00000000 0000112357899999999999999999999999998753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=336.57 Aligned_cols=265 Identities=26% Similarity=0.370 Sum_probs=198.6
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC-----chhHHHHHHHHHHHhhcC---CCCcceEeeeeeec
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-----GQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 539 (792)
..++|++.++||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999986 468899999986432 122356677887777764 99999999999876
Q ss_pred C-----eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeee
Q 003843 540 G-----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKI 614 (792)
Q Consensus 540 ~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL 614 (792)
. ..++||||+. ++|.+++.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 59988885432 234899999999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc-
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW- 693 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~- 693 (792)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence 9999998764332 22345789999999999999999999999999999999999999965443211 10000000
Q ss_pred --ccCccc---cccccccc-cCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 --KDDRVH---DLIDPVIM-QDE-----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 --~~~~~~---~~~~~~l~-~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...... ........ ... ........+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 00000000 000 011234578899999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.85 Aligned_cols=259 Identities=28% Similarity=0.427 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcE--EEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQE--VAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|+.. ++.. +|+|++... .....+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 368999999999999999999875 4554 499998653 334556789999999999 89999999999999999999
Q ss_pred EEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 545 ILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
||||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999985432 2346899999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAW 690 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~ 690 (792)
+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--~---- 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--Y---- 251 (327)
T ss_dssp EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--H----
T ss_pred EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--H----
Confidence 999999999743211 12223456889999999999999999999999999999998 9999864332111 0
Q ss_pred hhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
...... . ...........+.+++.+||+.+|++||++.|+++.|+.....
T Consensus 252 ~~~~~~-----~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 EKLPQG-----Y-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HHGGGT-----C-----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhhcC-----C-----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 011100 0 0111222345788999999999999999999999999876433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=370.45 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=202.0
Q ss_pred cCccccc-eecccCceeEEEEEEc---CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 8999999999999874 45679999997643 3467889999999999999999999999876 568999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999843 3456999999999999999999999998 99999999999999999999999999987643
Q ss_pred Cccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 626 DELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 626 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||........ . .....+.
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~--~----~~i~~~~------ 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV--M----AFIEQGK------ 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH--H----HHHHTTC------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--H----HHHHcCC------
Confidence 3211 11222345689999999999999999999999999999998 9999875433211 1 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+.....++.+|+.+||+.+|++||++.+|++.|+..
T Consensus 557 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 557 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112223456789999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.17 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=205.3
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeee-eecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC-VEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999997 5689999999865432 35688999999999998877666655 55677899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 624 (792)
|+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 99999998532 345999999999999999999999998 9999999999999 588999999999999875
Q ss_pred CCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhhhcccCcc
Q 003843 625 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRV 698 (792)
Q Consensus 625 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 698 (792)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----EKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH----HHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc----cccc
Confidence 44321 112345799999999999999999999999999999999999999975432211 1110000 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
. .. ........+.++.+++.+||+.||++||++++|++.|+...
T Consensus 236 ~----~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 236 S----TP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp H----SC--HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred C----Cc--hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0 00 00001112357889999999999999999999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.08 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=192.7
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecC--ee
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQG--EK 542 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 542 (792)
..++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4678999999999999999999875 5899999998643 3445677889999999997 999999999997544 68
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||++ ++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 58887773 246899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCc-------------------cccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccc
Q 003843 623 FGGDE-------------------LQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682 (792)
Q Consensus 623 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~ 682 (792)
+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 64311 0112234579999999999987 678999999999999999999999997543211
Q ss_pred cccccchhhhcccC-----------------------------ccccccc---cccccCCCCHHHHHHHHHHHHhccccC
Q 003843 683 FNLLGHAWDLWKDD-----------------------------RVHDLID---PVIMQDEISLPMLMRYINVALLCVQEN 730 (792)
Q Consensus 683 ~~~~~~~~~~~~~~-----------------------------~~~~~~~---~~l~~~~~~~~~~~~l~~li~~cl~~d 730 (792)
. +.......... .....+. ..+...........++.+|+.+||+.|
T Consensus 239 ~--~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 239 Q--LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp H--HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred H--HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1 00000000000 0000000 000000000122457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 003843 731 AADRPTMSDVISM 743 (792)
Q Consensus 731 p~~RPs~~evl~~ 743 (792)
|++|||++|++++
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.56 Aligned_cols=249 Identities=21% Similarity=0.238 Sum_probs=178.9
Q ss_pred ceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 477 CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
++||+|+||.||+++.. +++.||||++... ....+.+|+.+++.++ ||||+++++++.++...++||||+++++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999985 5889999999643 3467789999999997 99999999999999999999999999999
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC---CeeecccccceecCCCccccc
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKISDFGLARMFGGDELQGN 631 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kL~DFGla~~~~~~~~~~~ 631 (792)
.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 999843 356999999999999999999999998 99999999999997765 799999999987644321 2
Q ss_pred cceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhhhcccCccccccccccccCC
Q 003843 632 TKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRVHDLIDPVIMQDE 710 (792)
Q Consensus 632 ~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~ 710 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............+... . ..+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~-~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------F-EGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------C-CSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------C-Ccc
Confidence 2345789999999999999999999999999999999999999975432111 0000011111111000 0 000
Q ss_pred CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 711 ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 711 ~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.......++.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 001234678999999999999999999998744
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.74 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=204.9
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee---------
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--------- 538 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 538 (792)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3578999999999999999999986 68999999997543 356789999999999999999998864
Q ss_pred -------cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC
Q 003843 539 -------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN 611 (792)
Q Consensus 539 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~ 611 (792)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44689999999999999998543 2346899999999999999999999998 999999999999999999
Q ss_pred eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh
Q 003843 612 PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 612 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 691 (792)
+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHH
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHH
Confidence 99999999987754321 233468999999999999999999999999999999999988753110 0000
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCC
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHL 749 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~ 749 (792)
..... .........+.+++.+||+.||++||++.|++++|.....
T Consensus 230 ~~~~~-------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 230 DLRDG-------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHTT-------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred Hhhcc-------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00000 1111223467899999999999999999999999988743
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=350.23 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=191.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHH-HhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMML-IAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+++.+ +++.||||++.+.. ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 468999999999999999999986 47889999996542 2334556677776 467899999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999988843 346899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... . .. ++..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~----~~--------i~~~ 254 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--Y----DN--------ILNK 254 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--H----HH--------HHHS
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--H----HH--------HHhc
Confidence 221 223456899999999999999999999999999999999999999864332111 0 00 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSD 739 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 739 (792)
.+ ..+......+.+++.+||+.||++||++.+
T Consensus 255 ~~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 255 PL---QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CC---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cc---CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 00 111223457889999999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=352.76 Aligned_cols=200 Identities=26% Similarity=0.400 Sum_probs=168.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Ce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 541 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999875 4788999999753 334567899999999999999999999999776 57
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||++ ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 58988883 3456999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCccc--------------------cccceeecccceeCcccc-cCCCCCCcCceeehhHHHHHHHhCCCCCC
Q 003843 622 MFGGDELQ--------------------GNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSKKNTG 676 (792)
Q Consensus 622 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvll~elltg~~p~~ 676 (792)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87543211 123456889999999986 55679999999999999999998766654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.61 Aligned_cols=248 Identities=31% Similarity=0.448 Sum_probs=200.3
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999987 468899999996432 33456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||++ |+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 5776666332 346899999999999999999999998 99999999999999999999999999986543
Q ss_pred CccccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||........ ........
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~------ 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE------ 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC------
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC------
Confidence 2 2357899999999984 56789999999999999999999999864332110 00010000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
.+.+ ........+.+++.+||+.||++|||+++++++.
T Consensus 270 ~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 SPAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CCCC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 0101 1112245688999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.18 Aligned_cols=255 Identities=24% Similarity=0.312 Sum_probs=203.6
Q ss_pred hcCccccceecccCceeEEEEEE----cCCcEEEEEEecccC----chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL----LNGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 368999999986432 23446678899999999 6999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999843 345899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ....
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~------- 276 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISR------- 276 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHH-------
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHH-------
Confidence 87643322 12234579999999999986 357899999999999999999999997543221100 0000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISMI 744 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~L 744 (792)
.+... ....+......+.+|+.+||+.||++|| ++.|++++.
T Consensus 277 -~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 -RILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -HHHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -HHhcc---CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00000 1112223345788999999999999999 999998875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=359.69 Aligned_cols=254 Identities=26% Similarity=0.331 Sum_probs=207.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.++||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 577999999999999999999985 6899999999643 223456788999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999885432 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ..+...
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~---------~~i~~~ 404 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVE---------RLVKEV 404 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHH---------HHHHHC
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHH---------HHhhcc
Confidence 32 123357999999999999999999999999999999999999999754321110 0000 000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
...++.....++.+|+.+||+.||++|| +++||+++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1112223346789999999999999999 78888764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.27 Aligned_cols=253 Identities=17% Similarity=0.218 Sum_probs=192.2
Q ss_pred hcCcccc-ceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhh-cCCCCcceEeeeeee----cCee
Q 003843 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAK-LQHRNLVRLLGCCVE----QGEK 542 (792)
Q Consensus 470 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 542 (792)
.++|.+. ++||+|+||.||+++.. +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3567776 68999999999999875 5889999999632 456788888755 589999999999876 5678
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeeccccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~DFGl 619 (792)
++||||+++|+|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 9999999999999998542 2345899999999999999999999998 999999999999998 78899999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+..
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~- 284 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQY- 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCC-
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--HHHHHHHcCcc-
Confidence 98764322 2234678999999999999999999999999999999999999996543221100 00000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. + ..........++.+|+.+||+.||++|||+.|++++
T Consensus 285 ~-----~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 E-----F-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C-----C-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-----C-CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0 000111234578899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.24 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=201.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
++|....+||+|+||.||+|+.. +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34455569999999999999974 57899999998776666788999999999999999999999999999999999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-CCCeeecccccceecCCCcc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~ 628 (792)
++++|.+++........+++..+..++.||+.||+|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999865544456789999999999999999999998 999999999999987 8999999999998764322
Q ss_pred ccccceeecccceeCcccccCCC--CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.............. . ...
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~-------~~~---- 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--M-------FKV---- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--H-------HCC----
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--c-------ccc----
Confidence 1223457899999999997654 88999999999999999999999864322111000000 0 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+.....++.+++.+||+.||++||++.+++++
T Consensus 244 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 -HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111222334578899999999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=358.62 Aligned_cols=262 Identities=24% Similarity=0.264 Sum_probs=195.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------C
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 540 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 478999999999999999999875 5889999999754 344567889999999999999999999999654 3
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++||||++++ |.+.+. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999875 444441 23899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------hhh
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AWD 691 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~~~ 691 (792)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ..+.. .+.
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8764332 23446899999999999999999999999999999999999999975432110 00000 000
Q ss_pred --------hcccC------ccccccccccccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 --------LWKDD------RVHDLIDPVIMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 --------~~~~~------~~~~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... .....+...+... ........++.+|+.+||+.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000000 0011125678999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=355.11 Aligned_cols=196 Identities=25% Similarity=0.394 Sum_probs=155.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Ce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 541 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+++|++++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999875 5889999999653 334567899999999999999999999998543 56
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+ +++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 468888773 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccc-------------------------cccceeecccceeCcccc-cCCCCCCcCceeehhHHHHHHHhCC
Q 003843 622 MFGGDELQ-------------------------GNTKQIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSK 672 (792)
Q Consensus 622 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwSlGvll~elltg~ 672 (792)
........ ......+||+.|+|||++ ....++.++|||||||+||||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432111 123345789999999986 5667999999999999999999943
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.71 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=198.0
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-CeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+++. .++.||||++.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 57899999999999999999987 58899999997543 457899999999999999999999997654 478999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999998432 2234889999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . .......
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~----~~~~~~~---------- 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKGY---------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--H----HHHTTTC----------
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHhcCC----------
Confidence 122357889999999999999999999999999999998 9999864332111 0 0111110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...........+.+++.+||+.||++||++.|+++.|+.+
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=334.35 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=207.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.+.|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 467999999999999999999875 58899999996543 4456889999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999883 346899999999999999999999998 9999999999999999999999999998765433
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ .. ......
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~~---------- 235 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV--LF----LIPKNN---------- 235 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHSC----------
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH--HH----HhhcCC----------
Confidence 2 22345789999999999999999999999999999999999999864332111 00 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
...........+.+++.+||+.||++||++.+++++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 0111122345688999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.31 Aligned_cols=252 Identities=22% Similarity=0.377 Sum_probs=198.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 468999999999999999999875 58899999986543 3456889999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeecccccceec
Q 003843 548 YMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMF 623 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~~ 623 (792)
|+++++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999998885432 2356999999999999999999999998 9999999999999 45678999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||.......... .. .......
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~--~~--~~~~~~~----- 244 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ--KA--TYKEPNY----- 244 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH--HHCCCCC-----
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh--hh--ccCCccc-----
Confidence 4432 223457899999999876 568999999999999999999999986533221100 00 0000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.. .......++.+++.+||+.||++||++.|+++
T Consensus 245 -~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 -AV----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cc----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00112356789999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.96 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=206.2
Q ss_pred cHHHHHHHhcCcccc-ceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhc-CCCCcceEeeee
Q 003843 462 SLASITAATENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 536 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 536 (792)
.+.....-.+.|.+. ++||+|+||.||+|+.. +++.||||++... .......+.+|+.++..+ +||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 334445557788887 89999999999999876 5899999998653 234467899999999999 569999999999
Q ss_pred eecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCee
Q 003843 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPK 613 (792)
Q Consensus 537 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~k 613 (792)
.+....++||||+++++|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999988432 2356899999999999999999999998 999999999999988 78999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... . .
T Consensus 175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~----i 245 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL--N----I 245 (327)
T ss_dssp ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H----H
T ss_pred EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH--H----H
Confidence 99999999765332 1234579999999999999999999999999999999999999986533221100 0 0
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... . . ...........+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~-~-----~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQVNV-D-----Y-SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHTCC-C-----C-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred Hhccc-c-----c-CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00000 0 0 011112234568899999999999999999999865
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=349.08 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=192.1
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--------chhHHHHHHHHHHHhhcCCCCcceEeeeeee
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE 538 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 538 (792)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34689999999999999999999875 47899999986432 122335889999999999999999999975
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC---Ceeec
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NPKIS 615 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~kL~ 615 (792)
.+..++||||+++++|.+++. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999988883 3456999999999999999999999998 99999999999997544 59999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .. ..
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~----~~ 356 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LK----DQ 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HH----HH
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HH----HH
Confidence 999998765332 2334679999999999863 6788999999999999999999999964332111 00 00
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....... .... ........+.+++.+||+.||++||++.|++++
T Consensus 357 i~~~~~~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYN-FIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCC-CCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCC-CCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 0000 001124578899999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.24 Aligned_cols=246 Identities=20% Similarity=0.332 Sum_probs=199.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 578999999999999999999986 6899999998753 334567788999999999 999999999999999999999
Q ss_pred EEecCCCccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---------------
Q 003843 546 LEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--------------- 609 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~--------------- 609 (792)
|||+++++|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999854322 256899999999999999999999998 9999999999999844
Q ss_pred ----CCeeecccccceecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc
Q 003843 610 ----MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 684 (792)
Q Consensus 610 ----~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~ 684 (792)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 23589999999999876 667899999999999999999876532110
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+........ ...+......+.+++.+||+.||++||++.|++++
T Consensus 237 -----~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -----WHEIRQGRL----------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----HHHHHTTCC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----HHHHHcCCC----------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 001111111 01112234578899999999999999999999764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.78 Aligned_cols=264 Identities=23% Similarity=0.343 Sum_probs=205.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999986 5889999999765 34456789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|+++++|.+++.. ...+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999843 34589999999999999999999996 7 999999999999999999999999999755321
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch-----------------
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA----------------- 689 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~----------------- 689 (792)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 22345789999999999999999999999999999999999999975443221110000
Q ss_pred -------hhhcccCccccccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 690 -------WDLWKDDRVHDLIDPVIM---QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 690 -------~~~~~~~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.++.... ..........++.+|+.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000011111000 000111234578999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.85 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=206.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 578999999999999999999986 4788999998653 234567889999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988743 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-------- 231 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE-------- 231 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTC--------
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhhcc--------
Confidence 221 22335789999999999999999999999999999999999999864332111 00000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+......+.+++.+||+.||++||+++|++++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01112233568899999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=330.93 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=202.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999986 589999999865321 2467899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC----Ceeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kL~DFG 618 (792)
++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999843 346899999999999999999999998 99999999999998877 89999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .. .......
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LT----NISAVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHTTCC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HH----HhHhccc
Confidence 998764432 12335689999999999999999999999999999999999999864332110 00 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...... .......+.+++.+||+.||++||++.|++++
T Consensus 229 --~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 --DFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --CCCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --CCcchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 000000 01123568899999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.69 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=206.0
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+++... ++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5789999999999999999999864 788999998653 334567889999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988743 346899999999999999999999998 99999999999999999999999999987643
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~-------- 257 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNE-------- 257 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC--------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCC--------
Confidence 321 22345789999999999999999999999999999999999999864332111 00000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+......+.+++.+||+.||++||+++|++++
T Consensus 258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111223567899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=334.84 Aligned_cols=251 Identities=21% Similarity=0.317 Sum_probs=202.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 568999999999999999999975 6899999999766555557789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeecccccceecCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~~~~ 625 (792)
+++++|.+++.. .+.+++.++..++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999988843 345899999999999999999999998 9999999999999 7889999999999976533
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ... ....... ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~i~~~~~-~~---- 226 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFE----KIKEGYY-EF---- 226 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HHHHCCC-CC----
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHcCCC-CC----
Confidence 2 2233468999999999999999999999999999999999999986433211 100 0000000 00
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+........+.+++.+||+.||++||++.|++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 --ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011112234578899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.30 Aligned_cols=263 Identities=16% Similarity=0.187 Sum_probs=205.1
Q ss_pred hcCccccceecccCceeEEEEEEcC---------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcce---------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVR--------- 531 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 531 (792)
.++|++.+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999998764 789999999754 46789999999999999988
Q ss_pred ------Eeeeeee-cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcE
Q 003843 532 ------LLGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNI 604 (792)
Q Consensus 532 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NI 604 (792)
+++++.. +...++||||+ +++|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5667765 67889999999 99999999543 2356999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeeecccccceecCCCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCC
Q 003843 605 LLDKDM--NPKISDFGLARMFGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGV 677 (792)
Q Consensus 605 Ll~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~ 677 (792)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876533211 112334789999999999999999999999999999999999999975
Q ss_pred CCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 678 YNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 678 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.............. + ......+...... ......++.+++.+||+.||++||++++|++.|+++.
T Consensus 271 ~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNTEDIMKQKQK-F-VDKPGPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCHHHHHHHHHH-H-HHSCCCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHh-c-cCChhhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 43221111111000 0 0011111111100 0112357889999999999999999999999998864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.27 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=194.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCch-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQ-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.++||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999986 6889999999654322 222456799999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
++ ++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 5887777432 346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchhhhcccCcccccccc--
Q 003843 629 QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWDLWKDDRVHDLIDP-- 704 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-- 704 (792)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... .+..................
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence 12233478999999999876 56899999999999999999999999754422110 00000000000000000000
Q ss_pred -------ccccC---CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 -------VIMQD---EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 -------~l~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... ........++.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0011224577899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=331.76 Aligned_cols=247 Identities=22% Similarity=0.304 Sum_probs=204.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 468999999999999999999886 47789999986432 23356789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999998843 345899999999999999999999998 99999999999999999999999999976543
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ......
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~~~~--------- 227 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--H----RRIVNV--------- 227 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHHHTT---------
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--H----HHHhcc---------
Confidence 22 2335789999999999999999999999999999999999999864332111 0 000000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+......+.+++.+||+.||++||++++++++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 001112234578899999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=341.35 Aligned_cols=252 Identities=18% Similarity=0.252 Sum_probs=199.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.+.||+|+||.||+++.+ +++.||||++..... .+.+|++++.++ +||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 578999999999999999999986 588999999975433 235688888888 79999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-C---Ceeecccccceec
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-M---NPKISDFGLARMF 623 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~---~~kL~DFGla~~~ 623 (792)
|+++|+|.+++. +.+.+++.++..++.||+.||+|||+.+ |+||||||+|||+..+ + .+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998884 3456999999999999999999999998 9999999999998443 3 4999999999976
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+....+ ......+...
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~i~~~~~~---- 241 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LARIGSGKFS---- 241 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHHHHHCCCC----
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHHHccCCcc----
Confidence 44321 22345789999999999988899999999999999999999999974322111100 0011111000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+ ..........++.+|+.+||+.||++||++.|++++
T Consensus 242 --~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 --L-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --C-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --c-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111112234578899999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=370.21 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=197.9
Q ss_pred ceecccCceeEEEEEEc---CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46789999997542 344688999999999999999999999986 4568899999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc-cc
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL-QG 630 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~ 630 (792)
|+|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999994 3356899999999999999999999998 99999999999999999999999999987754322 12
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ......+. ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------~~~i~~~~----------~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGE----------RM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHTTC----------CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcCC----------CC
Confidence 2233456789999999999999999999999999999998 9999875433211 00111110 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.....++.+++.+||+.||++||++.+|++.|++.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223446789999999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=341.62 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=193.0
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
...++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34678999999999999999999865 68899999996543 2335667899999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-----CCCCeeeccccc
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-----KDMNPKISDFGL 619 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-----~~~~~kL~DFGl 619 (792)
||||+++ +|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999984 88888743 345899999999999999999999998 99999999999994 455599999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccchhhhcccCc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHAWDLWKDDR 697 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~ 697 (792)
++.+.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ............
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 98764332 122335689999999999875 48999999999999999999999986543211100 000000000000
Q ss_pred -------------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 698 -------------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 698 -------------~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
........+ ..........++.+|+.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTL-KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCH-HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccH-hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000000 00001112457889999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=355.45 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=207.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.++||+|+||.||+++.. +|+.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999985 58999999996532 23456789999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCC-CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDSTK-KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|||+++|+|..++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998865432 446999999999999999999999998 9999999999999999999999999999765
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... .++..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~--------~i~~~ 408 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ--------RVLEQ 408 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHH--------HHHHC
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHH--------HHhhc
Confidence 4322 233458999999999999999999999999999999999999999754321100 00000 00111
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVIS 742 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~ 742 (792)
...++......+.+++.+||+.||++||++ +++++
T Consensus 409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 011222345678899999999999999975 66654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=352.82 Aligned_cols=242 Identities=14% Similarity=0.162 Sum_probs=190.0
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecc---cCchhHHHHHHHH---HHHhhcCCCCcceEe-------ee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSN---QSGQGLKEFKNEM---MLIAKLQHRNLVRLL-------GC 535 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 535 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++.. ......+.|.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 57899999999999999999996 4689999999963 2344568899999 555556899999998 55
Q ss_pred eeecC-----------------eeEEEEEecCCCccceeeeccC----CCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003843 536 CVEQG-----------------EKILILEYMPNKSLNVFLFDST----KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594 (792)
Q Consensus 536 ~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 594 (792)
+.+.+ ..++||||+ +|+|.+++.... ....+++..++.++.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 55443 278999999 689999985421 1223556888899999999999999998 9
Q ss_pred eecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCC-----------CCCCcCceeehhH
Q 003843 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGI 663 (792)
Q Consensus 595 vH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DVwSlGv 663 (792)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 664 LMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 664 ll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
++|||++|+.||........ . ..+... ......++.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~--~------------~~~~~~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG--S------------EWIFRS-------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC--S------------GGGGSS-------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc--h------------hhhhhh-------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999864332111 0 000000 0112356889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.91 Aligned_cols=266 Identities=24% Similarity=0.339 Sum_probs=200.3
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4689999999999999999999864 8899999985543 334566889999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988763 3345899999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-cc--------chhhhcccC
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LG--------HAWDLWKDD 696 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~--------~~~~~~~~~ 696 (792)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......... .. .....+...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 21 22335689999999999875 78999999999999999999999987544221100 00 000000000
Q ss_pred -ccccccccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 -RVHDLIDPVIMQD----EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 -~~~~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.......+.+... .........+.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000111000 0011235678999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.29 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=199.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeee--------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-------- 538 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 538 (792)
.++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999984 68999999985442 2335678899999999999999999999987
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
.+..++||||+++ +|.+.+.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 3468999999986 56555532 2345899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCcc--ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccch-----
Q 003843 619 LARMFGGDEL--QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHA----- 689 (792)
Q Consensus 619 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~----- 689 (792)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987753221 122334578999999999876 46899999999999999999999998754422110 00000
Q ss_pred ---hhhcccCccccccccccccCCCCHH-------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 690 ---WDLWKDDRVHDLIDPVIMQDEISLP-------MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 690 ---~~~~~~~~~~~~~~~~l~~~~~~~~-------~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+.........+.+.... ....... ....+.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000000000 0001111 13458899999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=335.74 Aligned_cols=257 Identities=27% Similarity=0.371 Sum_probs=198.2
Q ss_pred hcCccccceecccCceeEEEEEEcC--Cc--EEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--GQ--EVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||+|++.. ++ .||||+++.. .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 5789999999999999999998642 33 6899998653 3445678999999999999999999999998765 8
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++|+||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998543 345899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ... ......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~---~~~~~~--- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHK---IDKEGE--- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH---HHTSCC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--HHH---HHccCC---
Confidence 7543221 12233467889999999999899999999999999999999 9999864432111 000 000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
...........+.+++.+||+.+|++||++.++++.|++.
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0111122346789999999999999999999999999886
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.65 Aligned_cols=260 Identities=24% Similarity=0.346 Sum_probs=204.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCch-----------------hHHHHHHHHHHHhhcCCCCcceE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQ-----------------GLKEFKNEMMLIAKLQHRNLVRL 532 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 532 (792)
.++|++.+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 8999999998643211 12789999999999999999999
Q ss_pred eeeeeecCeeEEEEEecCCCcccee------eeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEE
Q 003843 533 LGCCVEQGEKILILEYMPNKSLNVF------LFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNIL 605 (792)
Q Consensus 533 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NIL 605 (792)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||+|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 422 124679999999999999999999999 88 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCC-CCCC-cCceeehhHHHHHHHhCCCCCCCCCcccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSI-KSDVFSFGILMLETLSSKKNTGVYNADSF 683 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DVwSlGvll~elltg~~p~~~~~~~~~ 683 (792)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876443 23345789999999999887 6666 99999999999999999999975443111
Q ss_pred ccccchhhhcccCccc------cccccccc--cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 684 NLLGHAWDLWKDDRVH------DLIDPVIM--QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 684 ~~~~~~~~~~~~~~~~------~~~~~~l~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
... ........ ....+... ...........+.+++.+||+.||.+||++.|++++
T Consensus 261 -~~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 -LFN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HHH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 100 00000000 00000000 000112234678999999999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.23 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=204.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 544 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999885 5889999999653 34456789999999999999999999998854 568899
Q ss_pred EEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 545 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986432 2345899999999999999999999986 2349999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. .....+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LA----GKIREGKF--- 233 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHTCC---
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HH----HHHhhccc---
Confidence 7643321 1223468999999999999999999999999999999999999987543211 00 01111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
...+.....++.+++.+||+.||++||++.||++++..
T Consensus 234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 01122234578899999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.64 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=199.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC----chhHHHHHHHHHHHhhcCCCCcceEeeeee--ecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS----GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV--EQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 542 (792)
.++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|++++++++|+||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999875 58899999996532 344678999999999999999999999984 45688
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||++++ |.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 55555332 3456899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccccccceeecccceeCcccccCCC--CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
..............||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....... .. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~i~~~~--- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LF----ENIGKGS--- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHHCC---
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HH----HHHhcCC---
Confidence 75433333334457899999999998654 3789999999999999999999986432211 00 0000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+......+.+++.+||+.||++||+++|++++
T Consensus 230 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 --------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01112234577899999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.50 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=196.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999986 68999999986432 23456889999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 345899999999999999999999998 99999999999999999999999999987654
Q ss_pred CccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
... .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .. .......
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~~~~------- 227 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LF----KKIRGGV------- 227 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHCC-------
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HH----HHhhcCc-------
Confidence 321 223468999999999988765 689999999999999999999986432111 00 0000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+......+.+++.+||+.||++||++.|++++
T Consensus 228 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111223568899999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=335.76 Aligned_cols=252 Identities=24% Similarity=0.410 Sum_probs=199.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 578999999999999999999986 4889999999876666778999999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++++|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 9999999887442 345899999999999999999999998 9999999999999999999999999986432111
Q ss_pred ccccceeecccceeCcccc-----cCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYA-----LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.......||+.|+|||.+ ....++.++||||||+++|||++|+.|+........ .. .... ....
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---~~~~-~~~~---- 240 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL---KIAK-SDPP---- 240 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH---HHHH-SCCC----
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HH---HHhc-cCCc----
Confidence 112235789999999998 467789999999999999999999999875432111 00 0000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...........+.+++.+||+.||++|||+.++++
T Consensus 241 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 ----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00111223457889999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.98 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=199.2
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 542 (792)
...|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 456888899999999999999875 5788999998643 34556789999999999999999999999875 3568
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-CCCCeeecccccce
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLAR 621 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kL~DFGla~ 621 (792)
++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999999843 356899999999999999999999875 2499999999999997 78999999999997
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
..... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......... .........
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~--- 247 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVK--- 247 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCC---
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHHhccCC---
Confidence 64332 223457899999999887 45899999999999999999999998643321110 000111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+ .........++.+++.+||+.||++|||++|++++
T Consensus 248 --~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 --P----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --C----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --c----cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 01111123468899999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=368.14 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=206.0
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 543 (792)
..++|++.++||+|+||.||+|+.. +++.||||++++. .....+.+..|..++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999976 4788999999753 234456788999999988 7999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++|+|..++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999843 346999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.... .. . ++.
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~----~--------i~~ 556 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQ----S--------IME 556 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----H--------HHS
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HH----H--------HHh
Confidence 3322 224456899999999999999999999999999999999999999975332211 10 0 011
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTM-----SDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~evl~~ 743 (792)
. ...++.....++.+|+.+||+.||++||++ +||+++
T Consensus 557 ~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 557 H---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp S---CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred C---CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 011222345678999999999999999998 777653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=345.16 Aligned_cols=254 Identities=10% Similarity=0.081 Sum_probs=182.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc---hhHHHHHHHHHHHhhc--CCCCcceEe-------eee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---QGLKEFKNEMMLIAKL--QHRNLVRLL-------GCC 536 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 536 (792)
...|++.++||+|+||.||+|++. +++.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999975 688999999976532 3456678885555555 699988755 344
Q ss_pred eec-----------------CeeEEEEEecCCCccceeeeccCCCccCCHHHH------HHHHHHHHHHHHHHHhcCCCc
Q 003843 537 VEQ-----------------GEKILILEYMPNKSLNVFLFDSTKKRLLNWQAR------VRIIEGIAQGLLYLHQYSRFR 593 (792)
Q Consensus 537 ~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~ 593 (792)
... ...++||||++ ++|.+++... ...+.+..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 33799999999 8999998543 223455555 678899999999999998
Q ss_pred eeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhC
Q 003843 594 IIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSS 671 (792)
Q Consensus 594 ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg 671 (792)
|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999764321 13456799999999987 7899999999999999999999
Q ss_pred CCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 672 KKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 672 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
+.||............ ............ ..+........+.+|+.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK-------RPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCC-------BCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchh-------hhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999765432211110 000000000000 00111233567889999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=338.13 Aligned_cols=258 Identities=20% Similarity=0.306 Sum_probs=205.6
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--------hhHHHHHHHHHHHhhc-CCCCcceEe
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKL-QHRNLVRLL 533 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~ 533 (792)
.......++|++.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999986 699999999865431 2245688999999999 799999999
Q ss_pred eeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCee
Q 003843 534 GCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613 (792)
Q Consensus 534 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~k 613 (792)
+++......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999843 346899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCccccccceeecccceeCcccccC------CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccccc
Q 003843 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687 (792)
Q Consensus 614 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~ 687 (792)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~ 315 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLR 315 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHH
Confidence 99999998775432 2234679999999999863 358899999999999999999999986432111 000
Q ss_pred chhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....... ....+.. ......+.+++.+||+.||++||++.|++++
T Consensus 316 ----~i~~~~~-~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 316 ----MIMEGQY-QFSSPEW------DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ----HHHHTCC-CCCHHHH------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHhCCC-CCCCccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000000 0000000 0123468899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.66 Aligned_cols=266 Identities=23% Similarity=0.380 Sum_probs=188.2
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 44689999999999999999999864 68899999986432 34457789999999999999999999999999999999
Q ss_pred EEecCCCccceeeecc-----CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 546 LEYMPNKSLNVFLFDS-----TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
|||+++++|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998531 13456899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCcc---ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC
Q 003843 621 RMFGGDEL---QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 621 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
........ ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... . ... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~---~~~-~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM--L---TLQ-N 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--H---HHT-S
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH--H---Hhc-c
Confidence 87643211 112234578999999999876 568999999999999999999999987544321110 0 000 0
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... +...............++.+++.+||+.||++||++.+++++
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCC-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCc-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000 000000111112234578899999999999999999999763
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.08 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=195.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 6899999999543 3344677899999999999999999999997653
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899888843 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccc--------hh
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGH--------AW 690 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~--------~~ 690 (792)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||...+.... ..+.. ..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 876432 234578999999999987 6899999999999999999999999975432110 00000 00
Q ss_pred hhcccCcccccccc--cccc---CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 691 DLWKDDRVHDLIDP--VIMQ---DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 691 ~~~~~~~~~~~~~~--~l~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+........+.. .... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000000000000 0000 01112234578899999999999999999999885
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.30 Aligned_cols=267 Identities=26% Similarity=0.333 Sum_probs=197.3
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-----hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 541 (792)
...++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34678999999999999999999875 589999999864321 123468899999999999999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++ +|..++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 77777733 2345889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcc---cCc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWK---DDR 697 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 697 (792)
.+.... .......||+.|+|||.+.+. .++.++||||||+++|||++|.+||........ ......... ...
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHcCCCChhh
Confidence 764332 122345789999999999764 589999999999999999999998865432111 110000000 000
Q ss_pred ---cccccccccc--cCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003843 698 ---VHDLIDPVIM--QDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISMI 744 (792)
Q Consensus 698 ---~~~~~~~~l~--~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L 744 (792)
...+.+.... ....+ ......+.+++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000000000 00011 12246789999999999999999999998864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=332.12 Aligned_cols=258 Identities=19% Similarity=0.285 Sum_probs=200.9
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeee--cCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE--QGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 545 (792)
.++|++.++||+|+||.||+|+. .+++.||||++... ..+.+.+|+.++++++ |+||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 47899999999999999999987 46889999999743 3467899999999997 9999999999987 5678999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-CeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~~ 624 (792)
|||+++++|.+++. .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999988872 3889999999999999999999998 99999999999999777 89999999998765
Q ss_pred CCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccch--------hhhccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHA--------WDLWKD 695 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~ 695 (792)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........+.... ......
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence 4322 233578999999999987 6789999999999999999999999854332211111000 000000
Q ss_pred Cc--------------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 696 DR--------------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 696 ~~--------------~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ....... ............++.+|+.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWER-FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGG-GCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhh-hccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000000 00111122245678999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.52 Aligned_cols=263 Identities=19% Similarity=0.275 Sum_probs=197.4
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe------eE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE------KI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 543 (792)
..+|++.++||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4579999999999999999999988888999988643221 2469999999999999999999976543 78
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-CCCCeeeccccccee
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARM 622 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kL~DFGla~~ 622 (792)
+||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999988655444332334567999999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccch--------hhh
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHA--------WDL 692 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~--------~~~ 692 (792)
+..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......... .+... ...
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 644322 2235789999999999765 5899999999999999999999999754321110 00000 000
Q ss_pred ----cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 ----WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ----~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+............+ ..........++.+|+.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPF-SKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCH-HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcH-HHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000000 001112234578999999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=354.25 Aligned_cols=251 Identities=26% Similarity=0.348 Sum_probs=204.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 568999999999999999999986 68999999986432 34567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeeccccccee
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARM 622 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~ 622 (792)
|||+.+++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999988884 3356899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||....... ... .........
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~----~i~~~~~~~-- 246 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILK----KVEKGKYTF-- 246 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHCCCCC--
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHcCCCCC--
Confidence 65432 2234579999999999876 69999999999999999999999997543211 110 000010000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.....+..+.+++.+||+.+|++|||+.|++++
T Consensus 247 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 -----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000011234578899999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=337.61 Aligned_cols=261 Identities=25% Similarity=0.324 Sum_probs=184.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------C
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------G 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 540 (792)
.++|++.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999864 5889999999653 334567889999999999999999999998654 5
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899888832 46999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccch--------h
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA--------W 690 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~--------~ 690 (792)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... ..+... .
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 865432 234578999999999987 6789999999999999999999999965432110 000000 0
Q ss_pred hhcccCccccccccccccCCCCH-----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 691 DLWKDDRVHDLIDPVIMQDEISL-----PMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...........+........... .....+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000000000000001111 123568899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=352.48 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=198.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999986 58899999986542 334678899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---CCeeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kL~DFGla~~~ 623 (792)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+++.+
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999888743 345899999999999999999999998 9999999999999764 45999999999877
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||........ .. ....... ....
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~i~~~~~-~~~~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI--LR----KVEKGKY-TFDS 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTCC-CCCS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCCC-CCCc
Confidence 5432 233457999999999886 5689999999999999999999999975432211 10 0000000 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+. ....+..+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PE------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GG------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hh------cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00 01224578899999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.93 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=200.6
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4678999999999999999999886 48999999997543 35778999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++++|.+++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998842 2346899999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ... .... .+.
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~-~~~~-----~~~-- 244 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-----FMI-PTNP-----PPT-- 244 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHH-HHSC-----CCC--
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHH-hcCC-----Ccc--
Confidence 1 223457899999999999999999999999999999999999998643321100 000 0000 000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.+++.+||+.||++||++.+++++
T Consensus 245 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 245 -FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00111224578899999999999999999999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=352.11 Aligned_cols=251 Identities=26% Similarity=0.360 Sum_probs=201.9
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.++||+|+||+||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999975 6889999998543 2334678999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc---CCCCeeecccccceec
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kL~DFGla~~~ 623 (792)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999888743 346899999999999999999999998 99999999999995 4567999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ... .........
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~----~i~~~~~~~--- 241 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK----RVETGKYAF--- 241 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTCCCS---
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhCCCCC---
Confidence 4332 2234579999999999876 59999999999999999999999986433211 110 000000000
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.....+.++.+++.+||+.||++|||+.|++++
T Consensus 242 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 ----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000011234578899999999999999999999985
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=325.48 Aligned_cols=200 Identities=20% Similarity=0.247 Sum_probs=157.2
Q ss_pred hhcccccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCC----CceEEEeeC
Q 003843 20 KVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDN----NAVLTISNN 95 (792)
Q Consensus 20 ~~~~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~----~~~l~~~~~ 95 (792)
.++++.|+|++||+|++|++|+|++|+|+||||+++ ++|+ |+ |..+||+|||++|+.++ +++|+|+.|
T Consensus 9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~vvW~Anr~~p~~~~~~~~~~~l~l~~~ 80 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGATVWVANEQQPFSSTIPLRNKKAPLAFY 80 (276)
T ss_dssp CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTEEEEECSTTSTTEEEEECCCTTCCSEEE
T ss_pred eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCCeEEECCCCCCcCCcccccceEEEEeCC
Confidence 356688999999999999999999999999999554 6787 77 53399999999999885 789999999
Q ss_pred CcEEE--EcCCCceEEEeccCCC-----CCcceEEEecCCcEEEeeCCCCCCcccccccccCCCcchhhccccccccccc
Q 003843 96 GNLVL--LNQTNGTIWSTNVSSE-----VKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTLLQDMKLGWDFKN 168 (792)
Q Consensus 96 g~l~l--~~~~~~~~wst~~~~~-----~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Ptdtllpg~~l~~~~~~ 168 (792)
|+||| .|++|.+||+|+++.. ..+..|+|+|+|||||++ + .+|||| |||||+|||||||.++++
T Consensus 81 G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~-----~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 81 VQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--S-----LALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp ESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--E-----EEEEES--CTTSCCCCSCTTCEEECS
T ss_pred CcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--C-----ceeeCc--cccccccccccccccccc
Confidence 99999 7888999999998642 235789999999999998 3 689999 999999999999999888
Q ss_pred ccceeEEEeccCCCCCCccccee------eeeeccc-eeEE------------------------------EEeecCCCc
Q 003843 169 RLERYLSSWRSADDPSPDFLYKQ------FMMENKD-ECVY------------------------------WYEAYNRPS 211 (792)
Q Consensus 169 ~~~~~l~Sw~~~~dps~g~~~~~------~~~~~~~-~~~~------------------------------~~~~~~~~~ 211 (792)
|.. | ++.+||++|.+... ++++... ..|| |++......
T Consensus 152 g~~--L---~S~~dps~G~fsl~l~~dGnlvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~~~~ 226 (276)
T 3m7h_A 152 GSE--L---VQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHA 226 (276)
T ss_dssp SEE--E---CTTCEEEETTEEEEECTTSCEEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCTTCT
T ss_pred Ccc--c---ccCCCCCCceEEEeecCCceEEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCCCCC
Confidence 766 4 67788988874322 2222211 2222 222222233
Q ss_pred eeeEEeCCCCceEEEEEeCCCCceEEeeeccCC
Q 003843 212 IMTLKLNPSGFVTRQIWNENSNKWDELFSVPDQ 244 (792)
Q Consensus 212 ~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~~~~ 244 (792)
.+|++|+.||++++|.| ...|..++..|+.
T Consensus 227 ~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 227 SAVLRLQANGSIAILDE---KPVWARFGFQPTY 256 (276)
T ss_dssp TCEEEECTTSCEEEEEE---EEEEESSSCCTTS
T ss_pred CEEEEEcCCccEEEEcC---CCeEEccCccCCc
Confidence 47899999999999999 3568777776654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.78 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=187.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc--hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG--QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 578999999999999999999974 688999999965422 22334555666688889999999999999999999999
Q ss_pred EecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 547 EYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 547 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||+++ +|.+++... .....+++..+..++.||+.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99974 777776432 2345699999999999999999999998 8 9999999999999999999999999998764
Q ss_pred CCccccccceeecccceeCcccc----cCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||............ .....
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~---- 230 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----VVEEP---- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----HHHSC----
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----HhccC----
Confidence 432 12234689999999996 5667899999999999999999999998643322111110 00000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.+. ........++.+++.+||+.||++|||+.|+++
T Consensus 231 --~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 --SPQ----LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --CCC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCC----cccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000 011123457889999999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=340.23 Aligned_cols=263 Identities=20% Similarity=0.268 Sum_probs=201.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC--------CCCcceEeeeee---
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ--------HRNLVRLLGCCV--- 537 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 537 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999875 5889999999643 445678899999999985 788999999987
Q ss_pred -ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCC-----
Q 003843 538 -EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDM----- 610 (792)
Q Consensus 538 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~----- 610 (792)
.....++||||+.+ +|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 55688999999954 554444322 234589999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------CeeecccccceecCCCccccccceeecccceeCccc
Q 003843 611 --------------------------------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646 (792)
Q Consensus 611 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 646 (792)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999876432 233478999999999
Q ss_pred ccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc----ccchhhh------------------cc-cCccccccc
Q 003843 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL----LGHAWDL------------------WK-DDRVHDLID 703 (792)
Q Consensus 647 ~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~----~~~~~~~------------------~~-~~~~~~~~~ 703 (792)
+.+..++.++|||||||++|||++|+.||.......... ....... +. ......+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997544322110 0000000 00 000000000
Q ss_pred --------cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 --------PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 --------~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...............+.+|+.+||+.||++|||++|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0001113356677889999999999999999999999863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=336.82 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=199.3
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcC--CCCcceEeeeeeec
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ 539 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 539 (792)
..+....++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++.+++ |+||+++++++.++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 3344457889999999999999999999888999999998643 3455678999999999997 59999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
+..++||| +.+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 678899999843 346899999999999999999999998 999999999999964 8999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC-----------CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 688 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~ 688 (792)
++.+.............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--- 249 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL--- 249 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH---
Confidence 987654433323344578999999999876 478899999999999999999999986432211100
Q ss_pred hhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 689 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+++.. ....+......+.+++.+||+.||++||++.|++++
T Consensus 250 ----------~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 ----------HAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----------HHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------HHHHhccc-ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00111100 011111123578899999999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=339.31 Aligned_cols=271 Identities=23% Similarity=0.280 Sum_probs=199.4
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCc-----------hhHHHHHHHHHHHhhcCCCCcc
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG-----------QGLKEFKNEMMLIAKLQHRNLV 530 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv 530 (792)
...++....++|++.+.||+|+||.||+|+..+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45667778899999999999999999999988899999999854321 2247899999999999999999
Q ss_pred eEeeeeeec-----CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 531 RLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 531 ~l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 36799999998 577777642 3446999999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~ 684 (792)
++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999998543322 2234578999999999887 6789999999999999999999999975432111
Q ss_pred cccchhhhcccC-----------cccccccccccc------CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 685 LLGHAWDLWKDD-----------RVHDLIDPVIMQ------DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 685 ~~~~~~~~~~~~-----------~~~~~~~~~l~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........... ...+.+...... ..........+.+++.+||+.||++|||+.|++++
T Consensus 243 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 -LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000000000 000000000000 00111224568899999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=351.68 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=200.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-------------hhHHHHHHHHHHHhhcCCCCcceEeee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------------QGLKEFKNEMMLIAKLQHRNLVRLLGC 535 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 535 (792)
.++|++.++||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 678999999999999999999986 478999999865321 345778999999999999999999999
Q ss_pred eeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC---Ce
Q 003843 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM---NP 612 (792)
Q Consensus 536 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~---~~ 612 (792)
+.++...++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999888843 345999999999999999999999998 99999999999998876 69
Q ss_pred eecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
||+|||++..+.... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ .. .
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI--IK----K 258 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----H
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H
Confidence 999999999775432 223457999999999887 4689999999999999999999999975332211 00 0
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...+... .... .....+.++.+++.+||+.||.+|||++|++++
T Consensus 259 i~~~~~~--~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEKGKYY--FDFN-----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHCCCC--CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCC--CCcc-----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000 0000 001123578999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=347.11 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=204.1
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC-CCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+|+. .+++.||||++..... .+++.+|++++..++| +++..+..++.+....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57899999999999999999987 4689999998865432 2457899999999987 455566666677888999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---cCCCCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL---DKDMNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl---~~~~~~kL~DFGla~~~~ 624 (792)
|+ +++|.+++... ...+++.+++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999998532 345999999999999999999999998 9999999999999 688999999999999875
Q ss_pred CCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 625 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 625 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||........... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~i~~~~~~ 234 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---YEKISEKKVA 234 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH---HHHHHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH---HHHHhhcccc
Confidence 44321 122356799999999999999999999999999999999999999975433211100 0000000000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.. + ......++.+++..||+.+|++||++.+|+++|+.+
T Consensus 235 ~~~~~-l-----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 235 TSIEA-L-----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp SCHHH-H-----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccHHH-H-----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00100 0 011235789999999999999999999999999765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.59 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=195.6
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeee-----------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV----------- 537 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 537 (792)
.++|++.+.||+|+||.||+|+... ++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999864 8999999998777777888999999999999999999999873
Q ss_pred ---ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-CCCCee
Q 003843 538 ---EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPK 613 (792)
Q Consensus 538 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~k 613 (792)
+....++||||++ ++|.+++. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 68988883 356899999999999999999999998 99999999999997 567899
Q ss_pred ecccccceecCCCcc-ccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh
Q 003843 614 ISDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 614 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~ 691 (792)
|+|||+++....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||........ ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILE 239 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 999999987643211 112233467899999998865 6789999999999999999999999875432111 000000
Q ss_pred hc---ccCc-------cccccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 LW---KDDR-------VHDLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ~~---~~~~-------~~~~~~~~l~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. .... ....+......... ......++.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 0000 00000000000000 11234678999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=330.03 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=196.0
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--------chhHHHHHHHHHHHhhcCCCCcceEeeeeeec
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 539 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3578999999999999999999875 47899999986432 12234588999999999999999999998765
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeecc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISD 616 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~D 616 (792)
. .++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 899999999999998883 3456899999999999999999999998 999999999999987665 99999
Q ss_pred cccceecCCCccccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ... ..
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~----~~ 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKD----QI 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHH----HH
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHH----HH
Confidence 99998765432 123356899999999974 56789999999999999999999999864332211 000 00
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
..+... .. +.. .......+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~-~~-~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN-FI-PEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC-CC-HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc-cC-chh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000000 00 000 0112457889999999999999999999885
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.37 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=201.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Cee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 542 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 568999999999999999999875 57889999997543 34457889999999999999999999998765 368
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||++ ++|.+++. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 58888773 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCccc-cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc---
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR--- 697 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 697 (792)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence 6543221 12344589999999998754 5589999999999999999999999965432211 100000000000
Q ss_pred cc--------cccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VH--------DLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~--------~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ............. .....++.+|+.+||+.||++|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000000111 1224578899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=335.74 Aligned_cols=260 Identities=23% Similarity=0.266 Sum_probs=192.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999875 5889999999653 3345677899999999999999999999997654
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6766662 24889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh--------
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL-------- 692 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-------- 692 (792)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPEF 249 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence 8764322 22345789999999999999999999999999999999999999975432110 0000000
Q ss_pred c-----------------ccCccccccccccccC--CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 W-----------------KDDRVHDLIDPVIMQD--EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~-----------------~~~~~~~~~~~~l~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+ ........+....... .........+.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0 0000000000000000 0012235688999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.45 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=198.1
Q ss_pred HHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeee-----
Q 003843 466 ITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----- 538 (792)
Q Consensus 466 i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----- 538 (792)
+....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3345789999999999999999999974 68899999986543 3457889999999999 89999999999987
Q ss_pred -cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccc
Q 003843 539 -QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (792)
Q Consensus 539 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DF 617 (792)
....++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999998543 2356899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
|++....... .......|++.|+|||.+. +..++.++||||||+++|||++|+.||........ . ...
T Consensus 174 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~ 246 (326)
T 2x7f_A 174 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--L---FLI 246 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H---HHH
T ss_pred cCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--H---HHh
Confidence 9998764321 1223357899999999987 56789999999999999999999999864332110 0 000
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ... +.. ........+.+++.+||+.||++||++.+++++
T Consensus 247 ~~-~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 PR-NPA-----PRL----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH-SCC-----CCC----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hc-Ccc-----ccC----CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000 000 111223578899999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=337.73 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=200.3
Q ss_pred HHhcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
...++|++.+.||+|+||.||+|+... .+|+|++... .....+.+.+|+.++++++|+||+++++++.+....++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 346789999999999999999998753 5999998643 233446688899999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999843 2346899999999999999999999998 99999999999998 67999999999876532
Q ss_pred Cc---cccccceeecccceeCcccccC---------CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 626 DE---LQGNTKQIVGTYGYMSPEYALD---------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 626 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
.. .........|++.|+|||.+.. ..++.++||||||+++|||++|+.||........ .. ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~----~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IW----QM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HH----HH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----Hh
Confidence 21 1122233468999999999875 4578999999999999999999999875432211 00 00
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
.... .+.... .....++.+++.+||+.||++||++.+++++|+.+...
T Consensus 256 ~~~~-----~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 256 GTGM-----KPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HTTC-----CCCCCC----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ccCC-----CCCCCc----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0010 011100 11224578999999999999999999999999987443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=324.97 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=203.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---------chhHHHHHHHHHHHhhcC-CCCcceEeeeeee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---------GQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVE 538 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 538 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999985 58899999986542 123467889999999995 9999999999999
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
+...++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999843 346899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccccccceeecccceeCccccc------CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~ 692 (792)
++....... ......|++.|+|||.+. ...++.++||||||+++|||++|+.||........ .. .
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~~----~ 240 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LR----M 240 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----H
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH--HH----H
Confidence 998765432 223357899999999985 45688999999999999999999999864332110 00 0
Q ss_pred cccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 693 ~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....... . ..+........+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~-~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNYQ-F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCCC-C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCcc-c------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000000 0 00111223457899999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=344.55 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=193.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------ee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------EK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 542 (792)
..+|++.++||+|+||.||+|++. +++.||||++..... .+.+|+++|++++|+||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 357999999999999999999985 589999999865322 2347999999999999999999986432 36
Q ss_pred EEEEEecCCCccceeeec-cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeecccccc
Q 003843 543 ILILEYMPNKSLNVFLFD-STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLA 620 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFGla 620 (792)
++||||+++ +|..++.. ......+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999986 44444432 123456999999999999999999999998 9999999999999965 56899999999
Q ss_pred eecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh-------
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL------- 692 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~------- 692 (792)
+.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||........ +......
T Consensus 205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHH
T ss_pred hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 97644321 2335789999999999765 799999999999999999999999975432110 0000000
Q ss_pred -cc--cCccccccccccccC----CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 693 -WK--DDRVHDLIDPVIMQD----EISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 693 -~~--~~~~~~~~~~~l~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
+. .....+...+.+... .+......++.+|+.+||+.||++||++.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 000011111111000 0112234678999999999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.97 Aligned_cols=199 Identities=23% Similarity=0.289 Sum_probs=172.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhc------CCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL------QHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 542 (792)
..+|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 567999999999999999999875 4889999999753 34456778899888887 577999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC--eeecccccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN--PKISDFGLA 620 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~--~kL~DFGla 620 (792)
++||||+. ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 5888887543 2334899999999999999999999998 999999999999999987 999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
...... .....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 865432 233578999999999999999999999999999999999999987544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.84 Aligned_cols=263 Identities=20% Similarity=0.264 Sum_probs=203.9
Q ss_pred hcCccccceecccCceeEEEEEE--cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC------cceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL--LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 541 (792)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999987 35889999999653 345677899999999987654 9999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-------------
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK------------- 608 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~------------- 608 (792)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 88998888543 2235899999999999999999999998 999999999999987
Q ss_pred ------CCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc
Q 003843 609 ------DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682 (792)
Q Consensus 609 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~ 682 (792)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999875432 233578999999999999999999999999999999999999997544321
Q ss_pred cc-cccchh--------hhcccCcc------------------ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 683 FN-LLGHAW--------DLWKDDRV------------------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 683 ~~-~~~~~~--------~~~~~~~~------------------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
.. .+.... ........ .....+.............++.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 10 000000 00000000 0000000001122344567899999999999999999
Q ss_pred CHHHHHHH
Q 003843 736 TMSDVISM 743 (792)
Q Consensus 736 s~~evl~~ 743 (792)
|+.|++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=338.54 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=195.8
Q ss_pred HHHhcCccccceecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------
Q 003843 467 TAATENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------ 539 (792)
Q Consensus 467 ~~~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 539 (792)
....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34568999999999999999999987 4689999999865432 234799999999999999999998543
Q ss_pred --------------------------------CeeEEEEEecCCCccceeeecc-CCCccCCHHHHHHHHHHHHHHHHHH
Q 003843 540 --------------------------------GEKILILEYMPNKSLNVFLFDS-TKKRLLNWQARVRIIEGIAQGLLYL 586 (792)
Q Consensus 540 --------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~aL~yL 586 (792)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 4777666432 2345699999999999999999999
Q ss_pred HhcCCCceeecCCCCCcEEEc-CCCCeeecccccceecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHH
Q 003843 587 HQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGIL 664 (792)
Q Consensus 587 H~~~~~~ivH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvl 664 (792)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....+|+.|+|||.+.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999998 688999999999997644322 2335789999999998875 48999999999999
Q ss_pred HHHHHhCCCCCCCCCccccccccchhhhccc----------Cccccccccccc----cCCCCHHHHHHHHHHHHhccccC
Q 003843 665 MLETLSSKKNTGVYNADSFNLLGHAWDLWKD----------DRVHDLIDPVIM----QDEISLPMLMRYINVALLCVQEN 730 (792)
Q Consensus 665 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~l~----~~~~~~~~~~~l~~li~~cl~~d 730 (792)
+|||++|+.||........ +......... ....+..-+.+. ....+......+.+|+.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999975432211 0000000000 000000000000 00112223457899999999999
Q ss_pred CCCCCCHHHHHHH
Q 003843 731 AADRPTMSDVISM 743 (792)
Q Consensus 731 p~~RPs~~evl~~ 743 (792)
|++|||+.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=335.61 Aligned_cols=273 Identities=19% Similarity=0.230 Sum_probs=192.1
Q ss_pred HHHHHHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe-
Q 003843 464 ASITAATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE- 541 (792)
Q Consensus 464 ~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 541 (792)
.......++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566789999999999999999999985 58899999986532 333566788889999999999999999976443
Q ss_pred ------eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHH--hcCCCceeecCCCCCcEEEcC-CCCe
Q 003843 542 ------KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH--QYSRFRIIHRDLKASNILLDK-DMNP 612 (792)
Q Consensus 542 ------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~ivH~Dlkp~NILl~~-~~~~ 612 (792)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987544333222244567899999999999999999999 887 999999999999997 8999
Q ss_pred eecccccceecCCCccccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccc--
Q 003843 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGH-- 688 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~-- 688 (792)
||+|||+++.+..... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||......... .+..
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999987654322 22346899999999987654 899999999999999999999999754422110 0000
Q ss_pred ------hhhhcccCc-ccccccc-cc----ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 689 ------AWDLWKDDR-VHDLIDP-VI----MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 689 ------~~~~~~~~~-~~~~~~~-~l----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+....... .....+. .. ...........++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000000 0000000 00 0011122245689999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.83 Aligned_cols=266 Identities=22% Similarity=0.296 Sum_probs=199.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Cee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 542 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 578999999999999999999975 5889999999654 334456788999999999999999999988764 678
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+. ++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 588887732 46899999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCcccc--------ccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccchh--
Q 003843 623 FGGDELQG--------NTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHAW-- 690 (792)
Q Consensus 623 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~~-- 690 (792)
........ ......||+.|+|||++.. ..++.++||||||+++|||++|+.||.......... +....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 75332111 1223578999999998765 778999999999999999999999997543211100 00000
Q ss_pred -------hhcccCccccccccccccCCC-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 691 -------DLWKDDRVHDLIDPVIMQDEI-----SLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 691 -------~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........+.+......... ......++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000000000000000 11234578899999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.31 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=193.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee----------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE---------- 538 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 538 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 568999999999999999999975 689999999964 33456789999999999999999999998865
Q ss_pred ---cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 539 ---QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 539 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
....++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 4578999999999999999854 2345788999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCcc------------ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccc
Q 003843 616 DFGLARMFGGDEL------------QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682 (792)
Q Consensus 616 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~ 682 (792)
|||++........ ........|++.|+|||.+.+. .++.++||||||+++|||++ |+..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H
Confidence 9999987643210 1122345689999999999865 78999999999999999998 3321110 0
Q ss_pred cccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..... ..... ...+ ...........+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~----~~~~~------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILK----KLRSV------SIEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHH----HHHST------TCCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHH----hcccc------cccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00000 00000 0001 112233344578899999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=325.60 Aligned_cols=265 Identities=26% Similarity=0.386 Sum_probs=200.4
Q ss_pred HhcCccccceecccCceeEEEEEEc--CCcEEEEEEecccC--chhHHHHHHHHHHHhhc---CCCCcceEeeeee----
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCV---- 537 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 537 (792)
..++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4678999999999999999999983 57899999986432 22234566777777766 8999999999987
Q ss_pred -ecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecc
Q 003843 538 -EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISD 616 (792)
Q Consensus 538 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~D 616 (792)
.....++||||++ ++|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 58988885432 335899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh-----
Q 003843 617 FGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD----- 691 (792)
Q Consensus 617 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~----- 691 (792)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCC
Confidence 99998764322 23345789999999999999999999999999999999999999875432111 000000
Q ss_pred ---hcccCc-c-ccccccc--cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 ---LWKDDR-V-HDLIDPV--IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ---~~~~~~-~-~~~~~~~--l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.... . ....... .............+.+++.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0 0000000 00011112234678899999999999999999999854
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=342.50 Aligned_cols=268 Identities=22% Similarity=0.342 Sum_probs=182.7
Q ss_pred cCccc-cceecccCceeEEEEEEc---CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCeeEE
Q 003843 471 ENFSM-QCKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 544 (792)
Q Consensus 471 ~~y~~-~~~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 544 (792)
+.|++ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45666 458999999999999975 47889999997542 23578899999999999999999999954 678999
Q ss_pred EEEecCCCccceeeecc------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE----cCCCCeee
Q 003843 545 ILEYMPNKSLNVFLFDS------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL----DKDMNPKI 614 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl----~~~~~~kL 614 (792)
||||+++ +|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 666666321 12234899999999999999999999998 9999999999999 77889999
Q ss_pred cccccceecCCCcc-ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-------c
Q 003843 615 SDFGLARMFGGDEL-QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-------L 685 (792)
Q Consensus 615 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-------~ 685 (792)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....+... .
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653321 1223446789999999999874 5899999999999999999999999654332100 0
Q ss_pred ccchhhhcc---cCccccc---cc-----cccccC---CCC---------HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 686 LGHAWDLWK---DDRVHDL---ID-----PVIMQD---EIS---------LPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 686 ~~~~~~~~~---~~~~~~~---~~-----~~l~~~---~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
+........ ......+ .. ..+... ... ......+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0000000 00 000000 000 011346789999999999999999999988
Q ss_pred HH
Q 003843 743 MI 744 (792)
Q Consensus 743 ~L 744 (792)
+=
T Consensus 334 hp 335 (405)
T 3rgf_A 334 DP 335 (405)
T ss_dssp SG
T ss_pred Ch
Confidence 63
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=359.40 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=204.0
Q ss_pred HhcCccccceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
..++|++.+.||+|+||.||+|++.. +..||||++... .....+.|.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 45789999999999999999998743 457999998754 3445578999999999999999999999985 46789
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998532 335899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ... ......
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~----~i~~~~----- 609 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG----RIENGE----- 609 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHHTC-----
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHH----HHHcCC-----
Confidence 443221 1223456789999999999999999999999999999997 888986433211 100 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus 610 -----~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 -----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0111223346788999999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.07 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=196.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee----
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK---- 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 542 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 478999999999999999999875 5889999999754 334467889999999999999999999999877654
Q ss_pred --EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 543 --ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 543 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
++||||+. ++|.+++ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 5776665 223899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-------- 691 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-------- 691 (792)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 264 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCcHH
Confidence 865432 233568999999999987 6889999999999999999999999975432111 000000
Q ss_pred ---hcccCccccccccccccCC-----CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 ---LWKDDRVHDLIDPVIMQDE-----ISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ---~~~~~~~~~~~~~~l~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+........+........ ........+.+|+.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000000000000000 011224678999999999999999999999865
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=326.10 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=179.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHH-HHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMM-LIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++.... .....++..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999985 68899999997643 334455666666 677789999999999999999999999
Q ss_pred EecCCCccceeeec--cCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 547 EYMPNKSLNVFLFD--STKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 547 E~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 77666632 12245689999999999999999999998 8 999999999999999999999999999876
Q ss_pred CCCccccccceeecccceeCcccc----cCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
.... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||............ . ....
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~-~~~~-- 246 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----V-VKGD-- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC----C-CCSC--
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH----H-hcCC--
Confidence 4332 12234689999999998 4667899999999999999999999998753321110000 0 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.+.+ ...........+.+++.+||+.||++||++.++++
T Consensus 247 ---~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 ---PPQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0001 01111123457889999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=327.80 Aligned_cols=263 Identities=20% Similarity=0.304 Sum_probs=200.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-----------CCCcceEeeeee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCV 537 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 537 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999874 6889999999643 344567889999999886 899999999998
Q ss_pred ecC----eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEc-----
Q 003843 538 EQG----EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLD----- 607 (792)
Q Consensus 538 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~----- 607 (792)
..+ ..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 899999885432 34589999999999999999999998 8 99999999999994
Q ss_pred -CCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc--
Q 003843 608 -KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-- 684 (792)
Q Consensus 608 -~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-- 684 (792)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999876432 22347899999999999999999999999999999999999999754321110
Q ss_pred --cccchhhh------------------cccCccccccc--------cc-cccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 685 --LLGHAWDL------------------WKDDRVHDLID--------PV-IMQDEISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 685 --~~~~~~~~------------------~~~~~~~~~~~--------~~-l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
.+...... +........+. .. ......+.....++.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00000000 00000000000 00 001234566778999999999999999999
Q ss_pred CHHHHHHH
Q 003843 736 TMSDVISM 743 (792)
Q Consensus 736 s~~evl~~ 743 (792)
|++|++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=318.45 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=202.3
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
...++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34678999999999999999999986 6889999998643 23456789999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC---CCeeecccccce
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD---MNPKISDFGLAR 621 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~---~~~kL~DFGla~ 621 (792)
|+||+++++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999888743 345899999999999999999999998 9999999999999764 469999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
...... ......+++.|+|||.+.+ .++.++||||||+++|||++|+.||....... ... ....+....
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~----~~~~~~~~~- 241 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK----RVETGKYAF- 241 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHCCCCC-
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHcCCCCC-
Confidence 764332 1223468999999998876 48999999999999999999999986433211 110 000010000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. +.......++.+++.+||+.||++|||+.|++++
T Consensus 242 ---~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 ---DL---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---CS---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---Cc---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 0001124578899999999999999999999873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.32 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=196.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe-----
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 541 (792)
.++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 5899999999653 33445778999999999999999999999987654
Q ss_pred -eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 542 -KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 542 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
.++||||++ ++|.+++. ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58877762 24899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD-------- 691 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~-------- 691 (792)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE 246 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 865332 233578999999999887 6789999999999999999999999975432110 000000
Q ss_pred ---hcccCcccccccc---cc--ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 ---LWKDDRVHDLIDP---VI--MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ---~~~~~~~~~~~~~---~l--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+........+.. .. .-..........+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000000 00 0001122345678999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=329.71 Aligned_cols=199 Identities=27% Similarity=0.363 Sum_probs=170.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CC-----CcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HR-----NLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 542 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+++.+|+.++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 578999999999999999999875 5788999999743 344567888999998885 55 499999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh--cCCCceeecCCCCCcEEEc--CCCCeeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ--YSRFRIIHRDLKASNILLD--KDMNPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~--~~~~~ivH~Dlkp~NILl~--~~~~~kL~DFG 618 (792)
++||||++ ++|.+++.... ...+++..+..++.||+.||.|||. .+ |+||||||+|||++ .++.+||+|||
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEecc
Confidence 99999996 48888885432 2458999999999999999999995 45 99999999999994 57889999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCC
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYN 679 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~ 679 (792)
+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876432 234578999999999999999999999999999999999999997543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=324.60 Aligned_cols=253 Identities=19% Similarity=0.205 Sum_probs=173.9
Q ss_pred hcCccccc-eecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCeeE
Q 003843 470 TENFSMQC-KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKI 543 (792)
Q Consensus 470 ~~~y~~~~-~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 543 (792)
.++|++.+ +||+|+||.||+|+.. +++.||||++.... ....+....+..++|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 57899855 6999999999999986 58999999996531 122223334566799999999999876 45689
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeecccccc
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGLA 620 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~DFGla 620 (792)
+||||+++|+|.+++... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998543 2346999999999999999999999998 999999999999976 455999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
+...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||............ .......
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~---- 248 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM--KRRIRLG---- 248 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH--HHhhhcc----
Confidence 8764322 23457899999999999999999999999999999999999998644322110000 0000000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... ..+.......++.+++.+||+.||++|||+.|++++
T Consensus 249 --~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 --QYGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --cccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 011112234578899999999999999999999983
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=337.43 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=188.4
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEEec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
+.|.+.++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 455667899999999998776678999999998643 345678999999986 8999999999999999999999999
Q ss_pred CCCccceeeeccCCC----ccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-------------CCe
Q 003843 550 PNKSLNVFLFDSTKK----RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-------------MNP 612 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-------------~~~ 612 (792)
. |+|.+++...... ....+..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999998543221 11234456789999999999999998 9999999999999754 479
Q ss_pred eecccccceecCCCccc--cccceeecccceeCcccccC-------CCCCCcCceeehhHHHHHHHh-CCCCCCCCCccc
Q 003843 613 KISDFGLARMFGGDELQ--GNTKQIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SKKNTGVYNADS 682 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~ 682 (792)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987543221 12234579999999999976 678999999999999999999 899986432221
Q ss_pred cccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...... .. .. +.. ..........++.+++.+||+.||++||++.||++
T Consensus 248 ~~i~~~---~~---~~-----~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNIIRG---IF---SL-----DEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHT---CC---CC-----CCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhcC---CC---Cc-----ccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111100 00 00 000 11123456678999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.93 Aligned_cols=262 Identities=20% Similarity=0.274 Sum_probs=199.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CC-cEEEEEEecccCchhHHHHHHHHHHHhhcCCCC------cceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NG-QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN------LVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 541 (792)
.++|++.+.||+|+||.||+|+.. ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999875 34 68999999653 345577889999999997766 8999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE---------------
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL--------------- 606 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl--------------- 606 (792)
.++||||+ +++|.+++... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55555555332 2346899999999999999999999998 9999999999999
Q ss_pred ----cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccc
Q 003843 607 ----DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682 (792)
Q Consensus 607 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~ 682 (792)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999875332 233578999999999999999999999999999999999999997544221
Q ss_pred cc-cccchh--------hhcccCcc------------------ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCC
Q 003843 683 FN-LLGHAW--------DLWKDDRV------------------HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP 735 (792)
Q Consensus 683 ~~-~~~~~~--------~~~~~~~~------------------~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP 735 (792)
.. .+.... ........ .+...+.............++.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 10 000000 00000000 0000000001112234466889999999999999999
Q ss_pred CHHHHHH
Q 003843 736 TMSDVIS 742 (792)
Q Consensus 736 s~~evl~ 742 (792)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.87 Aligned_cols=243 Identities=22% Similarity=0.379 Sum_probs=191.2
Q ss_pred HHhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhc----CCCCcceEeeee
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKL----QHRNLVRLLGCC 536 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~~~ 536 (792)
...++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++.++ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34678999999999999999999874 588999999965432 1223456799999998 899999999999
Q ss_pred eecCeeEEEEEe-cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-CCCCeee
Q 003843 537 VEQGEKILILEY-MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKI 614 (792)
Q Consensus 537 ~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kL 614 (792)
.+.+..++|+|+ +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999999843 345899999999999999999999998 99999999999999 8899999
Q ss_pred cccccceecCCCccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 615 SDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 615 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~-------- 245 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----I-------- 245 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H--------
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----H--------
Confidence 9999998775432 233568999999999987766 4589999999999999999999853210 0
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.... ..........+.+++.+||+.||++||+++|++++
T Consensus 246 --------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 --------LEAE---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --------HHTC---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------hhhc---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01112234568899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=334.42 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=188.2
Q ss_pred HhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 547 (792)
...+|++.++||+|+||+||.....+++.||||++..... +.+.+|+++++++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3467999999999999997655566899999999965432 2356899999999 79999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-----CCCeeeccccccee
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARM 622 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kL~DFGla~~ 622 (792)
|+. |+|.+++.... ..+.+.+++.++.||+.||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 58988885332 23455567899999999999999998 999999999999953 33588999999987
Q ss_pred cCCCcc-ccccceeecccceeCccccc---CCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCc
Q 003843 623 FGGDEL-QGNTKQIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 623 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+..... ........||+.|+|||++. ...++.++|||||||++|||++ |..||+.......... .. ..
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~------~~-~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL------LG-AC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH------TT-CC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH------hc-cC
Confidence 754321 12233467999999999998 4567889999999999999999 8899864322211110 00 00
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
... ...........+.+|+.+||+.||++|||+.||++
T Consensus 246 ~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 01112234556889999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.62 Aligned_cols=242 Identities=22% Similarity=0.352 Sum_probs=198.4
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhcC--CCCcceEeeeeeec
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ 539 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 539 (792)
..++|++.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++ |+||+++++++.++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3678999999999999999999864 688999999865421 12345778999999996 59999999999999
Q ss_pred CeeEEEEEecCC-CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-CCCCeeeccc
Q 003843 540 GEKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDF 617 (792)
Q Consensus 540 ~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kL~DF 617 (792)
+..++|+|++.+ ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 899988843 356899999999999999999999998 99999999999999 7889999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccC
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 696 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 696 (792)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .....
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------~~~~~ 259 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIRGQ 259 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHHCC
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------hhccc
Confidence 9998775432 233568999999999987765 6889999999999999999999853210 00000
Q ss_pred ccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 RVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 ~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ........++.+++.+||+.||++||+++|++++
T Consensus 260 ---------~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 260 ---------V---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------C---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------c---cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111123568899999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.36 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=179.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc-h-hHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-Q-GLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 468999999999999999999985 689999999975432 2 2334455566788889999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
||+ ++.+..+... ....+++..+..++.||++||.|||+. + |+||||||+||+++.++.+||+|||++..+..
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4444444321 234689999999999999999999995 8 99999999999999999999999999986643
Q ss_pred CccccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
.. ......+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .... ... ..
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~---~~~-~~--- 246 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLTK---VLQ-EE--- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHH---HHH-SC---
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHHH---Hhc-cC---
Confidence 32 123356899999999994 56788999999999999999999999874332111 1000 000 00
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.+ +.......++.+++.+||+.||.+||++.+++++
T Consensus 247 --~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 --PPLL---PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCC---CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 0011233568899999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=345.01 Aligned_cols=264 Identities=24% Similarity=0.308 Sum_probs=200.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeee------cCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 541 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999874 5889999998754 44556789999999999999999999998765 667
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCC---eeecccc
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMN---PKISDFG 618 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~---~kL~DFG 618 (792)
.++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999976555557999999999999999999999998 999999999999997765 8999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc--c-c-chhhhcc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL--L-G-HAWDLWK 694 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~--~-~-~~~~~~~ 694 (792)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . . .......
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 9987654322 234578999999999999999999999999999999999999986432110000 0 0 0000000
Q ss_pred cCcccc--cccccc-ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 003843 695 DDRVHD--LIDPVI-MQDEISLPMLMRYINVALLCVQENAADRPTMSD 739 (792)
Q Consensus 695 ~~~~~~--~~~~~l-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 739 (792)
...... .....+ ............+.+++.+||+.||++|||+.|
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 000111 112234456788999999999999999999966
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=344.96 Aligned_cols=238 Identities=20% Similarity=0.312 Sum_probs=193.2
Q ss_pred hcCccccceecccCceeEEEEEEc--CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCe-----
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGE----- 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 541 (792)
.++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|++++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999985 5899999998654 34456678999999999999999999999988765
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 7999999999999887732 5899999999999999999999998 9999999999999986 99999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
..... ....||+.|+|||++.+.. +.++||||||+++|||++|.+|+...... .+
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GL 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SC
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------cc
Confidence 76432 3457999999999987764 89999999999999999998776421100 00
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHhc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPT-MSDVISMINN 746 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~evl~~L~~ 746 (792)
. ...........+.+++.+||+.||++||+ ++++.+.|..
T Consensus 285 ~-----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 P-----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp C-----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred c-----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00111123357889999999999999995 5666665544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=304.25 Aligned_cols=231 Identities=13% Similarity=0.113 Sum_probs=184.0
Q ss_pred hcCccccceecccCceeEEEEEEcC-CcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4689999999999999999999864 8999999997543 34457899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++++|.+++.. + ....++.+++.||+.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 355678899999999999999998 9999999999999999999997443
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
|++| ++.++||||||+++|||++|+.||......... .......... ....
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~~----~~~~- 225 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAGQ----PIEP- 225 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTSC----BCCH-
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhccC----CCCh-
Confidence 3333 688999999999999999999999754432110 0000000000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
.........++.+++.+||+.||++| |+.|+++.|+...
T Consensus 226 ---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp ---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00111234568999999999999999 9999999998864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.24 Aligned_cols=228 Identities=18% Similarity=0.243 Sum_probs=179.1
Q ss_pred hcCcccc-ceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHH-hhcCCCCcceEeeeeee----cCee
Q 003843 470 TENFSMQ-CKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLI-AKLQHRNLVRLLGCCVE----QGEK 542 (792)
Q Consensus 470 ~~~y~~~-~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 542 (792)
.++|.+. +.||+|+||.||+++.. +++.||+|++... ..+.+|+.++ +..+||||+++++++.. +...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567777 78999999999999874 5889999999642 4567888888 55699999999999987 6788
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeeccccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~DFGl 619 (792)
++||||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 9999999999999998543 2346899999999999999999999998 999999999999998 78899999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
+.... +..++.++||||||+++|||++|+.||.......... . ...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~--------~~~ 212 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G--------MKT 212 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C--------SCC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H--------HHH
Confidence 97542 2346788999999999999999999986433211100 0 000
Q ss_pred cccccccccCCCC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVIMQDEIS----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+... ....+ .....++.+++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 00111 1124578999999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=314.78 Aligned_cols=242 Identities=16% Similarity=0.151 Sum_probs=183.5
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccC--------chhHHHHHHHHHHHhhcC---------CCCcceE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--------GQGLKEFKNEMMLIAKLQ---------HRNLVRL 532 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 532 (792)
.++|++.++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 57899999999999999999998 78999999996542 234578899999999886 6666666
Q ss_pred eee-----------------eee-------------cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHH
Q 003843 533 LGC-----------------CVE-------------QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQG 582 (792)
Q Consensus 533 ~~~-----------------~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~a 582 (792)
.++ +.+ ....++||||+++|++.+.+. +..+++.++..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 554 333 678999999999997766652 2468999999999999999
Q ss_pred HHHHH-hcCCCceeecCCCCCcEEEcCCC--------------------CeeecccccceecCCCccccccceeecccce
Q 003843 583 LLYLH-QYSRFRIIHRDLKASNILLDKDM--------------------NPKISDFGLARMFGGDELQGNTKQIVGTYGY 641 (792)
Q Consensus 583 L~yLH-~~~~~~ivH~Dlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y 641 (792)
|+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 898 99999999999999887 8999999999876432 35799999
Q ss_pred eCcccccCCCCCCcCceeehhHH-HHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHH
Q 003843 642 MSPEYALDGLFSIKSDVFSFGIL-MLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYI 720 (792)
Q Consensus 642 ~aPE~~~~~~~s~~~DVwSlGvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~ 720 (792)
+|||++.+.. +.++||||||++ .+++++|..||..... ......... ...................++.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----LHYLTDKML----KQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----HHHHHHHHH----HTCCCSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-----hhHHHHhhh----hhhccCcccchhhhhhcCHHHH
Confidence 9999998776 899999998777 7788889888742100 000000000 0000000001111234677899
Q ss_pred HHHHhccccCCCCCCCHHHHH
Q 003843 721 NVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 721 ~li~~cl~~dp~~RPs~~evl 741 (792)
+|+.+||+.| |++|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999866 999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=318.79 Aligned_cols=241 Identities=15% Similarity=0.175 Sum_probs=179.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCC-CCcceE---------ee-
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH-RNLVRL---------LG- 534 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l---------~~- 534 (792)
...|.+.++||+|+||.||+|++. +|+.||||++.... ....+.|.+|+.++..++| +|...+ ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 456888899999999999999964 68999999987432 2346789999999999987 322111 11
Q ss_pred -----------eeee-----cCeeEEEEEecCCCccceeeec----cCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 003843 535 -----------CCVE-----QGEKILILEYMPNKSLNVFLFD----STKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRI 594 (792)
Q Consensus 535 -----------~~~~-----~~~~~lv~E~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 594 (792)
++.. ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111 11345666654 6888888731 123456889999999999999999999998 9
Q ss_pred eecCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccc----------cCCCCCCcCceeehhHH
Q 003843 595 IHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA----------LDGLFSIKSDVFSFGIL 664 (792)
Q Consensus 595 vH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~DVwSlGvl 664 (792)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875432 334567 999999999 55668899999999999
Q ss_pred HHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 003843 665 MLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVI 741 (792)
Q Consensus 665 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl 741 (792)
+|||++|+.||........ ...++.. ... .+..+.+|+.+||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~~--------------~~~~~~~---~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG--------------SEWIFRS---CKN----IPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC--------------SGGGGSS---CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhhh--------------HHHHHhh---ccc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999864332110 0011110 001 225789999999999999999976654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=262.06 Aligned_cols=179 Identities=17% Similarity=0.222 Sum_probs=134.8
Q ss_pred ccccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEc
Q 003843 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (792)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (792)
++.|+|.+||+|.+|++| ++|.|+|||+.+++ +.+|+. +|+||+|||+.| .++.|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 467999999999999999 59999999998875 344443 699999999988 47899999999999999
Q ss_pred CCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCCCcchh-hccccccccc-cccc-----ceeEE
Q 003843 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTDTL-LQDMKLGWDF-KNRL-----ERYLS 175 (792)
Q Consensus 103 ~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Ptdtl-lpg~~l~~~~-~~~~-----~~~l~ 175 (792)
++|.+||+|++........|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC--------SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEec--------CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 99999999998754445689999999999984 26999999999777 5554 4443 4444 45666
Q ss_pred EeccCCCCCCcccce------eeeeeccceeEEEEeecCCCceeeEEeCCCCceEEEE
Q 003843 176 SWRSADDPSPDFLYK------QFMMENKDECVYWYEAYNRPSIMTLKLNPSGFVTRQI 227 (792)
Q Consensus 176 Sw~~~~dps~g~~~~------~~~~~~~~~~~~~~~~~~~~~~~r~~l~~~G~l~~~~ 227 (792)
+..||++|.+.. ++++++....+|.....+.....++.|+.+|++..|.
T Consensus 143 ---s~~d~s~G~~~l~l~~dG~LvL~~~~~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~ 197 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLT 197 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEE
T ss_pred ---cCcEeecCcEEEEECCCCcEEEEcCCEeEEeCCCcCCCCceEEEECCCCcEEEEe
Confidence 478899887433 2444443433333222222233578899999988875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-28 Score=277.91 Aligned_cols=186 Identities=16% Similarity=0.155 Sum_probs=131.5
Q ss_pred ceecccCceeEEEEE-EcCCcEEEEEEecccC----------chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEE
Q 003843 477 CKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQS----------GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 544 (792)
..++.|++|.+..++ ...|+.+++|.+.... +...++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 346677777666654 3358899999986431 23456799999999999 79999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||++|++|.++|. +.+.++.. +|+.||+.||+|||++| ||||||||+|||++.++++||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999999994 33456654 58899999999999999 9999999999999999999999999998765
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCC
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN 674 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p 674 (792)
... ......+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 391 ~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 432 22344689999999999876 467789999999999888765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-25 Score=253.59 Aligned_cols=184 Identities=18% Similarity=0.197 Sum_probs=145.9
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEecccCc--------hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
..++||+|+||.||+|+. .++.+++|+...... ...++|.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 678899998643211 12456899999999999999997777777888889999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||++. ++||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 4589999999999999998 999999999999999 9999999999987553
Q ss_pred cccc-----ccceeecccceeCcccccC--CCCCCcCceeehhHHHHHHHhCCCCC
Q 003843 627 ELQG-----NTKQIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSKKNT 675 (792)
Q Consensus 627 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwSlGvll~elltg~~p~ 675 (792)
.... ......||+.|||||++.. ..|+...|+|+..+-..+.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1235689999999999987 56888899999999888888766553
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=175.31 Aligned_cols=105 Identities=17% Similarity=0.370 Sum_probs=93.3
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
.|+|.+||.|.+|++|.| |.|.|.|..+|+ |.++.. .++||+|||++|... .+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~~---~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYDH---STSTWASNTEIGGKS-GCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTCC-SCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEEC---CEEEEEecCCCCCCc-cEEEEEeCCccEEEECCC
Confidence 378999999999999998 789999999986 888764 489999999999865 678999999999999999
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
+.+||+|++........|+|+|+|||||++ ..||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYG--------SDIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEEC--------CcEecC
Confidence 999999998766666789999999999996 359998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=212.76 Aligned_cols=155 Identities=18% Similarity=0.142 Sum_probs=125.0
Q ss_pred cHHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCc------------------hhHHHHHHHHHHHhh
Q 003843 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAK 523 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~ 523 (792)
.+..+......|++.+.||+|+||.||+|+..+|+.||||+++.... .....+.+|+.++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455556677888899999999999999997799999999964321 135678999999999
Q ss_pred cCCCCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCc
Q 003843 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASN 603 (792)
Q Consensus 524 l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~N 603 (792)
++ | +++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+|
T Consensus 161 l~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 161 LQ--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp TT--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred cc--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 99 5 66666543 456799999999999988 411 234579999999999999998 9999999999
Q ss_pred EEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccC
Q 003843 604 ILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649 (792)
Q Consensus 604 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 649 (792)
||++ ++.+||+|||+++. +..++|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9999 99999999999974 335688888753
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=3e-21 Score=174.42 Aligned_cols=108 Identities=19% Similarity=0.367 Sum_probs=94.7
Q ss_pred ccccccCCCccccCCCeee--ecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEE
Q 003843 23 LAADTVTPASFIRDGEKLV--SSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100 (792)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l 100 (792)
++.|+|.+||+|.+|++|+ |++|.|+|+|+.+|+ + +||++ +++||+|||+.| +.++.|+|..||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn-----l-vly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN-----L-VLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC-----E-EEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4779999999999999999 999999999999885 3 58876 799999999876 3368899999999999
Q ss_pred EcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 101 ~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
+|.++.+||+|++....+...++|+|+|||||++ .++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC--------ccEeCC
Confidence 9999999999987654455678999999999997 259998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.8e-21 Score=170.36 Aligned_cols=109 Identities=25% Similarity=0.434 Sum_probs=95.4
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
+|+|.+||.|.+|++|+ ++|.|.|+|+.+|+ | ++|+ ..++||.||++.|. .++.|+|..||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECCC
Confidence 48999999999999999 99999999999886 3 6676 36999999998763 3578999999999999999
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCCC
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (792)
+.++|+|.+........++|+|+|||||++. .+||||+||
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~ 109 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGP 109 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcC
Confidence 9999999987555566889999999999862 599999998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=167.05 Aligned_cols=110 Identities=21% Similarity=0.383 Sum_probs=94.0
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
.|||.+||+|.+|++|+ +|.|+|+|+.+|+ +. +|+ ..++||+||++.|. .++.|.|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCCC--CceEEEECCCCcEEEECCC
Confidence 58999999999999998 7999999998885 33 355 36999999999883 3678999999999999998
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCCCcc
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Ptd 154 (792)
+.++|++++........++|+|+|||||++. ++||||.+++.
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999887544556899999999999952 59999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.7e-20 Score=163.27 Aligned_cols=110 Identities=24% Similarity=0.462 Sum_probs=93.4
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
+|||.+||+|.+|++| ++|.|+|+|+.+|+ | +||++ .++||+||++.+ +.++.|.|..||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 58999999999986 3 45765 699999999753 346789999999999999 8
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCCC
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYP 152 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~P 152 (792)
+.++|+|.+........++|+++|||||++..+ .++||||++.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~-----~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTS-----CEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCCC-----ceEEECCCcc
Confidence 889999987655556688999999999997543 6899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=158.77 Aligned_cols=105 Identities=26% Similarity=0.439 Sum_probs=89.1
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
.+||.|||.|.+|+.|+ +|.|.|+|+.+|+ |.+ |.. .++||++|++.+ +.++.|.|..||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 36899999999999996 7999999999885 444 554 589999999876 34678999999999999999
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCccccccccc
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (792)
+.++|++++........|+|+|+|||||++. .+|||=
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWATG 105 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeCC
Confidence 9999999987554456899999999999973 589983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.6e-18 Score=152.89 Aligned_cols=105 Identities=20% Similarity=0.347 Sum_probs=88.1
Q ss_pred ccccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEc
Q 003843 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (792)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (792)
+|.|||.|||.|..|+.|+|. .|.|.|...|+ |.+ |.. ++||.+|++.. +.++.|.|+.||||||+|
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 588999999999999999984 58898877775 666 554 58999999863 335789999999999999
Q ss_pred CCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 103 ~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.++.++|++++........|+|+|+|||||++ ..+|+|
T Consensus 71 ~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~--------~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG--------PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEEcCCcCCCCCEEEEEcCCccEEEec--------CCEecC
Confidence 99999999998654445789999999999997 258987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=179.62 Aligned_cols=141 Identities=16% Similarity=0.169 Sum_probs=108.2
Q ss_pred HhcCccccceecccCceeEEEEEE-cCCcE--EEEEEecccCch------------------------hHHHHHHHHHHH
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRL-LNGQE--VAVKRLSNQSGQ------------------------GLKEFKNEMMLI 521 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l 521 (792)
...-|++.+.||+|+||.||+|+. .+|+. ||||+++..... ....+.+|+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 334467889999999999999998 68888 999987543111 123688999999
Q ss_pred hhcCCCCc--ceEeeeeeecCeeEEEEEecCC-C----ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHH-hcCCCc
Q 003843 522 AKLQHRNL--VRLLGCCVEQGEKILILEYMPN-K----SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH-QYSRFR 593 (792)
Q Consensus 522 ~~l~h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ 593 (792)
.+++|+++ ..++.. ...++||||+.+ | +|.++.. ..++..+..++.|++.||.||| +.+
T Consensus 125 ~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~~g--- 191 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR------ELKELDVEGIFNDVVENVKRLYQEAE--- 191 (258)
T ss_dssp HHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG------GGGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred HHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh------ccChHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99988764 333332 367899999942 4 4433321 1234567889999999999999 888
Q ss_pred eeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 594 IIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 594 ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
|+||||||+|||++. .++|+|||+|....
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999999998 99999999998653
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=147.52 Aligned_cols=108 Identities=14% Similarity=0.297 Sum_probs=91.1
Q ss_pred ccccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEc
Q 003843 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (792)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (792)
.+.|+|.+||.|..|+.|.+ |.|.|.|..+|+ |.++.. ...++||.+|+..+ +.++.|.|..||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~-~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG-SKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET-TTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC-CCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 46799999999999999975 889999998886 777543 24689999999866 235789999999999999
Q ss_pred CCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 103 ~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.++.++|++++........|+|+|+|||||++ ..+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~--------~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG--------PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC--------SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec--------CCEecC
Confidence 99999999998754445789999999999996 359987
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.69 E-value=6.3e-17 Score=143.72 Aligned_cols=103 Identities=21% Similarity=0.384 Sum_probs=86.8
Q ss_pred ccccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEc
Q 003843 23 LAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLN 102 (792)
Q Consensus 23 ~~~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (792)
+|.|||.|||.|..|+.| .+|.|.|.|..+|+ |-+ |.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 57999999998886 444 442 699998765 336889999999999999
Q ss_pred CCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 103 QTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 103 ~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.++.++|++++........|+|+|||||||++ ..+|+|
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~--------~~~W~s 103 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG--------PSVFKI 103 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC--------SEEEEE
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe--------cCEECC
Confidence 99999999998754445689999999999996 359997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.7e-16 Score=170.17 Aligned_cols=148 Identities=14% Similarity=0.161 Sum_probs=105.4
Q ss_pred HHHHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCc--------------hhHHH--------HHHHHHH
Q 003843 463 LASITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG--------------QGLKE--------FKNEMML 520 (792)
Q Consensus 463 ~~~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~ 520 (792)
+..+.....-|++.++||+|+||.||+|...+|+.||||+++.... ..... ..+|...
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 3444444556999999999999999999998999999998753210 00111 2345566
Q ss_pred HhhcCCCCcceEeeeeeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 003843 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLK 600 (792)
Q Consensus 521 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlk 600 (792)
|.++.+.++....-+ .....++||||+++++|..+.. ......++.||+.+|.+||+.+ |||||||
T Consensus 167 L~rL~~~gv~vp~p~--~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLK 232 (397)
T 4gyi_A 167 MKALYEEGFPVPEPI--AQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFN 232 (397)
T ss_dssp HHHHHHTTCSCCCEE--EEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred HHHHHhcCCCCCeee--eccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence 666644433211111 1123479999999998866541 1234578899999999999998 9999999
Q ss_pred CCcEEEcCCCC----------eeecccccceecC
Q 003843 601 ASNILLDKDMN----------PKISDFGLARMFG 624 (792)
Q Consensus 601 p~NILl~~~~~----------~kL~DFGla~~~~ 624 (792)
|.|||+++++. +.|+||+-+....
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999988773 8999999887543
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.56 E-value=9.4e-15 Score=130.11 Aligned_cols=103 Identities=17% Similarity=0.286 Sum_probs=83.6
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
.|+|.+||.|.+|+.| .+|.|.|.|..+|+ |.+ |.. .. ||.+|+..+ ...+.|.|..||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~--~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE--AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS--SC-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC--CC-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 4799999999999999 47899999998886 555 443 24 999999876 23578999999999999988
Q ss_pred Cc-eEEEeccCC--CCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 105 NG-TIWSTNVSS--EVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 105 ~~-~~wst~~~~--~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
+. ++|++++.. ......++|+++|||||++ ..+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG--------PAIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC--------SEEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEec--------cCEEcc
Confidence 76 599999642 2245678999999999996 358987
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=116.03 Aligned_cols=59 Identities=27% Similarity=0.484 Sum_probs=51.0
Q ss_pred CCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccC
Q 003843 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (792)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (792)
...+|.|+.||||||++ .+.+||++++.....+..++|+++|||||++.++ .++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~-----~~~W~S~t 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSN-----RVIWQTKT 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECCC
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCC-----cEEEecCC
Confidence 36789999999999998 5899999998755556789999999999998755 78999994
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-12 Score=114.63 Aligned_cols=64 Identities=28% Similarity=0.563 Sum_probs=52.9
Q ss_pred CCCCCCCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCC
Q 003843 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (792)
Q Consensus 81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (792)
.|+.+...+|.|+.||||||++. +.+||++++.....+..|+|+++|||||++ ++ .++||||+.
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~~ 77 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNTN 77 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCCC
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCcc
Confidence 34445577899999999999987 789999998754455789999999999998 44 689999953
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.9e-11 Score=109.98 Aligned_cols=58 Identities=33% Similarity=0.440 Sum_probs=49.7
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccC
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (792)
..+|.|..||||||++. +.+||++++.....+..++|+|+|||||++.++ .++||||.
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~-----~~lW~S~~ 88 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSPV 88 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECSC
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCC-----cEEEcCCC
Confidence 45699999999999987 899999998755556789999999999998655 78999993
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=9.1e-12 Score=129.31 Aligned_cols=113 Identities=20% Similarity=0.394 Sum_probs=85.8
Q ss_pred ccccccCCCcc----ccCCCeeeecCCeEEEeEEcCC--CCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCC
Q 003843 23 LAADTVTPASF----IRDGEKLVSSSQRFELGFFSPG--KSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNG 96 (792)
Q Consensus 23 ~~~~~~~~~~~----l~~~~~l~s~~g~f~lgf~~~~--~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g 96 (792)
...||+.||+. |..|+.|.|+ ..++.|+|... .... +-+| .+ ..+++|.+++.++ + ...|.++.+|
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGn--lvLy-~~-~~~~yW~Sgt~~~--~-~~~l~l~~dG 205 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGN--LVAY-GP-NGAATWNAGTQGK--G-AVRAVFQGDG 205 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSC--EEEE-CT-TSSEEEECCCTTT--T-CCEEEECTTS
T ss_pred ccccccccccccccccccCcccccC-CCCCCceEEEeecCCce--EEEE-eC-CCeEEEECCCCCC--c-cEEEEEcCCC
Confidence 45799999999 8889998664 45555555321 1123 3343 32 2589999999876 2 3789999999
Q ss_pred cEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCC
Q 003843 97 NLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (792)
Q Consensus 97 ~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (792)
+|+++|.++.++|++++... ....|+|+++|||||++. .++||||||
T Consensus 206 nLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 206 NLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp CEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred eEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 99999998899999997643 357899999999999974 369999997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.8e-11 Score=127.12 Aligned_cols=146 Identities=16% Similarity=0.111 Sum_probs=115.0
Q ss_pred HHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEE
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 546 (792)
..-..|++...++.|+.+.||+... .++.+++|+...........+.+|+.+++.+. +..+.++++++.+.+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446798889999999999999975 47899999986532223346889999999984 677888999998888999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 590 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------ 590 (792)
||++|.+|.+.+. +......++.+++++|+.||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 12233478889999999999821
Q ss_pred --------------------CCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 591 --------------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 591 --------------------~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999998853
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=2.6e-11 Score=108.69 Aligned_cols=59 Identities=34% Similarity=0.483 Sum_probs=51.0
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCC
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (792)
...|.|+.||||||++ .+.+||++++.....+..++|+++|||||++.++ .++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~-----~~vW~S~~~ 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNN-----NDVWGSACW 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECCCC
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCc-----eEEEEcCCC
Confidence 5679999999999998 5789999998755456789999999999998654 689999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=9.2e-11 Score=121.17 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=103.0
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~ 548 (792)
.++.+..+.+.|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 445554444466679999998777888999997653 2356788999999986545 45688888877788999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-------------------------------------- 590 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------- 590 (792)
++|.+|. ... .. ...++.++++.|+.||...
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999884 211 11 2357788888888888753
Q ss_pred -----------------CCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 591 -----------------RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 591 -----------------~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
+..++|+|++|.||+++++..+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776677999999864
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.06 E-value=2.5e-10 Score=101.34 Aligned_cols=63 Identities=22% Similarity=0.344 Sum_probs=50.9
Q ss_pred CCCCCCCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCccccccccc
Q 003843 81 RPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (792)
Q Consensus 81 ~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (792)
.++.+....|.|+.||||||++.++ +|++++........++|+++|||||++.++ ..++|||.
T Consensus 15 ~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~ 77 (111)
T 3mez_A 15 NQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYP 77 (111)
T ss_dssp CEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEES
T ss_pred CEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEec
Confidence 3444446789999999999999876 999998755556788999999999998764 13599987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.06 E-value=1.4e-10 Score=103.42 Aligned_cols=66 Identities=20% Similarity=0.353 Sum_probs=54.6
Q ss_pred CCCCCCCCCceEEEeeCCcEEEEcC-CCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCccccccccc
Q 003843 79 RDRPISDNNAVLTISNNGNLVLLNQ-TNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSF 149 (792)
Q Consensus 79 r~~p~~~~~~~l~~~~~g~l~l~~~-~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSF 149 (792)
.+.|+.+...+|.|+.||||||++. .+.++|++++.....+..++|+++|||||++.++ .++|||=
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~-----~~iW~S~ 83 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRL-----NTVFVSN 83 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECS
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCC-----CEEEECC
Confidence 3556666678899999999999998 5899999998755456788999999999998765 6799973
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=8.5e-10 Score=97.74 Aligned_cols=58 Identities=28% Similarity=0.484 Sum_probs=49.1
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccC
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (792)
...|.|+.||||||++. +.++|++++.....+..++|+++|||||++.++ .++|||..
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~-----~~~W~S~t 77 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRN-----NPIWASNT 77 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTS-----CEEEECCC
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCC-----CEEEECCC
Confidence 57799999999999987 789999998755445788999999999998655 68998864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.00 E-value=7.8e-10 Score=98.00 Aligned_cols=58 Identities=26% Similarity=0.460 Sum_probs=48.4
Q ss_pred CCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccC
Q 003843 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (792)
Q Consensus 86 ~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (792)
.+..|.++.||||||++. .++|++++........++|+++|||||++.++ .++|||-.
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~-----~~iW~S~t 81 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF-----KTIWSSRS 81 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTC-----CEEEECCC
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCC-----CEEEEcCC
Confidence 357899999999999986 58999998755455688999999999998765 68999853
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.91 E-value=4.9e-09 Score=113.95 Aligned_cols=142 Identities=15% Similarity=0.249 Sum_probs=107.4
Q ss_pred ccceecccCceeEEEEEEcCCcEEEEEEec--ccC-chhHHHHHHHHHHHhhcC--CCCcceEeeeeeec---CeeEEEE
Q 003843 475 MQCKLGEGGFGPVYKGRLLNGQEVAVKRLS--NQS-GQGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQ---GEKILIL 546 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 546 (792)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3578999999999999874 4678888875 322 123456788999999997 45577888888766 4589999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS------------------------------------ 590 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------ 590 (792)
||++|..+.+.. -..++..++..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998874421 123678888899999999999999731
Q ss_pred -------------------CCceeecCCCCCcEEEcCCCC--eeeccccccee
Q 003843 591 -------------------RFRIIHRDLKASNILLDKDMN--PKISDFGLARM 622 (792)
Q Consensus 591 -------------------~~~ivH~Dlkp~NILl~~~~~--~kL~DFGla~~ 622 (792)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=4.5e-09 Score=111.51 Aligned_cols=187 Identities=18% Similarity=0.192 Sum_probs=122.5
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCC--cceEeeeeeecC---eeEEEEEec
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN--LVRLLGCCVEQG---EKILILEYM 549 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~ 549 (792)
.+.++.|....||+.. +.+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3569999999999863 56889986532 44577899999999884 433 334444433332 358899999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS--------------------------------------- 590 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 590 (792)
+|.+|..... ..++.+++..++.++++.|+.||...
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988864321 23677788888999999999998621
Q ss_pred ----------------CCceeecCCCCCcEEEcC--CCCeeecccccceecCCCccccccce------------eecccc
Q 003843 591 ----------------RFRIIHRDLKASNILLDK--DMNPKISDFGLARMFGGDELQGNTKQ------------IVGTYG 640 (792)
Q Consensus 591 ----------------~~~ivH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~------------~~gt~~ 640 (792)
...++|+|++|.||++++ ...+.|+||+.+..-.....-..... .....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 235899999999999998 45688999999876432110000000 000001
Q ss_pred eeC-cccccCCCCCCcCceeehhHHHHHHHhCCCCC
Q 003843 641 YMS-PEYALDGLFSIKSDVFSFGILMLETLSSKKNT 675 (792)
Q Consensus 641 y~a-PE~~~~~~~s~~~DVwSlGvll~elltg~~p~ 675 (792)
... |+.... .....+.|+++.+++++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 221111 112258899999999999998664
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.66 E-value=1.6e-08 Score=89.41 Aligned_cols=60 Identities=28% Similarity=0.536 Sum_probs=48.6
Q ss_pred CCCCCCCCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 80 DRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 80 ~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
+.|+.+....|.|+.||||||+++ +|+|++.....+..++|+++|||||++.++ .++|+|
T Consensus 15 g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~-----~~vWss 74 (109)
T 3r0e_A 15 EGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDG-----STVWKS 74 (109)
T ss_dssp TCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEEC
T ss_pred CCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCC-----CEEEcC
Confidence 345555577899999999999984 799998765556788999999999998755 678975
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.55 E-value=8.9e-08 Score=83.85 Aligned_cols=56 Identities=30% Similarity=0.510 Sum_probs=46.6
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCC-CcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.-+|.++.||||||++ .+.+||++++.... .++.+.|+++|||||++.++ .++|+|
T Consensus 20 ~y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~-----~~vWss 76 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG-----RSLWAS 76 (105)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC-----CEEEEC
T ss_pred CEEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCc-----EEEEEe
Confidence 4569999999999998 46899999986543 34678999999999999776 689986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=1.3e-06 Score=88.81 Aligned_cols=105 Identities=19% Similarity=0.290 Sum_probs=76.6
Q ss_pred cccccCCCc-------cccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCC
Q 003843 24 AADTVTPAS-------FIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNG 96 (792)
Q Consensus 24 ~~~~~~~~~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g 96 (792)
..|+|.+|| .|..++.+. .|.|.|.|.+.|+ +-+|... +++|.++..... .++.++|..+|
T Consensus 124 g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~~---~~~W~s~~~~~~--~~~~~~L~~~G 191 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDRD---DRVWSTNTAGKG--TGCRAVLQPNG 191 (236)
T ss_dssp CCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBTT---BCCSCCCCCSSC--SSCEEEEETTT
T ss_pred cceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcCC---EeEEeCCCcCCC--CceEEEECCCC
Confidence 467888988 555555554 6899999877762 5565432 578987754332 35779999999
Q ss_pred cEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 97 NLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 97 ~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
+|++++.++.++|.+.+........++|.++|||+++.. .+|+|
T Consensus 192 nl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~~--------~~W~s 235 (236)
T 1dlp_A 192 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 235 (236)
T ss_dssp EEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred cEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeCC--------CCccC
Confidence 999998888899998765443456789999999999952 47876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.9e-06 Score=88.78 Aligned_cols=136 Identities=22% Similarity=0.197 Sum_probs=96.7
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC---CcceEeeeee-ecCeeEEEEEecCC
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCV-EQGEKILILEYMPN 551 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~ 551 (792)
.+.++.|....||+. ++.+++|+.. .......+.+|+++|..+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 357889999999987 5778888853 234457889999999999753 2445565553 34567899999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS----------------------------------------- 590 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 590 (792)
..|..... ..++..+...++.++++.|+.||...
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88865321 12345555666666666666666432
Q ss_pred ----------------CCceeecCCCCCcEEEcC---CCCe-eeccccccee
Q 003843 591 ----------------RFRIIHRDLKASNILLDK---DMNP-KISDFGLARM 622 (792)
Q Consensus 591 ----------------~~~ivH~Dlkp~NILl~~---~~~~-kL~DFGla~~ 622 (792)
...++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 4554 8999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=3.3e-06 Score=91.37 Aligned_cols=81 Identities=7% Similarity=0.013 Sum_probs=57.4
Q ss_pred ccee-cccCceeEEEEEEc-------CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCC---CCcceEeeeeeec--
Q 003843 476 QCKL-GEGGFGPVYKGRLL-------NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQH---RNLVRLLGCCVEQ-- 539 (792)
Q Consensus 476 ~~~L-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~-- 539 (792)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4677 88999999998764 26788999865432 1012457788888888842 3466777776655
Q ss_pred -CeeEEEEEecCCCccce
Q 003843 540 -GEKILILEYMPNKSLNV 556 (792)
Q Consensus 540 -~~~~lv~E~~~~gsL~~ 556 (792)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.1e-05 Score=83.29 Aligned_cols=141 Identities=18% Similarity=0.187 Sum_probs=100.6
Q ss_pred cCccccceecccCce-eEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFG-PVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 547 (792)
..|+. +.+..|..+ .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+++..++|||
T Consensus 25 ~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 25 YGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp TTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred cCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 34443 345556555 68987764 4567999987532 3456888999998884 3346678888888899999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-------------------------------------- 589 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------- 589 (792)
++++.++.+.... .......+..++++.|+.||..
T Consensus 101 ~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 101 AIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp CCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred eeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999887654311 1223345667777777777742
Q ss_pred -----------------CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 590 -----------------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 590 -----------------~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
....++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999877778999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=3.1e-05 Score=84.98 Aligned_cols=75 Identities=12% Similarity=0.189 Sum_probs=50.4
Q ss_pred cceecccCceeEEEEEEc-CCcEEEEEEecccCc-------hhHHHHHHHHHHHhhcCC--CCcc-eEeeeeeecCeeEE
Q 003843 476 QCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-------QGLKEFKNEMMLIAKLQH--RNLV-RLLGCCVEQGEKIL 544 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 544 (792)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999754 468899998653211 123567789999988742 4444 45443 4456789
Q ss_pred EEEecCCC
Q 003843 545 ILEYMPNK 552 (792)
Q Consensus 545 v~E~~~~g 552 (792)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.77 E-value=7.3e-05 Score=78.10 Aligned_cols=81 Identities=16% Similarity=0.240 Sum_probs=60.3
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCC---CcceEeeeeeecCeeEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHR---NLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~ 546 (792)
.....-.+.+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.+... -+.+++++ +..++||
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~ 89 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAM 89 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEE
Confidence 3456667889999999999999999999999987655444456788999999988532 23344443 2347899
Q ss_pred EecCCCcc
Q 003843 547 EYMPNKSL 554 (792)
Q Consensus 547 E~~~~gsL 554 (792)
||++++..
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=8.8e-05 Score=79.23 Aligned_cols=141 Identities=16% Similarity=0.170 Sum_probs=80.7
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC--CCcceEee------eeeecCeeEEEEEe
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLG------CCVEQGEKILILEY 548 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~E~ 548 (792)
+.|+.|..+.||+....++ .+++|+.... .+.+..|+.++..+.. -.+.+++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987544 5899998652 1334455555555531 12333332 12345678999999
Q ss_pred cCCCccce-----------e---eeccCC----C-------ccCCHHHH-------------------------------
Q 003843 549 MPNKSLNV-----------F---LFDSTK----K-------RLLNWQAR------------------------------- 572 (792)
Q Consensus 549 ~~~gsL~~-----------~---l~~~~~----~-------~~l~~~~~------------------------------- 572 (792)
++|..+.. . ++.... . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 0 111000 0 01122211
Q ss_pred HHHHHHHHHHHHHHHh--------c--CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 573 VRIIEGIAQGLLYLHQ--------Y--SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 573 ~~i~~~ia~aL~yLH~--------~--~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
..+...+..++.+|+. . .+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666663 1 234599999999999998888999999998853
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00026 Score=74.67 Aligned_cols=138 Identities=22% Similarity=0.137 Sum_probs=92.1
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC---CCCcceEeeeeeecCeeEEEEEecCCC
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ---HRNLVRLLGCCVEQGEKILILEYMPNK 552 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~g 552 (792)
.+.|+.|....+|+... +++.+++|+.... ....|..|+..|+.+. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46799999999999876 5678899987542 3567889999999884 356778888887778899999999988
Q ss_pred cccee-----------eeccCC-C----------c--------cCCHHHHH---HHHH----------------HHHHH-
Q 003843 553 SLNVF-----------LFDSTK-K----------R--------LLNWQARV---RIIE----------------GIAQG- 582 (792)
Q Consensus 553 sL~~~-----------l~~~~~-~----------~--------~l~~~~~~---~i~~----------------~ia~a- 582 (792)
.+..- |+.... . + .-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 65321 111111 0 0 11343321 1111 11111
Q ss_pred HHHHHh-cCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 583 LLYLHQ-YSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 583 L~yLH~-~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
...|.. ..++.++|+|+.+.|++++.++ +.|+|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223332 2346799999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00041 Score=76.59 Aligned_cols=78 Identities=9% Similarity=0.042 Sum_probs=47.7
Q ss_pred CCceeecCCCCCcEEEcCCCCeeecccccceecCCCccccccceee--cccceeCcccccCC---CCCCcCceeehhHHH
Q 003843 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV--GTYGYMSPEYALDG---LFSIKSDVFSFGILM 665 (792)
Q Consensus 591 ~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~s~~~DVwSlGvll 665 (792)
...++|+|++|.|||++.++ ++|+||+.+..-.... . ..... -...|.+|+..... .-....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 34599999999999998876 9999999987532110 0 00001 12346666655321 111234555777788
Q ss_pred HHHHhCC
Q 003843 666 LETLSSK 672 (792)
Q Consensus 666 ~elltg~ 672 (792)
|+.+.++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00083 Score=71.07 Aligned_cols=157 Identities=14% Similarity=0.129 Sum_probs=86.5
Q ss_pred HHHHHHHhcCccc-----cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEeee
Q 003843 463 LASITAATENFSM-----QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC 535 (792)
Q Consensus 463 ~~~i~~~~~~y~~-----~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~ 535 (792)
..++...-..|.+ .+.|+.|....+|+....++ .+++|+.... ...+.+..|+.++..+.... +.+++..
T Consensus 9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 3444444444544 34577788899999987555 6889988652 12234566777777764222 2233321
Q ss_pred ------eeecCeeEEEEEecCCCcccee--------------eeccCC----C-----ccCCHHHHHH------------
Q 003843 536 ------CVEQGEKILILEYMPNKSLNVF--------------LFDSTK----K-----RLLNWQARVR------------ 574 (792)
Q Consensus 536 ------~~~~~~~~lv~E~~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~~------------ 574 (792)
....+..+++++|++|..+... ++.... . ....|...+.
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 1223567899999998765321 111000 0 0011222110
Q ss_pred HHHHHHHHHHHHHhc----CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 575 IIEGIAQGLLYLHQY----SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 575 i~~~ia~aL~yLH~~----~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
+...+.+.++.++.. .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 133599999999999998876668999998853
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0013 Score=68.97 Aligned_cols=128 Identities=14% Similarity=0.163 Sum_probs=77.7
Q ss_pred cceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEEEec-CCCc
Q 003843 476 QCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYM-PNKS 553 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gs 553 (792)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .+++++ +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 568889876532221 123568888877753333 355544 333457899999 6655
Q ss_pred cceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 003843 554 LNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-------------------------------------------- 589 (792)
Q Consensus 554 L~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------------------------------------------- 589 (792)
|....... +..++.++++.|+-||..
T Consensus 95 l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 53210000 001222233333333321
Q ss_pred ------CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 590 ------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 590 ------~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
....++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 2334899999999999 6677889999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00098 Score=73.72 Aligned_cols=74 Identities=20% Similarity=0.295 Sum_probs=51.4
Q ss_pred cceecccCceeEEEEEEcC--------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEE
Q 003843 476 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILIL 546 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 546 (792)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+.+|..++..+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3678889899999998753 4789999884421 12455679999988854444 466665542 3899
Q ss_pred EecCCCccc
Q 003843 547 EYMPNKSLN 555 (792)
Q Consensus 547 E~~~~gsL~ 555 (792)
||++|.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0027 Score=67.20 Aligned_cols=142 Identities=14% Similarity=0.143 Sum_probs=82.6
Q ss_pred ceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCC--cceEeee-----eeecCeeEEEEEec
Q 003843 477 CKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN--LVRLLGC-----CVEQGEKILILEYM 549 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lv~E~~ 549 (792)
+.|+ |....||+....+|+.+++|+..... ...+.+..|..++..+.... +.+++.. ...++..+++||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877677789999986331 23456677888888774222 3444432 12244567899999
Q ss_pred CCCcccee--------------eecc------CCCccCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 003843 550 PNKSLNVF--------------LFDS------TKKRLLNWQAR----VRI---------------IEGIAQGLLYLHQY- 589 (792)
Q Consensus 550 ~~gsL~~~--------------l~~~------~~~~~l~~~~~----~~i---------------~~~ia~aL~yLH~~- 589 (792)
+|..+... ++.. .....+++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 98765320 0100 00111222111 000 11111223333221
Q ss_pred ---CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 590 ---SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 590 ---~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234589999999999999 4 899999988764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.004 Score=69.24 Aligned_cols=74 Identities=12% Similarity=0.117 Sum_probs=49.7
Q ss_pred ceecccCceeEEEEEEcC-CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEEEecCCCcc
Q 003843 477 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
+.|+.|-...+|+....+ ++.+++|+.........+ -.+|..++..+...++ .++++.+. + .+|+||++|..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 678889999999998754 478899987543322221 2578999999875555 45666653 2 259999998666
Q ss_pred c
Q 003843 555 N 555 (792)
Q Consensus 555 ~ 555 (792)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0023 Score=69.27 Aligned_cols=141 Identities=21% Similarity=0.277 Sum_probs=82.9
Q ss_pred ceecccCceeEEEEEEc--------CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEEE
Q 003843 477 CKLGEGGFGPVYKGRLL--------NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILILE 547 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E 547 (792)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.+...++ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888889998764 2478999986432 2234566789999988853333 456666543 28999
Q ss_pred ecCCCcccee-e----------------ecc--CCCccCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 003843 548 YMPNKSLNVF-L----------------FDS--TKKRLLN--WQARVRIIEGIAQ-------------------GLLYL- 586 (792)
Q Consensus 548 ~~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------aL~yL- 586 (792)
|++|..|..- + +.. .-.+... +.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 0 000 0011111 3444444433321 12222
Q ss_pred ---Hhc-CCCceeecCCCCCcEEEcCC----CCeeeccccccee
Q 003843 587 ---HQY-SRFRIIHRDLKASNILLDKD----MNPKISDFGLARM 622 (792)
Q Consensus 587 ---H~~-~~~~ivH~Dlkp~NILl~~~----~~~kL~DFGla~~ 622 (792)
... ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 23459999999999999876 7899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0042 Score=66.02 Aligned_cols=142 Identities=13% Similarity=0.123 Sum_probs=71.7
Q ss_pred ceecccCcee-EEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC--CCcceEeeeeeecCeeEEEEEecCCCc
Q 003843 477 CKLGEGGFGP-VYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKS 553 (792)
Q Consensus 477 ~~LG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gs 553 (792)
+.|+.|+... +|+....+++.+++|....... +.+..|+.++..+.. -.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 6676654467788876543321 234456677766642 2344566653333 378999987655
Q ss_pred cceeeecc---------------------CC--CccCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 003843 554 LNVFLFDS---------------------TK--KRLLNWQARV-------R-------------IIEGIAQGLLYLH--- 587 (792)
Q Consensus 554 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~ia~aL~yLH--- 587 (792)
+.+++... .. ...++..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 53322110 00 0011111100 0 0011112222221
Q ss_pred hcCCCceeecCCCCCcEEEcCC----CCeeecccccceec
Q 003843 588 QYSRFRIIHRDLKASNILLDKD----MNPKISDFGLARMF 623 (792)
Q Consensus 588 ~~~~~~ivH~Dlkp~NILl~~~----~~~kL~DFGla~~~ 623 (792)
......++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123459999999999999875 67899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0036 Score=67.65 Aligned_cols=73 Identities=14% Similarity=0.147 Sum_probs=45.1
Q ss_pred ceecccCceeEEEEEEcC---------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEE
Q 003843 477 CKLGEGGFGPVYKGRLLN---------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILIL 546 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 546 (792)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 577888888999998653 268888887543222 1223678888888753343 3566543 2 36899
Q ss_pred EecCCCcc
Q 003843 547 EYMPNKSL 554 (792)
Q Consensus 547 E~~~~gsL 554 (792)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998655
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.014 Score=62.15 Aligned_cols=32 Identities=22% Similarity=0.458 Sum_probs=28.2
Q ss_pred CCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 591 ~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888999999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.016 Score=63.65 Aligned_cols=74 Identities=14% Similarity=0.163 Sum_probs=49.3
Q ss_pred cceecccCceeEEEEEEcC--------CcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc-ceEeeeeeecCeeEEEE
Q 003843 476 QCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL-VRLLGCCVEQGEKILIL 546 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 546 (792)
.+.|..|-...+|+....+ ++.+++|+......... .-.+|..+++.+...++ .++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778888999998753 57899998755432222 23578888888853334 34554332 37899
Q ss_pred EecCCCcc
Q 003843 547 EYMPNKSL 554 (792)
Q Consensus 547 E~~~~gsL 554 (792)
||++|..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.19 E-value=0.043 Score=53.62 Aligned_cols=99 Identities=15% Similarity=0.066 Sum_probs=63.3
Q ss_pred ccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccccc
Q 003843 553 SLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632 (792)
Q Consensus 553 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 632 (792)
+|.++|. ..+.+++++++|.++.|.+.+|.-+-... . -..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 6677773 24567999999999999999987763211 1 11333457899999999988764 1111
Q ss_pred ceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhC
Q 003843 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS 671 (792)
Q Consensus 633 ~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg 671 (792)
.....+.|||... ...+.+.=|||||+++|.-+--
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123466888653 3456778899999999999863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.95 E-value=0.14 Score=55.63 Aligned_cols=30 Identities=27% Similarity=0.401 Sum_probs=25.4
Q ss_pred ceeecCCCCCcEEE------cCCCCeeeccccccee
Q 003843 593 RIIHRDLKASNILL------DKDMNPKISDFGLARM 622 (792)
Q Consensus 593 ~ivH~Dlkp~NILl------~~~~~~kL~DFGla~~ 622 (792)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=82.85 E-value=5 Score=40.60 Aligned_cols=74 Identities=12% Similarity=0.270 Sum_probs=46.4
Q ss_pred EEEEeccCCCeEEEEecCCCC--CC----CCCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeC
Q 003843 62 LGIRFQQIPDAVVWVANRDRP--IS----DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDN 135 (792)
Q Consensus 62 ~~iw~~~~~~t~vW~anr~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~ 135 (792)
+.+| +.-..+++|...+..+ ++ .+++.+-++.++.+..+|.+|..+|............++.+.+||+++-+.
T Consensus 17 v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~~ 95 (276)
T 3no2_A 17 IAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAWC 95 (276)
T ss_dssp EEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEEE
T ss_pred EEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEec
Confidence 4455 2223478888876542 11 124555556666677788899999998864222233467788899888764
Q ss_pred C
Q 003843 136 S 136 (792)
Q Consensus 136 ~ 136 (792)
.
T Consensus 96 ~ 96 (276)
T 3no2_A 96 G 96 (276)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=81.63 E-value=1.5 Score=35.43 Aligned_cols=36 Identities=25% Similarity=0.504 Sum_probs=30.6
Q ss_pred ccCHHHHHHHHhhcCCceeeeccccCCCceeEEecccc
Q 003843 319 RMNLEQCKAECLKNCSCRAYANSNVKESSGCLMWYGDL 356 (792)
Q Consensus 319 ~~s~~~C~~~Cl~nCsC~ay~~~~~~~~~~C~~w~g~l 356 (792)
..++++|+..|+.+=.|.||.|. .....|++..+..
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN--~~s~~CflKs~~~ 64 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYN--VKSGLCYPKRGKP 64 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEE--TTTTEEEEEESSC
T ss_pred CCCHHHHHHHhhccCCCCeEEec--cCCCceEcccCCC
Confidence 46899999999999999999997 3467899887754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 792 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-22 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 7e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-14 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 8e-05 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 7e-70
Identities = 72/285 (25%), Positives = 130/285 (45%), Gaps = 20/285 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
++ ++G G FG VYKG+ V + ++ + Q L+ FKNE+ ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+G + ++ ++ SL L + + I AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL-- 648
IIHRDLK++NI L +D+ KI DFGLA + +Q+ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 649 -DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
+S +SDV++FGI++ E + TG + N + + P +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELM-----TGQLPYSNINNRDQIIFMVGRGYL----SPDLS 232
Query: 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 752
+ + P M+ + C+++ +RP +++ I +LP
Sbjct: 233 KVRSNCPKAMK--RLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 1e-65
Identities = 72/276 (26%), Positives = 124/276 (44%), Gaps = 26/276 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ ++G G FG V+ G LN +VA+K + + ++F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C+EQ L+ E+M + L + T++ L + + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + SPE
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 651 LFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708
+S KSDV+SFG+LM E S K N++ + + L+ P +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---------KPRLAS 228
Query: 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+ + C +E DRP S ++ +
Sbjct: 229 THV--------YQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-65
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 22/276 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
RL Q +I EYM N SL FL + +L + + IA+G+ ++ + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
IHRDL+A+NIL+ ++ KI+DFGLAR+ +E + +PE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 651 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710
F+IKSDV+SFGIL+ E ++ + + + + + +R + ++ P +E
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 711 ISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ + LC +E DRPT + S++ +
Sbjct: 239 L--------YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 7e-65
Identities = 64/291 (21%), Positives = 116/291 (39%), Gaps = 28/291 (9%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537
+G+G FG V++G+ G+EVAVK S++ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 538 EQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ----- 588
+ L+ +Y + SL +L + + + +++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF--GGDELQGNTKQIVGTYGYMSPEY 646
+ I HRDLK+ NIL+ K+ I+D GLA D + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 647 ALDGL------FSIKSDVFSFGILMLETLSSKKNTGVYNADSF-----NLLGHAWDLWKD 695
D + ++D+++ G++ E G++ + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 696 DRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ P I S L + C N A R T + ++
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-63
Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L G C +Q +I EYM N L + + Q + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
+ +HRDL A N L++ K+SDFGL+R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 651 LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDE 710
FS KSD+++FG+LM E S K + ++ + L P + ++
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 711 ISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
+ + C E A +RPT ++S I
Sbjct: 230 V--------YTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 5e-63
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 26/290 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 531 RLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+L + ++ EYM SL FL T K L V + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132
Query: 591 RFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDG 650
+HRDL+A+NIL+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 651 LFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708
F+IKSDV+SFGIL+ E + + G+ N + + + + + + +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL------ 243
Query: 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPA 758
++ C ++ +RPT + + + + + +P
Sbjct: 244 -----------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-61
Identities = 65/319 (20%), Positives = 126/319 (39%), Gaps = 43/319 (13%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGL-KEFKNEMMLIAKLQH 526
++F +LG G G V+K +G +A K + + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
+V G GE + +E+M SL+ L K + Q ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
+ +I+HRD+K SNIL++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK------------------------KNTGVYNADS 682
+S++SD++S G+ ++E + +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLM---RYINVALLCVQENAADRPTMSD 739
L + D + +L+D ++ + LP + + + C+ +N A+R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 740 V-----ISMINNEHLNLPS 753
+ I + E ++
Sbjct: 295 LMVHAFIKRSDAEEVDFAG 313
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 6e-61
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 32/279 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+ + +G+G FG V G G +VAVK + N + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 531 RLLGCCVEQGEKI-LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+LLG VE+ + ++ EYM SL +L + +L ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
+HRDL A N+L+ +D K+SDFGL + E + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
FS KSDV+SFGIL+ E S + + + D++ V
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVP-----------------YPRIPLKDVVPRVEKGY 217
Query: 710 EISLP--MLMRYINVALLCVQENAADRPTMSDVISMINN 746
++ P V C +AA RP+ + + +
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 31/299 (10%)
Query: 469 ATENFSMQ-CKLGEGGFGPVYKGRLL---NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 523
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L + +VRL+G C + +L++E L+ FL K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYM 642
YL + +HRDL A N+LL KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
+PE FS +SDV+S+G+ M E LS + +K + +++
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYKKMKGPEVM 222
Query: 703 DPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAF 759
+ + P + C DRP V + + +L S E
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 2e-60
Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 41/304 (13%)
Query: 461 FSLASITAATENFS---------MQCKLGEGGFGPVYKGRLL----NGQEVAVKRL-SNQ 506
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 507 SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL 566
+ + ++F +E ++ + H N++ L G + ++I E+M N SL+ FL + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 567 LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626
V ++ GIA G+ YL +HRDL A NIL++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 627 ELQGNTKQIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF 683
+G + +PE F+ SDV+S+GI+M E
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE---------------- 225
Query: 684 NLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVI 741
++ + + D D+I+ + + PM + L C Q++ RP ++
Sbjct: 226 -VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 742 SMIN 745
+ ++
Sbjct: 285 NTLD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 2e-59
Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 22/277 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V+LLG C + +I E+M +L +L + ++ ++ + + I+ + YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK 134
Query: 590 SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
IHRDL A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
FSIKSDV++FG+L+ E + + + +V++L++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDY-RM 235
Query: 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
E + + C Q N +DRP+ +++
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 3e-59
Identities = 72/311 (23%), Positives = 129/311 (41%), Gaps = 46/311 (14%)
Query: 462 SLASITAATENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQGL-KEF 514
L S+ N +GEG FG V++ R VAVK L ++ + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 515 KNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------- 566
+ E L+A+ + N+V+LLG C L+ EYM LN FL + +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 567 -------------LNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPK 613
L+ ++ I +A G+ YL + + +HRDL N L+ ++M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 614 ISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK 673
I+DFGL+R + +M PE ++ +SDV+++G+++ E S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 674 NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAAD 733
+ + ++ ++ + D I+ + P + N+ LC + AD
Sbjct: 241 Q-------------PYYGMAHEEVIYYVRDGNILACPENCP--LELYNLMRLCWSKLPAD 285
Query: 734 RPTMSDVISMI 744
RP+ + ++
Sbjct: 286 RPSFCSIHRIL 296
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 66/281 (23%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
E++ + +G G +G K R +G+ + K L + + + +E+ L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 528 NLVRLLGCCVEQGEKIL--ILEYMPNKSLNVFLFDSTKKR-LLNWQARVRIIEGIAQGLL 584
N+VR +++ L ++EY L + TK+R L+ + +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 585 YLHQYSR--FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
H+ S ++HRDLK +N+ LD N K+ DFGLAR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
SPE ++ KSD++S G L+ E L + +L
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYE------------------LCALMPPFTAFSQKELA 223
Query: 703 DPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVI 741
+ +P + + RP++ +++
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-58
Identities = 72/275 (26%), Positives = 117/275 (42%), Gaps = 23/275 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS-NQSGQGLKEFKNEMMLIAKLQHRN 528
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+ G E + L LEY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 649 DGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
F + DV+S GI++ L G D + + WK+ + + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233
Query: 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
++L L + + EN + R T+ D+
Sbjct: 234 SAPLAL--LHK-------ILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 32/277 (11%)
Query: 478 KLGEGGFGPVYKGRLLN---GQEVAVKRLSNQSGQG--LKEFKNEMMLIAKLQHRNLVRL 532
+LG G FG V KG + VAVK L N++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 533 LGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+G C E +L++E LN +L + R + + + ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 593 RIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTK-QIVGTYGYMSPEYALDGL 651
+HRDL A N+LL KISDFGL++ DE + + +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 652 FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEI 711
FS KSDV+SFG+LM E S + ++ + ++ + + +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQK-----------------PYRGMKGSEVTAMLEKGERM 229
Query: 712 SLP--MLMRYINVALLCVQENAADRPTMSDVISMINN 746
P ++ LC + +RP + V + N
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 2e-58
Identities = 67/273 (24%), Positives = 122/273 (44%), Gaps = 31/273 (11%)
Query: 478 KLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLG 534
++G G F VYKG EVA L ++ + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 535 CCVEQGEK----ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS 590
+ +L+ E M + +L +L + +++ + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 591 RFRIIHRDLKASNILL-DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
IIHRDLK NI + + KI D GLA + K ++GT +M+PE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
+ DV++FG+ MLE +S+ ++ +A +++ RV + P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYR--RVTSGVKPASFDK 236
Query: 710 EISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
+ + C+++N +R ++ D+++
Sbjct: 237 VAIPEV----KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-58
Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 478 KLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHRNLVRL 532
+G G FG VY G LL+ AVK L+ + G + +F E +++ H N++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 533 LGCCVE-QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LG C+ +G +++L YM + L F + + + +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDL--RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQ--IVGTYGYMSPEYALD 649
+ +HRDL A N +LD+ K++DFGLAR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
F+ KSDV+SFG+L+ E ++ N L + R L+ P D
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVYLLQGRR---LLQPEYCPD 261
Query: 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
+ V L C A RP+ S+++S I+
Sbjct: 262 PL--------YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 4e-58
Identities = 75/280 (26%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLS---NQSGQGLKEFKNEMMLIAKLQ 525
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H N ++ GC + + L++EY + ++ K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH + +IHRD+KA NILL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 646 YAL---DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
L +G + K DV+S GI +E + N + + + +++
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELA-----ERKPPLFNMNAMSALYHIAQNES----- 231
Query: 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
P + S N C+Q+ DRPT ++
Sbjct: 232 -PALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 5e-58
Identities = 62/283 (21%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRN 528
+ + + +LG+G FG VYK + A K + +S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+LL + +++E+ +++ + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
+IIHRDLKA NIL D + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 649 -----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
D + K+DV+S GI ++E + + ++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLL 225
Query: 704 PVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVIS 742
+ + +L R+ + C+++N R T S ++
Sbjct: 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 5e-57
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 45/305 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 523
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKK------------------ 564
L H N+V LLG C G LI EY L +L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 565 --RLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622
+L ++ + +A+G+ +L +HRDL A N+L+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 623 FGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS 682
D +M+PE +G+++IKSDV+S+GIL+ E S GV
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS----LGVNPYPG 269
Query: 683 FNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
+ + + L ++ D P +EI + C ++ RP+ ++ S
Sbjct: 270 IPVDANFYKLIQNGFKMDQ--PFYATEEI--------YIIMQSCWAFDSRKRPSFPNLTS 319
Query: 743 MINNE 747
+ +
Sbjct: 320 FLGCQ 324
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 71/300 (23%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEMMLIAK 523
S LG G FG V + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 524 L-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL---------------L 567
L H N+V LLG C G ++I EY L FL + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ + + +A+G+ +L IHRDL A NILL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687
+M+PE + +++ +SDV+S+GI + E S G +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS----LGSSPYPGMPVDS 255
Query: 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747
+ + K+ ++ P E+ ++ C + RPT ++ +I +
Sbjct: 256 KFYKMIKEG--FRMLSPEHAPAEM--------YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 5e-56
Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 27/282 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLSNQSGQG-LKEFKNEMMLIAKL 524
+ Q +G G FG VYKG L VA+K L + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
H N++RL G + ++I EYM N +L+ FL + K + V ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMS 643
YL +HRDL A NIL++ ++ K+SDFGL+R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 644 PEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703
PE F+ SDV+SFGI+M E ++ + W+L + + + D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAIND 228
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
+ + P + + + C Q+ A RP +D++S+++
Sbjct: 229 GFRLPTPMDCPSAIY--QLMMQCWQQERARRPKFADIVSILD 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-56
Identities = 68/278 (24%), Positives = 114/278 (41%), Gaps = 35/278 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSN---QSGQGLKEFKNEMMLIAKLQH 526
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
N++RL G + LILEY P ++ L K + Q I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
+ K D++S G+L E L K ++ + + I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYK-RI 216
Query: 707 MQDEISLPMLM--RYINVALLCVQENAADRPTMSDVIS 742
+ E + P + ++ ++ N + RP + +V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 9e-56
Identities = 75/312 (24%), Positives = 134/312 (42%), Gaps = 43/312 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQE-----VAVKRLS-NQSGQGLKEFKNEMMLIAKL 524
F LG G FG VYKG + E VA+K L S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 525 QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
+ ++ RLLG C+ LI + MP L + K + Q + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 585 YLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSP 644
YL R++HRDL A N+L+ + KI+DFGLA++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 645 EYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID- 703
E L +++ +SDV+S+G+ + E ++ +D + +++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEK 228
Query: 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI--------------NNEHL 749
+ + + + + C +A RP ++I +E +
Sbjct: 229 GERLPQPPICTIDVY--MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 750 NLPSPKEPAFTK 761
+LPSP + F +
Sbjct: 287 HLPSPTDSNFYR 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 39/293 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNG---QEVAVKRLS-NQSGQGLKEFKNEMMLIAKL-Q 525
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFL-------------FDSTKKRLLNWQAR 572
H N++ LLG C +G L +EY P+ +L FL ++ L+ Q
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 573 VRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT 632
+ +A+G+ YL Q + IHRDL A NIL+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 633 KQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL 692
+M+ E +++ SDV+S+G+L+ E +S + + A
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-------TPYCGMTCAELY 236
Query: 693 WKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745
K + + L P+ DE+ ++ C +E +RP+ + ++ +N
Sbjct: 237 EKLPQGYRLEKPLNCDDEV--------YDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-55
Identities = 59/286 (20%), Positives = 122/286 (42%), Gaps = 32/286 (11%)
Query: 462 SLASITAATENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMML 520
S+ S+ + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 521 IAKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIA 580
+ + ++ N+V L + E +++EY+ S L D + ++ +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 581 QGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYG 640
Q L +LH ++IHRD+K+ NILL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700
+M+PE + K D++S GI+ +E + + + ++
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------------------PYLNENPLR 223
Query: 701 LIDPVIMQDEISLPMLMRY----INVALLCVQENAADRPTMSDVIS 742
+ + L + + C+ + R + +++
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 9e-55
Identities = 68/282 (24%), Positives = 103/282 (36%), Gaps = 28/282 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAK 523
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L HRNL+RL G ++ E P SL + R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSL--LDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG-NTKQIVGTYGYM 642
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702
+PE FS SD + FG+ + E + + W ++ I
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ--------------EPWIGLNGSQILHKI 227
Query: 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMI 744
D + NV + C DRPT + +
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 74/304 (24%), Positives = 134/304 (44%), Gaps = 36/304 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLS-NQSGQGLKEFKNEMMLIAK 523
E +M +LG+G FG VY+G VA+K ++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRL-------LNWQARVRII 576
++VRLLG + ++I+E M L +L + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 577 EGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIV 636
IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 637 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDD 696
+MSPE DG+F+ SDV+SFG+++ E + + + ++
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242
Query: 697 RVHDLI-DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPK 755
+V + + ++ + P ++ + +C Q N RP+ ++IS I E P +
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLF--ELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFR 298
Query: 756 EPAF 759
E +F
Sbjct: 299 EVSF 302
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-52
Identities = 60/283 (21%), Positives = 117/283 (41%), Gaps = 31/283 (10%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQSGQGLKE-FKNEMMLIAKLQ 525
E + +GEG FG V++G ++ VA+K N + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H ++V+L+G E +I+E L F +K L+ + + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGEL--RSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
L R +HRD+ A N+L+ + K+ DFGL+R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
F+ SDV+ FG+ M E L ++ + +D+I +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRI 222
Query: 706 IMQDEISLP--MLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ + +P ++ C + + RP +++ + ++
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 39/298 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQSGQG-LKEFKNEM-MLIA 522
+ + LG G FG V + + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 523 KLQHRNLVRLLGCCVEQGEKILIL-EYMPNKSLNVFLF-------------DSTKKRLLN 568
H N+V LLG C + G ++++ E+ +L+ +L + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 569 WQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628
+ + +A+G+ +L + IHRDL A NILL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH 688
+M+PE D +++I+SDV+SFG+L+ E S +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEE 245
Query: 689 AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
K+ D + L C + RPT S+++ + N
Sbjct: 246 FCRRLKEGTRMRAPDYTTPE----------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-50
Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 39/300 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
E+F LGEG F V R L +E A+K L + + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
V+L + + L Y N L + R A+ + L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTR----FYTAEIVSAL 121
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
IIHRDLK NILL++DM+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706
+ SD+++ G ++ + ++ ++ + + I
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQK-I 222
Query: 707 MQDEISLP--MLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLPSPKEPAFTKGIN 764
++ E P + ++ + +A R ++ K F + +
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM--------EGYGPLKAHPFFESVT 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-50
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 45/301 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL--------NGQEVAVKRL-SNQSGQGLKEFKNEMMLI 521
+ + LGEG FG V + +VAVK L S+ + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 522 AKL-QHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLF-------------DSTKKRLL 567
+ +H+N++ LLG C + G +I+EY +L +L + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 568 NWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627
+ + V +A+G+ YL + IHRDL A N+L+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLG 687
T +M+PE D +++ +SDV+SFG+L+ E + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLM--RYINVALLCVQENAADRPTMSDVISMIN 745
+ V +L + + P + C + RPT ++ ++
Sbjct: 237 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 746 N 746
Sbjct: 293 R 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (446), Expect = 1e-49
Identities = 59/311 (18%), Positives = 110/311 (35%), Gaps = 35/311 (11%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+++ + +LG G FG V++ G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
V L + E ++I E+M L + D + ++ V + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 590 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+H DLK NI+ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI--DPV 705
+D++S G+L LS + DD +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL---------------SPFGGENDDETLRNVKSCDW 242
Query: 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMSDV-----ISMIN--NEHLNLPSPKEPA 758
M D + + + + R T+ ++ N +PS +
Sbjct: 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 759 FTKGINVKNSS 769
I K +
Sbjct: 303 IRDSIKTKYDA 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (437), Expect = 3e-48
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 36/294 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
+ + + +LG G FG V++ G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+ L ++ E +LILE++ L F + + ++ + + +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 590 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I+H D+K NI+ + KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
+D+++ G+L LS + + + + V
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKR 242
Query: 708 QDEISLPMLMRYINVALL-----CVQENAADRPTMSDVISM--INNEHLNLPSP 754
D ++ +Q+ R T+ D + + +H NL S
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 5e-45
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 21/291 (7%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 527
++ +GEG +G V +N VA+K++S Q + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N++ + + + Y+ + L+ K + L+ + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT-KQIVGTYGYMSPEY 646
++HRDLK SN+LL+ + KI DFGLAR+ D + V T Y +PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 647 ALDGLFSIKS-DVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
L+ KS D++S G ++ E LS++ G + D N + + ++ +I+
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 705 VIMQDEISLPMLMRY-------------INVALLCVQENAADRPTMSDVIS 742
+SLP + +++ + N R + ++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (399), Expect = 5e-44
Identities = 63/285 (22%), Positives = 118/285 (41%), Gaps = 29/285 (10%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG---LKEFKNEMMLIAKLQ 525
++ + + LG GG V+ R L ++VAVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 526 HRNLVRLLGCCVEQGEKI----LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
H +V + + +++EY+ +L + + + + + +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG-GDELQGNTKQIVGTYG 640
L + H + IIHRD+K +NI++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 641 YMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700
Y+SPE A +SDV+S G ++ E L TG + + A+ ++D +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVL-----TGEPPFTGDSPVSVAYQHVREDPIPP 234
Query: 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMI 744
+ ++ V L + +N +R T +++ + +
Sbjct: 235 SARHEGLSADL--------DAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-44
Identities = 52/278 (18%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+ L E ++I E++ + + +T LN + V + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 590 SRFRIIHRDLKASNILLDKDMNP--KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
I H D++ NI+ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
+ S +D++S G L+ LS + + +I+ ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMN 217
Query: 708 QDEISLPMLMRYINVALL-----CVQENAADRPTMSDV 740
+ + I++ + + + R T S+
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 1e-43
Identities = 53/281 (18%), Positives = 101/281 (35%), Gaps = 33/281 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQG-LKEFKNEMMLIAKLQHR 527
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V L G LI++ + L + +K + R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
+ LD+D ISDFGL++M + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707
+S D +S G++ L + D+ L + I+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFE-QIL 222
Query: 708 QDEISLPMLMR------YINVALLCVQENAADRPTMSDVIS 742
+ E + ++++ R T +
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 5e-43
Identities = 70/313 (22%), Positives = 110/313 (35%), Gaps = 43/313 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKN----EMMLIAKLQ 525
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 526 HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLY 585
H L + + ++EY+ L + + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 586 LHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
LH I++RDLK NILLDKD + KI+DFG+ + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 646 YALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
L ++ D +SFG+L+ E L + + +L
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHS- 214
Query: 706 IMQDEISLPMLMRYINVALL--CVQENAADRPTMSDVI------SMINNEHLN---LPSP 754
I D P + LL R + I IN E L + P
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 274
Query: 755 KEPAFTKGINVKN 767
P + N
Sbjct: 275 FRPKVKSPFDCSN 287
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (392), Expect = 6e-43
Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 49/294 (16%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGL---------KEFKNEMML 520
EN+ + LG G V + +E AVK + G + E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 521 IAKLQ-HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
+ K+ H N+++L L+ + M L +L T+K L+ + +I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTY 639
+ + LH + I+HRDLK NILLD DMN K++DFG + E +++ GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 640 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693
Y++PE + + + D++S G++M L+ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PF 215
Query: 694 KDDRVHDLIDPVIMQD-EISLPMLMRY----INVALLCVQENAADRPTMSDVIS 742
+ ++ ++ + + P Y ++ + R T + ++
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (394), Expect = 8e-43
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
++F + LG G FG V+ R NG+ A+K L + + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++R+ G + + +I++Y+ L F +R N A+ A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYA----AEVCLAL 117
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
II+RDLK NILLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKK 673
++ D +SFGIL+ E L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 9e-43
Identities = 73/300 (24%), Positives = 114/300 (38%), Gaps = 28/300 (9%)
Query: 478 KLGEGGFGPVYKGRLLN-GQEVAVKRLSNQSGQGLKE-----FKNEMMLIAKLQHRNLVR 531
LGEG F VYK R N Q VA+K++ K+ E+ L+ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 532 LLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSR 591
LL + L+ ++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 592 FRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD-G 650
I+HRDLK +N+LLD++ K++DFGLA+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 651 LFSIKSDVFSFGILMLETLS------SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704
++ + D+++ G ++ E L + L + W D
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 705 VIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVISM--INNEHLNLPSPKEP 757
I L + LL N R T + + M +N P + P
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 157 bits (397), Expect = 9e-43
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNE---MMLIAK 523
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
+V + + IL+ M L+ L + + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
++H +++RDLK +NILLD+ + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 644 PEYALDGL-FSIKSDVFSFGILMLETLSSK 672
PE G+ + +D FS G ++ + L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 5e-42
Identities = 44/287 (15%), Positives = 101/287 (35%), Gaps = 27/287 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL 529
++ + ++GEG FG +++G LLN Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 530 VRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY 589
+ + ++G +++ + SL L R + + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 590 SRFRIIHRDLKASNILLDKDMNP-----KISDFGLARMFGGDELQGN-----TKQIVGTY 639
+++RD+K N L+ + + + DFG+ + + + + K + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699
YMS L S + D+ + G + + L G + +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFL-----RGSLPWQGLKAATNKQKYERIGEKK 232
Query: 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
+ +Y++ P + + +
Sbjct: 233 QSTPLRELCAGFP-EEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 2e-41
Identities = 53/278 (19%), Positives = 97/278 (34%), Gaps = 25/278 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 537 VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596
+G+ +++ + SL + R + + + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSL--EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIH 126
Query: 597 RDLKASNIL---LDKDMNPKISDFGLARMFGGDELQGN-----TKQIVGTYGYMSPEYAL 648
RD+K N L K I DFGLA+ + + K + GT Y S L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 649 DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708
S + D+ S G +++ G + ++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFN-----LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241
Query: 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746
Y+N C D+P S + + N
Sbjct: 242 KGYP-SEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 26/294 (8%)
Query: 469 ATENFSMQCKLGEGGFGPVYKGRLL--NGQEVAVKRLSNQSGQG--LKEFKNE---MMLI 521
A + + ++GEG +G V+K R L G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 522 AKLQHRNLVRLLGCCVEQGEKILILEYMPNKSLN---VFLFDSTKKRLLNWQARVRIIEG 578
+H N+VRL C + + ++ D + + + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 579 IAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGT 638
+ +GL +LH R++HRDLK NIL+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 639 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKN-TGVYNADSF-NLLGHAWDLWKDD 696
Y +PE L ++ D++S G + E K G + D +L ++D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 697 RVHDLIDPVIMQDEISLPMLMRY--------INVALLCVQENAADRPTMSDVIS 742
D+ P S + ++ ++ L C+ N A R + +S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 5e-41
Identities = 59/287 (20%), Positives = 113/287 (39%), Gaps = 23/287 (8%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHRN 528
E + K+GEG +G VYK + G+ A+K RL + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 529 LVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ 588
+V+L + +L+ E++ + + L + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 589 YSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYAL 648
R++HRDLK N+L++++ KI+DFGLAR FG + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLM 173
Query: 649 -DGLFSIKSDVFSFGILMLETLS------SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701
+S D++S G + E ++ L W +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 702 IDPVIMQDE-ISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 742
DP E + ++ ++ + + ++ + R T +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 29/291 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
ENF K+GEG +G VYK R L G+ VA+K RL ++ E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+V+LL + + L+ E++ D++ + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE-Y 646
+ R++HRDLK N+L++ + K++DFGLAR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADS--------FNLLG----HAWDLWK 694
+S D++S G + E ++ + ++ DS F LG W
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 695 DDRVHDLIDPVIMQDEISL---PMLMRYINVALLCVQENAADRPTMSDVIS 742
+ P + + S P+ ++ + + R + ++
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-40
Identities = 67/311 (21%), Positives = 124/311 (39%), Gaps = 36/311 (11%)
Query: 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV 530
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 531 RLLGCCVEQGEK------ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLL 584
RL GEK L+L+Y+P V S K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 585 YLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYMS 643
Y+H + I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 644 PEYALDGL-FSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLGHAWDLWKDDR 697
PE ++ DV+S G ++ E L + + + +LG +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 698 VHDLIDPVIMQDEISLPMLMRYINV-----ALL--CVQENAADRPTMSDV-----ISMIN 745
+ + Q + + AL ++ R T + +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 746 NEHLNLPSPKE 756
+ ++ LP+ ++
Sbjct: 311 DPNVKLPNGRD 321
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 59/288 (20%), Positives = 107/288 (37%), Gaps = 43/288 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL------SNQSGQGLKEFKNEMMLIAK 523
+ + +LG G F V K R G + A K + S++ G ++ + E+ ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 524 LQHRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
+QH N++ L + + ILILE + L +K L + ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGEL---FDFLAEKESLTEEEATEFLKQILNG- 125
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNP----KISDFGLARMFGGDELQGNTKQIVGTY 639
++ +I H DLK NI+L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 640 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699
+++PE +++D++S G++ LS + D
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQ 222
Query: 700 DLIDPVIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 742
+ + V + + + ++ R T+ D +
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-39
Identities = 60/300 (20%), Positives = 107/300 (35%), Gaps = 51/300 (17%)
Query: 473 FSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKE------FKNEMMLIAKLQ 525
+ + LG GGFG VY G + + VA+K + E E++L+ K+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 526 --HRNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
++RLL +LILE T++ L + + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAV 123
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
+ H ++HRD+K NIL+D + K+ DFG + GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 643 SPEYAL-DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701
PE+ + V+S GIL+ + + ++ D +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDE-EII 217
Query: 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH---LNLPSPKEPA 758
V + +S ++ C+ +DRPT ++ H ++ P+E A
Sbjct: 218 RGQVFFRQRVSSEC----QHLIRWCLALRPSDRPTFEEIQ-----NHPWMQDVLLPQETA 268
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 69/319 (21%), Positives = 124/319 (38%), Gaps = 43/319 (13%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
+ K+G+G FG V+K R GQ+VA+K++ N+ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 528 NLVRLLGCCVEQGEKI--------LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGI 579
N+V L+ C + L+ ++ + + K R+++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 580 AQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNT--KQIVG 637
GL Y+H+ +I+HRD+KA+N+L+ +D K++DFGLAR F + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 638 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLG---- 687
T Y PE L + + D++ G +M E + A L G
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 688 HAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL------CVQENAADRPTMSDVI 741
W + +++ ++ V Q L Y+ + + A R D +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 742 SMINNEH---LNLPSPKEP 757
H + P P +
Sbjct: 304 -----NHDFFWSDPMPSDL 317
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 50/273 (18%), Positives = 102/273 (37%), Gaps = 30/273 (10%)
Query: 479 LGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCC 536
LG G G V + ++ A+K L + + + E+ L + Q ++VR++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 537 ----VEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRF 592
+ ++++E + L + D + + I++ I + + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHSI--- 130
Query: 593 RIIHRDLKASNILLDKDMNP---KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALD 649
I HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 650 GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709
+ D++S G++M G S + L + + R+ P
Sbjct: 188 EKYDKSCDMWSLGVIMYIL-----LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 710 EISLPMLMRYINVALLCVQENAADRPTMSDVIS 742
E+S + + ++ R T+++ ++
Sbjct: 243 EVSEEV----KMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-37
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
L L ++EY LF + + + R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
+++RD+K N++LDKD + KI+DFGL + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
D + D + G++M E + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (344), Expect = 2e-36
Identities = 57/288 (19%), Positives = 113/288 (39%), Gaps = 23/288 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVK--RLSNQSGQGLKEFKNEMMLIAKLQHR 527
+ + K+GEG +G V+K + + VA+K RL + E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 528 NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLH 587
N+VRL + L+ E+ F + + + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 588 QYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYA 647
++HRDLK N+L++++ K+++FGLAR F G ++ + ++V +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 648 LDGLFSIKSDVFSFGILMLETLSSKK--NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705
L+S D++S G + E ++ + G D + +++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 706 IMQDEISLPMLMRYINVA---------LL--CVQENAADRPTMSDVIS 742
+ P +NV LL ++ N R + + +
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 62/315 (19%), Positives = 120/315 (38%), Gaps = 39/315 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRL--SNQSGQGLKEFKNEMMLIAKLQHR 527
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 528 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
N++ LL + L++ +M + K L ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 642 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLG----HAWD 691
+PE L+ + ++ D++S G +M E ++ K + + + G
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVISM--I 744
+ D + + + ++ ++ + + + +A R T + ++
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304
Query: 745 NNEHLNLPSPKEPAF 759
+ H P+ +
Sbjct: 305 ESLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 3e-34
Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 15/206 (7%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQH 526
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 527 RNLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
LV+L + +++EY+ + L + + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 587 HQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEY 646
H +I+RDLK N+L+D+ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 647 ALDGLFSIKSDVFSFGILMLETLSSK 672
L ++ D ++ G+L+ E +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 3e-32
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 35/281 (12%)
Query: 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLS----NQSGQGLKEFKNEMMLIA 522
ENF + LG G +G V+ R + G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 523 KLQHR-NLVRLLGCCVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
++ LV L + + LIL+Y+ L L + Q + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
+L L + II+RD+K NILLD + + ++DFGL++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 642 MSPEYALDGL--FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699
M+P+ G D +S G+LM E L+ + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA---------------SPFTVDGEKNSQ 241
Query: 700 DLIDPVIMQDEISLPMLMRYINVALL--CVQENAADRPTMS 738
I I++ E P M + L+ + ++ R
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (313), Expect = 7e-32
Identities = 52/299 (17%), Positives = 113/299 (37%), Gaps = 42/299 (14%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRN 528
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 529 LVRLLGCCVEQGEK--ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYL 586
++ L + + L+ E++ N + L ++ R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 587 HQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPE 645
H I+HRD+K N+++D + ++ D+GLA + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 646 YALD-GLFSIKSDVFSFGILMLETLSSK------KNTGVYNADSFNLLGHAWDLWKDDRV 698
+D ++ D++S G ++ + K + +LG D+
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 699 HDLIDPVIMQ----------DEISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 742
+ +DP + ++ L ++ + R T + +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-30
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 471 ENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQHR 527
+ + +G G G V + + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 528 NLVRLLGCCVEQG------EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
N++ LL Q + L++E M V + L+ + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
G+ +LH IIHRDLK SNI++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 642 MSPEYALDGLFSIKSDVFSFGILMLETLSSK 672
+PE L + D++S G +M E + K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 35/296 (11%)
Query: 470 TENFSMQCKLGEGGFGPVYKGR-LLNGQEVAVKRLSN--QSGQGLKEFKNEMMLIAKLQH 526
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 527 RNLVRLLGCCVEQ-----GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQ 581
N++ LL + ++ ++ L + K + L +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD----LNNIVKCQKLTDDHVQFLIYQILR 132
Query: 582 GLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGY 641
GL Y+H IIHRDLK SN+ +++D KI DFGLAR V T Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184
Query: 642 MSPEYALDGL-FSIKSDVFSFGILMLETLSSK-----KNTGVYNADSFNLLG----HAWD 691
+PE L+ + ++ D++S G +M E L+ + + L+G
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALL-----CVQENAADRPTMSDVIS 742
+ + I + +++ + N + + ++ R T + ++
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 6e-28
Identities = 41/210 (19%), Positives = 84/210 (40%), Gaps = 18/210 (8%)
Query: 478 KLGEGGFGPVYKGR-LLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCC 536
KLG G F V+ + ++N VA+K + + ++E+ L+ ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 537 VEQGEKIL-------------ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
K+L ++ + + L + R + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 584 LYLHQYSRFRIIHRDLKASNILLDK-DMNPKISDFGLARMFGGDELQGNTKQIVGTYGYM 642
Y+H+ R IIH D+K N+L++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 643 SPEYALDGLFSIKSDVFSFGILMLETLSSK 672
SPE L + +D++S L+ E ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 101 bits (253), Expect = 2e-25
Identities = 28/158 (17%), Positives = 57/158 (36%), Gaps = 28/158 (17%)
Query: 478 KLGEGGFGPVYKGRLLNGQEVAVK--RLSNQSGQGLK--------EFKNEMMLIAKLQHR 527
+GEG V+ E VK ++ + S + +K F + A+ + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 528 NLVRLLGCCV----EQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGL 583
L +L G V +++E + K + + + +++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 584 LYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621
+ I+H DL N+L+ + I DF +
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.0 bits (223), Expect = 3e-22
Identities = 22/118 (18%), Positives = 47/118 (39%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTIS 93
+ +GE L + Q ++ + + L + VW +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD---HSTSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++GN V+ + ++W+++ N V L++DGN+VI + +W + Y
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 2/78 (2%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNP-VAQLRDDGNLVIRDNSSGNAT 141
+ + + NLVL + + ++W++N K A L+ DGN V+ D +
Sbjct: 16 LDVEPYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLW 74
Query: 142 ESYLWQSFDYPTDTLLQD 159
S+ + L +D
Sbjct: 75 ASHSVRGNGNYVLVLQED 92
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 69.1 bits (168), Expect = 7e-15
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 18/130 (13%)
Query: 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPIS 84
+D + + G L + + + VW + + S
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGKAS 50
Query: 85 DNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESY 144
VL + N+GNLV+ + + IW++N + + N L+ D N+VI DNS+ +
Sbjct: 51 --GCVLKMQNDGNLVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDYPTD 154
+W + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 68.5 bits (167), Expect = 1e-14
Identities = 26/126 (20%), Positives = 45/126 (35%), Gaps = 20/126 (15%)
Query: 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISD 85
+ + + GE L + F L + D +W N
Sbjct: 2 NILYSGETLSTGEFL--NYGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 NNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYL 145
+ L++ +GNLV+ N +N IW++N + N V L+ D N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDY 151
W + +
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 40.4 bits (94), Expect = 8e-05
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 83 ISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142
++ + V + + NLVL + + IW+TN ++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWQSFDYPTDTLLQDMKL 162
S L +D +
Sbjct: 75 SNTGGQNGNYVCILQKDRNV 94
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.0 bits (166), Expect = 2e-14
Identities = 16/89 (17%), Positives = 37/89 (41%), Gaps = 8/89 (8%)
Query: 71 DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNL 130
D + + + + L++ + NLVL ++ + +WSTN + + A L+ +G +
Sbjct: 20 DNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRM 78
Query: 131 VIRDNSSGNATESYLWQSFD--YPTDTLL 157
+ N + +W S + +
Sbjct: 79 DVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.3 bits (133), Expect = 6e-10
Identities = 19/96 (19%), Positives = 34/96 (35%), Gaps = 5/96 (5%)
Query: 41 VSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVL 100
+ ++Q +L + L + + D VW N + NG + +
Sbjct: 26 LHATQSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDV 80
Query: 101 LNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136
L N +W++ S V L+ D NL I +
Sbjct: 81 LTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGA 116
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.8 bits (160), Expect = 1e-13
Identities = 19/112 (16%), Positives = 41/112 (36%), Gaps = 18/112 (16%)
Query: 40 LVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLV 99
++ + + + L + + +W N N + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLYD---NNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151
++ N T+W + V+ + + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.4 bits (128), Expect = 2e-09
Identities = 26/134 (19%), Positives = 43/134 (32%), Gaps = 23/134 (17%)
Query: 12 SLIFLLSMKVSLAADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPD 71
+++F LS T+ A + F S L + D
Sbjct: 2 NILFGLS-HEGSHPQTLHAAQSLELS--------SFRFTMQSDCN-----LVLFD---SD 44
Query: 72 AVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLV 131
VW +N + ++G LV+L N WS+ + N V L+ D +
Sbjct: 45 VRVWASNTA---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVT 101
Query: 132 IRDN---SSGNATE 142
I SG + +
Sbjct: 102 IYGPGLWDSGTSNK 115
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 792 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.84 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.84 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.62 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.62 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.43 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.32 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.21 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.78 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.77 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.67 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.31 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.24 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.84 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.83 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.96 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=415.82 Aligned_cols=264 Identities=28% Similarity=0.435 Sum_probs=206.0
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||+||+|+.+ ..||||+++.. .....+.|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 468999999999999999999864 46999998643 45567889999999999999999999998754 56899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++.. .+..+++.+++.++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999853 2345999999999999999999999998 9999999999999999999999999998876544
Q ss_pred cccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.........||+.|||||++.+ ..++.++|||||||+||||++|+.||........ . ......+. ..+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~----~~~~~~~~----~~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-I----IFMVGRGY----LSP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHHHTS----CCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-H----HHHHhcCC----CCC
Confidence 4444456789999999999864 3589999999999999999999999875432211 0 00111110 011
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCCCC
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLNLP 752 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~~~ 752 (792)
.+ .......+.++.+|+.+||+.||++|||++||+++|+.+...+|
T Consensus 230 ~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11222334678999999999999999999999999988755444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=411.67 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=205.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999985 58999999996543 33456789999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 4457999999999999999999999998 99999999999999999999999999998754443
Q ss_pred ccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.......+||+.|||||++.+..+ +.++|||||||+||||++|+.||............ ......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~~~~~~--------- 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--------- 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----HHTTCT---------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCCC---------
Confidence 344455789999999999988876 57899999999999999999999654332211110 000000
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111123457789999999999999999999854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=411.24 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=199.7
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
++|++.++||+|+||.||+|++.+++.||||+++.. ....++|.+|++++++++|||||++++++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 578999999999999999999988999999999754 3445789999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+|+|.+++.. ....+++..++.++.|||.||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999998843 3356899999999999999999999998 999999999999999999999999999877543322
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCC-CCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......||+.|+|||++.+..++.++|||||||++|||+++.. |+...... ..... ...+ . ..
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~----i~~~--~--------~~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVED----ISTG--F--------RL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHH----HHHT--C--------CC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHhc--C--------CC
Confidence 2233578999999999999999999999999999999999644 44322211 11110 0000 0 01
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+...+.++.+++.+||+.||++||||+||+++|+++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11222345788999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=409.69 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=208.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 357999999999999999999874 5899999999766556678899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.+++. ++.+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.+.....
T Consensus 99 ~~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred cCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998773 245999999999999999999999998 99999999999999999999999999998754332
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQ 708 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 708 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ....... ..
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~---~~~~~~~---------~~ 235 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY---LIATNGT---------PE 235 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH---HHHHHCS---------CC
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HHH---HHHhCCC---------CC
Confidence 2344679999999999999999999999999999999999999996433211 000 0000000 01
Q ss_pred CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 709 DEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 709 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112233467899999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=403.57 Aligned_cols=245 Identities=26% Similarity=0.354 Sum_probs=205.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999985 5889999998643 2334677899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999843 346999999999999999999999998 999999999999999999999999999866433
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||....... ... .....
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~----~i~~~---------- 219 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYK----RISRV---------- 219 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH----HHHTT----------
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HHH----HHHcC----------
Confidence 2 334679999999999999999999999999999999999999996433211 110 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01112223457889999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=400.35 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=212.2
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecC
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMP 550 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 550 (792)
++|++.++||+|+||+||+|++++++.||||+++... ...++|++|+.++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6899999999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcccc
Q 003843 551 NKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQG 630 (792)
Q Consensus 551 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 630 (792)
+|+|..++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999988743 3446899999999999999999999998 999999999999999999999999999877554332
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||........ .. ....+. ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~--~~----~i~~~~----------~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AE----HIAQGL----------RL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH--HH----HHHTTC----------CC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH--HH----HHHhCC----------CC
Confidence 2333578999999999999999999999999999999998 7889875543221 11 011110 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINN 746 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~ 746 (792)
..+...+.++.+|+.+||+.||++|||++|++++|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1122234578999999999999999999999999965
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=406.99 Aligned_cols=256 Identities=30% Similarity=0.430 Sum_probs=207.5
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46899999999999999999999888999999997543 445789999999999999999999998754 5679999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++|+|.+++... ....+++.++++++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999887432 2335899999999999999999999998 999999999999999999999999999987544322
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......||+.|+|||++.+..++.++|||||||++|||+||..|+....... .... ....+ . ..
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~----~i~~~-----~-----~~ 229 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ----NLERG-----Y-----RM 229 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----HHHTT-----C-----CC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHhc-----C-----CC
Confidence 2233578999999999999999999999999999999999766543222111 1111 11110 0 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+...+.++.+|+.+||+.||++||||+||+++|++.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11223345789999999999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-48 Score=411.34 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=199.4
Q ss_pred cCccccceecccCceeEEEEEEcC-C---cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-G---QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
+.|++.++||+|+||+||+|+++. + ..||||++... .....++|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 568888999999999999998753 2 35899998654 445567899999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|.+++.. ..+.+++.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998743 3446999999999999999999999998 99999999999999999999999999997754
Q ss_pred Ccccc---ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccc
Q 003843 626 DELQG---NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 626 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
..... ......||+.|||||.+.+..++.++|||||||+||||+| |++||....... ... ....+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~----~i~~~----- 249 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VIN----AIEQD----- 249 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHTT-----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC-----
Confidence 43221 1222457899999999999999999999999999999998 899986433221 111 01000
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. ..+.+...+.++.+|+.+||+.||++|||++||++.|+++
T Consensus 250 ----~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 ----Y-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ----C-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----C-CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0 1122233456789999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-48 Score=410.77 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=212.2
Q ss_pred HhcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
..++|++.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3578999999999999999999986 4889999999654 3456789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998543 3456899999999999999999999998 9999999999999999999999999998765443
Q ss_pred cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.|+....... .. ......+ .
T Consensus 170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~----~~~i~~~---------~- 233 (287)
T d1opja_ 170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QV----YELLEKD---------Y- 233 (287)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HH----HHHHHTT---------C-
T ss_pred ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HH----HHHHhcC---------C-
Confidence 22 2233468899999999999999999999999999999999777654222111 00 1111111 0
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.+...+.++.+|+.+||+.||++|||++||++.|+..
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122223456789999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=407.66 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=207.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.+.|++.+.||+|+||+||+|+.. +++.||||++........+.|.+|+++|++++|||||++++++.+++..++||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 357899999999999999999975 5889999999877777788899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.+++.+. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999987432 346999999999999999999999998 9999999999999999999999999998653221
Q ss_pred ccccceeecccceeCccccc-----CCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.......||+.|+|||++. +..++.++|||||||++|||++|+.||........ ... ... ..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~---i~~-~~------ 231 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLK---IAK-SE------ 231 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHH---HHH-SC------
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHH---HHc-CC------
Confidence 1223467999999999984 45689999999999999999999999865432211 100 000 00
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 --PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011112233567899999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=412.89 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=208.0
Q ss_pred hcCccccceecccCceeEEEEEEcC------CcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN------GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 541 (792)
.++|++.++||+|+||+||+|+... ...||||++... .....+.|.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4689999999999999999998753 236999998653 344557899999999998 89999999999999999
Q ss_pred eEEEEEecCCCccceeeeccCC--------------------CccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 003843 542 KILILEYMPNKSLNVFLFDSTK--------------------KRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKA 601 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp 601 (792)
.++||||+++|+|.++|..... ...+++.+++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999864321 245899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCc
Q 003843 602 SNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNA 680 (792)
Q Consensus 602 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~ 680 (792)
+|||++.++++||+|||+|+...............||+.|||||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333445678999999999999999999999999999999998 8999865433
Q ss_pred cccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003843 681 DSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMIN 745 (792)
Q Consensus 681 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~ 745 (792)
... + ......+ . +.+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~-~----~~~~~~~---------~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN-F----YKLIQNG---------F-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH-H----HHHHHTT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-H----HHHHhcC---------C-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 0 0111111 0 11122233467899999999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=403.68 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=196.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee--cCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE--QGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 544 (792)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... .+...+.|.+|++++++++|||||++++++.+ +...++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999875 5889999998654 34456779999999999999999999999865 456899
Q ss_pred EEEecCCCccceeeeccC-CCccCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 545 ILEYMPNKSLNVFLFDST-KKRLLNWQARVRIIEGIAQGLLYLHQYS--RFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
||||+++|+|.+++.... .+..+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999985432 3456999999999999999999999875 2349999999999999999999999999999
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDL 701 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 701 (792)
.+..... ......||+.|||||++.+..++.++|||||||++|||++|+.||....... .. ........
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~----~~i~~~~~--- 231 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LA----GKIREGKF--- 231 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHHTCC---
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HH----HHHHcCCC---
Confidence 8754322 2334689999999999999999999999999999999999999986433221 11 01111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 702 IDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 702 ~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112233457899999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=401.16 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=208.3
Q ss_pred hcCccccc-eecccCceeEEEEEEc---CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQC-KLGEGGFGPVYKGRLL---NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~-~LG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|.+.+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45677777 4999999999999764 35579999997543 4456789999999999999999999999864 56899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.+++.. .+..+++.++++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998733 3356999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcc-ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 625 GDEL-QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 625 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .. .....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~----~~i~~~~----- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGK----- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH----HHHHTTC-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcCC-----
Confidence 5432 222334568999999999999999999999999999999998 899987543221 11 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.+...+.++.+|+.+||+.||++||||.+|++.|+..
T Consensus 230 -----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122233446789999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=405.84 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=204.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999985 6899999998643 2344578999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. ..+.+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998874 3456999999999999999999999998 999999999999999999999999999987655
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ... ......
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~----~i~~~~--------- 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQ----KIIKLE--------- 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHTTC---------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHH----HHHcCC---------
Confidence 44444455689999999999999999999999999999999999999997433211 110 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
..++.....++.+|+.+||+.||++|||++|+++
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0112223457889999999999999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=401.59 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=205.1
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYM 549 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 549 (792)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|+|||++++++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4689999999999999999999988889999999654 3345789999999999999999999999854 5689999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++|+|..++... ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+......
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999887543 2345999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 630 GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 630 ~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......||+.|+|||++....++.++||||||++||||++|+.|+....... ..... +..+. ..
T Consensus 170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~----i~~~~----------~~ 233 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ----VERGY----------RM 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH----HHTTC----------CC
T ss_pred -eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHH----HHhcC----------CC
Confidence 2233578999999999999999999999999999999999776654322211 11111 11010 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccCCC
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEHLN 750 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~~~ 750 (792)
+.+...++++.+++.+||+.||++||+|++|+++|+.....
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 22233456789999999999999999999999999986433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=402.48 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=200.7
Q ss_pred cCccccceecccCceeEEEEEEcCC-----cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNG-----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
+.|++.++||+|+||+||+|+++.. ..||||++... .....++|.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688899999999999999987642 36999999654 34455679999999999999999999999999999999
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+.+++|.+++.. ....+++.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887743 3346999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
..... .......||+.|||||++.+..++.++|||||||++|||+++..|+....... .... ....+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~----~i~~~------- 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMK----AINDG------- 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH----HHHTT-------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHH----HHhcc-------
Confidence 43221 22233568999999999999999999999999999999999766654322111 1111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
. +.+.+...+.++.+|+.+||+.||++||||.||+++|+.+
T Consensus 230 --~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 230 --F-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --C-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --C-CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 0 1122233456789999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=401.10 Aligned_cols=248 Identities=28% Similarity=0.394 Sum_probs=199.0
Q ss_pred ceecccCceeEEEEEEcC---CcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEecCC
Q 003843 477 CKLGEGGFGPVYKGRLLN---GQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEYMPN 551 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 551 (792)
++||+|+||+||+|.+.. ++.||||+++.. .....++|.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999999653 33446789999999999999999999999864 567899999999
Q ss_pred CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc-c
Q 003843 552 KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ-G 630 (792)
Q Consensus 552 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~-~ 630 (792)
|+|.+++. +...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999984 3456999999999999999999999998 999999999999999999999999999987544322 2
Q ss_pred ccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccccC
Q 003843 631 NTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQD 709 (792)
Q Consensus 631 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 709 (792)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||....... .. .....+. ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~----~~i~~~~----------~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT----AMLEKGE----------RM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTTC----------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HH----HHHHcCC----------CC
Confidence 2334578999999999999999999999999999999998 899987433211 11 1111110 11
Q ss_pred CCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 710 EISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 710 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.+...+.++.+|+.+||+.||++|||+++|+++|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 12223346788999999999999999999999988753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=410.31 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=206.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||+||+|+.. +|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999975 5889999999654 33445789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
|+++|+|.+++.+ .+.+++..+..++.||+.||.|||+. + |+||||||+|||++.++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999843 34699999999999999999999974 7 999999999999999999999999999865322
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhh-----------c--
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDL-----------W-- 693 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~-----------~-- 693 (792)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...+............. .
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 23346899999999999999999999999999999999999999975443221111000000 0
Q ss_pred -----------ccCccccccccccc---cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 -----------KDDRVHDLIDPVIM---QDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 -----------~~~~~~~~~~~~l~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
......+.++.... ........+.++.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000000000 000011124578899999999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=394.78 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=197.0
Q ss_pred ccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee----cCeeEEE
Q 003843 473 FSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE----QGEKILI 545 (792)
Q Consensus 473 y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv 545 (792)
|++.++||+|+||+||+|++. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ +...++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 466788999999999999985 5889999998653 34456789999999999999999999999875 3467999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc-CCCCeeecccccceecC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD-KDMNPKISDFGLARMFG 624 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~-~~~~~kL~DFGla~~~~ 624 (792)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+...
T Consensus 91 mE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999843 356899999999999999999999875 3499999999999996 57899999999998643
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||........ +. .....+. .+
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~----~~i~~~~-----~~ 231 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IY----RRVTSGV-----KP 231 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HH----HHHTTTC-----CC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HH----HHHHcCC-----CC
Confidence 32 2345689999999998875 599999999999999999999999964322110 10 0111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
...+.....++.+|+.+||+.||++|||++|+++
T Consensus 232 ----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111112346889999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-47 Score=403.46 Aligned_cols=264 Identities=26% Similarity=0.419 Sum_probs=213.4
Q ss_pred HHHHHhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeee
Q 003843 465 SITAATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCV 537 (792)
Q Consensus 465 ~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 537 (792)
+++.+.++|++.+.||+|+||+||+|+.+ +++.||||+++... ....++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 33445678999999999999999999864 35789999997543 344678999999999999999999999999
Q ss_pred ecCeeEEEEEecCCCccceeeeccC---------------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceee
Q 003843 538 EQGEKILILEYMPNKSLNVFLFDST---------------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIH 596 (792)
Q Consensus 538 ~~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 596 (792)
+....+++|||+++|+|.++++... ....+++..++.++.||+.||+|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999985322 1234899999999999999999999998 999
Q ss_pred cCCCCCcEEEcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCC-CCC
Q 003843 597 RDLKASNILLDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNT 675 (792)
Q Consensus 597 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~-~p~ 675 (792)
|||||+|||++.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|. +|+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998775544444445567899999999999999999999999999999999986 456
Q ss_pred CCCCccccccccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 676 GVYNADSFNLLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 676 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....... ... ....+.. .+.+...+.++.+|+.+||+.+|++||||.||+++|+++
T Consensus 244 ~~~~~~e--~~~----~v~~~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEE--VIY----YVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHH--HHH----HHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHH--HHH----HHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5433221 111 1111111 112223345789999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-46 Score=401.52 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=209.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
-++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999975 6899999999877767778899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc--CCCCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kL~DFGla~~~~~~ 626 (792)
+++|+|.+++.. ..+.+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999988843 3346999999999999999999999999 99999999999995 4678999999999987543
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||....... ..... ..... . .
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i----~~~~~-~-~---- 244 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNV----KSCDW-N-M---- 244 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH----HHTCC-C-S----
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHH----HhCCC-C-C----
Confidence 3 2344689999999999999999999999999999999999999996433211 11100 00000 0 0
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
........+.++.+|+.+||+.||++|||++|++++
T Consensus 245 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111234578899999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-46 Score=397.88 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=191.1
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
.+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999985 58899999996543 2334678899999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc---CCCCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kL~DFGla~~~~ 624 (792)
|+++|+|.++|. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999984 3456999999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDP 704 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 704 (792)
... ......||+.|||||++.+..++.++|||||||+||||++|+.||........ .. .......
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~----~i~~~~~------ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL--FE----QILKAEY------ 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HH----HHHTTCC------
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH--HH----HHhccCC------
Confidence 432 23346799999999999999999999999999999999999999964332111 00 0000000
Q ss_pred ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 705 VIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 705 ~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ..+.....+.++.+|+.+||+.||++|||++|++++
T Consensus 227 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 EF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 111122334678999999999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.1e-46 Score=400.71 Aligned_cols=257 Identities=22% Similarity=0.279 Sum_probs=211.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999974 6899999999876666677899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc--CCCCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD--KDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~--~~~~~kL~DFGla~~~~~~ 626 (792)
+++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999877632 3345999999999999999999999998 99999999999997 6789999999999987644
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .... ...... ..
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~----i~~~~~------~~ 247 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQN----VKRCDW------EF 247 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH----HHHCCC------CC
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HHhCCC------CC
Confidence 3 2344679999999999999999999999999999999999999996433211 1100 000000 00
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 747 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 747 (792)
........+.++.+|+.+||+.||++|||+.|++++ +.+.
T Consensus 248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 111112334578899999999999999999999885 5443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=399.44 Aligned_cols=246 Identities=31% Similarity=0.458 Sum_probs=201.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 545 (792)
.+.|+++++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 346999999999999999999875 58899999986543 33456799999999999999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|..++. .+..+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 94 ~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp EECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999976653 3356999999999999999999999998 99999999999999999999999999986533
Q ss_pred CccccccceeecccceeCcccccC---CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... ... ......
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~~~---~i~~~~------ 230 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY---HIAQNE------ 230 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH---HHHHSC------
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--HHH---HHHhCC------
Confidence 234579999999999864 468999999999999999999999986432211 000 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
.+. ......+.++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 SPA----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCC----CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC----CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 000 111223457899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=397.94 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=202.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCc----EEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQ----EVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
++|++.++||+|+||+||+|++. +|+ +||+|+++.. ..+..++|.+|++++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999875 343 6899988653 445678899999999999999999999999865 5678
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
++||+.+++|.+++.. ....+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999888743 3456999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
............||+.|+|||.+.+..++.++|||||||+||||+| |++||........ . .....+.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~--~----~~i~~~~------ 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S----SILEKGE------ 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH--H----HHHHHTC------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH--H----HHHHcCC------
Confidence 5544444445678999999999999999999999999999999998 7888764332211 0 0111110
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.+.+...+.++.+|+.+||+.||++|||+.||+++|...
T Consensus 231 ----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1112223446789999999999999999999999998765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=394.21 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=201.4
Q ss_pred HHhcCccccceecccCceeEEEEEEc------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 468 AATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 468 ~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
...++|++.++||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++++.++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 34578999999999999999999864 2468999999754 344566788888888887 689999999998765
Q ss_pred -CeeEEEEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 540 -GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 540 -~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
...++||||+++|+|.++|.... ....+++.+++.++.||++||+|||+++ |+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcccee
Confidence 46899999999999999986432 1345899999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCC-CCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~-~p~~~~~~~~~~ 684 (792)
|++++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999998775544444455578999999999999999999999999999999999975 56653322111
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+ ......+. ....+...+.++.+++.+||+.||++|||++||+++|+++
T Consensus 246 ~----~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 F----CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp H----HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 01111111 1112222345789999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=386.75 Aligned_cols=250 Identities=28% Similarity=0.405 Sum_probs=198.7
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-CeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-GEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~ 548 (792)
.++|++.++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++||||+++++++.++ +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46788999999999999999998 5789999999754 3457899999999999999999999998654 568999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+++|+|.++|... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999998542 2335899999999999999999999998 999999999999999999999999999865432
Q ss_pred ccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.....+|..|+|||++.+..++.++||||||+++|||++ |++|+....... ... ....+ .
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~----~i~~~-----~----- 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----RVEKG-----Y----- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHH----HHTTT-----C-----
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHH----HHHcC-----C-----
Confidence 233467899999999999999999999999999999998 677765432221 111 11111 1
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+.+.+.....++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122333446788999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=388.63 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=205.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccC------chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS------GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.|.+|+.+|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999984 68999999986432 22467899999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC----Ceeecccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM----NPKISDFG 618 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~----~~kL~DFG 618 (792)
++||||+++|+|.+++.. .+.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999843 346999999999999999999999998 99999999999998776 49999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRV 698 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 698 (792)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .......
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~----~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA----NVSAVNY 233 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHTTCC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HH----HHHhcCC
Confidence 998875432 22345789999999999999999999999999999999999999974332211 00 0000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 699 HDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 699 ~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ........+.++.+|+.+||+.||++|||++|++++
T Consensus 234 ------~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 ------EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CC-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000011124578899999999999999999999763
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=394.90 Aligned_cols=248 Identities=22% Similarity=0.293 Sum_probs=207.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++++.||+|+||.||+|+.+ +|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999974 6899999999653 2335678899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999884 3456899999999999999999999999 999999999999999999999999999876433
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. ......+||+.|+|||++.+..++.++|||||||++|||++|++||...+.... .. .....
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~i~~~---------- 220 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE----LILME---------- 220 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC----------
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HH----HHhcC----------
Confidence 2 223456899999999999999999999999999999999999999875432211 10 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
...++...+.++.+|+.+||+.||++||+ +.|++++
T Consensus 221 -~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 01112233457889999999999999995 7888764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=387.04 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=197.4
Q ss_pred hcCccccceecccCceeEEEEEEcC----CcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN----GQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKIL 544 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 544 (792)
.++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|++++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998753 356999998654 3445678999999999999999999999986 467899
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecC
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFG 624 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~ 624 (792)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999888743 3446899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCccccccc
Q 003843 625 GDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHDLID 703 (792)
Q Consensus 625 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 703 (792)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+|+........ .. ....+.
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~~----~i~~~~------ 226 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG----RIENGE------ 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH----HHHTTC------
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--HH----HHHcCC------
Confidence 4322 22334578999999999999999999999999999999998 8888865433211 11 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 704 PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 704 ~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.+...+.++.+|+.+||+.||++|||++||++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 227 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1112223446789999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=388.79 Aligned_cols=272 Identities=24% Similarity=0.304 Sum_probs=202.6
Q ss_pred hcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----eeEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKILI 545 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv 545 (792)
.+.|.+.++||+|+||.||+|++ +|+.||||+++.... ....++.|+..+..++|||||++++++.+++ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35688899999999999999997 689999999964322 1122334555556789999999999998764 57999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYS-----RFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
|||+++|+|.++|.. ..+++..+++++.|++.||+|||+.. +.+|+||||||+||||+.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999943 35899999999999999999999741 234999999999999999999999999999
Q ss_pred eecCCCcc--ccccceeecccceeCcccccCCC------CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc----
Q 003843 621 RMFGGDEL--QGNTKQIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH---- 688 (792)
Q Consensus 621 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~---- 688 (792)
+....... ........||+.|+|||++.+.. ++.++|||||||+||||++|..|++............
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 98754322 22334568999999999987653 5778999999999999999998876544322211110
Q ss_pred -hhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 689 -AWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 689 -~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.............+++.+.......+....+.+|+.+||+.||++|||+.||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00000001111122222222222334566799999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-46 Score=387.06 Aligned_cols=257 Identities=27% Similarity=0.367 Sum_probs=198.4
Q ss_pred hcCccccceecccCceeEEEEEEcC--C--cEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--G--QEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.+.||+|+||.||+|++.. + ..||||++... ..+..++|.+|+.+|++++|||||++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3679999999999999999998643 2 37899998653 34556789999999999999999999999976 467
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
++||||+++|+|.+++... ...+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 8999999999998887432 345999999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCccc-cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCccccccccchhhhcccCcccc
Q 003843 623 FGGDELQ-GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 623 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
+...... .......|+..|+|||.+.+..++.++||||||+++|||++ |+.||........ ... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~--~~~---i~~~~~--- 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHK---IDKEGE--- 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHH---HHTSCC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH--HHH---HHhCCC---
Confidence 7554322 22334567889999999999999999999999999999998 8999864432211 111 111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..+.+...+.++.+|+.+||+.||++|||++||++.|.+.
T Consensus 233 -------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112223345788999999999999999999999999763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-45 Score=389.54 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=205.1
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|++.++||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999985 5899999999643 2344678999999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999988873 3456889999999999999999999998 999999999999999999999999999976432
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+... ... .+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~------------~i~~~-- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYE------------KILNA-- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH------------HHHHC--
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HHH------------HHHcC--
Confidence 234689999999999999999999999999999999999999996433211 100 00000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~~ 743 (792)
....+...+.++.+++.+||+.||.+|| |+++++++
T Consensus 217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0111222345788999999999999996 89999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=389.00 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=209.3
Q ss_pred hcCccccceecccCceeEEEEEEcC--------CcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeec
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLLN--------GQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQ 539 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 539 (792)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 5789999999999999999998643 2479999997653 34567889999999988 899999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccC-------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEE
Q 003843 540 GEKILILEYMPNKSLNVFLFDST-------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILL 606 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl 606 (792)
+..++||||+++|+|.++|.... ....+++.+++.++.||+.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999995432 1245899999999999999999999998 9999999999999
Q ss_pred cCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHh-CCCCCCCCCcccccc
Q 003843 607 DKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SKKNTGVYNADSFNL 685 (792)
Q Consensus 607 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~ellt-g~~p~~~~~~~~~~~ 685 (792)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999998765554445555788999999999999999999999999999999998 677876433221
Q ss_pred ccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 686 LGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 686 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
....+..+. ..+.+...+.++.+|+.+||+.||++|||+.||+++|+++
T Consensus 246 ---~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 ---LFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111111111 1111222345789999999999999999999999999876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=9.6e-45 Score=380.71 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=201.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----e
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----E 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 541 (792)
.++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+.|.+|++++++++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 478999999999999999999874 6899999999654 2344567999999999999999999999998754 3
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++||||+++++|.+++. ..+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998873 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCc-cccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccc
Q 003843 622 MFGGDE-LQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHD 700 (792)
Q Consensus 622 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 700 (792)
...... .........||+.|+|||++.+..++.++|||||||++|||++|++||........ . .........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~---~~~~~~~~~-- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--A---YQHVREDPI-- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H---HHHHHCCCC--
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--H---HHHHhcCCC--
Confidence 764332 22234456899999999999999999999999999999999999999964332111 0 001111100
Q ss_pred ccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003843 701 LIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-TMSDVISMINNE 747 (792)
Q Consensus 701 ~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~evl~~L~~~ 747 (792)
. ........+.++.+++.+||+.||++|| |++++++.|.++
T Consensus 233 --~----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 --P----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --C----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --C----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0 0111122345788999999999999999 899999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=387.50 Aligned_cols=261 Identities=27% Similarity=0.388 Sum_probs=212.3
Q ss_pred HhcCccccceecccCceeEEEEEEc------CCcEEEEEEecccC-chhHHHHHHHHHHHhhc-CCCCcceEeeeeeecC
Q 003843 469 ATENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQG 540 (792)
Q Consensus 469 ~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 540 (792)
..++|++.++||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||++++++.++.
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3578999999999999999999863 35689999997543 34566799999999999 6999999999999999
Q ss_pred eeEEEEEecCCCccceeeeccC---------------CCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEE
Q 003843 541 EKILILEYMPNKSLNVFLFDST---------------KKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNIL 605 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NIL 605 (792)
..++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986432 2235899999999999999999999998 999999999999
Q ss_pred EcCCCCeeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCC-CCCCCCCccccc
Q 003843 606 LDKDMNPKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFN 684 (792)
Q Consensus 606 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~-~p~~~~~~~~~~ 684 (792)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++++ +|+........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999999876544444445578999999999999999999999999999999999954 44433222111
Q ss_pred cccchhhhcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 685 LLGHAWDLWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
+ .++++... ....+...+.++.+|+.+||+.||++||||+||+++|++.
T Consensus 257 ~-------------~~~i~~~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 257 F-------------YKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp H-------------HHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-------------HHHHhcCC-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0 01111111 1112223346789999999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=389.24 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=204.9
Q ss_pred cCccccceecccCceeEEEEEEcC-Cc--EEEEEEeccc-CchhHHHHHHHHHHHhhc-CCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLN-GQ--EVAVKRLSNQ-SGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 545 (792)
++|++.++||+|+||.||+|++++ +. .||||++... .....+.|.+|+++|.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 688999999999999999998754 43 5788888643 344567899999999998 799999999999999999999
Q ss_pred EEecCCCccceeeecc-------------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCe
Q 003843 546 LEYMPNKSLNVFLFDS-------------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNP 612 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~ 612 (792)
|||+++|+|.++|+.. .....+++.++.+++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999998 9999999999999999999
Q ss_pred eecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCC-CCCCCCccccccccchhh
Q 003843 613 KISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKK-NTGVYNADSFNLLGHAWD 691 (792)
Q Consensus 613 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~-p~~~~~~~~~~~~~~~~~ 691 (792)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. |+...+... +..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--~~~---- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYE---- 237 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--HHH----
Confidence 999999998653221 2234568999999999999999999999999999999999765 554332211 111
Q ss_pred hcccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 692 LWKDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
....+. ..+.+...+.++.+|+.+||+.||++||||+||+++|+++.
T Consensus 238 ~i~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 238 KLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011110 11222234568899999999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=383.82 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=202.4
Q ss_pred cceecccCceeEEEEEEcCC----cEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeee-cCeeEEEEEec
Q 003843 476 QCKLGEGGFGPVYKGRLLNG----QEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-QGEKILILEYM 549 (792)
Q Consensus 476 ~~~LG~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~E~~ 549 (792)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999987542 25899999753 55567889999999999999999999999876 45889999999
Q ss_pred CCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCccc
Q 003843 550 PNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDELQ 629 (792)
Q Consensus 550 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 629 (792)
++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998843 3445788899999999999999999998 999999999999999999999999999987544322
Q ss_pred --cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccccc
Q 003843 630 --GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVIM 707 (792)
Q Consensus 630 --~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 707 (792)
.......||+.|+|||.+....++.++||||||+++|||++|+.|+....... ..... ...+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~----i~~g~---------- 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVY----LLQGR---------- 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHH----HHTTC----------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHH----HHcCC----------
Confidence 22234578999999999999999999999999999999999888765422111 11111 01110
Q ss_pred cCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhccC
Q 003843 708 QDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNEH 748 (792)
Q Consensus 708 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~~ 748 (792)
....+.....++.+|+.+||+.||++||+|.||+++|+++.
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 00111223457889999999999999999999999998873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=386.16 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=212.1
Q ss_pred hcCccccceecccCceeEEEEEEc------CCcEEEEEEeccc-CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCee
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL------NGQEVAVKRLSNQ-SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEK 542 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 542 (792)
.++|++.++||+|+||+||+|.+. +++.||||+++.. ..+....|.+|++++++++||||+++++++..+...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 478999999999999999999863 2578999999754 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCccceeeecc-------CCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 543 ILILEYMPNKSLNVFLFDS-------TKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999988542 12234789999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCC-CCCCCCCccccccccchhhhcc
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSK-KNTGVYNADSFNLLGHAWDLWK 694 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 694 (792)
|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|. .|+....... .. ....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~----~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VL----RFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HH----HHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHH
Confidence 999999775554444445567899999999999999999999999999999999985 5664332211 11 0111
Q ss_pred cCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 695 DDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 695 ~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.+.. .+.+...+..+.+++.+||+.+|++||||++|+++|++.
T Consensus 250 ~~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 250 EGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred hCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1110 111222345789999999999999999999999999885
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-44 Score=387.04 Aligned_cols=244 Identities=20% Similarity=0.264 Sum_probs=205.2
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 546 (792)
++|+++++||+|+||.||+|+++ +|+.||||++... .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 58999999999999999999985 6899999998643 2344677899999999999999999999999999999999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGD 626 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~ 626 (792)
||+.+|+|..++.. .+.+++.++..++.||+.||.|||+++ ||||||||+|||++.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999988843 346999999999999999999999998 999999999999999999999999999976432
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
.....||+.|||||++.+..++.++|||||||++|||++|+.||....... .... . ...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~----i--------~~~-- 253 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEK----I--------VSG-- 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH----H--------HHC--
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--HHHH----H--------hcC--
Confidence 334689999999999999999999999999999999999999996432211 1110 0 000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 742 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~ 742 (792)
....+...+.++.+++.+||+.||++|+ |++++++
T Consensus 254 -~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0011222345788999999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-44 Score=376.04 Aligned_cols=251 Identities=23% Similarity=0.288 Sum_probs=204.5
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc---------hhHHHHHHHHHHHhhcC-CCCcceEeeeeeec
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG---------QGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ 539 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 539 (792)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999974 688999999865421 12346889999999997 99999999999999
Q ss_pred CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccccc
Q 003843 540 GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGL 619 (792)
Q Consensus 540 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGl 619 (792)
+..++||||+++|+|.++|.. ++.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999943 446999999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCccccccceeecccceeCcccccC------CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW 693 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~ 693 (792)
++.+.... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||........ . ...
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~----~~i 227 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--L----RMI 227 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--H----HHH
Confidence 99875432 2234679999999999863 3468899999999999999999999975432111 0 000
Q ss_pred ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..+.. .. ..+.....++++.+|+.+||+.||++|||++||+++
T Consensus 228 ~~~~~-~~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNY-QF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCC-CC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCC-CC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11100 00 111122344678999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-44 Score=389.08 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=199.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC---chhHHHHH---HHHHHHhhcCCCCcceEeeeeeecCeeE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS---GQGLKEFK---NEMMLIAKLQHRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 543 (792)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+. +|+.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999975 58999999985421 12223333 4577777888999999999999999999
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
+||||+++|+|.++|.. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999843 456899999999999999999999998 999999999999999999999999999977
Q ss_pred CCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLI 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 702 (792)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+.. . ..
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~--------~~ 222 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M--------TL 222 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---H--------SS
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h--------cc
Confidence 5432 334579999999999975 568999999999999999999999997543322111000 0 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 003843 703 DPVIMQDEISLPMLMRYINVALLCVQENAADRPT-----MSDVISM 743 (792)
Q Consensus 703 ~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~evl~~ 743 (792)
.. ....+...+.++.+|+.+||+.||++||| ++|++++
T Consensus 223 ~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 TM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SC---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cC---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 01112223457899999999999999999 6888753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=379.33 Aligned_cols=261 Identities=25% Similarity=0.281 Sum_probs=195.8
Q ss_pred ccceecccCceeEEEEEEc-CCcEEEEEEecccCc-----hhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 475 MQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG-----QGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 475 ~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.+++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3579999999999999975 589999999864322 1235689999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+.++++..++ .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9998876665 34556899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccchhhhcccCcc---ccccc
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHAWDLWKDDRV---HDLID 703 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~ 703 (792)
......||+.|+|||++... .++.++|||||||++|||++|++||........ ..+............ .....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 22345799999999998754 579999999999999999999999865432111 000000000000000 00000
Q ss_pred cc-c-ccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 704 PV-I-MQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 704 ~~-l-~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. . .....+ .....++.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 0 000011 1224578999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=376.29 Aligned_cols=268 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|+++++||+|+||+||+|+.. +++.||||+++... ....+++.+|+++|++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 58999999999999999999974 68999999996432 2346789999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
|+.++.+.... . .....+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765544332 2 23456999999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------hcccC-c
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD--------LWKDD-R 697 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~-~ 697 (792)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+.... +..... .+... .
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhcccccc
Confidence 2233457999999999987765 58899999999999999999999964432110 000000 00000 0
Q ss_pred ccccccc--ccccCC---CCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003843 698 VHDLIDP--VIMQDE---ISLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 747 (792)
Q Consensus 698 ~~~~~~~--~l~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 747 (792)
....... ...... .......++.+|+.+||+.||++|||++|++++ ++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 000000 011224578899999999999999999999986 6654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=384.87 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=202.8
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc---CchhHHHHHHHHHHHh-hcCCCCcceEeeeeeecCeeEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ---SGQGLKEFKNEMMLIA-KLQHRNLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 545 (792)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999985 5899999999643 2334566777777765 68999999999999999999999
Q ss_pred EEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCC
Q 003843 546 LEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGG 625 (792)
Q Consensus 546 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~ 625 (792)
|||+++|+|.+++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 3345899999999999999999999998 99999999999999999999999999987644
Q ss_pred CccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccccccccc
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPV 705 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 705 (792)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .....
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~----~i~~~--------- 218 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH----SIRMD--------- 218 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHC---------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHH----HHHcC---------
Confidence 32 22344689999999999999999999999999999999999999996433221 110 00000
Q ss_pred cccCCCCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 003843 706 IMQDEISLPMLMRYINVALLCVQENAADRPTMS-DVIS 742 (792)
Q Consensus 706 l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-evl~ 742 (792)
....+...+.++.+|+.+||+.||++||++. |+++
T Consensus 219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0111222345789999999999999999995 6754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=379.39 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=205.0
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
.++|++.+.||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+++..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999985 58899999997643 3345688999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC--CCeeecccccceecCCC
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD--MNPKISDFGLARMFGGD 626 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~--~~~kL~DFGla~~~~~~ 626 (792)
+++|+|.+++.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999998843 2336999999999999999999999998 9999999999999854 57999999999876443
Q ss_pred ccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCcccccccccc
Q 003843 627 ELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVHDLIDPVI 706 (792)
Q Consensus 627 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 706 (792)
. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. ....... .+....
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~----~i~~~~~--~~~~~~ 226 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IE----NIMNAEY--TFDEEA 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHHTCC--CCCHHH
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhCCC--CCChhh
Confidence 2 23446789999999999999999999999999999999999999975432211 00 0000000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 707 MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 707 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 227 -----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 -----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00124568899999999999999999999873
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=380.95 Aligned_cols=252 Identities=17% Similarity=0.213 Sum_probs=198.7
Q ss_pred hcCccccc-eecccCceeEEEEEE-cCCcEEEEEEecccCchhHHHHHHHHHHHhhc-CCCCcceEeeeeee----cCee
Q 003843 470 TENFSMQC-KLGEGGFGPVYKGRL-LNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKL-QHRNLVRLLGCCVE----QGEK 542 (792)
Q Consensus 470 ~~~y~~~~-~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 542 (792)
.++|++.+ .||+|+||+||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36798875 599999999999987 46899999999642 5678899987665 89999999999875 4678
Q ss_pred EEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC---CCCeeeccccc
Q 003843 543 ILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK---DMNPKISDFGL 619 (792)
Q Consensus 543 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~---~~~~kL~DFGl 619 (792)
++||||+++|+|.++|... ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 9999999999999998532 2346999999999999999999999998 999999999999975 46799999999
Q ss_pred ceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 620 ARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 620 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
|+...... ......||+.|||||++.+..++.++|||||||+||||++|+.||........ ..... .
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~--------~ 227 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMK--------T 227 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHH--------H
Confidence 99775433 23346799999999999999999999999999999999999999964332111 00000 0
Q ss_pred ccccccc-ccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 700 DLIDPVI-MQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 700 ~~~~~~l-~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+..... .........+.++.+|+.+||+.||++|||+.|++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000000 0001112235678999999999999999999999884
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-43 Score=371.96 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=202.1
Q ss_pred cCccccceecccCceeEEEEEEcCCcEEEEEEecccC--chhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEEe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQS--GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILEY 548 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 548 (792)
++|+++++||+|+||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++||||+++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999996542 33467899999999999999999999999999999999999
Q ss_pred cCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCcc
Q 003843 549 MPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDEL 628 (792)
Q Consensus 549 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 628 (792)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988777665 34567999999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhh--------hcc----c
Q 003843 629 QGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWD--------LWK----D 695 (792)
Q Consensus 629 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~--------~~~----~ 695 (792)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...... .+. .
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhh
Confidence 22334689999999998764 569999999999999999999999964432111 000000 000 0
Q ss_pred Cccccccc--cccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 696 DRVHDLID--PVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 696 ~~~~~~~~--~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
........ ...............+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 000011112223457889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=370.66 Aligned_cols=241 Identities=22% Similarity=0.341 Sum_probs=195.6
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCc------hhHHHHHHHHHHHhhcC--CCCcceEeeeeeecC
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSG------QGLKEFKNEMMLIAKLQ--HRNLVRLLGCCVEQG 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 540 (792)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999975 689999999864311 12244678999999996 899999999999999
Q ss_pred eeEEEEEecCC-CccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCC-CCeeecccc
Q 003843 541 EKILILEYMPN-KSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKD-MNPKISDFG 618 (792)
Q Consensus 541 ~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~-~~~kL~DFG 618 (792)
..++||||+.+ +++.+++. ++..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 56666663 3456999999999999999999999998 9999999999999855 789999999
Q ss_pred cceecCCCccccccceeecccceeCcccccCCCC-CCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 619 LARMFGGDELQGNTKQIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 619 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... . .. .
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i-------~~-~- 219 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----I-------IR-G- 219 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H-------HH-C-
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----H-------hh-c-
Confidence 998764332 234679999999999987765 5779999999999999999999863210 0 00 0
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
. ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus 220 -------~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 -------Q---VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -------C---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------c---cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 00111123578899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=367.86 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=197.9
Q ss_pred hcCccccceecccCceeEEEEEEc-C-CcEEEEEEecccC--chhHHHHHHHHHHHhhc---CCCCcceEeeeeee----
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-N-GQEVAVKRLSNQS--GQGLKEFKNEMMLIAKL---QHRNLVRLLGCCVE---- 538 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 538 (792)
.++|+++++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999974 4 5679999986432 22234566777777665 79999999999863
Q ss_pred -cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeeccc
Q 003843 539 -QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDF 617 (792)
Q Consensus 539 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DF 617 (792)
....+++|||++++.+.... ......+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 34689999999998775443 234456899999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-ccccch-----hh
Q 003843 618 GLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NLLGHA-----WD 691 (792)
Q Consensus 618 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~~~~~-----~~ 691 (792)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+... ..
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 999865332 233456899999999999999999999999999999999999999975432111 000000 00
Q ss_pred hcccCc-c-ccccccc--cccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 LWKDDR-V-HDLIDPV--IMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 ~~~~~~-~-~~~~~~~--l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.+.... . ....... .............+.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 0 0000000 00011122234578899999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=362.75 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=198.3
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee--------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE-------- 538 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 538 (792)
-++|+++++||+|+||+||+|+.. +|+.||||++... .+...+++.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999974 6899999998543 33456788999999999999999999999865
Q ss_pred cCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccc
Q 003843 539 QGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFG 618 (792)
Q Consensus 539 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFG 618 (792)
+...++||||+.++.+..+. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34679999999988776554 33456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCccc--cccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchhh---
Q 003843 619 LARMFGGDELQ--GNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAWD--- 691 (792)
Q Consensus 619 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~~--- 691 (792)
+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99877543322 222335799999999999765 6899999999999999999999998643321110 0000000
Q ss_pred -----hcccCccccccccccccCCCCHH-------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 692 -----LWKDDRVHDLIDPVIMQDEISLP-------MLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 692 -----~~~~~~~~~~~~~~l~~~~~~~~-------~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
..........+.... ....... ....+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000110000 1111111 13467889999999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=366.36 Aligned_cols=261 Identities=22% Similarity=0.257 Sum_probs=195.8
Q ss_pred CccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceEeeeeeec------CeeEE
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ------GEKIL 544 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 544 (792)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|+++|++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888999999999999999985 589999999975432 234799999999999999999998643 24789
Q ss_pred EEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-Ceeecccccceec
Q 003843 545 ILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMF 623 (792)
Q Consensus 545 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~ 623 (792)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755544433344567999999999999999999999998 99999999999999775 8999999999877
Q ss_pred CCCccccccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-ccc--------chhhhc
Q 003843 624 GGDELQGNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLG--------HAWDLW 693 (792)
Q Consensus 624 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~--------~~~~~~ 693 (792)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... .+. ..+...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 54432 233579999999998875 56899999999999999999999999654421110 000 000000
Q ss_pred ----ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 ----KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ----~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
............. ..........++.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCG-GGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCch-hhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000 011122234578899999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=365.51 Aligned_cols=267 Identities=20% Similarity=0.277 Sum_probs=198.1
Q ss_pred hcCccccceecccCceeEEEEEE-cCCcEEEEEEecccC-chhHHHHHHHHHHHhhcCCCCcceEeeeeeecC----eeE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRL-LNGQEVAVKRLSNQS-GQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG----EKI 543 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 543 (792)
+++|+++++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999987 469999999997543 345678999999999999999999999987654 345
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceec
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMF 623 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~ 623 (792)
++++++.+|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6667788999999984 235999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCccc-cccceeecccceeCcccccC-CCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-ccchhhhcccC----
Q 003843 624 GGDELQ-GNTKQIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-LGHAWDLWKDD---- 696 (792)
Q Consensus 624 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~---- 696 (792)
...... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||.......... ...........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 543222 22345679999999999854 567899999999999999999999986543211100 00000000000
Q ss_pred ----ccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 697 ----RVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 697 ----~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
...............+ .....++.+|+.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000111 1123468899999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-41 Score=355.86 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=196.5
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcceE-eeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLVRL-LGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||.||+|++. +|+.||||++..... .+++..|+++++.++|+|++.. .++..++...++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 357999999999999999999874 588999999865432 2457889999999987776554 555567778899999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEc---CCCCeeecccccceecC
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLD---KDMNPKISDFGLARMFG 624 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~---~~~~~kL~DFGla~~~~ 624 (792)
|+.+ +|...+. ...+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 84 ~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EcCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9954 5544442 23456999999999999999999999998 99999999999985 45579999999999875
Q ss_pred CCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 625 GDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 625 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
..... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~---~~~~-- 232 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI---SEKK-- 232 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH---HHHH--
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh---hccc--
Confidence 43221 2234568999999999999999999999999999999999999999754432211110000 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
.... ........+.++.+++..||+.+|++||+++++.+.|+..
T Consensus 233 --~~~~--~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 233 --MSTP--IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHSC--HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred --CCCC--hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 0001112235788999999999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-40 Score=356.69 Aligned_cols=257 Identities=20% Similarity=0.316 Sum_probs=197.9
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeec--CeeEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQ--GEKILIL 546 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 546 (792)
++|+++++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 68999999999999999999984 6899999999753 3467899999999995 99999999998754 5689999
Q ss_pred EecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCC-CeeecccccceecCC
Q 003843 547 EYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDM-NPKISDFGLARMFGG 625 (792)
Q Consensus 547 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~-~~kL~DFGla~~~~~ 625 (792)
||+++++|..+. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997654 35899999999999999999999999 99999999999998765 589999999997754
Q ss_pred CccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccc--------hhhhc---
Q 003843 626 DELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGH--------AWDLW--- 693 (792)
Q Consensus 626 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~--------~~~~~--- 693 (792)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............. .....
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 33 23345789999999998775 47999999999999999999999987544321110000 00000
Q ss_pred c---cCcccccc-------ccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 003843 694 K---DDRVHDLI-------DPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVIS 742 (792)
Q Consensus 694 ~---~~~~~~~~-------~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~ 742 (792)
. ........ ...............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000 0001111112223457889999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=363.99 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=195.8
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecC------
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQG------ 540 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 540 (792)
.++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999975 5899999999753 3445678899999999999999999999997654
Q ss_pred eeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccc
Q 003843 541 EKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLA 620 (792)
Q Consensus 541 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla 620 (792)
..++||||+ +.+|..++ +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 55666655 3346999999999999999999999999 999999999999999999999999999
Q ss_pred eecCCCccccccceeecccceeCcccccCC-CCCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccc--------hh
Q 003843 621 RMFGGDELQGNTKQIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGH--------AW 690 (792)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~--------~~ 690 (792)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+..... .... ..
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876433 2345789999999998764 5689999999999999999999998654321110 0000 00
Q ss_pred hhcccCc-------cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003843 691 DLWKDDR-------VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM--INNE 747 (792)
Q Consensus 691 ~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~--L~~~ 747 (792)
....... ..+.....+ ..........+.+|+.+||+.||++|||++|++++ |+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 000000000 01112234567899999999999999999999986 5554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=352.21 Aligned_cols=264 Identities=21% Similarity=0.271 Sum_probs=204.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeecCeeEEEEE
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 547 (792)
++|+++++||+|+||+||+|++. +++.||||+++.. .....+++.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 58999999999999999999975 6889999998543 33456889999999999999999999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccceecCCCc
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLARMFGGDE 627 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~ 627 (792)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999887763 4456899999999999999999999998 9999999999999999999999999999875433
Q ss_pred cccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhc-------------
Q 003843 628 LQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLW------------- 693 (792)
Q Consensus 628 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~------------- 693 (792)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||........ .........
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChhhhhhhhh
Confidence 2 222345788999999987765 68999999999999999999999743222111 110000000
Q ss_pred -ccCccccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 -KDDRVHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 -~~~~~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.........................+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000111222334578899999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-40 Score=351.41 Aligned_cols=261 Identities=17% Similarity=0.225 Sum_probs=204.4
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcCC-CCcceEeeeeeecCeeEEEEE
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGEKILILE 547 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 547 (792)
.++|++.++||+|+||+||+|++. +|+.||||++..... .+.+.+|+++++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999975 588999999865432 2457789999999965 899999999999999999999
Q ss_pred ecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcC-----CCCeeeccccccee
Q 003843 548 YMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDK-----DMNPKISDFGLARM 622 (792)
Q Consensus 548 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~-----~~~~kL~DFGla~~ 622 (792)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6888888743 3346899999999999999999999999 999999999999974 57899999999998
Q ss_pred cCCCccc-----cccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCc
Q 003843 623 FGGDELQ-----GNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDR 697 (792)
Q Consensus 623 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 697 (792)
+...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||............ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~---~~i~~~~ 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---ERIGEKK 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH---HHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH---HHHHhcc
Confidence 7543211 1234468999999999999999999999999999999999999999754432211100 0000000
Q ss_pred cccccccccccCCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003843 698 VHDLIDPVIMQDEISLPMLMRYINVALLCVQENAADRPTMSDVISMINNE 747 (792)
Q Consensus 698 ~~~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~L~~~ 747 (792)
..... +.+ ....+.++.+++..|++.+|++||+++.+.+.|++.
T Consensus 233 ~~~~~-~~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 233 QSTPL-REL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHSCH-HHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCCCh-HHh-----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00000 000 111235688999999999999999999998888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=356.49 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=201.2
Q ss_pred cCccccceecccCceeEEEEEEc----CCcEEEEEEeccc----CchhHHHHHHHHHHHhhcCC-CCcceEeeeeeecCe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL----NGQEVAVKRLSNQ----SGQGLKEFKNEMMLIAKLQH-RNLVRLLGCCVEQGE 541 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 541 (792)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999862 4789999998543 22345678899999999966 899999999999999
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.+++|||+.+|+|.+++.. .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999843 345788999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCC--CCCCcCceeehhHHHHHHHhCCCCCCCCCccccccccchhhhcccCccc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNLLGHAWDLWKDDRVH 699 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 699 (792)
.+...... ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... ....
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~------- 247 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRR------- 247 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHH-------
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHh-------
Confidence 76543322 23345789999999999765 468899999999999999999999975443221100 0000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003843 700 DLIDPVIMQDEISLPMLMRYINVALLCVQENAADRP-----TMSDVIS 742 (792)
Q Consensus 700 ~~~~~~l~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~evl~ 742 (792)
.... ..+.+.....++.+++.+||+.||++|| |++|+++
T Consensus 248 -~~~~---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 -ILKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -HHHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -cccC---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 1122233456889999999999999999 4788876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-39 Score=351.49 Aligned_cols=261 Identities=23% Similarity=0.253 Sum_probs=191.4
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeee------cCe
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVE------QGE 541 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 541 (792)
++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999986 5899999999654 34455678999999999999999999999964 367
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.|+||||+.++.+..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999876665432 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccccc-c-----cchhhhc--
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSFNL-L-----GHAWDLW-- 693 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~~-~-----~~~~~~~-- 693 (792)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+...... + ......+
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 764432 2344578999999999999999999999999999999999999986443211100 0 0000000
Q ss_pred ---------cc------Ccccccccccccc--CCCCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 694 ---------KD------DRVHDLIDPVIMQ--DEISLPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 694 ---------~~------~~~~~~~~~~l~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.. ............. .........++.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000011111100 01122346788999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=354.08 Aligned_cols=262 Identities=25% Similarity=0.324 Sum_probs=195.7
Q ss_pred hcCccccceecccCceeEEEEEEc-CCcEEEEEEeccc--CchhHHHHHHHHHHHhhcCCCCcceEeeeeeec-----Ce
Q 003843 470 TENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQ--SGQGLKEFKNEMMLIAKLQHRNLVRLLGCCVEQ-----GE 541 (792)
Q Consensus 470 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 541 (792)
.++|+++++||+|+||+||+|+.. +|+.||||+++.. .....+++.+|+++|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999874 6999999999754 334556789999999999999999999998643 34
Q ss_pred eEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeecccccce
Q 003843 542 KILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKISDFGLAR 621 (792)
Q Consensus 542 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~ 621 (792)
.++++||+.+|+|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999883 345999999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCccccccceeecccceeCcccccCCC-CCCcCceeehhHHHHHHHhCCCCCCCCCccccc-cccchh-----hhcc
Q 003843 622 MFGGDELQGNTKQIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSKKNTGVYNADSFN-LLGHAW-----DLWK 694 (792)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwSlGvll~elltg~~p~~~~~~~~~~-~~~~~~-----~~~~ 694 (792)
.... ......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||...+..... .+.... ....
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 6532 233457899999999877754 689999999999999999999998644321110 000000 0000
Q ss_pred ---cCccccccccccccCCCC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 003843 695 ---DDRVHDLIDPVIMQDEIS-----LPMLMRYINVALLCVQENAADRPTMSDVISM 743 (792)
Q Consensus 695 ---~~~~~~~~~~~l~~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~evl~~ 743 (792)
.................. .....++.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000000011 1124568899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-35 Score=322.64 Aligned_cols=264 Identities=18% Similarity=0.254 Sum_probs=194.3
Q ss_pred cCccccceecccCceeEEEEEEc-CCcEEEEEEecccCchhHHHHHHHHHHHhhcC-----------CCCcceEeeeeee
Q 003843 471 ENFSMQCKLGEGGFGPVYKGRLL-NGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-----------HRNLVRLLGCCVE 538 (792)
Q Consensus 471 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 538 (792)
.+|+++++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999974 6899999999754 234567888999998875 4789999988865
Q ss_pred c--CeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCcEEEcCCCC----
Q 003843 539 Q--GEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQ-YSRFRIIHRDLKASNILLDKDMN---- 611 (792)
Q Consensus 539 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~ivH~Dlkp~NILl~~~~~---- 611 (792)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4667777777665544443344555678999999999999999999998 76 999999999999987654
Q ss_pred --eeecccccceecCCCccccccceeecccceeCcccccCCCCCCcCceeehhHHHHHHHhCCCCCCCCCcccc-cc---
Q 003843 612 --PKISDFGLARMFGGDELQGNTKQIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSKKNTGVYNADSF-NL--- 685 (792)
Q Consensus 612 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwSlGvll~elltg~~p~~~~~~~~~-~~--- 685 (792)
+||+|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||........ ..
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 999999999865322 2345799999999999999999999999999999999999999864332110 00
Q ss_pred ccchhh------------------hcccCcccccccc---------ccccCCCCHHHHHHHHHHHHhccccCCCCCCCHH
Q 003843 686 LGHAWD------------------LWKDDRVHDLIDP---------VIMQDEISLPMLMRYINVALLCVQENAADRPTMS 738 (792)
Q Consensus 686 ~~~~~~------------------~~~~~~~~~~~~~---------~l~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 738 (792)
...... ..........+.. .............++.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 000000 0000000000000 0012233456778899999999999999999999
Q ss_pred HHHHH
Q 003843 739 DVISM 743 (792)
Q Consensus 739 evl~~ 743 (792)
|++++
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.6e-22 Score=196.71 Aligned_cols=164 Identities=17% Similarity=0.201 Sum_probs=121.9
Q ss_pred cccceecccCceeEEEEEEcCCcEEEEEEecccCc------------------hhHHHHHHHHHHHhhcCCCCcceEeee
Q 003843 474 SMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSG------------------QGLKEFKNEMMLIAKLQHRNLVRLLGC 535 (792)
Q Consensus 474 ~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 535 (792)
.+.++||+|+||+||+|+..+|+.||||+++.... .....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 46789999999999999998999999998753110 112345678899999999999988765
Q ss_pred eeecCeeEEEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCcEEEcCCCCeeec
Q 003843 536 CVEQGEKILILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQYSRFRIIHRDLKASNILLDKDMNPKIS 615 (792)
Q Consensus 536 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH~Dlkp~NILl~~~~~~kL~ 615 (792)
. ..+++|||+++..+.. ++......++.|++++|+|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998866533 344556689999999999999998 9999999999999865 48999
Q ss_pred ccccceecCCCccccccceeecccceeCcc-----cccCCCCCCcCceeehhHHH
Q 003843 616 DFGLARMFGGDELQGNTKQIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILM 665 (792)
Q Consensus 616 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~s~~~DVwSlGvll 665 (792)
|||+|.....+... .|.... ......|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99999876433211 111110 01235678899999976444
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=1.2e-21 Score=173.32 Aligned_cols=112 Identities=24% Similarity=0.416 Sum_probs=96.6
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
+|||.|||.|..|+.|+| |.|.|+|+.+|+ |.|+.. .++||.||++.|.. .+.|.|+.||+|||+++
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCTTSCS--SEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEcC---CcEEEEccCccCCC--CcEEEEeccccEEEEec-
Confidence 489999999999999985 899999999996 777763 48999999998743 56899999999999996
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCCCcc
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDYPTD 154 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~Ptd 154 (792)
+.++|++++........|+|+|+|||||++.++ .++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~-----~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTS-----CEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCCC-----cEEecCCCccCC
Confidence 577888887766566789999999999998765 689999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.84 E-value=3.3e-21 Score=168.81 Aligned_cols=107 Identities=24% Similarity=0.357 Sum_probs=93.5
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
.|+|.+||.|..|+.|. +|.|.|+|+.+|+ |.||.. .++||.||++.|. +.+.|.|+.+|+|+|++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~~---~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYDV---DKPIWATNTGGLS--RSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEET---TEEEEECCCTTSC--SSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEeC---CceeeEeCCCCCC--CccEEEEeccceEEEECCC
Confidence 37899999999999995 6999999999997 888764 4889999999874 3568999999999999999
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCC
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (792)
|.+||++++.......+|+|+|||||||++. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987666667889999999999962 38999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.84 E-value=7.6e-21 Score=166.54 Aligned_cols=108 Identities=20% Similarity=0.353 Sum_probs=93.4
Q ss_pred ccccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCC
Q 003843 25 ADTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQT 104 (792)
Q Consensus 25 ~~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (792)
.|+|.|||.|.+|+.|.+ |.|.|+|..+|+ |.++.. .++||+||++.|... .+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~~---~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYDH---STSVWASNTGILGKK-GCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET---TEEEEECCCCCTTCC-CCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEeC---CEEEEEeCCCCCCce-eEEEEEcCCceEEEEeCC
Confidence 378999999999999974 889999998886 667643 489999999999865 678999999999999999
Q ss_pred CceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccCC
Q 003843 105 NGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFDY 151 (792)
Q Consensus 105 ~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd~ 151 (792)
|.+||+|+++.......|+|+|||||||++ ..+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEEC--------CEEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEEC--------CCEecCCCc
Confidence 999999998765566789999999999995 249999864
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=3.3e-16 Score=138.93 Aligned_cols=82 Identities=21% Similarity=0.336 Sum_probs=71.2
Q ss_pred EEEeccCC-CeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCc
Q 003843 63 GIRFQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNAT 141 (792)
Q Consensus 63 ~iw~~~~~-~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~ 141 (792)
-|||.+++ ++.+|++|++.|+....-+|.|+.||||||++. +.++|++++...+....|.|+++|||||++.++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~---- 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN---- 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCC----
Confidence 58998887 599999999999988777899999999999985 678999998876667789999999999999776
Q ss_pred ccccccccC
Q 003843 142 ESYLWQSFD 150 (792)
Q Consensus 142 ~~~~WqSFd 150 (792)
.++||||.
T Consensus 86 -~~lW~S~t 93 (120)
T d1dlpa2 86 -IAVWTSGN 93 (120)
T ss_dssp -EEEEECCC
T ss_pred -CEEEEeCC
Confidence 78999983
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.62 E-value=1.2e-15 Score=134.76 Aligned_cols=103 Identities=18% Similarity=0.350 Sum_probs=83.8
Q ss_pred cccCCCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCC
Q 003843 26 DTVTPASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTN 105 (792)
Q Consensus 26 ~~~~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~ 105 (792)
++|.++|+| .+.+..|.|.|.|..+|+ |.++ . +.++||.||+..+. ....|.|+.||+|+|+|++|
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVLy-~--~~~~vWssnt~~~~--~~~~l~l~~dGnLvL~d~~g 80 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVLY-D--NNNPIWATNTGGLG--NGCRAVLQPDGVLVVITNEN 80 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEEE-E--TTEEEEECCCTTSC--SSCEEEECTTSCEEEECTTC
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEEE-E--CCeEEEEecCCCCC--cceEEEEEeCCCEEEECCCC
Confidence 455555555 346789999999999997 6664 2 35899999998764 35789999999999999999
Q ss_pred ceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccC
Q 003843 106 GTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (792)
Q Consensus 106 ~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (792)
.+||++++........++|+|||||||++ ..+|||-.
T Consensus 81 ~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T 117 (119)
T d1b2pa_ 81 VTVWQSPVAGKAGHYVLVLQPDRNVVIYG--------DALWATQT 117 (119)
T ss_dssp CEEEECSCCCCSSCEEEEECTTSCEEEEE--------SEEEECCC
T ss_pred cEEEECCCcCCCCceEEEEcCCCCEEEEC--------CCEeccCC
Confidence 99999998766666678999999999995 35999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.43 E-value=6.4e-14 Score=122.61 Aligned_cols=98 Identities=23% Similarity=0.354 Sum_probs=78.7
Q ss_pred ccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCCceEEEe
Q 003843 32 SFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWST 111 (792)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst 111 (792)
|.|..++.| .+|.|.|.|..+|+ |.++. +.++||.+|...+ ..+.|.|..||||||+|.++.+||++
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEEEEc
Confidence 444555555 46789999999997 87865 3578999997542 36789999999999999999999999
Q ss_pred ccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccccC
Q 003843 112 NVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQSFD 150 (792)
Q Consensus 112 ~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqSFd 150 (792)
.+.......+++|++||||||++ ..+|+|-.
T Consensus 82 ~t~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt 112 (115)
T d1dlpa1 82 GTKGSIGNYVLVLQPDRTVTIYG--------PGLWDSGT 112 (115)
T ss_dssp CCCCCSSCCEEEECSSSCEEEEC--------SEEEECSC
T ss_pred CCCCCCCCEEEEECCCCcEEEeC--------CCeecCCC
Confidence 98766667789999999999994 35899853
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.32 E-value=4e-13 Score=117.44 Aligned_cols=80 Identities=23% Similarity=0.332 Sum_probs=67.0
Q ss_pred EEeccCC-CeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcc
Q 003843 64 IRFQQIP-DAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATE 142 (792)
Q Consensus 64 iw~~~~~-~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~ 142 (792)
|||.-.+ .+..|+.+.+.++.+...+|.|+.||||||++ .+.++|++++.+ ..+..+.|+++|||||++.++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~~----- 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQN----- 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTTT-----
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCC-CCceEEEEeccCCEEEEccCC-----
Confidence 6665443 47779999999998877889999999999998 578999999864 446788999999999998776
Q ss_pred cccccccC
Q 003843 143 SYLWQSFD 150 (792)
Q Consensus 143 ~~~WqSFd 150 (792)
.+||||+-
T Consensus 76 ~~vWsS~t 83 (115)
T d1dlpa1 76 TIRWSSGT 83 (115)
T ss_dssp CCSCCCCC
T ss_pred CEEEEcCC
Confidence 78999873
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.21 E-value=1.5e-11 Score=108.50 Aligned_cols=99 Identities=21% Similarity=0.318 Sum_probs=76.5
Q ss_pred CCccccCCCeeeecCCeEEEeEEcCCCCCceEEEEEeccCCCeEEEEecCCCCCCCCCceEEEeeCCcEEEEcCCCceEE
Q 003843 30 PASFIRDGEKLVSSSQRFELGFFSPGKSKSRYLGIRFQQIPDAVVWVANRDRPISDNNAVLTISNNGNLVLLNQTNGTIW 109 (792)
Q Consensus 30 ~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~y~~iw~~~~~~t~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (792)
+.+.|..++.| ..|.|.|.|...|+ |.|+. +..+||.+|.. .......+.|..+|||||+|.++.++|
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~--~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTA--GKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCC--SSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEccc--cCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 34555555555 35779999988885 77764 24778998853 334467899999999999999999999
Q ss_pred EeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 110 STNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 110 st~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
++++........++|++|||||||+ ..+|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~--------~~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYG--------GALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEEC--------CCCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeC--------CCcccC
Confidence 9998766666788999999999994 238976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.78 E-value=1e-08 Score=89.52 Aligned_cols=54 Identities=35% Similarity=0.540 Sum_probs=46.6
Q ss_pred eEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 89 VLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 89 ~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.|.|..||||||+++ +.++|++++.+......+.|+++|||||++.++ .++|+|
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g-----~~vWsS 86 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQS 86 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEEC
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCC-----cEEEEC
Confidence 589999999999975 578999998866667789999999999999776 689975
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.77 E-value=1.2e-08 Score=87.87 Aligned_cols=56 Identities=30% Similarity=0.575 Sum_probs=48.2
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.-+|.++.||||||++ .+.+||++++...+....+.|+++|||||++.++ .++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g-----~~vWsS 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSN-----KPIWAS 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEEC
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCc-----cceEEc
Confidence 4569999999999998 5689999998876666789999999999998776 789976
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.67 E-value=5.2e-08 Score=84.46 Aligned_cols=49 Identities=33% Similarity=0.607 Sum_probs=41.9
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCCCcceEEEecCCcEEEeeCC
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEVKNPVAQLRDDGNLVIRDNS 136 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~~~~~~~l~d~GNlvl~~~~ 136 (792)
.-.|.|+.||||||++ .+.+||+++......++.+.|+.+|||||++..
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~ 68 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS 68 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC
Confidence 4579999999999997 568999999876666678899999999999853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2.4e-07 Score=93.18 Aligned_cols=149 Identities=16% Similarity=0.115 Sum_probs=105.9
Q ss_pred HHHHHhcCccccceecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcC-CCCcceEeeeeeecCeeE
Q 003843 465 SITAATENFSMQCKLGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQ-HRNLVRLLGCCVEQGEKI 543 (792)
Q Consensus 465 ~i~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 543 (792)
++...-+.|++.+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3445567888777665555678998864 56778899887655555556788988888774 434567788888888899
Q ss_pred EEEEecCCCccceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 003843 544 LILEYMPNKSLNVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY---------------------------------- 589 (792)
Q Consensus 544 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------------------------------- 589 (792)
+||+++++.++.+... +......++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~--------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTT--------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccc--------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999988754431 1112234566666777777742
Q ss_pred ----------------------CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 590 ----------------------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 590 ----------------------~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
....++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 012279999999999999877677999998863
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.31 E-value=3.5e-07 Score=78.45 Aligned_cols=56 Identities=30% Similarity=0.509 Sum_probs=46.3
Q ss_pred CceEEEeeCCcEEEEcCCCceEEEeccCCCC-CcceEEEecCCcEEEeeCCCCCCcccccccc
Q 003843 87 NAVLTISNNGNLVLLNQTNGTIWSTNVSSEV-KNPVAQLRDDGNLVIRDNSSGNATESYLWQS 148 (792)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~wst~~~~~~-~~~~~~l~d~GNlvl~~~~~~~~~~~~~WqS 148 (792)
.-.|.|..||||||++ .+.+||++++.... ....+.|+++|||||++.++ .++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~s 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-----RSLWAS 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS-----CEEEEC
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC-----cEEEEE
Confidence 4568999999999997 56899999887543 35678999999999999776 789987
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=4.5e-05 Score=75.42 Aligned_cols=131 Identities=18% Similarity=0.181 Sum_probs=89.2
Q ss_pred eecccCc-eeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCC--CCcceEeeeeeecCeeEEEEEecCCCcc
Q 003843 478 KLGEGGF-GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQH--RNLVRLLGCCVEQGEKILILEYMPNKSL 554 (792)
Q Consensus 478 ~LG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL 554 (792)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++.+..+++..++|||+++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 678999887788899998755432 346678888877743 3356678887888889999999998776
Q ss_pred ceeeeccCCCccCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 003843 555 NVFLFDSTKKRLLNWQARVRIIEGIAQGLLYLHQY--------------------------------------------- 589 (792)
Q Consensus 555 ~~~l~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------------- 589 (792)
.+.. +.. ...+.++++.|+-||..
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4432 111 12233444445555521
Q ss_pred ----------CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 590 ----------SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 590 ----------~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
.+..++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 112379999999999999877678999998863
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.41 E-value=0.00018 Score=76.00 Aligned_cols=75 Identities=11% Similarity=0.150 Sum_probs=48.7
Q ss_pred ceecccCceeEEEEEEcC-CcEEEEEEeccc-------CchhHHHHHHHHHHHhhcC-C-C-CcceEeeeeeecCeeEEE
Q 003843 477 CKLGEGGFGPVYKGRLLN-GQEVAVKRLSNQ-------SGQGLKEFKNEMMLIAKLQ-H-R-NLVRLLGCCVEQGEKILI 545 (792)
Q Consensus 477 ~~LG~G~fg~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lv 545 (792)
+.||.|....||+....+ ++.++||.-... .+...++...|.+.|+.+. + | .+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998654 678999975321 1123345567888887762 3 3 34445443 55567899
Q ss_pred EEecCCCc
Q 003843 546 LEYMPNKS 553 (792)
Q Consensus 546 ~E~~~~gs 553 (792)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0018 Score=66.27 Aligned_cols=135 Identities=13% Similarity=0.114 Sum_probs=79.3
Q ss_pred eeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc--ceEe-----eeeeecCeeEEEEEecCCCcccee
Q 003843 485 GPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLL-----GCCVEQGEKILILEYMPNKSLNVF 557 (792)
Q Consensus 485 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~gsL~~~ 557 (792)
-.||+++..+|+.+++|+.+.. ....+++..|...+..|....+ +..+ ..+..++..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999989999999998653 2345677888888888753322 1111 122345667889999987654321
Q ss_pred e--------------ec------cCCCccCCH-------------------HHHHHHHHHHHHHHHHHHhc----CCCce
Q 003843 558 L--------------FD------STKKRLLNW-------------------QARVRIIEGIAQGLLYLHQY----SRFRI 594 (792)
Q Consensus 558 l--------------~~------~~~~~~l~~-------------------~~~~~i~~~ia~aL~yLH~~----~~~~i 594 (792)
- +. ......++. .....+...+.+.++.+... .+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 00 000111111 11112222223333333322 23458
Q ss_pred eecCCCCCcEEEcCCCCeeeccccccee
Q 003843 595 IHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 595 vH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.0031 Score=66.19 Aligned_cols=76 Identities=20% Similarity=0.305 Sum_probs=51.4
Q ss_pred CccccceecccCceeEEEEEEcCC--------cEEEEEEecccCchhHHHHHHHHHHHhhcCCCCcc-eEeeeeeecCee
Q 003843 472 NFSMQCKLGEGGFGPVYKGRLLNG--------QEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNLV-RLLGCCVEQGEK 542 (792)
Q Consensus 472 ~y~~~~~LG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~ 542 (792)
.+++ +.|+.|--=.+|+....++ +.|.+++... ... .-...+|..+++.+.-.++. ++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3443 6788888889999987543 4577777653 222 23456899999988544554 67776643
Q ss_pred EEEEEecCCCcc
Q 003843 543 ILILEYMPNKSL 554 (792)
Q Consensus 543 ~lv~E~~~~gsL 554 (792)
.+|+||+++..|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 688999987655
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.24 E-value=0.11 Score=51.77 Aligned_cols=158 Identities=13% Similarity=0.050 Sum_probs=81.1
Q ss_pred cHHHHHHHhcCccccce-----ecccCceeEEEEEEcCCcEEEEEEecccCchhHHHHHHHHHHHhhcCCCCc--ceEee
Q 003843 462 SLASITAATENFSMQCK-----LGEGGFGPVYKGRLLNGQEVAVKRLSNQSGQGLKEFKNEMMLIAKLQHRNL--VRLLG 534 (792)
Q Consensus 462 ~~~~i~~~~~~y~~~~~-----LG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~ 534 (792)
+.+++.....+|.+.+. |..|---+.|+.+..+| .+++|+..... ..+++..|++++..+.+.++ ...+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 34555666677766443 44666678899987655 58999986432 22344556667776643222 11111
Q ss_pred ------eeeecCeeEEEEEecCCCccceeeec--------------------cCCCccC------------------CHH
Q 003843 535 ------CCVEQGEKILILEYMPNKSLNVFLFD--------------------STKKRLL------------------NWQ 570 (792)
Q Consensus 535 ------~~~~~~~~~lv~E~~~~gsL~~~l~~--------------------~~~~~~l------------------~~~ 570 (792)
+.........++.+..+......-.. ....... ...
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11223455667777766543221100 0000000 001
Q ss_pred HHHHHHHHHHHHHHHHHhc-CCCceeecCCCCCcEEEcCCCCeeeccccccee
Q 003843 571 ARVRIIEGIAQGLLYLHQY-SRFRIIHRDLKASNILLDKDMNPKISDFGLARM 622 (792)
Q Consensus 571 ~~~~i~~~ia~aL~yLH~~-~~~~ivH~Dlkp~NILl~~~~~~kL~DFGla~~ 622 (792)
.....+..+...+.-.+.. -+..+||+|+.++||+++.+...-|+||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 1111222222222222211 123499999999999999887778999998863
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.84 E-value=0.038 Score=34.57 Aligned_cols=33 Identities=30% Similarity=0.561 Sum_probs=26.4
Q ss_pred CCcCCCCCCCCCCcccCCC-CCCCccccCCccccC
Q 003843 243 DQYCGKYGYCGANTICSLD-QKPMCECLEGFKLES 276 (792)
Q Consensus 243 ~~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 276 (792)
.|.|.+-..|| ||.|++- ..-.|.|-+||+|..
T Consensus 1 tdECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 1 TDECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CCGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CCccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 36799999998 6889754 445799999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.83 E-value=0.16 Score=33.90 Aligned_cols=31 Identities=23% Similarity=0.509 Sum_probs=24.1
Q ss_pred CcCCC-CCCCCCCcccCCC-CCCCccccCCccc
Q 003843 244 QYCGK-YGYCGANTICSLD-QKPMCECLEGFKL 274 (792)
Q Consensus 244 ~~C~~-~g~CG~~g~C~~~-~~~~C~C~~Gf~~ 274 (792)
|.|.. ...|..+|.|... .+-.|.|++||+-
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTG 36 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEES
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcC
Confidence 56764 4789999999765 4568999999973
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.96 E-value=0.34 Score=31.59 Aligned_cols=31 Identities=29% Similarity=0.638 Sum_probs=23.7
Q ss_pred CcCCCCCCCCCCcccCCC-CCCCccccCCcccc
Q 003843 244 QYCGKYGYCGANTICSLD-QKPMCECLEGFKLE 275 (792)
Q Consensus 244 ~~C~~~g~CG~~g~C~~~-~~~~C~C~~Gf~~~ 275 (792)
|.|. ...|...|.|... ..-.|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 4778889999765 46789999999754
|